14,The participants and field researchers assessing patient outcomes were blinded to the identity of practices that participated in the educational intervention.
0,Ovarian adhesions will be diagnosed in women with evidence of restricted ovarian mobility on targeted palpation using transvaginal ultrasound probe [14].
14,Statistical analysis follows a pre-specified analysis plan.
0,"The rationale for providing these items was to assure that the participants had appropriate shoes, clothes, and accessories to aid their comfort and confidence during their exercise sessions."
1,"This is an observer-blind prospective, controlled and randomised parallel group study."
0,"Binomial tests of equality were used to assess differences at baseline for categorical variables.Participants were also divided into four equal groups based on the magnitude of the change they made in low GI fruit intake, expressed as a percentage of daily available carbohydrate from fruit The significance of differences between those in the upper quartile of change in low GI fruit intake vs those in the lowest quartile was assessed using an ANOVA model (Proc GLM in SAS version 9.2) [20], with percentage change in measurements as the response variable.Finally, to assess the contribution of low GI fruit to the absolute change in HbA1c, as the primary outcome in the context of the other major low GI food components, a regression analysis was undertaken in SAS using an ANOVA model."
8,"A trial with 20 patients in each treatment group will provide us with a power (1-β) of 80% to detect a relative reduction in number of patients with persisting PDPH after 24 hours of 50% (OR = 12) and a power of 99% to detect a relative risk reduction of 80%, (OR = 81, at the usual significance level α = 5%, taking into account that in approximately 10% of the patients the PDPH will have resolved spontaneously after one day."
0,DNA was stored in −80 °C until testing.
1,"The study is a (prospective) cluster-randomized, open, three-armed intervention study."
0,Biochemical analyses on human muscle samples were performed as single-blind tests.
1,The design of a cluster randomized study was chosen because this has optimal internal validity (absence of confounders) while avoiding contamination of interventions associated with patient randomization.
0,Statistical differences within quantitative parameters were determined by Wilcoxon rank-test (non-parametric test) for two samples.
8,"Based on a power of 80% and a Type I error rate of α = 0.052-tailed, a sample size of 80 participants per group was required to detect an estimated important difference of 2 between the treatment arms, in the change in WOMAC pain dimension score from baseline to final (with standard deviation of 4.5)."
0,"Left atrial diameter and area as well as calculation of the left ventricular ejection fraction were performed by using the Simpson biplane method [17,18]."
8,"A total sample size of 200 participants (100 per treatment group) was specified in the protocol, which allowed for a non-evaluable rate of up to 20%."
0,"However, the resulting total sample size of 80 patients can also be regarded sufficient for this investigation."
1,The study protocol was approved by the Institutional Review Board of Erciyes University and informed consent was obtained from the patients' relatives.
0,"We will examine whether increased weight loss slows disease progression and how changes in the biomechanical and inflammatory pathways result in improved function, diminished pain, and slower disease progression."
1,"This placebo-controlled, randomized, double-blind, single-center study was performed at the Department of Medical Intensive Care Unit and the Department of Infectious Diseases of Erciyes University Medical School during a 2-year period (from May 1997 to April 1999)."
0,The ZNA5–18 is a well-standardized motor instrument with good psychometric properties (see for more information [132].
16,"Student's t-test and the Mann-Whitney U multivariate analysis test were used for continuous variables, χ2 and Fisher's χ2 tests were used for proportions, and logistic regression was used for effects of factors on mortality."
0,"An additional subset of 17, 10–10 electrodes are shown as open circles."
16,"Values are expressed as means ± SD, odds ratio (OR) and 95% confidence interval (CI) or proportion."
0,The following definition of a fall was used: 'A fall is an event which results in a person coming to rest inadvertently on the ground or other lower level'.
3,"After approval by the faculty ethics committee, patients with severe sepsis (temperature >38°C or <36°C, heart rate >90 beats/min, respiratory rate >20/min or PaCO2 < 32 mmHg, white blood cell count >12,000/mm3 or <4000/mm3, documented infection and dysfunction of an organ or hypotension) were enrolled in the study."
0,"Ontario is Canada’s most populous province, with approximately 13 million residents."
6,"Primary outcomes were BCVA, CNV size and rate of closure, and OCT measurements at the foveal center."
0,"To account for multiple testing, we used the Bonferroni correction approach, using a significance level of alpha divided by the number of independent outcomes, that is 0.05/8 = 0.006."
6,Main secondary outcome was retreatment rates.
0,Protective efficacy was assessed by conducting a homologous 3D7 strain sporozoite challenge 3 weeks after the second NMRC-MV-Ad-PfC immunization.
1,"The study consisted of two parts, a single-dose analysis investigating the effects of a single ingestion of red wine (RW) versus dealcoholized red wine (DRW) and a long-term dietary intervention trial in which RW and DRW were consumed daily for 6 wk."
0,"Women who develop prelabour ruptured membranes after trial entry will remain in their treatment groups for the purposes of analysis, but will be advised to discontinue using vaginal pessaries to reduce the risk of introducing vaginal or ascending infection."
1,"Both trials were prospective, randomized and controlled studies."
0,Electroacupuncture (EA) Group: Electroacupuncture with needles stimulated by an electrical current (dense wave at 4 HZ and disperse wave at 20 HZ) generated by the generator (Model G6805-2) and intermittent non-specific manual twirling.
8,A difference of 2.5 points change in score of the primary outcome measure (RDQ) between each of the three active treatment groups and the waiting list group was considered to be clinically relevant [53].
0,The number of insertion attempts was recorded.
8,"Based on a 2-sided α of 0.05 and a 1-β of 0.90, with a standard deviation (SD) of the RDQ change of 4, a minimum of 220 patients (55 patients per group) needed to be recruited."
0,"The chromatographic separation was achieved on a Phenosphere NEXT CN, 5 μm, 4.6 × 50 mm column (Phenomenex), with mobile phase at a flow rate of 1 mL/min."
5,"Details of the interventions used have previously been published[18], but a brief description is given below."
0,– Freedom to work within whatever model the client brings.
1,"The proposed study is a randomised controlled trial, with blinded treatment allocation, assessment and analysis, in which 70 patients undergoing a scheduled unilateral TKA will be evaluated to assess the added value of CPM at home, using function and mobility as the main outcomes."
0,"We hypothesize the TeamCare-PCN intervention will reduce depressive symptoms, increase achievements of targets for cardio-metabolic measures, improve lifestyle behaviors, and be cost-effective."
4,"This study was conducted between November 2002 and April 2005, in the paediatric inpatient services of two hospitals in Beirut: the American University of Beirut Medical Centre (AUBMC), which is a tertiary care facility; and Najjar Hospital, a secondary care facility."
0,"Verbal consent will be obtained, and participants informed that they can stop taking part at any time."
4,"The study was approved by the Institutional Review Board and the Ethics Committee of the American University of Beirut, as well as the Board of Najjar Hospital."
0,The total cost per person was calculated by multiplying the number of units of service (quantity) and unit cost (price).
1,"This study is a randomized clinical trial to study short-term and long-term (cost) effectiveness of exercise therapy in combination with advice and information on the background of PFPS compared to advice and information on the background of PFPS only (""wait and see"") The study design (Figure 1) was approved by the Medical Ethics Committee at the Erasmus MC – university medical centre Rotterdam."
0,"We chose to use a vignette in the present study as we wanted to assess the practitioners' decisions about appropriate healthcare for a specific clinical scenario, which is precisely what clinical guidelines are intended to facilitate [6]."
1,All patients gave written informed consent.
0,The 23 subjects on insulin glargine were transitioned to equivalent doses of insulin detemir; while the 5 subjects on insulin lispro were also transitioned equivalent doses of insulin aspart in a 1:1 ratio.
16,"In this study, continuous variables were statistically compared using analysis of variance, paired and unpaired t-test analysis (α = 0.05) and multiple regression analysis."
0,"International normalized ratios values were not available in the databases and, therefore, not included in the HAS-BLED score calculation."
16,"For the sample size of the cohorts in this study and the primary endpoint of volume response, the statistical analysis had a power of 0.95 for an alpha = 0.01."
0,"In the event of a significant time/group interaction, independent sample t-tests were conducted using the Bonferroni correction in among-group analyses and comparisons within groups were conducted using paired sample t-tests."
16,"Data were analysed by Statistical Package for the Social Sciences (SPSS) version 10.0, × 2 test for qualitative variables, and Student's t test for quantitative variables."
0,"OS and PFS were calculated using Kaplan–Meier estimates, with medians and corresponding two-sided 95 % CIs reported."
1,The study was a randomised controlled trial of a solution-focused follow-up versus regular follow-up.
0,"Moreover, adverse events were recorded throughout the trial."
1,"We conducted a randomized controlled trial in the University of North Carolina (UNC) General Internal Medicine Practice, which serves a wide socioeconomic range of patients."
0,"In total, sequences from 35/0, 90/57, 117/104, and 147/148 pairs were obtained in env and gag for the first through final adjudications, respectively."
1,"The practice, staffed by over 20 attending faculty and 70 medical residents, cares for over 500 patients with heart failure."
0,ii- Provision of written and graphic educational materials with the foregoing information.
14,"Blinding of researchers was not practical in this study, however a person independent of the study has kept the master list of all randomised groups and will audit the integrity of the randomisation prior to analysis."
0,UGE was collected for 24 h beginning at 8:00 AM.
14,Participating women were made aware that two methods of providing information were being trialed but were not advised of the alternative resource to the one they received.
0,"The purpose of the First Experimental Study of Transference-interpretations [10, 17] was to measure the effects of Transference Work (TW) in dynamic psychotherapy."
1,"We conducted a single blind RCT with individuals randomly allocated to intervention (receipt of immediate welfare rights assessment, advice and active assistance with claims) or control condition (receipt of the intervention after a six month delay)."
0,The protocol was approved by the institutional review boards of all participating centers.
4,Four practices working from five premises in Newcastle upon Tyne participated.
0,The physical activity component consisted of encouragement to be moderately physically active for 30–60 minutes daily.
4,"Three premises were in the top ten per cent of the most deprived wards in England and two were in the top one per cent, measured using the Index of Multiple Deprivation[16]."
0,"The QST was performed at baseline and at the clinical visits: at 1 month (day 30–36), 2 months (day 60–66), and 3 months (day 90–96) after patch application (fig."
4,"The study was carried out with approval from the Johns Hopkins University, School of Medicine Institutional Review Board (IRB) and Informed Consent was obtained from the participants in accord with Helsinki Declaration and following careful explanation of all study conditions and procedures."
0,The logic model presents inputs (resources) and the activities related to each component.
4,"The study was conducted at the Lions Vision Center, Wilmer Eye Institute, Johns Hopkins University between May 2001 and November 2002."
0,"Data for this study were collected within Achieve BP, a larger randomized clinical trial (RCT) which integrated an interactive kiosk with an evidence- based curriculum into the clinical discharge process of an urban emergency department."
3,"Criteria for heart failure was left ventricular ejection fraction (LVEF) < 40 % at echocardiography or at least two of the criteria pulmonary rates, peripheral oedema, a third heart sound and signs of heart failure at chest X-ray."
0,"The counselor and patient collaboratively agreed on 2–4 activation goals to improve/maintain mood and facilitate smoking cessation, to be completed before the next session, and problem-solved barriers to completion."
3,"Patients with somatic disease or physical handicap with difficulties to communicate or handle the technical equipment and patients with only little knowledge in Swedish and patients with expected problems with compliance due to alcohol/drug abuse or major psychiatric illness, and participation in a trial, were excluded."
0,"Pain (at the pubic insertion of rectus abdominis) on squeeze test, positive crossover test, pain on resisted lower abdominal muscle contraction."
14,The registrar of the questionnaire data was blinded to group allocation.
0,"The inclusion criteria were:Treatment in the core study,completed 36 month visit of the core study,informed and written consent andcommitment to participate in the study over the entire study duration."
14,The researchers who scored the other study outcomes were blinded to the allocation of participants and whether the results were pre- or post-tests.
0,Biological samples were collected at baseline prior to any supplementation.
1,(See figure 2: flow chart) The study is a prospective randomised two-armed intervention study.
0,"If willing, they sign a consultee agreement form."
1,Subjects are randomised by an independent statistician and assigned to intervention (stepped care programme) or control group (care as usual).
0,We extracted the raw reads from the BAM files and aligned them to human genome hg19 using BWA (v0.6.2) [23].
6,"Assessments take place at baseline (T0), start of the programme (T1), at three (T2), six (T3), nine (T4) and twelve months (T5) and then at eighteen = follow-up1 (T6) and twenty-four = follow-up2 (T7) months."
0,Each patient served as his own control and was required to take the prescribed aspirin dose daily.
8,"Sample size estimation was based on GMBF data from our previous study, in which the standard deviation of GMBF was 160 units at inclusion [9]."
0,"The three groups were defined by the number of axillary local anaesthetic injections, namely single, double and triple-deposit groups."
8,"In the actual protocol, 20 patients were planned to be included so as to detect a difference between the two groups of 240 units with a type I error of 5% and a power of 95%."
0,"BL1 eligible participants were presented by the examining clinician to the case review panel, which rendered an eligibility determination [50]."
1,"Randomized, double blind, placebo-controlled, cross-over clinical trial (Figure 2)."
0,These studies are rated by clinicians who are trained to assess articles they believe would be important to practicing primary care physicians.
1,Singleblinded Radomized Clinical Trial.
0,"The participants will get a deadline for sending their data sets, before they are able to receive an individual feedback report, and the Rx-PAD will remind their group to send data sets before the second peer group meeting."
16,An unpaired Mann–Whitney nonparametric test with Bonferroni correction for multiple testing was performed to compare for differences between the AT and placebo group.
0,"Lesions and surrounding skin were evaluated for pain, erythema, and edema each day that the topical creams were administered and at follow-up study visits."
16,"P < 0.05 was considered statistically significant, and all data are presented as the mean ± standard deviation or as the median (minimum–maximum) unless otherwise indicated."
0,"In the final multivariable model three clinically significant covariates, age, gender and NT-proBNP were included."
4,"The trial is conducted within 'the Diabetes Care System (DCS)', a managed care system that was implemented in The Netherlands, as described above."
0,"A goal setting meeting (GSM) was arranged for all eligible participants to set a unique goal for the child to achieve by consensus between the teacher and the parent, and second, to define and operationalise specific behaviours that they hoped to increase and decrease."
4,"This care system has a well organised infrastructure with experienced medical assistants, diabetes nurses and dieticians and is therefore a suitable setting to implement a new therapy for patients with diabetes."
0,"Patients evaluated the ""ease of use"" for each of the 4 injections performed (Days 1, 8, 15, 22) by using the Ease-of-Use Grading Scale to indicate how easy it was for the patient to perform the injection."
6,The primary outcome measure is the difference between intervention and control group in change in cardiovascular risk score after 12 months.
0,"The insulin dose was to be adjusted weekly during weeks 1–4, twice weekly during weeks 5–12, and then weekly up to week 36."
6,"The cardiovascular risk score is based on the Oxford Risk Engine (algorithm that includes: age at diagnosis, duration of diabetes, sex, ethnicity, smoking status, systolic blood pressure, HbA1c, total cholesterol, HDL-cholesterol) [38]."
0,Ertumaxomab was administered as an i.v.
12,Given the cluster design participant concealment was not possible but data extraction and analysis was carried out in blind fashion by one of us (DM).
0,"The intensity of all solicited adverse events except fever was graded on a standard scale of (0–3), Grade 1 being those that did not interfere with normal activities and Grade 3 being those that prevented normal activities (Grade 3 redness and swelling: diameter > 100 mm); fever was graded on a 0−4 scale, Grade 3 being axillary temperatures ≥ 39.0- ≤ 40.0°C and Grade 4 being axillary temperatures > 40.0°C."
16,"We carried out comparisons of primary outcomes between the intervention and control arms at cluster (GP) level as this was the unit of randomisation [22] and data were analysed using a cluster specific method, Generalised Estimating Equation (GEE) model [23,24]."
0,"Parents or guardians gave written consent for children younger than 16 years and children also provided written assent, where able to do so, witnessed by the parent or guardian."
6,The primary outcome measure was whether a woman was allowed a companion with her during childbirth.
0,"Study staff also secures a location to conduct confidential study activities, or used a large mobile van."
6,"Secondary outcomes were (a) other beneficial policies (being allowed to move around in the 1st and in the 2nd stage of labour); (b) painful obstetric policies where benefit doubtful (routine episiotomy, routine enema); (c) indicators of humane care (being offered food, being offered water); and (d) indicators of inhumane care (being shouted at, being slapped or struck, being left alone)."
0,"This study was approved by the Institutional Review Board, and signed informed consent forms were obtained from all participants."
1,The MaDO study is a multi-centre pre-post uncontrolled prospective study and involves breast cancer patients who are operated on with curative intent.
0,The policy in Uganda supports public-private partnerships to improve health outcomes and registered drug shops are thus supposed to participate in the prevention and treatment of malaria [20].
1,Both pre and post- measurements last six months with an implementation period of six months in between.
0,"Severe hypoglycaemia was defined as a hypoglycaemic event requiring third‐party assistance, and minor hypoglycaemia was defined as measured blood glucose ≤ 3.9 mmol/l (≤ 56 mg/dl), with or without symptoms."
10,The randomization schedule was created using permuted blocks using a block size of 5 (corresponding to the five treatments).
0,"This study was approved by The Central Denmark Regions Committee on Biomedical Research Ethics as it adheres to the Helsinki Declaration II, and all participants gave their informed consent to participate in this study with the intent to publish."
10,Randomization was stratified by SNAP status (2 levels: negative: 0–4 :V vs. positive: >4 :V) and was assigned in a ratio of 1∶1∶1∶1∶1.
0,The standard soft tissue analysis is performed using software supplied by the manufacturer.
8,This trial is designed to demonstrate a 66% reduction of neonatal sepsis from 7.5% in women in the expectant group to 2.5% in women in the induction group.
0,"For the preparation of Biferonex® + HSA solutions, the contents of three syringes were added to a sterile 5.0 ml glass vial containing 1.6 ml of HSA solution at 30 mg/ml."
8,This requires a total sample size of 520 patients with 80 % power and a significance level of p = 0.05.
0,The detailed methods are described in Additional file 2 (Appendix 3).
1,"We conducted a 3-month prospective, controlled study with a quasi-experimental design (i.e., a nonrandomized controlled sample with geographic stratification [30 areas])."
0,"The participation, schedule of enrolment, interventions and assessment are presented in Table 4."
1,Control and intervention areas were selected for their similarities in rural-to-urban distribution of the population and patients' access to GPs and to minimize risk of overlap between areas.
0,Resting blood pressure was measured 3 times at 1-min intervals using a 765CP oscillometric sphygmomanometer (Omron) with participants seated after a 5-min rest.
5,"At baseline, all patients received medical care and oral information as usually provided by GPs."
0,The first will be discarded and the mean of the last two used in the analysis.
5,"In the intervention group, all patients also received the “back book.”"
0,Measured serum calcium concentration was corrected for serum albumin [14].
1,"This multicenter, open-label, randomized, phase I-B trial was conducted at six HIV-vaccine trial sites in France."
0,The individual plasma-concentration versus actual time data for gepotidacin were used to derive the pharmacokinetic parameters by using noncompartmental pharmacokinetic methods.
1,"The protocol was reviewed and approved by the Pitié–Salpêtrière Hospital Ethics Committee (Paris, France) and all volunteers gave informed consent."
0,A standardized procedure was used.
8,"The null hypothesis was that the intradermal and intramuscular routes would each have a 45% possibly, probably or certainly vaccination-related grade 2 or higher adverse event rate, excluding local pain, i.e., that observed in an ANRS pilot trial using LIPO-4 vaccine (unpublished data)."
0,"All necessary adjustments were made by a second independent, blind clinician."
8,"To detect a between-arm difference of 45 versus 80% in a two group continuity corrected chi square test with 80% power and a two-sided significance level of 0.05, 35 patients per arm suffice."
0,"The goal is to reach, with the mouse cursor, the bubble that changes color (from gray to red) randomly."
14,"In this open-label study regarding safety assessment, all laboratory analyses were performed by individuals blinded to administration route assignments."
0,"The vector is designed to be E1, E3, and E4 deleted, and express the recombinant gene from the E1 position in the adenovirus genome, and is produced in 293-ORF6 cells [26]."
14,Clinical staff and volunteers were aware of route assignments.
0,Tests of discrimination and calibration were performed sequentially after step-wise updating of the model intercept (‘recalibration-in-the-large’) and slope to allow for differences in baseline risk between the derivation and validation populations.
3,"Eligible patients were adults with endoscopically documented grade II, III or IV esophageal varices [14], absence of prior bleeding from varices, evidence of active and/or progressive liver disease (e.g. as indicated by repeatedly elevated serum transaminases or increasing serum bilirubin levels or development of ascites within the past year) or documented increase in the size of esophageal varices; all patients gave informed consent."
0,"Subjects enrolled at the Johns Hopkins Scleroderma Center also had serial measurements of digital perfusion performed at each pharmacokinetic visit pre-dose and 1, 2, 4, 6, 8, 10 and 12 hours post-dose."
3,"Patients were excluded for the following reasons: use of β-blockers and nitrates, malignancy, hemophilia, age older than 70–75 years, no opportunity for follow-up visits."
0,"Immunodeficient male and female athymic nude rats (Csl:NIH-Foxn1rnu strain code 316 (homozygous) (Charles River Laboratories, San Diego, CA, USA) received bilateral injections of ISC-hpNSC with three injection tracks per hemisphere: two tracks for the striatum and one for the substantia nigra, totaling 6 injection tracks per brain (Supplementary Table S3)."
1,A nested qualitative study utilising two data sources: semi-structured interviews with GP referrers and CMHT team leaders and Consultant Psychiatrists and recordings of CMHT 'allocation' meetings at which decisions were made about whether new referrals should be accepted and the patient assessed by a member the CMHT.
0,"The patients were randomized to individualized, nutritional treatment (intervention) or to routine care (control) using sequentially numbered envelopes containing the name of the allocated study group."
1,"Ethical, local Research & Development (R&D) and primary care R&D approvals were obtained for each site."
0,Patients were additionally excluded from the study if a failed block was diagnosed (normal sensation).
4,"This study is set in the Dutch Obstetric Consortium, a collaboration of obstetric clinics in the Netherlands."
0,Children who were ≥9 years of age or had prior receipt of ≥2 doses of an influenza vaccine at least 1 month apart were considered “primed.”
4,"The study will be carried out in nine hospitals, including academic hospitals and non-academic teaching hospitals [23]."
0,"In order to select variables that seemed to be most suitable and consistent for the study of upper limbs, a preliminary analysis was done with the help of video recordings."
3,"Exclusion criteria: breech presentation, twin pregnancies, maternal age < 18 years or absent informed consent."
0,The questionnaire quantifies physical activity level (kcal/day or in kJ if kcal are multiplied by 4.1855) throughout a 24hr-day as previously described [9].
3,"Healthy volunteers of both sexes, aged between 18 and 45 years, with a BMI >18.5 and <30 were included if they gave written informed consent."
0,Others have previously commented on this [25].
3,"Volunteers were excluded if they lived in the past in a malaria endemic area, had visited such an area in the last 12 months, had a history of clinical malaria, had used any investigational or non-registered drug or vaccine within 30 days preceding the first dose of study vaccine, had acute or chronic, clinically significant pulmonary, cardiovascular, hepatic or renal functional abnormality, as determined by physical examination or laboratory screening tests, had diabetes, had history of chronic alcohol consumption and/or intravenous drug abuse, had any confirmed or suspected acquired immunosuppressive or immunodeficient condition, including human immunodeficiency virus (HIV) infection, or history of congenital or hereditary immunodeficiency, had a history of allergic disease or reactions likely to be exacerbated by any component of the vaccine, had acute disease at the time of enrolment, were under immunosuppressive drugs within six months prior to the first vaccine dose, were under chronic drug therapy, were pregnant or planning to become pregnant for female volunteers."
0,"All mothers were offered at least five visits, one of which occurred towards the end of pregnancy."
12,Allocation concealment was done using sealed envelopes with numbers (1 to 46) corresponding to the sequence of assignment to the study.
0,"Following extraction, the analyte was eluted from the substrate using perchloric acid (0.1 M)."
12,All procedures for screening and group allocation of one subject were completed before the next subject was seen.
0,"We plan to consider the following covariates in adjusted models: Administrative union (Bangladesh) or location (Kenya);Field staff team member who recorded the measurement;Time between intervention delivery and measurement;Month of measurement, to account for seasonal variation;Household food insecurity;Child age;Child sex;Mother's age;Mother's height;Mother's education level and literacy;Number of children <15 years in the household;Number of individuals living in the compound;Distance (in minutes) to the primary water source;Housing materials (floor, walls and roof) and household assets."
13,"The randomization was done by PV, statistician at the Swiss Tropical Institute, who did not have any contact with the clinicians or the participants."
0,"The swab was removed, placed into 0.9 ml of buffered salt solution and vortexed to release fluid and processed as previously reported [7]."
13,"The physician in charge of the screening and inclusion of the participants opened the envelopes sequentially, using one block for each sex."
0,"All filter papers were subsequently transferred to the Institute of Tropical Medicine (Antwerp, Belgium) where centralized genotyping was conducted; deoxyribonucleic acid was purified as described elsewhere [9]."
14,The study was single blind (participant unaware of product applied).
0,"An employer is obliged to start rehabilitation as soon as possible, in order that the employee can resume own work or other adequate work."
8,"Assuming a conservative estimate of 30% attrition at 1 year (a lower attrition would increase the power of the study) due to death and loss to follow-up (15% in Jolly 1999 [66]), a sample size of 650 patients (450 evaluable at 1 year) would have 90% power, at the 5% significance level, to detect the differences tabulated (table 3) (population standard deviations estimated from Jolly 1999 [66])."
0,"A process evaluation is carried out to evaluate whether the nutritional intervention follows the protocol, with regard to the dietetic counselling and the consumption of the nutritional supplement."
3,Study patients were adults (≥ 18 years of age) with chronic nonmalignant pain and stable analgesic requirements (daily opioid requirement of ≥ 45 mg morphine equivalents).
0,The investigator was not blinded to the pre-treatment ERUS results.
3,"Exclusion criteria included hypersensitivity to hydromorphone or other opioid agonists; gastrointestinal disorders that could affect the intake, absorption or transit of study medication; significant disorders of the central nervous system; respiratory compromise; risk of serious decrease in blood pressure with an opioid analgesic; significant organ or metabolic dysfunction; a history of drug or alcohol abuse; requirement for radiation treatment; pregnancy or lactation; and use of any investigational drug within 30 days of study initiation."
0,"Measurements of CIMT were made using IMT measurement software (Intimascope; Media Cross Co., Tokyo, Japan) at 3 levels of the lateral and medial walls, 1–3 cm proximal to the carotid bifurcation."
8,"Assuming a risk of recrudescence adjusted by genotyping of 6% for MAS3 and 1% for DHA-PPQ group, we calculated that a minimum of 250 patients would be needed in each treatment arm to detect a significant difference at 5% significance level and 80% power."
0,"Intracellular cytokine staining (ICS) assays were done using whole blood, TCL (6 hours) or PBMC (overnight), stimulated with JEV peptides (3–10 μg/ml), peptide pools (3 μg/ml), JEV infected cell lysate, or approximately 103.4 to 104.4 plaque forming units (PFU) of JEV SA14-14-2 in the presence of 10 μg/ml brefeldin A during the stimulation."
16,Results were immunologic analyses were primarily descriptive.
0,The study is designed as a double-blind placebo controlled randomised clinical trial.
16,A Kaplan-Meier disease-free survival estimate and 95% confidence bounds was generated for the clinical data.
0,"Finally, the CGI-BP-S is a 7-point scale that rates a patient’s severity of bipolar illness in 3 categories: mania, depression, and overall; higher scores indicate more severe disease (Spearing et al. 1997)."
8,"A sample size of 31 per group was estimated to have at least 80% power to detect (with 95% confidence) a difference of 35% between the success rates for 4% dimeticone lotion and 0.5% malathion liquid, based on a 70% success rate for dimeticone 4% lotion and evidence suggesting lower success rates with 0.5% malathion liquid, of about 19%–35%."
0,The trial statistician employed a randomly generated number sequence to allocate patients to the surgical and medical groups.
8,"[1], [2], [11] The planned sample sizes of 34 per group made some allowance for drop out."
0,"Only women with confirmed endometrial hyperplasia fulfilling the inclusion criteria were eligible, after having signed the informed consent during the second consultation."
8,This study was designed as a pilot for a larger randomized clinical trial.
0,"The nutrition treatment group received a regular supply of lipid-based nutrient supplements (Nutriset, Malaunay, France) for children aged 6–24 months."
8,The sample size was chosen based on financial and logistical restraints.
0,The 2-hour cut-off was chosen because it is the maximum pre-hospital delay that allows for eligible patients to receive thrombolysis within 3 hours.
4,"Data will be collected into a web-based data base designed to capture all visit information including medical history, results form laboratory analysis and adverse events."
0,Figure 1 shows both silicone cups being applied to the low back area.
4,Baseline data and ongoing data collection as outlined in table 3 will be obtained.
0,"At the time the protocol was designed, we identified two instruments used to investigate reasons for pre-hospital delay [22, 23]."
6,The primary outcome for the follow-up study was the composite measure of death or neurosensory disability at age of 18 months.17
0,"The assessment included history of clinical symptoms, possible adverse events, concomitant drug consumption and clinical examination including measurement of axillary temperature."
6,"Secondary outcomes for the children were death alone, each individual measure of neurosensory disability alone, delayed speech, other disability and contact with health services."
0,We used binary logistic regression modeling to assess the independent effect of vildagliptin (vs. metformin only) on the likelihood of IL-1ß changes beyond the lowest tertile (changes greater than recorded in the lowest tertile).
3,• Age ≥ 18 years • Patients with acute cholecystitis with three of the following symptoms or signs • Abdominal pain in the upper right quadrant • Murphy's sign • Leukocytosis > 10 × 103/μl • Rectal temperature > 38°C or < 36.5°C plus • Cholecystolithiasis (stones/sludge) or sonographic signs of cholecystitis (thickening and triple layer formation of the gall bladder wall) • Immediate antibiotic therapy (400 mg Moxifloxacin i.v.
0,All participants were required to qualify for the glycemia trial and at least one of the nested trials (BP or lipid).
3,once a day) • Laparoscopic cholecystectomy possible within 24 hours after presentation of the patient • Informed consent Exclusion criteria
0,Correlation of ABA status and clinical responses was performed in post-hoc hypotheses-generating analyses.
5,"Participants were randomized to receive a standard dose of AS and SP (AS+SP) over three days, or AS+SP over the first three days plus primaquine (PQ) administered on the fourth day."
0,Safety evaluations were performed on all participants who were randomized.
8,In a previous trial [23] 30% of subjects were gametocyte positive on day 7 after treatment with SP and 3 doses of artesunate.
0,All AEs were classified according to the preferred term in the Medical Dictionary for Regulatory Activities (MedDRA).
8,"Assuming a similar rate, a trial with 60 subjects in each arm would have at least 90% power (using a significance level of 0.05) to detect a difference between treatments if gametocyte prevalence detected by RT-PCR after treatment is 30% or more on day 14 in the AS+SP arm and 5% or less in AS+SP+PQ, allowing for 10% loss to follow up."
0,Strong standardized verbal encouragement was given during all trials.
14,The trial was not blinded; however laboratory staff performing the PCR assays were unaware of the treatment allocation.
0,"Blood samples were collected within 7 days before starting ART (baseline) and at weeks 12, 24, and 48 during ART."
6,"The primary measure of effectiveness was infection with HIV-1 or HIV-2, measured by detecting antibodies in oral mucosal transudate (OMT) (OraQuick® ADVANCE Rapid HIV-1/2 Antibody Test, Orasure Technologies) and confirmed by an enzyme-linked immunosorbent assay (ELISA) (Genetic Systems™ HIV-1/HIV-2 Plus O ELISA from BioRad) and/or Western Blot (Genetic Systems™ HIV-1 Western Blot, BioRad) from a finger prick or serum specimen."
0,"WBB calibration provides an accurate measure of COP[27,75]."
6,We evaluated safety by comparing the incidence of adverse events (AEs) including pelvic exam findings and sexually transmitted infections (STIs).
0,Insulin dose was then titrated up or down to meet a target blood glucose of 5–7 mmol/L according to at least 7-point blood glucose profiles (before and after meals and at bedtime) for the next 3 days.
6,Primary outcome is the changes in the pain score at week 10.
0,Patients were excluded if they refused consent or if they had been previously enrolled in the study.Conduct of the study
6,"Secondary outcomes included the changes in the ACR core disease measures, including the number of tender and swollen joints, physician global assessment, patient global assessment and the HAQ; DAS 28 score and the number of patients who achieved ACR 20 at week 10."
0,"After enzyme-substrate reaction was stopped by addition of 5 M sulfuric acid solution, the plates were read at 490 nm with 650 nm as a reference using Spectramax M2 microplate reader (Molecular Devices)."
10,We randomized enrolled participants to either SAVVY or placebo using a 1∶1 allocation ratio.
0,"It is comprised of 3 positively worded (e.g., ""I'm always optimistic about my future""), 3 negatively worded items (e.g. ""I hardly ever expect things to go my way"") and the other 4 are filler questions."
10,"An FHI statistician developed the allocation sequence using a computer random number generator and randomly varied permuted-blocks of size 12, 18, and 24, stratified on site."
0,Phone contact was attempted up to seven times before the parent was deemed a non-respondent.
13,An FHI statistician not otherwise involved with the study developed the allocation sequence.
0,Fasting body weight was measured for laboratory checkup.
13,Clinic managers assigned participants to their study groups.
0,"Smokers will be allowed to smoke ad libitum, rather than according to a pre-specified quantity or timetable."
10,The statistician provided computer-generated lists of random numbers allocating patients in a 1∶1 ratio to receive indomethacin or placebo.
0,"At baseline, participants' mean ± SD BMI was 31.1 ± 4.5kg/m2 and age was 55 ± 7 years."
10,"For each center, a separate randomization list was provided."
0,"The patients and/or their caretakers signed a written consent form at inclusion, or provided a thumb print after the consent form was read to them."
12,Randomization codes were held by the pharmacy of the Radboud University Nijmegen Medical Center that labeled and dispensed all trial medication.
0,All patients and the observational investigators were blinded to the administered dose of DMT.
12,Allocation was concealed from all investigators and patients.
0,The commercially available console (M2 or M3 by LigthLab Co.) was used.
13,Eligible patients were allocated to a randomization number in the same order they were enrolled in the trial at both trial sites.
0,"Additional requirements were Eastern Cooperative Oncology Group (ECOG) performance status 0–2 and adequate hematologic and organ function including absolute neutrophil count (ANC) ≥ 1000/uL, platelets ≥100,000/uL, total bilirubin ≤1.5 x upper limit of normal (ULN), transaminases ≤3 x ULN, and serum creatinine ≤2.0 x ULN."
13,"At each visit, patients received a supply of medication (indomethacin or placebo) by the pharmacy, labeled with their randomization number."
0,These randomisations were computer-generated after HIV status was assessed.
1,"A prospective, placebo-controlled, randomized, double blind, phase II study was conducted in seven centres in France."
0,Smears were classified as positive when ≥1 AFB in 100 fields were detected.
1,"The protocol was approved by the Consultative Committee for the Protection of People in Biomedical Research (Comité Consultatif de Protection des Personnes dans la Recherche Biomédicale) of Saint-Germain en Laye, France on 15 March 2001."
0,The online supplement provides additional details and a flowchart of the identification cohort and comparator cohorts (online Additional file 1: Figure E1).
3,"Patients older than 18 years and hospitalized in participating intensive care units (ICUs) were enrolled in the study if they met the following criteria: severe documented infection, as evidenced by one or more of a positive culture or Gram stain of a normally sterile body fluid, of a clinical patent focus of infection (for example, faecal peritonitis, community pneumonia) and of a nosocomial documented infection (for example, ventilation-acquired nosocomial pneumonia or catheter-related infection); a need for mechanical ventilation; severe septic shock, defined as circulatory failure that required at least 1,000 ml fluid replacement in the previous 24 hours and was treated for at least 1 hour with more than 15 μg/kg/min dopamine or more than 0.2 μg/kg/min epinephrine or norepinephrine corresponding to class 4 of cardiovascular failure in the Sequential Organ Failure Assessment (SOFA) score; a Simplified Acute Physiologic Score II of 25 or more; and written informed consent from the patients themselves or their representatives."
0,Pain measurements were normalized to worst pain imaginable reported by the patient.
3,"Patients were excluded if they were pregnant, if they had end-phase chronic disease, if they had a medical staff decision of limitation of care, if they had preliminary circulatory failure, if they had shock due to a urinary infection without bacteraemia, if they had peritonitis related to peritoneal dialysis or trauma, or if they were participating in another clinical trial."
0,"They received no formal, standardized breastfeeding support."
5,"Fifteen patients with PTEN-deficient tumors, who also met all other eligibility criteria, were enrolled at the time of tumor recurrence and received neoadjuvant oral daily rapamycin (2 mg, 5 mg, or 10 mg/d) for approximately 1 wk (median: 6 d, mean: 7.5 d) prior to salvage surgical resection (S2)."
0,"In short, LumiNunc Maxisorp white assay plates (Nunc, Denmark) were coated with 0.5 µg per well of our human PCSK9 antibody by incubation at 37°C for 3 h in PBS (10 mM NaPO4, 0.15 M NaCl, pH 7.4) containing sodium azide (1 g/L), then stored at 4°C."
5,"After recovery from surgery, patients resumed daily rapamycin treatment at the neoadjuvant dose until clinical and/or radiographic evidence for tumor progression was found."
0,"On this basis, we calculated a sample size of 472 subjects (236 per arm)."
6,The study schedule is shown in Table 2; of note is the assessment of diabetic retinopathy at screening and final visit or withdrawal.
0,AE severity was graded using the Common Terminology Criteria for AEs (CTCAE) v 3.0.
6,"This will allow baseline data to be collected in the diabetic participants, who can be followed long-term for changes in retinopathy status."
0,"Therefore, we developed a novel bimanual training program (i.e., bilateral isometric handgrip force training) with visual feedback and symmetric force generation, based on the concept of bilateral movement therapy."
3,"Participants were healthy children available for the duration of the trial (52 weeks) aged 2 to 3 years old living in the village of Donéguébougou, a village with high seasonal malaria transmission occurring from July to November [13]."
0,Slides from decontaminated sputa were auramine stained and read on a fluorescence microscope for acid-fast bacilli grading as previously described [22].
3,"Exclusion criteria included recent or current participation in another investigational vaccine or drug trial, history of severe allergic reaction or asthma, known immunodeficiency, recent use of systemic corticosteroids or immunosuppressive drugs, recent receipt of a licensed vaccine or blood transfusion, history of splenectomy, previous receipt of an investigational malaria vaccine or Hemophilus influenza B vaccine, known thrombocytopenia or bleeding disorder, abnormal screening laboratories (alanine aminotransferase (ALT) >62 U/L, serum creatinine >61 mmol/L, hemoglobin <8.5 g/dL, absolute leukocyte count <3000/mm3 or >14,500/mm3, absolute lymphocyte count <1000/mm3, or platelet count <120,000/mm3), and any other clinically significant disease or condition which might confound the interpretation of study results."
0,"A similar survey was conducted in 2016, updated to include 46 questions [19]."
8,"In this phase 1 descriptive study focusing on safety and immunogenicity, sample sizes were derived from logistic considerations, rather than by power analyses."
0,"We included individual participant data for up to 133 449 participants of European ancestry from 40 studies (appendix pp 1–7, 11–12)."
8,The larger number of volunteers in the 50 mcg cohort was designed to yield sufficient interested volunteers to enable a malaria challenge trial after the third vaccination.
0,"When arteries with stenosis >20% were visually perceived, an FFR pressure wire (Certus, St."
10,"Using SAS, a randomization list was prepared in advance of vaccination activities with randomized block of N = 2 (one subject receiving saline and the other Alhydrogel formulated vaccine) for the August 2002 cohorts."
0,Blood was collected into K2 EDTA tubes and within 10 min was centrifuged at 1100–1300 g for 10 min.
14,"The participants, vaccine administrators and clinical staff providing safety follow-up were blinded to which formulation of vaccine subjects had received prior to removal of the saline formulated vaccine from the study."
0,The validity and reliability of this questionnaire has been reported previously.
14,"Neither the subjects nor investigators were blinded once the saline formulation was removed from the trial, because only one formulation was used and because the dose-escalation design required that the safety of the 20 mcg dose be evaluated prior to administration of the 50 mcg dose."
0,"Scale sum scores have been standardised (0–100), with high values indicating less pain or better physical functioning [32]."
10,A table of random numbers was computer-generated by randomization such that there was equal distribution among the two groups in fifty participants.
0,Subjects will be assessed for incident psychiatric symptoms throughout the intervention period.
10,"Sachets of the appropriate ORS were packaged, as per the random table, in sealed opaque covers bearing serial study numbers."
0,"The first couple of topics chosen (for the spring 2007 round) are: 'drugs for the treatment of benign prostatic hyperplasia', and 'drugs for the primary prevention of osteoporotic fractures in elderly people'."
13,The allocation sequence was generated by SV prior to the start of the study.
0,Corresponding p values should be interpreted in a descriptive-exploratory way.
13,Participants were enrolled by the study medical officers (including VM and BKS) who assigned participants to their groups by handing over the sealed cover bearing the next serial study number (containing the appropriate packaged ORS) to the study nurses.
0,"A randomized study was performed at the 24-bed medicosurgical intensive care unit (ICU) of the Hospital Universitario de Canarias (Tenerife, Spain), a 650-bed tertiary hospital, from 1 January 2005 to 31 December 2005."
6,"To evaluate whether performing preoperative Breast MRI will improve breast cancer management, we will collect data on all biopsies (including biopsies performed for lesions that were detected on MRI only) and all surgical procedures during 1 year of follow-up after the LCNB."
0,"Current smokers included those with self-reported current smoking, those who had quit smoking within <1 month and those with plasma cotinine >85 ng/mL [12]."
6,The number of biopsies and surgical procedures in patients in the MRI group will be compared to the number of procedures in the control group.
0,Participants will not be paid to participate in the trial.
8,"A sample size of 180 participants was required to detect a difference of 5 kg weight loss (approximately 5% of body weight) or less than 2.5 kg/m2 in BMI between the two groups with 80% power, assuming a two-sample t-test, 5% significance levels, a standard deviation for weight of 12 kg and for BMI of 5.5 kg/m2."
0,A mixed model was applied to assess treatment effects on HRV with the baseline values and follow-up time as fixed effects and centre as random effect.
8,"An additional 22% of participants were recruited to take account of any loss to follow-up, giving a recruitment target figure of 220."
0,"However, results from a recent modelling study suggested that simply summing the activity of the agonist and antagonist may give the best indication of articular loading [16]."
3,All patients between 16–65 years with an acute lateral ankle sprain (less than 1 week since injury) will be considered for participation in the study.
0,The lower limit of detection in the C-peptide assay was 0.05 nmol/L.
6,The primary endpoint for this study was defined as loss of detectable serum HCV RNA 24 weeks after the end of treatment.
0,Changes in odds ratio (OR) were used as approximated changes in RR since the primary outcome was rare.
6,The secondary endpoint was normalisation of alanine aminotransferase 24 weeks after treatment.
0,"Evaluations of physical activity and pain scores, serum biochemistry, haematology, urine biochemistry and proinflammatory cytokines were done at baseline (day 0) and on days 7, 30, 60 and 90 during follow up."
12,The randomization code of the monotherapy arms of the study remained concealed until all patients had completed their follow up and the database had been verified and closed.
0,"At any moment, an unpleasant sensation reported by the patient led to a decrease in the current amplitude or the omission of the last-added pad."
5,"The probiotic (10 g lyophilized powder containing live bacteria: Lactobacillus salivarius (CUL61) 6.25 × 109 cfu (colony forming units), Lactobacilllus paracasei (CUL08) 1.25 × 109cfu, Bifidobacterium infantis (CUL34) 1.25 × 109 cfuand Bifidobacterium bifidum (CUL20) 1.25 × 109 cfu) and the placebo (10 g maltodextrin) capsule were the same colour, size, smell and contained powder of identical appearance."
0,"In the event of elevated IOP (e.g., >21 mmHg) or optic nerve findings’ (e.g., worsened nerve appearance together with visual field progression) post-treatment, subjects were to be treated with additional therapy."
5,Capsules were sent through the post and participants were instructed to keep the capsules in the refrigerator and take 1 capsule by mouth daily for 3 months.
0,"This study utilizes data collected during a 6-week, prospective, uncontrolled trial (ClinicalTrials.gov identifier NCT02431377), evaluating GI tolerance, as well as HRQoL, temperament, and eating behaviors in Filipino infants."
6,Outcome 1: to fulfil the revised CONSORT statement for reporting of parallel-group randomised trials for an internet-based RCT of a CAM (probiotics).
0,"As early as the first post-operative day, targeted exercises were performed with the goal of stimulating muscle contraction and load bearing across the scaffold implantation site."
6,"Outcome 2: Comparison of probiotic and placebo group in terms of well-being, bowel symptoms and arthritis severity (disease activity and function) after 12 weeks of treatment."
0,Written consent for participation was obtained from all participants.
10,"A random allocation sequence, without the use of blocks, was generated by the manufacturer of the probiotic intervention (Cultech Ltd., Port Talbot, UK) using a computer generated random number sequence."
0,Maintenance therapy was chosen by the treating physician from a predefined set of standard-of-care options.
10,The sequence allocated participants on a 1:1 basis to either the probiotic or placebo arms of the study.
0,"We retained three specific hypotheses regarding the outcome of the intervention from the 2009 [14] study and tested them in the fully automated sample: (1) conditions 2, 3, and 4 will outperform condition 1, (2) condition 4 will obtain the best quit rates, followed by condition 3, followed by condition 2, followed by condition 1, and (3) conditions 3 and 4 (containing mood management) will outperform conditions 1 and 2."
14,Participants and researchers were blinded to group assignment.
0,"One patient who withdrew from the continuation study reported an adverse event (AE) leading to discontinuation, but the investigator‐recorded reason for withdrawal was “physician decision.”"
14,No member of the research team had face-to-face contact with any of the participants.
0,"The study - which was approved by the Sainte Justine Hospital ethical committee (Montreal, Canada) and by Health Canada and was registered on clinicaltrials.gov (NCT01095406) - was realised between January 2010 and January 2011 in the paediatric ICU of the Sainte Justine Hospital, Montreal, Canada."
16,Time to event outcomes (progression-free survival and overall survival) were analyzed using Kaplan-Meier curves.
0,The effects these differences may have on early postnatal growth have not been systematically examined.
16,Median survival estimates were derived and 95% confidence intervals for median survival were calculated using the Greenwood formula.
0,"This uses the variance of differences between observations on the same person when there should be no change, between baseline and 2 weeks, and when change should have taken place in at least some participants, between baseline and 4 months."
4,"The study will be conducted in a physical therapy practice specialized in management of persons with musculoskeletal disorders of the neck, shoulder and arm."
0,Cell counts were expressed as both total and differential counts.
4,After randomisation every patient assigned to the experimental group will be treated by the same physical therapist.
0,Photographs taken of five samples of each menu item serve as the “before” reference photographs.
8,The initial sample size is based on the assumption that the overall score of the primary outcome measure DASH shows a mean improvement of 15 points [SD = 22] [51].
0,"Briefly, increases in consultations for malaria, diarrhoea, pneumonia, antenatal care and facility deliveries were estimated using data from the trial clusters, as described above."
8,"To test the null hypothesis of equality of treatment at α = .05 with 90% power and assuming a uniform dropout rate of 5%, it was calculated that 52 patients in each group would be sufficient."
0,Participants presented to the lab after a 12-h fast and were required to provide a 4-days food-log that recorded their consumption of food and energy containing fluids.
10,"The randomization code was generated by computer at GlaxoSmithKline, Greenford, UK."
0,"The patients were provided with information on chest pain, potential causes, chest pain management, avoidance behavior, and how this can maintain or exacerbate chest pain."
10,Different codes were allocated for adult sex strata and child age strata and distributed using scratch cards bearing unique study numbers.
0,"In elderly patients with advanced sleep phase syndrome (ASPS), it has been found that evening exposure to bright light on daily basis can be beneficial [31-37]."
12,This was an open-label study.
0,"Given the natural presence of theobromine and caffeine in cocoa extract, both theobromine and caffeine were added to the control beverage mix in order to match the composition of alkaloids in the CF-containing test product."
13,Scratch cards were provided to clinicians and were selected consecutively on patient enrolment to reveal treatment allocation.
0,"Data also indicated that 2-point measures with a 5% circumference change threshold have high sensitivity and specificity (80% and 71%, respectively), close correlation to limb volume calculations using water displacement, and compare favorably with the sensitivity and specificity of multiple-point measurements with high test-retest and interrater reliability.42–44"
14,Baseline and follow up data are gathered by independent and blinded interviewers.
0,The training was based in the motor-learning concepts including repetitive and task-specific practice.
14,Participants are not blinded.
0,Clinic staff followed up with participants if they failed to keep the mandatory follow-up appointment.
14,Due to practical and ethical reasons neither the employee nor the physician will be blinded to group assignment during the initial visit.
0,The flow rate was set at 0.6 mL/min.
14,Allocation is also open to the two interviewers and to the other possible physicians during later visits.
0,Patients that are discharged from the ICU before a stopping advice could have been issued and who are still being treated with antibiotics are considered “dropped out”.
14,"The clinicians, those administering the trial medication, the caregivers, the relatives, the patients themselves, and those assessing the outcomes were all blinded to treatment allocation."
0,"Waist circumference (cm) was measured at the iliac crest during maximum exhalation using a nonstretch, nontension fiberglass Gulick II tape measure positioned horizontally to the floor according to the U.S."
4,"The Phase I trial was a randomized, single blinded, placebo-controlled, dose-escalation study conducted at theChinese National Medicament Clinical Study Base, Changhai Hospital in Shanghai, China."
0,"Random allocation of diary periods means that data can be imputed for the whole trial period and used as a patient record of their depression free days, as well to validate the scores calculated using the BDI-II scores by the method of Lave et al. [25]."
4,The protocol for this trial and supporting CONSORT checklist are available as supporting information; see Checklist S1 and Protocol S1.
0,Antibody levels were measured as International Units per Liter (IU/L).
6,"Primary outcome measure is the level of depression, measured by the online administered self-reported depression questionnaire Center for Epidemiological Studies Depression scale (CES-D) [26] at baseline, directly after completion of the course and at one and six months follow-up."
0,None of the patients had a fine needle/core biopsy or mediastinoscopy within 7 days before treatment.
6,"Secondary outcome measures are: diabetes-specific emotional distress (PAID) [27], satisfaction with the course (self-developed questions), perceived health status (EQ5D and SF-12) [28], diabetes self-care behaviours (Amsterdam Diabetes Self Care Inventory), self-reported episodes of hypoglycaemia and glycaemic control (HbA1c) retrieved from the patients' medical charts via their physician."
0,"Causal mediation analysis helps to identify process or mediating variables that lie in the causal pathways between the treatment and the outcome [30, 31]."
14,"For obvious reasons the GPs, physical therapists and patients were not blinded for treatment allocation."
0,Subjects will be discharged from the clinical site following their final 24-h urine collection on Day 7 (Group F) or after their last pharmacokinetic assessment on Day 8 (Groups A-E).
14,The statistical analysis and interpretation of the findings was audited and verified by an independent statistician.
0,"The breakfast bread was baked according the same standardized procedure as WWB, reference product."
1,An assessor-blind randomised controlled trial with six-month follow-up.
0,"The primary objective of this study was to assess the safety of PrePex MMC procedures during routine service delivery in Nyanza Province, Kenya."
1,Ethical approval was obtained from the Northern Ireland Office for Research Ethics Committee.
0,"Each subject was randomized to a sequence of three of five treatments in accordance with a pre-specified randomization schedule: UMEC/VI 62.5/25 μg (delivering 55/22 μg), UMEC/VI 125/25 μg (delivering 113/22 μg), UMEC 62.5 μg (delivering 55 μg), UMEC 125 μg (delivering 113 μg), or VI 25 μg (delivering 22 μg)."
14,This is a single-blind feasibility RCT; all outcomes will be collected by a blinded outcome assessor.
0,H3: combined nutrition and WASH interventions reduce diarrhoea and improve linear growth more than each component alone We will compare the combined nutrition + WASH arm (NWSH) treatment effects for growth to the nutrition arm (N) and the combined WASH arm (WSH).
14,It is not possible to blind either participants or physiotherapy practitioners to treatment due to the interventions under investigation.
0,"Taken into account a dropout rate of 10%, the sample size has to be 43 for the complete cohort."
6,Outcome measures and assessment moments are presented in table 2.
0,Regular use of MTX for at least 12 weeks and treatment at a stable dose of 10–25 mg/week for at least 8 weeks prior to baseline was required.
16,"We compared baseline sociodemographic, diagnostic, and symptom severity variables by recruitment strategy using t tests for continuous data and chi-square analyses for categorical data."
0,"If heart rate was greater than 70 beats per min prior to imaging, patients received up to 100 mg oral metoprolol tartrate (Mylan Pharmaceuticals, Canonsburg, Pennsylvania, USA)."
8,Safety and tolerability was assessed on the basis of a sample size of 10 patients per dose level.
0,"Under normal circumstances, the music centers accept written applications from adult guardians on behalf of one or more children."
14,"Participants and those administering interventions were not blinded to the interventions, but participants were not informed of the specific nature of the other interventions applied to other participating households."
0,We undertook a pragmatic RCT which aimed to evaluate the health effects of welfare rights advice in primary care among people aged over 60.
1,"A research assistant randomized participants to either the EG or CG, according to a random number table (Table 1) and assigned a code number to each participant."
0,The solution was finally transferred to a vial for subsequent analyses.
1,"Another research assistant, different from the one who supervised the treatment and analyzed data, administered the questionnaires used to gather information at baseline and after 3 and 8 months of the programme."
0,This design has been used to study various interventions where two-sided noncompliance is possible [20-23].
14,This study was conducted as an open study.
0,Patients allocated to the Usual Care Group received the current standard post-surgical ICU care which includes no prescriptions around the use of mirrors.
3,"Male and female infants who had a birth weight ≥2 kg (when known) and who were 6 to 8 weeks of age at the time of first vaccination were enrolled in the study provided that they had none of the following exclusion criteria: (1) malnutrition, (2) a history of neurological disorder or immunodeficiency, (3) a family history of immunodeficiency, (4) a history of receiving immunosuppressants, (5) previous vaccines or treatments prohibited by the protocol, (6) exposure, by direct contact, to diphtheria (D), tetanus (T), pertussis (Pw), hepatitis B (HBV), Haemophilus influenzae type b (Hib), and/or meningococcal disease since birth."
0,"Plasma concentrations of omeprazole, omeprazole sulfone, 5-OH omeprazole, and lansoprazole (internal standard) were determined by ultra-high performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) with some modifications (2829)."
3,"Witnessed, written, informed consent was obtained from the parents or guardians of each infant before enrolment."
0,The study was conducted in accordance with good clinical practice and the Declaration of Helsinki and was approved by an institutional review committee at each participating centre.
1,The study was controlled and double-blind.
0,A hierarchical testing procedure was used for the analyses of primary and secondary endpoints at the α=0.025 level of significance.
1,"Infants were allocated to either DTPw-HBV/Hib-MenAC (study group) or DTPw-HBV/Hib (control group), following a randomization-blocking scheme (1:1 ratio, block 4, no covariates were used for blocking)."
0,"The variable “sport activity” was generated by merging all the information obtained about the child’s leisure time participation in sports activities during the week, measured as minutes per week (weekdays and weekend days combined) spent on sports activities."
1,The study was carried out in three phases: the first was translation into Spanish and cultural adaptation of the NDI and COM; the second was a pilot study to assess the comprehensibility and reproducibility of those Spanish versions; and the third was a validation study to determine their metric characteristics and to compare them with those of the NPQ.
0,"Owing to retrospective type of analysis or insufficient data, the following criteria were not applicable: finding of non-obstructive coronary artery disease, unsuitable coronary anatomy, pregnancy, patients with an estimated glomerular filtration rate of 30–59 who were likely to have significant unprotected left main stenosis, inability to comply with the ISCHEMIA protocol, very dissatisfied with medical treatment, ischemic stroke within 6-months, history of non-compliance Statistical analysis"
3,The GPs were identified by the database of the Danish Medical Association (DMA) on May 3rd 2007.
0,Habitual physical activity will be measured using the ‘Global Physical Activity Questionnaire’ (GPAQ) [31].
3,Characteristics of Danish GPs are presented in Table 1.
0,"A respiratory therapist, who was not involved in the patient care, used a table of a computer-generated randomization list with a block size of 4."
1,"A randomised controlled trial, with blinded treatment allocation, assessment and analysis, was carried out, with local medical ethics committee approval, to assess the added value of prolonged CPM use at home, using function and mobility as the main outcomes."
0,"The IPAQ is the most widely validated questionnaire, however, with some inconsistent evidence on its reliability and validity.76"
14,The vials were labeled by letter codes at Shantha Biotechnics in Hyderabad according to the list prepared by the statistician at IVI.
0,These data will be collected in the U.S.
14,All study personnel and participants were blinded to treatment assignment during the duration of the study.
0,Other treatments and procedures for complications of RVO during the study period were allowed.
1,"The M.A.K.E. study is a prospective, nationwide multicenter study."
0,"ProADM was detected in EDTA plasma of all patients with a new sandwich immunoassay (MR-proADM, BRAHMS AG, Hennigsdorf, Berlin, Germany), as described [24]."
1,All eight genetic centres in the Netherlands will participate.
0,The R2 and the bias of the observed versus predicted plots as well as the log-likelihood of each run were taken into account for the goodness-of-fit evaluation.
3,Participants are pregnant women choosing to have amniocentesis for either advanced maternal age or increased risk following prenatal screening.
0,"Before the intervention: • Questionnaire to the GPs in the intervention group on background variables (age, experience as GP, approximate number of patients with moderate or severe mental health problems, etc.)."
3,"Women undergoing amniocentesis for ultrasound abnormalities, parental chromosomal abnormality, or a previous child with chromosomal abnormality are excluded."
0,Numbers needed to treat (NNT) was calculated using this unadjusted difference in success between groups at each follow-up.
8,"Adopting the results of karyotyping as the gold standard and assuming that MLPA and karyotyping do not produce different test results, that not more than 1/500 missed cases of Down syndrome are accepted, and that the proportion of discordant test results is 0.002, we need at least 4500 paired test results to test the null-hypothesis of clinical equivalence (one-sided alpha 0.05, power = 1-beta = 0.90)."
0,"The final 16S PCR reaction mix contained 1X Platinum uracil DNA glycosylase Mastermix (Life Technologies, Paisley, UK), 0.2 µM bovine serum albumin (Sigma, Dorset, UK), a total of 4 mmol/L MgCl2, 0.4 µM forward and reverse primers, 0.1 µM hybridisation probe, nuclease-free water (Promega, Southampton, UK) and 2 µL of target template for a final reaction volume of 10 µL."
10,A randomization list was computer generated by an off-site investigator.
0,"To establish the net effect, the results will be compared with those of the control group calculated with the same method."
10,"Sequentially numbered, sealed envelopes containing the treatment group assignments were prepared from the randomization list."
0,"Toxicities are graded using Common Terminology Criteria for Adverse Events (CTCAE) v4.0, and responses are measured using RECIST v1.1."
13,The nurse administered treatment by opening an envelope with a matching treatment number sequentially assigned by the study physician.
0,"Clinical changes were evaluated on the basis of the total muscle strength scores obtained at baseline (pre-treatment) to scores obtained after treatment, as determined at 2-month intervals."
1,"A multicenter, prospective randomized clinical trial."
0,"To be marked with potential depression, panic disorder, generalized anxiety disorder or social phobia the participant had to answer affirmative to a set of question similar to the diagnostic criteria from the DSM-IV."
1,Eligible patients will be randomized for either radio guided occult lesion localization (ROLL) or wire guided localization (WGL).
0,"To study the immune cell infiltration (CD3, CD8, Foxp3, CD163) into the tumour by histochemistry, To analyse PD-1, PD-L1, CTLA-4 expression by histochemistry."
4,Short-term outcomes (up to discharge from hospital) will be assessed from hospital notes.
0,"An equipment rack was built for the purpose with monitors, laptop and cables securely clamped."
4,"Major morbidity at 18 months will be assessed by a research paediatrician, blind to study allocation, using a standardised neurological examination and the revised Bayley Scales of Infant Development (BSID-II)."
0,"This was a single-centre (France), open-label, Phase I study consisting of a dose-escalation phase and an expansion phase."
16,"The relative risks of outcomes between the intensive care with cooling group and the intensive care group will be calculated, along with 95% confidence intervals."
0,"The precision of the assay is >85%, and the detection limit is 0.03 μg/L."
1,"The study was designed as a double blind, placebo controlled study to compare the antipyretic efficacy of ibuprofen versus placebo in children with uncomplicated falciparum malaria."
0,"However, training remained integral throughout the trial and was a continuous process."
8,The primary endpoint was PCR corrected ACPR by day 28.
0,All persons being followed in the outpatient clinics at the participating sites will be screened for eligibility prior to their planned appointments in the clinics and offered participation in the trial.
8,"A sample size of 510 children was chosen on the basis of the following assumptions: (1) the efficacy of AL would be 95%; (2) the study would have 80% power at 95% significance level to detect a 10% difference in efficacy as measured by the parasitological failure at day 28 post-treatment in the AS+AQ, and AS+CD groups compared with the AL group; (3) loss to follow up by day 28 post treatment would be <5%."
0,"To increase the sample size, a different method requiring less DNA input was applied at Genentech Laboratories, San Francisco, CA, USA."
3,Altogether 75 overweight or obese (BMI 28–40 kg/m2) subjects aged 40 to 70 years were recruited to the GENOBIN study [28].
0,Patients provide written informed consent for participating in the study and for allowing to collect tissue and blood samples.
3,"The subjects had IFG (fasting plasma glucose concentration 5.6–7.0 mmol/l) or IGT (2-hour plasma glucose concentration 7.8–11.0 mmol/l) and at least 2 other features of the metabolic syndrome according to the Adult Treatment Panel III criteria [29]: waist circumference >102 cm (males)/>88 cm (females), fasting serum TG concentration ≥1.7 mmol/l, fasting serum HDL-cholesterol <1.0 mmol/l (males)/<1.3 mmol/l (females), blood pressure ≥130/85 mmHg."
0,"Samples which produced a low yield were re-pooled and sequenced on a single MiSeq run (v2 chemistry, read length 250 bp)."
4,"Demographic and arrest data is collected according to Utstein guidelines and stored in a database designed with Microsoft access software (Microsoft Inc., Redmond, WA)."
0,"A standard, silicon wire reinforced, 20 Charrière Bard FasTrac pull PEG catheter (Bard Norden AB, Sweden) was used in all patients."
8,"A group size of 10 volunteers per dose was chosen based on the distribution of antibody responses from previous clinical trials [22], [23], and would permit detection of at least a five-fold difference in antibody concentration between dose groups using a Mann-Whitney test, assuming a level of significance of 0.05 and a power of 0.80."
0,Fig. 1 Flow diagram Measurements
8,This sample size also gave 0.80 probability for detecting one or more adverse events that occurred with a probability of 0.15 per volunteer.
0,"Prior to implementation, we pilot tested the revised QICTSI and QILSS with a convenience sample of 20 change leaders and 4 coaches who did not participate in NIATx200."
8,"In order to demonstrate a standardized effect size of 0.35 (a medium-sized effect [22]) a minimum of eighty participants in each condition is required at the time of the follow-up measurement (t2), based on a statistical power (1-beta) of 0.80, a one-sided test, and a conventional alpha of 0.05 (power calculation in Stata 7.0)."
0,Stimuli recordings from a female or a male speaker were randomly selected for each trial.
8,"Anticipating a drop-out of 20% between t0 and t2, slightly over one hundred participants per condition were included at t0, the baseline measurement."
0,For an effect size of 1.46 a total of 50 subjects should suffice to test the contrasts.
14,"In this study residents, therapists and interviewers collecting data for the qualitative part of the study were not blinded."
0,Secondary endpoint was to investigate the difference in the number of participants with adverse events between patients receiving standard triple therapy plus pronase and patients receiving control treatment.
14,Therapists are encouraged to present both the experimental and the control condition with equal enthusiasm.
0,Edward Keystone was the principal investigator and signatory of the clinical study report.
1,"We conducted a multicenter, open-label, prospective cohort study assessing thromboprophylaxis with dalteparin 5,000 IU once daily until ICU discharge or for a maximum of 30 days in critically ill ICU patients with severe renal insufficiency, and we found that dalteparin bioaccumulation did not occur as measured by twice-weekly trough anti-activated factor X (anti-FXa) levels [10]."
0,Sheeran and Orbell found the implementation intention intervention to increase cervical cancer screening attendance by 23% compared with a control group.
1,"The purpose of the present report is to estimate the prevalence, incidence and risk factors for venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency."
0,"The study village was Kwashemshi village in Korogwe District, Tanga Region, Tanzania."
14,"An independent physiotherapist blinded to group allocation will assess all participants using the battery of outcome assessments on entry to the study, on completion of the eight-week trial and finally at the three month follow-up stage."
0,"GO‐VIBRANT is a phase III, multicenter, randomized, placebo‐controlled trial."
3,"Hemodynamically stable women ≥ 18 years of age with a presumptive diagnosis of tubal EP who are scheduled for surgery, are eligible for the trial."
0,Demographic information and clinical measurements were collected from each enrolled patient’s medical record.
3,"Excluded are women without desire for future pregnancy, patients pregnant after IVF, patients with a pregnancy in a solitary tube and those patients with a contra lateral tubal occlusion or hydrosalpinx as documented earlier at hysterosalpingography or laparoscopy or as found during surgery for the index EP."
0,Participants were recruited during fall 2014 using poster and online advertisements in Guelph and throughout Ontario.
17,"Pre conceived subgroup analyses are planned for age (under and over 30 years), history of a previous EP, pre-operative serum hCG-level (< 3,000 IU/l, 3,000–6,000 IU/l, and > 6,000 IU/l), and size of the ectopic mass (less or more than 4 cm)."
0,The current analyses were performed on a sub-population of 1000 COPD subjects of the ECLIPSE cohort composed of the 500 subjects that progressed the most and the 500 subjects that progressed the least in terms of FEV1 decline over the three year study period.
16,The analysis will be performed in accordance with the intention to treat principle.
0,The orthotist then decided if altering bolster locations and pressure levels might improve correction.
3,The patient population we aim to investigate consists of 300 mild to moderately depressed adults.
0,All three scaffold materials were decellularized to meet established minimum criteria for DNA removal.31
3,"Patients are eligible to participate if they meet the following criteria: age 18 to 65 years; access to the Internet at home; at least mild to moderate depressive complaints (BDI-II score > 16), although a DSM-III-R diagnosis of major depression was not required; duration of depressive complaints 3 months or more; no current psychological treatment for depression; no continuous antidepressant treatment for 3 months or more prior to entry; fluent in Dutch language; no alcohol and/or drug dependence; and no severe psychiatric co-morbidity (e.g. psychotic disorders)."
0,Drug treatment for these specific conditions is an alternative indicator.
5,"Patients were randomised to receive either open-label combined aspirin (A, 75 mg od), clopidogrel (C, 75 mg od), and modified release dipyridamole (D, 200 mg bd) (ACD) or aspirin (75 mg od) alone (no dipyridamole or clopidogrel placebo) on a 1∶1 ratio."
0,"Patients were male or female, aged 18 to 75 years, with a diagnosis of schizophrenia (DSM-IV or DSM-IV-TR), and a PANSS-derived Brief Psychiatric Rating Scale (BPRS, 0-6 scale) score ≥30, reflecting a moderate-to-high level of illness severity."
5,Mono-therapy with aspirin was chosen as the active comparator since this was the standard of care at the time of trial design; the comparison of triple with mono therapy meant that a smaller sample size was possible since any difference in the primary outcome (tolerability) was likely to be maximised.
0,"A mild sprain is diagnosed if the person had reasonably good ability to bear weight on the foot (walking), if there was mild swelling and pain, if there was no visible bruising, and if the anterior drawer test was negative."
10,"Randomisation was performed following consent using computer minimisation on age (>70 years), delay from ischaemic event, ischaemic event (stroke or TIA) and baseline systolic blood pressure (SBP)."
0,Figure 1 Selection process after data from 441 general practitioners (GPs) and 25 093 respiratory tract infection episodes for 1 year (December 2004 through November 2005) were collected.
13,Patients were identified and enrolled by research nurses (with consent obtained by clinical research fellows); treatment assignment was performed by a third party.
0,"Because the exoskeleton drove extension of the second and third digits, AROM values for the second and third digits and fourth and fifth digits were averaged separately."
14,The interventions were unblinded to both patients and treating staff.
0,"For an overview of all outcome measures, see Table 1."
14,"However, patient assessments on and at the end of treatment, adjudication of events, and assessment of haematology and haemodynamic measures, were performed blinded to treatment assignment by trained staff."
0,The data was processed by using MZmine 2 software [30] and the lipid identification was based on an internal spectral library.
6,The primary outcome was the time of first P. aeruginosa acquisition.
0,"Subjects were awakened, if necessary, and the measurements of blood pressure, heart rate, and IOP were taken supine under dim light (<10 lux)."
6,"The secondary outcomes were the times of P. aeruginosa respiratory tract infection or colonization and P. aeruginosa gastric colonization, and the number of patients with persistent gastric colonization with L. casei rhamnosus."
0,Cell-mediated response to RSV was measured by RSV interferon γ enzyme-linked immunospot (ELISPOT) assay [19] in subjects who met the primary end point or who were randomly selected on the basis of sample availability (samples were obtained only from sites in the United States capable of appropriate processing and freezing).
1,"Multicenter, double blind, randomized and placebo controlled trial."
0,Investigators were blinded to block length; microbiology and laboratory personnel were blinded to group assignments.
8,"We expected smaller effects for adolescents than for parents, so sample sizes were chosen to provide 80% power to detect a 0.20 SD difference between intervention and control adolescents in outcome changes from baseline (α=0.05, two tailed)."
0,Final matches were validated by comparing trial versus OPTN reports of donor and recipient ABO blood types.
8,"Assuming 1.25 eligible adolescents per parent (85% of whom would complete all four surveys), design effects totalling 1.20 from clustering and weighting, and an outcome correlation of 0.6 within participants from baseline to nine months, we calculated that we needed to enrol a total of 570 parents (with 712 corresponding adolescents)."
0,"Regardless of study arm, case managers notified MCO staff about children with uncontrolled asthma for further evaluation."
1,A prospective multi-centre randomized controlled trial was performed evaluating non-inferiority of low vs. high frequencies of SMBG with respect to metabolic control T2D.
0,This will be without disadvantages for the subject.
1,"The study was approved by the ethical committees of all six institutions participating, and all patients provided their written informed consent."
0,"OB-DM subjects underwent laparoscopic RYGBP with a 30-mL gastric pouch, 40-cm afferent limb, 150-cm Roux limb, and 12-mm gastrojejunostomy, as described previously (19).Experimental Procedures"
4,"Interviews, physical activity consultations and completion of questionnaires took place in a specially allocated study room within a University building."
0,BTX injections were performed under EMG guidance.
4,Physiological assessments took place in a University laboratory.
0,The registries and time points for primary outcome assessment are summarized in Table 5.
5,Forty ambulatory patients with KOA are randomly assigned to receive Tai Chi (n = 20) or attention control (wellness education and stretching) (n = 20) in twice-weekly one-hour group sessions for 12 weeks (Figure 1).
0,"Candida colonization (lung, gastrointestinal tract, urine, mouth, pharynx and anus as well as the injury, wound or drain) was assessed at day 1 and then twice a week."
1,"The REACT-trial is a prospective, patient-randomized study that will compare the clinical work-up of trauma patients in a setting where the CT scanner is located in the shockroom (AMC) with the standard situation where CT scanning takes place at the Radiology Department (VUmc)."
0,"Height and weight were measured to the nearest 0.1 cm and 0.1 kg, respectively."
6,"The primary outcome was the comparison of A1C change and the proportion of subjects who reached the treatment target (A1C ≤7.0 or ≤6.5% at 6 and 12 months, respectively)."
0,Eligible patients were required to have stable renal function and must have been undergoing a predefined on‐pump cardiac surgery with a high‐risk of developing AKI in 1 of 3 categories: (1) coronary artery bypass grafting (CABG) and surgery of ≥1 cardiac valves (valve[s] surgery) or surgery of the aortic root or ascending part of the aorta combined with CABG and/or valve(s) surgery; (2) surgery of >1 cardiac valve(s) or surgery of the aortic root or ascending part of the aorta; or (3) patients undergoing either CABG or single‐valve surgery were required to have chronic kidney disease (CKD; eGFR 16–59 mL/min per 1.73 m2).
1,A scheme-diagram of the trial protocol is presented in figure 1.
0,This post hoc analysis was performed to assess the independent role of baseline C trachomatis in the development of CIN by comparing results from the HPV-stratified and HPV-adjusted analyses.
1,Figure 1 Scheme-diagram of the trial protocol.
0,The primary outcome measure will be the longitudinal change in 4h-D/Pcreatinine in the sequential PET examinations.
8,"Martiny et al. [21] found a moderate effect size (ES>0,50 maximum 0,66) for bright light treated group in comparison with dim light treated group on both self-assessment and observer rating scales in patients with a high prevalence of melancholic depression."
0,See Table 1 for detailed definitions of end-points.
8,"Based on the literature on the expected response rate, and using conventional values for α (0.05) and β (0.80), and two-tailed tests with equal groups, the sample size aimed for in the current study is 63 patients per arm [42]."
0,The daytime period was set from 6:00 AM to 10:00 PM.
6,"Secondary outcome measures are clinical response (i.e. 50% reduction in depressive symptoms) on the 29-items SIGH-SAD, the Atypical-8 subset from the SIGH-SAD, the HAMD-6 depression core features subscore, and the MADRS."
0,Training also utilizes videos showing providers using the SDM techniques.
6,Specially trained clinical research staff conducted the interviews.
0,Subjects were screened for serosuitablilty from 56 days to 3 days before inoculation day.
8,"Assuming a cure rate of 80%, a study size of 62 participants would be needed per group to detect an absolute difference of 25% in cure rates between treatment groups (power = 80%)."
0,The study protocol was written following the principles of the Declaration of Helsinki and was reviewed by the MRC Scientific Coordinating Committee (SCC) and approved by the joint Gambian Government/MRC Ethics Committee.
8,"Considering loss to follow-up (children who wanted to return from the holiday resort to their homes during the study period) and possible post-randomization protocol violations, a study size of about 70 participants per group was considered to be sufficient."
0,Stratification of patients regarding performance status prior to randomization may improve the power of the trial.
1,This is a randomized controlled trial where obese participants with MDD are randomized to one of two treatment conditions: BA or ST.
0,All answers were evaluated separately and a total score summarizing all assessed GI symptoms as well as a score for bloating and abdominal discomfort was calculated.
1,All procedures and material were approved by the University of Massachusetts Medical School's Internal Review Board.
0,"Allocation at the point of delivery was made from instruction sheets enclosed in opaque, sealed, sequentially numbered envelopes distributed to the investigators in batches of 12."
16,"Descriptive statistics for previous treatment, preferences, and willingness to undergo knee replacement surgery were calculated."
0,The measurements were performed in a standing position with the pelvis supported [17].
16,"Since the duration of knee pain was not normally distributed and there was a large disparity in numbers of participants who reported receiving treatment (n = 380) and those who did not (n = 35) the non-parametric Mann-Whitney U-tests was used to establish if there were differences in demographic factors (age, disease duration) between people who had received treatment and those who had not."
0,Authors had full access to data and certify the accuracy and completeness of data analysis.
8,The sample size and power were calculated to detect a treatment difference in the primary analysis of a mean change from baseline in DAS28 (ESR) for the abatacept vs placebo groups at day 197.
0,"A recruitment brochure delineating the details of the study and the benefits for participating sites was distributed to subsidized housing complexes in Providence County, Rhode Island that had at least 190 units."
8,"Prospectively, this study was not powered with a superiority or non-inferiority design to compare the two active arms."
0,"A picture naming test was chosen for language, and Mahieux’s test for ideational and ideomotor apraxia."
1,"The study was an investigator-initiated, single-centre, randomized, double-masked, parallel trial of metformin versus placebo treatments."
0,The manipulation target areas were restricted to the lumbar spine and sacroiliac joints.
3,"Inclusion, exclusion and withdrawal criteria are presented in Table 1."
0,"When parasites on day 0 and the day of failure were different from each other at one or more loci in their microsatellite profile, then these parasites were considered genetically non-identical and regarded as different strains for the purpose of this study."
3,"The data were collected at Steno Diabetes Center, Gentofte, Denmark."
0,"This is different from the approach usually taken in economic evaluation of healthcare interventions delivered at the individual level, where costs and QALYs are calculated per patient."
10,"Randomization was performed using a pre-established computer-generated sequence in blocks of three and four, with the block size masked during the trial."
0,All participants provided written informed consent.
10,Patients were stratified into four groups according to the baseline level of HbA1c (≤ or >9.5%) and BMI (< or ≥25 kg/m2).
0,BMD print-outs were sent directly from the investigator centers to Biotrial and data captured.
1,"Quasi-experimental, prospective, multi-centre study, with a concurrent control group, conducted between 2003 and late 2006, focusing on public home care services delivered by Primary Health Care in four districts in Andalusia (Spain), namely Malaga (DSM), Almeria (DSA), Granada (DSG) and Costa del Sol (DSCS)."
0,"Also sex hormones, such as sex hormone binding globulin and testosterone, were measured, but data were incomplete and therefore not included in further analyses."
16,"Quantitative data (e.g. duration of the assessments, perceived benefit) were analyzed by means of descriptive statistics."
0,Table 3 Paresthesia of sufficient enough to cause work/school absenteeism or a medical consultation after the 2009 pandemic vaccine.
16,"Qualitative data (i.e. answers to open questions in the self-administered questionnaires, individual interviews and the plenary group discussion) were classified into categories, based on the content of the answers given."
0,Initial topic guides were based on issues identified in previous telemonitoring studies and were refined iteratively in response to the initial interviews.
1,"We conducted a prospective, randomized, double-blind, placebo-controlled, single-center trial with the approval of the institutional ethics committee."
0,"Based on this overview, environmental goals can be prioritised."
8,"Accepting an α error of 0.05 and a β error of 0.2 in a bilateral hypothesis contrast, we estimated that 47 patients were needed in each group to detect differences of 30% or greater in the control of ICH."
0,"Levels of NEFA were quantified by an enzymatic method (Wako Chemicals, Neuss, Germany)."
8,"To calculate sample size, we assumed that the therapeutic response rate in the pentobarbital group would be 50%, excluding patients lost to follow up."
0,First the patient is asked to sit at the end of the radiographic table that is adjusted to the patient’s height so that the forearm is resting on the table.
8,"Based on the differences in incidences in infectious morbidity (76% and 50% respectively) in the GEEF study [22], and a two-tailed α = 0.05, β = 0.20, a sample size of 2 × [2*7.85*0.63(0,37)]/(0,26)2 = 2 × 54 infants is calculated."
0,Other details of the clinical trial protocol can be found in [13].
8,Based on an expected drop-out rate of 10% during the study period 2 × 60 infants will be included.
0,A particular focus was placed on assessing signs of umbilical cord infection.
3,"Our service targeted primary care providers in Family Health Networks (FHNs) and Family Health Groups (FHGs), two recently introduced models for primary care service delivery in Ontario."
0,"Dose incrementation was stopped after the maximum dose of 2.1 μg/kg per minute had been reached, SBP had changed by >25 mm Hg, or HR had dropped <40 bpm."
1,"The Clinical Pathways for Effective and Appropriate Care Study was designed as a multi-centre cluster randomized controlled trial, in which the experimental group contains stroke patients treated according to specific clinical pathways, while the control group received usual care."
0,"Chi square and nonparametric (Mann–Whitney) testing was used to access the differences in demographic data (gender, age, weight, received general anesthesia or not, received local anesthesia or not, needle size, first-attempt success rate) between both groups."
1,"A cluster design was used (with single hospitals and rehabilitation long-term care facilities of the same area as the randomization units) because of the Ethical and logistical issues associated with the implementation of clinical pathways, which involves a series of complex actions at institutional level [11-14]."
0,"The strategy began by hiring a professional marketing firm that provided recommendations for branding, marketing and advertising based on the findings of our formative work."
6,"We defined the primary outcome as an injury to the lower extremity (foot, ankle, lower leg, knee, thigh, groin, and hip) and secondary outcomes as any injury, or an injury to the ankle, knee, or other body parts."
0,A linear mixed model will be used to analyze treatment effects of transference interventions in depressed adolescents.
6,We included all injuries reported after an intervention club had completed the first prevention training session (matched with the same date in a control club) to compare the risk of injury between the groups.
0,"To identify genes that were changing between groups, different two-tailed P-value thresholds were applied calculated by Welch modified two-sample t-test in dChip."
6,The primary outcome measure was the proportion of subjects who preferred using the VOCEL® Mobile Diary vs the traditional paper diary.
0,"The institutional promoter is the University Hospital of Lyon (Hospices Civils de Lyon), France."
6,"Secondary outcome measures included 1) influence of diary type on drug assessment as reflected by recorded compliance, use of rescue medication, PEFRs, asthma symptom scores, and nocturnal awakenings and 2) ciclesonide efficacy and safety as reflected by both diary entries and objective assessment of pulmonary function at the end of each diary period."
0,"Immediately following the conclusion of the follow-up period, we assessed the effectiveness of blinding among participants."
1,We conducted a two-site double-blind RCT comparing nebulized racemic albuterol to nebulized racemic epinephrine.
0,MAR is a less restrictive assumption than missing completely at random and allows loss to follow-up to be related to baseline characteristics that are incorporated in the regression model.
1,Both sites had institutional review board (IRB) approval for the study.
0,"Baseline and month 6 visual field examinations were evaluated in this report, which included 1511 of 1982 hemifields that met the IIHTT criteria for abnormality."
1,Randomised controlled trial over one year The flow of participants through the trial is shown in figure 1.
0,"Patients were required to have an inadequate response to methotrexate and to be receiving methotrexate 7.5–25 mg/week for at least 12 weeks, and at a stable dose for at least 4 weeks, before baseline."
1,Figure 1 Design and timetable of trial of screening for chlamydia to prevent pelvic inflammatory disease (PID).
0,"The 12 domains cover delusions, hallucinations, agitation/aggression, depression/dysphoria, anxiety, elation, apathy, disinhibition, irritability/lability, aberrant motor behaviour, sleep and appetite disturbance."
3,Sexually experienced female students aged ≤ 27 years were eligible for the study.
0,The complete list of study criteria is provided in the Supplementary material online.
3,"Pregnant women, those who had never been sexually active, women aged >27, and women who had been tested for chlamydia in the past 3 months were excluded."
0,The 24-h version was administered to compare performance of the two versions and was administered only at study visits and not as a daily diary; thus it does not give full coverage over the time period of the study.
1,The effectiveness of Go4it will be evaluated in a randomised controlled trial with an economic evaluation alongside.
0,"The size of the tube was chosen based on the patient’s height and mainstem bronchial diameter, and the correct position of the tube was confirmed with a flexible fiber-optic bronchoscope."
1,The Medical Ethics Committee of VU University Medical Center approved the study protocol.
0,"Additionally, we aimed to ask 25% of consenting participants to give hair samples that were later analysed by a specialist hair analysis company (TrichoTech Ltd, Abingdon, Oxfordshire) to detect the presence of illicit drug use."
1,"We conducted a prospective, randomized two-arm trial to evaluate the effectiveness and efficiency of community leg ulcer clinics (intervention) with care delivered through home visiting (usual care) by comparing individual and system level outcomes, including a one year post-healing follow-up."
0,Orsola-Malpighi University Hospital and the study protocol was registered with ClinicalTrials.gov under the title “University of Bologna Protocol Record T.E.A.
1,We hypothesized that receiving care in the clinic setting would improve healing rates at 3 months (primary outcome).
0,"Other serum and urine biochemical analytes were measured on the Beckman DXC880i analyzer (Beckman Coulter, Woerden, The Netherlands)."
1,A randomised cross over design will be used.
0,"This has nine questions which form three domains (work for working people, study for students and activity impairment for both subgroups)."
1,"Forty-seven subjects will be randomised into either Group A or Group B using sealed, computer generated random numbers."
0,"Programs were assigned a zero (<33rd centile), 1 (33rd to 66th centile), or 2 (>66th centile)."
4,"The study was conducted in two transitional nurseries in neonatal intensive care units at Pediatric University Hospital, Cairo, Egypt."
0,All patients take their morning medication after the venipuncture.
4,Mothers in the current study setting were not instructed on how to express breast milk.
0,Tumors were harvested one day after the last treatment.
16,Our primary analysis will be to determine the sample size for the full-scale trial.
0,"PFS, OS, and the landmark analyses were estimated using Kaplan–Meier product‐limit methodology 1."
16,"We will conduct an exploratory analysis on an intention-to-treat basis, using analysis of covariance (ANCOVA), which incorporates an adjustment for differences between groups at baseline."
0,Research data are gathered at baseline and at 6 months after the start of the study.
6,Proportion of patients completing 28–31 days of heat treatment in patients with small ulcers (≤2 cm) or 50–55 days in patients with large ulcers (>2 cm) and ulcers with prominent surrounding oedema Proportion of patients cured 6 months after completing heat treatment (including skin grafting where necessary).
0,Comprehensive metabolic panel and CPK measurements were performed in the CLIA-certified hospital laboratories of University of Washington Medical Center and Vanderbilt University Medical Center.
6,Cure is defined as complete closure of the wound by epithelialisation or scarification or by skin graft.
0,"On the 8th day, researchers telephoned the participants to collect pedometer data (to prevent pedometer data from being automatically erased), and participants in Arms A and B were asked to return their pedometer and questionnaire in the pre-paid envelope."
8,"Based on the available literature, it was predicted that a final sample of 102 participants would be required to have 80% power at P = 0.05 of detecting a reduction in occurrences of urinary infection from 16% in the cranberry group to 1% in the trimethoprim group.5,6"
0,"Isometric strength testing of the affected limb was measured 1–2 days prior to ECM implantation, and again at 6–8 weeks, 10–12 weeks and 24–28 weeks post-operatively."
8,"In anticipation of a dropout rate of 15%, we intended to recruit at least 120 participants."
0,The time taken to be ready for PACU discharge was also recorded.
4,"Lazio is a region of about 5,3 million inhabitants, located in Central Italy, that include Rome (3 million inhabitants)."
0,"The randomization schedule was prepared by statisticians at the Data Coordinating Center, EMMES Corporation."
1,"This small preliminary randomised, double blind, placebo controlled parallel group study investigated the effect of Aquamin on NSAID dose reduction in subjects with OA of the knee."
0,The physician explained the definition of SPC and recommended routine screening for other common cancers.
1,We used anecdotal information along with our experience from a previous study with a similar endpoint to estimate the number of subjects that might be needed for this small pilot study [12].
0,We determined actual prostate cancer screening rates in two ways.
16,"An independent statistician analysed the data using t-tests (for single between-group comparisons), ANCOVA (for between-group comparisons at specific timepoints, using baseline score as a covariate) and a mixed linear regression model on repeated measures data (for between-group comparisons across all timepoints) to analyze data for an Intent to Treat Group (including all subjects enrolled and treated in this trial with values imputed for their Last Observation Carried Forward (LOCF) for any subjects who did not complete the trial) and a Completer's Group (including only data from subjects who completed the trial per protocol)."
0,"No later than 15 min after arrival at the laboratory the CSF samples were centrifuged at 1,800 g for 10 min at 4°C and aliquoted into polypropylene tubes that were stored at -20°C."
8,"In order to detect a 15% difference in adequate parasite clearance by day 28 between symptomatic 6–59 month old children and asymptomatic 2–10 month old children with 80% power at the 5% significance level using a ratio of 2 symptomatic cases to 1 asymptomatic case, we estimated that 292 symptomatic children and 146 asymptomatic infants would be required."
0,"The left vertical pair of images was obtained from study participant no. 12 during conventional ventilation (CV), the middle pair of images was obtained from participant no. 7 during 7-Hz high-frequency oscillation (HFO), and the right pair of images was obtained from participant no. 13 during 4-Hz HFO."
1,This is a multi-center randomized controlled trial comparing postoperative QOL between LUAL and LAVH for the treatment of symptomatic uterine fibroids.
0,"For ethical reasons, a placebo controlled trial would not be appropriate [36]."
1,Eligible patients were randomized in a 1:2 ratio to undergo either LAUL or LAVH.
0,"Samples were pretreated and assayed using Bühlmann laboratories Direct Saliva Melatonin ELISA kits (EK-DSM, ALPCO, ltd., Windham, NH)."
3,"• Age ≥ 40 years • Premenopausal patients • Patients who do not want conception any more • Patients who agree to the current study protocol with informed consent • Patients with more than 2 cm sized uterine fibroids on ultrasonography (USG) • Patients with symptomatic uterine fibroids such as menorrhagia, dysmenorrhea, lower abdominal discomfort or pain, lower back pain and urological symptoms including dysuria and frequency • Patients without underlying disease affecting QOL • At least six months interval after last medication if patients have been treated with GnRH agonists."
0,"The exact nature and content of external facilitation varies between sites, depending on clinician needs and logistical constraints."
8,Sample size calculations were based on other studies with similar design and allow for a detection of standardized effect sizes of 0.9 with 80% power to detect changes in intramuscular phosphocreatine (PCr) levels.
0,The balance between the two current return paths is modulated by their respective impedances.
16,Statistical analyses (Student's t-test and ANOVA) were performed using the Statistical Package for the Social Sciences (SPSS) software.
0,All were otherwise healthy and had a stable body weight (<2 kg change in weight in the past 6 months) and a sedentary lifestyle (<20 min of exercise twice a week).
16,Graphical representations of relative changes in measured variables were performed using Sigma Plot statistical package.
0,"(Overall, there was less than 2% missing data.) Due to skewness of primary outcomes, data were transformed the log10 scale before modelling."
16,"Wilcoxon rank-sum test was used to compare differences between healthy children and CF children at baseline in plasma and red cell folates, plasma vitamin B12, plasma homocysteine, red blood cell MDA, membrane ion pathways, red cell cation content and fatty acid percentages bound either to phosphatidylethanolamine (PE) or to phosphatidylcholine (PC)."
0,The authors concluded that both treatments produced a significant reduction in OA symptoms but there was no statistically significant difference between the two groups.
16,Wilcoxon signed-rank test was used to compare differences between CF children at baseline and after 5-MTHF and vitamin B12 supplementation in fatty acid percentages bound either to PE or to PC.
0,Samples were analysed within 24 h using a FACScan flow cytometer (Becton-Dickinson).
1,We conducted a postal survey among recruiting physicians of a respiratory rehabilitation trial enrolling patients with Chronic Obstructive Pulmonary Disease (COPD).
0,All research related activities are excluded from the cost analysis.
1,"To optimize the return rate of the questionnaires, we informed the recruiting physicians in our quarterly electronic newsletter 2 weeks before mailing the questionnaires and reminded participants once electronically two weeks after sending the questionnaire to them."
0,"For participants with a BMI > 25 kg/m2 (90% of participants), the REE for each participant was computed using the Harris-Benedict equation after adjustment of body weight for overweight status, and they were prescribed energy intake deficits of 500 kcal in accordance with the ADA’s guidelines to facilitate modest weight loss [8]."
1,A multi-centre assessor blind RCT that evaluates the clinical effectiveness of two physiotherapy interventions for patients with osteoarthritis of the hip will be conducted.
0,"After agreement to participate, patients were asked to remain in fasting conditions between 6 and 8 hours before randomization."
1,"The methodology will follow CONSORT (Consolidation of Standards of Reporting Trials) guidelines [51,52]."
0,Peak torque values for flexion and extension ultimately depend on user input.
3,Potential participants will be recruited from the physiotherapy waiting lists in the four participating hospitals if they meet the inclusion criteria as shown in Table 1.
0,"COPD exacerbations in the year prior to the study were recorded, as well as body mass index (BMI)."
5,Interventions will be administered by senior chartered physiotherapists in the four participating hospitals.
0,The estimated SD for a follow-up measure after adjusting for the baseline value is 8.3 × the square root of (1 – 0.22) = 8.132.
5,All treating therapists will have attended two training sessions which will focus on the exercise and manual therapy interventions to ensure a standardised approach to treatment across the four trial centres.
0,"The primary endpoint component, clinically significant anemia of presumed occult GI origin, was defined as a hemoglobin decrease of more than 2 mg/dl from baseline, which had no apparent non-GI cause to explain the decrease."
1,"Multicentred randomised, double blind, placebo-controlled trial."
0,The intervention allocation was concealed in a non-transparent envelope.
6,The primary end points were all cause mortality and adverse events leading to an interruption of trial drug.
0,"Regarding the Belgian legislation, single embryo transfers were performed when the patients entered for the first time an IVF/ICSI cycle."
8,"Assuming a death rate of 15 per 100 person years in the previously untreated participants (based on a death rate of 18/100 person years in a trial in a similar population of patients in Lusaka15), a total of 1408 person years of observation would be needed to show a 35% reduction in death rate in patients receiving co-trimoxazole, at the 5% level of significance with 80% power; a 40% reduction would require 1045 person years."
0,The findings and conclusions in this publication are those of the authors.
3,"Patients diagnosed with TS, aged 7–14 years, either sex, with a minimum score of 40 points on the Yale Global Tic Severity Scale (YGTSS) [29], among whom the onset of clinical exacerbation has been observed."
0,"Joints were evaluated clinically for tenderness and swelling (clinical synovitis), followed by a blinded assessment for ultrasound (US)-confirmed synovitis in B-mode and power Doppler ultrasound (PDUS) at baseline and 4 months after start of anti-TNF."
4,"This project was carried out in the city of Lawrence, Massachusetts, a primarily Latino community characterized by families struggling with high levels of poverty, limited access to jobs, and limited access to resources families need to prosper [11]."
0,"As this was a pragmatic trial, centres maintained their usual practice other than providing the intervention standard components."
6,"Outcome measures were changes in anthropometry (BMI, weight, waist, waist-to-hip ratio), VO2max, self-reported physical activity, blood pressure, triglycerides, cholesterols (total, HDL, and LDL), fasting blood glucose, glucose tolerance, and HbA1c."
0,The Medical Outcomes Trust's Short Form 12 (SF-12) was included to provide a generic measure health-related quality of life.32
5,Data on the treatment effects of liraglutide 1.2 mg and 1.8 mg or rosiglitazone added to glimepiride were extracted from the LEAD-1 study (Table 1).
0,"We will then explore the extent to which receipt of WH-PACT concordant care (PACT features, comprehensive WH care, gender sensitive care delivery) is associated with improved WH-PACT outcomes (aim #2)."
1,"A two-arm parallel group, multi-centre, randomised controlled trial with outcome data collection every 12 weeks to 48 weeks post-randomisation."
0,"The primary efficacy outcome was the proportion of patients who achieved a CDAI-70 clinical response (ie, a decrease from baseline in CDAI ≥70 points) at week 8 or week 12."
3,"The trial methodology was described in detail in the protocol and has been published elsewhere with the inclusion criteria, ethics approval, and consent criteria.1,2"
0,The forms will be kept under lock and key in the central ASD office with only the PI and project coordinator having access to them.
3,Table 1 shows the baseline characteristics.
0,We used a cluster randomisation with the households serving as clusters.
4,"Demographic, behavioral and clinical data were collected from enrolled participants through interviewer-administered questions using forms translated into local languages and back translated to ensure appropriate content."
0,"Training was supported by detailed materials, conducted in the local language (isiZulu) and included both theoretical and clinical components."
4,"Data forms were scanned and entered using intelligent character recognition (ICR) DataFax software (DataFax, ver 3.7-004, Clinical DataFax Systems Inc., Hamilton, Ontario, Canada) and centrally double-verified by independent data technicians."
0,In the placebo arm patients received methotrexate placebo and tocilizumab placebo for 8 weeks (two infusions); from week 8 placebo infusion was replaced by tocilizumab 8 mg/kg infusion for the remaining 16 weeks of the study.
14,Outcome assessors were blinded to a participant's allocation.
0,The majority of text messages contained motivational quotes or practice suggestions.
14,Success of blinding was evaluated by asking assessors to identify each participant's allocation at each assessment; if they identified rehabilitation they were further asked to identify whether the participant had been in the Indiv-rehab or Grp-rehab arm.
0,Change from baseline in ADAS-Cog at week 24 was a coprimary endpoint in both studies.
16,Differences in proportions of those allocated simvastatin versus those allocated placebo were assessed using standard parametric methods and an intention-to-treat approach.
0,"A temperature of −20°C inside the condensing chamber, which was maintained throughout the collection time, produced immediate sample freezing."
16,"No adjustment has been made for multiple hypothesis testing, but due allowance is made in the interpretation of the results."
0,Read counts from the SAM files were obtained using bedtools multicov from bedtools [32].
3,"Healthy volunteers aged 18 to 57 years (that is, <60 years at Year 3 of the study) were eligible."
0,"During their ICU stay, patients in both groups were evaluated by the nursing staff using the RASS and the CIWA-Ar scale (either every 2 h or prior to rescue therapy)."
3,"Exclusion criteria were: allergies to egg or chicken proteins or any of the vaccine constituents; a chronic illness in the active phase; acute febrile disease within 72 hours of any of the vaccinations or an axillary temperature >37.5°C on the day of vaccination; influenza vaccination within 6 months of the first study vaccination; any vaccination within 28 days of each study vaccination; pregnancy or breastfeeding; treatment with immunosuppressive or cancer therapy within 1 month of each vaccination, or an immunoglobulin injection within 3 months of each vaccination."
0,"As secondary outcome measures, evaluators assessed walking quality using the Walking Index for Spinal Cord Injury and Spinal Cord Injury Functional Ambulation Inventory.Statistical analyses."
14,Neither the general health workers nor TB programme managers were blinded to the allocation.
0,Expectations for amounts of daily crying at different points during infancy are also detailed.
14,"Although we did not blind the laboratory technicians, they were not informed whether the sputum specimens were from the intervention or control kebeles."
0,"Various behavior change techniques were incorporated into the intervention to increase intentions to exercise (i.e., motivation to do the exercise program), planning for exercise (i.e., detailed plans for the exercise program), instrumental attitudes (i.e., anticipated benefits of the exercise program), affective attitudes (i.e., anticipated enjoyment of the exercise program), injunctive norm (i.e., perceived approval and social support for the exercise program), descriptive norm (i.e., perceived role modeling of the exercise program), and perceived behavioral control (i.e., perceived controllability and self-efficacy for doing the exercise program)."
4,TB case finding and treatment outcome data were collected from TB registers at health facilities and districts.
0,Data were processed and summarised in 15-s epochs by using the ActiLife six software.
4,"The information collected included date, age, sex, address, TB classification, smear results and treatment outcome using the official reporting system of the NTLCP."
0,The peer health coaches and staff are both involved in the sustainability planning process.
6,The primary efficacy measure was A1C at end point (last observation carried forward [LOCF] to 24 weeks).
0,"Evaluation is also carried using a quantitative digitizer scoring system, as described by Vrieling et al. [17]."
6,"Secondary outcome measures included change in A1C from baseline to end point, A1C at each visit, percentage of patients with end point A1C <7.0% and ≤6.5%, seven-point SMPG profiles, weight change from baseline, total daily insulin (TDI) dose at end point, and incidence and rate of hypoglycemic episodes."
0,The trial protocol was reviewed and approved by all central and local Institutional Review Boards.
3,Inclusion and exclusion criteria are listed in Table 1.
0,Device implantation was then scheduled in participants randomized to the VNS group.
3,"According to these criteria, the sample of patients included in the study is representative of patients who qualify for treatment in an outpatient setting who suffer from either anorexia nervosa or subsyndromal anorexia nervosa."
0,Figure 1 Progress of intervention.
6,"The primary endpoint was the duration of the weaning process, from the moment the patient started to breathe spontaneously until successful extubation."
0,"The sliding head piece of the stadiometer was lowered so that the hair was pressed flat, and height was recorded to the nearest millimetre."
6,"Secondary endpoints were: levels of pressure support, TV, RR, FiO2, SpO2, PEEP levels and RR/VT required during the weaning process, need of reintubation or need of non-invasive ventilation (Figure 1)."
0,"However, a single-blind design was maintained through the use of a “drug administrator” (eg, a physician or nurse) who instructed the patient how to use the study drug, but who was not involved in any study assessments."
6,"The primary end point in the NORCCAP trial 1 is incidence of colorectal cancer to be reported after 5, 10, and 15 years of follow-up on an intention to screen basis, in which all randomised, eligible people are included, regardless of their compliance with the screening examination."
0,"Afterwards, this catheter will be exchanged for the cryoballoon catheter or the mesh ablator, respectively."
6,Further end points are mortality from and incidence of colorectal cancer within the reach of the flexible sigmoidoscope (rectum and sigmoid colon) for attenders (per protocol analysis).
0,Apoptosis was demonstrated by terminal deoxynucleotidyl transferase (TdT) dUTP nick end labeling (TUNEL) [9].
5,"In the BCG-BCG study, volunteers were vaccinated with BCG (a single immunisation with BCG (BCG Denmark, Statens Serum Institute, Copenhagen, Denmark), 100 µl administered intradermally over the deltoid region (n = 14))."
0,"The difference in Q‐TWiST between the 2 arms was measured over the time from the date of randomization (so‐called gain‐of‐function analysis; see Fig. 1C).9, 10"
5,"In the BCG-MVA85A study, subjects were vaccinated intradermally with a single immunisation of 5×107 pfu MVA85A [24]."
0,Hemoglobin concentrations were quantified through finger prick or peripheral blood samples using HemoCueTM.
8,"We calculated that to detect whether pralidoxime reduced the case fatality in symptomatic patients from 25% to 19% (two-sided significance level of 5%, power 80%), a minimum of 750 patients was required in each arm."
0,"Patients will wear a 'watch' with an accelerometer inside (Actiwatch [41]) on both wrists for three days, during waking hours."
8,The trial was set up as a superiority trial.
0,"A large, randomized control trial previously demonstrated that there is no significant difference in pregnancy outcomes between 2 and 3 times daily dosing of PVI [21]."
5,"During the first month, subjects in the intervention group received instruction from the physician to use NNS when craving appears and at least 2 puffs/hour, for an average of 1 mg nicotine/hour when awake."
0,The respiratory variation that resembles the lung 'sinusoid sign' is either fully (panel b) or partially (panel d) visible.
5,Instructions were given to the patient as if this was the usual way of using the NNS.
0,"Only consonant comprehension was tested, to both increase the difficulty of the test and increase the matching between the speech perception evaluation and the frequency areas tested by the eABR (from 1,107 Hz to 4,883 Hz)."
3,• Pregnant or lactating women • Women planning on becoming pregnant within the next year • Any illness or reason where the GP feels that the patient should not be taking part in a clinical trial.
0,The algorithm identified patients who had been in contact with different parts of the healthcare system for lung-related complaints; consequently the category “unsure” was added to the confirmed verified diagnosis of COPD.
1,"A multiprofessional team comprising a consultant diabetologist, diabetes specialist nurse, specialist diabetes dietician and clinical health psychologist designed the BITES intervention."
0,The average number of total events acquired was about 7 x 105 cells.
1,"Randomized, double-blinded, placebo-controlled, phase II clinical trial."
0,Participants indicated availability for predetermined meeting times; these intact groups were stratified by their baseline BMI percentile value and then were randomized using a biased coin approach.
6,The efficacy of lovastatin to control HIV-1 replication allowing an improved immune reconstitution will be determined by primary and secondary outcomes.
0,Compliance to the extracorporeal shock wave therapy was naturally measured.
6,"The primary outcome will be the viral load measured as RNA copies per mL of peripheral blood, and the secondary outcome will be the CD4 T-cell count measured as cells per μL of peripheral blood; both determined at enrolment, and 6 and 12 months after the intervention."
0,The use of portable sippy cups is discussed with a focus on avoidance of frequent drinking of caloric beverages (e.g. milk) at non-meal times.
3,"• Left ventricular systolic dysfunction, left ventricular ejection fraction ≤35%, as documented at the moment of ICD implantation; • Implantation with a wireless-transmission-enabled Medtronic ICD or CRT-D; • Ability and willingness to undergo remote follow-up instead of scheduled routine in-office follow-up visits; • Ability to attend all required follow-up examinations at the study center."
0,"To ensure equal proportions of age and BMI in each study arm, randomization was stratified by those variables."
3,• Age less than 18 years; • Unwillingness or inability to give informed consent; • Life expectancy less than 12 months; • Participation in another clinical study that may have an impact on the endpoints of the present study.
0,Informed consent was obtained from all patients prior to entry into the study.
8,"Based on a recent systematic review and meta-analysis of 26 randomized controlled trials, we anticipate an incidence of CIN at 48 to 96 hours of approximately 15%[16] In order to detect a 30% relative risk reduction (RRR), with 90% statistical power, and a two-tailed alpha of 5%, we will need to include at least 2,300 patients."
0,"The questionnaires were used to collect information from patients, relatives, physicians and the nursing staff."
1,"The study will be a prospective randomized controlled trial (RCT) with three arms (i) walking programme, (ii) a supervised exercise class, (iii) usual physiotherapy of up to 8 weeks duration."
0,"All patients were prospectively followed for 6 months postsurgery for assessment of vital status, readmission, and adverse events."
1,"Outcomes will be assessed at baseline and 3, 6 and 12 months [follow-up by pre-paid postage]."
0,Fig. 1 Sketch map of the left jackknife position Fig. 2 Trocar placement in the left jackknife position.
4,"A sample of patients will be recruited in Dublin, Ireland through the physiotherapy departments of acute public hospitals that provide physiotherapy treatment for people with CLBP."
0,The safety profile was also recorded.
8,"For the primary objective, the study had a 90% power to detect a difference between the proportion of subjects experiencing a grade 3 solicited or unsolicited general reaction following vaccination, should the difference in the proportion afflicted exceed approximately 20% to 30%, depending on the rates in the control group (rates of between 5% and 50% were assumed)."
0,Disease activity was estimated using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) [19].
8,"For the secondary vaccine efficacy endpoint, the study had 90% power to detect significant (p<0.05) vaccine efficacy of either candidate malaria vaccine versus control assuming an infection rate of 72% over the 14 week period for surveillance of infection and a true vaccine efficacy of 45%."
0,A negative control outcome (urinary tract infection) was used to assess the presence of trends not associated with influenza.
14,"Due to the differences in visual appearance of each of the study vaccines, blinding was maintained by preparation of the vaccines by the pharmacy staff in an area separate from where vaccination occurred."
0,"This sample size was expected to detect a difference in risk of 5% assuming 80 physician clusters, 50 patients per physician, a cluster correlation of 0.01, and a Type I and II error of 5% and 20%, respectively."
14,Post-vaccination evaluations of AEs were conducted by a separate team.
0,Scheme managers were supportive of the trial and encouraged their staff to participate as recruiters.
13,"The investigator, who was informed from the Copenhagen Trial Unit via telephone or email whether a patient was randomised to intervention or control group, told the patient the result of the randomisation."
0,Patients were asked to play the games three times.
13,For those in the intervention group the investigator arranged an appointment with the physiotherapist or provided the intervention herself.
0,The CKD273 classifier is a Support Vector Machine (SVM)-based classification model21 22 that was developed for discrimination between patients with CKD and controls.23
6,"The outcome was the incidence density of ankle sprain and its 95% confidence interval, expressed as incident ankle sprains per 1000 hours of exposure."
0,Samples were run against a bovine blood calibration curve spiked with Se (Se standard solution 1000 ppm; Fisher Chemical).
6,"We differentiated self reported sudden inversions of the same ankle according to severity27: recurrences leading to loss of sports time and recurrences resulting in healthcare costs or lost productivity costs, or both."
0,"The oral probenecid (Watson Pharmaceuticals, Parsippany, NJ) daily dose was 2 g (1 g twice per day), which based on previous publications corresponds to a mean serum concentration of 149 ng/mL.25"
3,"Anyone with a diagnosis of MS confirmed by their consultant physician or neurologist, resident in the republic of Ireland is eligible to take part."
0,"In the pre-diagnosis phase, only screening of CRN contributed to the costs but the treatment was included."
3,It is not necessary for participants to be members of MSI.
0,"Army Medical Research and Materiel Command (USAMRMC), the Medical Ethical Committee of the Institut Pasteur de Tunis, Tunisia, and the Consultation Committee for the Protection of Individuals in Biomedical Research at Hospital Tarnier-Cochin, Paris, France."
14,"For practical end ethical reasons, neither the patient nor doctors or nurses are blinded with respect to the type of treatment used."
0,"When the answer to the analysis is ready, the answers are sent out to via the database to ensure blinding of PCT-analysis in the control-arm."
14,"Events will, however, be evaluated by an independent committee that will be blinded."
0,"• Blood count, blood chemistry obligatory (within 7 days before inclusion in the study and within 4 weeks before start of treatment): Haematocrit, haemoglobin, white blood cell (WBC) count, red blood cell (RBC) count, lymphocyte count, neutrophil count, platelet count, aPTT and PT-INR, SGOT, SGPT, alkaline phosphatase, bilirubin (total), urea (blood urea nitrogen), creatinine, creatinine clearance (CrCl) calculated using Cockcroft and Gault formula, calcium, potassium, sodium, magnesium, glucose, lactate dehydrogenase (LDH), albumin, amylase, TSH, free T4, urine dipstick for protein • Women of childbearing potential must have a negative pregnancy test (HCG in urine/serum) not more than 7 days old on start of treatment."
8,900 patients including 450 patients randomised for OPCAB and 450 randomized for CCABG.
0,"From this list, 10 patients per practice were selected by the study team using random numbers produced by SPSS (Version 15.0, SPSS Sciences, Chicago, USA)."
8,"To detect a reduction in PHS of 3 days (SD 5 days), which is in agreement with the study of Lobo et al. [17], with a two-sided 5% significance level and a power of 80%, a sample size of 50 patients per group was necessary, given an anticipated dropout rate of 10%."
0,"PDA = patent ductus arteriosus; MPA = main pulmonary artery; RPA = right pulmonary artery; PV = pulmonary valve; AD = aorta descendens; AA = aorta ascendens, LV = left ventricle, RV = right ventricle, LA = left atrium Streamlines (Figs. 2a, b, c) and particle traces (see Additional file 2) originating from the main pulmonary artery, as well as 3D velocity vector fields (Figs. 2d, e, f), demonstrated that left-to-right ductal shunting caused retrograde blood flow along the anterior wall of the main pulmonary artery, reversing direction from retrograde to anterograde above the pulmonary valve."
8,To recruit this number of patients a 12-month inclusion period was anticipated.
0,Analyse peripheral T cell immune response before and after treatment start using telomerase immunomonitoring.
4,"Data on patient characteristics, complications, and restoration of gastric function were extracted from the (electronic) patient dossiers and case report forms (HV, MS)."
0,Children who attained the eligibility criteria were given pre-medications 3 days before randomisation to treatment allocation.
4,Raw data regarding the primary and secondary endpoints were checked by an independent investigator (GB) and all disagreements were referred to a third reviewer (DU).
0,Patients received morphine prior to surgical incision.
8,"We calculated that we would need 524 participants recruited from 60 clusters (practices) in order to show a reduction in the proportion of children who reconsult from 20% to 10%, with 80% power, at a 5% significance level, and with an intracluster coefficient of 0.04."
0,The randomization was performed by a researcher not involved in the data collection using the participant identification (subject ID) after stratification for EPDS score and previous history of depression.
8,Our aim was to ask 60 practices to recruit ten children each (total of 600 participants) which would allow for loss to follow-up and missing data.
0,"After randomization and stratified by initial SA nasal carrier status, we enrolled 50 patients in the intervention group and 39 patients in the control group."
8,"Mean recruitment haemoglobin for the PMMST study was 11.7 g/dL, (SD 1.5 g/dL) for a population of 1156."
0,"General psychiatric features – The Structured Clinical Interview for DSM-IV (First, Gibbon, & Williams, 1997) was used at baseline to identify the presence of co-existing general psychiatric disorders, and the level of depressive features was measured using the Beck Depression Inventory (BDI) (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961)."
8,A sample of 150 for each trial arm was required in order to detect a change in haemoglobin of 0.5 g/dL between study arms with 5% significance and 80% power.
0,Potential participants coming for a visit to their Meuhedet clinic will be find posters and flyers advertising for participants in the project.
10,GlaxoSmithKline generated the randomization schedule comprising blocks of six patients by center.
0,"While the validity of the screening tests used in the comprehensive geriatric assessment has been established [12], aspects of test reliability have rarely been explored."
14,"Investigators, technicians performing microbiological assessments and patients were blinded to study treatments."
0,The study was designed to detect a clinically important detectable difference of 10 points in mean Rowe score.
8,"Using data from the pilot study, we estimated we would need about 750 to 800 participants per group to achieve 80% power to test each one of the three hypotheses at 0.0167 alpha level (after applying a Bonferroni correction)."
0,Detailed reports were prepared summarizing the feedback and UI/UX recommendations based on the comments.
6,The primary outcome was weight in kilograms measured in the research offices using a calibrated scale.
0,"We used the median and interquartile range to describe the distribution of GA estimated by each method and the Wilcoxon signed rank sum test to assess statistically significant differences between methods because GA distributions estimated by LMP, Farr and ultrasound were slightly skewed."
3,Table 3 shows the inclusion and exclusion criteria.
0,"Villages were not matched or stratified based on baseline rates of morbidity, mortality or health-seeking patterns."
3,These criteria were established in order to ensure the representativeness of the study sample to the population who would receive the BIS outside of the trial.
0,"The enrolled patients were hospitalized and randomly assigned treatment with artemether-lumefantrine (Coartem; Novartis), either accompanied with or without intake of 200 ml of full cream milk together with each drug dose."
16,"In order to examine the feasibility of the trial methodology, the following were examined: response rates to the trial; response rates to the individual questionnaires and items; comments relating to the trial functioning made during interviews with patients, carers, referrers and BIS providers; and, researcher fieldwork notes."
0,Study site staff at each clinic invited all clinical trial participants to participate in the interviews at enrollment.
8,The targeted sample size of 100 (50 AC-1202 and 50 Placebo) was determined empirically.
0,"If approached patients refuse to participate, reason(s) are noted."
8,"Due to the exploratory nature of this study and the lack of clinical/statistical references for ADAS-Cog change effect sizes associated with ketosis, the formal statistical power could not be calculated."
0,The clinical and laboratory test data can be collected on occasion of a second interview to be arranged with the participants and/or relatives.
14,"The participants, those administering the interventions, and those assessing the outcomes were blinded to group assignment."
0,vaccination (0·5 mL).
14,The double-blinding was achieved through the production and use of a Placebo similar in taste and appearance to the investigational product AC-1202.
0,"Content will be analysed in terms of countable concepts/objects e.g. descriptive statistics, or in the broadest terms (e.g. majority, some, very few)."
16,Statistical comparisons of BIAsp 30 outcome measures at baseline and final visit were performed with paired t-tests for continuous variables and with Wilcoxon signed-rank tests for discrete variables.
0,Subsequent eligible volunteers were enrolled first into the vaccination group and subsequently into the control challenge group.
16,All testing used two-sided tests with the criteria set at α = 0.05.
0,"The trial participant's unique and personal identification number will be submitted to the Danish National Board of Health in order to link to data from the Danish Central Psychiatric Register, the Medicinal Product Statistics, and the Danish Medical Register on Vital Statistics to the study data."
3,"A consecutive sample of 24 male patients with an idiopathic Parkinson disease diagnosed by a neurologist, with the following criteria were entered into the study: age ≤ 65 years, stage 2 to 3 of the Hoehn and Yahr scales [16], no cardiovascular, orthopaedic, or other neurological disease, no cognitive impairment (MMSE score >24; [17]), and had not received exercise therapy within the 6 months prior to the study."
0,This study was approved by the Institutional Review Board of Severance Hospital and the ethics committee.
3,"• Written informed consent • Age: between 18 and 75 years • Chronic tinnitus since at least 6 month, but not more than 5 years."
0,Intraindividual differences were compared by the paired t-test.
3,"• Objective tinnitus • Acute or chronic inflammation of the middle ear, acute hearing loss, hearing loss due to an acoustic trauma within less than past 6 weeks • Morbus Menière or fluctuating hearing loss • Epilepsy • Brain trauma • Brain surgery • Heart pacemaker • Intake of anticonvulsants, antipsychotics, and regular intake of benzodiazepin • Suicidality • Other severe pathological chronic condition that might confound treatment effects or interpretation of data • Pregnancy • Participation in another clinical study regarding tinnitus within the past 3 months and during enrolment in our study."
0,Hypoglycemia was defined as blood glucose <3.5 mmol/l.
8,"In order to detect a moderate to large effect size of 0.55 in change in illness and treatment beliefs, with 80% power and a significance level of 5%, a sample size of 100 will be needed."
0,"As a second step, the data was re-analyzed inductively using an editing organizing style to identify other therapeutic processes (ie, those not explicitly related to ACT)."
8,"We anticipate that 30% of those invited will agree to participate, and 80% of those recruited will return their final questionnaires; so that 400 patients will need to be sent letters inviting them to participate, 120 will be recruited, and 100 will return final questionnaires."
0,"Central laboratory assays of lipid profile were conducted at randomisation in samples obtained from all participants, in about 10% of participants attending study visits at 1 and 4 years after the initial randomisation, and from all participants attending the 2·5-year visit."
16,"A non-parametric rank-sum test for non-normalized distribution of data was used to compare changes in IHC markers between cases and controls, as well as between baseline and treated cases."
0,"A statistician not involved in enrolment computer generated the concealed allocation sequence, and the researchers who did outcome assessments were blinded to group allocation."
16,Significance was established at a p value of < 0.05.
0,"They were acquired using a standard one-dimensional (1D) pulse sequence [recycle delay (RD)–90°–t1–90°–tm–90°-acquire free induction decay (FID)] with water suppression applied during RD of 2 s, a mixing time Tm of 100 ms and a 90 pulse set at 7.70 μs."
6,"The primary endpoints were the cumulative incidence of malaria (parasite density > = 300/uL with an axillary temperature > = 37.5°C or a history of fever in the previous 48 hours), and the proportion of children who experienced moderate or severe adverse events."
0,"Patients were excluded if they had intercurrent illness or co-morbidities making completion of the trial unlikely, worsening breathlessness requiring urgent medical intervention, or prior breathing training."
6,"Secondary endpoints were malaria incidence with any parasitaemia in the presence of fever or a history of fever, compliance with and acceptability of the regimen, the prevalence of parasitaemia, the mean haemoglobin concentration and the prevalence of moderate (Hb<9 g/dL) and severe anaemia (Hb<5 g/dL), and the proportion of children carrying parasite genotypes associated with resistance to sulfadoxine or pyrimethamine at the end of the transmission season (one month after the final treatment round)."
0,Subjects willing to participate are subsequently sent written information on the study procedures along with an informed consent form.
4,"An adapted version of the client service receipt inventory was used to collect economic data at individual level,7 8 administered as a self completion questionnaire alongside the other outcome measures at the baseline assessment before randomisation (in the general practice) and at the four month and 12 month follow-up (both by post)."
0,"Safety profile evaluation included collection of adverse events (AEs) and serious AEs (SAEs), clinical laboratory values, vital signs, and 12-lead ECG from randomization through study day 84."
4,"It focused on arthritis related resource use for the previous three months and, alongside personal characteristics, covered income and employment status; use of health and social care resources (drugs and hospital and community based health and social care); costs borne by participants, their family, and friends (out of pocket expenses, lost pay, and informal care); indirect impacts (time off work for participants and carers); and receipt of social security benefits."
0,"The average reaction time, number of omission and commissions and mean amplitude of CNV and P300 is assessed."
8,"For any comparison between two study groups, the study had 80 percent power to detect an approximately 3 fold increase of events, for an event occurring at a frequency of ten percent in the comparator group, by Fisher exact test (alpha 5%)."
0,) and in patient populations (.90
8,"For the secondary immunogenicity endpoints, anti-CS titres, a sample size of 75 evaluable subjects per group would have 90% power to demonstrate equivalence of the two vaccine regimens under comparison (i.e. x versus y, 95% CI of the GMT ratio x/y is within the range 0.33 to 3.0) at any time point assuming a log standard deviation of 0.9 in both groups, alpha = 0.025."
0,Blood hemoglobin levels were collected in real time using a HemoCueTM Hb 201+ photometer to test for anemia (iron deficiency).
4,Five acute older persons' care wards at Nottingham University Hospitals NHS Trust (NUH).
0,All assays were performed by the Brigham and Women’s Hospital Research Assay Core; the Core was blinded to study condition.
3,All patients admitted to five older persons' care wards are eligible for inclusion into the trial.
0,Definitions of clinical risk factors are presented in online supplementary methodology.
3,"Patients will be excluded from the study if they were permanently bed bound prior to admission, moribund/unconscious, or receiving end of life care on admission, or if they have previously been included in the study in an earlier admission."
0,In patients randomized to “the implantation of the device followed by traditional 10 J safety margin testing” ventricular fibrillation was twice induced by a shock on T (1 J) and was terminated by a shock 10 J below the maximal available energy of the respective ICD (Table 1).
8,"Based on data obtained from our wards during 2005, we anticipate a rate of bedside falls of 8.0 per 1,000 bed days in the control group, assuming that 53% of all falls occur at the bedside and that the average length of stay is 19 days (mean number of falls per patient = 0.15)."
0,"Because infiltrations were performed bilaterally, the higher degeneration grade was used for further statistical analyses."
8,"To detect a 35% reduction in the rate of bedside falls among the intervention group, assuming 80% power, alpha = 0.05 and an over dispersion parameter of 1.5 (to allow for non-independence of falls within individuals), 905 participants are required in each arm of the trial."
0,"During the first visit, personal and family history, as well as medication, was recorded in a specially designed 1-page form (Table 1)."
8,EDIPS-Newcastle was designed to contribute to the European study.
0,All animal studies were performed in accordance with American Association for Laboratory Animal Care institutional guidelines.
8,"We aimed for a sample size of 100 participants (50 in each arm), contributing to a planned total of 750 participants across Europe."
0,No post-deployment ballooning was used.
8,"We assume that the proportion of patients achieving ≥ 30% reduction in iPTH in the last four weeks of the treatment period would be 50% in the alfacalcidol group and 68% in the paricalcitol group [13,14]."
0,"Video counseling was delivered via Polycom PVX, a program installed on desktop computers and linked to the University of Kansas Medical Center study staff via the Internet."
8,"Based on 0.8 power to detect a significant difference (P = 0.05, McNemars test), 117 patients is required for inclusion."
0,We chose even block sizes between 4 and 12 to minimize the possibility that clinical staff will be able to guess the next treatment allocation.
14,This is an open-label study.
0,"This included tests for coordination (heel-toe ataxia), fine finger dexterity (ability to pick up a 500 mg paracetamol tablet that is 10 mm diameter and 0.5 mm thick), nystagmus and balance (assessment of sway when standing with feet together and eyes shut) [18] and ability of those >5 years old to rise from a squatting position."
6,"The incidence of first recurrent suicidal behavior (expressed as attempted or completed suicides/person-year) will be used as the primary outcome, because an individual who reattempts suicide is at high risk for completion of suicide."
0,"Participants were randomly assigned to one of three intervention arms: 1) RTS,S/AS01E as three injections, one month apart (0, 1, 2 months schedule [012]; n = 170), 2) RTS,S/AS01E extended schedule (0, 1, 7 months schedule [017]; n = 170) or 3) control (EPI vaccines alone; n = 171)."
6,"Therefore, in order to develop effective suicide prevention strategies, it is essential to measure the time to the next suicidal behavior."
0,"An indwelling intravenous catheter was inserted following aseptic techniques, and blood samples were drawn for the determination of pre-dose concentrations of artemether, dihydroartemisinin and lumefantrine."
1,A two-arm parallel group randomised controlled trial with outcome data collection every 4 weeks to 32 weeks post-randomisation.
0,Each block of 90 numbers was sent from the central office to a person who acted as the randomisation manager in each hospital.
4,"Participants will be seen at hospital every 3-4 weeks until 24 weeks after randomisation, follow up visits will occur at months 9 and 12, and then at yearly intervals."
0,"The key messages combined the evidence based guidelines on falls prevention [12,13] with information from the case note audit and survey and included: the benefits of the use of aspirin in residents with increased stroke risk, the monitoring and treatment of hypertension, the benefits of the use of warfarin in residents with atrial fibrillation, and the risk of psychotropic drug use."
4,Research staff at the hospitals will be expected to complete trial CRFs which record evidence of primary and secondary outcome measures.
0,The group was used to better characterize age-related trends in balance which were required to determine parameters of complexity-based measures of sway as described below.
14,"Given the nature of the intervention, it was impossible to blind the patients and the trainers as to which condition they participated in."
0,Participants were asked to “pull initially with a moderate intensity and slowly increase the intensity to maximum exertion while keeping the upper body extended and upright”.
14,The outcomes will be assessed by blinded interviewers.
0,Table 1 IMMI curriculum.
8,"Based on existing default rates of 13%, we calculated that we needed to enrol 270 patients to detect a reduction in the primary outcome (default rate) to an acceptable 3%, with 80% power and an α of 0.05."
0,"Assays were performed at GSK Vaccines, Siena, Italy, by ELISpot, following standard procedures (Slifka and Ahmed, 1996)."
16,"Data at the end of the three treatment periods were compared using a mixed-effects model (SAS Proc Mixed, SAS Institute)."
0,The purpose of the sub-study was to determine the effects of the intervention on physical fitness and objectively-measured physical activity.
16,"To adjust for multiple comparisons across the three treatment periods, we defined statistical significance at the 1.7% level."
0,Our experience and the literature have shown that coupling training with a site implementation strategy optimizes the benefits of EBP training.
1,"Multicentered randomised, double-blind, placebo-controlled trial."
0,"The primary aims are to test the hypotheses that the intervention is more effective than usual care in: 1) reducing weight and body mass index (BMI); 2) reducing fasting insulin levels and increasing insulin sensitivity; and 3) reducing total cholesterol and LDL cholesterol at 6, 12, and 24 months."
1,"This was a double-blind randomized controlled trial, where children between six months and 12 years of age attending the sickle cell clinic were randomized to receive either monthly SP or weekly chloroquine."
0,"Ethics approval was received from the Faculty of Medicine Ethics Committee, Colombo, and Oxfordshire Clinical Research Ethics Committee."
1,"The sample size of 242 was based on the assumption that the prevalence of malaria would 29.4% in the chloroquine group and 11.1% in the SP group [18,19] with an α = 0.05, a power of 90% and an estimated 10% loss to follow."
0,"The key areas explored were reasons for participation, barriers to receiving the intervention, and perception of the intervention process including participants’ initial expectations and reflections."
4,Patients were recruited from the practices of 11 general practitioners in the northern part of the Netherlands.
0,"For the first survey all GPs received a letter of invitation, and the survey booklet (Additional file 1)."
8,This study was designed as a non-inferiority trial.
0,Cox proportional-hazards model was used to explore the probability of death before and after TB therapy adjusting for confounding variables and factors of interest.
8,"Assuming 80% statistical power, a one-sided α level of 2.5%, and adopting an unequal 2∶1 randomisation ratio, 1,500 patients (1000 DHA-PQP, 500 AL) were needed to show that the difference of the day 28 PCR-corrected cure rates between DHA-PQP and AL was within −5%, assuming a response rate for AL of at least 92%."
0,"Routine monitoring included 5-lead ECG, pulse oximetry, non-invasive blood pressure, bispectral index, cerebral oximetry, continuous arterial blood pressure, pulmonary artery catheter, and transoesophageal echocardiography."
16,"Univariate, correlation and analysis of variance analyses were performed using SAS version 9.1 (Cary, NC)."
0,"Subsequently, potential subjects in the study provided their own written consent to information provided on audiotape in Bambara (the local language)."
16,Tests of statistical significance used a Type I error rate of 0.05.
0,"The cases identified in the register linkage were confirmed by medical history data, which were obtained based on the informed consent from the hospitals and hospital municipal health centers."
1,"E-LITE is a randomized controlled clinical trial in which overweight or obese adults with an increased risk for CVD and diabetes are equally randomized to one of three arms: UC (control), SM, or CM."
0,"The time and motion methodology consisted of 1) dividing a process into key tasks, and 2) observing each task to assess the average time required to perform it."
1,All procedures and materials were approved by the Palo Alto Medical Foundation Research Institute's Institutional Review Board.
0,"The diffraction data were analyzed by using the Mie diffraction method, which is used for accurately measuring the light-scattering behavior of spherical particles over a large size range (0.02–2000 μm) (Malvern Instruments Ltd.)."
8,"Based on differences in the postprandial responses of triglycerides in the chylomicrons and VLDL fractions between diabetic and control subjects (0.7 mmol/l per 6 h, SD 0.85 mmol/l) (12), we considered as clinically relevant a 30% difference between the two treatments of the primary end point (postprandial incremental area of triglycerides content in chylomicrons and VLDL fraction)."
0,A thick and thin blood smear for parasitaemia and a blood sample on filter paper (Whatman 3MM) for later molecular analysis were collected before treatment.
3,"In brief, patients aged 12–75 years, who fulfilled ACR criteria [19], with a diagnosis of SLE and histologically confirmed LN (Classes III–V with active or active/chronic lesions, International Society of Nephrology/Renal Pathology Society classification [20]) were enrolled at 88 hospital clinics in 20 countries in Asia, Australia, Europe, Latin America, USA and Canada between July 2005 and October 2006."
0,The data for this manuscript derive from baseline salivary samples obtained prior to randomization.
6,The primary efficacy parameter was the proportion of patients responding to treatment at the end of the 24-week induction phase of the study.
0,"Pedometers have a sticker over the display during the baseline assessment period, and no step-count goals or feedback are provided during this stage."
6,"Response was defined as a decrease in urine protein/creatinine ratio (P/Cr), measured over 24 h, to <3 in patients with baseline nephrotic range P/Cr (⩾3 at baseline), or by ⩾50% in patients with sub-nephrotic baseline P/Cr (<3) and stabilization (±25%) or improvement in serum creatinine levels.Secondary efficacy variables included the BILAG index, the Safety of Exogenous Estrogens in Lupus Erythematosus National Assessment–SLEDAI (SELENA–SLEDAI) scale [22–24], the immunological complement concentration (C3 and C4) and anti-dsDNA autoantibody binding levels."
0,It ranges from 0 (dead) to 100 (fully able).
1,The experimental phase of the study will be conducted using a two-group prospective RCT design comparing the effects of two provider mailing conditions: control (Usual Care) versus intervention (CIS + Questions).
0,"In Study 2, participants were also required to have ≥6 months' history of donepezil therapy, with 2 months at a stable dose and no intent to change during the study."
1,The RCT design will be 2 × 2 factorial with Clinic (EFHC versus PAC) and Letter (Usual Care versus Intervention) as between subjects factors.
0,"Both alarm points and transport points can be used to treat diseases of specific Zang-Fu organs; for example, Zhongwan (CV12) and Weishu (BL21) are the alarm and transport points of the stomach and can be used to treat diseases related to this organ."
6,There are three primary study outcomes 1) telephone calls to CIS (call volume); 2) timely completion of medical follow-up (within 6 months); 3) patient satisfaction with doctor-patient communication at medical follow-up.
0,Participants in both groups underwent clinical training but this was the only type of training provided to the control group.
8,"We estimated that 2% of women would be breast cancer aware at baseline (Burgess et al, 2009) and that there would be a 12% difference between trial arms."
0,"Ambulatory BP monitoring (24-h ABP) was performed with a standardized ABP device (Meditech ABPM-04 monitor, PMS Instruments, Maidenhead, UK) that was applied around the patient's nondominant arm."
8,"Incorporating a design effect to take account of clustering by centre and radiographer (Lee and Thompson, 2005) (assuming an intracluster correlation coefficient of 0.08 and 14 participants per centre–radiographer cluster) and allowing for 70% response, we required 238 women per arm (total 714) with a significance level of 5% (two-sided) and power of 80%."
0,The caloric content of food provided was verified through bomb calorimetry (14) of an average of three samples by the UAB Nutrition Obesity Research Center core laboratory.
5,"The intervention consists of: - Information feed-back to the health-care professionals (clinician and nurse) generated from the clinical history and from the patient interview - Training provided to the health-care professionals based on a course of 20 h in which the aspects considered are: CPG, motivational interview, treatment of the tobacco habit, correct use of inhalers, diets, physical exercise, physiotherapy - Implementation in the PCC of the health-education program to patients with COPD by those who have received the training To be able to evaluate the efficacy of this intervention, the comparison is between the intervention group and the control group (formed of patients attended-to by the health-care professionals who did not attend the training course)."
0,"Blood samples were analyzed on a Hitachi 7600–110 analyzer (Hitachi High-Technologies Corporation, Japan)."
5,"The pre-intervention data collection is from the year 2004 and, after 1 year, the same information is collected post-intervention."
0,We will produce public replication files for our primary analyses in both countries.
4,"The study was conducted at the Rockefeller University Hospital in New York City, USA, and the University of Rochester Medical Center in Rochester, New York, USA."
0,Further details are reported elsewhere.15
4,The protocol for this trial and supporting CONSORT checklist are available as supporting information: see Checklist S1 and Protocol S1.
0,Twelve addiction experts participated in the semi-structured interviews about the relationship between tobacco and cannabis use and the demand for and possible design of an ISCP.
3,"• Histologically or cytologically confirmed gastric adenocarcinoma with or without prior resection of the primary or metastatic disease • Limited metastatic disease that is measurable by CT, mandatory PET scan and/or MRI: - Esophageal invasion <4 cm that does not require thoracotomy (Seiwert II and III lesions) - Hepatic metastases (unilateral or bilateral, ≤ 5 lesions, ≤ 15 cm total diameter) - Primary peritoneal metastases (small disease load, ≤ P2 disease) without clinically significant ascites or intestinal obstruction - Lung metastases (≤ 3 unilateral/bilateral, 9 cm total diameter) - Patients who present with both hepatic and peritoneal metastases must have no evidence of extensive para-aortic/retro-pancreatic lymph node metastases • All disease should be deemed resectable to negative margins (NED) based on imaging studies • Patients with or without prior chemotherapy treatments for metastatic disease will be eligible • Age greater than 18 years • Clinical performance status of ECOG ≤ 2 • Life expectancy of greater than three months • No history of prior/other malignancies within the 2 years prior to enrollment with the exception of basal cell carcinoma • Laboratory parameters within acceptable limits to undergo surgical resection and/or systemic chemotherapy Exclusion Criteria"
0,"After written informed consent, children will be included into the study if all study selection criteria (see Table 1) are met."
1,"The ACCORD study is a double 2×2 factorial, randomised, controlled trial designed to test the effect of intensive glucose control compared with standard control on cardiovascular outcomes in patients with type 2 diabetes, and either intensive blood pressure control versus standard control or a lipid strategy that targets low density lipoprotein cholesterol, high density lipoprotein, and triglyceride levels versus a strategy that targets low density lipoprotein cholesterol levels only.16 17"
0,During the examination the presence of cervicitis and pain or tenderness on bimanual pelvic examination in keeping with a clinical diagnosis of pelvic inflammatory disease were noted.
1,The full ACCORD study protocol is available at: http://www.accordtrial.org/web/public/documents/Protocol%20All%20Chapters.pdf?CFID=360349&CFTOKEN=40333908.
0,Patients who want to participate have to fill in the informed consent form.
6,"Participants were examined at the end of weeks 2, 6, 12, 24 and then every 12 weeks; and had a safety follow-up visit one week after the end of treatment."
0,"Of these, 70 met exclusion criteria (including significant neurocognitive disability, inability to communicate in English or French, imminent graft failure, imminent transfer to adult care)."
6,"Characteristics of participants and non-participants were compared using chi-square tests and Kruskal-Wallis tests, as appropriate."
0,"We also collected information on previous screening and, if so, type of medical assistance (private or public), frequency of visits, the result of the last cytology test performed and previous HPV tests."
3,Patients are selected based on the following inclusion criteria: 1) post-bronchodilator FEV1/FVC ratio < 70%; 2) age > 40 years; 3) smoking history of more than 20 years or 15 pack-years; 4) diagnosis of COPD as major functionally limiting disease and 5) current use of bronchodilator therapy.
0,"Before starting recruitment, we detailed the processes and procedures that we would use in a manual of procedures."
3,"Exclusion criteria are: 1) primary diagnosis of asthma (onset < 35 years, ≥ 12% post-bronchodilator reversibility); 2) primary diagnosis of cardiac disease and 3) presence of disease that could either affect mortality or participation in the study (e.g. confusional states)."
0,Interested patients who met the eligibility criteria were met by the clinical research coordinators (CRCs) in the prescreening unit for discussion of the protocol.
3,Male and female subjects aged ≥ 50 and < 70 years will be eligible for the study if they meet the following inclusion criteria: Inclusion Criteria
0,This database has been used to store information regarding patients’ medical histories at our institution since 2006.
3,"• Clinical diagnosis of type 2 diabetes lasting more than one year, based on standard diagnostic criteria (patients on treatment with oral hypoglycaemic agents or insulin or with fasting plasma glucose > 126 mg/dl on two occasions) irrespective of diabetes treatment • Cardiovascular risk equal or higher than 10% according to the Italian risk chart available on Progetto Cuore website [14,15] • Ability to exercise and willingness to comply with all study requirements Exclusion Criteria"
0,"In both arms, radiotherapy is delivered with CT-based 3D-conformal treatment planning with a defined pelvic clinical target volume (CTV)."
9,During the study interim analyses will be performed every year with the scope of verifying the correctness of the assumptions made for sample size estimation with regard to the primary end point event rate (this information can influence the duration of follow up) and to avoid unforecast excess of event rate in the treatment group.
0,Many studies provided evidence for the merit of adventure-based programming as means of creating positive change for patients with major depression [22].
3,Study participants were recruited from the Audiology Clinics at the Seattle and American Lake Divisions of the Puget Sound Health Care System from February 2006 through October 2007.
0,"A safety review committee assessed available pharmacokinetic, safety and tolerability data after each cohort was dosed to determine the next dose level."
3,Participants were eligible to enroll if they met the following criteria: • No previous hearing aid use • Monaural or binaural air-conduction hearing aids were fit as a result of findings at the hearing aid evaluation visit.
0,FAME was identified with authentic standards.
6,"The primary outcome was the incidence of severe postpartum haemorrhage after vaginal deliveries, defined as a composite of all women who experienced one or more of blood transfusion, intravenous plasma expansion, arterial embolisation, surgical procedure, admission to an intensive care unit, treatment with recombinant factor VII, and death."
0,These selected images were used for mean far-wall common carotid artery IMT measurements via manual tracings.14
6,"Secondary outcomes were each of the components of the primary outcome, manual removal of the placenta, and administration of prostaglandins after delivery."
0,Written informed consent was obtained from all study subjects; consent procedure included two educational sessions with confirmed understanding by the site investigator.
8,The sample size calculation took into account the cluster randomised design; we estimated the intracluster correlation coefficient to be 0.01.
0,"At the first day of enrolment, all children attending standards one to five received an empty stool container together with a consent form; both labeled with unique identification numbers (ID)."
8,"With the assumption of an event rate for the primary outcome of 2.5% in the control group, 82 clusters (41 in each arm of the trial) were required to detect a decrease in the event rate to 1.5% (a 40% relative risk reduction) with 80% power, a two sided significance level of 5%, and an average cluster size of 300 women.25"
0,The UK decision threshold of £20 000–£30 000/QALY will be used to determine cost-effectiveness.17
10,The allocation schedule is generated prior to the study by the Sheffield Clinical Trials Research Unit.
0,Vinorelbine was administered in line with product labeling.
10,The randomisation sequence is computer-generated.
0,Participants had to be able to complete standard academic performance tests (our primary outcome).
12,The allocation schedule will be concealed through the use of a centralised web-based randomisation service.
0,In all cases with all three devices the tip of the laryngoscope blade was placed in the vallecula and external pressure was applied to the neck if necessary.
14,"Data analysts will be blind to treatment allocation, but the study manager, research assistants and participants (who are also outcome assessors) will not be blinded."
0,"During this process, eligibility for inclusion into the study was assessed by the physical therapist assigned to the patient."
1,"Cluster randomized trial, controlled and multicentric."
0,"For the AMA1 allelic forms the competitor/soluble antigens were titrated 3-fold over 7 wells from 100 to 0.137 µg mL−1 with PfAMA1 from the FVO, 3D7, HB3 or CAMP alleles (Figure 1)."
1,Randomization unit: Primary Care Team (PCT).
0,The primary endpoint was accuracy against FFR ≤ 0.80 and compared using a McNemar test between metrics.
1,This will be a single-blind 2 arm pragmatic randomised controlled trial of individually prescribed exercise in a class setting versus usual care.
0,"The MetaCore analytical suite (GeneGo, St."
4,"The study will take place within Primary care practices in the geographical care covered by the North Thames Dementias and Neurodegenerative Diseases Research Network (NT DeNDRoN); Metropolitan North London, Essex, Hertfordshire and Bedfordshire."
0,All other variants are in Tier 5 and considered variants of uncertain significance (VUS).
6,"Effectiveness was measured by the difference in the change in sickness absence days between the two treatment arms, i.e., the difference in sickness absence days between follow-up and prior year was calculated."
0,"Therefore, the relative expression levels of the target genes in the patient groups were calculated according to the comparative Ct method (−ΔΔCt method)37 using GAPDH as the reference gene."
6,"Employee-specific sickness absence data, without medical diagnosis, were obtained from the employer’s records, covering two consecutive periods from 1st October 2003 to 30th September 2004 (prior year) and from 1st October 2004 to 30th September 2005 (follow-up)."
0,It was not possible to blind the involved parties due to the complex nature of the intervention and the study design.
5,All women who are identified as having suspected foetal distress and have given informed consent prior to delivery will be randomized in two groups: One group of pregnant women will receive one IV dosage of 500 mg ALLO.
0,"Rates of response, remission and dropouts will be compared between the two groups using Pearson's chi-square test for categorical data."
5,The other group will receive one IV dosage of placebo antenatally.
0,Written informed consent was obtained from the participants before enrollment.
1,"Three-pronged, randomized clinical trial in a primary health care setting in Mallorca."
0,Estimation of the respiratory rate from the amplitude modulation of the PPG requires a preprocessing stage in which an appropriate low-pass filter attenuates as much high-frequency content (corresponding to the cardiac frequency) as possible while preserving the low-frequency content (corresponding to the respiratory frequency).
1,"We carried out the following: an intensive individual intervention (III) and an intensive group intervention (IGI) as experimental branches, and the standard minimal intervention (MI) as the control branch."
0,Manual tracing of endocardial borders in each successive slice position at the chosen end diastolic and end systolic phase was performed.
3,"The current multicenter study will be conducted in three representative areas in China, Shandong province, Hubei province and Guangdong province, which locate in northern, central and southern parts of China, respectively."
0,"Allocation was minimized [18] by sex and age retaining a probabilistic element using a computer-generated random number sequence, and was implemented using an automated telephone randomization service provided by the Bristol Randomized Trials Collaboration to ensure concealment from clinical staff undertaking recruitment."
3,Women who attend routine pregnancy diagnosis in hospitals or maternal healthcare centers will be invited to take part in the randomized controlled intervention trial.
0,"Participants are subjects who met the following inclusion criteria: (i) no history of asthma before apprenticeship, and, (ii) for ""non-exposed"" subjects, not to have worked, before or after apprenticeship, in an occupation at risk of OA."
1,The FINALE programme consists of 3 randomized controlled trials (RCT) and 1 exploratory case-control study involving several workplaces.
0,"To ascertain HIV status at baseline and follow-up visits, we used the Advanced Quality™ Rapid Anti-HIV (1&2) test which is a colloidal gold-enhanced, immunochromatographic assay for the qualitative detection of HIV antibodies in whole blood, serum or plasma."
6,"The common main outcomes of the interventions composing the FINALE programme are the measures for physical deterioration; musculoskeletal disorders, work ability and sickness absence."
0,Blood samples were drawn from a venous catheter into lithium heparin tubes and centrifuged immediately at 344g for 15 minutes.
6,"However, the primary and secondary outcomes are specifically tailored for each respective intervention."
0,aPatients received the same doses as in the MM-021 trial.
8,"Under the assumption of four successful follow-up assessments and a within-subject correlation of r = 0.40, 72 participants in total would yield, at a two-sided alpha < 0.05, a power of 0.81 to detect a medium effect size of d = 0.35 for main effects [62], i.e. a difference of 0.35 of the pooled standard deviation."
0,"Briefly, PBMC were thawed from different time points and treated with DNAse."
1,"This randomised, open, cross-over clinical trial was conducted in four centres in The Netherlands: in Amsterdam, Hengelo, Heerlen and Delft."
0,"The consortia provide these data openly on their respective websites: GLGC: http://www.sph.umich.edu/csg/abecasis/public/lipids2013; MAGIC: http://www.magicinvestigators.org; DIAGRAM: http://diagram-consortium.org; and, CARDIoGRAMplusC4D: http://www.cardiogramplusc4d.org."
1,"The trial, which was conducted between February 2003 and November 2003, was approved centrally by the Stichting Therapeutische Evaluatie Geneesmiddelen and by the local Ethics Committees."
0,"In preparation for phase 1, we will develop baseline assessments, recruit and randomize practices, integrate the IPHR into the EHRs and PHRs of study sites, assist with practice training, and support local tailoring of IPHR content."
1,"The study is designed as a mono center, single arm phase I/II pilot trial."
0,Each parameter was measured off-line in triplicate and averaged.
16,"Prism© software (Graphpad, Inc., La Jolla, CA) was used for statistical analyses by linear regression, non-linear regression, or repeated measures two way analyses of variance (2-way ANOVA) followed by Bonferroni posttests as detailed in the results."
0,"On Day 21, an on-treatment MTT was performed, identical to the one done on Day −1."
16,Prism© was used for preparation of graphs.
0,Weight assessments were conducted using digital clinic scales with shoes off and clothes worn.
14,"Patients, investigators, clinical staff performing assessments, data analysts, and the sponsor's trial team were blinded to treatment from the time of randomisation to database lock (unless there were any patient emergencies)."
0,METs are the cost of exercise as a multiple of resting VO2.
14,"All the study drugs were identical in appearance, packaging, labelling, and administration schedule."
0,"In general practice, adults were either assigned to the intervention group or to the control group (2:1)."
1,Cross-sectional and multicentre study.
0,"Venous access, number and size of sheaths were at the operator’s discretion."
6,"Outcome measurements encompassed: a) the number of mf present in skin snip biopsies taken at baseline, 4, 12 and 21 months after the start of treatment, b) the quantity of a Wolbachia single copy gene (Wolbachia surface protein; wsp) within extirpated nodule tissue 21 months after the start of treatment and the immunohistochemical staining of Wolbachia within adult O. volvulus tissues 21 months after the start of treatment, c) the histological assessment of the frequency of embryonic stages present within female O. volvulus uteri 21 months after the start of treatment, d) the detection of adult O. volvulus motility within onchocercomas using ultrasonography e) histological assessment of parasite viability, f) the clinical monitoring and assessment of adverse reactions during primary drug allocation (doxycycline) or secondary drug allocation (ivermectin) in patients singly infected with O. volvulus or co-infected with L. loa and g) the number of L. loa and M. perstans mf present in 50 µl thick blood smears taken at baseline, 4, 12 and 21 months after the start of treatment."
0,Secondary outcomes include child and parental knowledge and attitudes related to SSBs.
1,A single arm Phase 2a study examining the efficacy of a liquid nicotine cigarette as an aid to smoking cessation.
0,New risks for subjects become known.
6,"Consistent with established guidelines, cessation was defined as an exhaled carbon monoxide (CO) level of less than or equal to 8 parts per million (ppm) [11,12]."
0,Patients alive without progressive disease at the time of data analysis will be censored at the time of the most recent follow-up visit.
6,Participants who failed to complete appointments were assumed to have returned to smoking.
0,AEs were coded using the Medical Dictionary for Regulatory Activities (MedDRA).
1,"Multicenter randomized clinical trial designed to compare antibiotic prescription in patients with acute pharyngitis in two groups of physicians, one with the use of RADT and the other without these tests."
0,"Plates were then developed with chromogenic substrate tetramethylbenzidine dihydrochloride monohydrate (Sigma-Aldrich, Dorset, UK)."
4,The trial will be conducted in Primary Health Care Centers in Catalonia (Spain) in which the clinical history records are accessed electronically.
0,"Allocation sequences were kept by the statistician centrally, and the allocation was facsimiled to us after the research assistant ascertained the eligibility and the written informed consent."
8,"Two hundred seventy-six patients are required in each arm to detect a reduction of 10% in antibiotic prescription from 85% in the control group to 75% in the intervention group, assuming a rate of 85% of prescription in the control group, allowing 10% for losses in the follow-up visits, with a power of 90% and a level of significance of 5% (2-sided) and performance values of the RADT given by the manufacturer."
0,"From each aliquot (I, II, and III), 2 × 1 mL (sample and backup) were gently mixed before transferring into 2-mL amber screw-cap tubes (Fisher Scientific) by using plastic disposable transfer pipettes (Fisher Scientific) and immediately stored at −20°C on site."
14,"It is not possible to blind participants, patients or doctors."
0,Visitors had excellent social skills and general competency and were trained to deliver social attention absent of any intuitive form of communication therapy or strategy.
14,Data will be analyzed blinded to treatment group allocation.
0,Patient time to death was then extracted from the study database and grouped according to these time points.
1,"BE WELL is a two-arm randomized controlled clinical trial (RCT) in which obese patients ages 18-70 years with suboptimally controlled, persistent asthma (n = 324) will be equally randomized to the WL or UC arm."
0,"Before the health interview started, all students were asked to complete a baseline questionnaire."
1,All procedures and materials were approved by the Kaiser Foundation Research Institute's Institutional Review Board.
0,The trial was designed as a prospective single-centre randomised controlled trial (RCT) with a one-year follow-up period at a level-one orthopaedic and trauma centre.
6,The primary outcome was the difference in the proportion of patients with parasitologically-confirmed recurrence of P. vivax infection at or before day 56 between the two arms.
0,"On subsequent study dates, participants performed eight bouts of submaximal constant-load exercise with work rates alternating between 30 W and 35% VO2peak."
6,"Secondary outcomes were parasite and fever clearance times, recurrence at earlier time points, gametocytaemia at day 28 and 56, haemoglobin recovery, and safety and tolerability of the treatments."
0,High on-treatment platelet reactivity (HPR) was defined as 5 μmol/L ADP-induced maximal PA >46% (LTA) or P2Y12 reaction units (PRU) >235 (VerifyNow) (9).
8,"Given the relatively high predicted efficacy of chloroquine, a non-inferiority design was used [23] with the aim of testing whether dihydroartemisinin-piperaquine was non-inferior to (i.e. equivalent or better than) chloroquine in terms of the proportion of patients with parasitological failure at 56 days; the non-inferiority margin (Δ) was set at 5%."
0,"After the closure of the McCord study site, the McCord Hospital Medical Research Ethics Committee transferred the protocol to the University of KwaZulu-Natal Biomedical Research Ethics Committee (BREC)."
8,"The sample size was 550 patients (275 per arm), calculated assuming a 95% cure rate with chloroquine, a one-sided alpha of 0.05 and 80% power."
0,Fluid challenge consisted of 250 ml of colloid when hemodynamic indicators were in favor of hypovolemia (pulse pressure variation (PPV)>15% and variation of CI>10%).
6,"Cognitive score from the Bayley scales of Infant and Toddler Development, 3rd edition (Bayley-III) [33] at age of 2 years (24 - 27 months)."
0,Our empirical approach therefore relies on the time series variations before and after the tax implementation in October 2014.
6,"• Death • Neurological optimality score [34,35] • Gross and fine motor score from the Bayley-III [33] • Cerebral Palsy • Gross motor function classification score (GMFCS) [36] • Seizures requiring regular anticonvulsant treatment • Visual difficulties not corrected by spectacles • Hearing difficulties requiring aids • Language - expressive and receptive scores from the Bayley-III [33] • Parent Report of Children's Abilities, (PARCA-R) [37-39] • Infant Characteristics Questionnaire [40] • The Brief Infant-Toddler Social and Emotional Assessment (BITSEA) [41] • Measures of growth - height, weight and head circumference [10] A child will be considered to be functioning within the normal range for age if their results are within the normal range for all Bayley scores and they have a normal neurological examination, normal vision (including with spectacles) and normal hearing (no aids)."
0,(B) Oxygen controller.
14,"Given the nature of the interventions, local researchers cannot be blinded as to the treatment delivered."
0,The assessors were not blinded to group assignment.
14,Central research staff will be unaware of treatment condition when carrying out analyses to assess outcomes.
8,"We determined that to detect a 35% reduction in the rate of falls from an expected rate of 2.0 falls per year to 1.3 falls per year with 80% power and 5% significance (two sided), and assuming an overdispersion of 1.5, we needed a sample size of 160 participants (80 in each arm)."
0,"No attempt was made to standardise energy intake across groups as the overall purpose of the study was to determine the relative effectiveness of commercial diet programmes in overweight, but otherwise healthy subjects, who were free to interpret the dietary regimen as they chose."
8,"Allowing for 20% dropout, we set a recruitment target of 200 people (100 in each arm)."
0,Assessments were performed during initial patient screening (within 28 days of study day 1); 14 days after dosing in cycle 4; every 12 weeks (± 1 week) thereafter; and at the end of treatment.
14,It was not possible to blind the participants and treating therapists to allocation group as they would be aware of receiving or giving falls rehabilitation.
0,"After optimization, two concentrations (10-1 and 10-3 ng/μl) were selected as positive controls."
14,The assessors who contacted the participants to collect missing data on outcome measures and the research staff who input data were blinded to allocation group.
0,"We stratified our analyses to evaluate possible effect modification by maternal age at conception (18-22, 23-26, and ≥27 years old), age at vaccination (18-22, 23-26, and ≥27 years old), and age at enrolment to the first phase of the trial (18-22, 23-26, and ≥27 years old)."
4,"Data were collected at baseline and after 12 months from the following two sources: (i) a self-completed postal patient questionnaire (comprising questions on demographic and socioeconomic status, a questionnaire to ascertain patient satisfaction (Grunfeld et al, 1999), the Short Form-36 (SF-36) questionnaire (Ware, 1993) and the Hospital Anxiety and Depression Scale (HADS) (Zigmond and Snaith, 1983)) and (ii) patients' general practice-held medical records for information about the initial melanoma diagnosis as well as treatment and use of primary and secondary care services in the previous 12 months."
0,"Additionally, the estimation of the distance and speed walked was highly accurate (r = 1 between the actual and the processed distances and r = 0.97 between the actual and the processed speeds)."
14,Blinding of the general practitioners regarding group identity is not possible.
0,Insulin levels were determined by ELISA.
14,"Patients do only know that different types of blood pressure record booklets are being distributed, but they do not know in detail what the difference between the booklets is."
0,"After a negative HC2 test result, any initial ASCUS diagnoses were routinely downgraded to normal cytology, with women being referred back to routine screening."
16,Statistical analysis was performed using the software SAS 9.1.3 (SAS Institute Inc.
0,A common clinical protocol was approved for each site by the appropriate Ethical Review Board.
16,"Cary, NC, USA) and included non-parametric group comparison tests (Mann-Whitney and Wilcoxon-test) nonparametric (Spearman) correlation tests, and parametric (Cox proportional) and nonparametric (Kaplan-Meier) survival analysis with p < 0.05 considered significant."
0,They will be calculated using BDI-II assessment scores following the method of Lave et al. [25].
1,The study will be a prospective feasibility randomized controlled trial (RCT) with three arms (i) a supervised exercise class of 8 weeks duration (ii) a walking programme of 8 weeks duration and (iii) usual physiotherapy.
0,Percent NI was determined by subtracting NA activity from 100%.
1,Outcomes will be assessed at baseline and 3 [face-to-face] and 6 month [pre-paid postage] follow-up.
0,"In order to finalise the structure of the VAPI questionnaire, a factorial approach was chosen in order to analyse the questionnaire in its entirety."
4,A sample of patients will be recruited in Beaumont Hospital physiotherapy department that provides physiotherapy treatment for people with CLBP in the Northside of Dublin City.
0,Diagnostic performance differences were noted between the sites based upon the presence of non-overlapping confidence intervals for sensitivity or specificity calculations for any particular drug.
1,The effectiveness of the TECNOB program will be assessed in a two-arm randomized controlled trial.
0,Written informed consent was obtained from all participants.
1,"Participants will be randomly allocated in 2 groups: 1) TECNOB group: in-hospital treatment (diet, physical activity, psychological and dietitian counseling) plus extensive outpatient telecare through a web-platform and mobile phones; 2) CONTROL group: in-hospital treatment (diet, physical activity, psychological and dietitian counseling) and follow-up assessment at the 3rd, 6th and 12th month; The Medical Ethics Committee of Istituto Auxologico Italiano approved the study protocol."
0,All Israeli citizens are covered by the National Health Insurance Law through one of four Health Maintenance Organizations (HMOs).
3,This study was part of the Hyperinsulinaemia: the Outcome of its Metabolic Effects (HOME) randomised trial investigating the effects of metformin on metabolism and on microvascular and macrovascular disease in type 2 diabetes.
0,"New children’s menus are printed with the restaurant and project logos and include the price and what the price includes (e.g., with or without a beverage)."
3,"The trial included 390 patients aged 30-80 years with type 2 diabetes who were receiving treatment with insulin, as previously described.3 16"
0,First the T1 images were aligned to a single subject template in MNI space.
8,Sample size was calculated by estimating that a 20-hour difference in mean CTT would be found between placebo and active tea at the end of the study.
0,"Following MCAo, animals were randomly assigned to receive oral NSI‐189 (n = 24) or vehicle (n = 24), starting at 6 hr after stroke, and daily for the next 12 weeks."
8,"Using data from a Brazilian sample of constipated patients were mean CTT (± standard deviation) was 113.1 ± 23.1 hours [16], with a power (1-β) of 80% and an alpha error of 0.05, the minimum number of patients required to detect a statistically significant difference was 22 in each period."
0,"PFS was calculated as the time between study enrollment and first documented progressive disease or death, whichever occurred first, based on EBMT criteria."
3,"Patients must fulfill all of the following inclusion criteria: • Peripheral or central intravenous catheter and urinary catheter • Early AKI • ≥ 2 criteria for the systemic inflammatory response syndrome (SIRS) within 24 hours • Achieved immediate resuscitation goals (as directed by the treating physician) including fluid resuscitation AND/OR vasoactive therapy to achieve mean arterial pressure ≥65 mmHg, central venous pressure ≥8 cmH2O, central venous oxygen saturation ≥70% (if measured) AND/OR cardiac index ≥2.5 L/min/1.73 m2 (if measured)."
0,"At the randomization visit, baseline spirometry, CF related quality of Life (CFQ-R QOL) [23] and Gastroesophageal Symptom Assessment Score (GSAS) measuring number and severity of reflux symptoms [24] were collected."
16,Differences between participants assigned to the ILI and DSE treatments were compared at baseline and 1-year using Student t test for unpaired data for continuous variables and a χ2 test for categorical variables.
0,"All patients received prophylactic low molecular weight heparin (LMWH) (dalteparin, Pfizer Inc."
16,Results are given as median values and range or interquartile range.
0,All patients in the study were offered the option to enroll in the PSP.
16,Wilcoxon rank-sum (P < 0.05) and Spearman nonparametric tests (P < 0.05) were used when appropriate.
0,Potential controls were randomly selected from the booking lists and the gestation for interview calculated from the expected date of delivery.
6,"Plasma glucose was measured using a bedside YSI glucose analyzer (2300 Stat Plus; Yellow Springs Instruments, Yellow Springs, OH) throughout the study at regularly timed intervals."
0,"For the mass spectrometric analysis, heated electrospray ionization (HESI) was operated at a spray voltage of -2.5kV, a capillary temperature of 225°C and a vaporizer temperature of 382°C."
6,"Blood samples were collected pre- and postprandially for exenatide, insulin, C-peptide, GLP-1, and glucagon."
0,Descriptive data analysis was performed for all parameters.
5,"Patients self-administered the new formulation of sc IFN beta-1a, 44 mcg tiw, in a multi-dose cartridge, using the new electronic device for 12 weeks."
0,"First, participants had to attend two online webinars; second, each participant had to assess a set of training vignettes and achieve a criterion level of performance."
5,The baseline device 'comfort settings' were the same for all patients.
0,The two pediatric wards were selected because evidence of the impact of ABHR on HAIs among pediatric patients has been particularly scarce in resource limited settings [7].
6,"The Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) Axis I Disorders, Clinical Version (SCID-I) and the Structured Clinical Interview for DSM-IV Personality Disorders (SIDP-IV) were used for diagnostic screening for PTSD and BPD, respectively."
0,"A clopidogrel loading dose (600 or 300 mg, at the discretion of the operator) or matching placebo was given at the time of PCI."
16,"Descriptive statistics, chi-square, independent sample t-test, analyses of covariance adjusted for possible confounders and multivariable analysis were used with a two-sided significance level of 5%."
0,"The limits of detection were 0.3 pm/L, 1.3 pm/L, and 0.02 IU/L, respectively."
16,SPSS version 15 was applied for both data management and analysis.
0,"Stimulation was performed in the presence of anti-CD28 and anti CD49 (BD) at final concentrations of 1 μg/ml, monensin (BD) at 1 μg/ml and Brefeldin A at 5 mg/ml (Sigma-Aldrich, Germany)."
1,"The MIPA study was a cluster-randomised controlled trial in 12 pathology laboratories and the 29 community hospitals in their catchment area, examining the effectiveness of a tailored implementation strategy for the MIPA procedure compared to standard implementation."
0,The study Comorbidities and Virologic Outcome Among Patients on Anti-retroviral Therapy in Rural Lesotho (CART-1) is a registered observational study assessing comorbidities and virologic outcomes among patients on first-line ART in Lesotho (registration: April 28th 2014; NCT02126696).
1,The Committee on Research Involving Human Subjects Region Arnhem–Nijmegen approved the study and waived the need for written consent from patients (project approval 2004/156).
0,Both a contrast enhanced CT scan and an 18F-FDG-PET-CT scan were done at the end of treatment.
1,"To evaluate the decision aid, we will conduct a patient-level single center pilot randomized trial."
0,Plasma concentrations of caspase-cleaved CK-18 were determined using a validated ELISA.
1,The Mayo Clinic Institutional Review Board has approved all study procedures.
0,"In our analyses, we characterize lung dysfunction respectively as: (1) no lung dysfunction (ppFEV1 ≥ 90 %), mild (70 ≤ ppFEV1 < 90 %), moderate (40 ≤ ppFEV1 < 70 %), and severe (FEV1 < 40 %); (2) deciles of ppFEV1; and (3) ppFEV1 treated as a continuous variable in multivariate analyses."
3,Patients were eligible for the enrolment if they had ACS with ST-elevation (rest chest pain less than 12 hours before admission and ≥ 1 mm ST-segment elevation in 2 or more contiguous leads or new left bundle branch block on ECG) or non-ST elevation ACS (rest chest pain during the past 48 hours and ≥ 1 mm ST segment depression or negative T waves in 2 or more contiguous leads).
0,"All men were followed-up for prostate cancer incidence, which was ascertained by record linkage to the Israel National Cancer Registry (INCR)."
3,"Exclusion criteria were: concomitant active liver disease or persistent elevation of transaminases more than three times above the upper limit of normal, history of lipid lowering therapy less than 30 days before index event, known allergy for fluvastatin or any present additives in the drug, disability of oral drug administration, disability of follow-up, pregnancy or nursing, women of fertile age without effective contraception, suspicions of muscle disease like myositis, subjects younger than 18 years, creatine kinase ≥ 5 times of the upper limit of normal range with other casual explanation than presence of myocardial infarction."
0,"The response factor was calculated for methyl esters of phytanic acid and short-chained fatty acid, based on the response of palmitic acid methyl ester (C16:0)."
6,The primary end point was peak anti-factor Xa levels.
0,The software also incorporates biometric data capture (fingerprint images) allowing storage of system-generated unique non-identifiable reference keys that are linked to study identification numbers.
6,"Secondary outcomes included AT, PT, aPTT, TAT, fibrinogen, platelets, and D-dimer."
0,Potential covariates were separately entered into the model and statistically tested by use of the likelihood ratio test.
17,"Within the experimental communities, outcomes will be compared looking at factors such as total number of MI sessions attended, number of fluoride varnish applications, individual DHR and individual community."
0,Fig 1 Schematic representation of the e-POCT algorithm.
17,Within the entire study sample outcomes will be compared looking at factors such as number of fluoride varnish applications and reported frequency of tooth brushing.
0,Soreness was normalized to 100% of the maximal perceived level.
1,"We will conduct a comparative study with retrospective and prospective parts, in which we will compare the redesigned stroke service in the intervention region with a comparable region that offers the usual stroke care."
0,"Antibodies of 4 colors were used to determine CD4 and CD8 T cell responses to HIV antigens including: CD3 (APC conjugated), CD4 (PerCP conjugated), CD8 (FITC conjugated), and a combination of antibodies to IL-2, and IFN-γ (both PE conjugated)."
6,"Frailty indicators (weakness, fatigue, weight loss, low physical activity, poor balance, slow gait speed and impaired cognition), performance of daily activities and morbidity."
0,"At booking eligible women are randomized to one of four intervention arms: 1.) Iron-folate (FeFol), representing the usual standard of care during pregnancy, as per Gambian Government guidelines; 2.) Multiple micronutrients (MMN), a combination of 15 micronutrients, specifically designed for use during pregnancy, and as formulated by UNICEF/WHO/UNU."
6,"Quality of life, life satisfaction, assistive technology, accessibility, feeling of loneliness, social interaction, social support, participatory activities, falls, fear of falling, health care consumption and mortality."
0,"The RCT recruited 187 participants with moderate to severe depression from the three sites as follows: Nottingham (137), Derby (21) and Cambridge (29):."
16,The main analyses included all subjects in the groups to which they were randomized.
0,We performed an open cohort study with longitudinal data collection.
6,"There were two main objectives of the Cycloset Safety Trial: 1) assessment of overall safety of bromocriptine-QR by measuring the frequency of serious adverse events (SAEs) among patients taking bromocriptine-QR and placebo, and 2) cardiovascular safety assessed by determining the frequency of major cardiovascular events, defined as a composite of first myocardial infarction, stroke, coronary revascularization, or hospitalization for angina or congestive heart failure that occurred after randomization."
0,"Assuming the same success rate in the control group, we calculated that 50 patients (25 per each group) were needed to show that AnapnoGuard 100 success (no AE or SAE the during intubation period) is at least 80%."
6,The outcomes were all-cause and CVD mortality (adjudicated by a blinded panel using predefined adjudication processes).
0,These included a “Practice Member Survey” that was distributed to all the providers and staff at each practice.
3,"Individuals at least 3 months post-stroke were recruited from stroke rehabilitation programs, outpatient follow-up clinics and from the community, and were eligible if they were able to provide informed consent, understand the evaluation procedures, walk more than 10 meters independently with or without aids and have a Chedoke-McMaster Stroke Assessment [6] leg impairment score of 3 (marked spasticity and weakness) or higher (representing less impairment) at the start of the program."
0,"A dedicated phone line will be available at IRCCS Stella Maris Foundation, a research assistant responds during business hours and an answering machine at all other times."
3,"Exclusion criteria included contraindications to maximal exercise testing [7], or significant musculoskeletal, pain, cognitive or behavioural issues that would limit the ability to perform the exercise testing and/or participate in the program."
0,"Utilizing Kappa statistics, good agreements (>0.8) were obtained for reproducibility of all recorded clinical parameters."
8,With the 100 participants per study group and a standard deviation of changes in ACQ score of 0.69 we were able to detect at least a 0.28 difference between ACQ score changes in the two study groups (significance level 0.05 two-sided; power 0.80 one-sided) [15].
0,Safety analyses were descriptive.
8,A clinically important decrease in ACQ score of at least 0.50 could thus be detected if at least 30 participants were present per subgroup [14].
0,"Clinicians tend to refer families to this service when family members have lasting and/or multiple difficulties within somatic, addiction, marital, social and economic areas in addition to psychiatric problems."
4,"Data were collected on Case Report Forms by the investigators, and entered in a data base using the Clininfo SA software (Clininfo SA, 99 rue de Gerland, 69007 Lyon, France)."
0,Any antidepressant medication taken at study entry must be discontinued (after consent) before beginning escitalopram.
8,The sample size was calculated according to data given by Hindmarch [25].
0,"Due to slow accrual of patients three other centres (University of Heidelberg, University of Mannheim, Salem Hospital in Heidelberg) were initiated in December 2007."
8,"Using a between-group mean score difference of 10 points, a score standard deviation of 15 points, α = 5%, power = 90%, the number of subjects needed is 100; i.e., 50 subjects per group."
0,"We used multivariate regression to assess the relationship between demographic, clinical and service-use variables with changes from baseline to 6-months in each of the outcome domains."
5,"After the diagnostic assessments, the patients are allocated for one of the following groups of treatment: Group I: lithium + valproic acid Group II: lithium + carbamazepine Lithium: Starting at 600 mg daily, dose weekly adjusted according to blood serum level (0,6 -1,2mEq/l), efficacy and tolerability Valproic acid: Starting at 500 mg daily, dose weekly adjusted according to blood serum level (50 and 125 μg/ml), efficacy and tolerability Carbamazepine: Starting at 200 mg daily and getting 600 mg daily at the end of the first week."
0,The quantitative and qualitative data are collected concurrently with the quantitative being the predominant design to gain perspectives from the different types of data [29].
3,"The study will include patients with liver-dominant metastases, of any histology, who cannot be treated by standard treatment options such as surgery and systemic chemotherapy, due to advanced stage of disease, significant side effects or unsatisfactory tumour response."
0,An intravenous line was placed 10–15 minutes prior to injection of 370 MBq FDG.
3,The detailed inclusion and exclusion criteria are listed in Appendix 1.
0,"Enrolled children were treated with the anthelminthic drug albendazole (PT Indofarma Pharmaceutical, Bandung, Indonesia) 400 mg OD for three consecutive days."
4,Patients with liver metastases who agree to participate in the study must be referred to the principle investigator by the department of Surgery.
0,CRP was obtained at the screening and final visit.
4,The principle investigator will inform every patient and obtain their informed consent.
0,"The FIB-4 score is computed using age, platelet, aspartate and alanine transaminase values, and provides an estimate of the degree of liver fibrosis in HIV and hepatitis C virus co-infected patients [7]."
1,Two simultaneous multicentre parallel group double-blind randomised placebo controlled trials of Propranolol and Pizotifen.
0,"The Betaseron Pregnancy Registry was a voluntary, prospective, observational, exposure registration and follow-up study."
4,Secondary care paediatric headache or neurology clinics.
0,Fig. 1 Illustration of the RIC-COR study protocol.RIPC = remote ischaemic preconditioning.
4,"The trial is taking place in three centres (Poole, Bristol, Southampton/Portsmouth) and each centre has a team of trained facilitators to deliver the fatigue management programme."
0,"Following a successful initial 6 months pilot where 475 women were recruited, it was observed that 64% had two or more social risk factors, and it was agreed to increase the sample size to allow power to detect differences in primary outcomes in the prespecified subgroup of women with two or more social risk factors, that is, so that the required sample size of 421 would be recruited within this subgroup."
8,"The planned sample size was 150 subjects, of whom at least 70% should be aged 10 years or younger, as this was the target age of the vaccine, randomised to M01ZH09 or placebo in a 2∶1 ratio."
0,"The service was established to improve the care pathways of young people ensuring that all cases of first episode psychosis have direct access to EIS, enabling and maintaining good levels of engagement with young people from their earliest presentation."
8,No formal sample size calculation was considered appropriate; it was aimed to include a sufficient sample size to assess safety and immunogenicity based on previous observations in adult studies and immunogenicity rates of licensed typhoid vaccines in children.
0,"The distribution balance will be achieved on six baseline covariates: age, sex, baseline stroke severity (measured by the National Institutes of Health Stroke Severity Scale (NIHSS) score), site of arterial occlusion, baseline Alberta Stroke Program Early CT score (ASPECTS) score, and treatment with intravenously administered alteplase (Table 1)."
1,The study is a double blind randomised controlled clinical trial with two parallel groups.
0,"The HOPE Registry was a prospective, Phase IV, multicenter, observational registry."
3,Female or male patients over 18 years old undergoing an elective repair for a midline incisional hernia are eligible for participation (table 3).
0,"Two exercise intensities were used, corresponding to 70% and 90% of maximal voluntary contraction established in 3 brief trials prior to MRS acquisition (in pilot experiments these intensities gave acceptable PCr depletion with minimal acidification in typical subjects)."
3,50 adult participants (Male or Female; aged 18 years or over) with LBP persisting for at least twelve weeks will be included in the study.
0,"GP screening providers were purposively sampled from this population to include those who (1) participated fully in the trial, (2) dropped out of the trial or (3) did not agree to participate in the trial."
3,Participants will be recruited through a number of different sources using previously employed methods [20].
0,"Facilitators were locally recruited based on their research experience, community knowledge, familiarity with the health care system, and qualitative research expertise."
16,Fisher’s exact test was used to evaluate the treatment effect on the proportion of responders at each cutoff time point.
0,If trastuzumab therapy is discontinued due to cardiac toxicity outside of the 3 or 12 month cardiac MRI scans then participants will return for another clinically indicated cardiac MRI within 1 week of chemotherapy termination.
16,"All statistical analyses were performed using SAS® version 9.1 or higher (SAS Institute, Cary, NC)."
0,"This questionnaire, based on a FV barriers questionnaire previously developed by Appleton et al. [18], contained twenty-one closed statements focusing on various aspects of FV consumption."
16,Statistical differences between groups were analyzed using the Student's t-test and the Fisher exact test with two-tailed p < 0.05 considered significant.
0,"Briefly, the assay was performed in multiscreen 96-well plates (MAHAS 4510, Millipore) coated with anti-human IFN-γ capture antibody (1-D1K; Mabtech AB)."
8,"Assuming a median time from enrolment to resolution of viraemia or NS1 antigenaemia in the placebo group of 72 hours and a reduction of this time by 24 hours due to CQ treatment (corresponding to a hazard ratio of 0.67 assuming an exponential distribution of the resolution times), we would need to observe viraemia or NS1 antigenaemia resolution in 191 patients to show such an effect with 80% power at the two-sided 5% significance level."
0,Male and female Arab students attending colleges and universities in Israel from 2007 to 2010 were recruited to participate in this study.
8,"Assuming sufficient follow-up to observe viraemia or NS1 antigenaemia resolution in 90% of patients, we would need to include at least 213 patients with confirmed dengue."
0,The setting was maternity booking in early pregnancy in NHS Greater Glasgow and Clyde in the West of Scotland where all pregnant women are routinely asked about their smoking status and a CO breath test is administered as an objective proxy measure of smoking status – about 97 % of pregnant women at first maternity booking in Greater Glasgow and Clyde undergo this test [20].
16,"Descriptive summaries with frequencies of reactogenicity measures, immune assay response rates and geometric mean titer results are presented along with nonparametric comparisons of antibody levels and reaction severity."
0,"Every patient received 10 µg iloprost (low dose iloprost), 20 µg iloprost (high dose iloprost) or placebo (normal saline) on three different study days."
16,An exact 2-sided 95% confidence interval for the rate of sterile abscess or delayed local reaction is calculated.
0,A cross-sectional survey was conducted between April and June 2014.
16,STATA10.1 was used for the calculations [16].
0,The list was prepared and maintained by an independent statistician at an independent clinical trial unit.
14,In a study of this type it is impossible to mask the intervention.
0,The PBMC were frozen in aliquots and stored in liquid nitrogen for later examination.
14,"To mask the analysis of data, the persons charged with this task were blind to the arm to which each PHCC had been assigned."
0,Functional blood-derived miRNAs have been recognised as potential robust biomarkers in the detection of various types of cancer.
4,Patients were recruited from the practices of 20 general practitioners in the northern part of the Netherlands.
0,The treatment was conducted within an exposure-extinction paradigm and patients were encouraged to use mindfulness and acceptance towards aversive internal events.
1,This controlled clinical trial was named Support for Increased Physical Activity (Stöd till Aktivare Motion or STAM in Swedish).
0,"Reverse osmosis filtered water was accessible ad libitum, while animals were fed certified chow biscuits twice daily and were provided both tactile and food enrichment in the form of various vegetables and fruits, foraging mix boards, as well as in and on cage tactile enrichment devices daily."
3,"Pregnant women were eligible for the study if they had at least one of the following risk factors: BMI ≥ 25 kg/m2, GDM or any signs of glucose intolerance or macrosomic newborn (≥ 4500 g) in any earlier pregnancy, type 1 or 2 diabetes in first or second grade relatives or age ≥ 40 years."
0,"At each visit, the field worker evaluated the child for the presence of clinical danger signs, and evidence of uncomplicated diarrhea, fever, or malaria, which were treated in the community, as described above."
3,"Women were excluded if they had at least one of the following: a pathological value in the baseline oral glucose tolerance test (OGTT) at 8-12 weeks' gestation (blood glucose > 5.3 mmol/l at fasting, > 10.0 mmol/l at 1-hour or >8.6 mmol/l at 2-hour), pre-pregnant type 1 or 2 diabetes, inability to speak Finnish, age < 18 years, twin pregnancy, physical restriction preventing from physical activity, substance abuse, treatment or clinical history of psychiatric illness."
0,"In addition, the subjects had to have fewer than 12 ventricular ectopic beats during a 3‐hour continuous recording at screening, as well as a baseline heart rate corrected QT (QTc) of <450 ms for men (470 ms for women), using Fridericia's correction.23"
4,All volunteers will be screened via telephone to ensure they meet the inclusion criteria.
0,"Cholesterol, phospholipids, triglycerides and total proteins were measured using standard colorimetric assays, SDS-PAGE was used as a quality control [16]."
4,"Participants meeting these criteria will be examined by the study physician (JAB) who will confirm their eligibility, complete a standardised physical examination which includes pubertal staging and measurement of blood pressure."
0,"Briefly, donor NK cells expressing a mismatched MHC class I allele for which a specific monoclonal antibody was available were spiked into a suspension of recipient blood mononuclear cells at dilutions ranging from 1:20 to 1:200."
3,"1) co-morbid conditions that limit physical activity such as severe cardiac disease, recent myocardial infarction, severe asthma or breathlessness, uncontrolled hypertension (blood pressure > 160/95 mm/Hg), or severe pain; 2) medical conditions that require a reduced fruit and vegetable diet (e.g. kidney failure); 3) history of insulin dependent diabetes; 4) treated with any type of steroid hormone; 5) treated for any other cancer; and 6) life expectancy of less than 2 years."
0,Participants were instructed to depress the foot pedal as hard and quickly as possible.
4,"The setting of the study is the Department of General-, Visceral-, Trauma Surgery and Outpatient Clinic of the University of Heidelberg, Medical School."
0,The existing model for EWRs has not tried to target every provider in a clinical area.
14,The dermatopathologists (JTS and JWP) were unaware of the study group during the primary assessments.
0,We used single data entry with visual verification on a predetermined random sample of records from the data set determined using a continuous sampling plan (CSP-1).13
6,"The primary endpoint of this study was the rate of MACCE, a composite ischemic vascular event following PCI, including cardiac death, nonfatal MI, TLR and ischemic stroke at 6 months in the DAT and TAT group."
0,"H0: p ≥ 0.1 versus H1: p < 0.05, which are tested with the one-sample Binomial-test at a one-sided significance level of α = 0.025."
6,"The key secondary endpoints defined a priori are - P2Y12 reaction unit (PRU) as assessed by VerifyNow® P2Y12 assay - Cardiac death, nonfatal MI, TLR, target vessel revascularization (TVR), stent thrombosis and ischemic stroke - MACCE according to the type of statin and its interaction with clopidogrel - Bleeding, as defined according to the TIMI bleeding classifications [22], major bleeding defined by the presence of at least 1 of the following: intracranial bleeding (documented with magnetic resonance imaging, computed tomography, any other examination or autopsy), or clinically overt bleeding resulting in a 5 g/dL decrease in hemoglobin value (or, when hemoglobin values were not available, a 15% decrease in hematocrit)."
0,"TILs from this patient were cultured for 5 hours with i) the DC-vaccine, ii) autologous DCs transfected with p53, survivin and hTERT mRNA, iii) autologous DCs transfected with single mRNA and iv) autologous DCs transfected with mock mRNA (i.e. negative control) at an effector/target ratio of 10:1."
8,"To test the hypothesis that TAT is superior to DAT in reducing MACCE at 6 months after PCI, based on the previous outcome data [10,13,23], we assumed that MACCE rate in DAT and TAT group would be 10% and 5% respectively."
0,"Total RNA was extracted from epithelial cells and alveolar macrophages using TRIzol (Invitrogen, Carlsbad, CA) followed by Rneasy (Qiagen, Valencia, CA) to remove residual DNA."
8,"Using a superiority design, an estimated total of 960 patients was needed to ensure a power of at least 80% to detect a 5% difference in the composite of ischemic vascular events between the two anti-platelet therapy groups using a two-sided t-test, with a sampling ratio of DAT:TAT at 1:1, bilateral risk set at 5% and drop-out rate estimated to be 10%."
0,"Sociodemographic factors (age, gender, ethnicity, marital status, education, composition of household), physical characteristics (e.g. height, weight, acuity of vision), environmental factors (e.g. pets, adjustments to the house), use of walking devices, medication, and use of health care services (e.g."
8,Sample size estimation of 30 subjects was based on the primary outcome of the driving test in order to obtain a power of at least 90%.
0,"The study was conducted in accordance with the Declaration of Helsinki, registered with ClinicalTrials.gov (NCT01272349), and reported according to CONSORT 2010 guidelines.Block design and randomization."
8,Slow enrollment caused an early study termination after 18 patients were completed (Verster et al. 2008).
0,Plasma was prepared within 20 min of blood collection and immediately ultrafiltered (for free platinum) or frozen at −70°C until analyzed for topotecan.
3,"From June 2002 to June 2008, 848 patients with pmVSD were enrolled for attempted transcatheter closure using the pmVSD occluders available at our centre."
0,All patients provided written informed consent before randomisation.
3,"The study was registered with ClinicalTrials.gov, number NCT00890799, was approved by the ethics committee of Xijing Hospital, and was carried out in accordance with the Declaration of Helsinki (1996) and all relevant Chinese laws."
0,"In summary, the Project CERCA intervention has incorporated the following strategic elements in an effort to improve ASRH in select communities: 1) PARTICIPATORY APPROACH: The core principle of Project CERCA is “community-embeddedness”, which means developing and implementing project objectives in close collaboration with adolescents, parents/grandparents and family members of adolescents, health providers, teachers, local leaders and public health authorities in each of the selected project sites."
3,"Patients who live in a nursing home, have a clinical diagnosis of dementia, have a score of 29 or higher on the Kokmen Short Test of Mental Status, cannot give informed consent, or do not have the ability to use the Intel Health Guide (due to severe visual impairment and lack of a caregiver, an unwillingness to use the device, or lack of a grounded outlet or 3G mobile communications coverage) are excluded from the study."
0,"Each site generated a list of all patients who met age, diagnosis, and A1C inclusion criteria from their patient databases or chart review."
8,"This was calculated using the data published by Guarino [18], who described the effects of a product that combined three probiotics in children with rotavirus diarrhoea and found that diarrhoea decreased from 120 ± 30 to 96 ± 30 (24 hours decrease); using 0.8 power, 0.05 (one-sided) significance and assuming 24 hours difference between the experimental and control groups the sample size was calculated as 20 cases per group."
0,Antifungal treatment (iv plus oral if used) was maintained for ≥14 days after the last positive Candida culture.
9,Annual interim analyses were performed.
0,"Whereas the primary endpoint was more pragmatic, the key secondary endpoints (self-reported 7-day PPA at week 26 and continuous abstinence rates [CAR] at weeks 26–52, confirmed by urine cotinine) were more explanatory."
9,"Blinded summary tables and listings of adverse events, including solicited reactogenicity events, were presented to an independent DSMB."
0,The adverse event reporting form will monitor the following specific events: Miscarriages Twinning Death of mother Death of infant (if occurring in the neonatal period) Overdose of pills by mother Ingestion of pills by anyone other than the mother Illness in mother requiring hospitalization or medical treatment Illness of infant (if occurring in the neonatal period) Occurrence of Preeclampsia.
4,"Demographic data, co-morbidities, APACHE II (Acute Physiology and Chronic Health Evaluation, SOFA score [4], treatment data, ICU and hospital length of stay (LOS), and hospital mortality were registered."
0,The process evaluation data collection has not yet been undertaken.
3,"Age 70 years or older, living locally in the community (in sheltered accommodation or own home), fallen at least once in the preceding 12 months and have an abbreviated mental test (AMT) [7] of seven or over (maximum score 10)."
0,"MNCs were counted and seeded at a density of 0.16 × 106 cells/cm2 in T1 75 cm2 tissue culture flask (NUNC, USA) in complete media."
3,"Wheelchair bound individuals, people living in a care homes or long-term hospital care and current enrolment in an exercise or rehabilitation programme."
0,"The IOL is inserted between the remaining fragments and the posterior capsule, E."
4,"Sociodemographic variables were collected either from women's medical records or self-completed questionnaires at trial entry and included: maternal age, ethnicity, body mass index, social-economic status as measured by Socio-Economic Indexes for Area (SEIFA) score [11], maternal education, smoking status and blood pressure at trial entry."
0,"IL-6 mRNA levels were normalized to those of β-actin and converted into fold changes based on the doubling of PCR product in each PCR cycle according to the manufacturer's guidelines, as previously described [43]."
1,"The study was a pragmatic, single-blinded, randomised, parallel-group trial with follow-up periods of 2, 6 and 12 months."
0,A table of 12 motor exercises and variations with facilitating music for each exercise was developed by the researcher through collaboration with a volunteer with stroke and used throughout the study.9
1,It was conducted in accordance with The Declaration of Helsinki 2000 and approved by the local Research Ethics Committee (ref.
0,"This analysis used data from all initially HIV-uninfected men enrolled in either trial who contributed follow-up time for determination of incident HIV infection, and for whom we had HSV-2 serology at enrollment and follow up."
14,"The same investigator (PHS) managed the baseline examination and controlled the follow-up forms, blinded to the treatment group."
0,"This procedure of using commercially available software to measure prosthesis alignment from CT images was selected because it has very good intraobserver accuracy (intraclass correlation coefficient > 0.8) and coefficient of variation of 11% to 17% [29,30]."
14,"In the data, treatment groups were named X and Y until the end of analyses."
0,The device acquires radius of curvature measurements in the flat and steep meridians on a 3.0-mm diameter field of the central cornea.
6,"The key outcomes derived from the web-logs were: Total time spent on site Total number of main content pages accessed on site Time spent viewing each module (“The PSA Test,”’ “It’s your Choice,” “Prostate Cancer”) Time spent viewing each section (eg, “What is the PSA test?” and “PSA test results” Time spent viewing each page (eg, “Why is the PSA test done?”) Number of pages accessed in each module and section and actual pages accessed Total number of interactive elements used (ie, videos and animations) Whether the participant tracked their decision using the “Decision Stacker” Whether the participant used the integrated print function The 3 components of informed decision making assessed were: (1) knowledge of PSA testing and prostate cancer-related issues; (2) attitudes toward testing; (3) behavior, for which a proxy measure was the declared intention to have the PSA test."
0,Ten million cells were considered the optimal dose for each administration.
1,"A Web-based randomized controlled trial (RCT) was designed, composed of four groups: two intervention groups and two control groups."
0,The primary study objectives of part I was to determine MTD (Maximum Tolerated Dose) and safety.
4,"Men were invited to participate by their general practitioners (GPs) in South Wales, United Kingdom."
0,Assays for samples with results above the highest standard were repeated after dilution.
6,The primary outcome was the number of participants that reported commencing or increasing treatment with lipid lowering medication.
0,Informed consent was obtained from all individual participants included in the study.
6,"Secondary outcomes were the number of participants that had their cholesterol levels checked, visited a doctor, commenced eating a healthy diet, started trying to lose weight, started taking regular exercise, started using special cholesterol-lowering margarine, stopped smoking, had their blood pressure checked, or recommended the website to a friend or relative."
0,We will use chi-squared tests to compare the proportion of (yes/no) for each of the primary outcomes between C and C + C type of supports.
5,"On day 0, children were randomly assigned to receive SP (Fansidar, Roche, 500 mg/25 mg tablets, 25 mg/kg sulfadoxine and 1.25 mg/kg pyrimethamine per treatment as a single dose), AQ+SP (Camoquin, Parke-Davis, 200 mg tablets, 10 mg/kg on days 0 and 1, and 5 mg/kg on day 2), DP (Duocotexin, Holley Pharm, 40 mg dihydroartemisinin/320 mg piperaquine tablets targeting a total dose of 6.4 and 51.2 mg/kg of dihydroartemisinin and piperaquine, respectively, given in 3 equally divided daily doses to the nearest ¼ tablet), or placebo (Cosmos Limited, Nairobi, Kenya) administered to simulate the amodiaquine dosing schedule."
0,The active constituents of the multivitamin/mineral interventions are shown in Table 1.
5,Children in the SP group also received placebo tablets on days 1 and 2.
0,"During the next 2 years, the authors of this article developed a complete study protocol and associated documents, including a manual of operations and template informed consent forms; solicited and selected study sites; and built the infrastructure necessary for the conduct of the trial.D2d was reviewed favorably by an independent external evaluation committee (convened by NIDDK) in March 2012, recommended for funding by an NIDDK special emphasis review panel in August 2012, and approved by the NIDDK Advisory Council in February 2013."
1,"The Hepatica study is a two-arm, international, multicenter, randomized, comparative efficacy and safety study comparing adjuvant CAPOX vs CAPOX and bevacizumab in patients with resected or resected in combination with ablated colorectal liver metastases."
0,Outputs will be averaged for the two crossings within each speed set.
1,Randomization is stratified according to clinical prognostication and treatment site.
0,"Due to the commitment required from caregivers, families with more than three children in the household were excluded."
4,Patients will be enrolled in 28 Dutch hospitals and 3 Swedish centers.
0,Responsive feeding styles will be practiced by mothers during the feeding sessions and observed.
3,• Histologically confirmed or surgically removed malignant tumour of the salivary glands (head and neck) • Inoperable tumour • G2/3 • Macroscopic or microscopic residual tumour (R2/R1) or • ≥T3/T4 or • perineural invasion (Pn+) • written informed consent • pts aged 18 - 80 years • effective contraception for pts in childbearing age (< 12 months post beginning of menopause) Exclusion criteria
0,"Ratios were derived by Proteome Discoverer version 1.2 using the following criteria: fragment ion tolerance as 50 ppm for the most confident centroid peak, iTRAQ reagent purity corrections factors was used, ion intensity threshold of 1000 and missing values were replaced with the minimum intensity."
3,"Male and female patients aged ≥40 years with moderate-to-severe COPD (GOLD 2006), a smoking history of at least 10 pack-years (current or previous smokers), post-bronchodilator FEV1 ≥30% but <80% of the predicted normal value, and post-bronchodilator FEV1/forced vital capacity (FVC) <70% were included in the study."
0,"If there is no improvement after 7 days or if the liver enzyme abnormality continues to worsen, depending on the clinical severity, then the treatment will be stopped."
3,Patients were excluded from the study if they had been hospitalized for a COPD exacerbation in the 6 weeks prior to screening or during the run-in period; had a history of asthma; or had concomitant pulmonary disease or a significant unstable cardiovascular or metabolic comorbidity.
0,"Patients of the WL Group were then offered the Program and completed follow-up measures at the end of the intervention (T1), and 3 months later (T2), thereby providing efficacy data from another cohort of patients."
16,"We will compare the groups at baseline on socio- demographic characteristics, and functional and clinical data to check whether the randomization has been successful."
0,"Within the US, data from US Medicare were evaluated across all 50 states over the first 29 months of saxagliptin availability (1 August 2009 to 31 December 2011), due to the lag in availability of these data."
16,The main analyses will be intention to treat.
0,The clip will then be transferred to the EuroHYP-1 outcome adjudication web portal.
1,This is a feasibility study for a randomised controlled trial (RCT).
0,"A cluster, randomized, clinical trial (type: parallel group) will be performed with patients attended in the ICS primary care setting."
1,The investigation was as a case-control study.
0,Subjects were recruited from the outpatient clinic of the endocrinology department at Seoul National University Bundang Hospital (SNUBH).
4,Healthy participants were recruited by advertisements in public and private institutions in Holstebro.
0,Additionally we compared the change EQ-5D health utility scores for subjects achieving and not achieving a ≥20-point improvement in SAQAF domain score; a threshold previously reported as the minimally important clinical difference on the SAQAF domain score [11].
4,"Patients with primary hypertension or chronic renal failure were recruited from the Out-patients' Clinic, Department of Medicine, Section of Nephrology, Holstebro Hospital."
0,"In order to generate awareness and mobilize communities, teams visited each village the week before trainings to explain the study to village leaders."
14,Study personnel conducting assessments at baseline and follow-up will be blinded to treatment assignment.
0,"Collectively, they will be known as the ‘study treatment’."
14,"Only the trial statistician and the data safety monitoring committee will have access to unblinded data, but none will have any direct contact with study participants or study personnel."
0,"The secondary endpoints were progression-free survival (PFS) and overall survival (OS), which were assessed using the Kaplan-Meier method with hazard ratio (HR) and 95 % CI via Cox’s proportional hazard model."
8,Sixteen pairs of premises provide 80% power to detect a 0.8 standard deviation difference in premises-level rates of intoxication and violence using a two-tailed alpha of 0.05.
0,"RNA from whole blood was isolated according to the PAX kit manufacturer, including the optional on-column DNase digestion."
8,The study was an exploratory trial and a significant effect was not anticipated.
0,Predicted SIE rates were based upon each patient’s covariate distribution and were obtained at regular time intervals up to the date of the last recorded SIE in RCT CZP (day 301) and up to 2 years in the All CZP group.
6,"Participants were assessed at baseline and at the end of the treatment by an investigator (physiotherapist) who was blinded to the randomization, the severity of pain, functional disability, and TrA activation capacity."
0,Group 2: Morbus Fabry patients with cornea verticillata ≥ grade 2.
1,"As we wanted to assess how the HHF worked over time, we embedded this RCT in a longitudinal cohort study which aimed to describe the course of breathlessness over time [7]."
0,"When operators felt that the OCT result was clinically unsatisfactory, further optimization was performed followed by repeat imaging (Figure 1)."
6,The secondary outcomes are: overall rates of caesarean section and of caesarean section for non-reassuring fetal state; overall rates of instrumental vaginal delivery and of instrumental vaginal delivery for non-reassuring fetal state; fetal blood sampling rates; incidence of 5-minute Apgar score < 7; need for neonatal intensive care unit admission; incidence of moderate and severe neonatal encephalopathy with a hypoxic marker; perinatal death; rate of delayed interventions (interval between red alerts - offline analysis in the control arm - and delivery in metabolic acidosis cases); internal FHR monitoring rates; tracing quality and signal loss.
0,The figures were investigated on an ITT basis using SPSS v.14
9,"Due to the calculated rather short recruiting phase of only 2 years and the 12-week follow-up, we do not plan to perform an interims analysis."
0,"For Group 3 only, after enrollment of 54 subjects, if ≥5 responses was observed, up to 50 additional evaluable patients were to be enrolled to obtain a more precise estimate of the response rate."
9,"Furthermore, due to the low if at all adverse effects reported for extracorporeal shock wave therapy applied in our dosages we do not expect that the trial has to be ended or stopped early for ethical reasons."
0,Analysis of MG effect upon response was undertaken using a model that incorporated a term for treatment:MG interactions.
10,"Sequentially numbered, opaque and sealed envelopes were opened by one researcher (BJ) after the participants was deemed appropriate fulfilling all inclusion criteria and no exclusion criteria as stated above."
0,"During impression making, the trays which were used first (A or B) and the impression material which was used first (alginate of silicone) was randomised."
3,- Karnofsky Performance Score ≥60% - Age >18 years and <80 years - Informed consent signed by the patient - Histological confirmation of chordoma with infiltration of the skull base.
0,The Institute of Hepatobiliary Surgery of Southwest Hospital is responsible for the coordination of this trial.
3,"- Inability to understand the aims of the study, no informed consent - Prior RT of skull base region - Other malignancies with disease-free interval < 5 years (excepting pre-cancerous lesions) - Participation in another trial - Pregnancy - Simultaneous CHT or Immunotherapy."
0,"The negative mode used a spray voltage of −4.0 kV, capillary voltage of −35.0 V, and tube lens of −120 V."
4,Participants were recruited by advertisements in public and private institutions.
0,The women were asked to estimate pain on the VAS before each course and at day 10 between treatment courses.
3,"Between October 2004 and April 2007 research teams in two centres (Manchester and London) recruited participants from adult services in six large NHS mental health trusts in the UK covering Greater Manchester, Lancashire, and south London."
0,"For each SNP with a minimum depth of sequencing ≥10 reads, BAF was calculated as:Heterozygous calls were defined as BAF between 0.4 and 0.6, and were compared between the TS cohort, female control subjects, and male control subjects."
3,"Inclusion criteria were the following: age more than 16 years; in current contact with mental health services; a current clinical diagnosis of non-affective psychotic disorder (international classification of diseases, 10th revision (ICD-10), Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV), or both); DSM-IV diagnosis of dependence on or abuse of drugs, alcohol, or both; minimum level of weekly alcohol use (exceeding 28 units for males and 21 units for females on at least half the weeks in the past three months) or illicit drug use (use on at least two days a week in at least half the weeks in the past three months); no significant history of organic factors implicated in the aetiology of psychotic symptoms; English speaking; and of a fixed abode (including bed and breakfast or hostel)."
0,"The resulting solution was analysed using a triple quadrupole Ultra Performance LC/MS in MRM mode (Waters, Saint-Quentin en Yvelines, France) with a detection limit of 50 ng/ml."
3,- Karnofsky Performance Score ≥60% - Age >18 years and <80 years - Informed consent signed by the patient - Histological confirmation of low/intermediate grade chondrosarcoma with infiltration of the skull base.
0,"Because electronic monitors (using medication event monitoring systems [MEMs]) cannot be used in the mDOT arm, we have chosen not to use MEMs."
3,"- Inability to understand the aims of the study, no informed consent - Prior RT of skull base region - Other malignancies with disease-free interval < 5 years (excepting pre-cancerous lesions) - Participation in another trial - Pregnancy - Simultaneous CHT or Immunotherapy."
0,"Their utility and accuracy to screen for patients with lower health literacy as a substitute for the SAHL-S&E (which is a research instrument not practical for typical ED use), compared to this “gold standard” instrument will be assessed."
3,"Exclusion criteria included age (<45 years or >80 years), ill defined diagnosis of cardiovascular disease, inability or unwillingness to comply with study treatment, and disease or treatment that might interfere with metabolism of homocysteine or omega 3 fatty acids, in particular methotrexate for treating cancer or rheumatoid arthritis and chronic renal failure (plasma creatinine concentration >200 μmol/l or creatinine clearance <40 ml/min)."
0,"Fifty percent of the participants completed all five evaluations, while 4% attended only the baseline evaluation."
5,"Children randomised to group A received a standard titre Edmonston-Zagreb vaccine from the Serum Institute of India, Pune, India, at 4.5 and 9 months of age."
0,"Random allocation to therapy plus standard care or standard care alone was performed using a remote independent service, with a minimisation algorithm taking into account substance type (alcohol alone, drugs alone, or alcohol and drugs), main drug of use (cannabis, amphetamines, opiates, or other), and NHS trust."
5,"At 9 months of age, the children in group B received the same Edmonston-Zagreb measles vaccine, and children in group C received a Schwarz measles vaccine (Rouvax) from Pasteur Merieux, France."
0,"Continuous variables are summarized as means, standard deviations, medians, and ranges."
8,"The study planned to recruit 90 subjects in each cross-over study, based on an expected standardized mean difference of placebo effect on continuous subjective outcome of 0.36[2], type I error of 0.05, type II error of 0.1, paired design, and 10% dropout rate."
0,The secondary objective was to assess the efficacy of abatacept treatment.
3,"Atypical symptoms - (unexplained weight loss, rectal bleeding), diagnosis of inflammatory bowel disease, Coeliac disease or peptic ulcer disease, pregnant or breast feeding, currently taking or allergy to mebeverine or methylcellulose."
0,PHWs were nominated by fellow patients at each clinic site with final approval by RHSP staff if they met all qualifications.
3,"If patients are already taking mebeverine or methlycellulose but are keen to enter the trial they will be able to do so if they fulfil the inclusion criteria, do not meet any of the other exclusion criteria and they undertake a 4 week mebeverine and methylcellulose free wash out period before entering the trial."
0,"Anemia status of pregnant women was based on hemoglobin concentration, in g/dL, recorded within two weeks of enrollment."
4,"Four community-based cardiac rehabilitation programs, three located in one urban/suburban environment (Halifax, Nova Scotia, Canada) and one in a more rural setting (Kentville, Nova Scotia, Canada) have been selected at intervention sites based on recruitment potential, adherence to the national guidelines for hyperacute and acute management of NDS and TIA [60], and availability of existing programs that could be adapted to meet the protocol for this trial."
0,The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
6,"Safety assessment included visual assessment of the injection site on day of administration (predose) and at 30 minutes post-dose and on Days 1, 14 and 28; solicitation of local and systemic reactogenicity; and local and systemic reactogenicity reporting in the 7 days after vaccination."
0,"During the baseline visit, potential participants were provided with information related to the purpose, setting, and duration of the program; the nature of the behavioral change program; information on the number, duration, timing, and content of the automated SMS text messages; participant and community health coach expectations; and the assessments."
6,The immunogenicity assessment was determined by serum IgG responses to M2e and HAI was assessed before vaccination on Day 0 and on Days 14 and 28 after vaccination.
0,"Assuming 15 % loss to follow-up, 339 participants are required in each of the food and cash transfer arms."
3,"■ Contraindication to weight loss - Receiving active cancer treatment (radiation/chemotherapy) - Liver failure - History of anorexia nervosa; ■ Cardiovascular event (unstable angina, myocardial infarction) within previous 6 months; ■ Prior or planned bariatric surgery; Use of prescription weight loss medication or over-the-counter orlistat within 3 months if participant does not agree to stop taking it; ■ Twenty pound or greater weight loss in 3 months prior to baseline, as documented by staff measurement; ■ Inability to walk to participate in exercise class; ■ Pregnant or planning a pregnancy during study period."
0,Regulatory approval was received from the University of Cape Town Research Ethics Committee and the South African Medicines Control Council (Clinical Trial Registration number NCT00869700).
3,"Nursing mothers would need approval from physician; ■ Alcohol or substance use disorder either: 1) active and determined to be incompatible with participation in the intervention through discussion with program staff; or 2) new abstinence from alcohol or substance use disorder in past 30 days; ■ Planning to leave rehabilitation center within 6 months or move out of geographic area within 18 months; ■ Investigator judgment (e.g., for concerns over safety, adherence or follow-up); ■ Weight greater than 400 pounds."
0,"Biopsies were performed using standard biopsy forceps without needles (FB210K, Olympus co., Japan)."
6,Co-primary outcome measures are the duration of antibiotic therapy and the proportion of infants with a recurrence of infection requiring additional courses of antibiotic therapy (within 72 hours after ending antibiotic therapy) and/or death in the first month of life (safety of study intervention).
0,"The MNH Registry tracks all pregnancies, deliveries and delivery outcomes with its own staff which functions independently from the EMONC trial staff in order to reduce bias due to joint outcome data collection."
6,A secondary outcome measure is the length of hospitalisation stay.
0,Secondary endpoints included the immune background of the patients treated with the preparation of Tregs.
1,"Multi-centric, open cluster randomized field trial."
0,"By flow cytometry (MACSQuant, Miltenyi Biotech, Bergisch-Gladbach, Germany), monocytes were defined as CD15-CD19-CD86+."
1,"Unit of randomization: Primary Care teams formed by a pediatrician and a pediatric nurse, both responsible for the same infant population."
0,All subjects had recent chest imaging which did not show any lesion accountable for the sputum detection of atypical cells.
4,Pediatric Primary Care consultations in Catalonia.
0,"We used multivariable logistic regression, including a random effect for cluster to account for the collection of data from discrete slum localities."
4,All of the basic health areas of Catalonia will be offered participation through the xarxa de centres sense fum (network of smoke free centers).
0,"The scores were calculated by the Liposcience group during NMR analysis, and the algorithm used is described in detail in the manuscript by Shalaurova and Otvos et al. [30]."
5,"A Polypill (Red Heart pill 2b, Reddy's Laboratories, India) containing 75 mg aspirin, 20 mg simvastatin, 10 mg lisinopril and 12.5 mg hydrochlorothiazide was compared to the level of Standard Practice as defined by the study investigators."
0,"At 10 weeks, NMS significantly increased the proportion of patient-reported adherence by 10.2–70.7%, compared with normal practice of 60.5% [20, 21]."
5,Decisions related to discontinuing the study interventions or adding medications during study participation were made at the discretion of the specialist physicians who were in charge of patient care.
0,"Direct health care costs included the costs of hospitalizations and visits to health care providers (e.g. general practitioner, specialist, physical therapist, alternative medicine providers) and the use of prescription and over-the-counter medications."
1,"A multicenter randomised controlled three-armed study will be conducted to compare the effects of group exercise (on land or in a hydrotherapy pool), to a group of participants receiving no intervention."
0,Informant Questionnaire on Cognitive Decline (IQCODE)[29] is an instrument to detect cognitive decline reported by an informant.
3,"A sample of people with RA taking anti-TNFα therapy medication will be recruited from a rheumatology service based in two hospitals in Dublin, Ireland."
0,"After visit 3, the dose could not be changed: participants unable to tolerate the study drug after this point were withdrawn from the study and attended an early termination visit."
3,"Inclusion criteria: • Consenting male and females, aged 18 - 70 years • Documented diagnosis of RA as classified by the American College of Rheumatology (ACR) criteria • Receiving anti-TNFα therapy medication for more than three months • ACR functional class I, II, III • Willing to exercise bi-weekly on a fixed schedule • Living within a 50 km radius of both recruiting hospitals Exclusion criteria: • Physiotherapy in the previous three months • Intra-articular corticosteroid injection within the previous four weeks • Joint surgery in the previous six months • Unable to understand the concepts, assessments and treatments that would be involved • Contraindications to exercise therapy or hydrotherapy The flow of participants through the study is presented in figure 1."
0,Figure 1 Study flow and participant retention at each level of the study.
6,The primary efficacy measure was duration from the time participants first achieved an A1C ≤7.0% to when they were no longer at the A1C goal.
0,"Dose-limiting toxicity criteria were grade 4 neutropenia lasting ≥7 days, febrile neutropenia, grade 3 thrombocytopenia, grade 3 non-hematologic toxicity, except for nausea/vomiting or diarrhea (nausea/vomiting or diarrhea was considered a DLT in patients who had grade 3 toxicity for ≥3 days or grade 4 toxicity of any duration), and any study drug-related toxicity resulting in treatment delay >2 weeks or discontinuation of treatment at the assigned dose level."
6,"Secondary measures included A1C change from baseline (randomization), A1C by visit, 7-point SMPG profile, 1,5-anhydroglucitol, weight change, total daily insulin dose, and hypoglycemia rate, and incidence."
0,"Patients returned for follow‐up visits at 3, 6, and 12 months and every 6 months thereafter until study completion, and data were collected by blinded physicians."
6,"The primary outcomes of the study were differences between treatment groups in mean daily BG concentration and a composite of postoperative complications including wound infection, pneumonia, bacteremia, respiratory failure, and acute renal failure."
0,"Tandem mass spectrometry detection was with positive electrospray ionization (ESI+), using 3 kV and 30 V for capillary and cone voltage, respectively."
6,"Secondary outcomes included differences between treatment groups in any of the following measures: occurrence of mild and severe hypoglycemia (<70 mg/dL and <40 mg/dL, respectively), length of hospital stay, surgical complications (wound infection and dehiscence, bacteremia, pneumonia, and acute renal failure defined as an increased in serum creatinine >50% of baseline and/or a serum creatinine >2.5 mg/dL), admission to the ICU, and death."
0,"To pursue a balance of safety and efficacy, the following treatment volume parameters have been set (Figure 3): Figure 3 Hypothesized improvements in safety and efficacy using the STEP-UP algorithm."
1,"This was a Phase 1, placebo-controlled, randomized, double blind, study in sexually-abstinent young women conducted at the Pediatric Clinical Research Center at the University of California, San Francisco (UCSF), USA and the Research Care and Training Program unit of the Center for Microbiology Research at the Kenya Medical Research Institute (KEMRI) in Kisumu, Kenya."
0,"This study had a prospective, unblinded, and single-center design."
1,Procedures were reviewed by investigators and study personnel at both sites prior to and during study implementation.
0,Neither the leaflet given to the control group nor the stage-based manuals directly addressed partner quitting.
8,"A total sample size of 24 (12 subjects in each arm) was selected a priori to allow 80% power to detect of a 0.55 log unit difference in immune mediator concentrations between groups, assuming a standard deviation of ∼0.5 log units for most mediators [2] and a 5% alpha value."
0,This will be the primary population for evaluating all efficacy endpoints as well as subject characteristics.
8,"To supplement loss to follow-up, we committed to enrolling 30 participants."
0,The average wash‐out duration between conditions was 65 days (minimum = 42 day; maximum = 112 day).
8,"The randomised trial will have a sample size of around 500 inhibited children, providing 80% power at the 5% level of significance to detect the level of reduction in internalising problems found in Rapee's prior efficacy trials, namely a 14% reduction in child internalising disorders between the intervention (50%) and control (64%) groups [41]."
0,The primary endpoint was the reduction of organ failure as measured by the maximum SOFA score within 28 days after trauma.
8,"This sample size estimation considers an achievable attrition rate for a quality trial, allowing for up to 20% loss to follow up."
0,"Fluorochrome-conjugated mAb used were as follows: PerCP-, PE-Cy7-, or APC-Cy7-CD3 clone SK7; PerCP-CD4 clone SK3, APC-H7- or APC-CD4 clone RPA-T4, PerCP- or APC-H7-CD8 clone SK1; PE-CD56 clone NCAM16.2 (BD Biosciences); biotinylated anti-human ICOS clone ISA-3 (eBioscience); and Alexa Fluor 488-anti-FoxP3 clone 259D (Biolegend)."
4,"The study was performed within three organised screening programmes from three different Italian regions: Florence (Tuscany), Rome southern city (Lazio) and Teramo (Abruzzo)."
0,"For bioenergetic assessments, each blood sample will be analyzed with 4–6 assay replicates and data will be presented as means ± standard errors."
4,"In these areas, programmes actively invite all the resident female population aged 25–64 years for a Pap-test every 3 years."
0,"Blood for serum was collected in serum-separator gel tubes and centrifuged after 30 min to 2 h, and blood for plasma was collected in EDTA-tubes and centrifuged within 30 min at room temperature at the study site."
16,The analysis will be performed in accordance with intention-to-treat principle.
0,"The brush specimens were tested for hrHPV using the clinically validated and Federal Drug Agency (FDA)-approved Cobas® 4800 HPV DNA test (Roche Diagnostics, GmBH, Switzerland), according to the manufacturer’s instructions."
1,This was an open label randomized controlled trial of parallel groups comparing the effect on QL of a specific educational program designed for the prevention of WMSD versus a general health orientation program.
0,CDT group participants and occasionally family members received training in self –massage.
8,"Estimating that a difference of 10 points in variation of the physical functioning SF-36 score would be clinically relevant, and considering a standard deviation of 14.0 for this variation in both groups [24], 32 patients in each experimental group would provide 80.0% statistical power to detect a significant difference (P ≤ 0.05)."
0,"The patient lay supine in a hybrid PET/CT (computed tomgraphy) scanner (GE Discovery STE; GE Health Care, Waukesha, WI)."
8,"However, considering the possibility of loss to follow up of some individuals, a total of 101 employees underwent stratified randomization."
0,"Thirty parents were requested to complete the Vietnamese version of the CP QOL-Child questionnaire since they have a deep understanding of their children, who have difficulties expressing themselves."
4,"The study will be conducted in a non-government organisation, Community Care Centre (referred to here as the Centre) which is a community social service located in NSW, Australia providing financial counselling, relationship counselling, Life Skills courses, emergency relief and a communal use room/waiting area."
0,The agreement analysis examined the level of agreement between the patient and GP as information sources.
4,"The Centre operates 7 days a week, providing counselling services 4 days a week and predominantly assists those on government income assistance (95% of clients)."
0,"Ethical approval for the study was obtained from the institutional review boards of the University of California, Davis; Ghana Health Service and University of Ghana Noguchi Memorial Institute for Medical Research (NMIMR)."
16,"Within this paper, we calculated descriptive summaries of baseline (Week 0) demographic, psychosocial characteristics and smoking history of the participants using frequencies and percentages for categorical variables and means and standard deviations for quantitative variables."
0,Follow-up testing was performed at 6- and 12-month follow-up.
16,"Phenotyping, genotyping, and evaluation of abstinence outcomes will be presented in future manuscripts."
0,The survey was planned to be repeated at least in the end of the study.
8,"The planned sample size was determined on the basis of an assumed mean improvement of the primary outcome, a DASH questionnaire score of 15 points (SD ± 22), which implies an effect size of 0.68 [56]."
0,"Questions for the gastrointestinal symptom questionnaire (Figure 1) were based on previously validated bowel symptom questionnaires [30,44,46,47] and included gastrointestinal symptoms commonly reported to be associated with the oral intake of ferrous iron salts: i.e. nausea, vomiting, heartburn, abdominal pain, diarrhoea, and constipation [5,19,48,49]."
8,"To test the null hypothesis at α = 0.05 with 90% power and assuming a uniform dropout rate of 5%, it was calculated that 52 patients in each group would be required."
0,The study coordination team provides a blood sample kit (Royal Mail Safebox™) which is sent to participants along with the follow-up physical activity monitor.
14,"Because the primary and secondary end points of the study were laboratory measurements (qPCR and ELISpot) of blood samples with minimal opportunity for conscious or subconscious subjective bias, we felt that the benefit of blinding would be outweighed by its logistic difficulties, so no attempt at blinding was made."
0,Duos of GPs and nurses will be randomly allocated to one of the two conditions: 1.
1,This is an analysis of cross-sectional baseline data from a non-randomized clinical trial comparing the effects of a comprehensive lifestyle modification program and bariatric surgery on arterial stiffness in morbidly obese patients.
0,The subjects were inoculated with the challenge virus on Day 0 and remained isolated in individual en-suite rooms to prevent transmission of the virus to others.
1,(http://ClinicalTrials.gov Identifier NCT00626964).
0,"All concomitant medications, except use of bortezomib, were allowed."
4,"The study was performed at a tertiary care centre (the Morbid Obesity Centre, Vestfold Hospital Trust, Tønsberg, Norway) between February 2008 and January 2010."
0,Serum aldosterone was measured in the SAS Steroid Centre (Leeds Teaching Hospitals) with an in-house radio-immunoassay with typical CV 11% at 218 pmol/L.
4,"Before inclusion patients were either assigned to a comprehensive lifestyle modification program at the Hospital for Rehabilitation, Stavern, or to bariatric surgery at the Morbid Obesity Centre."
0,A total of 5625 patients were enrolled from the KorAHF registry from March 2011 to February 2014 at 10 tertiary centers.
1,"The VAFO is a randomized clinical trial in which obese adults with CHD risk are randomized to one of three study arms: UC, CM, or CM+CHW."
0,"Related publications describe the sampling procedure which procured 10 public and nine private hospitals [31, 32, 39]."
1,All study procedures and materials were approved by the Stanford Institutional Review Board (IRB) and an independent IRB serving San Mateo Medical Centers (SMMC).
0,This provided a total contraction time of 3 min 20 s in each 20 min session.
3,"Obese Spanish-speaking patients age 18 and older with at least one conventional CHD risk factor (i.e. diabetes, elevated fasting glucose or hemoglobin A1c levels, high blood pressure, elevated lipid levels) are eligible to join the study."
0,"Lean body mass and fat mass, total and regional (appendicular and trunk), were measured by DEXA at baseline and week 23."
3,Exclusion criteria are designed to: 1) minimize safety concerns; 2) prevent loss to follow-up; and 3) avoid potential contamination between study arms (Table 1).
0,The laboratory used HiCrome Agar (M1466) by HiMedia.
1,"The ACCEPT trial is a prospective, non-randomized phase II feasibility trial evaluating toxicity (any toxicity ≥ grade 3 CTCAE v."
0,"Three specimens of each fish species were collected: Nile perch (Lates niloticus), tilapia (Oreochromis niloticus), and dagaa/silver cyprinid (Rastrineobola argentea)."
1,4) of the combined treatment as primary endpoint.
0,SLNB was performed before NAST and ALND after NAST in all patients.
3,"• Histologically proven adenoid-cystic carcinoma of the head and neck and Macroscopic or microscopic tumor rest (R1/R2) or • Tumor stage >T3/T4 or • perineural invasion and • M0 • Written informed consent • Age between 18 and 70 a • Karnofsky-Index ≥ 70% • adequate bone-marrow, liver, and kidney function • effective contraception for patients in procreative age Exclusion criteria"
0,UV signal was recorded at 330 nm and fractions were collected every 20 s for gamma counting.
1,Patients were included from seven out of the nine psychiatric wards in The Capital Region of Denmark.
0,healthy snacks for the school breaks.
14,Blinding of patients and the treating clinicians was not possible as patients were randomised to the mood disorder clinic or to standard treatment.
0,The BRV-PV is stable at 25 °Cfor 30 months and at 40 °Cfor 18 months.
14,"Nevertheless, statistical analyses and the writing of the scientific paper including introduction and results will be carried out before data are unblinded."
0,"Initial doses of detemir were to equal previous basal insulin doses, either injected at bedtime (once-daily group) or half before breakfast and half at bedtime (twice-daily group)."
1,"The study is a prospective, multicentre, double-blind randomized controlled trial."
0,Antihypertensive medications and all other medications were recorded at baseline and patients did not change doses or the number of their antihypertensive medications throughout the trial.
1,The study will be coordinated by the Institute for Maternal and Child Health - IRCCS Burlo Garofolo (Trieste) and by the Maternal and Child Health Laboratory of the Institute Mario Negri (Milan).
0,"Thirty minutes before the end of surgery, morphine 3 mg and ondansetron 4 mg were administered to each patient."
9,"Besides the planned analysis during the dose escalation, no further interim analyses are planned."
0,"These procedures were as follows: study drug was prepared and provided to the patient each morning, either at home or in the clinic, by persons who were independent of the other clinical trial processes (referred to as 'independent study blinding coordinators' or 'ISBCs') to preserve the integrity of the blind."
16,"Selected epidemiologic and biological variables were compared in linked and unlinked pairs, evaluating for statistical significance with the two-sided Fisher's exact test for categorical variables and Wilcoxon rank sum test for continuous variables."
0,"Patients were randomized to receive the Nexgen LPS Trabecular Metal tibial monoblock component (n = 37) (Zimmer, Warsaw, IN) or the cemented NexGen Option Stemmed tibial component (n = 33) (also Zimmer)."
3,All patients from the 24-week maintenance study [2] who had been randomly assigned to 1 of 3 therapeutic doses of olanzapine LAI (N = 599) were included in these analyses.
0,"They will be instructed (and reminded per e-mail) to complete one session per week, during 8 consecutive weeks."
3,Patients were 18 to 75 years of age with a diagnosis of schizophrenia according to the DSM-IV or DSM-IV-TR.
0,"At the last visit, records were turned in and reviewed for liquid ingestion, macro-nutrient composition and total energy intake by the same technician."
16,Descriptive statistics were calculated as means and frequencies using SPSS version 16.
0,Part of the neonates will be eligible for inclusion immediately after birth.
16,Notes from the interviews were compared and themes identified.
0,"The study was open-label, except for blinded assessments of ISRs."
4,"Information on the study variables will be collected on three occasions: when the woman enters to the study (baseline), once intervention is complete (at three months) and after three more months of follow-up (six months)."
0,"Coagulation forceps (Olympus FD-1U-1, Olympus Europe, Hamburg, Germany) at the setting SOFT COAG E5, 80W were only used for bleedings not amenable to coagulation with the HybridKnife."
3,The target population was patients with advanced CKD who did not yet require dialysis and whose serum phosphorus was elevated in the absence of phosphate binder therapy.
0,"For a subject who undergoes tumor resection following disease control but prior to disease progression, irPFS will be censored on the date of the last evaluable tumor assessment or prior to the date of resection."
3,We hypothesized that calcium acetate would safely improve such patients' phosphorus control compared with placebo.
0,Patients were stratified by age (≤18 years vs >18 years) and histological subtype (uterine leiomyosarcoma vs synovial sarcoma vs pleomorphic sarcoma vs other eligible sarcomas).
3,"-High-risk patient according to cardiological evaluation (e.g. necessary perioperative continuation of the ASA application shortly after coronary stent implantation, interfering bleeding disorders etc.) -Emergency procedure -Withdrawn or missing written consent -Simultaneous participation in another clinical trial with interference of intervention and outcome -Severe psychiatric or neurologic diseases or a mental condition rendering the patient incapable of understanding the nature, scope, and consequences of the trial."
0,In the period February-March 2010 the clinical pharmacist handed out written information about the study to eligible patients at the end of the consultation.
3,Inclusion criterion is GPs in Scotland.
0,"Both the Bangladesh and Kenya studies include three enabling technologies in the compound-level sanitation intervention with the goals of reducing children's exposure to faeces in the household environment and increasing latrine use: (1) a locally developed sani-scoop dedicated to the removal of child and animal faeces from the compound,88 (2) plastic child potties for children aged 6 months and older until they use the latrine and (3) a new or upgraded latrine for each household in the compound."
3,Exclusion criterion is the inability to obtain both an email address and a postal address for the GP.
0,"The stool samples from each container of 24-hour collection were homogenized and the fat content in the feces was quantified by the near-infrared reflectance analysis27 at 700 to 2500 nm, using FENIR 8820-Infrared Analyzer (Stimotron, Wendelstein, Germany)."
14,"Study participants, the trialists, and the trial statistician will be blind to allocation."
0,"We formulated a so-called worry cycle early in the intervention: feeling under threat leads to activation of positive beliefs about worry and hence engagement in this thinking style, resulting in dwelling on the worst outcomes and an increase in the initial feelings of threat."
14,Staff at the SPCRN will know the allocation for the email versus postal invitation study but not the web-based IME intervention study.
0,Active insulin time and carbohydrate-to-insulin ratio(s) were carried over when Auto Mode was enabled.
1,"This is a single blind, randomized controlled 2 × 2 factorial trial designed to evaluate the effectiveness of micronutrients supplementation and regular aerobic exercise during pregnancy."
0,The volume fraction (Vv) of collagen fibrils per intercellular tissue volume was estimated with the point counting technique as the number of points hitting collagen fibres divided by the number of points hitting the intercellular tissue (including collagen fibrils) using a point grid of 36 points.
1,This design provides the advantage of assessing the independent and cumulative effects of the interventions in nulliparous pregnant women.
0,"Surveillance for influenza was conducted between 14 November 2005 through 30 April 2006 (Season 1), and 13 November 2006 through 30 April 2007 (Season 2)."
4,"Patients were assessed at baseline, after 6 weeks of treatment and 12 weeks after treatment (18 weeks from study begin)."
0,The physical evaluations included assessments of the neurological and liver disease.
4,The study protocol is outlined in Fig. 1.
0,"To optimize intervention uptake, timing and intervals between face-to-face and telephone contacts were tailored to the participants’ preferences."
1,"Cluster randomised, controlled, multicentre trial."
0,"With the exception of HFSR and elevated TSH, all other AEs were reported and graded using the National Cancer Institute Common Terminology Criteria for AEs (CTCAE) v3.0 and Medical Dictionary for Regulatory Activities (MedDRA) v15.1 terminology (National Cancer Institute 2006, International Conference on Harmonisation 2006)."
1,Randomisation unit: primary care team (PCT).
0,"The main aim of the VEDERA study (Very Early versus Delayed ETN in Rheumatoid Arthritis) is to evaluate the depth of remission, sustainability of remission and immunological normalisation induced by very early TNFi or the current standard of care (with or without delayed TNFi if required), in patients with early, treatment-naive RA."
3,All the pregnant women over the age of 17 years attending consultation to a midwife during the first trimester of gestation in the different participating PCC during the study period (2007-2010).
0,"Further, the patients appeared with active disease less than six months, less than or equal to two swollen joints at baseline, and were aged 18 to 75 years [23,24]."
3,"Pregnant women in the second or third trimester of gestation; pregnant women with diagnosed thyroid disease; pregnant women without a telephone; pregnant women with communication difficulties (cognitive or sensory deterioration, language barrier); pregnant women who do not consent to participate in the study."
0,The study was approved by the Commission for Medical Ethics of the university Hospital Leuven (approval reference number S55685) and registered as a clinical trial (NCT02639715).
1,"Single centre, randomized, controlled study of two Physical Complex Therapies."
0,"Cardiac interval measurements were performed on the Global Superimposed Median Beat (GSMB), a methodology that allows measurements that consider each of the 12 individual median beats [16]."
1,The total follow-up period per patient is 6 months.
0,"All toxicities were graded using National Cancer Institute Common Terminology Criteria for Adverse Events, V.3.0."
6,"The day-42 PCR corrected parasitological cure rate was the primary efficacy outcome, i.e. proportion of patients with clearance of asexual parasitaemia within seven days of initiation of treatment, without recrudescence within 42 days after initiation of treatment, and without use of rescue medication for clinical signs of malaria."
0,"TP is the average number of nonzero covariates being correctly selected, and FP is the average number of zero covariates being incorrectly selected."
6,Secondary outcomes included PCR corrected parasitological cure rates on days 14 and 28 after treatment; risk of reinfections after treatment; day 7 blood lumefantrine concentrations; selection of genetic markers (SNPs) in pfcrt and pfmdr1; and adverse events defined as signs and symptoms that occurred or increased in severity after treatment started.
0,Signs of potentially not balanced PEEPi (expiratory flow that does not reach zero prior to inspiration or ineffective efforts).
1,"This prospective, open-label, non-randomized, feasibility trial was conducted in a western suburb of the Greater Toronto Area (GTA) from May to November 2009."
0,"The local story contests were co-organized by respective local CDCs and MSM CBOs in the eight cities and aimed to promote continuing community engagement and HIV testing by soliciting stories of HIV testing from local individuals (S3 Text, three stories selected from the story contests)."
1,The primary objective was to determine feasibility and sample size estimates for a larger randomized controlled trial of ginkgo for vitiligo.
0,"By approaching the HEs in this collaborative manner, the project benefited from their insights while simultaneously strengthening their engagement in their respective roles."
8,The planned sample size of 40 patients per group was sufficient to show a difference of 15 points for the primary end point (expected difference between groups in the normalised net incremental area under the curve for BASDAI) assuming a SD of 20.
0,"The M.I.N.I has well-established reliability and validity [34,35]."
8,This sample size was based on a power of 90% and a two-sided type 1 error of 5%.
0,The first was a pointing task which aims to evaluate the ability and time required for reaching a virtual target.
16,All statistical methods were performed using the R software package.
0,"The peer‐counselling manual was developed and enhanced based on an adapted Information‐Motivation‐Behavioural Skills (IMB) model 27, 28, 29, 30, 31."
1,"We carried out a randomised, triple blind, placebo controlled clinical trial between April 2008 and June 2010 at the Instituto de Medicina Integral Prof Fernando Figueira (IMIP), Recife, a large tertiary teaching hospital in the northeast of Brazil."
0,Synovial thickness area (STA) is a count of the number of pixels with synovial hypertrophy within a defined region of interest.
3,"○ Patients who call 911, and are: ○ Suspected by the paramedics to have ischemic chest pain for greater than 30 minutes but less than 6 hours, and ○ 18 years of age or older ○ Experiencing chest pain that fails to resolve with nitrates given as per protocol Exclusion Criteria"
0,"The intervention lasts 3 months and integrates participatory ergonomics, physical training and CBT tailored to the target group."
6,The primary outcome of this study is to compare the proportion of study subjects who receive reperfusion within the target door-to-reperfusion times across the four care strategies.
0,"Aim—To restore patient’s occupational function and supervise return to work Period—From week 2 to full sustainable return to work, or after receipt of 26 sessions of graded activity (within maximum of 12 weeks) Content—Baseline (consisting of three sessions) to test patient’s functional capacity; individually graded exercise programme, teaching patients that, despite pain, moving is safe while increasing activity level Outcome measures"
6,Target door to reperfusion times are 90 minutes for primary PCI intervention (door-to-balloon time) and 30 minutes for fibrinolysis (door-to-needle time)[30-32].
0,"BVMT and verbal fluency T scores were included as dependent variables, and model effects included age, sex, and regional perfusion or vasoreactivity."
16,"Data were entered into Excel (Version 5, Microsoft, Seattle, WA), and analyzed in SAS (SAS/STAT Software, Release 6.11, Cary, NC)."
0,Clinical response was evaluated using the Response Evaluation Criteria in Solid Tumors v1.0 [30].
16,"Differences in measurement data were determined with the student t-test; categorical data were determined with Fisher's Exact Test, while differences between multiple parametric data sets were determined with Fishers Least Significant Difference Method."
0,"Following informed consent, patients indicated for the implantation of a dual‐chamber pacemaker (either as a primary implant or an implantable pulse generator exchange or upgrade from a single‐chamber pulse generator) were screened for hypertension medications and blood pressure measurements in the office on 2 separate days (1–7 days apart) to determine eligibility."
8,Based on previous studies18 we anticipated that overnight closed loop delivery would increase the time that plasma glucose concentrations were between 3.91 and 8.00 mmol/L by a mean 37% (SD 40%).
0,"The cumulative survival rate (CSR) was calculated using life table analysis, and the implant success rate was evaluated according to van Steenberghe criteria [25]."
8,We calculated that 12 participants would provide 80% power at the 5% level of significance to detect this difference between conventional and closed loop insulin delivery systems.
0,"After the predetermined dose of propofol was administered, loss of the eyelash reflex and verbal response was assessed for 2 minutes."
16,We used the ANOVA test to compare both the averages by time and groups.
0,"In a very different scenario in which the patient is generally healthy and does not have a family history suggestive of a genetic condition, the genome could be sequenced as a part of routine preventive medicine."
16,The Pearson product-moment correlation coefficient was calculated with its interval at 95% (IC 95%) to analyze the relation between the interested variables.
0,"Furthermore, we asked all patients the following question: ''If you could keep the automated telemonitoring system in your home, would you continue to use it in the future?''."
1,We conducted a pragmatic27 cluster randomised trial28 of the effects of adding outreach education to a roll-out of decentralised nurse run HIV/AIDS/ART services at primary care clinics.
0,Written informed consent in Kiswahili was obtained from parents or guardians during the screening visit.
3,"Subjects who were at least 18 years of age were eligible for study enrollment if they had a diagnosis of schizophrenia per the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) [21], established at least 1 year before screening, and if they had a Positive and Negative Syndrome Scale (PANSS) [22] total score of at least 70 at screening and between 60 and 120, inclusive, at baseline [19]."
0,"In the ultrasound arm, the physician should overrule the DAS based decision and proceed to the next treatment regimen if indicated by the ultrasound score."
3,The criterion for inclusion in this subgroup analysis was a Clinical Global Impressions-Severity (CGI-S) [23] score ≥5 at baseline (markedly to severely ill).
0,Fasting venous blood samples were collected between 8 am and 10 am.
8,"This was a pilot study and a sample size of ten patients in each of the randomised treatment arms was deemed to be sufficient after discussion with clinical experts and the trial statistician, No formal sample size calculation was performed for the pilot but the information from this study will informa power analysis for any larger trial."
0,"For example, mindfulness practice included examples of how to deal with negative thoughts and emotions (e.g., sadness, guilt, anger) associated with depressive states."
9,Two planned safety interim analyses were conducted after complete data were received on the first 500 and 900 women randomised.
0,"Additionally, a positive vote of the Bundesamt für Strahlenschutz (BfS) has been obtained."
9,Results were reviewed by an independent Data Safety and Monitoring Board blinded to group assignment.
0,"Exclusion criteria were having diabetes (any type), current use of antihyperglycemic medication, pregnancy or attempting to become pregnant, current smoking, and/or co-morbid conditions or medications (e.g., antipsychotic drugs or steroid hormones) that could impact weight or ability to engage in moderate intensity physical activity."
1,"This was a two-centre controlled trial of group CBT for fatigue self-management versus group information (usual care), with balanced randomisation (1:1), conducted in the UK."
0,"Day to day variability in performing Wingate anaerobic capacity tests in our laboratory yielded an SEM of 53 W, an SEM as a percent of grand mean of 8.9%, a CV 0.26, and an intraclass correlation coefficient of 0.89 for mean power."
8,"Forty-four patients in each arm were needed to show a difference of 7 MAF points in fatigue impact between trial arms, with 90% power and estimated SD 10 points (two-tailed significance 0.05) (based on unpublished data)."
0,"Efficacy was evaluated on Day 1 (baseline, Hour 3), Day 2 and Day 8 by blinded investigator (CEA) and subject (PSA) assessments, and photographs were taken at baseline and Hour 3 on Day 1 using the equipment of the investigational sites."
8,"No minimal clinically important difference has been published for MAF in RA, but is 5 in lupus.45"
0,"Upon PROVEN’s roll-out, monthly telephone group “check-in” conference calls were held among the approximately 30 ACP champions from each nursing home implementation wave, the HCS’ clinical education specialist, and the research implementation team."
14,"Delivery methods and the need to encourage participants to make cognitive and behavioural changes, rendered blinding of participants and clinicians impossible."
0,This study was conducted in compliance with the Helsinki declaration.
14,"However, all assessments were self-reports using validated measures and analysed blind to allocation (JP)."
0,CBT was done on the basis of the fear avoidance theory of chronic fatigue syndrome.
3,"We studied 8 healthy men aged 24.6±1.8 year (mean ± SE) with a mean body mass index of 24.2±1.2 kgxm−2 in a randomized, crossover design."
0,"When more than two pins were used for fixation of joint fragments, they were introduced tangentially to the joint surface of the radius (figure 1D)."
3,"Routine blood chemistry including fasting blood glucose and HbA1c levels were normal in all participants, none of whom received any medication."
0,"Blood samples for total plasma fatty acid composition, lipoprotein fraction isolation, plasma triacylglycerol, cholesterol, NEFAs, and nitrite/nitric oxide metabolite (NOx) concentrations were collected into EDTA-coated tubes and centrifuged at 1500 × g for 15 min at 4°C."
16,Endpoints were chosen as follows: 1.
0,Weight gain goal was discussed and emphasized through consultation.
16,"For the population treated by chemotherapy: • Primary endpoint of the study is Disease-Free Survival (DFS) • Secondary endpoints are: Overall Survival (OS) and Safety, and • side-effects of chemotherapy in each study arm 2."
0,"Standard diagnostic workup consisted of repeated COPD-6™ lung function testing followed by spirometry with a bronchodilator (salbutamol), history, physical examination and specialist consultation."
3,Adult patients (>18 years) were recruited from Siriraj Hospital if characteristic rhabditiform larvae of S. stercoralis were present on fecal microscopy.
0,Support and/or immobilization devices can be used to increase patient comfort or to ensure set-up reproducibility.
3,"Exclusion criteria included a history of allergic reaction to either study medication, treatment within the month prior to the study with any drug known to have anti-strongyloides activity, pregnancy or lactation and any suggestion of disseminated strongyloidiasis."
0,"In the SI joints, the six consecutive slices covering the cartilaginous part of the joints, which is the most relevant part of the SI joints when looking for inflammation, are scored."
1,"The study was designed as a single-blinded, placebo-controlled, eight-week cross-over study."
0,Informed consent was obtained from all participants (ClinicalTrials.gov identifier: NCT02754674).
1,"A written consent was signed before patients entered the study and were randomly assigned to initial treatment with either L-lysine dissolved in a soft drink or a soft drink only (the placebo) and screened for the outcome measures at baseline, after 28 days of treatment when treatment was crossed over, and after 56 days when treatment was terminated."
0,"Other key exclusion criteria were diseases or conditions associated with constipation, diseases or conditions that could affect GI motility or defecation, medical history of cancer, or other uncontrolled medical conditions."
16,Statistical analysis was performed by one- or two-way ANOVA when appropriate and multiple testing was subjected to Bonferroni correction with the significance level set to 0.05.
0,After the test the TcpO2 values were automatically corrected according to a temperature of 37 °C by the TINA device.
16,Linear regression analysis was also performed to test if blood level of L-lysine concentration could predict functional outcome of any of the outcome measures collected.
0,"From the allele frequencies (AFs) reported by Gragert et al. (36), estimated “phenotype frequencies” (PFs) were calculated indicating probabilities that an individual carries at least 1 of SV-BR-1-GM’s expressed HLA-A, HLA-B, or HLA-DRB3 alleles (HLA-A*24:02, HLA-B*35:08, HLA-B*55:01, HLA-DRB3*01:01, HLA-DRB3*02:02) or allele groups (HLA-A*24, HLA-B*35, HLA-B*55, HLA-DRB3*01, HLA-DRB3*02)."
4,"The study was conducted at the Rockefeller University Hospital in New York City, USA."
0,"However, if the patient has a positive mammogram, the patient will require further navigation to obtain a diagnostic test (biopsy)."
1,"The first phase will comprise a cross-sectional observational study with a control group, while the second phase will consist of a prospective observational study with annual follow-up during four years."
0,"While this alleviated many of the safety concerns related to benzalkonium chloride, it prevented the use of a subject-blinded design because there was no placebo for an alcohol-based product."
1,The study will be carried out in the urban primary care setting.
0,The research was conducted according to the principles expressed in the Declaration of Helsinki.
3,"A total of 30 periodontal healthy, non-smoking volunteers (16 males and 14 females, mean age: 43.9 ± 18.5 years) without medical disorders, and not undergoing any antibiotic or other antimicrobial therapy participated in the present study."
0,"The WICK group received a statim dose of proparacaine followed by insertion of a mydriatic-soaked wick (BD visidrain™ eye fluid wick, cut into 1 cm strips) into the lower fornix."
16,"Descriptive statistics and counts were performed using Microsoft Excel, Microsoft Office XP, Microsoft Corporation, US, and tests of significance (as detailed in the text) were carried out using SPSS statistical software version 15.0 (SPSS Inc., Chicago, Illinois, US)."
0,"In the event of disagreement, treatment continued until agreement was reached on healing status."
16,Statistical significance was accepted if the p-value was <0.05.
0,"The CTV around the pathological lymph nodes is defined as the gross GTV + 3D margin of 5mm, adjusted for anatomical borders in which microscopic disease is unlikely to extend."
1,"The EBP training program will be tested using a randomised controlled design, using a waitlist control group."
0,From in vivo precision of DXA scans a sd of 0.187 in total body fat (TBF) at two consecutive measures was known [48].
1,The study uses a controlled pre/post design to test an intervention using audit and feedback of healthcare providers to improve their compliance with ABU guidelines.
0,"Three participants did not complete one test occasion each (one for mango, one for bilberry and one for blackcurrant) and were hence excluded from the data analysis of the corresponding group."
1,The intervention and the control sites are two different VA hospitals.
0,"An attention control is designed to simulate a behavioral intervention, providing the same amount of contact as the individual counseling in the BA condition, but is not believed to be an effective treatment for depression [30]."
6,"Objective 1 focuses on the clinical outcomes of inappropriate screening for and treatment of catheter-associated ABU, as well as on complications of inappropriately prescribed antibiotics (Table 3)."
0,The primary endpoint was change in cfPWV after 24 weeks.
6,Objective 2 focuses on measuring changes in knowledge and attitudes concerning the ABU and CAUTI guidelines (see Table 2).
0,This is the reference treatment advised by the Dutch Society of Surgeons [28].
1,"The IMRT-HIT-SNT trial is a prospective, non-randomized phase II feasibility trial evaluating acute mucositis ≥ CTCAE°III as the primary endpoint."
0,"It was borne in mind that patients had already participated in the group phase, and issues related to relapse prevention were left mainly for the final group session."
3,• Histologically confirmed or incompletely resected adenocarcinoma or squamous cell carcinoma of the nasal cavity or paranasal sinuses • Inoperable tumour or refusal to undergo surgical resection • Macroscopic or microscopic residual tumour (R2/R1) or • ≥T3/T4 or • written informed consent • pts aged 18 - 80 years • effective contraception for pts in childbearing age (<12 months post beginning of menopause) Exclusion criteria
0,Any events occurring after the first cardiovascular presentation were ignored.
6,"Efficacy was assessed using PANSS total scores at Days 4, 8, 22, 36, 64, and 92 (or study endpoint)."
0,The technique for detecting CQ and DCQ has been validated in blood8 and urine9 and was performed at the Centers for Disease Control (CDC).
6,Tolerability assessments included treatment-emergent adverse events reports and adverse-event related study discontinuations.
0,Intracellular cytokine staining was performed using IFNγ − PE (BD Bioscience) followed by flow cytometry analysis.
6,"Using flow cytometer technique, we will identify whether the homing markers CLA and β7 are expressed on blood T cells and DC in the three groups."
0,Participants could divide the total dose either twice or 4 times daily.
6,"In addition, the production of the pro-inflammatory cytokines; TNF- α, IL-12, IL-17A and IFN- y in DC from blood and tissue in these group will be determined."
0,The limit of detection of the picoAMH ELISA is 0.003 ng/ml.
10,"The randomisation sequence is generated using a computer random number generator, in a 1:1 ratio, and a permuted block design with varying block sizes up to 6, stratified by prior care home residence."
0,"Pharmacopeia) dissolution apparatus (Sotax AT7; Sotax, MA, USA)."
12,The randomisation sequence is concealed from clinical staff who use the computer to allocate patients.
0,Outcome assessments were performed by a group of trained medical or nursing staff from the Guinea-Bissau Ministry of Health who had no role in study design or supplement distribution.
12,"However, research staff collecting baseline data are not blind to treatment allocation."
0,"Patients with missing follow-up data were censored at the last date they were known to be alive (overall survival), or alive without disease progression."
3,The study population consisted of HIV-1-infected male and female patients at least 13 years of age who had not received previous ART and participated in the ACTG 5142 study.
0,This means that the risk decreases more rapidly at shorter distances and flattens off at higher distances.
3,Data from the 2 NRTI-containing arms with LPV or EFV were used for this analysis.
0,"Randomization was done using a computer-generated table of random numbers, placing them in a sealed envelope, and then opening the envelope on the morning of surgery."
1,"A Markov model of HIV-disease [23,24,21] was populated with data (on viral load, CD4+ T-cell count, treatment-emergent resistance, treatment-emergent lipoatrophy (measured by DEXA scan) and health-related quality of life (HRQOL) from the ACTG 5142 study to estimate the economic outcomes of starting ARV therapy with a PI-containing regimen as compared to an NNRTI-containing regimen, given their virologic and immunologic efficacy and effects on cholesterol and lipoatrophy."
0,The detailed algorithms of the feedback messages are available in the supplementary information [Additional file 3].
1,"The effects of CNS toxicities were not included in the model because of their often transient nature, and the effects of diarrhea were not included in the model because of short duration which decreased overtime, the low cost remedies used in management, and lack of significant effect on patients' quality of life measure (p = .0818) in the trial data and hence lack of economic impact on the model results."
0,The design of the main study has been published elsewhere [19].
6,The following dependent and independent variables were examined in this study.
0,"Inclusion criteria for participation were: healthy nulliparous women with normal singleton pregnancies and a foetus in cephalic presentation admitted to the delivery ward in an active or latent phase of labour, after a spontaneous onset of labour."
1,The study was a randomised controlled trial conducted between 2005 and 2008 at 7 paediatric HIV clinics in Uganda.
0,"Plasma glucose concentrations were measured spectrophotometrically on a Cobas c 111 analyzer (Roche, F."
1,Participants were allocated to the intervention or 'standard of care' supplement in a 1:1 ratio.
0,"If participants are < 16 years of age, assent will also be obtained as necessary."
6,- To evaluate feasibility and toxicity of intra-arterial gemcitabine therapy - To establish the maximum tolerated dose Secondary Objectives
0,"Characteristics of IPs in each image were systematically classified by imaging modality, according to five categories, adapted from one prior study of IP and four prior studies of AD and HP including gross appearance, contour, surface pattern, pit pattern, and appearance of surrounding mucosa.5, 6, 8, 9, 15"
16,"Holter data analysis will be done using Spacelabs Pathfinder Software Kit (version 9.019) and under supervision of a cardiologist of the Academic Medical Centre Amsterdam, The Netherlands."
0,"Stratifying for age and gender, the last author SGH, who had no participant contact, block-randomized three consecutively enrolled cohorts of n = 24 to intervention in individual format, group-format, or treatment as usual (TAU), involving e.g., extra GP visits, or stress leave."
6,The primary endpoint is the percentage of patients that develop AF during the first 72 hours postoperatively.
0,The motor block level was also evaluated using a modified Bromage scale (Dar et al. 2015) and surgery was started after establishment of adequate sensory block level.
6,"Secondary endpoints include the percentage of patients with AF on each post-operative day, the total duration of AF and the number of episodes, the length of stay on the ICU as well as the in hospital stay and the MACE rate at 30 days, 3 months and 1 year follow-up."
0,"For a subset of patients, levels of Bacteroides species were measured by plating dilutions onto Bacteroides Bile Esculin agar (Becton Dickinson)."
3,"Parents, at least one obese or two overweight, are eligible to participate if they are able to communicate in Swedish, can freely give informed consent and have a child of one year of age."
0,"The product of QRS duration times the Cornell voltage combination (R in lead aVL+S in lead V3, with 0.6 mV added in women)17 >2400 mm×ms or Sokolow–Lyon voltage (S in lead V1+R in lead V5 or V6)18 >38 mm was calculated to identify ECG‐LVH.7"
3,"Infants with chronic health problems that are likely to influence height, weight, levels of PA or eating habits are excluded from this study but are welcome to receive the health promoting information."
0,"Using the SphygmoCor System (Px Pulse Wave Analysis) by an investigator, with the patient in the sitting position and resting the arm on a rigid surface, pulse wave analysis will be made with a sensor in the radial artery, using mathematical transformation to estimate the aortic pulse wave."
8,"The intervention is planned to include 200 families, 100 in each group, providing 80% power at the 5% significance level (double-sided test), considering a 15-20% dropout rate (based on the previous STOPP study)."
0,"Apical 4-chamber, 2-chamber and long axis view images taken five beats post flash demonstrating subendocardial and transmural hypoperfusion in the apical left ventricular segments marked with green arrows."
8,The power calculation is based on detecting a 50% lower prevalence of child overweight and obesity in the intervention group; 20% in the intervention group compared to 40% in the control group.
0,Patients eligible for the study will be seen in clinics following upfront chemotherapy to check the inclusion and exclusion criteria.
16,"Per-protocol analysis with ANOVA with repeated measures was conducted to test CAPS, IES-R and SCL-90-R scores for differences between groups over time."
0,"Skeletal X-ray survey was performed, consisting of anteroposterior and lateral views of the skull and spine, as well as anteroposterior views of the ribs, pelvis, and upper and lower limbs."
16,The Holm’s sequential Bonferroni correction for multiplicity was employed after a significant ANOVA for the four post-hoc tests for differences between groups.
0,"Although majority have some college education (41.2%), only 19% of the study participants have a college degree and more than half are out of work by self-identifying as either unemployed (28%) or unable to work (25%)."
4,Subjects will be enrolled in multiple academic and non-academic (teaching and non-teaching) hospitals in the Netherlands.
0,Ozone was applied to the peri-implantitis sites following mechanical debridement in the ozone group.
3,A total of 1000 adult patients of both sexes with pN0micro+ will be randomized to receive adjuvant chemotherapy.
0,"Moreover, the Geriatric Assessment by CRASH score, defined as the identification of four categories of different toxicity risk (low, medium-low, medium-high, high), will be prospectively correlated with toxicity."
3,"- pN0micro+ colon cancer patients (stage I/II, Dukes A/B) - patients deemed to be fit for chemotherapy treatment (WHO classification ≤ 1; ASA classification ≤ 2) Exclusion criteria for randomization"
0,"Response choices for all items were never, once, few, many."
9,An interim analysis will be performed when half of the required number of events have been observed.
0,"The MZmine 2 data processing included chromatogram building, peak deconvolution, deisotoping, alignment, filtering and gap filling."
9,"Based on the O'Brien-Fleming alpha-spending function, the first analysis will be performed at nominal alpha level 0.003, the second at nominal alpha level 0.047, to ensure an overall alpha of 0.05."
0,Propensity score method used to balance baseline variables may reduce the number of patients who will be valid for primary analysis (Austin 2011).
3,"LEAD 6 included patients aged 18–80 years with Type 2 diabetes who were receiving a stable regimen of metformin, sulphonylurea or both for at least 3 months, and had HbA1c values of 7.0–11.0% (53–97 mmol/mol) and a BMI ≤ 45 kg/m2."
0,"For low dose preparations (10 µg) five times more AS02 adjuvant was added to the 62.5 µg vial of AMA1, from which five 0.5 ml low vaccine doses could be obtained."
3,"Patients had no previous treatment with insulin, exenatide or liraglutide."
0,All growth measurements were converted to age‐adjusted z scores in standard deviations (SD) based on World Health Organization (WHO) standards.15
14,Data collectors and the laboratory technologist were blinded to the random allocation of the clusters.
0,Measurements were made for the total body (BMC and BMD) and the L2–L4 lumbar spine (lumbar BMC and lumbar BMD) in mothers and the total body and total body less head (less head BMC and less head BMD) in infants.
14,"However, this being a behaviour change community trial, it was difficult to fully blind the data collectors and participants."
1,"This was a prospective multi-country, randomized non-inferiority trial conducted in Ethiopia, Nepal, Nigeria, and Yemen to determine whether a scheme collecting two sputum specimens on the first day of consultation plus a morning specimen on the following day (SSM) had sensitivity and specificity that are non-inferior to the standard SSM scheme for the diagnosis of pulmonary TB (see Text S1)."
0,A steady diet was maintained in order to not confound observed clinical results.
3,Patients ≥18 y old with cough ≥2 wk duration who had not received anti-TB treatment in the previous month presenting at the study site health service providers between 1 January 2008 and 30 March 2009 were eligible to participate.
0,Bar charts were created using absolute frequencies.
3,"All thermally injured pediatric patients with burns covering more than 30% of their TBSA were admitted to our institution between 1998 and 2008, required at least one surgical intervention, and consented to the University of Texas Medical Branch Institutional Review Board-approved experimental protocol were included in this study."
0,"However, due to the emergence of the 2009 H1N1 pandemic virus, the independent data-monitoring committee, without any prior knowledge of the results, recommended terminating the trial and conducting an early analysis on May 6th 2009."
3,"Patient, parent or legal guardian provided with written consent for participation in the study."
0,"Furthermore, during the colonisation study, positive profile results obtained by REP-PCR were confirmed by two different RAPD PCR using two primers: RAPD3 and RAPD4 for L. crispatus strains; RAPD4 and RAPD6 (5'-TGGGCGTCAA-3') (primer OPL-2, [15]) for L. gasseri strains; and RAPD1 (5'-ATGTAACGCC-3') (primer P2, [17]) and RAPD4 for L. rhamnosus."
3,"Although assessments and sampling are conducted during pregnancy, only a proportion of pregnant mothers attend antenatal clinics, and formal recruitment into the cohort occurs around the time of birth."
0,All patients underwent conventional MRI and DCE-MRI scans 1 ~ 2 days prior to the start of radiotherapy (Pre-RT).
3,Entry criteria into the study are: 1) healthy normal baby less than 14 days old; 2) at least one stool sample collected from the mother; 3) the family has lived in the District for the last 2 years and does not plan to move out of the District over the following 3 years; 4) the home is accessible; and 5) the mother is 17 years or older.
0,"At 75% confluence, the growth medium was replaced by basal medium (DMEM supplemented with 2% heat inactivated FCS, 50 U/ml penicillin, 50 µg/ml streptomycin, 1.25 µg/ml amphotericin B, and supplemented with 25 pmol/l insulin) in order to induce differentiation."
4,The trial will be conducted within an acute NHS Hospital Trust with an ED based within the North West region of England.
0,Three months after the first consultation of the worker with the occupational physician the status of RTW was measured based on the data of the collaborating occupational health service.
4,"In order to minimise the risk of contamination from other alcohol interventions, the setting currently has no protocols for screening or advice within their ED or hospital wards."
0,"After intravenous administration of 11C-(R)-rolipram, PET images were acquired for 90 minutes."
1,"The trial comprises three parts: the first is a test of the clinical effectiveness of the EBI, the second is an assessment of the patient's experience of the intervention using qualitative methods, while the third is an assessment of cost effectiveness of the BI."
0,"The three studies were performed within the period of the Brazilian national immunization campaign for influenza, and all were approved by the Ethics Committee of the Faculdade de Medicina da Universidade de São Paulo and were registered at ClinicalTrials.gov (2013 study: NCT02819115, 2014 study: NCT02819180, and 2015 study: NCT 02313740)."
1,"A single centre, parallel group, randomised controlled trial with blinding of parents and outcome assessors."
0,"These two groups were then randomly subdivided into blocks of two subjects for control or intervention groups; that is, if a mother was selected to the control group, the next eligible mother would necessarily be included in the intervention group."
1,"The control group will receive the standardised, concentrated neonatal parenteral nutrition formulation (scNPN) used in current clinical practice and the intervention group will receive a similar formulation containing additional macronutrients (scNPNmax)."
0,"Vacc-4x (5 mg/ml) or Gag p24 (1 mg/ml) in sodium carbonate buffer pH 9.5 was used as coating antigen adsorbed on F8 MaxiSorp Immuno Plates (Nunc, Roskilde, Denmark)."
6,"The primary outcome measure was the percentage of patients with control of all three cardiovascular risk factors, defined as: BP <130/80 mmHg, LDL <100 mg/dL, and HbA1c <8.0%."
0,The PHQ-15 has shown to be equal or superior to other brief measures for assessing somatic symptoms and screening for somatoform disorders [32].
1,"This was a prospective Phase 1b, single-center, randomized, double-blind, controlled, age-deescalating study."
0,It was consistent with public sector health services in most parts of South Africa.
1,The protocol for this trial and supporting CONSORT checklist are available as supporting information; see and Protocol S1 and Checklist S1.
0,"Patients were transferred back to the ward, where the radial site and femoral site were clearly monitored for bleeding and other complications."
3,"In all, 26 healthy male volunteers (25–60 years old, body weight >50 kg and body mass index 19–30 kg m−2) were recruited from the London area by a research organisation, Hammersmith Medical Research, contracted by the GSK Clinical Imaging Centre, London."
0,The 150 subjects included in the present analysis comprise the wait-list arm of the Alberta Population-based Prospective Evaluation of the Quality of Life Outcomes and Economic Impact of Bariatric Surgery (APPLES) study.
3,"All subjects satisfied eligibility criteria and passed a medical screen for fitness to participate (see Supplementary Information for details), and provided informed consent for participation in writing."
0,"PWVc (m/s) was measured using tonometry by Complior (Alam Medical, Vincennes, France)."
6,"The primary outcome was the proportion of students who experienced an asthma exacerbation each month defined as one or more of the following: (1) a red (<50% of personal best) or yellow (50–70% of personal best) peak flow meter reading, (2) increased use of quick relief medication from baseline (≥ 4 puffs), or (3) a respiratory-related school absence [29]."
0,"At the baseline visit, patients underwent a review of informed consent, demographic information, medical history, and current medical therapies."
3,"Students who (1) attended one of the participating schools, (2) had physician diagnosed asthma, and (3) could use a peak flow meter were eligible for the study."
0,The D-Option is a scale used to assess perceived involvement in decision making from the perspective of both the patient and the physician (as opposed to that of a third observer) and includes 10 items.
1,"The study employed a within-subject crossover design - with method (3 - P&P, EARS and EARS II), meal (2 - HF and LF) and time (11 - time points) as the independent factors."
0,"A randomized, placebo-controlled trial was conducted in a primary care setting in the city of Sarpsborg, Norway, as outlined in the published protocol [19]."
1,All participants took part in two identical study days using both high- and low-fat meal manipulations.
0,"This scale was implemented in China by Qian et al.,[32] with a test-retest reliability of 0.61–0.87 and a Cronbach's coefficient of 0.70–0.92."
8,"Using the DASH as the primary outcome measure, where a difference of 15 points is considered to be a minimal important change (MIC) [16] and using a between-group standard deviation of 22 points [17] a total of 51 patients would be needed in each group for a power of 90%."
0,"A self-administered baseline questionnaire was used to obtain demographics, medical, reproductive and family history for exercise group participants."
8,Allowing for a 20% loss to follow-up a total of 128 randomised patients was aimed for.
0,"In addition, multiple regression models were used to analyse inference between variables."
3,"Men and women aged 18–70 years were eligible if they had had RA for ≥6 months as defined by the American College of Rheumatology criteria,30 received methotrexate treatment for ≥3 months (stable dose of 10–25 mg/week for ≥8 weeks) and had a Disease Activity Score 28-joint assessment (DAS28) ≤4.8 (mild to moderate) for ≥3 months."
0,"Patients with only Q-waves on 12-lead ECG in the absence of clinical MI were not excluded, since one of the main aims of the study was to compare the prevalence of non-Q-wave to that of Q-wave UMI."
3,"Exclusion criteria included any form of arthritis other than RA, current or recent serious infection, significant systemic illness or malignancy, neutropenia, use of biological agents for RA within 6 months before the baseline visit and concomitant use of disease-modifying antirheumatic drugs other than methotrexate."
0,The COIN trial protocol is available on the MRC Clinical Trials Unit website.
1,"The MRC Myeloma IX trial was a multicentre (n=120), randomised, open-label, two-by-two factorial trial, with equal group allocation that was designed to compare primary and maintenance treatments and the effects of an oral (clodronic acid) versus an intravenous bisphosphonate (zoledronic acid)."
0,"The PLATO definition of non‐CABG‐related major bleeding included both life‐threatening bleeding (fatal, intracranial, or intrapericardial bleeding; hypovolemic shock or severe hypotension attributed to bleeding and requiring vasopressors or surgery; and decline in hemoglobin of >50 g/L) and other major bleeding (bleeding leading to significant disability; decline in hemoglobin of 30–50 g/L)."
1,Full details have already been reported.12
0,"Progression will be defined according to the RANO-HGG as well as to the MacDonald-Criteria [29, 30]."
1,An open label randomized comparison of gatifloxacin (10 mg/kg/day once-a-day orally) for 3 days versus ciprofloxacin (30 mg/kg/day in twice-a-day orally) for 3 days for the treatment of uncomplicated bacillary dysentery in children.
0,"Face to face interviews with staff and trainers were conducted by six interviewers (EC, ML, CLB, MJ, VB and GR)."
1,This trial was design to demonstrate the superiority of gatifloxacin over ciprofloxacin.
0,Further lifestyle modification was encouraged and prescribed on the basis of the EHR-integrated PHR module.
3,Patients meeting the following criteria will be considered for admission to the trial: • All patients aged >18 years and <70 years after breast conserving surgery.
0,Univariable regression was also used to explore an association between SWS type and water availability.
3,"Participants were eligible if between 18 and 50 years of age, in good general health based on history, clinical examination and laboratory investigations, practiced behaviors that placed them at low or intermediate risk for HIV acquisition, had no history of receiving investigational products, immunosuppressive medication, blood products, immunoglobulin or vaccines within study-defined periods prior to enrollment."
0,"DP was dosed using weight-based guidelines targeting a total dose of 6.4 mg/kg dihydroartemisinin and 51.2 mg/kg piperaquine, given with glucose biscuits."
3,Female participants of childbearing potential were not pregnant or planning to become pregnant and agreed to consistently use contraception for 21 days prior to their first vaccination until 9 months after first vaccination.
0,"The eyeGuide is tailored on the following variables: name, gender, race/ethnicity, ophthalmologist’s name, ophthalmologist’s gender, glaucoma type, past glaucoma surgeries or lasers, optic nerve photographs, visual field test results, use of the internet and/or smartphone, family support for eye drop instillation, and barriers to optimal glaucoma medication adherence."
8,"Assuming a maximum loss of 0.6 kg/week, and expecting a total weight loss during the intervention period of 2.4 ± 2.5 kg compared to the free-living period, for an α value of 0.05 (5%) and an statistical power of 80%, the number of participants needed was estimated at 13 volunteers."
0,All participants provided written informed consent.
8,"Assuming an expected 20% drop-out during the trial, the minimum sample size required was established at 16 volunteers."
0,"It is an 80-point scale that includes direct assessment of learning (word list), naming (objects), following commands, constructional praxis (figure copying), ideational praxis (mailing a letter), orientation (person, time, place), recognition memory and remembering test instructions."
1,A partial factorial cluster randomized controlled trial design was used to assess rates of informed choice in women offered antenatal SCT screening.7
0,"Blood samples for the determination of HCV RNA levels and for viral sequencing were collected at screening, at baseline and at each study visit throughout treatment (Weeks 4, 8, 12, 16, 20 and 24) and follow-up (Weeks 1, 2, 4, 8, 12, 16, 20, 24, 28, 36, and 48) as pre-specified in the time and events schedule."
3,Women eligible to complete assessments of informed choice comprised those who attended a participating practice to report their pregnancies and: – planned to continue their pregnancies– were less than or equal to 19 weeks and six days gestation at their consultation to confirm pregnancy in primary care (based on self-reported last menstrual period)– for whom there was no written record of sickle cell and thalassaemia carrier status in primary care– were aged 18 or over– agreed to be contacted by the research team.
0,Permission to carry out the study was obtained from the Department of Paediatrics and Child Health of the College of Health Sciences.
3,Women who miscarried before being contacted by the research team were also excluded.
0,"Stable medication regimens used for at least 30 days pre-dose to treat conditions related to renal impairment or underlying disease states, and for prophylaxis, were permitted during the study."
3,"Included in the study are all general practices that had performed at least four relevant POCT--INR, hemoglobin, or glucose--in the baseline study period (1 January to 31 April 2010) and had access to POCT within their own practice."
0,"All statistical tests were two-tailed, and a p-value < 0.05 was set a priori as the threshold for statistical significance."
3,These practices were identified in the GP database of the Capital area and in the laboratory database.
0,"For the transverse STA (Trans STA) the ROI should envelop the MCPJ synovium from the lower border of the triangular structure (if bone, this is indicated by a continuous hyperechoic line or if cartilage by a homogenous anechoic line above bone) to the joint capsule superiorly (Figure 1)."
1,"This was a single centre, outcome assessor blinded, parallel group study with imbalanced randomisation [2∶1] conducted in Aberdeen, Scotland, UK (Trial registration: ISRCTN90101501; CONSORT checklist S1)."
0,"Serum BTH1677 levels were measured by a beta-glucan specific enzyme-linked immunosorbent assay (ELISA) developed at Biothera Pharmaceuticals, Inc., which had a lower limit of detection of 1.2 ng/mL and a lower limit of quantitation of 4.7 ng/mL."
4,"The Clinical Research Facility of the University of Aberdeen, set up at the central hospital site for ambulatory clinical research such as clinical trials staffed with specifically trained research nurses."
0,"Reported adherence has been 88% of days in controlled trials,14 in part due to the ease of incorporating it into existing feeding routines."
5,"Participants were randomly allocated to either a face-to-face group behaviour change intervention focusing on dietary and physical activity changes for weight loss, or a control group."
0,"The study was approved by the Human Research Protections Program at the University of California, San Diego (UCSD IRB #050417), and all participants provided informed consent."
8,"The study aimed to recruit 90 participants as this gives precision of at least 5 percentage points on any estimated acceptability/feasibility proportion (i.e. the 95% confidence interval limits around the estimated proportion of, for instance, willingness to be randomised ±10%) [49]."
0,Details of GO-RAISE patient eligibility criteria and study design have been reported1 and are summarised in the online supplement.
3,All adolescents aged 13-18 years who have had type 1 diabetes for more than one year will be invited to participate together with their parents if they meet the following criteria: ▪ HbA1c ≥ 8.0% at the last visit before entry into the study and ▪ Average HbA1c > 7.5% during the last year before entry into the study.
0,"Interrater and intrarater reliability was assessed in 10 healthy volunteers with excellent reliability based on intraclass correlation coefficients of 0.95 and 0.93, respectively."
3,"Adolescents will be excluded from participating in the study if they meet any of the following criteria: ▪ Diagnosed with a psychiatric disease ▪ Consulting a psychologist at the time of recruitment ▪ Unable to understand, talk or read Danish."
0,"Next, we calculate the overall performance by taking the average of 5-fold CV scores across iterations."
4,"The study setting is multinational, with approximately 91 sites in North America, Europe, and Asia."
0,Brief Visuospatial Memory Test–Revised (BVMT-R): (total recall score over three learning trials).
4,"Patients are currently being enrolled in 19 countries: the United States, Germany, Italy, France, Poland, UK, Denmark, Spain, Sweden, Netherlands, Austria, Belgium, China, South Korea, Japan, Russia, Slovakia, Bulgaria, and Saudi Arabia."
0,This work is represented by the ‘reach’ and ‘delivery to patient’ boxes in figure 1.Practices would then have to maintain this activity over the 48 weeks the intervention was active (‘maintenance’ in figure 1).
6,The primary outcome of the trial was limited to change in 2 specific genes (IGF-1 and COX-2) and has been reported previously [13].
0,"After a 2 h equilibrium period (14 h of fasting), three blood samples were drawn for determination of basal glucose concentrations, isotope enrichment, and levels of glucoregulatory hormones and NEFA."
6,"The current report provides results for the secondary, exploratory aim, that was to investigate the changes in global gene expression and modulation of canonical pathways in normal prostate tissue between baseline and 3 month biopsies, and between diet groups at baseline (see below)."
0,The pressure setting of the Cut Suit pump was consistently set to the maximum flow rate of 12 psi (82.74 kPa).
4,Study visits were conducted at the University Hospital of North Norway (Clinical Trial Unit and Department of Neurology).
0,"Focus groups were held at local community sites and stratified by age (40–64, 65+)."
6,"Outcome measures were the impact of MDA on i) malaria morbidity by active and passive case detection; ii) asexual parasite prevalence and density by microscopy, rapid diagnostic test and molecular detection methods; iii) gametocyte prevalence and density by microscopy and molecular detection methods; iv) transmission intensity quantified by the entomologic inoculation rate."
0,Fatigue score and HRQL (SF-36 questionnaires [24]).
16,Parasite prevalence by microscopy and molecular methods was compared between study arms using Generalized Estimating Equations (GEE) to account for correlations between observations from the same cluster and the same survey.
0,Individual fatty acids were expressed as percent of total fatty acids and as grams fatty acid/grams oil in order to calculate the fatty acid doses for each intervention arm.
16,"Poisson regression was used for the comparison of malaria incidence between the intervention and control arm, using GEE to account for correlations among children residing in the same cluster."
0,"An AE was defined as any untoward medical occurrence in a study participant, to whom the study drug was administered, including occurrences, which are not necessarily caused or related to that drug."
14,Blinding of investigators and patients is not feasible as it is immediately recognizable and impossible to conceal that only one group (Group A) receives saline intravenously.
0,"Antibodies from fecal samples were extracted as described before [8, 19, 20]."
1,"This was a randomized, double blind, placebo controlled, parallel group interventional study."
0,"This was a phase III, randomised, observer-blind study (NCT00753272)."
3,"Inclusion criteria were: generally healthy men and women, age 30-70 years with a Body Mass Index (BMI) of 25-40 kg/m2 and a fasting plasma glucose value of 95-140 mg/dl."
0,A value for p<0.05 was considered significant.
3,"Subjects were excluded if they were previously diagnosed as having T2DM, food allergy or sensitivity to study product ingredients, celiac disease, uncontrolled hypertension, fasting serum triglyceride >250 mg/dl, untreated hypothyroidism, recent history of weight loss, were pregnant, breast feeding or at risk of becoming pregnant, current or recent history of drug, alcohol or chemical abuse, or if they had used medications or herbal remedies for weight loss within 3 months before treatment in this clinical trial."
0,Randomisation was concealed until the beginning of the preventive treatment phase.
1,"This was a parallel group balanced (1:1) client randomized and single blind superiority controlled trial conducted in three health facilities in Iganga district, eastern Uganda."
0,"As secondary outcomes, eGFR, relapse rate, and improvement of hypoalbuminemia and hypercholesterolemia at 48 weeks were compared between the 2 groups."
3,"Eligible participants consisted of all newly screened HIV-positive adult clients (>18 yrs) at the three recruitment centres at the start of the study, who were of sound mental status, and who were not under the prevention of mother to child transmission (PMTCT) program or bound to leave the district during the period of follow-up."
0,"Breath samples were taken at 0 minutes, 10 minutes, 20 minutes and 30 minutes."
1,"Randomised, open, general practice-based pragmatic clinical trial."
0,The study protocol is also registered and available at ClinicalTrials.gov (NCT02114450).
1,"This is a pragmatic, two-arm, multi-centre, parallel, randomised controlled clinical trial."
0,"Over three quarters (79.5%) of the participants were female (see Table 1) and represented financial, procurement, research and clinical-based support services and departments."
1,"The AIO KRK 0110 ML22011 trial is a two-arm, multicenter, open-label randomized phase III trial comparing the efficacy and safety of capecitabine plus bevacizumab versus capecitabine plus irinotecan plus bevacizumab in the first-line treatment of metastatic colorectal cancer."
0,Reliability of measurement was ICC=0.89 (p<0.001).
1,"This trial is designed for patients with disseminated, but asymptomatic metastatic disease in good general condition (ECOG 0-1) who may not benefit from aggressive first-line treatment according to the definition of group-3 defined in the German S3-guidelines for colorectal cancer [12,13]."
0,"Polar HR monitors (Polar Electro Inc., Woodbury, NY) were used to monitor HR during all exercise sessions."
9,"If excess harm is observed, or if a statistically significant benefit (resulting from a pre-specified sequential analysis procedure) is observed, the study is stopped and the patient is informed of the results."
0,"SN-38 (7-ethyl-10-hydroxycamptothecin, Sigma, St Louis, MO) and lenalidomide (obtained by extraction from donated patient capsules as previously reported [39]) were used as positive and negative control, respectively."
9,"Also the trial can be stopped after consideration of justified medical, administrative or pharmaceutical reasons by principal investigator or sponsor."
0,"We measured men’s intent for screening before and after the intervention using a single item question: “In the next 12 months, do you plan to get a PSA test?” Measuring actual screening rates"
8,"Based on published data on FOLFIRI or CAPIRI plus bevacizumab and with regard to a marginally decreased prognosis due to exclusion of resectable patients, a median time to failure of strategy (TFS) of 10 months will be expected."
0,"To attenuate asexual parasite replication, participants were admitted for 48 hours confinement and given 480 mg piperaquine phosphate (Penn Pharmaceuticals) on day 7 pi (group 1) or day 8 pi (groups 2 and 3)."
8,"Assuming equal TFS in both arms and in order to statistically exclude an inferior TFS corresponding to a median of 8 months in the experimental arm, 253 observed failures per group are required, i.e. a total of 506 events, to achieve a power of 80% with a one-sided type I level of 0.05 Under assumption of a recruitment period of 3 years and of a minimum follow-up period of 3 years the number of patients to recruit is 258 per treatment arm and a total of 516 in the study."
0,Search results were imported and duplicates were removed.
3,"Female volunteers aged between 18–45 years were recruited by advertisement, and gave written informed consent to participate."
0,"Between April and August 2015, a total of 955 invitations were sent to trial non-participants registered at five GP surgeries in the East of England, UK."
3,"Participants were eligible if they were not pregnant or breastfeeding, had a regular menstrual cycle, were in good general health as determined by medical history and physical/pelvic examination and Pap smear, did not have any sexually transmitted, urinary or vaginal infections, were not using any vaginal products, and were using a reliable form of contraception (i.e., sterilisation, inter-uterine device or non-vaginal hormonal contraception)."
0,"A cluster power calculation was performed with POWERLIB20 SAS/IML modules, which incorporate the methods described in Muller [54]."
1,The study examines the effect of GMCs on patient empowerment and psychological distress of BRCA mutation carriers as well as several secondary outcome measures.
0,"Following each BAT-CS session, counselors also completed treatment fidelity checklists, recorded activation goals set, and recorded participant self-report of the percent completion of each activation goal from the previous session (rated from 0 to 100% completed)."
1,"This randomized controlled trial (RCT) will compare two groups; the intervention group, who will participate in a GMC once and the control group, who will receive care as usual (surveillance in an individual visit)."
0,A second tumor specimen was obtained from each patient during definitive surgery under general anesthesia.
4,"Participating Clinicians were asked to recruit consecutive eligible patients from October to November 2006, and from late January to March 2007."
0,"Prompts (when required) included focus on the group nature of the programme, the extent of specificity to their individual needs and any perceived impact of the intervention (both positive and negative)."
1,"The study was performed as a consecutive treatment, open label, follow-up study."
0,"To do this, we noted how many choices were involved at each level of the shortest pathway to online CBT to calculate an approximate probability of reaching online CBT."
3,The TODAY study design and participant characteristics have been reported (3).
0,"If the latter showed also at least one identical allele between day of recurrent infection and day 0, then the infection was classified as a recrudescence [12]."
3,The protocol was approved by an External Evaluation Committee convened by the National Institute of Diabetes and Digestive and Kidney Diseases and by institutional review boards of each participating institution.
0,The active muscle contraction condition will be standardized by (i) using audio-visual feedback provided to the subject for consistent levels of muscle contraction (10% MVC) and (ii) triggering TMS discharge when EMG activation is maintained at 10% MVC.
16,"Descriptive statistics at randomization are reported as means, SDs, or percents above cutoffs for serious level of depressive symptoms."
0,All participating centres' ethics committees will have issued positive votes on NODPAM before the start of the study.
16,"Analysis of variance or t tests were used to compare mean depressive symptoms and χ2 tests for percent above predefined cut points, by sex and race/ethnic group."
0,A rough estimate of the required sample size is based on the primary outcome physical activity as measured by ActiGraph accelerometer.
3,"To participate in this study, the participants must have a minimum age of 65 years, have had an ICU stay of at least 48 hours (ICU group) or no stay for the last 15 years (comparison group), be able to speak and read either German or French, and live in Switzerland."
0,"Ten-year CVD-related mortality risk for each patient was estimated using the SCORE algorithms for high-risk and low-risk countries, as appropriate [1]."
3,"Excluded were participants because of temporary tracheostomies, chronic mechanical ventilation, illness-related cognitive impairment (dementia), or psychotic illnesses including delusions and changes in mental state, and potentially terminal illnesses such as lung or heart diseases and cancer."
0,"Relative wall thickness (RWT) calculated according to the formula: RWT = 2PWTd/LVEDD (PWTd posterior wall thickness at end-diastole; LVEDD LV end-diastolic dimension) was used in a similar fashion to M/V to classify subjects into the different patterns of remodelling and hypertrophy (see Supplementary data online, Table S1)."
3,Eligible participants will be adults (age 18+) of both sexes who are: 1) associated with one of the two participating community mental health centres; 2) diagnosed following the ICD-10 criteria of schizophrenia or bipolar disorder; 3) able to speak and understand Danish; 4) giving informed consent verbally and in writing.
0,IOP; data from the right eye were used in subjects with two study eyes with equal 8 a.m.
3,"Patients will be excluded if they have: 1) a guardian or a forensic psychiatric arrangement; 2) comorbidity with the ICD-10 criteria of the diagnoses of dementia or mental retardation; 3) a large-scale substance abuse - if later on the abuse is under control, inclusion in the trial will be possible; 4) a current home of supported housing - since the treatment as usual given to this group of patients is significant different from patients living independently; 5) a current involvement in a psycho-educational course - patients are eligible for participation in the trial after the psycho-educational course has ended if they meet the inclusion criteria at this point; 6) not given informed consent."
0,Most general practices in the Netherlands use two rooms for the mass influenza vaccination.
6,"At baseline, the participants' socio-demographic information on education, employment, marital status, clinical diagnosis, suicide attempts, and earliest contract with psychiatric services will be collected."
0,"Spectroscopy acquisition took 24 minutes, and the total exam duration, including volumetric imaging and voxel planning, was about 45 minutes."
1,"Randomised, double-blind, placebo-controlled experimental trial to determine the efficacy of plant sterol esters as dietary supplement in reducing lipids."
0,Field workers traced patients missing the day 7 follow-up.
4,"Research staff placed posters and brochures describing the study in the drug-treatment clinics, provided presentations about the study at IDU drop-in centers, and were available at the clinics to discuss the study with individuals interested in joining the trial."
0,"If all three items were available the website was rated as “good”, if only two criteria were fulfilled the rating was “medium”, and if only one or even none were fulfilled the rating was “bad”."
4,"Potential participants received an explanation of study objectives and design, eligibility criteria, and study activities and procedures."
0,"After the first year of the study, the investigators raised a concern about the number of serious adverse events (SAEs) and treatment discontinuations observed in the AmphoB treatment arm."
1,"The STITCH trial has been designed as a prospective, multicenter, double-blind, randomized controlled trial, in which the large bites technique will be compared with the small bites technique."
0,"Additional exclusion criteria were to suffer from complications due to type 2 diabetes (microangiopathy, polyneuropathy, cardiopathy, hepatic and renal impairments, etc) or having a recent (within the three months prior to the beginning of the study) uncontrolled diagnostic of hypercholesterolemia and/or hypertryglyceridemia."
6,"• Primary outcome will be incisional hernia occurrence within one year after surgery, either clinically and/or ultrasonographically detected."
0,This is followed by heating on a boiling waterbath for 20 minutes.
8,"To detect a clinically relevant change in the CRQ score of 10 points with 80% power, 40 patients per group were needed [24]."
0,General; Educational history of family.
8,"The target sample size was 50 patients per group, considering a probability of 20% drop-out of randomized patients."
0,The dose per site is approximately 0.05 ml.
1,"This is a pragmatic, multi-centre, randomised clinical trial with parallel economic analysis."
0,Any participant felt to be endangered by the use of one closure method was withdrawn from the study prior to allocation.
1,"The study was approved by the Research Ethic Committee (Ref: 10/H1210/10) and the NHS CSP (Ref:NIHR CRN study ID 8956), and registered with the International Standard Randomised Controlled Trial Register (Ref: ISRCTN31379280)."
0,"In the CEA, we will estimate the direct costs that would be incurred by an agency, e.g., a county council, in implementing this type of intervention, by comparing the intervention with care as usual with regard to differences in costs (incremental costs) divided by differences in health effects."
10,A computer generated pseudo-random list using random permuted blocks of randomly varying size will be used.
0,The study population was selected until the subject No 100 and their allocation to the groups of normal or OSA sufferers was based on the results of the polysomnography.
10,Access to the sequence will be confined to the Nottingham Clinical Trials Support Unit (CTSU) Data Manager.
0,Adults over the age of 18 years with symptoms of UI and/or OAB were recruited via a variety of advertising media including newspapers advertisements and notices posted at community centres.
14,"It is not possible to blind participants to the intervention in this study, but outcomes will be collected by researchers who are blind to allocation and all analyses will be carried out blind to allocation."
0,"3) Follow-up questions/probes: exploring specific issues or queries that had previously been identified, or had arisen earlier in the interview."
14,G6PD genotype and phenotype were determined by laboratory staff blinded to treatment.
0,Subcutaneous exendin-4 AlbudAb dosing began on Day 0 (Red Arrow) and ended on Day 28 for the DIO study (right Black Arrow) and on Day 14 for the db/db study (middle Black Arrow); final body composition measurements were also made on that day.
14,Clinical investigators were blinded to drug treatment and G6PD status was not available to clinical investigators until after the trial was complete.
0,"If the entry was not submitted within 90 minutes, the form was closed."
3,Exclusion criteria are - pregnant women - proven or suspected liver cirrhosis - coagulopathy (platelet count below 50'000/μl) - double medication on platelet antagonists (acetylsalicylic acid and clopidogrel) - international normalized ratio (INR) below 1.4 -
0,Ascorbic acid or placebo solutions were prepared in matching volumes with amber shrouding for light protection and to preserve the blind.
3,Non-German speakers - patients who are unable to understand the study purpose.
0,"Samples at baseline (weeks 1 and week 2), after treatment (weeks 6, 7 and 8) and follow-up (weeks 9 and 10) were considered for the analysis."
4,"Kenyatta National Hospital [Kenya], ENT department."
0,"The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated as described previously using the HOMA2-IR online calculator [41, 42]."
3,"Eligible participants fulfil the following criteria: i) ICD-10 schizophrenia, schizoaffective (F20,22,23,25,28,29: WHO, 1999) [21], or ICD-10 diagnosis of Mood disorders (F32) under care of the clinical team (ii) age ≥16, (iii) history of command hallucinations of at least 6 months with history of harm to self, others or major social transgressions as a result of the commands; or harmful command hallucinations where the individual is distressed and appeasing the powerful voice."
0,Written informed consent was obtained from all participants and study design was reviewed by a local ethics committee in accordance with the Declaration of Helsinki.
3,Exclusion criteria include: organic impairment or addictive disorder considered to be the primary diagnosis and insufficient command of the English language.
0,"During the dose-escalation phase, PK assessments were conducted in all patients who took at least one dose of trial medication and provided at least one blood sample following drug administration."
3,"We recruited 100 patients with HCV liver-related cirrhosis at a tertiary care academic centre (National Institute of Gastroenterology, Havana, Cuba) between May 2005 and June 2007, and who fulfilled the following inclusion criteria: male and female patients of 18–70 years of age, clinical or histological diagnosis of cirrhosis, naïve patients or non-responders to previous treatment with PEG-IFN plus RBV with decompensated cirrhosis, defined as a Child–Pugh score ≥7 or clinical evidence or history of ascites, encephalopathy, upper-gastrointestinal bleeding and/or impaired hepatic synthetic function, who had contraindicated the antiviral treatment, absence of active alcoholism (alcohol abstinence was monitored at each clinic visit in the course of patient interview) and ability to provide informed consent."
0,Ethical approval for this study was granted by the National Research Ethics Service for England (Nottingham Research Ethics Committee).
3,"Patients were excluded if they had presence of other causes of liver disease, uncontrollable clinical or biochemical complications related to severe liver failure (hepatic encephalopathy, hepatorenal syndrome, gastrointestinal bleeding, serum total bilirubin >85 mmol/l (5 mg/dl), international normalised ratio >2.5), serum creatinine >180 mmol/l (2 mg/dl), positive screening for viral hepatitis A and B and HIV, pregnancy or lactation, concomitant disease with reduced life expectancy, severe psychiatric conditions, drug dependence, and if they had presence of other causes of liver diseases at entry into the study on the basis of ultrasonography and α-fetoprotein levels higher than 200 ng/l."
0,"Hypertension was defined as having a history of hypertension diagnosed and treated with medication, blood pressure greater than 140 mm Hg systolic or 90 mm Hg diastolic on at least two occasions or greater than 130 mm Hg systolic or 80 mm Hg diastolic on at least two occasions for patients with diabetes or chronic kidney disease (CKD)."
3,"Eligible patients were aged 75 years or older, they or their proxy were able to answer questions in English, and they resided in the city of Hamilton, Ontario, Canada."
0,"Additionally, given that (i) using randomized order in this study will results in consuming POMj then PLA supplementations for some participants with only 48h wash-out period, while (ii) the delayed beneficial effects of POMj could persist up to 3weeks after the interruption of consumption [28], authors in the present study tried to avoid any alteration in the biochemical blood levels at the beginning and during PLA administration period, by avoiding the consumption of POMj before PLA."
3,"Patients were ineligible if they received home care services, lived in a nursing home or long term care home, were identified by their family physician as needing palliative care, were scheduled for major elective surgery in the next year, or were planning to leave the country for more than one month during the 12 month follow-up period."
0,All these described practices were performed to increase the participants’ level of confidence to understand and undertake treatment-related behavioral and cognitive strategies.
17,"Because we were interested in exploring the differential effect of the intervention on patients at higher compared with lower risk of functional decline, we did a post hoc analysis (using two way analysis of variance and its F tests) of differences in outcomes for patients who were at greater risk of functional decline (Sherbrooke postal questionnaire scores of 4-6) compared with those who were at lower risk of functional decline (scores of 2-3)."
0,"For patients treated with open reduction and osteofixation with the Philos plate and threaded cerclages, the proximal humerus is regarded stable for exercises immediately after operation with limitations against resistance exercises during the first 6 weeks after surgery."
1,"The study is a cluster-randomised, community intervention trial evaluating a participatory strategy, conducted by facilitators who collaborate with the local CHC staff and significant community members."
0,"Eligibility criteria included ART-naïve patients, co-infected with TB, who had not been started on ATT and were aged >18 years with no Diabetes Mellitus or co-infection with Hepatitis B or C."
6,"The primary outcome, neonatal mortality, will be evaluated using the surveillance data and case-referent interviews described above."
0,Patients who did not show received one reminder.
6,GIS-based analyses of neonatal mortality will also be performed.
0,Variables with a univariate P-value < 0.20 were considered as possible predictors in the multivariate model.
8,"The original sample size of 500 patients had 80% power and 95% confidence to detect a 15% difference in the primary end point, assuming a 50% recurrence rate in the CQ group, allowing for up to 15% loss to follow-up by day 63."
0,"Secondary objectives were interval adherence, which is defined as the number of measurements in which the target level is reached out of the total number of measurements and time required completing the questionnaire and documentation."
1,"The study was conducted as a research collaboration between AstraZeneca, Södertälje, Sweden and the Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden, and was approved by the local Ethics and Radiation Safety Committees and the Medical Products Agency in Sweden."
0,Haemodynamic monitoring and determination of the positive or negative haemodynamic responses were conducted by an independent anaesthesiologist who was not aware of the study purpose and blinded to the effect-site concentration of remifentanil.
1,"The study was designed as an open label, one-sequence cross-over study, where each subject was his own control."
0,"Recruitment was organised via counselling facilities, and participants received financial reimbursement for participation."
1,"This was an assessor blinded RCT, with the primary aim to evaluate the effect of regular exercise on maternal weight gain [31]."
0,"They were also treated as a valuable project resource; when areas in need of improvement were identified, the HEs were actively solicited for feedback and suggestions on what could be done differently."
1,The complete study (including this secondary analysis) was conducted in agreement with the most recent CONSORT statement http://www.consort-statement.org.
0,"Forty-five mice were treated with lapatinib at 100 mg/kg every 12 hours (6 doses), and another 45 were treated at a dose of 200 mg/kg every 24 hours (3 doses)."
16,Statistical analysis was carried out using independent samples student t-tests.
0,Pearson’s correlation was employed to compare Fitbit usage with age and baseline BDI scores.
16,Results were considered statistically significant where p < 0.05 and results are expressed as mean ± the standard deviation.
0,"Anonymised diagnostic brain imaging before treatment was analysed at the central trial office (University College London, Institute of Neurology, London, UK)."
16,"The sample size of 420 patients was chosen to allow for the potential identification of a trend towards prolonged survival with L-BLP25 while taking the following factors into account: a 2:1 randomization ratio (L-BLP25 vs control arm), an increase of median overall survival time from 24 months in the control arm to 31 months with L-BLP25, a linearly increasing cumulative enrolment over 30 months and a total trial duration of 54 months (follow-up of 24 months)."
0,"This was an open-label, single-arm, multicentre Phase I/II trial."
16,Follow-up will be event-driven with analysis to take place after 211 deaths are reported.
0,The accelerometer was attached to an adjustable elastic belt and worn around participants’ waists at the center of their lower back to be unobtrusive [25].
8,"The sample size required was estimated based on results from the UK study conducted by Huskisson and Donnelly, in which the adjusted means difference between treatment groups for VAS pain on movement at 6 months was equal to 15.04 mm, and the corresponding effect size was equal to 0.52 for completers [18]."
0,The TFIR DVDs were implemented during the first 10 min of the designated 30-min time for gross motor play (in the classroom setting).
8,Sixty patients in each group were required to ensure adequate power to detect a similar between-groups difference.
0,"Between 2005 and 2010, patients of the Medical University of Graz undergoing right heart catheterization due to suspected pulmonary hypertension were included into the retrospective part of the study."
3,"Participants were eligible for the study if they a) had their first visit at the recruiting clinic and were diagnosed during the recruitment period, b) had IBS symptoms as their primary reason for consultation, c) fulfilled Rome III-criteria for IBS [1], d) were between 18 and 65 years old, e) had no presence of current or previous inflammatory bowel disease, and f) lived in Stockholm County."
0,Anaesthesia was maintained with propofol 4 ?g ml?1 and remifentanil 0.25 ?g Kg?1 min.
3,"Eligible patients were excluded if they g) reported debut of IBS symptoms after 50 years of age and were judged to require continued monitoring at the clinic, h) suffered from such severe diarrhea that IBS-symptom modifying drugs with psychotropic effects, such as tricyclic antidepressants or selective serotonin reuptake inhibitors, were judged to be the treatment of choice, i) could not read or write Swedish j) did not have access to the internet, k) were judged to be highly unsuitable for ICBT for somatic or psychological reasons as assessed by the gastroenterologist, or l) were not willing to participate in the study."
0,Allocation concealment was verified using closed envelopes including group allocation information that were handed over to the therapist after inclusion of a new patient.
1,"The study was performed in the city of Uppsala, Sweden, and nested in a larger long-term trial (‘main study’) comparing the effects of eccentric or concentric exercise."
0,All patients were trained to apply the same measures of lid hygiene (washing the face and cleaning the lid with a cotton bud according to standards of each study center).
1,"The present study was performed as a randomized controlled trial during 3 months of the effect of exercise, eccentric or concentric, versus being wait-listed on pain and muscle strength."
0,Good compliance was defined as taking at least 90% of the medication.
1,"Multicentre prospective cohort study with a follow-up to 1.5, 5, and 10 years from the participant inclusion in the study."
0,"Participants wore the SenseWear® Armband (Body Media, Inc., Pittsburgh, PA) between screening visits."
3,"Inclusion criteria: aged 18 and over; residents of geographical patches in Mbare, Harare, covered by the ten selected lay workers; score > 7 on Shona Symptom Questionnaire screen for common mental disorders."
0,Participants who were randomized to TCA with no response to blinded injections were referred to secondary care for operative treatment and not included in the long-term analysis.
3,Exclusion criteria: requiring acute medical attention such that they cannot participate; severe psychiatric symptoms and/or risk to self or others requiring specialist referral as assessed by primary care research nurse Ethical approval was obtained from the Medical Research Council of Zimbabwe and written informed consent was sought from all participants.
0,"The Thermofocus is a non-contact spot thermometer, which measures the emitted thermal radiation of a selected ROI of the foot and converts that measurement into a temperature."
3,"Children 6 months of age and older with JIA [8], kidney transplant recipients, RA [9], HIV-infected, and cancer patients 18 years of age and older, and elderly 60 years of age and older without any immunosuppressive condition, hereafter referred to as the elderly, were eligible to participate in the study (See Appendix S1 for full eligibility criteria)."
0,Half of the devices are equipped with an injection reminder.
4,"Participants will be seen at hospital at randomisation, the end of each treatment cycle, then at Month 6, 9, 12, 16, 20, 24, 36, 48, and 60 after randomisation."
0,The difference in the levels of ACE in granulomatous and a non-granulomatous groups were not compared.
4,Research staff at the hospitals will be expected to complete trial CRFs which record evidence of primary and secondary outcome measures.
0,The present article reports observational data from a subgroup of participants in the DOIT with complete baseline data collection.
6,Clinical assessments will be done by the 'BeweegKuur' health care providers (LSA or physiotherapist) in their own practice.
0,We collected all data over the phone via interviewer-administered surveys at baseline and 6-months.
6,"After the baseline measurement, three different measurement intervals will be used, depending on the variable to be measured: (A) 3 months, (B) 6 months and (C) 12 months (figure 1 and table 2)."
0,Patients with tuberculosis were eligible for inclusion if they were aged ≥18 and agreed to receive tuberculosis treatment at the diagnosing clinic for eight months.
8,"Based on an expected reduction of the prevalence of unprotected intercourse abroad of 30% (15% to 10%), a power of 80% and a significance of 0.05, we calculated an original sample size of 726 travelers per arm for a total of 2178."
0,"Calcium levels in the extracorporeal circuit were not measured routinely, in order to keep the treatment protocol simple."
8,"However, due to logistical constraints and a recruitment rate slower than expected, an interim analysis was performed after 3 years and the study stopped due to absence of impact of any of the interventions."
0,"Allocation was stratified by center and by duration of infection (acute or early), with random permuted blocks of size two and four."
1,"Pragmatic, blinded, multicentre, randomised, controlled clinical trial with four branches, and a three years follow-up."
0,One part of the eligibility criteria are checked preoperatively.
1,The randomisation unit was BHCA.
0,The questionnaire is completed by the first responsible caregiver together with a qualified nursing staff.
1,"This was a qualitative evaluation study, nested in the HIVIS03 trial to evaluate social issues as stated in the project protocol."
0,The safety analysis was designed to demonstrate that the combination of neoadjuvant intensity-modulated radiation therapy with surgery and intraoperative radiation therapy will not result in an increased rate of severe acute gastrointestinal toxicity.
1,The qualitative method was chosen because it explores the shared perspectives and range of issues as expressed in the participants' own words better than the quantitative method.
0,"The particle exposure was associated with concentrations of nitrogen dioxide (NO2) of 0.9±0.1 ppm, NO of 3.1±0.2 ppm and total hydrocarbons of 2.5±0.2 ppm."
1,"We used a mixed-method design that is both exploratory (i.e., by developing the conceptual model of systems leader information and advice networks) and confirmatory (i.e., by testing the conceptual model) [23], achieving three types of integration of quantitative and qualitative data: (1) convergence: using both types of data to answer the same question; (2) complementarity: using each type of data to answer related questions, where the type of data is specific to the question asked (e.g., using qualitative data to generate hypotheses, provide depth of understanding, and focus on the function and context of social networks and quantitative data to confirm hypotheses, provide breadth of understanding, and focus on social-network structure and predictors of implementation stage); and (3) expansion: using one type of data to address questions raised by the use of the other type of data (e.g., using qualitative data to explain results of quantitative analyses) [18]."
0,The study randomized patients to cardioversion using either PB or BTE shocks and investigated the use of 100% oxygen versus room air during the cardioversion procedure.
1,We conducted a randomised controlled trial (parallel group study with 1:1 randomisation) comparing delayed and early cord clamping.
0,"After completing the acute trial, patients could enroll in this 50-week OLE trial."
1,"The study was conducted between April 2008 and September 2009 at the Hospital of Halland, Halmstad, Sweden."
0,The main experimental outcomes were serum TgAb and thyroperoxidase antibody (TPOAb) levels.
14,The study design precluded either the mother giving birth or the midwife performing the intervention being blinded.
0,"That is, Holm's procedure first ranks the three p-values from lowest to highest."
14,"Physicians performing neonatal examinations, staff members responsible for collection of blood samples and background data, and laboratory staff performing analyses of blood samples were blinded to each infant’s allocation group."
0,"The questionnaire includes the following scales: Performance Expectancy, Effort Expectancy, Social Influence, Facilitating Conditions, Attitude toward use, Self-Efficacy, Anxiety and Behavioral Intention."
1,"The present study was in two phases: an initial study of practical utility and reliability of the cognitive outcome measures over three weeks, followed by a 10 week exploratory RCT."
0,All patients were encouraged to receive prasugrel or first ticagrelor dose between 8 and 9 a.m.
8,"By using a two-tailed test and assuming a 90% follow-up, it was calculated that 56 episodes would be needed (28 in each group) to detect a difference of 15% in the need of mechanical ventilation between the control group and intervention group, the one treated with corticosteroids (80% power, 5% significance level)."
0,The blots were washed three times for 10 min in TBST.
8,"In a preliminary study, the mean ± standard deviation (SD) volume of PPH observed at T4 was 1,340 mL ± 490 mL."
0,"Rights to sutezolid were acquired by Sequella, Inc. in 2013."
8,"To demonstrate a decrease of 20% in the volume of PPH in the TA group, the number of patients had to be 144 for a type I error of 5% and a power of 90% [12]."
0,Moreover information to support organizational level decisions about dissemination of the intervention content to other departments is withheld as long as possible until proper systematic evaluation can be conducted when all four intervention deliveries are finalized.
8,"We estimated that enrolling 226 children would provide 80% power to detect a 20 percentage point difference in the proportion of children rehydrated two hours after the start of treatment, given a two sided type I error probability of 0.05 and a 40% success rate in the standard group."
0,"Early insulin exposure and early glucose-lowering effect were evaluated by deriving the early partial areas under the curve (AUCs) for serum IAsp and GIR, both within the first 2 h after dosing."
8,"This calculation included a 5% adjustment for losses to follow-up, withdrawals, and missing data.23"
0,"The second vaginal swab was transferred from transport medium (Amies, Deltalab, Barcelona, Spain) to 1 ml Man, Rogosa, and Sharpes (MRS) broth (Difco Laboratories Inc., Detroit, MI,USA) and agitated for 1 min."
1,We conducted two randomized controlled trials.
0,Any discrepancy was resolved by consensus.
1,Ethical approval was obtained for both trials from University College London ethics committee.
0,"Fourteen days after docetaxel, patients received an initial DRibble vaccine intradermally in the abdominal wall."
4,"Both incentive studies were embedded in the Down Your Drink online trial of a Web-based intervention to reduce alcohol consumption [12,13]."
0,We used four sources of information to identify end-points: (1) repeated contacts with participants; (2) family physicians; (3) yearly review of medical records; and (4) consultation of the National Death Index.
4,The DYD trial and both incentive studies were conducted entirely online (see Textbox 1 for further information on the DYD trial).
0,These Type III clinics serve a lower income population within Mexico City.
1,"This was a single-arm field trial of Mobilyze!, an 8-week multimodal intervention for depression, that included 1) mobile phone sensing and ecological momentary intervention, 2) an interactive website for behavioral skills training, and 3) email and telephone support from a coach assigned to each participant."
0,"For the current psychometric analysis reported in this paper, the earliest time point data for each trial was analysed (i.e. the first time that patients completed the ACTS Burdens and Benefits scales; day 15)."
1,"The trial was approved by the institutional review board at Northwestern University (Chicago, IL, USA)."
0,"For the purposes of the present study, participants did not complete the full instrument; they were instead presented with a checklist of 121 PROMIS-PF items and were asked to indicate which items were relevant to them based on their experiences with TGCT."
1,"Our four-step usability and pilot testing approach consisted of (1) system conceptualization using the Delphi technique to identify key functionalities that would overcome barriers in provider referrals for smoking cessation, (2) Web system programming and refinement using agile methodology and think-aloud usability testing, (3) implementation planning using the nominal group technique (NGT) for the effective deployment of the system in practices, and (4) pilot testing to identify practice recruitment and system-use barriers (Figure 1)."
0,The participants performed a minimum of three attempts with steady increasing force to reach maximum within 3–5 s.
1,Figure 1 Development stages of ReferASmoker.org (RCT = randomized controlled trial).
0,Written informed consent must be obtained from each patient before any study-specific procedure takes place.
1,"The study was an open-labelled, randomized controlled trial design with two groups: control group (TID) and intervention group (BID)."
0,"We also hypothesized that compared with the unconstrained ABA approach, the constrained ABA algorithm will lead to a smoother transformation, and therefore a smaller bending energy."
1,The trial was registered at ClinicalTrials.gov Identifier: NCT00522210.
0,"At the initial hospital visit, patients were requested to collect 24-hour sputum in a clear plastic pot, for 3 consecutive days, when clinically stable."
1,"This study is designed as a multicenter phase I/II trial evaluating the optimal dose for pazopanib (phase I) as well as activity and tolerability of a combination regimen consisting of pazopanib and metronomic cyclophosphamide in the palliative treatment of patients with recurrent, platinum-resistant, pre-treated ovarian cancer (phase II)."
0,"Target limb postures were selected such that the subject had to control each DOF of the prosthesis through 75% of its range of movement, stop within the posture location (±5° of each DOF), and maintain the target posture location for 2 s."
3,Biederman et al previously described full inclusion/exclusion criteria [17].
0,Patients received postoperative 5-fluorouracil based adjuvant chemotherapy for 4 months.
3,"Briefly, children aged 6 to 12 years who met DSM-IV-TR criteria for a primary diagnosis of ADHD [18] and had a ADHD Rating Scale IV (ADHD-RS-IV) [19,20] score of ≥ 28 at baseline after washout were eligible for inclusion, regardless of medication used for ADHD at screening."
0,"An infant who is not fully adherent is considered “partially adherent” if he/she received 100% of scheduled antibiotics on days 1–3 or by the time of treatment failure; received at least 50% of the scheduled doses of each antibiotic during days 4–7, or by the time of treatment failure; is not known to have received any nonstudy injectable antibiotic before day 8 assessment; and is not known to have received any nonstudy oral antibiotic on days 1–3."
4,"The trial was conducted in Goa, a state in West India, by a consortium of organisations led by Sangath, in collaboration with the Government of Goa’s Directorate of Health Services, the Voluntary Health Association of Goa, private general practitioners and the London School of Hygiene & Tropical Medicine."
0,"QOL was assessed using FACT-L [11], FACT-Taxane [12], and FACIT-Sp [13,14] at baseline (pre-treatment), prior to the third treatment cycle (Week 6), prior to the fifth treatment cycle (Week 12), and at the end of sixth treatment cycle (Week 18) or at study withdrawal."
14,Masking of the research assessor was maximised by: carrying out evaluations at home and by an independent research institution not associated with the intervention; randomly allocating unique participant IDs; and carrying out the primary outcome assessment prior to all other assessments.
0,DXA scans were analyzed by an experienced Certified Clinical Densitometrist (M.J.) with special attention for region of interest (ROI) placing and for artifacts.
4,"Data was mainly gathered using problem-oriented interviews [9] with a) children ( n = 5 ), b) parents ( n = 4 ) and c) project staff ( n = 4 ), focusing on their experiences with the project."
0,Results are expressed relative to substrate oxidation levels in control cells (ASMC cultured without eosinophils).
4,"extensive case-files of every family, as recorded by the project’s staff (social workers, family-health-nurse) participatory observation during the young carers groups, focusing on how the children behave in the group."
0,"Following repeated reading of the short transcripts, codes were generated and built into themes.16"
3,"Inclusion criteria were as follows: age 45–69 years, BMI > 25 kg/m2 and, for people with Type 2 diabetes, HbA1c between 57 and 78 mmol/mol [International Federation of Clinical Chemistry (IFCC) standard], comparable with 7.4–9.3% [National Glycohemoglobin Standardization Program (NGSP) standard]."
0,"If the UCF persisted, the OCA adhesive was applied twice more at intervals of 30 days following the same protocol, before the medical procedure was deemed to have failed."
3,"Exclusion criteria were physical impairment, symptoms of angina pectoris (chest pain on physical strain), atrial fibrillation determined by electrocardiogram systolic or diastolic blood pressure > 160 or > 100 mmHg, respectively, and insulin treatment."
0,"Secondary FRI endpoints included image-based airway volume (iVaw) and image-based airway resistance (iRaw) without adjustment for lobar volume at Day 15, and other FRI endpoints included image-based lobe volume (iVlobe) at total lung capacity (TLC) at Day 15 and mass of deposited particles at TLC."
1,The study was conducted as a cluster-randomised controlled trial highly pragmatic in attitude including 40 Danish general practices and their diabetes populations.
0,These included Action for AIDS (AfA) and Humanitarian Organisation for Migration Economics (HOME) that have been conducting outreach activities for FEWs in Singapore.
14,The patients will also be blind to their treatment allocation to allow for an unbiased comparison to be made between the two interventions.
0,"Patients allocated to the intervention received 1 × 1010 colony-forming units of L. rhamnosus GG (Culturelle, Locin Industries, Ltd) in one capsule suspended in tap water, administered via gastric or duodenal tube twice daily while in the ICU."
14,"The surgeons will, of course, not be blind to the treatment but will take no part in the post-operative assessment of the patients."
0,These populations were selected because they were known to be at moderate-to-high risk of HIV infection and because HIV incidence was expected to be sufficiently high to meet the sample size requirements of the trial.
8,"Based on our previous data on the mean serum 25(OH)D in Iranian diabetic patients (57.8 ± 47.8 nmol/L) [11], to detect a change in mean 25(OH)D of 1 standard deviation (SD; effect size of 1) and to have a power of 90%, the calculated sample size was 50 in each group."
0,"FFR waveform analysis was performed at the Institute of Clinical Medicine, Aarhus University, Denmark."
6,"At baseline and at each study visit (post-treatment Day 1, Day 2, Week 1 and Week 5 of each treatment period), physicians assessed global disease activity and rash using a 5-point scale: absent, minimal, mild, moderate or severe."
0,"During refinement, maps were generated from combinations of positional, group B-factor, and TLS (translation/libration/screw) refinement algorithms."
6,"Blood samples were collected for assessment of CRP and SAA (at each study visit) and to assess hematological and biochemical markers (baseline, post-treatment Day 1, Day 2, Week 1, Week 5 and thereafter monthly each period) and immunogenicity (baseline, 1 day pre-dose, and Week 5 of each period)."
0,"Exclusion criteria included: (a) cystic pancreatic lesions without the evidence of solid component suspected with malignant transformation; (b) hemodynamical instability; (c) severe coagulopathy (international normalized ratio > 1.5 or platelet count < 50,000 cells/cubic millimeter [cmm3]); (d) inability to suspend antithrombotic therapy; (e) pregnancy; and (f) refusal to provide informed consent or participate in the study."
1,We conducted a cluster randomized trial in which the hospital emergency department was the unit (cluster) of allocation and men and women with a low trauma fracture were the unit of analysis.
0,"The original CARES contains 139 items; however, not all 139 items apply to all patients and therefore patients complete a minimum of 93 items or a maximum of 132 items."
1,"Since the purpose of the trial was to change practice behaviour and patients in these communities were likely to have the same primary care physician, a cluster design was chosen to minimize contamination."
0,The total number of shoulder muscles with active and latent MTrPs was counted.
5,"The multi-faceted intervention was comprised of having the centralized coordinator, a physical therapist, follow-up with fracture patients and their physicians to provide evidenced-based recommendations about fracture risk and osteoporosis treatment and assist with arranging telehealth consultations to the Multidisciplinary Osteoporosis Program (MOP) [25] at a teaching hospital for complex patients if requested."
0,"The hypothesis of this study is that adding PET and SL to additional staging in these patients will lead to a change of treatment strategy in 27% of patients, leading to an annual cost reduction in the Netherlands of €916.438 by reducing futile treatment."
8,"Based on a prior study of anakinra treatment for fatigue in RA [20], we estimated that 30 patients were needed to detect a difference in 25 points on the fatigue VAS with a power of 80% and a two-sided α of 0.05."
0,"The scale measures the constructs of uncertainty and factors contributing to uncertainty (such as feeling uninformed, unclear about values, and unsupported in decision making)."
5,"In all pharmacies, both in the control group and in the experimental group, pharmacists and pharmacy technicians were instructed to provide education at first dispensing (EAFD) and education at second dispensing (EASD) to new statin users, guided by the same protocols for EAFD and EASD."
0,"For the present study, we excluded participants with prevalent cancer (n = 87), cardiovascular disease (n = 320) or self-reported diabetes (n = 94) and ended up with 4,073 participants (3,536 participants in the analysis of ∆WC)."
5,The difference between the two groups consisted of the way they were supported with the implementation of EAFD and EASD.
0,"The secondary outcomes are: i) weight gain velocity at 21 days since enrollment and weight gain velocity from birth to 36 weeks corrected gestational age; ii) parent stress and anxiety; iii) breastfeeding rate at hospital discharge; iv) clinical outcomes including NICU mortality and major neonatal morbidities; v) safety as indicated by the number of critical incident reports per 1000 patient days; and vi) resource use including duration of oxygen therapy, duration of hospital stay, and potential cost savings due to reduced length of stay estimated using per diem costs [39]."
8,"Because this was the sequel of a trial which was designed to enhance statin prescribing for patients with cardiovascular disease, the sample size needed was not calculated for the primary outcome of this study, but for the primary outcome of the first part of the trial."
0,"MVA85A-IMX313 (lot number 0010812), which expresses the IMX313 fusion protein, was constructed as described elsewhere [11]."
8,We planned to include 7980 patients from 76 pharmacies.
0,"Randomization lists for each age group and centre featured a list of sequentially assigned subject number and, concealed underneath a scratchable patch, the corresponding vaccine assigned assigned to that subject number."
3,"Of 3,597 participants with baseline and 1-year data available, 93.3% consented to genetic analyses."
0,There were no exclusion criteria.
3,"Of these, 56.1% were non-Hispanic white (NHW), 20.4% were African American, 16.7% were Hispanic, 4.4% were Asian American, and 2.5% were American Indian; on average participants were middle-aged and obese (see Supplementary Table 1 for participant characteristics)."
0,"To evaluate the β-cell function, fasting and glucagon-stimulated C-peptide levels were examined at baseline and after treatments with SCE therapy."
6,The primary endpoints were: 1) effectiveness measured as the number and proportion of patients correctly diagnosed (true positive + true negative) and treated; and 2) incremental cost per additional case correctly diagnosed and treated (incremental cost effectiveness ratio - ICER) defined as the change in costs over the change in effectiveness of moving from the presumptive strategy (the base case) to the next best alternative.
0,"Provider-incurred costs included the cost of study-related visits, materials, and equipment."
16,Survival data were plotted using the Kaplan-Meier method and were compared by the log-rank test or Student's t-test as noted.
0,Vascular disease was defined as peripheral artery disease and/or coronary artery disease (CAD) with a history of acute coronary syndromes.
1,Phase III clinical trial to evaluate the efficacy and safety of already marketed drugs in a new indication.
0,Following blood sampling for pharmacokinetic analysis subjects will be discharged from the clinic following safety assessments.
1,"Parallel group, randomized, double blind, placebo controlled trial."
0,"Membranes were incubated with HRP-conjugated secondary antibodies diluted in TBST supplemented with 5% non-fat milk at a 1:5000 dilution (Amersham, GE Healthcare Life Sciences [Pittsburgh, PA] NA931, NA934) for 1 hr at room temperature."
8,"Sample size was not based on hypothesis testing, but instead on a reasonable estimation of the sample size necessary to 1) assess the feasibility of the intervention, and 2) determine the effect sizes for the main effects of the intervention."
0,Potentially amplified transmission risk partners are the number of condomless anal sex partners who are HIV-negative or unknown serostatus where participants have a HIV viral load greater than 200 copies/mL at the same assessment visit.
1,This was an observational multicentre study in which we firstly developed the PREdiction of DELIRium for Intensive Care patients (PRE-DELIRIC) model and then temporally validated it in a second prospective cohort in the same hospital.
0,"Following completion of their sixth dosing cycle, patients who experienced a response (CR or PR) or had remained stable (SD) were eligible to continue on maintenance therapy receiving BTH1677 and cetuximab (BTH1677 arm) or cetuximab alone (Control arm)."
1,We then validated the model externally in four other Dutch hospitals.
0,"They collect data regarding predefined clinical outcomes (overt stroke or TIA, adverse vascular events, bleeding, infection and kidney injury), and administer the Lawton iADL Scale, Modified Rankin Scale, GDS and EQ-5D questionnaires."
16,"Given the exploratory nature of the study, all analyses were descriptive, with no formal statistical test performed on the data."
0,He was tapered off hydroxyurea and was completely off on day +14.
1,The Cooperative Huntington Observational Research Trial (COHORT) is an observational study designed to collect phenotypic data and biological samples from individuals with HD and their family members.
0,"The first page of the newsletter addressed general information related to healthy eating, activity, or other relevant behaviors; the sidebar on page one also presented site-specific information regarding upcoming events."
3,"Eligible research participants were from four groups: (1) individuals with clinically diagnosed HD, (2) individuals who pursued genetic testing prior to baseline, carry an expanded allele, but did not have clinically diagnosed HD; (3) first-degree or second-degree relatives of individuals in the first two groups; and (4) spouses or caregivers of individuals enrolled from group one or two."
0,"Consecutive 10-s epochs of EEG data from each channel were subjected to a fast Fourier transform, from which EEG power density was computed from 1 to 50 Hz."
3,Individuals under 18 years could only enroll if they were clinically diagnosed with HD.
0,"All converted patients, i.e. preoperative and intraoperative, remained in the laparoscopic group for analysis based on intention-to-treat principle."
6,"Once a week, participants of both groups rated forearm pain intensity at its worst during the previous 7 days on a 100 mm Visual Analogue Scale (VAS), where 0 mm is ‘no pain at all’ and 100 mm is ‘worst possible pain’.17"
0,The study was conducted in accordance with the Declaration of Helsinki [17] and Good Clinical Practice (WHO Guidelines) [18].
10,"The 16 PHCCs will be assigned to the intervention or the control group following a simple, computer-generated random sequence (EPIDAT 3.1)."
0,Table 1 grade of toxicity Inclusion criteria
14,"In the study, the patients, the professionals implementing the interventions, and those assessing the outcomes will not be blinded to the assignment group."
0,"CL clearance, KA absorption rate constant, Q intercompartmental clearance, F relative oral bioavailability, popPK population pharmacokinetic The existing base model was applied to the OPTIMIZE data only according to a Bayesian feedback procedure [16] (i.e."
14,"However, analysis data will be performed by independent professionals blinded to the assignment group."
0,The game rules for all four conditions are illustrated in Fig. 3.
8,This was an observational and descriptive study to assess the safety and immunogenicity of ChAd63 AMA1 and MVA AMA1.
0,"The exclusion criteria were subjects who are HTS naive, had a reported intolerance to HTS, currently participating in another study or have participated in another study with an investigational drug within 1 month of screening, or had a clinically significant condition other than CF or CF-related conditions that could compromise the safety of the patient or the quality of the data."
8,"The sample size (n = 16) was chosen to allow determination of the magnitude of the primary outcome measures, especially of serious and severe adverse events (AEs), rather than assessment of statistically significant differences between groups."
0,"All patients who discontinue treatment before week 104 for any reason specified in the case report form (CRF) e.g. an adverse event, withdrawal of informed consent, loss to follow-up, are classed as dropouts."
14,It was not possible to mask Soldiers because they actively participated in the exercise and education training programs.
0,"At study visits, participants provided data on medical history and COPD symptoms; completed the Saint George’s Respiratory Questionnaire (SGRC) and the American Thoracic Society-Division of Lung Disease Respiratory Questionnaire (ATA-DLD, baseline only); underwent a physical examination, pre and post bronchodilator spirometry, lung volume measurements, carbon monoxide diffusing capacity (DLCO) and pulse oximetry; and provided blood, urine and expired breath condensate specimens."
14,All outcomes were assessed by raters blinded to group assignment or were obtained via self-report.
0,All subjects provided written informed consent prior to study procedures and the study was approved by the UCSF Committee on Human Research.
3,"The participants were community-dwelling men and women >20 years of age, with prehypertension (systolic BP: 120–139 mm Hg or diastolic BP: 80–89 mm Hg) and stage 1 hypertension (systolic BP: 140–159 mm Hg or diastolic BP: 90–99 mm Hg), LDL-c between 3.35 mmol/L (130 mg/dL) and 4.88 mmol/L (189 mg/dL), and at least one CVD risk factor such as age (men ≥45 years; women ≥55 years), smoking habit, low high density lipoprotein cholesterol (HDL-c) concentration of <1.0 mmol/L (40 mg/dL) and <1.18 mmol/L (46 mg/dL) in men and women, respectively; family history of premature CVD (in male first-degree relative <55 years of age, in female first-degree relative <65 years of age."
0,"The ID and DPAI interventions were not based on SDT or other psychological theory, however behaviour change techniques included; information provision, setting and negotiating achievable physical activity and/or eating behaviour and weight loss goals, weighing at appointments, barrier identification and assistance to overcome them, encouragement to self-monitor weight, completion of food and or/physical activity diaries and wearing a pedometer."
3,"Exclusion criteria included diabetes mellitus, any chronic disease, current hypolipemic treatment, triglycerides (TG) >3.97 mmol/L (350 mg/dL) in fasting state, body mass index (BMI) >35 kg/m2."
0,"To construct the ‘civic participation’ scale respondents were asked about their attendance (yes/no) to activities, events, actions in an attempt to solve a problem affecting local people and volunteering in the last 12 months."
14,"The cocoa cream products were manufactured by La Morella Nuts S.A. (Castellvell, Spain) specifically for the trial (Table 1) and all the products were designed to have the same texture and visual characteristics."
0,Brefeldin A (BD Bioscience) was added at a final concentration of 0.6 μL/mL and incubated at 37°C with 5% CO2 for approximately 12–15 hr.
14,"Table 1 Nutritional composition of each cream (13 g dose).a The participants, clinical investigators and laboratory personnel were blinded with respect to the type of cream being consumed."
0,The intervals of drug-administration will be prolonged stepwise depending on the PASI and DLQI score.
6,The primary outcomes for the study were global functioning (measured using the global assessment of functioning scale)13 and symptoms of schizophrenia (measured using the positive and negative syndrome scale) assessed at 24 months.14
0,"A 14-item questionnaire using Likert scales (ranging from 1 to 10) and open-ended questions was developed to gather data relevant to the CFIR domains, and will be applied weekly for the first four weeks of the SAIA intervention, followed by monthly for the remaining five months, with facility managers and a rotating group of facility nurses."
6,"Secondary outcomes were global functioning and mental health symptoms measured at 12 months as well as levels of group attendance, social functioning (measured using the social function questionnaire),15 adherence with prescribed drugs (measured using the Morisky scale),16 satisfaction with care (measured using the client satisfaction questionnaire),17 mental wellbeing (measured using the general wellbeing scale),18 and health related quality of life (measured using the five item EQ-5D)19 assessed at 12 and 24 months after randomisation.20"
0,"Renal dysfunction was defined as doubling of serum creatinine concentrations, of 4 mg/dL or more, or progression to end-stage renal disease (renal transplantation or haemodialysis)."
4,"Four Melbourne (state of Victoria, Australia) Local Government Areas (LGAs) of Brimbank, Wyndham, Moonee Valley and Yarra."
0,Blood test results and lists of potential adverse effects are therefore kept separately in a locked safe to which only medical doctors responsible for patient safety and the person involved in the blinding of the study medication have access.
4,We selected these LGAs based on a Victorian government request to carry out the study in the north-western region of Melbourne and on annual birth rates in excess of 1000 to maximise recruitment.
0,"In old fracture talus with dislocation of ankle joint should reduce the talus and maximal tibiotalar joint contact surface, increase fusion rate and preserve the limb length."
4,Donors coming for a whole blood donation at the Lausanne Blood Transfusion Centre of the Swiss Red Cross were recruited.
0,Study day 0 was defined as the day of randomization.
4,Randomization and follow-up took place at the Department of Ambulatory Care and Community Medicine of Lausanne University Hospital.
0,An epoch length (time sampling interval) of 15 seconds was specified.
3,"Women will be eligible to participate if they are aged 16 years and over; are booked into the birthing unit at Queen Mary Maternity Unit, Dunedin Hospital, or we are notified by their home birth LMC, before 34 weeks gestation; are able to communicate in English or te reo Māori (Māori language); and are not planning to leave the local area prior to their child's second birthday."
0,"Because of this, communication between the OP and GP was part of the intervention protocol to try to prevent contradictory advises for the workers and to facilitate return to work."
3,"After birth, babies will be excluded if they are born before full term (36.5 weeks), or if a congenital abnormality or a physical or intellectual disability likely to affect feeding, physical activity or growth is identified."
0,The main analysis will be of feasibility outcomes.
3,"Patients who meet the following inclusion criteria are eligible for participation in this trial: diagnosis of a distal adenocarcinoma within 10 cm of the anal verge, staged as cT1-T3 tumour on imaging, age > 18 years and written informed consent."
0,"QL-Ranclin software (Qualilab, France) was used to generate the randomized list prior to enrollment."
3,"Exclusion criteria are: Low risk T1, tumour ineligible for TEM (circular or intra-anal tumour), pre-existing faecal incontinence (soiling is not), synchronous tumours, or presence of mesorectal lymph nodes larger than 5 mm on CT, MRI and/or endorectal ultrasound and contraindications for capecitabine."
0,Respondents' self-perceived health was also elicited (Very good/Good/Average/Poor/Very poor/Can't say).
6,Primary objective of the study is to demonstrate that more than 12 of 55 patients have minimal residual disease 8 - 10 weeks after neoadjuvant CRT.
0,"We explored implementation and adoption issues through focus groups and semi-structured interviews with practitioners, and reported the results elsewhere [30]."
6,Minimal residual disease is defined as an ypT0 or ypT1 stage.
0,This measurement of a patient’s single overall best tophus response was intended to control for patients with multiple tophi and varying responses (Figure 1).
3,"Participants will be excluded if they: A) have severe generalized skin conditions such as eczema, psoriasis, and atopy(hay fever, asthma) B) have severe allergic reactions in the past C) have taken oral anti-histamines or topical corticosteroids in the preceding 3 months D) have any acute or chronic illness E) have cardiovascular disease, liver or kidney disease F) have allergies on soybean foods G) have taken any prescribed or investigation medication during the 8 weeks preceding enrolment."
0,"Medical care was determined by faculty surgeons, fellows, and residents according to clinical protocols that have been previously described [18]."
10,Participants were randomly assigned following simple randomization procedures (computerized random numbers) to one of two treatment groups.
0,The study was conducted according to the principles of the Declaration of Helsinki and in compliance with International Conference on Harmonization/Good Clinical Practice regulations.
10,Independent pharmacists dispensed either Pioglitazone or Prednisone according to a computer generated randomization list.
0,"After removing shoes, height was measured to the nearest 0.1 cm with a daily-calibrated freestanding stadiometer Leicester Height Measure (Seca 214, UK)."
13,Block randomization was by a computer generated random number list prepared by a pharmacist with no clinical involvement in the trial.
0,"LV Left ventricle, PV-loops Pressure-Volume loops."
13,"After the research nurse had obtained the subject's consent, she contacted the pharmacist who was independent of the recruitment process for allocation consignment."
0,where PCr is serum creatinine measured in micromole per litre.
14,"Whereas patients and physicians allocated to the intervention groups were aware of the allocated arm, outcome assessors and data analysts of primary and secondary end-points were kept blinded to the allocation."
0,Gating strategy for analyzing CD8+ and CD4+ T cell responses in memory subsets are illustrated in S3 Fig.
3,"Key inclusion criteria were ≥12 years of age; asthma diagnosis for ≥12 months; previous treatment with a medium-dose ICS, either alone or with a LABA, for ≥12 weeks before screening; stable asthma treatment regimen (daily dose unchanged) for ≥2 weeks before screening; history of ≥2 unscheduled asthma-related visits to a physician or emergency department within the past year, or ≥3 unscheduled asthma-related visits within the past 2 years; forced expiratory volume in 1 second (FEV1) 60%-90% predicted at screening and baseline; an increase in absolute FEV1 of ≥12% and ≥200 mL within 15-20 minutes after administration of short-acting β2-agonist (SABA) rescue medication or peak expiratory flow (PEF) variability > 20%; and use of ≥12 inhalations of rescue medication in the final 10 days of the run-in period."
0,The 1-stage procedure with immediate temporization without full occlusal loading had to be indicated for the patient’s condition.
3,"Key exclusion criteria were > 20% change in absolute FEV1 between screening and baseline; use of > 8 inhalations per day of a SABA-MDI or ≥2 nebulized treatments per day of 2.5 mg SABA on any 2 consecutive days between screening and baseline; 2 consecutive days before randomization with a decrease in PEF below the run-in stability limit, calculated over the preceding 7 days; clinical deterioration of asthma between screening and baseline that resulted in emergency treatment or hospitalization, or treatment with asthma medications other than a SABA; asthma-related emergency department visit or hospital admission in the past 3 months; current smoker or ex-smoker (ie, smoked in the previous year or had a cumulative smoking history > 10 pack-years)."
0,"If FFR interrogation of a coronary lesion between 40 and 90 % is considered as imparting excess risk to a study subject for anatomical or other reasons, it will be avoided."
8,"We estimated that a sample size of 2,314 women would have statistical power of 80% (two-tailed alpha level 0.05) to detect an increase of 2% in the risk of fetal death or liveborn infant death prior to discharge or serious infant outcome from 1.6% for planned ERC [24] to 3.6% for planned VBAC (Text S1) [13]."
0,AEs were coded using the MedDRA Dictionary (v10.0).
8,The sample size for this clinical investigation was based on detecting a difference in the intra-patient changes in ET (seconds) between the randomized treatment groups using a 2-tailed test and a type 1 error rate of 5%.
0,Central randomisation at the Copenhagen Trial Unit was conducted according to a computer generated allocation sequence in two steps according to the 2×3 factorial design.
8,"With a minimum of 100 patients enrolled per treatment arm, a mean difference between the active treatment arm and placebo arm equivalent to 40% of the common standard deviation would have 80% power to detect a difference using a 2-tailed analysis with an alpha of 5%."
0,The direct genome sequencing method was used for resistance surveillance of viral genotypic mutation(s) only in patients with virological breakthrough on antiviral therapy (defined as >1 log10 increase from nadir).
8,"Sample size was determined on the basis of the predecessor study, which found significant results with N = 15 patients."
0,"Placental tissues were collected (approximately 13 from each pregnant mouse), washed with PBS, minced, and lysed using 1% NP40 in the presence of protease inhibitors (Roche Diagnostics, Indianapolis, IN, USA)."
8,Since we wanted to split our sample in two subsamples we recruited with N = 37 more than twice as many patients in order to arrive at least at the same statistical power for each subsample than in the original study.
0,over a period of 5 min through a sterile injection system consisting of a 2-way catheter and a septum injection port.
1,"This phase I-II trial is a national multi-center dose-escalation study of low-dose oral cyclophosphamide in combination with a fixed dose of everolimus in patients with mRCC not amenable to, or progressive after, a VEGF-receptor tyrosine kinase inhibitor containing treatment regimen."
0,A Sonosite Micromax ultrasound device paired with a 5-10 Mhz multifrequency high-resolution linear transducer with Sonocal software will be used for performing automatic measurements of IMT in order to optimize reproducibility.
4,The study is initiated by the department of medical oncology of the VU University Medical Center and will be conducted within the context of the Netherlands Working Group on Immunotherapy of Oncology (WIN-O) with a present participation of 13 hospitals.
0,Participants were randomized to receive two doses of vaccine or placebo at a 14-day interval and instructed not to eat 1 hour before and 30 minutes after dosing.
8,Approximately 240 patients were expected to be randomized to ensure that 220 evaluable subjects would be included in the analysis of the full analysis set (FAS) population (110 per treatment group).
0,"Data were then exported to Microsoft Excel, concatenated into a single comma separated values (cmv) format and imported into FlowJo version 10 for further analysis."
8,"With this enrollment, the study was assumed to have 95% power to detect a treatment difference of 10% in percent change from baseline between ezetimibe/simvastatin 10/40 mg and atorvastatin 40 mg assuming a standard deviation (SD) of 20% (at significance level = 0.05, 2-sided)."
0,Fig. 1 Participant with right hemiparesis receiving transcranial direct current magnetic stimulation (tDCS) in their home simultaneous while performing the finger movement tracking task on the tracking computer (left).
9,"An interim analysis will be performed when half of the patients are recruited, blinded to investigators in order to a) detect possible imbalances between the three arms of the trial with respect to a list of independent secondary endpoints, and b) assess whether the primary efficacy endpoint was obtained at this point in the trial."
0,We conduct two interviews with each man.
9,"The list of independent secondary endpoints will include the following: age, sex, type of fracture (subcapital/intertrochanteric), baseline hemoglobin level and type of surgery."
0,The activities offered to the intervention group are specified and adjusted to the respective company by a modified intervention mapping approach [28].
8,A multivariate approach power calculation was made: The summed squared correlations (Σrho2) to the risk of the antibiotic drug investigated were set to 0.3.
0,Parent data on service use will be supplemented with data on educational service use at pupil level collected from schools.
8,"The frequency of the end point in the standard-exposure group was set to 20%, the sample size was set to 1200 and the frequency of the exposure was set at 30%, which resulted in a detection limit for OR of ≥1.5 (or ≤0.67)."
0,"Mucosal healing was defined by a Mayo endoscopy subscore of 0 or 12, 11, 13 as assessed by a local endoscopist."
1,The trial protocol has been described in details elsewhere [26].
0,Ingestion of water was encouraged.
1,A summary of the design and methods is presented in the following.
0,Patients considered eligible to this study were summoned to a clinical encounter at our study center after which a final decision on inclusion was made.
3,"We recruited patients aged 12 and over who were registered with participating practices, had poorly controlled asthma (defined as score ≥1.5 on asthma control questionnaire (ACQ)19), and had, or were willing to borrow, a compatible mobile phone handset and a contract with a compatible network."
0,Prior written consent to approach village leaders was obtained from each district council.
3,"We excluded people who had other lung disease, were unable to communicate in English, or were receiving specialist care for severe/difficult asthma, and those whose general practitioner advised against inclusion for major social/clinical problems."
0,"The Sponsor, the investigator, and all study staff having a role in the day-to-day conduct of the study remained blinded to treatment."
6,"Primary end point was the level of TG at the end of follow up, as measured by the peak of TG with saline as agonist."
0,It consists of 36 items subdivided in eight scaled scores.
6,"Other outcomes were peak TG with arachidonic acid, tissue factor, ADP and lag time with arachidonic acid."
0,"Participants were assured about confidentiality and data protection of gathered personal information, which would only be used by the researchers in an anonymised format."
8,We calculated that a total of 7 patients in every treatment combination would provide 90% power to detect a difference of at least 55 nmol/l (with an standard deviation of 35 nmol/l) in the assessment of the PTG with saline between groups using a factorial design [18].
0,The contribution of the predictors in combination with covariance structure was assessed based on BIC and the results of the “best” model (smallest BIC) is reported.
8,This sample size would also provide 80% power to detect the presence of interaction.
0,Subjects were identified from non-specialist general medical or family medicine clinics at the hospital.
5,"CBT-P was delivered for 9 months, with a planned minimum of 12 and a maximum of 20 sessions."
0,"Together with the counsellor, the smoker will choose one of the two intervention types, based on his personal risk profile and his own preferences."
5,The therapy in our generic CBT-P manual (Fowler et al. 1995) was augmented with specific relapse prevention techniques.
0,Details of the trial design have been published previously.15
3,"Patients were recruited from the database of the rehabilitation centre, according to the inclusion criteria: first ischemic or hemorrhagic stroke at least 3 months before, able to stand with or without a cane for at least 30 seconds on a normal hard floor, able to walk 20 metres with or without a cane or an orthosis, older than 18 years, score at least 20 on the Mini-Mental State Examination, given written informed consent."
0,"For ethical reasons, patients who decline to participate will still be offered the intervention in their clinic."
3,"Patients were excluded if they had: joint replacements (knee, hip, shoulder), motor task limiting pain in the upper or lower body evaluated with the 11-point visual analogue scale, limited range of motion in the hip, knee, ankle joints or toes, bodyweight exceeding 90 kilograms, or had a comprised mental capacity to give written informed consent."
0,"Since this is an open-label trial, knowledge of block sizes could, under certain situations, permit determination of future allocations."
4,"Participants included in this pragmatic trial were recruited between November 2007 and August 2008 from the outpatient clinic at the Department of Rheumatology, Frederiksberg Hospital, Frederiksberg, Denmark, through advertisements in newspapers and on the website of the Parker Institute."
0,"Given that the co-smokers in the preliminary study preferred age-specific groups, we set the minimum age for participation in the ISCP at 20 years."
4,"Additionally, local general practitioners were informed about the possibility of assigning patients to the project."
0,This operation was carried out by a magnetic card specific to each patient so that both the patient and the operator remained blind to the operation mode.
1,The purpose of the study is to investigate the value of a neoadjuvant hypofractionated short course radiation therapy schedule followed by immediate surgery and an intraoperative boost to the tumor bed in patients with primarily resectable pancreatic cancer.
0,"Two additional visits per week were scheduled for the two-week duration of Lopimune therapy during which a structured questionnaire was filled out and a physical examination performed, both of which were conducted by either the Nairobi PI (IOM) or study doctor (Dr Masinde, Resident in Gynaecology, University of Nairobi) in order to assess occurrence of adverse drug reactions and drug compliance (S3 Text and S4 Text)."
1,The trial will be performed as a single-center one-armed phase I/II study.
0,Refer to the box 1 for a full list of inclusion and exclusion criteria.
3,Children of either sex between ages of 5-15 years with mild acute exacerbation of asthma were enrolled after obtaining written informed consent from the parents.
0,"Participants allocated to the INT group will receive four once-weekly general sleep hygiene education classes, followed by 20 weeks of (1) individually timed BLT based on the participant’s sleep profile and (2) individually tailored PA promotion."
3,"Children with acute life threatening asthma, chronic respiratory illness and those who took salbutamol 6 h prior or those getting long acting β2 agonists were excluded."
0,Subfertile women between 18 and 43 years of age with an indication for treatment with intrauterine insemination were eligible for the trial.
5,Children were administered 2 actuations of each MDI to receive either formoterol (12 μg) or salbutamol (200 μg) with a spacer; both groups received 200 μg budesonide.
0,These biomarkers were measured by the Laboratory for Clinical Biochemistry Research at the University of Vermont.
5,"Participants were explained about the study, spirometry and inhalation of medicines with metered dose inhaler and spacer."
0,6414 M) and the ECs of all local clinical centers.
6,"The primary outcome variable was FEV1 (% predicted) in the two groups at 1, 5, 15, 30, 60 min after administration of the study drug."
0,Ultrasound will be used only for pregnancy dating and no other purpose.
6,"Secondary outcome variables that were evaluated included the difference in Modified Pulmonary Index Score between the two groups, adverse effects like tremors, vomiting, palpitation, etc., number of patients requiring hospitalization at end of study period, and number of children who deteriorated during 1-h study period."
0,"All the primer sequences, optimal annealing temperatures and size of each amplicon are listed in Additional file 1: Table S1."
8,Sample size was calculated for equivalence.
0,This in turn helped people create conditions favourable for community mobilisation for change.
8,"If there is truly no difference between control (Salbutamol) and experimental (Formoterol) groups, then 72 patients are required to be 80% sure that the 95% confidence interval will exclude a difference in mean FEV1 (% predicted) of more than 10 [(assuming SD of 15, based on our unpublished data and data from another study [8,10]."
0,The kidney was immediately flushed at the back table.
6,"We focused on three outcome domains: physician assessments of ICU eligibility, in-hospital and 6-month mortality, and changes in functional status ; where a change in functional status was defined as a minimum of one point change in at least one dimension of the ADL with respect to baseline during the 6 months following the ED visit."
0,"Then 3% refined beeswax was added to prepare blank paraffin blocks of 32 mm × 15 mm × 10 mm, which were cooled at room temperature."
6,"The main outcome measures were (1) clinical adverse events including mild, moderate and greater severity renal toxicities and serious adverse events, (2) willingness to use the study regimen, if shown to be effective, (3) adherence rates for daily and intermittent dosing, (4) change in HIV-associated risk behavior during trial participation, (5) the proportion of volunteers with HIV-specific immune responses as measured by Interferon-γ ELISpot."
0,Randomised participants were prescribed 42 tablets.
14,"Allocation to FTC/TDF or identical placebo pill was blinded to study volunteers, all research staff and the study sponsor."
0,"The subcutaneous injections should be administered on the same day of each week, and subjects providing blood samples to be used in the population pharmacokinetic model were encouraged to inject in the same area of the body throughout the trial."
14,Allocation to daily or intermittent dosing was not blinded.
0,"Demographics, medical history, gestation of diagnosis of GDM and dose of metformin therapy were recorded at the time of randomisation."
5,"Participants were randomized into one of four groups for 24 weeks: healthy weight maintenance diet (Control); caloric restriction (CR): 25% caloric restriction from baseline energy requirements; caloric restriction and exercise (CR+EX): 12.5% caloric restriction and 12.5% increase in energy expenditure through structured aerobic exercise; or, liquid calorie diet (LCD; 890 kcal/day) to rapidly achieve 15% weight loss followed by weight stabilization with a eucaloric diet designed to maintain body mass at this level."
0,"In general, we calculated the direct medical costs of the interventions by assessing resources used and applying standard unit costs [5]."
5,"The group assignment was stratified to ensure equal distributions of sex and BMI in the four groups, and participants were analyzed as intention-to-treat."
0,This standardized the exposures to physiologic levels of ovarian steroids to avoid the confound of varying levels of estradiol and progesterone across the normal menstrual cycle.
3,"Participants are considered eligible if they satisfy the following criteria: • Male or female, between 18 and 75 years of age inclusive, and able to provide informed consent • History of tobacco cigarette smoking for at least 6 months."
0,"The NEADL assesses the ability of participants to perform 20 extended activities of daily living, covering mobility, kitchen, domestic, and leisure activities."
3,"Participants will be excluded if they have: • Doubts about smoking cessation • Existing pharmacotherapy for smoking cessation • History of major psychiatric disorder or chronic pain syndromes • More than 2 failed attempts of smoking cessation in the previous 3 years, either with pharmacological methods or any forms of acupuncture/acupressure."
0,"They attempted to upgrade staff nurse knowledge and skills through case reviews, demonstrations and modeling of good practice, bed-side case discussions, and small group teachings on such issues as partograph use, management of normal labour and complications management."
5,Both intervention groups receive written information and education delivered during one-to-one sessions with a physiotherapist.
0,"Information will collected on: - length of hospital stay - length of stay in ICU - reinterventions Data on extramural care, work absence and other patient costs will be gathered via questionnaires at each follow-up (1 and 12 months)."
16,Mixed models with repeated measures similar to the original analyses (5) were fitted separately to subgroups.
0,"This double-blind, six-way crossover study was conducted in 14 healthy fasting volunteers."
8,"Sample size for the trial was determined by the rarest outcome, pregnancy-related mortality, to allow for the detection of a reduction of 33% in pregnancy-related mortality in the vitamin A arm, with 90% power and at 5% significance, and allowing for a 10% design effect."
0,"Participants complete a risk questionnaire assessing drug use, incarceration, and sexual activity during the previous 3 months using an ACASI at enrollment and every 3 months thereafter."
8,"The sample size of 62 000 infants was also sufficient to detect at least a 15% effect of vitamin A supplementation on neonatal, early infant and late infant mortality."
0,"The effect of vortioxetine (15 or 20 mg/day) versus placebo on health-related quality of life (HRQoL) and satisfaction related to various areas of functioning was assessed at baseline and at completion using the Quality of Life Enjoyment and Satisfaction Questionnaire – Short Form [Q-LES-Q (SF)] (Endicott et al., 1993) and the Sheehan Disability Scale (SDS) (Sheehan et al., 1996)."
3,"Working men and women with subthreshold depression were recruited at 13 factories and offices of a large manufacturing company (19,742 employees) in Japan."
0,Thin smears were used to determine the parasite species.
1,"While these data derive from a randomized trial [14], the study design for this analysis was an observational cohort."
0,Frail older patients and their informal caregivers were recruited as participants through these practices.
1,"Women were pooled across trial arms as the experimental product was found to be ineffective against HIV [14], [15] and was not hypothesized to affect fertility."
0,We assessed this enrolment target as feasible after observing there were approximately 508 eligible patients per month based on medical centre data collected from the year prior.
6,"The primary outcome was the rate of post-discharge hospital utilisation, defined as the total number of emergency department (ED) visits and readmissions per subject, within 30 days of their index discharge."
0,Viral replication was visualized by hemagglutination of chicken red blood cells.
6,Any ED visit in which a subject was subsequently admitted to the hospital was only counted as a readmission.
0,"Electrocardiograms were recorded using continuous digital 12-lead Holter devices (model CM 3000-12; GETEMED Medizin und Informationstechnik AG, Teltow, Berlin, Germany) and a modified Einthoven-Goldberger lead system (the Mason-Likar lead system) [20]."
4,"Upon admission into the ICU, the following items were recorded for each patient: age, gender, chief complaints for admission, symptoms, APACHE II scores, Sequential Organ Failure Assessment (SOFA) scores, white blood cell (WBC) counts, serum c-reactive protein (CRP), PCT, urine sTREM-1, CCr, SCr, BUN, urine output, mechanical ventilation, continuous renal replacement treatment (CRRT), AKI, etiological factors and underlying diseases."
0,Intervention group participants and peer navigators each received a smartphone running the Android operating system.
4,A record was also kept of 28-day survivals.
0,"In the present study, a modified version of the low back pain participatory workplace intervention is developed and will be used."
14,In a study of this type it is impossible to mask the intervention.
0,Sustained low disease activity was chosen as the entry criterion for period 2 as a clinically relevant criterion that can be used to identify patients who are proven responders to treatment.
14,The analysis data will be performed by independent professionals blinded to the assignment group.
0,"The recommended home practice was up to 45 minutes a day for 6 days a week, with guided audio CD and outlined instructions for the home practice."
1,"The study was a double-blind, randomized, placebo-controlled, multi-centre, pilot clinical trial incorporating two parallel treatment arms."
0,The comparison between the IAU condition and the IAU+P4P condition calculated the costs and impact of adding P4P onto the existing SAMHSA/CSAT program.
1,"Patients underwent study assessments at baseline, and at 4, 12, 24, and 48 weeks after randomization."
0,The implementation in intervention communities was standardised at the community and household levels (see Additional file 1).
3,Patients were eligible for inclusion in the COMPAS trial if (i) they had undergone implantation of a PHILOS II DR-T DDD pacemaker (Biotronik SE and Co.
0,These interventions are the most important interventions which have impact on the quality of care or the length of stay.
3,"KG, Berlin, Germany) with an A/V bipolar lead, for standard pacing indications, at least 1 month earlier,1,2 and (ii) were able to (a) comply with the study protocol and (b) sign an informed consent."
0,Analyses of secondary outcome variables were conducted similarly.
1,"We used a double-blind, placebo-controlled, randomized, crossover design with four experiential conditions (placebo-placebo, duloxetine-placebo, placebo-MDMA, and duloxetine-MDMA) in a balanced order."
0,Progression-free survival (PFS) by FRA expression level was also assessed in subjects whose tumor tissue samples were available.
1,The washout periods between the sessions were at least 10 days long.
0,A personal health questionnaire was assessed in order to measure personal health-related quality of life.
6,"After discharge home directly from the PACU, patients were contacted by telephone to collect outcome data at 24 hours, 48 hours, and 12 weeks postoperatively using a structured interview."
0,Fundus controlled fixation testing with dilated pupils was also performed with the MP1 prior to microperimetry and retinal imaging.
1,A two-group randomized controlled clinical trial was undertaken.
0,"Then, physical activity factor was considered in order to calculate total energy requirements according to the “Food and Nutrition Board, National Research Council: Recommended Dietary Allowances: 10th ed.”"
16,Individuals in the cohorts were summarized using means and compared using two-sided Wilcoxon Rank-Sum tests.
0,The estimation of average cost per participant was conducted by a top-down and bottom-up approach.
16,All tests were exploratory because of the small sample size.
0,Those who denied having persistent symptoms or who qualified for only one symptom category were placed in the lower-risk group.
1,"The study design is an individually randomised controlled trial involving three primary care trusts (PCTs) in Birmingham, with nulliparous women assessed as having social risk, randomised to standard maternity care or the addition of referral to the POW support service (See Figure 1)."
0,Patients without DM were defined as those without a previous history of DM and with a fasting plasma glucose level <5.6 mmol/L (<100 mg/dL) and HbA1c <6% (<42 mmol/mol).
1,Figure 1 Flow diagram to summarise allocation and contact throughout the trial.
0,All patients will benefit from the placement of a surgical drain during the operative procedure.
16,"A mixed multiple analysis of variance (MANOVA) (Group X Time) will be conducted to determine if there is a significant interaction between the between- group (Group) and within-group (Time) comparisons for: Bone health (bone mineral density) at baseline and 12-month follow-up session; HRQOL (FACT-P and SF-36), and physical function (FACT-Fatigue, ABC, SPPB, and 6MWT) at baseline, 3, 6, 9, and 12-month follow-up sessions."
0,Our report accords with the CONSORT 2010 statement.24
14,The study was single blinded with members of the study team assessing baseline and follow-up measurements blinded to group assignment.
0,"All investigators, trial personnel and patients were blinded to treatment assignment for the duration of the study."
1,"The REACT-2 trial is an international, multicenter randomized clinical trial in six high-volume trauma centers that will compare the effects of immediate total-body CT scanning in severely injured trauma patients with conventional imaging protocols."
0,Ten therapists were engaged to run the PE and nutritional treatment groups (PED-T programme).
6,The primary outcome criterion for this trial is in-hospital mortality.
0,"Those diagnosed with PI met RDC for primary insomnia and had no findings on the structured interview suggesting a medical, psychiatric or medication cause for their insomnia."
6,"As secondary parameters for the trial focus on additional clinical consequences for the patients and cost-effectiveness and cost-utility: - mortality (24-h, 30-day and 1-year mortality); - morbidity (complications and total number of (re-)interventions and re-admissions up to 6 months post trauma; transfusion requirements, length of ICU stay and number of ventilation days); - several time intervals during initial evaluation (time of arrival, time to CT, scanning time, time to diagnosis and time in the ED); - radiation exposure; - quality of life 6 and 12 months after the trauma as recorded by completing the EuroQol-6D; - general health 6 and 12 months after the trauma as recorded by completing the HUI-3; Economic parameters/endpoints: - total costs of imaging during the initial/index hospital stay; - total direct and indirect medical and non-medical costs during the first half year posttrauma; - quality adjusted life-years (QALY's)."
0,"If time to extubation was more than one hour after skin closure, it was defined as late extubation."
3,"Eligible patients were aged 20–75 years, with a histologically or cytologically confirmed solid tumor refractory to standard therapies or for which a standard effective therapy did not exist, Eastern Cooperative Oncology Group Performance Status (ECOG PS) 0–2, and adequate renal, hepatic, and bone marrow function (absolute neutrophil count ≥1,000/μL, platelets ≥100,000/μL, and hemoglobin ≥9.0 g/dL)."
0,"Adverse events, if any, were reported at each of the follow-up visits."
3,"Exclusion criteria included body weight ≤41 kg (0.05 and 0.10 mg/kg cohort) or ≥63 kg (0.05 mg/kg cohort), central nervous system metastasis, proteinuria greater than Grade 1 per the National Cancer Institute Common Terminology Criteria for Adverse Events version 3.0 (CTCAE v3) [18], hypertension (systolic/diastolic blood pressure >150/>95 mmHg), left ventricular ejection fraction <50%, and serum positivity for human immunodeficiency virus, or hepatitis B or C virus."
0,"Usual care participants were free to use all types of care, including community-based mental health services or support resources other than family meetings at any time throughout the 18 months follow-up, therefore reflecting standard care."
6,"The primary endpoint was survival time, i.e. time between inclusion in the study and death or last patient contact."
0,"Anaesthesia was induced using fentanyl (10 µg/kg), propofol (1–2 mg/kg) and cisatracurium (0.1 mg/kg) and maintained with sevoflurane 0.5–3% and continuous infusion of remifentanil (15–30 µg/kg/hour)."
6,"Secondary efficacy outcomes were incidence of tracheotomy, and of NIV during study period, ALSFRS-R, and its changes, Quality of life using the EUROQoL EQ-5D and its changes."
0,"BASE is an ongoing prospective multicenter convenience sample study, registered as NCT02014896 and approved by each participating Institutional Review Board."
14,The trial was double-blinded.
0,"ADEPT was a phase III, randomized, double-blind, placebo-controlled trial in which patients were randomized to receive subcutaneous placebo or adalimumab 40 mg every other week."
14,Study medication was packed and blinded by Haupt Pharma Brackenheim.
0,Hs-cTnT concentrations were tested immediately from fresh blood samples.
3,"Participants were between 20 and 55 years old (inclusive); had a body mass index (BMI) between 25 and 35 kg/m2 (inclusive); were fluent in spoken and written English; had a primary care physician; had access to a personal computer with an available USB port, speakers, and Internet access; and either answered no to all 7 questions on the Physical Activity Readiness Questionnaire (PAR-Q) or obtained written permission from their primary care physician to take part in the study."
0,"Patients must have adequate haematological, renal and liver function."
3,The PAR-Q is a validated screening tool designed to identify adults with medical problems that might preclude them from safely initiating an exercise regimen [20].
0,"During the baseline period, participants will be required to meet the following eligibility criteria: a) record ≥ 2 meals per day and have ≥ 2 items per meal recorded, and b) record their daily weight in the morning."
3,"Between April 2005 and August 2009, 52 patients were screened."
0,Table 2 Comparison of risk factors in children between the three groups Statistical analysis
3,"Eligibility criteria included histologically confirmed unresectable metastatic melanoma in progression; age >18 years; WHO performance status 0–2; clinically and/or radiographically measurable disease according to RECIST; >4 weeks since adjuvant interferon; no prior interferon or interleukin for metastatic disease; recovered from prior chemotherapy; no major surgery within 28 days; no known brain metastases; absolute neutrophils >1.0×109/L; platelets >100×109/L; bilirubin, creatinine, INR <1.5×upper normal limit; no symptomatic congestive heart failure, angina pectoris, cardiac arrhythmia, history of thrombosis, uncontrolled hypertension, full dose coumarin-derived anticoagulants or NSAIDS."
0,"Patients were instructed to receive their capsules once daily, 2 hours before bedtime."
3,"Participants were excluded if they were unable to complete the outcome measures, they had a diagnosis of Alzheimer’s disease or other dementia, if they were undergoing surgical procedures under regional anaesthesia or if they had delirium at 1 week post surgery."
0,"Providing local technical assistance was an important implementation strategy; however, the lack of available consultants, need for special training, and lack of funding for consultant time meant that NAPSACC was often not available or could only be supported in a few ECE programs."
1,"An open label, parallel-arm multi-centre individually randomized controlled trial."
0,"In this study, the primary outcome measures will be changes in the ADOS Calibrated Severity Scores (ADOS-CSS)."
3,"This study enrolled subjects ≥18 years old, suffering from idiopathic CD with a TWSTRS severity score ≥159 and a ≥12-week interval between the last injection (BoNT-A or BoNT-B) and the first study visit."
0,The telemedicine training was individualized and based on participant’s needs and goals.
3,"To create a homogeneous population for study, subjects with secondary CD were excluded from the study, as were subjects with contraindications of BoNT-A treatment."
0,"In addition, for any individual in the guided intervention (Lantern), program coaches will monitor for worsening symptoms and express student preference to receive more intensive treatment and provide a referral to the on-campus counselor as necessary."
8,"In order to detect a 30% difference in liver fat content between treatments with a 80% power at 5% significance level, 40 patients had to be studied."
0,c) UCLA Loneliness Scale (V3) [31].
8,The expected changes in liver fat content after treatment correspond to the differences observed between obese patients with or without type 2 diabetes in a previous study (1).
0,The equality of variances among the study groups was tested using the Levene test.
3,"Eligible participants were insulin-naïve adults (18–80 years) with type 2 diabetes treated for ≥3 months with ≥1,500 mg/day metformin and A1C values of 7.0–10.0% or with metformin and sulfonylurea (less than or equal to half of the maximum approved dose) and A1C values of 7.0–8.5% (Supplementary Data online)."
0,"Pain therapy was documented daily, as well as occurrence of PONV, time of first enteral nutrition, intestinal paralysis, and start and duration of mobilization."
4,"The patients with essential hypertension were recruited from the Nephrological out-patient clinic of the Department of Medicine, Holstebro Hospital."
0,"Since one cycle of cidofovir (5 mg/kg KG) did not result in a significant reduction of the HCMV viral load, a salvage therapy was induced which consisted of leflunomide (80 mg p.o."
4,The control subjects were recruited by advertising in public institutions and private companies.
0,"For participants in the active treatment arm, the mean dose of chlorhexidine at each application visit was expected to be approximately 33 mg (or 330 μL), so that the cumulative mean dose for participants completing all five applications was expected to be 165 mg."
1,This is a prospective randomized controlled single-blind trial.
0,Patients in group A received intravenous Enhancin [Co-Amoxiclav] at induction at a dose of 25 mg/kg and Pacimol [Paracetamol] suppositories 125 mg for patients under 5 years and 250 mg for those above 5 years [8].
1,"The trial is registered, ClinicalTrials.gov, number NCT00355368."
0,The SEE has some evidence for construct and criterion validity being significantly associated with the mental and physical health domain measures of the 12‐item Short Form health survey and aerobic exercise activity in the past 3 months 27.
4,"The trial took place in the medical and surgical ICUs of the University Hospital of Basel, a tertiary care center."
0,"Therefore, prior to randomisation using CECT images and a 'summarized case report' an expert panel consisting of three surgeons (MAB, HSH, HGG), a gastroenterologist (RT) and three radiologists (TLB, MSVL, JSL) will assess the indication and feasibility of surgical, gastroenterological or radiological intervention."
16,"The quantitative bacterial counts of C. difficile and calculated CFU per gram of target organism group by real-time qPCR were log transformed, after which changes in each time of collection were compared between fidaxomicin and vancomycin treatments, using Wilcoxon signed-rank tests for nonparametric data (GraphPad Prism; GraphPad, San Diego, CA)."
0,"Patients are recruited from Queen Mary Hospital Specialist Renal Outpatients Clinic, Sai Ying Pun Family Medicine Specialty Clinic, Sai Ying Pun Jockey Club General Out-patient Clinic, Kennedy Town Jockey Club General Out-patient Clinic, Aberdeen Family Medicine Specialty Clinic, Aberdeen Jockey Club General Out-patient Clinic; and Diabetes Complication Screening Clinic and Renal Clinic of Tung Wah Hospital."
6,"The primary outcome was the number of days in hospital after surgery [9-13] Secondary outcomes included cost-effectiveness at six months, measured by the Net Benefit statistic, which is calculated using the following equation: ((λ * quality adjusted life year (QALY)) - costs) where λ indicates society's 'willingness to pay' (λ is typically set at £20,000) [24], QALY are calculated using EQ-5D scores and costs included both primary and secondary care costs [25]."
0,The trial registration identifier is NCT01454960 at ClinicalTrials.gov.
6,"Other secondary outcomes, including measures of health status, included changes in health status and quality of life over 6 months after surgery and quality of life at 48 hours, 1, 3 and 6 months after surgery, measured using SF-36 and EQ-5D [25-27]; health care costs including full hospital costs and primary care costs; mortality measured using time-to-event analysis; and the level of major morbidities in hospital using the Post-Operative Morbidity Survey at days 1, 3 and 7 after surgery (POMS) [28] Serious adverse events were assessed by clinical leads defined according to standard definitions, (that is, an untoward occurrence that results in death, is life-threatening, requires hospitalisation or prolongation of existing hospitalisation, results in persistent or significant disability or incapacity, consists of a congenital anomaly or birth defect, or is otherwise considered medically significant by the investigator) [29]."
0,"IDENTITY and IDENTITY2 were implemented at 300 sites in 31 countries, with enrollment from April 2008 to May 2010."
6,"Point smoking cessation at month 6 and/or month 12 confirmed by a urine cotinine test; self-declared smoking cessation at months 6 and 12; reduction in the number of self-declared cigarettes consumed when smoking cessation is not accomplished at months 6 and 12; variation in the phase of process of smoking cessation: from pre-contemplation to contemplation or preparation phase, or from contemplation to preparation phase, at months 6 and 12."
0,"If a tracheostomy was required, the bronchoscopy was performed before its realization."
1,"This clinical trial is a multicenter cohort study with a longitudinal design, which is part of the larger PARA 2010 study."
0,Two neuroradiologists independently reviewed the CT scans.
1,The intervention sample will be compared to a representative comparison sample.
0,"During the course of the trial, after monitoring adherence and follow-up rates in May 2008, it was clear that the initial concerns justifying the adoption of a shorter follow-up were not supported by the data."
1,"MIPA was a 6-month, double-blind, parallel-group RCT in which patients with active PsA were randomized to receive MTX (target dose 15 mg/week) or matched placebo."
0,The 'standard' letter to trial participants was to offer them the study results and this letter was going out to all centres including those not participating in this study.
1,The allocation ratio of active to placebo treatment was 1 : 1.
0,Figure 1 Trial profile.
14,"Although participants could not be blinded to their treatment, staff were separated into intervention and assessment teams to ensure blinding of all assessment staff to participant randomisation assignment."
0,Participants were offered the opportunity to have a sit-stand workstation installed for 8 weeks after all data collection.
14,Participants were consistently reminded to refrain from discussing their randomisation assignments with outcome assessment staff.
0,We chose this outcome not to mix unclear with documented poor outcome.
3,"Healthy male and female volunteers, 18–70 years of age, were recruited from the greater Baton Rouge, Louisiana area."
0,"Heparinized plasma was frozen for central determination of insulin aspart concentrations using an insulin chemiluminescence assay (Invitron, Monmouth, U.K.) (S."
3,Eligible participants were free of chronic disease with fasting serum glucose levels of ≤125 mg/dL and a BMI between 25 and 35 kg/m2.
0,A total of nine organizations operating 26 unique programs agreed to participate.
1,"A pragmatic randomised controlled trial, with nested process and economic evaluations (for full details, see published study protocol12)."
0,Training the HEs to approach marijuana in a way that was appropriate and respectful of cultural norms while remaining in harmony with the principles of brief intervention and the known risks of marijuana use was accomplished in several steps.
8,"Sample size was determined to detect a difference in total minutes of weekly activity at 12 months, with 1052 participants in each group providing 90% power to detect an effect size of 0.15 with no loss to follow-up and, more realistically, 87% and 84% power to detect an effect size of 0.15 if 20% and 25%, respectively, of randomised participants who were lost to follow-up."
0,"In South Africa, there have been two validation studies of the EPDS in community samples."
3,Inclusion criteria: all participants must: Â· be â‰¥65â€‰years of age Â· be attending a primary healthcare centre for consultation on some medical matter Â· provide their informed consent to be included Â· have a serum B12 concentration of <179â€‰pg/ml.
0,BAL cells were collected during bronchoscopy as previously described [16].
16,"OS and PFS were analyzed by the Kaplan-Meier method, and the statistical differences were analyzed by Log-rank method."
0,"Weight was measured to the nearest 0.1 kg with a calibrated digital scale (Scale-Tronix, Wheaton, IL)."
16,All statistical analyses were performed with SPSS statistics 17.0 (SPSS Inc.).
0,We valued each hour of patient and caregiver time at the average hourly wage rate ($22.50 per hour) published for Albertans in 2010 as was done in a previous study [22].
3,Patients aged 18 to 75 years who were undergoing colorectal cancer elective surgery by laparotomic approach were eligible for enrollment.
0,"The Toolkit materials consist of T-shirts, books, booklets, posters, and facilitation guides for about 60 different activities."
3,"Exclusion criteria were a history of allergy to dressing components, evidence of active infection at or adjacent to the operative site, coagulopathy (defined as platelet count less than 50,000 cells/μL or a prothrombin time more than 18 seconds), intestinal obstruction, active bowel bleeding, life expectancy less than 6 months, inability to give written informed consent or a program of minimally invasive surgery (laparoscopy or robot- assisted)."
0,"The trial was monitored continuously for treatment-related adverse events, using NCI Common Terminology Criteria for Adverse Events version 4.03."
5,"Caregivers randomized to the intervention group were invited to participate in six in-person counseling sessions: one individual preparation session, followed by four structured meetings that included their relatives and/or friends, and one additional individual evaluation session."
0,"Participants were also interviewed by telephone by the first author (CS) to assess adverse events (see Additional file 4) through the following question: “Have you at any point during treatment experienced one or more unwanted events that you feel was caused by the treatment, or experienced one or more unwanted effects due to the treatment?” Three months after treatment was completed, participants completed the post-treatment questionnaires again."
5,The family meetings were held once every 2 to 3 months in the year following enrollment in the program.
0,Patients identified targets by pressing the “yes” or “no” buttons.
1,"This is a randomized-controlled, double-blind, double dummy multicentre trial assessing the comparative effectiveness of immediate vs. conditional antibiotic therapy in uncomplicated UTI."
0,"All primary care physicians within Capital Health (the greater Edmonton metropolitan area, Alberta, Canada) were mailed a one-page survey (based on a previously validated opinion leader nomination instrument [3,4,21]) asking them to nominate local colleagues who best match standard descriptions of ""educationally influential"" opinion leaders (see Additional File: 2)."
6,The primary effect parameter for the study was the between group difference (change) in sum of electric or pressure pain thresholds after three weeks of study medication vs. baseline values.
0,The data will be analyzed for multiple time points to allow for a comparison between immediate and long-term provider impact and to increase the reliability of observed trends.
6,[17] Between group differences in change in individual dermatome thresholds and CPM paradigm results were secondary endpoints.
0,Additional individual visits were arranged when needed e.g. in case the dietary or weight management goals were not met or the study subject had special dietary restrictions.
6,"We monitored the safety of BCG in advanced type 1 diabetes and its action on immune and pancreas outcomes, including levels of insulin-autoreactive T cells, Treg cells, autoantibodies (including GAD), and C-peptide, an indicator of endogenous insulin secretion."
0,"Patients will be allocated to Care Managers systematically, being allocated to the next Care Manager on the appropriate site-specific list."
8,Sample size for the randomized population was determined in conjunction with the FDA and with the intense use of serial biomarker studies as outlined by the Institute of Medicine guidelines for clinical trials [18].
0,"This image analysis platform differentiates different histological features through computer-based learning algorithms by running repetitive training sequences using examples of different cellular morphologies to define ‘classes.' H&E sections were first reviewed to identify appropriate tumour regions for analysis, excluding large areas of necrosis, atrophic pancreas and non-neoplastic tissues."
8,A sample size of 6 randomized patients was determined as appropriate for the intense serial blood monitoring required in this proof-of-concept trial for the placebo or BCG interventional limbs and an expanded population of diabetics and non-diabetic controls for assay validation that is referred to as reference subjects.
0,"Functional exercise capacity was assessed using 6MWT according to the ATS guidelines and expressed as walked distance in meters and as % of predicted according to Trooster et al. [23, 24]."
6,"On day 1 of each treatment cycle, a physical examination and laboratory assessments (complete blood count [CBC] with differential and serum chemistry profile) were obtained, use of concomitant medication(s) was documented, AEs were assessed, and RBC transfusion requirements were documented for the preceding 8-week baseline period."
0,"MRI of the SIJ and spine was performed at baseline and weeks 12, 52, and 104."
6,CBC with differential and platelet count was obtained weekly.
0,The protocol for stem cell preparation has been previously set out by Schächinger et al.26
6,"The 130 participants who agreed to participate in the FU2 study were sent a package by mail containing a pre-programmed accelerometer and information on how and when to use it, a questionnaire and a prepaid envelope for return."
0,"Response options were (1) not sure, (2) a little sure, or (3) very sure; higher scores indicated greater self-efficacy."
3,"The key inclusion criteria were: upper lobe predominant emphysema determined from HRCT, aged 40 to 75 years, FEV1 between 15% and 45% predicted, residual volume (RV) >150% predicted, total lung capacity > 100%, diffusing capacity for carbon monoxide > 20% predicted, 6MWD > 140 m, partial pressure of CO2 < 55 mmHg and partial pressure of O2 > 45 mmHg, nonsmoking ≥4 months, and recent participation in pulmonary rehabilitation."
0,"Participants in the intervention condition (i.e., those provided access) were told, “we thought you might be interested in looking at a website that will let you see how your drinking compares with other university students."
3,"Key exclusion criteria were: known α-1-antitrypsin deficiency, clinically significant asthma, chronic bronchitis or bronchiectasis, recent pneumothorax, bullae > 1/3 of lobe, thoracotomy, left ventricular ejection fraction ≤ 40%, and pulmonary hypertension (peak systolic pulmonary artery pressure ≥ 45 mmHg or mean pulmonary artery pressure ≥ 35 mmHg)."
0,Trial participants will be asked for additional optional consent to participate in this aspect of the study.
3,"Based on the 1991 ACCP/SCCM Sepsis Directory [8] and the diagnostic criteria advanced by the 2001 International Sepsis Definition Conference [9], patients exhibiting two or more of the following signs during their first 24 h in the ICU were eligible for selection: (1) temperature of >38°C or <36°C, (2) pulse rate of >90 beats/min, (3) respiratory rate of >20 breaths/min or hyperventilation with a partial pressure of arterial carbon dioxide (PaCO2) of <32 mmHg, or (4) white blood cell (WBC) count of >12,000μL-1 or <4000 μL-1, or >10% immature cells."
0,All statistical analysis was carried out using the statistical package SPSS.
3,"Exclusion criteria were: (1) <18 years of age, (2) acquired immunodeficiency syndrome, (3) reduced polymorphonuclear granulocyte count (<500 μL-1), or (4) died within 24 h after admission into the ICU, refused to participate in the study, or declined treatment during the observation period."
0,"Therefore, the choice of pads shaping the electrode was primarily guided by the clinicians’ visual inspection of the twitch protocol and their choice of a satisfactory set of DF/PF pads."
1,"A two-year prospective follow-up study, carried out during the period from March 2008 to February 2010."
0,Figure 1 An overview of the behavior change techniques (BCTs).
4,"The study will be conducted in cooperation with a major national private health insurer, Discovery Health."
0,A rigorous external quality assurance process was implemented at all sites for all laboratory procedures that produced study end points.
4,"Large companies (>300 employees) that are clients of this insurer, offering health and wellness days and that are based in three South African cities will be eligible to participate in this study."
0,"(Phillipsburg, NJ, USA)."
14,"Due to the nature of the research, the wellness specialists will not blinded and knew which companies were receiving the intervention."
0,"Index participants (i.e., those with an incident A/C referral, n = 200 acupuncture and 200 chiropractic) and matched comparison participants in this prospective portion of the study must meet the overall CMP eligibility criteria listed in Table 1 and be able to read and respond to assessment questionnaires."
14,"However, the employees participating in the research study were not aware of the expected outcomes of the study, nor were they aware of the other (either control or intervention) group participating in the research study."
0,The presence of both fluorescent signals indicated heterozygosity.
8,"We assumed that 43% of men in the control group would return for the day seven visit, as observed in our Kenya male circumcision program."
0,The column temperature was maintained at 30°C.
8,"To provide at least 90% power to detect a relative risk (RR) between the two arms of 1.22 or larger for return to clinic (equivalent to an increase from 43% to 52.5%), we needed to enrol 1200 men (600 in each arm)."
0,"To prevent contamination bias, the control group participants will belong to areas different to those of the experimental groups."
8,Power calculations were performed based on the only previous RCT to assess both reading ability and behavior in children [7].
0,"In each city, the target population consists of persons living independently, aged 75 years or more, who are, according to their GP, expected to be able to participate in the study for at least 6 months."
8,"The results indicated that 180 participants per group would provide 90% power with an α of 5%, for an effect size of r = −0.169 (Cohen's d = −0.343)."
0,The investigator is responsible for ensuring that all sections of the eCRF are completed correctly and that entries can be verified against source data.
14,"Investigators, participants and those assessing outcomes were all blind to treatment allocation."
0,"It consists of statements referring to feeling calm, tense, upset, relaxed, content or worried on a four-point scale."
14,"Post-intervention, both teachers and parents of participants were asked whether they thought their child had been allocated to Active treatment or Placebo, and these estimates were used to assess the maintenance of blinding."
0,Each participating centre assigns a data abstractor responsible for data collection.
1,"Two-arm, randomized, controlled trial."
0,TOWER was conducted in accordance with the International Conference on Harmonisation Guidelines for Good Clinical Practice9 and the Declaration of Helsinki.10
8,The study is designed to detect a difference of 1.03 kg/m2 in BMI at the 0.05 alpha level and 80% statistical power using a two-tailed test for differences.
0,"An initial loading dose was delivered BID on day 1 of each cycle and patients subsequently received MLN8237 once daily (QD) on days 2–14 or 2–21, followed by 14 or 7 days’ rest, respectively, in 28-day cycles."
8,We increased the target sample size to account for examination of effect modifiers and mediators.
0,"A power analysis will be performed again once 60 patients with AIS, NMS, or AD have been enrolled into the study."
3,"Eligible participants were undergraduate university students (first and second year students; academic year 2008/9) from U.K. universities, recruited through university information systems (posters, email messages, bulletin boards) and through online social networking sites."
0,These analyses may be modified in the final statistical analysis plan at any time prior to the investigators accessing the study data in an unblinded fashion.
3,"Participants were incentivised to respond through entry into a prize draw, with prizes including games consoles, mp3 players and store vouchers."
0,The sample size calculation was based on the results obtained from a previous study that compared the rate of sustained extubation using NCPAP vs. high flow oxygen in our unit.
10,"Participants who provided informed consent were individually randomised to intervention or control groups via concealed centrally-allocated computer generated random numbers, with a 1∶1∶1 allocation ratio, without stratification or blocking on any variables."
0,"Thus, female gender appeared to be a negative predictor for a good surgical outcome [3]."
12,The computer-based randomisation ensured that researchers and participants were not aware of allocated group.
0,"The testing was carried out at the HPV laboratory at the INSP in Cuernavaca, Mexico according to manufacturer’s instructions (Roche Diagnostics)."
3,Men and women aged 20–80 y who reported low or no habitual consumption of oily fish were recruited.
0,"Baseline PTSD-related symptoms were assessed at one month post-ICU, as per best practice recommendations [15], just prior to randomisation to study group using the Post-Traumatic Stress Syndrome 14 (PTSS-14) screening tool [16]."
3,"Exclusion criteria were as follows: a diagnosis of diabetes, cancer, cardiovascular disease, or other chronic clinical conditions; untreated hypertension; concomitant prescription of anticoagulants, nonsteroidal antiinflammatory drugs, aspirin, steroids, or immunosuppressants; an allergy or intolerance to fish; the consumption of fish-oil supplements in the past 3 mo; the consumption of oily fish more than once per month; smoking; a history of substance abuse or alcoholism; pregnant, <1 y postpartum, or planning a pregnancy; recent weight change (>2 kg in the past 1 mo), planning to change dietary habits, increase physical activity, change body weight, move away from the study center locality, or take a lengthy vacation during the time of the study; and BMI (in kg/m2) <18 or >35."
0,Orsola-Malpighi Hospital also approved the study.
1,"We conducted an open randomized, phase III clinical trial to compare the differences in efficacy and safety between thermotherapy and meglumine antimoniate."
0,"In essence, the SD quantifies the consistency relative to the device’s average performance that can be expected from one sensor to another for a given CGM device."
3,"Patients included in this study met the following criteria: a) positive parasitologic diagnosis of leishmaniasis, b) no previous treatment for this parasitic infection, c) laboratory exams including renal, hepatic and hematologic testing and d) voluntary agreement to participate in the study."
0,Participants were then asked to discuss their experiences with the prescribed tasks of the preceding week (including the practice of new self-management strategies) (15 min).
3,"Patients with the following characteristics were excluded: a) chronic concomitant diseases, b) lesions compromising the mucosa, c) presence of 10 or more cutaneous lesions with a negative Montenegro test or d) cutaneous lesions located less than 2 cm from the nasal or oral mucosa, eyes or near the anal or urogenital orifices."
0,Brief universal screening can therefore be reliably placed in the preschool setting.
6,"The primary outcome measure is the pain WOMAC score (Table 2), based on the OARSI task force [32]."
0,Height and weight were measured using a periodically calibrated scale accurate to 0.1 kg.
6,"Table 2 Outcome measures The secondary outcomes are: total WOMAC score; joint stiffness and disability WOMAC subscale scores; knee pain symptom on movement, at rest, and at night with a VAS; walking distance in the six-minute walk test; Lequesne score; intake of paracetamol (500 gm) (number of days and quantity) over six months; knee load during gait; global medical assessment score; and global patient self-assessment score (Table 2)."
0,Metformin and pioglitazone dosages were increased in weekly increments up to target doses; metformin could be increased to 2500 mg/day depending on glycemic control.
3,"To be eligible for the study, patients had to have definite RA fulfilling the 1987 criteria of the American College of Rheumatology [21]."
0,"All patients who received TA and study treatment concurrently, following a treatment emergent VTE, were included in this analysis."
3,"The disease had to be active according to the following definition: Disease Activity Score 28-erythrocyte sedimentation rate (DAS28-ESR) > 3.2 and at least one of the following: ≥ 4 swollen joints or C-reactive protein (CRP) ≥ 10 mg/l or ESR ≥ 28 mm/1st H, and the patient had to be eligible for tumor-necrosis factor (TNF) blocker therapy as recommended by the French Society of Rheumatology [25]."
0,"Three single nucleotide polymorphisms (SNP) of the CYP2C19 gene were determined, CYP2C19*2 (c.681"
3,· Weight at birth ranging: 700–1501 grams; · Gestational age up to 25 weeks and 6 days; · Written informed consent from parents or guardians.
0,All the women included in the study will undergo a passive follow-up interview at day 30th after delivery.
1,"A double-blind, placebo-controlled, parallel-group designed, equally randomized (1:1) clinical trial was conducted in Bangladesh from January 2005 to January 2009."
0,Neutralization titers were defined as the reciprocal serum dilution (before the addition of cells) at which 50% of cells are protected from virus induced killing.
1,"The Trial Registration number is ClinicalTrials.gov, NCT00800930."
0,Eligible participants were nurses’ aides employed in elderly care more than 20 hours a week and being 18–65 years of age.
3,Patients attending outpatient departments with a clinically diagnosed white patch requiring a biopsy for histological diagnosis were identified.
0,This approach will ensure proper data collection for future analysis for the entire duration of the monitoring period and confirm that NIRS machines are working properly.
3,Those meeting the inclusion and exclusion criteria outlined in Table 1 were approached for consent to participate in the trial.
0,"Given the number of parameters involved in the model, we made a ‘best guess’ (Thoemmes et al, p 515)120 at effect size, assuming it to be medium, R2=0.13.121 Simulation indicated the need for 200 participants per group (NFP and control)."
8,"We intended to recruit forty patients in total, with ten patients sequentially allocated to each of the four study arms."
0,"After hospital treatment, all the patients were followed-up on an outpatients' basis."
6,The primary outcome measures were recruitment rates and Prostaglandin E2 levels by ELISA between the pre- and post-treatment biopsies as a measure of the activity of the oral topical COX inhibition.
0,Maternal BMI was calculated and dichotomized into normal weight (BMI <25 kg/m2) or overweight (BMI ≥25 kg/m2) [38].
6,"Secondary outcome measures included COX-1/COX-2 protein expression by immunocytochemistry and western blotting, the comparison of WHO histological grade, the clinical size of dysplastic lesion before and after treatment and the safety and tolerability of an Aspirin mouthwash, assessed by a patient diary."
0,IIH:DT is sponsored by the University of Birmingham (RG 13-022).
3,"Patients with refractory chronic CH were enrolled in the study according to the following inclusion criteria: chronic CH according to ICHD-II criteria [2]; disease duration over 3 years; resistance to pharmacological prophylactic treatment with adequate trials (verapamil up to 960 mg/day, lithium with plasma level from 0.6 to 1 mEq/l, association of both; in absence of adverse events); daily attacks; absence of substance abuse or dependence; age 18–65-year-old; normal findings on magnetic resonance imaging; no contraindications to surgery or anesthesia."
0,"Where indicated, DHA or DPA was added before the stimulus at a final concentration of 30 µM."
14,"Blinding of local investigators, research fellows or trust staff to interventions was not possible because the intervention required their active participation."
0,Participants assigned to the trained group attended 20 1-h training sessions over 10–12 weeks.
14,"Patients were aware of the study, but not informed of the intervention allocated to the trust."
0,"With the addition of cetuximab it is felt that a treatment failure-free rate of less than 60% would not be sufficiently large enough to warrant further investigation in a Phase III setting, but that a rate of 75% or higher would warrant further investigation."
1,Three-arm cluster randomised controlled trial comprising Arm A (combined approach of Toddlers Without Tears program followed by the Family Check-Up program); Arm B (Family Check-Up program only); and Arm C (Usual care) (see Figure 1).
0,"Patients were also required to have adequate bone marrow, renal, and hepatic function, which was indicated by neutrophils >3000 ul−1, platelets ≥100 000 ul−1, and hemoglobin >9 g dl−1, serum creatinine <1.5 mg dl−1 (if values were borderline, the creatinine clearance had to be ≥60 ml min−1 by Cockcroft and Gault formula), total bilirubin ≤1.5 times the normal limit, and alanine aminotransferase and aspartate aminotransferase ≤3 times the upper limit of normal."
1,The trial runs from 2010 to 2014.
0,All T2DM patients completed the 16-week VLCD and no patients were lost to follow-up.
6,Patients were asked to rate their current mood at baseline and three months after baseline by placing a cross on a Visual Analogue Mood Scale (VAMS) with the following instruction: ‘You can answer the following question by placing a cross on the line from 0 to 10: at the moment I feel.’
0,"The primary outcome was AE severity, as assessed by blinded research nurses, using an objective severity scale [14]."
6,. The VAMS measured 100 mm between the two anchors with the descriptor “happy” located to the left of the center while “sad” was located on the right.
0,Table 1 shows the final content and delivery schedule of all text messages deployed.
3,"Male and female patients (≥20 years) with unanaesthetised Schirmer test results of ≤5 mm/5 min, fluorescein staining scores of ≥3 points (out of 9 points) and rose bengal staining scores of ≥3 points (out of 15 points) at the end of the run-in period were enrolled."
0,The publicly available information can be viewed at https://www.gistar.eu.
3,"Patients with a history of heamatopoietic stem cell transplantation or keratorefractive surgery, Stevens-Johnson syndrome, ocular pemphigoid or ocular disease other than dry eye requiring treatment were excluded."
0,"Coaching training, yeah, and I found that very, very beneficial."
14,"This was an open label dose-escalating study, with both participants and those conducting clinical and laboratory assessments aware of the interventions received."
0,"The primary outcome of the safety part of the study was the acceptability of the phage products by the patients as determined by clinical observation and liver, renal and hematology tests described previously (Sarker et al., 2012, McCallin et al., 2013)."
8,A total sample size of 36 (18 subjects in each arm) was selected a priori to allow 80% power to observe statistically significant equivalence of means if we assume that Acidform and HEC have no impact on anti-HSV activity and consider the mean difference of 1 standard deviation as the equivalence limit.
0,"Enrollment screening began on 24 Sep 2003, and the study ended 30 June, 2009."
4,"All patients will be screened, randomized and treated in our university hospital, a level 1 trauma centre in a rural area of The Netherlands."
0,"Table 1 Selection criteria of the study population Table 2 Timing of functional and clinical evaluations and endoscopic procedures Fiberoptic bronchoscopy, BT and bronchial biopsies"
4,Approximately 150 patients with suspected CRPS-1 are referred to our multidisciplinary outpatient department annually.
0,"Briefly, a series of 126 pictures (42 HCF, e.g., ice cream, pizza; 42 LCF, e.g., salads, fruits; and 42 NF pictures, e.g., book, bicycle) were presented in random trials across six runs during the fMRI session (Fig. 1)."
1,"A stepped wedge cluster randomised controlled design [18] was chosen following piloting to facilitate roll out of the intervention, ensure equity, and prevent contamination and disappointment effects in hospitals not randomised to the intervention."
0,We developed a novel open-source mobile and Web app to record daily functional activity and adverse events.
1,Figure 2 Timeline for randomisation and implementation.
0,Covariate relationships were considered for all combinations of pharmacokinetic parameters (those with inter-individual variability) and patient factors.
8,"The methods for sample size calculations are fully described elsewhere [21] and comprise a simulation approach [30], parameterised by exploratory trial observations [23] on one ITU and 3 ACE wards."
0,"Meeting full DSM-IV criteria for current major depressive disorder was not required, because many aging depressed people are significantly troubled by minor depressive disorders without meeting criteria for major depressive disorder [44]."
8,"A linear “mixed” model was fitted to the simulated compliance data which gave a stepped wedge trial of 36 months duration and six-weekly hand-hygiene observations 79% power to detect differences in hand-hygiene compliance of 7% or greater for 16 hospitals, and 89% power to detect differences of 8% or more."
0,The protocol was flexible with respect to the discipline of the provider who should offer the videos but suggested the individuals typically responsible for ACP activities.
12,Infection control teams and ward managers were informed of their own hospital’s allocation in May 2007.
0,"The bisulfite conversion reaction was incubated at 65 °C for 30 min, 95 °C for 1.5 min, 65 °C for 30 min, 95 °C for 1.5 min, 65 °C for 30 min with a final incubation at 4 °C for up to 4 h in a PCR thermocycler."
12,Only the research team knew the allocation of all hospitals.
0,The study protocol was reviewed and approved by the institutional review board of the Ewha Womans University Mokdong Hospital (IRB No.
1,"The present study has a double design; - an open intervention with stimulation therapy to which a randomised double blinded and placebo-controlled clinical trial (RCT) with donepezil is added, constituting a two-by-two factorial design."
0,The intervention started in January 2008 and was completed by the end of December 2008.
3,Patients who meet the following criteria are eligible to participate in the study: (i) men and non-pregnant women > 18 years of age; (ii) implantation of an ICD or CRT-D for standard indications within 2–8 weeks; (iii) willing and able to be followed by the same medical centre throughout the study; and (iv) capable of understanding and completing the EQ-5D questionnaire.
0,There was no discussion of the importance of depressed mood or goal setting in the SC condition.
1,"The study had a multicentre, randomised, controlled, crossover design."
0,"After the intravenous induction of anaesthesia with propofol (2 mg/kg), rocuronium bromide (0.5 mg/kg), and fentanyl (2 μg/kg), the patients were intubated with a suitable endotracheal tube."
8,"A sample size of 124 participants (62 randomised to sequence On/Off and 62 randomised to sequence Off/On) provided 90% power to detect a mean difference of 0.3% in the primary endpoint, assuming an SD of 1.0%, a two-tailed matched-pairs t test and a type I error of 5%."
0,The NCT is a simple tool for testing cognitive speed and performance that is frequently reported to be reduced in FMS patients.
8,"To account for the duration of the study and possible dropouts, the sample size was increased by approximately 20%, to 160 participants."
0,The ascending aorta was defined as the segment of the aorta from the lower level of the right pulmonary artery up to the last slice at which the aorta maintained its circular cross-sectional appearance.
1,"This was a single centre, two-armed, parallel-group, observer-blinded randomized clinical superiority trial."
0,The dose was within the range of doses that are taken for recreational purposes and expected to induce robust effects in humans (Passie et al. 2008).
1,"The participants were enrolled at the trial site in Copenhagen (Denmark) and randomized to either aerobic exercise or an attention control group (i.e., stretching exercise)."
0,"PMTCT services in Kenya are primarily provided through public sector and private not-for-private health facilities, and use a mixed approach that includes the World Health Organization’s Option B + strategy in high volume facilities, with Option B and A in lower volume facilities."
16,Statistical analysis was carried out using GraphPad Prism software version 5·04.
0,Sub cultures of Candida Spp.
16,"The non-parametric Mann-Whitney U-test was employed to test for significant differences between groups of volunteers, and the non-parametric Wilcoxon signed rank test was used to test for significant differences between time points within the same group of volunteers."
0,"Our previous online studies have found some applicants each time who attempt to screen-in to a study by providing false information (eg, same name or IP address shows inconsistent age, gender, ethnicity, or country) [36,37,49-51]."
1,This was a two-arm randomised controlled trial designed to evaluate the efficacy of Emotional and Social Mind Training (ESM) compared to group CBT for adults with BN consecutively referred to the South London and Maudsley (SLaM) NHS Foundation Trust Eating Disorders Outpatient Service.
0,"Infection was monitored three times a week by measuring the thickness of the foot lesions with a dial caliper (Mitutoyo Corp., Japan)."
1,The protocol for ths trial and supporting CONSORT checklist are available as supporting information; see Checklist S1 and Protocol S1.
0,We selected subjects who satisfied the inclusion and exclusion criteria (recorded as the date of recruitment).
3,"Males and females ≥40 yrs of age, with a smoking history of ≥10 pack-yrs, a diagnosis of moderate-to-severe stable COPD (as defined in the 2008 Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines) [9], post-bronchodilator FEV1 ≥30% and <80% of the predicted normal, and post-bronchodilator FEV1/forced vital capacity (FVC) <0.70 were enrolled."
0,"Table 1 Criterion values for the graded response score The statistical analysis of the GRS score compared the effects of placebo and teduglutide, starting with the 0.10 mg/kg/day dose according to a pre-specified step-down procedure."
3,"Exclusion criteria included lower respiratory tract infection in the 6 weeks prior to screening; concomitant pulmonary disease (such as pulmonary tuberculosis or clinically significant bronchiectasis); history of asthma, malignancy of any organ system/long QT syndrome or QTc >450 ms (males) or >470 (females) at screening, symptomatic prostatic hyperplasia, bladder-neck obstruction, moderate/severe renal impairment, urinary retention, narrow-angle glaucoma, a known history of α1-antitrypsin deficiency; participation in the active phase of a supervised pulmonary rehabilitation programme; and contraindications for tiotropium or ipratropium or history of adverse reactions to inhaled anticholinergics."
0,The overall and subscale scores have high internal consistencies and predict abstinence [90].
1,"A cohort study was nested within the PROMISE-EBF trial ( http://www.clinicaltrials.govNCT00397150 ), a community-based, cluster-randomized trial to promote exclusive breastfeeding (EBF) through individual peer-counselling, which was implemented in 24 villages of Banfora Health District as reported elsewhere [14,15]."
0,"All those who were in the high suicide risk group were interviewed within 2 working days (but in over 90%, this happened within 24 hours of completion of the screening)."
1,Children born to all pregnant women enrolled in both arms of the main PROMISE-EBF trial formed a prospective cohort that was followed until 12 months of age.
0,Fig. 1 Design of the lurasidone open-label core and extension switch studies.* 144 of the 235 (61 %) patients included in the core 6-week study of HRQoL were included Study patients
14,The research assistants who performed baseline and outcome assessments were blinded from the randomization status.
0,The participants’ PA level was scored through an interview within 3 days and at 1 year poststroke considering the PA level during the previous 6 months.
14,"However, blinding to the intervention research assistants or participants was not possible with the designed interventions."
0,"Kendler's revision of the original PBI (12) also included a version for self-reported current parenting practices toward offspring, which was used in this study based on approved item translations (12, 19)."
6,Four aims were identified as the main outcomes for the study.
0,"For the 64-min periods of continuous activity in the morning and evening, we calculated:The median activity count per minute, as a measure of overall activity level.The standard deviation (SD) for each time series, as an intra-individual measure of fluctuations in activity.The root mean squared successive difference (RMSSD, which describes the difference in successive counts from minute to minute), as a measure of intra-individual variability in the time series.Sample entropy, as a non-linear measure of the degree of regularity (complexity) of a time series."
6,"To have a minimum of 400 employee participants from each university site reach a level of 10, 000 steps per day on at least 100 days (3.5 months) during the trial period; To have 70% of the employee participants from each university site maintain two or fewer inactive days per week, defined as a level of less than 3,000 steps per day; To describe the socio-demographic, psychosocial, environmental and health-related determinants of success in the intervention; To evaluate the effects of a pedometer-based walking intervention in a university setting on changes in self-perceived health and stress level, sleep patterns, anthropometric measures and fitness."
0,"Finally, the system promotes outcomes monitoring and feedback via collection of data on progress toward youth and family needs statements (eg, on a 0-10 scale)."
1,"This was a single-centre, single-blind, prospective randomised control trial."
0,This study has been described previously.17
5,"Subjects were randomised to a 6-week home-based resistance-training (RT) exercise program, a 6-week home NMES program (NMES) or a control group (C) receiving standard care."
0,"Schools approached were primary, junior or middle schools located in the North East of England who were working or had in the past worked with Sustrans, a charity actively involved in ATS promotion in schools [16], as contact details were provided by one of their officers."
14,"Whereas patients and exercise specialists were aware of the allocated intervention, outcome assessors and data analysts were kept blinded to the allocation."
0,"Women randomised to the control group received standard antenatal care, as provided by the health trust."
14,Patients were repeatedly reminded not to disclose their intervention to outcome assessors.
0,The solutions contained a minimum of 57 kcal/kg/day with 2.5 g/kg of protein on the first day of life and up to 90–100 kcal/kg/day and 4 g/kg/day of protein within the first week [18].
5,"• Skin closure with metallic staples • Skin closure with suture material – type of suture (non-absorbable or absorbable) and technique (simple, horizontal mattress, vertical mattress, subcuticular) at the discretion of the surgeon."
0,All patients underwent informed consent and the institutional review board of the Medical University of Vienna approved the study protocol.
6,Additional unscheduled episodes of care as defined by: • Dressing changes by homecare/patient at home or self-reported visits to other healthcare professionals.
0,"Based on the medical literature, the mean incidence of the combined frequency of mortality and severe neurodevelopmental disability in survivors at 18 months of age is approximately 50%."
3,"Subjects were not eligible if they were immunosuppressed from any cause, had previously been vaccinated with a meningococcal polysaccharide vaccine within the past 5 y or meningococcal conjugate vaccine at any time previously, had received tetanus toxoid within the last month, or had a history of meningococcal disease."
0,"Compared to QF-PCR, MLPA avoids the problem of non-informativeness of the polymorphic markers that may occur with QF-PCR [17]."
3,Pregnant or lactating females were also excluded.
0,This study was approved by the local ethics committee and all participants or their legal caregivers voluntarily signed the individual informed consents.
1,The trial is designed as a prospective single-center one-armed phase I/II study to assess the efficacy and safety of a combination regimen consisting of neoadjuvant intensity-modulated dose-escalated radiation therapy followed by surgery and an intraoperative electron radiation therapy boost to the tumor bed in patients with gross resectable or borderline resectable soft tissue sarcomas of the retroperitoneal space.
0,Thinking about how I will manage on my own makes me insecure.
1,"This was a multicentre phase Ib, multiple-arm, nonrandomized, open label, uncontrolled, serial cohort, dose-escalation study evaluating PR-104 in combination with gemcitabine or docetaxel."
0,Eligible subjects were ≥18 years old with a diagnosis of dcSSc.
1,A conventional three-plus-three phase I study design was used to establish the MTD of these PR-104 chemotherapy combinations.
0,"Using an intent-to-treat analysis, the last post-treatment observation was carried forward thus missing values during the follow-up were replaced with the last previous non-missing value."
16,"Data were analysed using descriptive statistics including the median, range and proportion, and mean and standard deviation for normally distributed data."
0,"After a week, the same procedures were repeated with the other cereal-based test meal."
16,Cohorts of up to six patients at each PR-104 dose-level were considered adequate for defining the DLT and MTD.
0,"Each leg is tested separately, a minimum of 5 attempts is carried out for each leg, however the participant continues until two attempts are lower than the maximum."
5,Researchers will undertake a one-day training course for this trial.
0,Difficulty was increased in successive levels by reducing the percentage fundamental frequency difference that indicates reward.
5,"This course will cover the study protocol, the recording method for the clinical record form (CRF), and basic information about clinical research, a researcher's responsibility and research monitoring."
0,We obtained MRIs with contrast to also assess synovial volume (see below).
16,Student’s t and the Mann–Whitney U-tests were used for statistical analyses.
0,Protocol amendments occurring after the study start are summarized in the Supplementary Data online.
3,Age <18 years of Abdominal discomfort without tenderness or rebound or clinical suspicion of appendicitis Pregnancy Patients with impaired consciousness Patients not able to provide informed consent (Non-German Speakers) Patients that will receive an appendectomy as part of another elective procedure Patients who are unable to understand the study purpose.
0,Blood pressure was recorded after the child had been seated for at least 1 min with legs uncrossed.
3,"Twenty-one villages in Sibanor, Western Region, The Gambia, were selected as being representative of rural areas in The Gambia, as described previously [13]."
0,"The PREFER-PREGNANCY study is a prospective cohort study designed to obtain and centralize data on two major issues: 1) the clinical outcomes of breast cancer survivors that achieve a pregnancy after prior diagnosis and treatment of breast cancer including the outcomes of their pregnancies; 2) the management of PABC, including fetal, obstetrical and paediatric care of children born after prior in utero exposure to anticancer treatments, and the long-term survival outcomes of these patients."
1,The study is a cluster randomised controlled trial.
0,These categories were used for descriptive analysis.
1,"This was an 18 months follow-up of an open, prospective comparative observational study."
0,Patients were preoxygenated with 100% oxygen for 5 min.
3,"Eligible participants were patients with age 18–85 years with a history of NB; diagnosed according to the European guidelines [34], with persistent symptoms ≥6 months post-treatment, such as fatigue, facial palsy, headache, radiculitis and cognitive and neurological dysfunctions."
0,Quality assessment was performed using the simpleaffy (v2.36.1) [23] and arrayQualityMetrics (v3.14.0) [24] packages.
3,"The exclusion criteria consisted of systemic immunosuppression (corticosteroids or other immunosuppressive drugs), a current infection or ongoing antibiotic treatment, allergy to doxycycline, pregnancy, lactation, psychiatric disorders, multiple sclerosis, rheumatoid arthritis, diabetes mellitus type I or II, systemic inflammatory diseases, liver or kidney dysfunction, current malignancy and treatment with Didanosine, Quinapril or antacids."
0,Pregnant patients in the first trimester were given quinine (Thai Government Pharmaceutical Organization [GPO]) plus clindamycin (Thai GPO) (WHO 2006).
6,"The primary endpoints were a statistically significant doxycycline-mediated improvement of the persistent symptoms, with respect to; a) the neurological examinations, b) the assessment of symptom severity, and/or; c) the estimated QOL."
0,"All interviews were recorded then transcribed and coded using NVivo10 (QSR, Cambridge, MA, USA) and interpreted in the context of the conceptual model."
6,The secondary endpoint was a statistically significant doxycycline-mediated effect on systemic cytokine responses.
0,"An 8-weeks, randomized, placebo-controlled study was conducted with 150 healthy adults."
3,"Adult CKD patients were eligible if they had been clinically stable on hemodialysis for ≥6 months, had received epoetin alfa for ≥8 weeks, had 3 stable Hb values within 10.0 to 12.5 g/dL and evidence of adequate iron stores."
0,"As a pilot trial, the emphasis was on process outcomes to establish the feasibility for a full trial."
3,"The main exclusion criteria were intolerance to ESAs or parenteral iron supplementation, a history of antibodies to ESAs or pure red cell aplasia (see Additional file 1: Table S1 for complete inclusion and exclusion criteria)."
0,"To be eligible to participate, physicians had to provide general primary care services for a minimum of two years before the intervention began."
1,"This was a 24 month, multicentre, investigator blinded, three arm, parallel group, randomised controlled trial."
0,Additional non-study assessments are permitted at the discretion of the treating investigator.
1,"After having obtained signed informed consent, we randomly allocated participating patients with COPD to comprehensive self management as an adjunct to usual care, routine monitoring through scheduled periodic monitoring visits as an adjunct to usual care, or usual care alone."
0,"For the remaining five questions (ie, restless sleep, daytime drowsiness, difficulty falling asleep, awakening from sleep and experiencing difficulty returning to sleep, staying awake during the day), participants were asked to respond on a 5-point scale, ranging from ‘none of the time’ to ‘all of the time’."
16,"Survival was defined as the time from initiation of treatment until death or last date of follow-up (March 1st, 2012)."
0,Patients with and without an SA during the study period will be compared between the MEDIA and CLASSIC groups.
16,Time from treatment initiation until exclusion from the trial due to disease progression was defined as time to progression (TTP).
0,None were engaged in any physical activity aimed at increasing muscle strength and mass for the six months before the experiment.
6,"Our primary outcome was adherence, measured using three methods: a Visual Analogue Scale (VAS); Self Report (SR); and Pharmacy Refill Data (PRD)."
0,The response to HIV peptides was never the only positive finding.
6,"Our Secondary outcomes were clinical: weight, body mass index (BMI), opportunistic infections (OI); QOL: Measured using the SF-12 QOL assessment form [12]; all cause mortality and retention in the trial."
0,"A blood sample was drawn by venipuncture at 8:00 a.m., after a 12-h fast, at baseline, and at 6 and 24 months and stored at −80°C."
3,"We adhered to the following inclusion criteria: (i) preschool-aged children (<6 years); (ii) written informed consent by parents/guardians; (iii) submission of at least one sufficiently large stool sample for duplicate Kato-Katz thick smears, and one urine sample for a 10 ml filtrate and a single point-of-care circulating cathodic antigen (POC-CCA) cassette test; (iv) no abnormal medical condition, as judged by the study physician on the day of the treatment; (v) no recent anthelmintic treatment (within the past 4 weeks) according to a parental questionnaire; and (vi) no participation in any other clinical trial."
0,We assisted the participants in setting attainable goals to improve their health-promoting behavior.
6,"Baseline descriptive data will be obtained by questionnaire and will include age, sex, weight, height, medication use and previous health problems."
0,"Of these 119 patients, 39 were excluded for the following reasons: single-bundle reconstruction (4), revisional ACL reconstruction (7), combined surgeries such as meniscal allograft transplantation (2), any previous ligament surgery or bony procedure in the area of graft attachment (10), degenerative arthritic knee (1), pregnancy (1), and other reasons (14) (Fig. 1)."
1,"The SARAH trial is a pragmatic, multi-centre randomised controlled trial (Figure 1)."
0,"Lifestyle advice consisted of three sessions of interactive, tailored web-based information [41]."
1,Figure 1 Flowchart of study design.
0,"Throughout the study, a Safety Monitoring Committee comprising physicians, some employed by MedImmune, met monthly and ad hoc to independently review cumulative safety surveillance data and the medical monitor’s decisions on dose escalation, and to make recommendations regarding study progression."
3,"Elderly patients (≥ 70 years) with histologically verified unifocal (mammography, ultrasound), ductal-invasive, small (≤ 3.5 cm) breast cancer without clinical signs of lymph node involvement or distant metastases."
0,Answering the clinical question based from the evidence found.
3,histologically verified invasive-ductal breast cancer cT1 or small cT2 (≤ 3.5 cm) cN0 cM0 ≥ 70 years of age informed consent compliance Exclusion criteria
0,"Exclusion criteria included hepatic decompensation; liver disease of non‐HCV etiology; infection/coinfection with HCV non‐GT1a/GT1b, hepatitis B, or human immunodeficiency virus; and significant laboratory abnormalities or presence of other clinically significant disease."
16,To compare the regression rate of HPV infection in the two groups the Fischer’s exact test has been used and P values less than 0.05 were considered statistically significant.
0,This increase is thought to be due to the impending end of the supply of free cigarettes.
16,"The analysis has been conducted using GraphPad Prism software (Graph Pad Software, Inc., La Jolla USA)."
0,Duration of overall response is defined as the time from the first radiological examination showing partial or complete response (whichever is first recorded) to the objectively documented progression of disease.
4,"The following characteristics of each patient were recorded before the suctioning maneuver: age, sex, height, tracheal tube size, time from intubation, value of Ramsay score [9], mode of mechanical ventilation, the level of set tidal volume, respiratory rate and PEEP,and peak inspiratory pressure."
0,The primary outcome was the change in morning peak expiratory flow (PEF) rate from baseline to the end of the treatment period (mean of weeks 23–24).
4,"The main evaluation criterion was the sealing of the cuff, defined by the absence of leakage of blue dye either in the cuff wall or in the trachea under the cuff."
0,"Neutralizing antibodies equal to or greater than 1∶8 were defined as seropositivity [3], [4], [21], [22]."
13,The generation of random sequences was performed by the co-author who is a biostatistician (MLT) and who was not involved in site selection or participant enrollment.
0,"Fasting total plasma cholesterol and triglyceride levels were measured enzymatically, and the HDL cholesterol fraction was measured after precipitation of low-density lipoprotein (LDL) and very-low-density lipoprotein (VLDL) with dextran sulfatemagnesium, LDL levels were determined by the direct LDL reagents."
13,Participants were assigned to interventions based on the allocation of their home health facility to arm.
0,Change from baseline in the concentrations of oxidized and reduced glutathione (GSH/GSSG) was calculated.
14,This study was not blinded.
0,"The feasibility study was a single-centre, unblinded, cluster RCT, comparing the feasibility of measuring the effectiveness and cost-effectiveness of Social Stories at altering the behaviour of children with ASD in a mainstream school setting with a comparator group using an attention control."
6,"The primary objective of the thiamin treatment trial was to determine whether the frequency of adverse events, after anti-malarial therapy, were significantly lower in those who received thiamin supplementation in comparison to those who did not."
0,The diagnosis of functional dyspepsia was based on Rome III criteria [1].
6,"Here the PCR-corrected adequate clinical and parasitological responses at day 42 [26], the PCT (the time in hours from the first treatment dose to the first of two consecutive thick films that were negative for asexual falciparum parasites after checking ≥500 oil fields) and fever clearance times (FCT, time in hours from the start of treatment at which the tympanic temperature first dropped below 37.50 C and remained below 37.50 C for 48 hours), gametocytaemia, the frequency of adverse events, and changes in haematocrit following anti-malarial treatment are described."
0,Optical density was measured at 405 nm.
1,"The research design is a 3 × 4 factorial with one between subjects factor (treatment condition) with three levels and one within subjects factor (time) with four levels (baseline, 3-, 6-, and 12-months)."
0,"Four criteria were used to ensure rigor: credibility, auditability, confirmability and applicability."
1,Participants will be randomized to one of three groups: a) Standard behavioral weight loss program (STND); b) technology-supported behavioral weight loss program (TECH); or c) self-guided behavioral weight loss program (SELF).
0,"Potential consequences included physiological responses (loss of consciousness, seizure), emergency treatment, and accident or injury."
3,"Patients inclusion criteria were: Male and female patients between 40 and 80 years with osteoarthritis of the knee according to ACR criteria (American College of Rheumatology) [15], X-ray classification: Kellgren-Lawrence Grading Scale: 2 – 4 [16,17], and subjective pain intensity at baseline > 40 mm on the visual analogue scale and no other OA therapy except NSAID in the previous 4 weeks."
0,"Amplicons were extracted from 2 % agarose gels and purified using an AxyPrep DNA Gel Extraction Kit (Axygen Biosciences, Union City, CA, USA) according to the manufacturer’s instructions, and quantified using QuantiFluor-ST (Promega, Madison, WI, USA)."
3,"Patients were excluded if they fulfilled one or more of the following criteria: current use of anticoagulants (e.g., Phenprocoumon, Heparin), coagulopathy, or any form of cupping therapy in the previous 12 months; intra-articular injection of corticosteroids or NSAID into the knee joint in the previous 4 months; arthroscopy of the knee joint in the previous 12 months, use of systemic corticosteroids in the previous 4 weeks; physical therapy, leeches or acupuncture in the previous 4 months or other CAM therapies for osteoarthritis in the previous 4 weeks."
0,"The study was approved by the local regional ethics committee of Northern Norway (Regional komité for medisinsk og helsefaglig forskningsetikk, Nord-Norge, REK Nord) and the Norwegian Medicines Agency and registered in the European Clinical Trials Database (EudraCT no. 2008-006940-20), the WHO Initiative for Vaccine Research [10] and National Institute for Health (NIH, Clinical trials.gov, Study: NCT00868218)."
6,"The primary outcome was the types of PCIs encountered by the participants, as identified by the pharmacists."
0,Cutoffs and references were established according previously published models [12–14].
6,"The secondary outcomes were the causes and clinical significance of the PCIs, and outcome of the interventions made by the pharmacists."
0,The resource use questionnaire was developed by our working group.
4,"The study setting is multi-national with approximately 20–25 centres in Canada, Israel, Qatar, and Chile."
0,"During a follow-up home visit, trained interviewers asked mothers about demographic and socioeconomic characteristics, including questions on household food insecurity."
4,Enrollment began in June 2012 and is expected to be completed in 36–42 months.
0,"To make the two methods comparable, enzyme activities were reported as the percentages of the mean of the reference values."
16,Data were summarized using descriptive statistics.
0,"This is a reliable instrument for assessing physical activity in community settings and recent studies have used SOPARC to specifically assess physical activity in parks [45,46]."
16,All subjects who received at least 1 dose of palivizumab were included in the analyses.
0,"Posters were placed in coffee shops, libraries, community centres, and public health units."
8,"A sample size of 76 patients would have 80% power to detect a difference in preference rates of 30% between the two dentures (30% vs 60%) at a significance level of 5%, assuming that 10% of patients express no preference; 67 patients would be required to detect a different of 30% (25% vs 55%) assuming 20% express no preference."
0,An example item is: “How often does your job require you to work under time pressure?”.
8,"A total of 85 patients will be recruited overall to allow for a dropout rate of around 10%, consistent with previous studies."
0,The IND application to the FDA for a new site of administration (inguinal-subcutaneous) was supported by Sanofi Pasteur and held by Dr.
1,Randomised controlled trial (RCT) allocating CRC patients to a CM intervention group or a control group (ratio 1 : 1).
0,Motivational salience assesses to the extent to which persons attend to their appearance and engage in appearance-management behaviors [44].
1,We conducted a cross-sectional analysis of participants visiting the Vancouver Falls Prevention Clinic ( http://www.fallsclinic.com) due to a fall from January 2009 through May 2011.
0,Screening took place between February and November 2007 at the clinical trial site.
6,The data presented in this paper include baseline characteristics collected at participants’ first clinic assessment.
0,The objectives of the economic evaluation will be to estimate the net incremental cost of the intervention strategy and to estimate an incremental cost-effectiveness ratio.
6,"The ICECAP-O and EQ-5D, were collected once at 12 months post first clinic assessment."
0,"In order to observe the intake of the evening doses of AL, patients randomized to receive AL were visited at home at around 8 h, 32 h and 56 h after the first dose."
16,Descriptive statistics were used to characterize the study sample.
0,"Table 2 Delivery and content of lifestyle coach face to face visit The intervention aimed to help women increase physical activity, modify their diet, lower their alcohol intake, and set individual weight management goals (weight loss or avoidance of weight gain)."
1,An individually randomized controlled trial (RCT) [19].
0,"Among them, 14 CDI subjects consented to have stool samples collected serially after treatment for microbiome analysis."
3,"Inclusion criteria: patients aged over 18 with type 2 diabetes, defined in accordance with WHO criteria treated for at least one year (OAD and/or insulin and/or GLP-1 analog); HbA1c ≥ 7.5% for three months or over; treatment regimen stable for at least three months (except for possible changes to insulin doses in the previous three months); living in Reunion Island, affiliated to French national health insurance, and patients having signed a consent form for participation in the trial."
0,"The intervention group started with 3.5 g/kg/d of amino acids and 2.0 g/kg/d of fish oil-containing lipid emulsion (SMOF; Fresenius Kabi, Norway), and the control group started with 2.0 g/kg/d of amino acids and 0.5 g/kg/d of lipid emulsion (Clinoleic; Baxter, Norway)."
3,"Non-inclusion criteria: current or scheduled treatment liable to influence blood sugar levels, such as corticotherapy; current or recent hospitalisation (< three months) associated with the diabetes; structured education intervention in hospital or on outpatient basis in previous three months; severe evolving current complication: ischemic or proliferative retinopathy, severe chronic renal insufficiency (clearance < 15 ml/min), coronary heart disease, foot lesions; current pregnancy or desire for pregnancy during the trial; evolving cancer (except baso-cellular or spino-cellular cutaneous epithelioma); severe physical, cognitive or mental illness handicap; concomitant participation in a therapeutic intervention trial."
0,"Initial assessments will include: baseline CMR (to be completed within 4 weeks of the patient beginning INHD); physical performance assessments; body composition analysis; questionnaires exploring quality of life functional capacity, sleep quality, fatigue and symptom burden and blood sample collection."
14,"For all patients, the first phase (group-based initial education cycle) will be conducted blind with regard to the randomisation arm for patients, until 12 weeks at the latest, researchers and education team."
0,Accrual rates and follow-up will be monitored periodically throughout the study period.
14,At the end of this first phase the follow-up will therefore be unblinded.
0,"If a household was not sprayed, the reasons for a lack of spraying were obtained and if the surrounding households in the village were sprayed, the date of spraying was obtained from surrounding homes."
5,Patients randomly allocated to the intervention arm will receive clinical care from a nurse who has received two weeks’ training in palliative care and ongoing clinical support and supervision from experienced palliative care providers.
0,"In study 2, the eligible subjects also were required to report chemotherapy-induced eyelash hypotrichosis after completion of standard adjuvant chemotherapy for an early-stage solid tumor."
5,The palliative care trained nurse will also have the option to refer complex cases for management at a hospice.
0,"A multiplex real-time PCR will be used for the specific amplification and detection of A. duodenale-, N. americanus-, A. lumbricoides, and S. stercoralis DNA [44,45]."
1,"A pilot randomised controlled trial using a PROBE design (prospective, randomised, open-label, blinded end point), compared two models of care: routine GP-led care or an onsite HF team."
0,"If a proxy was unavailable, then if permitted by local regulation, consent is deferred or waived."
16,Data analysis was conducted by intention to treat and using SPSS version 19.
0,There were no equivalent guidelines in Group A or B.
16,"Differences in proportions were analysed using Fisher’s exact test, cross tabulations of more than two categories using Pearson chi-square, and continuous variables using unpaired Student’s t-test."
0,Inclusion criteria: BMI ≥30 kg/m2 and singleton pregnancy; gestational age >15+0 weeks and <17+6 weeks’ gestation.
6,"In order to maximize the likelihood of observing a significant effect of the PCCI, we selected outcome measures that demonstrated sensitivity to the intervention in our pilot work."
0,"All primary and secondary efficacy analyses were performed on the intent-to-treat (ITT) population, which was defined as all randomized subjects who had a baseline sUA ≥8.0 mg/dL and received at least 1 dose of study drug."
6,The outcome measures for patient and the nursing staff are described.
0,"Protein concentrations were quantified using a bicinchoninic acid (BCA) protein assay reagent (Pierce Biotechnology, Inc.), and 20 µg total protein was electrophoresed on a 10% SDS-PAGE gel."
3,"We included patients who screened positive for an alcohol use disorder and who were alert and oriented, aged 18 or more, resident within 20 miles of the practice, and able to understand English sufficiently to complete study questionnaires."
0,Both the MI and HE interventions were scripted to assure fidelity among the counselors who were from varied backgrounds and expertise [22].
3,"We excluded patients already involved in an alcohol research study or who were specifically seeking help for alcohol problems and those who were severely injured or unwell, had a serious mental health problem, were grossly intoxicated, or had no fixed abode."
0,FEV1 was measured using a standard spirometry method [21].
1,"The study included 120 pregnant women randomly assigned to one of the following three groups: Group I (40 pregnant women), control group with no dilations; Group II (40 pregnant women), dilations performed using Hegar dilators (HeDs); and Group III (40 pregnant women), dilations performed using the CCBD."
0,"Based on the local and very limited European epidemiological data available at the time, it was expected that the trial would need 30 months for recruitment and 12 month for post-randomisation follow-up, making the total duration 42 months (3.5 years)."
1,The experiments were undertaken with the understanding and appropriate informed consent of each patient.
0,"The trial was conducted in four typical community physiotherapy services in four different areas of England (Bristol, Somerset, Stoke-on-Trent, and Cheshire), which drew patients from 94 general practices covering a wide range of types of geographical area and population."
14,"The pharmacists who will carry out the initial evaluation before randomization, monthly evaluations of DRPs, and compliance, and the final evaluation of the health care questionnaires after the end of the patient follow-up will be blinded to the patient’s assigned group."
0,"Patients could be excluded because of insufficient information to confirm an IGE diagnosis (e.g., if the patient had only generalized tonic-clonic seizures and a normal EEG) or incorrect IGE diagnosis (e.g., slow spike-wave, developmental delay, or age at onset within first year of life)."
14,Physicians conducting the six-minute-walk test will also be blinded to group assignment.
0,The information collected was used to further refine the intervention protocol.
16,The primary goal of the study was to demonstrate that the infusion-related reaction rate for one-hour infusion did not exceed 5% with a one-sided exact binomial test at 10% significance level (alpha=0.10).
0,"Footpad tissue was harvested, minced with fine scissors, suspended in 1.5 ml PBS, serially diluted, and plated on Middlebrook selective 7H11 plates (Becton-Dickinson, Sparks, MD)."
16,110 subjects would provide 90% power to reject the null hypothesis (infusion-related reaction rate ≥5%) when the true infusion-related reaction rate did not exceed 1%.
0,It has demonstrated excellent test-retest reliability (ICC = 0.83) and day to day retest reliability (ICC = 0.89) in 48 healthy pain-free subjects [89].
3,Included in the study were IVF patients who received ICSI as part of their ART treatment and whose care was being managed by the staff of the participating IVF programs.
0,"The interrater and intrarater reliability of this particular algometer has been shown to be 0.89 and 0.92, respectively [30]."
3,"Excluded from the study were patients using testicular sperm, donor or cryopreserved gametes, patients receiving preimplantation genetic diagnosis or sperm sorting procedures and patients receiving a partial ICSI where only a proportion of the oocytes received ICSI."
0,"Mary's Hospital Catholic IRB, Kyung-Hee University Hospital IRB, Dong-A University Hospital IRB, Pusan National University Hospital IRB, Severance Hospital IRB, Ewha Womans University Medical Center IRB, Chonnam National University Hospital IRB, Chonbuk National University Hospital IRB, Chung-Ang University Hospital IRB, Chungnam National University Hospital IRB, and Hallym University Sacred Heart Hospital IRB."
3,All patients admitted to these wards as an emergency between February 1st 2010 and January 31st 2012 were eligible for the study.
0,"The human uterine epithelial cell line ECC-1, kindly provided by Prof."
3,"Exclusion criteria included patients who were nil by mouth, receiving tube feeds, under 70 years old, male, on the Liverpool Care Pathway for the dying patient or being nursed in side rooms."
0,"Statistical testing was used only for descriptive purposes, and no multiplicity adjustments were performed."
8,Sample size calculations were based on a change in energy intake resulting from the intervention.
0,The trial has two secondary efficacy outcomes.
8,"A sample size of 100 subjects per ward per year is estimated to be sufficient to detect a difference in intake of 218 kcal/day with 80% power and p = 0.05, based on a mean (SD) intake of 1300 (550) kcal/day."
0,"In addition to group exercise sessions, participants were connected to their group members via email primarily so they could communicate about planned or unplanned absences."
1,The origin of the data in this study is a cluster randomised controlled trial (CRCT) designed to evaluate a 3-month disorder-specific group intervention for patients with somatoform disorders conducted by their general practitioner (GP) and a psychosomatic specialist together in the GP’s office.
0,All subjects gave their written consent to participate in the study.
1,It is called the “speciAL” trial (specific collaborative group intervention for patients with somatoform disorders in generAL practice) (ISRCTN55280791) [16].
0,Clinical Research Coordinators (CRCs) visited patients daily during inpatient hospitalization.
14,"The participating nursing homes, patients, informal caregivers and the multidisciplinary teams who are participating in the study are not blinded for the treatment allocation."
0,The trial was registered at clinicaltrials.gov (NCT 02067403).
14,Research assistants involved in data collection and data analyses are blinded for treatment allocation.
0,"In order to show a mean difference of 10.5 mmol/mol (Mono S: one percent) between two groups with the power of 0.80 at a significance level of 5%, it would take 30 children in each group."
1,The CHANGE-2 trial is a three arm cluster-randomized controlled trial that measures antibiotic prescription rates over three successive winter periods and reverts to administrative data of the German statutory health insurance company AOK.
0,Values below the LLOQ were taken as zero for descriptive statistics of concentrations.
4,The study was conducted at the Alternative Georgia ( http://www.altgeorgia.ge/?lang=2) field site.
0,The Phys-Can project is a randomized controlled trial with a preceding descriptive observational study to be used for comparisons.
4,"This independent nonprofit research institution is located in a central district of Tbilisi, Georgia."
0,Doppler timing intervals for the calculation of Eessb and V100 were measured by a separate research sonographer.
16,"Descriptive information on background characteristics, HIV and HCV status, sex risk, physical abuse, and feeling unsafe in the current relationship is presented in terms of frequencies and percentages or means and standard deviations."
0,This article is based on previously conducted studies and does not involve any new studies of human or animal subjects performed by any of the authors.
16,"One-way ANOVA for repeated measures test was used to compare the difference between analyzed variables obtained at baseline, during treatment, and after treatment."
0,"The dose was 450 ml/70 kg (i.e., adjusted for weight), divided into equal thirds (i.e., 150 ml/70 kg for each third)."
16,"All statistical analysis was done using JMP 8.0 (SAS Institute, Inc., NC)."
0,The 50% neutralisation titer of a serum was calculated by the Reed and Muench method.41
3,"The two groups were similar in age, sex, HAART-treatment, CD4-level, and viral load, at time of inclusion (Table 1)."
0,"In addition, if important baseline imbalances are noticed, a sensitivity analysis will be conducted adding these imbalances to the aforementioned models."
8,The trial was powered to detect an effect on the primary outcome of d = 0.45 with 80% power and alpha = 0.05 using a conservative simple post-treatment standardized difference method (d = M treatment − M control/SD).
0,Then t-tests were used to identify differentially expressed genes (both p value and FDR less than 0.05).
16,"Continuous variables were analyzed using student’s t-tests (paired for intragroup comparisons, unpaired for intergroup comparisons; equal variances were not assumed)."
0,Endotracheal tube or laryngeal mask airway placement was pursued as usual.
16,Categorical variables were analyzed with Fisher’s exact test.
0,Acceptability of randomisation and procedures was determined by measuring loss to follow-up and by exploring children’s and parents’ views about their participation in the research.
5,"All patients were prescribed oral miglustat 100 mg capsules three times daily throughout the 24-month treatment period, as specified in the prescribing information [11]."
0,These subgroups were used as the predictive variable in the model.
5,"Dose reduction to 100 mg once or twice a day was permitted if patients experienced treatment-related diarrhea or other gastrointestinal symptoms, and this reduction was maintained until the symptoms subsided."
0,Cardiac output was measured by thermodilution in triplicate with 10 ml of ice-cold (less than 5.0°C) 5% dextrose solution injected asynchronously with the respiratory cycle.
16,Descriptive statistical summaries were performed for safety and efficacy parameters.
0,RNA isolation was performed using the Tripure reagent (Roche Diagnostics).
16,There were no predictive statistical designs used in this pilot study.
0,"With respect to this intervention, the social environment includes modeling by peers and adults (teachers)."
6,"The outcomes measured in this study included HbA1c, fasting plasma glucose (FPG), body weight, fasting lipids, blood pressure, HOMA-B, fasting insulin, safety, and tolerability."
0,Children in intervention schools received IPT with one dose of sulfadoxine-pyrimethamine and three daily doses of amodiaquine on three occasions within a 12-month period (once each school term).
6,"Plasma analytes and HbA1c were quantitated by Quintiles Laboratories Ltd, (Smyrna, GA, USA) using standard methods.17"
0,The cells with 105 events in the lymphocyte gate were acquired and analyzed using a FACSCalibur flow cytometer (BD Biosciences).
1,"This was a mixed-method study incorporating a randomised controlled trial (RCT) to assess the effectiveness of three different evidence summary formats with semi-structured follow-up interviews to explore panel members’ views of these formats, experience with appraisal, use of and engagement with the research evidence."
0,"In such cases, the presence of a witness who also signed the consent form to confirm that the patient had freely given consent was required."
1,"Multicenter, randomized, paralleled, double-blinded trial with concealed allocation of patients with cerebral hypoperfusion 1:1 to volume therapy using 6% HES 130/0.4 in 0.9% sodium chloride (Voluven, Fresenius Kabi, Germany) or 0.9% sodium chloride solution (normal saline, NS), is stratified by presence of stroke or not."
0,Review of the electronic health record (EHR) identified patients eligible for screening and possible recruitment because they received primary care at one of the three study sites and had screened positive for unhealthy alcohol use on the AUDIT-C at ≥4 points for women and ≥5 points for men [72].
1,"We use digital subtraction angiography (DSA) to verify the severity of ICA or MCA stenosis [21], and evaluate cerebral hypoperfusion in unilateral intracranial artery territories by time to peak (TTP), one of parameters in CTP imaging [22]."
0,Waist circumference was measured according to the 2007 recommendations of the Spanish Society for the Study of Obesity [39].
3,"Eligibility criteria included any child born to a mother who was HBsAg negative, aged between six and 10 weeks at the time of first vaccination, who did not present with any serious acute or chronic illness as determined by clinical or physical examination, medical history records or laboratory screening tests of haematology, and renal and hepatic function."
0,A composite impulsivity index was also calculated to provide a general measure of impulsivity [34].
14,Health care professionals and participants will be aware of the allocation arm but blinded to the results of any former assessment.
0,If parents are not alive the evaluation is based on memory of them or internalized object relations.
14,Health care professionals who are outcome assessors will be blinded to participants’ allocation.
0,The psychiatric diagnoses were register based and determined by the responsible doctor in previous treatment contacts.
3,"To be eligible for enrollment, subjects were required to: be generally healthy as confirmed by screening laboratory results, medical history and physical examination, be between 21 and 70 years of age, have a body mass index of 18.5–34.9 kg/m2, have screening fasting serum levels of LDL-C 3.37–4.92 mmol/l and be willing to take a supplement three times daily for 6 weeks and comply with other study procedures."
0,The flow of participants from initial contact to completion is given in Figure 1.
3,"Subjects were excluded if they had: diabetes mellitus, cancer, gastrointestinal disease and cardiovascular disease, were pregnant or lactating, fasting serum TGs >3.39 mmol/l, been taking lipid-altering drugs or dietary supplements within 4 weeks of screening, experienced a >5% change in body weight within 4 weeks of screening or had a known hypersensitivity or intolerance to fiber or fiber-containing products."
0,Exercise capacity was estimated by 2 tests (completed within 4 weeks of each other and ≥3 days apart) with ≥1 test completed within 4 weeks before baseline visit.
3,"Patients (n = 300) over the age of 18 years, with a recent diagnosis of breast cancer, colorectal cancer, lymphoma, prostate cancer or testicle cancer and scheduled for adjuvant and/or curative treatment in the form of chemotherapy, radiation therapy and/or hormonal therapy at the Department of Oncology and Medical Physics, Haukeland University Hospital (Department of Oncology), Bergen, will be consecutively included in the present study."
0,The study was conducted in compliance with International Conference on Harmonization - Good Clinical Practice (ICH-GCP).
3,Criteria for exclusion are an ongoing psychiatric condition or language deficiencies in Norwegian.
0,Each patient who was enrolled in this study gave written informed consent.
1,"This study is a prospective, randomized, three-group design with multiple dependent variables."
0,AEs and concomitant treatments were recorded at each 4-weekly treatment visit and at the final evaluation.
1,"The three groups include: (1) Participants receiving care as usual (Usual Care Group); (2) Participants receiving stationary 1:1 interaction time with research personnel in order to control for the interpersonal interaction (Interpersonal Interaction Group); and, (3) Participants engaging in an individualized, progressive, one-to-one supervised walking program five days per week (Walking Program Group)."
0,"Then, we constituted a sample of protocols reporting various pharmacologic interventions and non-pharmacologic treatments (surgery, implantable devices, rehabilitation, education, etc.; see sample size below)."
3,"Eligible patients met the American College of Rheumatology (ACR) 1987 classification criteria for RA (16), were at least 18 years of age, had a confirmed diagnosis of RA for ≤5 years, had an inadequate response to MTX, and had not received previous bDMARD therapy."
0,The protocol for this trial and supporting CONSORT checklist are available as supporting information; see Checklist S1 and Protocol S1.
3,"At randomization, patients were required to have active disease, defined as a score of ≥3.2 on the Disease Activity Score in 28 joints using the C-reactive protein level (DAS28-CRP) (17), as well as a history of one or both of the following features: 1) seropositivity for anti–cyclic citrullinated peptide antibodies or rheumatoid factor, and/or 2) an elevated erythrocyte sedimentation rate (ESR) or CRP level."
0,"Of these families, 271 (38%) were excluded, for reasons explained below."
16,"The effect of aggressive antihypertensive treatment on the risk of the primary outcome was assessed adjusted for time-dependent systolic blood pressure using a Cox proportional hazards regression with combined stabilized weights (i.e., a marginal structural Cox model), as well as unadjusted for time-dependent systolic blood pressure using a Cox proportional hazards regression without weights (i.e., a standard time-dependent Cox model)."
0,They were eligible if they worked in the EDs of nontrauma centers.
17,"Cost-effectiveness analysis was conducted also for the subgroup of adherent women (n = 55), to describe successful lifestyle counselling rather than attendance of counselling etc."
0,"Prior to randomization, baseline levels of concordance are established for each eligible and consenting dyad, as follows."
17,"Inclusion criteria for this subgroup were weight gain during pregnancy remaining within recommended limits, physical activity exceeding 800 MET minutes at week 36–37 of pregnancy [28], and/or achievement of three of five dietary aims (consisting of intake of dietary fibre, saccharose, total fat, and saturated and polyunsaturated fatty acids [21])."
0,The second-last optode of each probe set was placed over the electrode positions T3 and T4 (detectors) respectively according to the international 10–20 system (Additional file 4: FigureS3).
1,"A multicenter, randomised controlled trial will be conducted in the three Dutch burn centres: Beverwijk, Groningen and Rotterdam."
0,"Moreover, regression analyses will be performed according to Twisk and Proper [73], using data from the post-measures adjusting for baseline measures, to assess differences between (1) the control group and the intervention group (between design) for all outcome variables, and (2) within the intervention group when comparing the three different arms regarding total amount of bicycling and PA, transportation habits, and self-reported health and HRQoL."
3,"All consecutive patients of any ages with acute burns of indeterminate depth (assessed by the treating clinician), who are seen within 5 days post burn at one of the three burn centres, are eligible."
0,"Eligible participants were healthy people, aged ≥18 years with Web and email experience, interested in a healthy lifestyle, and willing to commit the necessary time and effort to the study."
3,"Inclusion criteria: • Patients with acute burns of indeterminate depth (=intermediate depth; the burn wound is not obviously superficial or obviously full thickness) • Outpatient treatment or admission in one of the three Dutch burn centres • Presentation within 5 days post burn Exclusion criteria: • The presence of full thickness wounds, next to intermediate wounds • Topical treatment/dressings that impair scanning (e.g. hydrocolloid dressings) • Patients with peri-orbital facial burns, in which the eyes are unable to shield • Patients or their next of kin if they are under aged or temporary incompetent who can not be expected to give informed consent e.g. because of cognitive dysfunction or poor Dutch proficiency."
0,"Postoperative follow-up visits were scheduled at 24–48 h, 5–9 d, and 4–6 wk."
4,All participants received information about the research and gave their written consent before participation.
0,The ultimate goal of the preoperative home-based exercise program is to ensure that the patients perform cardiovascular exercise of moderate-vigorous intensity (~60-80% of maximum heart rate (HRmax)) for at least 30 minutes every day until surgery.
4,We performed a general clinical interview which included an exercise test and a spirometry.
0,"We determined plasma caffeine concentrations using reversed-phase HPLC with ultraviolet detection set at 273 nm, according to Schreiber-Deturmeny and Bruguerolle [16]."
8,"The sample size was calculated with an alpha error of 0.05, a power of 0.80 and a beta risk of 0.20 according to the effect size of EQ-5D that it was made according to Cohen’s criteria [21]."
0,"The level of CRP was quantified by particle-enhanced immunonephelometry with an Image analyzer (Dade Behring, IL, USA)."
8,One hundred subjects took part in this research against 60 individuals are needed in a priori estimation: 30 individuals in the IG and 30 in the CG.
0,"A prospective, multi-center, randomized, open-label, parallel design clinical trial was conducted between July 2014 and May 2015 in 14 tertiary hospitals from different regions in Korea."
3,"All women listed in CHW referral books as participating in the SNL study, whose babies had been referred to health facilities were invited to participate in this sub-study."
0,The data analyzes are conducted in STATA 14 in cooperation with a statistician.
3,"Mothers who no longer resided in Umlazi during the time of the referral data collection, and those who denied receiving referrals despite being listed in CHW referral books were excluded from this sub- study."
0,FIG 1 Study outline for oral live S. sonnei vaccine candidate WRSS1 immunization and wild-type S. sonnei 53G challenge of Thai adults.
1,The study design as presented in Figure 1 is a two-arm parallel multicenter randomized controlled trial (usual treatment followed on the initiative of each participant versus treatment through the global prevention program).
0,All houses are visited every month to register new pregnancies and births.
1,"Figure 1 Organizational structure of the PRESLO study (OHP = Occupational Health Physician, PT = Physiotherapist, PRM = Physical and Rehabilitation Medicine Physician)."
0,"The CNVs were partially overlapping, but had different endpoints (Figure 1)."
16,"As the parameters studied did not have a normal distribution, data are shown as the median with 25% and 75% interquartile ranges."
0,This expression was performed either manually or automatically using a workstation Protemist DTII (CellFree Sciences) designed for bilayer synthesis.
16,"Medians were compared using a Kruskal-Wallis one-way analysis of variance on ranks and paired tests when P < 0.05 using Sigma Stats for Windows version 3.5 (Systat Software, Inc., Richmond, CA, US)."
0,Subjects who received a preliminary positive test result were immediately referred for phlebotomy for confirmatory testing with Western blot.
1,"Details of the EDIPS protocol were similar in each country, have been published for each trial cohort [5], [7], [8] and are described briefly here."
0,"Coverage of antenatal care and facility deliveries were also estimated for each country, using the same approach as for the Burkina Faso projections."
3,"We included adults over 40 years with BMI≥25 kgm−2 (or family history of T2D in the SLIM study) and with IGT, defined as plasma glucose concentration 7·8 to 11·0 mmoll−1 (140 to 199 mg/dl) two hours after a standard fasting Oral Glucose Tolerance Test (OGTT) (glucose load 75 g)."
0,This allows the system to adjust the warming blanket temperature to ensure the delivery of appropriate thermal energy to the site for maximum warming while preventing any undesired complications due to the delivery of excess heat.
3,"[18] Exclusion criteria were diagnosis of T2D, chronic illness making participation in moderate physical activity impossible and medication (e.g. corticosteroids) that would compromise the intervention."
0,Participants were then provided a choice of three isocaloric (150 kcal) energy bar preloads to standardize homeostatic hunger and increase the ability to demonstrate individual differences in food reinforcement (22).
8,Sample size was primarily driven by budgetary and practical considerations.
0,"Scheduled follow-up visits were made at 1, 2, 3, 6, 9, and 12 months, during which study pediatricians assessed infant feeding using standard questionnaires, which we validated against chart reviews."
8,We expected the 128 individuals would provide adequate power for the overall comparison of interventions arms for most outcomes of interest.
0,"Once eligibility consensus is reached, the research clinician completes the participant-specific case review form located on a secure, password-protected web module programmed with study-specific exclusion criteria."
1,"The APPAC trial has been designed as a prospective randomized controlled, open label, non-inferiority multicenter trial to compare antibiotic therapy (intravenous ertapenem) with emergency appendectomy in the treatment of uncomplicated appendicitis."
0,"In the ICU, the patients were not infused with crystalloids according to a standard protocol."
8,"With a standard deviation of 7.1 estimated from Poisson regression, two-sided alpha of 0.05 and power of 0.90, the sample size required was 89 physicians per group (n = 178)."
0,Iontophoretic conditions are given in Text S1.
8,"Protocol modifications due to recruitment challenges included inclusion of group practice physicians (excluded in original protocol), and reduction of the minimum required number of patients with T2DM (original protocol = 50) and insulin-eligible patients (original protocol = 8)."
0,The safety population included all randomized patients who received ≥1 dose of study drug.
16,"As a result of the early termination of POTENT due to poor patient enrollment, statistical tests were not applied to the observational data that were collected."
0,"As shown in Figure 1, in the final GET-D, criteria were rated according to their presence or absence in the goal or action plan."
1,"The study used a single center, randomized, parallel-group design at the outset, with the addition of a second site at a later stage to overcome recruitment problems."
0,Treatment-related AEs were defined as TEAEs that were identified by the investigator to be related to the study drug.
4,"The experiments were performed at the University Department of Anesthesiology and Pain Therapy, Inselspital Bern, Switzerland."
0,"More than 500 MHS procedures are performed annually in the Department of Cardiovascular Surgery, which is a large referral unit."
4,"Pharmacokinetic and pharmacogenomic investigations were performed at the Division of Clinical Pharmacology and Toxicology, University Hospital of Geneva."
0,"SLE- Systemic lupus erythematosus, LN- Lupus Nephritis, ACR- American college of rheumatology, CYC- cyclophosphamide, MMF- mycophenolate mofetil Detailed history was taken; physical examination was done and recorded in the preformed pro-forma of the study."
6,The primary endpoint was the area of static hyperalgesia induced by intradermal capsaicin injection.
0,Lymphocytes were gated in FSC/SSC dot plot and CD3 positive lymphocytes were eliminated from the analysis by plotting lymphocytes in an FSC/CD3 expression dot plot.
6,The additional measures were secondary endpoints.
0,"A post hoc composite GI event category was developed to quantify GI tolerability events, namely nausea/vomiting, abdominal pain, and all other GI events."
1,"We conducted an open-label, randomized, parallel-group controlled trial from April to December, 2011."
0,Fig. 1 Trial profile.a.
1,"Recruitment and screening procedures were launched in the first 6 months, after which a 12-week intervention period was carried on."
0,A total of 21 facilitators were trained by experienced master trainers from the UK (Oxford Brooks University).
14,Patients attending the study facilities were blinded to group assignment.
0,Another substudy evaluated the patients’ self-efficacy.
14,"For obvious reasons, those administering the intervention and health professionals implementing the intervention were not blinded."
0,The RUD Lite is used every 3 months during a one year period.
1,"A randomized, intervention study conducted in a human performance laboratory."
0,"Based on the guidelines for the diagnosis and management of candidiasis issued by the Infectious Diseases Society of America [12] and the European Society of Clinical Microbiology and Infectious Diseases [13], the evidence used to treat antifungal infection in the China-SCAN trial was divided into the following four categories: Clinical signs of infection diagnosed by the opinion of treating physician had to meet two or more of the following clinical features [14]: (i) body temperature ≥ 38 or < 36 °C; (ii) respiratory rate ≥ 30 breaths per min; (iii) pulse rate ≥ 120 beats per min; and (iv) abnormal total peripheral white blood cell counts ≥ 10,000 or < 4000 per mm3, or immature neutrophils > 15%."
14,"Both participants and mechanical evaluation technicians were blinded with respect to the type of intervention applied, i.e. superficial or deep needle insertion."
0,"Participants completed postal questionnaires at baseline (after recruitment), before surgery, and one month, three months and six months after surgery."
14,Workers and companies are blinded for randomisation since they are not aware of the allocation of their OP.
0,"In addition, a clinical examination of joint mobility as well as muscle function and tenderness was performed."
14,The researcher who performs the analyses (KvB) is blinded for allocation to intervention or care as usual.
0,"The Gross Motor Function Classification System (GMFCS) [66] will be used to classify the gross motor function of children and stratify children based on severity (less severe, levels I and II; more severe, levels III-V)."
8,"The sample size was estimated based in an open pilot study with 48 patients, where it was showed a weight difference of -1 kg (weight loss) and a standard deviation of 2 after three months."
0,"Blood was drawn from the antecubital vein into dry serum tubes (Vacutainer, Becton, Dickinson and Company, Franklin Lakes, NJ)."
8,"Taking into account a 35% of drop-outs (α=0.05, power 0.8), the expected number in each group was found to be 90 patients."
0,"The Likert version was used in this study, with five response levels for each item, representing different degrees of intensity (none, mild, moderate, severe, or extreme) that were scored from 0 to 4."
1,"A parallel group, randomized controlled trial."
0,"Participants described their experiences of HFNS in the context of breast cancer, outlined their goals for treatment, discussed and recorded particular triggers of hot flushes, and practised relaxation."
6,The primary outcome was the attendance for eligibility screening with the study nurse.
0,"Data collected as secondary outcomes included safety/mortality, patient/carer satisfaction, readmission rates, total hospital LOS/days of care, functional status/quality of life and symptom improvement."
6,The secondary outcome was enrollment into the SCOPE trial.
0,This group included women who tested negative with ELISA at baseline and then either tested positive with ELISA at six weeks or did not provide blood samples before testing positive at three months or later.
8,These were observational and descriptive studies to assess the safety and immunogenicity of ChAd63 ME-TRAP and MVA ME-TRAP in malaria exposed adults.
0,"For DNA testing, a real-time PCR targeting the cryptic plasmid was performed using 10 µl of prepared sample (in-house PCR; Amsterdam, The Netherlands) [21]."
8,"The sample sizes were chosen to allow estimation of the magnitude of the primary outcome measures, especially of serious adverse events (AEs) rather than assessment of statistically significant differences between groups."
0,"In the end-of-study questionnaire, the following two questions were included: 1) How satisfied were you with either three-monthly or six-monthly monitoring?"
3,Eighteen healthy nonsmoking male volunteers were recruited into the series of vascular studies.
0,Samples were also collected at the final visit.
3,"Participants had no documented medical history, were taking no regular medications, and tested negative in a urinary toxicology screen (Nova Test, One Step Diagnostic Rapid Test, CA) for recreational drugs."
0,To monitor individual peptide responses we used Ag85A peptide pools in different combinations so that an individual peptide response would be clearly identifiable when two pools with the same peptide responded within a matrix.
1,"The TYNERGY study used a one-armed trial design to evaluate the natalizumab treatment effect on fatigue with a well-defined and validated instrument, the FSMC, designed for use in MS patients."
0,The details of this treatment have previously been described [6].
1,"A randomised controlled trial was not performed because at the time of the start of this trial there was no comparator available for the patient population with highly-active MS or with a need of second line MS therapy, which constitutes the patients fulfilling the indication for natalizumab."
0,The modified set of ROIs was then applied to the parametric PIB-PET image and the average BPND within each ROI was extracted.
3,We queried dentists working in outpatient dental practices who were affiliated with JDPBRN (n = 282).
0,"According to official guidelines of FB [4], if the patient was not well-sedated after 2 min, midazolam bolus was repeated in increments of 1 mg/min until moderate sedation (purposeful response to verbal or tactile stimulation) was achieved [4], [25]."
3,Participants who indicated that they perform restorative dentistry at their practice were recruited from the JDPBRN website and mailings.
0,"Secondary end points included the PMR-AS response and the PMR-AS (ESR) response (used to eliminate bias due to the direct effect of tocilizumab on CRP), at weeks 2, 4, 8, 12, 16, 20 and 24."
1,"This was a randomized, open-label, pilot feasibility study of four two-dose vaccine regimens using two commercially available trivalent seasonal influenza vaccines to compare immune responses and in vitro cross-reactivity against avian H5N1 and pandemic 2009 H1N1 viruses."
0,The measurements for this ancillary study were performed before the end of the REMI study in the first 100 consecutive patients to validate readers and anticipate the final reading.
1,The protocol for this trial and supporting CONSORT checklist are available as supporting information; see Checklist S1 and Protocol S1.
0,"We used a previously validated, predictive case-finding algorithm to identify patients at high risk for future hospital admissions, described in detail elsewhere [1,12,13]."
3,"26 healthy U.S. citizens living in Bangkok, Thailand, aged 18–49 years who had not received influenza vaccination (either seasonal or 2009 pandemic H1N1) within the preceding 6 months were recruited into the study if they tested negative for HIV and had a normal complete blood count at screening."
0,"Patients were requested to locate the level of knee pain on the line with a small vertical mark (25, 26).(2)The proprioception test was carried out in a sitting position, on an examination table, without contact with the base of the lower half of the posterior part of the thigh."
3,All subjects gave written informed consent prior to study participation.
0,All participating centers approved the trial by local Institutional Review Boards subsequently.
1,"The ESCAPE trial is an open label randomized controlled, parallel, superiority multicenter trial."
0,"After nested PCR amplifications using primers for 546 bp and 166 bp amplicons within pfcrt (appendix),16, 17 dideoxynucleotide sequencing was done to identify the pfcrt haplotypes (aminoacids 72–76—ie, CVIET and CVMNK) of the isolates from all participants."
8,"A sample size was calculated to allow for appropriate power to detect group differences in cognitive scores between children receiving zinc plus vitamin A compared with children receiving no vitamin A or zinc, averaging the difference in children receiving glutamine and children not receiving glutamine."
0,"Eligible patients were randomly assigned to receive either a sachet of pCGS 1500 mg (Rottapharm Madaus, Monza, Italy) plus placebo once daily or pCGS 1500 mg plus diacerein 50 mg once daily (TRB Chemedica International S.A., Geneva, Switzerland) for 6 months."
8,"Using a two-tailed test with type I error = 5%, 35 children per cell were calculated to be sufficient to have 80% power to detect a difference of 0.36 (small to medium effect size) and 90% power to detect a difference of 0.42 (medium effect size)."
0,Participants that are deemed eligible will be provided with two 24 hours urine collection bottles for return at the time of the baseline visit in order to measure osmolality and urine volume.
3,The BEST study includes women with histologically confirmed primary breast cancer who are scheduled for adjuvant radiotherapy at the University of Heidelberg Medical Center and who do not have any contraindications for a progressive resistance training.
0,All subjects provided written signed informed consent prior to participation.
3,Inclusion and exclusion criteria are provided in Table 1.
0,"The blood samples were gently inverted and centrifuged within 30 min at 1400×g (15 min, 2–8 °C) to separate the plasma."
3,"Healthy, HIV-negative subjects between the ages of 18 and 50 at the time of enrollment."
0,Fig. 1 Patient enrollment Outcome measures
10,"The randomization sequence was generated in SAS (SAS Institute Inc., Cary, NC) by a study statistician and provided to the research pharmacist."
0,The PAP-M assumes that people behave qualitatively different at different stages of change [39].
10,Randomization was stratified on study site and presence or absence of impaired glucose tolerance and used permuted blocks of four.
0,Emergency radiographs were taken of both anteroposterior and lateral views to rule out any fractures.
14,Study subjects and all study personnel were blinded to group assignments.
0,Blood pool and segmental myocardial time-intensity curves.
14,Only the research pharmacist and study statistician had access to information about group assignment.
0,"The manual consists of 10 chapters, accompanied by a tasks workbook for each session."
6,The primary outcome parameter was the proportion of days without assisted ventilation in a 28-day period (“ventilator-free” days within 28 days [28-VFD]) and in a 60 days period (“ventilator-free” days within 60 days [60-VFD]) [17].
0,The sample size is based on change in TC levels and the blood profile indicator is anticipated to show the smallest change of means (and hence expected to require the largest sample size).
6,"Secondary outcomes were: inspiratory plateau pressure levels (Pplat), the proportion of spontaneous breathing as a percentage of the minute ventilation (automatically calculated by the ventilator’s software), the RASS score, hemodynamic changes, the incidence of complications or adverse reactions, the frequency and duration of other adjunctive therapeutic measures, transfusion requirements [packed red blood cell transfusions (units), fresh frozen plasma units, platelet transfusion], the daily cumulative doses of analgesic and sedative agents, cumulative catecholamine requirements/24 h throughout the study period, frequency and duration of renal replacement therapy, the number of failing organs, the “organ-failure-free days” within 28 days after randomisation, and “in-hospital” mortality."
0,"Research assistants randomly selected four to six patients per day from the patients with an appointment with the GP, using random starting points for each day, generated using a random number generator."
16,Experiments were carried out in triplicates and the data are expressed as mean±SD.
0,The subjects were supplied with new medication every third month.
16,"Statistical analysis was performed using two-tailed student t-test, with significance set at p<0.05."
0,"The study protocol was approved by the Deakin University Human Research Ethics Committee, the Victorian Department of Education and Early Childhood Development and the Catholic Education Office."
6,Outcome assessments for analyses were completed at baseline and 10 months by trained research assistants.
0,Patients were stratified by second-line bevacizumab use (yes or no) and low/high baseline ANC (<5.5 or ≥5.5 x 109/L).
6,The details of these procedures have been published elsewhere.14
0,"Levels of urinary LTE4 were measured by ELISA (Cayman Chemical, catalog #520411) as previously described [40] and normalized for creatinine, measured by mass spectrometry as described in the S1 File."
3,"Participants were healthy boys or girls between 2 and 10 years of age at the time of vaccination, who had completed routine childhood vaccination to the best of their parents/guardians knowledge."
0,Specific edema imaging sequences were analyzed randomly and independently from each other to avoid observer bias.
3,"Children who were immunosuppressed from any cause, had a history of meningococcal disease, had previously received a meningococcal conjugate vaccine at any time, had had previous vaccination with a meningococcal polysaccharide vaccine (for participants younger than 6 years of age) or within the last 5 years (for participants 6 years of age and older), or had previously received immunoglobulins or blood products within 3 months preceding the study were excluded from the trial."
0,"As such, it is important to examine this benefit, especially at a time when providers, health care administrators, and policy makers are being increasingly required to rein in health care costs that are spiraling upward while resources for public health care are diminishing [36]."
1,"This was a prospective, non-controlled, multi-centre, observational, Phase IV cohort study conducted in 19 countries in three global regions: Asia Pacific (China, Indonesia, Malaysia, Pakistan, the Philippines and Singapore); Europe (Austria, France, Germany, The Netherlands and Romania); and the Middle East (Bahrain, Egypt, Jordan, Kuwait, Lebanon, Saudi Arabia, United Arab Emirates, Yemen)."
0,"The use of a single switched current source to generate the stimulus pulses has the advantage of intrinsic charge matching for symmetric biphasic pulses, as the same circuitry is used to produce both phases."
3,We recruited all physicians–teachers and residents–who provided care in one of the nine family practice teaching units (out of 12) that enrolled in the study.
0,All of the bronchoscopists and investigators were qualified for intensive and critical care and advanced cardiac life support.
3,"We excluded physicians who participated in the pilot trial [21], [22] and those who would not be practicing at the family practice teaching unit during the trial (e.g. residents ending their residency program, physicians doing rotations outside the family practice teaching unit, physicians who expected to be pregnant and physicians planning to retire)."
0,"Participants were overweight adults, recruited in two cohorts from an ongoing 12-month weight-loss trial based at Stanford University (parent trial), in which individuals were 18–50 years of age, had baseline body mass index (BMI) of 28–40 kg/m2, were non-diabetic and non-hypertensive, had no cancer or heart, renal, or liver disease, and lived in the geographic area surrounding Stanford."
3,"All eligible participants met the following criteria: (1) a PHQ-9 score of 8 or above with either depressed mood or anhedonia and/or were considering treatment for depressed mood, (2) were accepting of at least one form of treatment for depression, (3) had not viewed or posted messages more than once in the past month on any ISG, (4) did not self-report being diagnosed with bipolar disorder by a health professional, (5) was 18 years of age or older, (6) attends a primary care clinic and had visited it in the past 6 months, and (7) had Internet access for the subsequent 4 weeks, had been on the Internet at least 3 times, and was able to use email."
0,"Plasma and erythrocytes samples were analyzed in triplicate, and leukocyte samples were analyzed in duplicate."
3,"We excluded those considered to be at high risk for suicide attempts, which included those with past psychiatric hospitalizations, past suicide attempts, diagnosed bipolar disorder, or a score of greater than 1 on the PHQ-9 suicide assessment item (bothered by thoughts that he/she would be better off dead or of hurting him/herself in some way more than half the days in past 2 weeks), or who reported intent for self-harm as per assessment."
0,"The model was developed using non-linear mixed effect modeling, with NONMEM® program version 7.3.0."
1,"This was a 12-week multi-centre open-label therapeutic Phase IV study designed to evaluate the effects of a single inhaler budesonide/formoterol maintenance and reliever therapy on asthma patients in 5 countries/areas across Asia whose asthma condition remained inadequately controlled despite having been on continuous treatment with various asthma therapies, except budesonide/formoterol, for at least 4 weeks."
0,These individuals were not informed of patient allocation groups or study period.
1,The study was designed to mimic as much as possible routine clinical practice to minimise interference with physicians’ and patients’ behaviours that might influence outcomes.
0,Fig. 1 Flow diagram summarizing selection of study participants for the study Standard of reference
3,We recruited 53 patients (35 men and 18 women) with unilateral stroke identified by brain imaging.
0,"The first part of this phase II, randomised, open-label study (NCT00397215) was conducted in multiple centres in Italy and Belgium and has been reported previously [13]."
3,"Eligibility criteria included first clinical stroke diagnosis, status 6 months to 5 years poststroke, mild-to-moderate motor impairment (score of 20 to 66 on the FMA for the upper limb) [19,40], no severe spasticity in any joints of the paretic arm (Modified Ashworth spasticity score ≤ 3) [41], no serious cognitive deficits (Mini-Mental State Evaluation score ≥ 22) [42], and no participation within the past 3 months in any experimental rehabilitation or drug studies."
0,All patients provided written informed consent.
8,"In June 2007, sample size calculations were based on a significance level of 5% and power set at 80%, which indicated that we needed 136 patients to detect a 10 units QoL difference (ie, a small to moderate improvement) on the EORTC QLQ C-30 Global Health score with an SD of 20."
0,The desolvation gas flow was 800 L/h and the temperature was set to 350°C.
8,"Definitions of a small-to-moderate improvement on QoL (ie, 10 units on the global health score), and SD estimates of QoL (patients with localised colon cancer) were retrieved from previous published publications.21 22"
0,"BP was assessed after 5 min of rest in the sitting position using appropriate sized cuffs, between 0800–1000 h before taking any antihypertensive drug, through validated oscillometric semiautomatic devices (Omron 705IT, Kyoto, Japan)."
1,"This study reports on results of the baseline measurements among the 66 women, who thereafter entered a randomized controlled trial (LEVA, Livsstil vid Effektiv Viktminskning under Amning; Lifestyle for effective weight loss during lactation)."
0,"During the night hours, the subjects were equipped with night vision devices."
16,"The t-test for paired samples was used to compare means between groups, and the normal approximation test for two ratios or the Fisher’s exact test, as recommended, were used to compare event probability in both groups."
0,As a measure of time to treatment we used the time from stroke onset to groin puncture.
16,Statistical analysis was performed using the Minitab computer program version 12.22 (Minitab Inc®) and the adopted level of significance was 5% (p-value < 0.05).
0,Originally we had planned to do our trial in close co-operation with WISDOM.
6,We include one objective (Chair Stand Test) and two patient-reported outcome measures (pain and function subscale of the KOOS questionnaire) in this trial to test the effect of the intervention on lower extremity function (see Table 1).
0,"We conducted a prospective cohort study of community-acquired sepsis and severe sepsis [20] in patients in nine public hospitals in Indonesia (n = 3), Thailand (n = 3), and Vietnam (n = 3) (Additional file 1: Figure S1)."
1,"The HDP trial was conducted as a multicentre, randomised, double-blind, placebo-controlled phase 1 trial."
0,"Finally, at 21–22 weeks (after DDDCM), whereby the mean ± SD peak response was 3285 ± 2091 SFU/106 PBMC, we had 80% power to detect a 1.58-fold increase."
1,Subjects and investigators were not only blinded to the group allocation process but also to the identity of the drug.
0,"At the time of randomization, patients were required to have a DAS28‐CRP of ≥3.2 and a history of anti–cyclic citrullinated peptide or rheumatoid factor seropositivity or (if seronegative) an elevated erythrocyte sedimentation rate or CRP level."
1,"The study will consist of a three-armed (Control, CBT and CBT+ICT) simple-blind randomised controlled trial, with five assessment periods (pre-treatment, post-treatment, and three follow-ups at 3, 6 and 12 months)."
0,"The purpose of this component was to provide information on the processes that might help to explain the quantitative outcomes, a technique used and recommended by previous researchers conducting pragmatic trials [17]."
1,The study will follow the CONSORT guideline [34].
0,"Pittsburgh Sleep Quality Index (PSQI)66 measures seven components of sleep quality (subjective sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbance, use of sleep medication and daytime dysfunction) over a 1 month time interval, via 19 items."
8,"The sample size calculation determined that 16 subjects per treatment arm would provide a 80% power to detect a true difference of 0.6 μV among the three study groups using the reduction in the mean RMS between LTA and RTA as the primary outcome variable, assuming that the common standard deviation is 0.6 μV."
0,"After collection, samples were processed immediately and stored at −80°C until shipment to the central research laboratory."
8,"Accordingly, a sample of 20 subjects per arm was recruited to overcome the possibility of dropouts."
0,The nurses recruited pregnant women when they contacted the maternity clinic for the first time by telephone (up to 12 weeks' gestation).
1,"The study was carried out in a randomized, open-label, parallel group design comparing an intervention group receiving eplerenone with a control group over a 24 week period."
0,"All analyses were performed according to the instructions of the manufacturer and have been detailed previously.13,23–29"
1,"Randomization was done by the GCP-unit, University of Copenhagen."
0,CHWs were assessed using a dual assessment.
5,Dose titration of eplerenone from an initial 25 mg daily to 50 mg daily as maximal dose is recommended in the Summary of Product Characteristics (SPC).
0,"Clinical assessment of liver function post transplantation were evaluated by measuring serum levels of alanine transaminase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (AP), bilirubin, and coagulation times, specifically prothrombin time (PT) and partial thromboplastin time (PTT)."
5,"The dose was chosen after considerations on safety regarding potential risk of hyperkalaemia in CKD stage 3–4, as well as the intention of studying BP independent effects of eplerenone rather than reduction in arterial stiffness due to haemodynamic changes."
0,All measurements were performed in the morning after fasting for ≥8 hours.
1,Figure 1 summarizes the overall study design and protocol for this randomized pilot study.
0,"(a) area of numbness 3 cm2 (patient 11, MOP group); (b) area of numbness 73 cm2 (patient 7, COP group) Fig. 3 Radiological outcome of a clavicle midshaft fracture OTA B2.3 (patient 11, MOP group)."
1,"Figure 1 Screening, randomization, follow-up and analysis flowchart."
0,Each platoon had a bus and two or three four-wheel drive vehicles.
6,"Efficacy was assessed by clinical and parasitological outcomes using WHO definitions, with a 42-day follow-up period [30], with treatment failure defined as 1) clinical deterioration due to P. vivax illness requiring hospitalization in presence of parasitemia; or 2) presence of parasitemia and axillary temperature ≥37.5°C anytime between days 3 and 28/42; or 3) presence of parasitemia on any day between days 7 and 28/42, irrespective of clinical conditions."
0,Participants consumed only water after 1900 h.
6,"If no failure was recorded, outcome was classified as a treatment success."
0,"Seven sizes of coil were available (70, 85, 100, 125, 150, 175 and 200 mm)."
16,"The Mann–Whitney U-test was used to compare pre-/post-treatment differences in analyte concentrations in serum, plasma and CSF."
0,"Table 1 Randomization of patients to Study Stage 1 and 2 In Stage 1 of this study, patients received either one single dose of ibuprofen/caffeine, ibuprofen, caffeine or placebo and in Stage 2 patients received multiple doses of either ibuprofen/caffeine or ibuprofen according to the randomization scheme above."
16,Statistical significance level was set at 0.05.
0,Seizures (whether noted on aEEG or clinically) will be treated using a standardised approach.
1,The present study is a triple blind randomized controlled trial.
0,"However, the Health Technology Assessment funders agreed to allow for type C1 as cured before the trial started,23 24 25 and we accordingly revised the original power calculation with community prevalence data on A and C1 types.7"
3,"The inclusion criterion is the presence of Class I HELLP syndrome, both in antepartum or postpartum period."
0,The initial temporal frequency is above the normal critical flicker fusion frequency (60 Hz) and is reduced at 6 Hz/sec.
3,"Exclusion criteria are: dexamethasone use in the last 15 days before diagnosis of HELLP syndrome; chronic use of corticosteroids; chronic diseases that alter laboratory parameters of HELLP Syndrome, such as chronic liver disease or purpura; patients unable to consent (coma or critical clinical condition) and without accompanying persons that may consent to study participation."
0,"The study drug, delivery device, and matched placebo were provided by the manufacturer of DAS181, Ansun Biopharma, Inc."
1,"This was an open label, non-randomized, Phase I safety and immunogenicity clinical trial in healthy, previously BCG-vaccinated, adult subjects."
0,"The SF-36 is a health survey on pain and quality of life that is scored from 0-100 (0 = worst pain and quality of life, 100 = no pain and the best quality of life)."
8,"The planned sample size was 36 subjects, with 12 subjects in each group, aiming to detect frequently occurring AEs."
0,"Assignments were not blinded, but patients and investigators were not informed of their assignment until after the manometry on the day of the test."
8,Sample size calculations were performed using Stata 9 and 12 subjects per group gave a 90% power to detect a 40% difference in immune responses between two groups.
0,"Although this counseling format has not been studied among TKR patients, it has been well studied for medical patients with other conditions and has been used alone or in combination with in-person sessions and print materials [18-20]."
3,The patients and methods for this study were previously described [2].
0,We will also provide descriptive statistics on the changes in concomitant diabetes medications during the observational period (proportion of subjects adding therapy or increasing dose of preexisting therapy; proportion stopping therapy or decreasing dose; proportion not changing therapy).
3,"Briefly, eligible patients had documented disease progression after failure of fluoropyrimidines, prespecified exposure to oxaliplatin and irinotecan, Eastern Cooperative Oncology Group (ECOG) performance status 0-2, no brain metastases, no systemic chemotherapy, or radiotherapy within 30 days before randomization, and no prior anti-EGFR therapy."
0,The participant was asked to complete 3 diary entries per day using the smartphone.
8,"A total of 36 subjects were planned and analyzed, with 12 subjects in each treatment group."
0,We used Friedman test for more than 3 groups for the comparison of the baseline or last values of the FOGQ and UPDRS scores and the mean value of the FOGQ and UPDRS scores that were measured during each admission.
8,"However, there was no formal sample size power calculation for this study."
0,"In this subject, an abdominal X-ray confirmed (6 days after administration) that the capsule was not withhold."
14,The study was single blinded: the research assistant who acquired the data (IM) was blinded for group allocation.
0,The trial protocol was registered at clinicaltrials.gov under NCT02411994.
14,It was not possible to blind professionals for group allocation.
0,"A change was made to the inclusion criteria after 1 week of recruitment, the upper age limit of 70 was removed as this excluded a number of potential participants."
1,"This study is a part of a previously reported randomized controlled exercise study, studying the effects of a moderate-to-high-intensity Nordic walking (NW) program and a supervised low-intensity walking (LIW) program."
0,"Plasma triglyceride and glucose concentrations were measured using the Dimension Clinical Chemistry System (Dade Behring Inc, USA)."
1,"The effects of Nordic walking on body function were reported previously [63], showing that NW resulted in better improvement in the 6-minute walk test (6MWT) and aerobic capacity, when compared with LIW."
0,"Women and their infants randomised to the control arm followed the local SOC, with referral out of the MCH clinic—to general adult ART services for the mother and “well baby” (child health) services for the infant—by nurse-midwives as soon as possible postpartum, typically at their first postnatal visit."
4,Study visits occurred at weekly intervals for a three-week period.
0,"When comparing change in fat infiltration over time between treatment groups, all available patients were examined according to the intention-to-treat (ITT) analysis, but in a secondary per protocol analysis we excluded patients deviating from the study protocol (Fig. 1)."
4,"During the baseline visit, demographic and HIV and other medical history data was collected including concurrent medications, validated questionnaires pertaining to antiretroviral adherence [31] and symptom distress [32] were completed, weight was measured and blood work to assess laboratory values was drawn."
0,"Individuals with untreated hypertension (blood pressure higher than 160/90 mm Hg) or hyperlipidemia (triglycerides ≥ 4.5 mM, cholesterol > 6.2 mM, LDL cholesterol > 4.3 mM) were referred to their doctor for therapy and allowed to enter if they were treated with a antihypertensive or lipid-lowering drug that did not affect glucose metabolism."
8,"Based on the results of a pilot study with 171 patients, we found a standard deviation (SD) of 1.2% in HbA1c and, given that that the mean SD in literature is around 2%, we used an SD of 1.5% to calculate the sample size."
0,Human alveolar adenocarcinoma cells (A549) from passages four to six were used for the experiments.
8,"Considering an intra-class correlation of 0.05 [18] and an average of 10 participants per group, we calculated that we needed 277 participants per study arm to detect a clinically relevant difference of 0.5% in HbA1c levels at 12 months, with 80% power, with p-value of 0.05 and assuming a dropout rate of 15%."
0,"If this percentage exceeded 5%, the array was called an “outlier.”"
14,"Because of the nature of the intervention, no blinding was possible in this study."
0,"Patients were to maintain a stable diet for at least 30 days prior to screening, use contraception where applicable, and were not to have participated in a previous plecanatide clinical trial."
14,Data extractors were not blinded as it was considered neither practical nor feasible to conceal from them the intervention status of the clinics from which they collected data.
0,The safety profile was evaluated by recording the incidence and severity of AEs.
4,"The following data were collected: gender, age in years, height in meters, weight in kilograms, body mass index (BMI), the Simplified Acute Physiology Score II (SAPS II), diagnosis on hospitalization, duration of mechanical ventilation prior to PCT (in days), indication for tracheostomy, anatomical palpation data (short neck, palpated goiter, deviation of the trachea, vessels, puncture site, and cricoid-manubrium distance in centimeters), US data (thyroid, tracheal deviation, aberrant vessels, puncture site, subcutaneous tissue thickness (in centimeters) defined by the distance between the skin and the anterior wall of the trachea measured perpendicularly to the skin at the puncture level, tracheal diameter in centimeters, and installation time in minutes), the duration of the tracheostomy defined by the time (in minutes) between the puncture of the trachea and the ventilation of the patient, difficulty in achieving US-guided PCT (rated on a simple numerical scale; 1: easy; 2: a few difficulties in identifying anatomical structures and in implementation; 3: moderate difficulties in identifying anatomical structures; 4: very difficult; and 5: impossible), hemodynamic data before and after the completion of PCT (blood pressure in millimeters of mercury and heart rate in beats per minute), and complications."
0,"We accepted the pacing configuration (multipolar and bipolar CRT-d pacing) testing the absence of PNS at pacing output of 7.5 V, with a measured pacing threshold less than or equal to 2.5 V."
6,"Primary outcomes included 24-hour UUN levels, nitrogen balance, serum albumin concentrations, and prealbumin concentrations."
0,"By projecting barycentres of the patients with same characteristics on the first axis, we identified influential cofactors."
6,"Secondary outcomes included ICU days, ventilator days, hospital days, acute renal injury, bloodstream infection, blood transfusions, gastrointestinal bleeding, moderate hypoglycemia, severe hypoglycemia, and hospital mortality rate."
0,The virus was isolated from a combined nasal/throat swab collected from an otherwise healthy 3 year-old boy exhibiting typical influenza-like illness in June 2009.
6,The primary outcome measures were the EA-level prevalence of TF and of Ct infection in 0–5 year olds at the 36 months survey.
0,"Because both districts are known to have a high prevalence of schistosomiasis among school-aged children, women are tested for Schistosoma haematobium infection at baseline and at 32 weeks by urinary microscopy; women testing positive are referred for postnatal praziquantel treatment per MoHCC policy."
1,We conducted an unblinded RCT of continuous venovenous hemofiltration (CVVH) vs. continuous venovenous hemodialysis (CVVHD) with concealed allocation (http://Clinicaltrials.gov registration number NCT00675818).
0,"Both needles were provided by the manufacturer (Vitrolife Sweden AB, Göteborg, Sweden)."
1,Our reporting follows the updated CONSORT statement [8].
0,Laboratory tests were not performed on participants with any clinically significant abnormality as determined from medical history or physical examination.
14,Open-label study given the type of strategies used and given that an effect on their beliefs and the antibiotic use is expected.
0,"Any patient who was ≥50 years old, was on a general medicine ward, was ambulatory, and had a morning blood sample drawn to assess a basic metabolic panel (BMP) was eligible for this study."
6,"The primary end point was HbA1c, and the secondary end points were mild and severe hypoglycemia, mean blood glucose, diabetes treatment satisfaction, quality of life, and patient preference for the IMI; all were measured 12 and 24 weeks after the run-in period."
0,The ability to screen for these miRNAs and to perform FLIM of the epidermal growth factor receptor (ErbB) family members will add important prognostic and predictive information for diagnosis and stratification of patients to treatment.
4,"The trial was carried out in 34 different IVF centers, 20 in Europe and 14 in North America."
0,Analysis was conducted on all participants who completed the study as well as on those who did not complete (all of whom dropped out after 8 wk).
3,"Women aged 18–36 years with a body weight from 60–90 kg, a body mass index of 18–32 kg/m2, a menstrual cycle length of 24–35 days and access to ejaculatory sperm and an indication for COS before IVF or ICSI were eligible."
0,Researchers encouraged participants to plan how they could incorporate the weekly WfH groups alongside walking independently or with family/friends.
3,"Between 1997 and 2011, 220 consecutive patients with a hematological malignancy underwent a myeloablative T cell depleted (TCD) SCT from an HLA-identical sibling on National Heart, Lung and Blood Institute (NHLBI) institutional review board–approved protocols."
0,"Endpoint data on diet and physical activity was collected through methods similar to those used in previous diet/physical activity studies in urban South India [2,31,32]."
3,Patients and donors provided written informed consent before enrolling in the transplantation protocols.
0,Table 4 Sample size and detectable change in study outcomes Ethics
4,"Patients were recruited from general practitioners and psychiatrists, open wards at the local mental health centre and a few patients through advertisements."
0,"MMF was started at 1,000 mg twice daily on postoperative day 1, and dose adjustments were made, if required, in response to leukopenia."
14,"Blinding of assessors at the daily assessments on the ward was not possible, as patients in the wake group would show signs of not having slept during wake nights."
0,All CR programs start the first working day after randomisation and are performed in the CR units at each of the three hospitals.
14,Assessments on the ward were thus done by other raters than assessments at weekly visits that were done by Hamilton raters blinded to treatment assignment.
0,"You might also tie your thoughts and feelings about your negative experiences to other parts of your life - your childhood, people you love, who you are or who you want to be."
9,No interim analyses were planned or performed.
0,"The content of the course is similar to the standard course, but focuses more specifically on facts, signs and symptoms of distress and mental disorders among teenagers, making use of case studies to illustrate the particular difficulties young people may face and consider helping strategies."
9,"Criteria for discontinuation of study treatment was: a wish to discontinue treatment, intolerable or clinically significant side effects, a score of 15 or more on the Mania Scale (MAS), continued clinical worsening of depression, change of mood stabilizer in bipolar patients, and non-compliance with elements of the study."
0,Approval by the local ethics committee and informed consent were obtained.
3,"Eligible patients were women: (1) aged between 18 and 65 years; (2) in paid employment or self-employed; (3) living or working in Lothian or Tayside, Scotland, UK; (4) diagnosed with an invasive breast cancer tumour or ductal carcinoma in situ (DCIS); (5) treated first with surgery."
0,Figure 1 Co-localized stains of serial sections of the aortic arch in Apo-E−/− mouse.
3,Breast care nurses (BCN) assessed eligibility of patients attending hospital in the preoperative phase.
0,The procedures of this study complied with the guidelines provided by the Declaration of Helsinki and were in accordance with the International Conference on Harmonization Good Clinical Practice guidelines.
4,Recruitment was conducted over a 14-month period between September 11 2010 and 29 December 2011.
0,Three urine samples were collected for each data point: on the morning of the visit and on two preceding mornings.
6,"The primary outcome was four weeks of smoking cessation, defined as self reported abstinence for four weeks and validated by measuring a level of exhaled carbon monoxide of 10 ppm.15"
0,Study sites used a centralized data system (MasterScope CT) to capture spirometry results at each visit.
6,"Secondary outcomes included the proportions (%) of smokers who were offered and accepted behavioural support or pharmacotherapy as inpatients, were discharged with cessation therapy and with post-discharge support arranged, were given support from a local stop smoking service after hospital discharge, were abstinent from smoking with validation based on measuring levels of exhaled carbon monoxide at discharge, and had self reported continuous abstinence for six months with validation based on measuring levels of exhaled carbon monoxide."
0,Blood samples were collected from patients.
8,"The required sample size was determined to be 246 (123 per treatment group) to detect a difference in VAS score of 10 mm (equivalent to 20% for a patient with a baseline VAS of 50 mm), assuming a 24 mm standard deviation, with significance level of 5% and power 90% using a 2-sided test."
0,"Children are instructed to remove their shoes and any heavy clothing (e.g., jackets, sweatshirts tied around their waists, etc.) prior to measurement."
3,Multiple births were included with both babies randomized to the same arm.
0,Oxaliplatin was given as a 120–minute infusion on day 1 of each cycle at a dose of 130 mg/m2.
3,"The following were excluded: infants born to mothers with known thyroid disease, on antithyroid medications or amiodarone; infants with major congenital or chromosomal abnormalities known to affect thyroid function or brain development; infants whose mothers died within 5 days of giving birth."
0,"This included 280 CAP and 652 PRINCE samples (N = 932) that were genotyped at 620,901 sites using the HumanQuad610 bead chip (Illumina), which is also designed to tag common variation within individuals of European ancestry, and a partially-overlapping set of 292 CAP and 634 PRINCE samples that were genotyped at 12,959 sites using a custom-made iSelect chip (N = 926)."
14,"Owing to the nature of the interventions, this trial was an unblinded study."
0,"Parent/guardians provided written consent, adolescents provided written assent, and the protocol was reviewed and approved both by the University of California Irvine Institutional Review Board and by the Research Review Committee of the Long Beach Unified School District."
14,"However, assessors were not told which the control villages were and which the intervention villages were."
0,"Participants used diaries to record safety and tolerability (primary endpoints), efficacy, and satisfaction data."
1,This study was conducted within the randomized clinical research of the Cardiovascular Risk and Intervention Study in Croatia-family medicine (CRISIC-fm) in the Republic of Croatia and was registered as a clinical trial (International Standard Randomized Controlled Trial Number Register – ISRCTN31857696).
0,"Participants were asked, in collaboration with the care home staff, to complete the exercise component of the intervention 3 times per week (on days of their own choosing) for 3 months."
1,It was a two-phase study that ran from May through July 2008.
0,"Whole Blood samples for microarray RNA expression were collected in PAXgene (QIAGEN/BD) tubes at baseline, and at 12, and 24 hours after the beginning of the infusion of intervention drugs on V3d."
3,"The study included 3245 participants of both sexes, aged ≥40."
0,The 56 cDNA samples were assayed in triplicate for each gene of interest and the control.
3,"Exclusion criteria were the inability to communicate due to conditions such as dysphasia, aphasia, serious dementia or psychiatric decompensation, and an expected survival of less than 6 months."
0,The global asynchrony index was computed as the sum of the five types of major asynchronies but not pseudo-autotriggerings.
4,"Participants were recruited through a home page announcement on SMART Recovery’s website, announcements of the study at SMART Recovery face-to-face and online group meetings nationally, and on their blog."
0,"As doctors had appropriate qualifications, it was assumed that their skills are comparable."
4,We also placed a thread on the SMART Recovery online forum announcing the study and invited individuals who were new to SMART Recovery to participate in the study.
0,All intervened coronary arteries were excluded from the analysis.
16,"Consistent with intent-to-treat analyses, we examined the entire sample as well as examined changes within the randomly assigned groups, both with and without imputation to account for missing data."
0,Informed written consent was obtained from parents prior to joining the project.
16,"In addition, we formed groups based on their use of either SMART Recovery meetings or the OA application to examine actual use outcomes."
0,"Thus, a less-negative Ecc value indicates diminished regional LV function."
8,"Based on previously published data and on diabetic subgroup analysis (15), we hypothesized that 90 mg ticagrelor twice daily would be superior to 10 mg prasugrel once daily, resulting in an absolute PR difference of 40 PRU (with the assumption that the within-patient standard deviation of the response variable is 50)."
0,"The intervention period lasted for a median of 4 years, after which a postintervention follow-up lasting for a median of 3 years was carried out (9)."
8,"Choosing a power of 80% and a two-sided α-level of 0.05, at least 27 patients in total were required to reach statistical significance based on the above assumptions."
0,"GOPCs provide primary care for about 190,000 people with diabetes, which account for about 60% of all the people with diabetes in Hong Kong."
1,"In this crossover, double-blind, randomized trial, all participants received either methadone 5 mg or placebo (bid) for three weeks, followed by a 3-week washout period and then another three-week treatment period with methadone and placebo, according to the randomized treatment sequence."
0,The SCID-I will be administered by researchers that have received a SCID-I training from a professional that received an official SCID training.
1,The methadone and placebo pills looked identical.
0,The protocol for end-point acquisition and assessment is illustrated in Fig. 1.
1,"The evaluation of the Program SI! in children aged 3 to 5 years (and their parents, teachers, and school environment) was designed as a cluster-randomized controlled open label intervention in the city of Madrid."
0,The system includes tube gels and proprietary data analysis software to determine the subfraction concentrations based on area under the curve [38].
1,"The unit of randomization, intervention, and analysis is the participating school."
0,"On the normal ward, pain treatment is provided and customized twice daily by an acute pain unit, consisting of anaesthesiologists and nursing staff."
5,Interventions included the following: (1) GDHT to attain oxygen delivery index >600 mL/ min-1 m-2 (using fluids and dobutamine) and (2) a protocol-guided routine fluid treatment.
0,The guiding principles underlying the motivational interview are [11]: 1.
5,"Both groups were monitored with the LiDCO™ monitor ( LiDCO Ltd., Sawston, Cambridge, United Kingdom)."
0,Results were fed back to the informal health care providers by local health surveillance assistants.
1,"The present study was designed as an open-label, sequential-cohort, dose-escalation, phase I trial conducted at 3 clinical institutes in Japan."
0,"To check the comparability of patient groups, the main features are compared using the χ 2 test for qualitative variables, analysis of variance or the Mann-Whitney test for quantitative variables.(ii)A description of deviations from the protocol.(iii)Inter-group comparison of clinical outcomes and cost-result ratios, with adjustment for any characteristic differing between two groups."
1,It was approved by the institutional review board of all the participating institutes and was conducted in accordance with the ethical principles of the Declaration of Helsinki and the Japanese Good Clinical Practice guidelines.
0,Informed written consent was obtained from the parents of patients younger than 18 years and from patients of 18 years of age.
3,Patients aged 18 to 65 years undergoing primary kidney transplantation were eligible.
0,"MTX was given initially at 7.5 mg/week, increased at 4 weeks to 10 mg/week and at 8 weeks to the target dose of 15 mg/week."
3,"Key exclusion criteria included no evidence of graft function within 24 hours of transplantation, patients of kidneys with a cold ischemia time >24 hours; donor age >65 years; patients of multiorgan, ABO-incompatible, positive T-cell cross-match or HLA identical living-related-donor transplants; or most recent anti-HLA class I panel-reactive antibodies >20% by complement-dependent cytotoxicity-based assay or >50% by flow cytometry or ELISA."
0,This test measures absolute and relative peak and mean power and total work.
8,"We assume that the average cluster size is 15000 population, considering a crude annual birth rate of 20 per 1000 population and estimated average perinatal mortality rate of 60/1000 with a coefficient of variation (k) between clusters of 0.125, an intracluster correlation coefficient of 0.05 and to detect a 20% difference in the mortality rates between intervention and control clusters, we would require at least 20 clusters, ten clusters per arm to provide the study with a power of 90% over a three-year intervention period."
0,The study coordinator oversaw all the results.
8,"According a pilot study, a priori sample size calculation indicated 14 patients per group were required to detect a significant difference of 20% in fatigue analogue scale between the intervention and control group (Effect size d =1, alpha=0.05, beta=0.08)."
0,"Follow-up interrupted included treatment protocol violation, lost to follow-up, use of other anti-malarials outside the study protocol or withdrawal of consent prohibiting further follow-up."
3,"The study population will consist of working adults aged 30 to 50 years who are physically inactive, defined as not meeting the current physical activity recommendations [1]."
0,The letters of invitation were delivered by a Community Health Mobilizer (CHM).
3,The intended population for this study is patients with HF and predominant CSA.
0,The exclusion criteria are listed in the study protocol.
3,"Consecutive, eligible subjects meeting the detailed inclusion and exclusion criteria (Table 1) will be considered for the study."
0,"Provided they continued to meet eligibility criteria, patients from Study 1 who had completed the high-dose regimen of V930 DNA-EP (2.5 mg/injection) were eligible to enroll directly into Study 2, as long as at least 4 weeks but no more than 24 weeks had elapsed since the fifth and final injection of V930 DNA-EP."
16,All obtained data are registered in the NOR-SYS Research Registry.
0,"OVD was injected into the anterior chamber according to the randomization, and capsulorhexis was performed."
16,Statistical analyses are performed by’ STATA/SE for Windows’and ‘R’ in cooperation with a biostatistician.
0,"(b) The manual evaluation requires to the therapist/parent to select among three different buttons: score 0 if the player did not achieve the goal, 1 for partial achievement, and 2 for successfully satisfying the goal."
1,"START is an assessor-blinded, single-center, 18-month, parallel design randomized controlled trial."
0,"For mortality, the least frequently expected outcome, the additional sample of 500 should allow for 140 events."
1,"Participants are randomized into one of 3 groups: high-intensity strength training (H), low-intensity strength training (L), or healthy living education (C)."
0,A heavy growth bacteria from the swab culture can often be equated to approximately 105 colony-forming units of bacteria per gram of tissue [39].
3,"Patients who were at least 18 years old, had signed informed consent and met all criteria listed in Table 1 were enrolled in the study."
0,All data will be double entered and data entry errors corrected.
6,"Outcome measures were prescribing rates and proportion of non-penicillin V prescribing at the group level before and after the intervention, compared with equivalent data from the control arm."
0,"Investigators, study staff and sponsor remained blinded to treatment and randomization information until after the conclusion of the study."
8,"Study-T: one thousand participants allowed to detect a minimum of 2.7-3.3% difference between relatively low AE frequencies (1-2% in one study arm, versus 3.7-5.3% in the other study arm), and a minimum of 8–8.4% differences for relatively high AE frequencies (25-30% in one study arm versus 38.4% in the second arm (80% power and 0.05 significance level) (Power Analysis and Sample Size calculation Software for Windows, 2007, NCSS, Utah, USA)."
0,"Participants will have an indefinite amount of time to make a decision, and those that agree, will be asked to sign two copies of the informed consent form."
8,The Study-E sample size was powered to assess the non-inferiority of ASAQ versus AL treatment efficacy [13].
0,The determinations were performed at two minute intervals.
6,The primary follow-up outcome was the number of days in hospital during the 12 year follow-up period.
0,The ITT-only population of 23 patients was analyzed as a subgroup.
6,"Secondary objectives were number of psychiatric admissions, number of outpatient psychiatric contacts, use of involuntary admissions, duration of inpatient and outpatient involuntary treatment, and mortality."
0,"Noncontinuous data including the occurrence and frequency of medical complications will be analyzed by the X2 technique and organized in tables to include sample size, absolute and relative frequency."
8,"For calculating sample size, we used the outcome measure ‘number of issues discussed by the GP’ and considered a difference of 0.5 standard deviation (which corresponded with one extra issue discussed by the GP) between intervention and control conditions as a clinically relevant difference."
0,At least 80% compliance overall would be considered acceptable.
8,"Such a difference can be detected with 64 GPs in each group (power 0.80, two-sided alpha 0.05)."
0,"The locations and manipulations of acupoints and non-acupoints are shown in Table 2, Figure 2 and Figure 3."
3,"Infants born between May 2007 and October 2008 with a GA <32 weeks and/or birth weight (BW) <1500 g who were admitted to the level III neonatal intensive care unit (NICU) of the VU University Medical Center (VUmc) of Amsterdam, were eligible for participation in the study."
0,The prespecified primary end point was plasma renin concentration (PRC).
3,"Exclusion criteria were small for gestational age, infants with a GA >34 weeks (even with BW <1500 g), major congenital or chromosomal anomalies, death <48 hours after birth and transfer to another hospital <48 hours after birth."
0,"For subjects included in the study, the index date was defined as the day when they received a first prescription for single-ingredient paracetamol and/or single-ingredient ibuprofen."
1,This study was an assessor-blinded randomized controlled trial (RCT; ISRCTN57754429) comparing a brief Internet-based early psychological intervention with a care-as-usual control group in two trauma centers (see Multimedia Appendix 1 for the CONSORT E-HEALTH Checklist of the trial).
0,"Eligibility will be assessed at an in-person screening visit involving detailed history, physical examination, and laboratory assessment."
3,"The Reading, Imperial, Surrey, Cambridge, and Kings study (http://www.controlled-trials.com/ISRCTN; ISRCTN 29111298), which was conducted between January 2004 and December 2007, was approved by the South East Multi-center Research Ethics Committee (reference MREC04/MRE01/2)."
0,APCs used motivational interviewing techniques to help parents identify problematic unhealthy behavioral practices related to television watching and nutrition.
3,"Men and women aged 30–70 y were recruited from the general population by using an advertisement and were selected as being at risk of metabolic syndrome on the basis of measurements of waist circumference and blood pressure, fasting insulin, glucose, blood pressure, and lipid concentrations as described elsewhere (17)."
0,"Before image acquisition started, participants performed a test task to ensure that the task was understood properly."
3,"Consecutive patients referred to Timika TB clinic with newly diagnosed with PTB (≥2 direct sputum specimens positive for acid fast bacilli [AFB]) were assessed for eligibility: sputum smear positive, >15 years, not pregnant, without hypercalcaemia (ionized calcium ≤1.32 mmol/L), not previously treated for TB, agreeing to stay in Timika for 6 months and providing written informed consent."
0,The intra- and inter-assay coefficients of variation for 25(OH)D are 11% and 8% respectively.
3,Written informed consent was obtained after discussion in Indonesian or a relevant Papuan language aided by pictorial and written information.
0,It was stopped after expectoration of an adequate amount of sputum.
1,Type of study: open randomized clinical trial.
0,"PBMCs were generated from human buffy coats and CD19+ B cells were isolated from PBMC using the EasySep Human B Cell Enrichment Cocktail protocol (STEMCELL Technologies, Vancouver, British Columbia, Canada)."
1,Follow-up period: one year.
0,"Considering these inclusion criteria, we drew a random sample of about 4000 people from the health insurance scheme’s data pool."
14,Blinding is not possible as the intervention is a multifactorial approach.
0,"As described in the Introduction, we only take into account severe OSA patients (patients with an AHI greater than 30 events per hour)."
14,That’s why the control group is selected after the intervention is made but for the same period of time.
0,"Data for the registry was updated nightly from the electronic health record and included demographics, laboratory results, medications, transplant and dialysis status, and information about past and future clinic appointments."
1,"The Clinical and Cost Effectiveness of Collaborative Care for Depression in UK Primary Care Trial (CADET) was a multicentre, two group, cluster randomised controlled trial."
0,"However, as the CES-D was designed specifically for the screening of depression and as the criterion validity for depression was considerably better than for anxiety disorders, for follow-up purposes, the CES-D will be combined with additional items from the Hospital Anxiety and Depression scale – anxiety section (HADS-A) [25]."
6,Our primary outcome was individual participant depression severity measured by the patient health questionnaire 9 (PHQ-9)22 at four months.
0,"We calculated that 16 patients were needed to detect a within-patient difference in cardiac index of 25% for low versus high TV strategy, with power of 0.80 and level of significance of 0.05."
6,"Secondary outcomes were the PHQ-9 at 12 months; quality of life (short form 36 questionnaire; SF-36) at baseline, four months, and 12 months23; worry and anxiety (generalised anxiety disorder; GAD-7)24 at four and 12 months; and patient satisfaction (client satisfaction questionnaire 8; CSQ-8)25 at four months."
0,Vaginal dilatation was assessed at four hourly intervals.
3,"Candidates who were insulin-naïve adults with T2DM for ≥6 months, HbA1c 7–10% (53–86 mmol/mol, inclusive), BMI ≤45 kg/m2, and previous treatment with metformin with or without additional oral antidiabetic drugs for ≥3 months were eligible to participate in the study."
0,The stain score per subject was determined by averaging scores across tooth sites for that subject.
3,"Key exclusion criteria included thiazolidinedione, exenatide, or liraglutide use within 3 months of participation in the trial, cardiovascular disease (e.g., stroke, myocardial infarction, unstable angina pectoris) within 6 months of the trial, uncontrolled hypertension (systolic blood pressure ≥180 mmHg or diastolic blood pressure ≥100 mmHg), impaired liver function (alanine aminotransferase ≥2.5 times the upper limit of normal), impaired renal function (serum creatinine ≥125 µmol/L or ≥1.4 mg/dL for males and ≥110 µmol/L or ≥1.3 mg/dL for females), recurrent severe hypoglycemia (more than one episode requiring assistance in the previous 12 months) or hypoglycemic unawareness, hospitalization for diabetic ketoacidosis within 6 months of the trial, and proliferative retinopathy or maculopathy."
0,"The measure has 5 health domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), each with three response-levels: no problems, some problems, and severe problems [24]."
3,"To be eligible, the woman had to be at least 15 years old, in her first or second trimester of pregnancy, be eligible for coverage by Oregon Health Plan Plus (the state administered Medicaid program which provides medical and dental services to adults and children), and speak English."
0,Other exploratory analyses are conducted based on the consensus of the Steering Committee.
8,The sample size is 400 women with 80 to 120 women enrolled within any one county.
0,Schools were selected for focus group interviews and observations in order to obtain maximum variation [17] in geographical location and in teachers’ satisfaction level with the Boost FV delivery at the beginning of the intervention period.
3,"Inclusion criteria included a CF diagnosis (sweat Cl– >60 mmol/L or two CF-associated mutations with organ system manifestation of CF), age ≥6 yrs, FEV1 ≥40% predicted, chronic P aeruginosa infection (four positive cultures over 2 years, including one within 3 months before screening and one at screening), clinical stability off of inhaled, or intravenous antibiotics 28 days before dosing, and no known allergy to amikacin."
0,"The percentage contribution of hepatic DNL to endogenous palmitate synthesis was determined by the incorporation of 2H2O in the palmitate present in the plasma total triglyceride pool, as previously described [24], [25]."
3,Additional information regarding study subjects is found in the online supplement.
0,"This was an open-label, multicenter, international, phase 2 study of retreatment in patients who had responded to brentuximab vedotin monotherapy on a previous clinical trial."
16,"The following analyses were conducted: (1) assessment of systematic differences between the two single VAS scores for a particular formulation (paired Z tests); (2) in case of no significant differences, calculation of the mean VAS scores per child and formulation; (3) evaluation of a potential cross-over or period effect (Z test on the order of the best accepted formulation), in case of such an effect analysis 3 and 4 were done for the administrations of the first formulation only (day 1) and for all data (all 4 days); (4) estimation of the mean VAS score per formulation and computation of the corresponding 95% CIs (Z statistics); (5) testing of differences between the mean VAS scores of two different formulations (Wilcoxon and Mann–Whitney tests); (6) estimation of the mean number of intakes that were fully swallowed by a child per formulation and computation of the corresponding 95% CIs (Z statistics); (7) computation of estimates and associated 95% CIs of the probabilities that the child and parents preferred a particular formulation, and comparison between the four probabilities (Z tests)."
0,"The first 45 children meeting the inclusion and exclusion criteria (Box S1) were enrolled, assigned a unique identification number and given an identity card to assist in correct identification."
16,"All statistics were conducted applying Excel 2007 (Microsoft, Redmond, Washington), R V.2.13 (R development core team)."
0,No bevacizumab dose reductions were allowed.
3,"Individuals who had suffered a previous MI, had coronary artery bypass graft (CABG) surgery, coronary angioplasty, or stroke, who were not permanent residents of Ontario, and who did not have an Ontario health card were excluded."
0,"The study was performed in compliance with Good Clinical Practice (according to GCP-V, 2004) and all applicable laws and regulations."
8,"Sample size was based on the RDQ score as the primary outcome with a minimally detectable and clinically meaningful effect size determined as a difference of 0.4 standard deviation (SD) in change scores or a 2-point difference, based on published data [38,43,44]."
0,"The importance of good adherence was emphasized, encouraging the patients to use the CPAP device throughout sleep every day."
8,"To detect a difference of 0.4 SD with 80% power using a two-sided 0.05 level 2 group t test, we sought to enroll 130 subjects in each group, to allow for an attrition rate of 25% at 1 year."
0,"At the time of the study, the Ecuadorian school system was comprised of four levels: elementary school (3–5 year-old children), primary school (1st-7th grade; 6–11 year-old children), middle school (8th to 10th grade; 12–14-year-old adolescents) and high school (1st-3rd year high school; 15–17 year-old adolescents)."
1,"This was a multicentre, pragmatic randomised clinical trial with two parallel arms."
0,"To detect 35% reduction in the incidence of ARS at 1 year after SPS, the estimate of the sample size indicated a total of 56 patients would be required: 28 patients randomized to BFT group and 28 to the control group."
1,An independent trial steering committee and a data monitoring committee reviewed the progress of the trial.22
0,"Two days following the last dose of fludarabine, a second infusion of T cells was administered."
1,"The DREAMS trial is a two stage trial, comprising a pilot study followed by a large, phase III double-blind, multicenter, randomized controlled trial comparing the effects of a single dose of 8 mg intravenous dexamethasone on patient recovery after major gastrointestinal surgery."
0,"Invasive coronary angiography could be performed in the event of a (i) Positive test (for delineation of anatomy and planning revascularization), (ii) negative initial test but high clinical suspicion, (iii) inconclusive initial test result, (iv) positive initial test but low clinical suspicion (suspected false positive, to rule out CAD)."
1,Centers in the UK undertaking major elective gastrointestinal surgery will be eligible to take part.
0,"Resting metabolic rate was measured from time 210 to 225 min after meal intake by indirect calorimetry using a tight facemask connected to a calorimeter, which measures the gas exchange breath-by-breath via an O2 alkali cell and an infrared CO2 sensor (CCMexpress®, Medgraphics, St."
6,The primary outcome to be measured is the change in the brachial-ankle PWV (ba-PWV) between baseline and after 12 weeks of treatment.
0,"Levels of agreement that were > 0.81 were defined as excellent agreement, levels between 0.61 and 0.80 were defined as good agreement, levels between 0.41 and 0.60 were defined as moderate agreement, levels between 0.21 and 0.40 were defined as fair agreement and levels less than 0.21 were defined as poor agreement [18,24]."
6,"The secondary outcomes will include changes in the ABI, urine albumin to creatinine ratio, eGFR, lipid profiles, and blood pressure from baseline to after treatment."
0,Participants are offered modules in the order noted above as they follow logically from one to the next.
14,"Whereas patients and health personnel were not blinded after randomization, outcome assessors and data analysts will be blinded to the allocation, however for some of the secondary outcomes it is difficult for researchers to remain blind as the patients knew which group they were in."
0,Imatinib and chemotherapy proceeded at the same dose if toxicity resolved within two weeks.
6,"We used a combined outcome measure of all-cause mortality and incident stroke, transient ischaemic attack (TIA), myocardial infarction (MI), advanced coronary artery disease, new cardiac failure and death, during the follow up period."
0,For 86 patients a follow-up could be obtained (ten patients were lost to follow-up).
6,"Advanced coronary artery disease was defined as at least one of; coronary artery revascularisation procedures, progressive angina, angina at rest, and acute coronary syndrome not otherwise diagnosed as MI."
0,"Diabetic neuropathy will be examined using the Valk neuropathy test [32], while hand grip strength [33,34] and the timed 'up and go' test will be used as measures of functional capacity [35]."
16,"The negative and positive predictive values were calculated using the sensitivity, specificity, and prevalence of ROP type 1 for the study group."
0,For all dimensions the cut-off score of ≥ 3 indicate a clinically sleep(-related) problem.
16,95% confidence interval (CIs) was calculated.
0,"The twenty imputed (completed) datasets were then analyzed separately and the resultant estimates combined using Rubin’s variance rules and their multivariate generalizations (Rubin, 1987)."
1,"The Feedback, Awareness and Behaviour (FAB) study was a parallel group, open randomised controlled trial in which eligible participants were allocated to receive either no personalised feedback about physical activity (control group), or one of three different types of feedback: simple, visual, or contextualised (intervention groups)."
0,"This design permits the evaluation of the additive value of each of the elements (i.e., expert consultation, technology-assisted expert consultation)."
1,The trial used a randomised placebo-controlled double-blind crossover design in which each participant served as his/her own control.
0,The retrospective group received blood glucose control using insulin infusions using the sliding scale presented in Table 1 as a guideline.
3,"Eligible patients were recruited from primary care, had been diagnosed with rheumatoid arthritis, were adults (aged 18 or over), and reported chronic pain (≥3 months duration and ≥30/100 on a pain visual analogue scale) at the time of enrolment."
0,We searched for any potential predictors of early (non-)reinstitution of antithrombotic treatment at discharge.
6,"Since multiple embryos were transferred, the primary outcome measure was ongoing IRs with FCA (number of fetal sacs with cardiac activity/number of embryos transferred at 12 weeks of gestation)."
0,"Patients will be asked to fill out follow-up quality of life questionnaires including EuroQoL, 5D3L, HADS, SF-36, SCL-90 also concerning the development of the child."
6,"Secondary outcome measures included positive hCG rates, clinical pregnancy rates (presence of gestational sac with FCA at 7 weeks of gestation), and ongoing pregnancy rates (presence of gestational sac with FCA at 12 weeks of gestation), as well as incidence of multiple pregnancy, biochemical pregnancy (positive hCG test not reaching clinical pregnancy), and clinical miscarriage (clinical pregnancy not reaching ongoing pregnancy)."
0,Total PA was estimated as the sum of school PE and leisure-time PA.
1,"This is an open-label, single-arm, national phase I trial performed at two study centres of sunitinib administered concurrently to preoperative irradiation in patients with soft tissue sarcoma (figure 1)."
0,Combining these two methods resulted in stringent criteria for movement and a sample of 22 adolescents (11 in each group).
1,Figure 1 Study design.
0,"Patients randomly assigned to ACZ885 in the second cohort received 1 mg/kg, in the third cohort 3 mg/kg, and finally in the fourth cohort 10 mg/kg."
3,Men and women aged 21–84 years with type 2 diabetes receiving ≥1.5 g/day metformin and with HbA1c 7–10% (between 53 and 86 mmol/mol) were included in the study.
0,"hs-CRP was measured by immunochemiluminometric assay using a quantitative C-reactive protein kit (Roche Diagnostics, Basel, Switzerland), IL-6 by ELISA using a Quantikine human IL-6 kit (R&D Systems, Minneapolis, Minnesota, USA), D-dimer by immunoturbidimetric assay using a D-dimer assay (Liatest) kit (Diagnostica Stago, Asnieres, France) and fibrinogen by polymerization function by the Clauss method using the Stago Fibrinogen kit (Diagnostica Stago); these biomarkers were measured by LabCorp Clinical Trials (Cranford, New Jersey, USA)."
3,"The main exclusion criteria were as follows: use of oral or injectable glucose-lowering agents other than metformin within 3 months before the time of screening; FPG at screening >13.9 mmol/L (250 mg/dL); history of unexplained pancreatitis, chronic pancreatitis, pancreatectomy, stomach/gastric surgery, or inflammatory bowel disease; history of metabolic acidosis, including diabetic ketoacidosis, within 1 year before screening; history within the previous 6 months of myocardial infarction, stroke, or heart failure requiring hospitalization; and clinically relevant history of gastrointestinal disease, with prolonged nausea and vomiting during the previous 6 months."
0,"Additionally, the incidence of treatment-emergent genotypic and phenotypic resistance to DTG and other on-study ART was assessed for any subject with protocol-defined virologic failure (PDVF)."
1,"A randomized, crossover study design was used to compare overnight blood glucose control during OL and CL therapy on days with and without antecedent afternoon exercise."
0,"Pegasys dose was de-escalated or temporarily discontinued if neutrophil counts were <750/mm3 or <500/mm3, respectively."
1,"We hypothesized that CL insulin delivery would be superior to OL control in preventing NH, especially on nights after antecedent afternoon exercise, and that CL control would be able to maintain a higher proportion of blood glucose levels within the 70–180 mg/dL target range, even in the face of afternoon exercise."
0,Patients were selected based on the World Medical Association Helsinki Declaration for Ethical Principles for medical research involving human subjects [12].
16,The data were analysed using descriptive statistics in Microsoft® Excel 2007.
0,The 6MWD was to be performed as close to trough levels of sildenafil and peak levels of bosentan as possible.
6,"The main outcome measures were: (1) clinical adverse events including mild, moderate and greater severity renal toxicities and serious adverse events (2), adherence rates to daily and intermittent dosing (3), willingness to use the study regimen, if shown to be effective (4) change in HIV-associated risk behaviour during trial participation (5), the proportion of volunteers with HIV-specific immune responses as measured by interferon-γ ELISpot."
0,"In the control group, the time matched samples after transplantation was labeled and mixed with unlabeled baseline samples."
6,"The primary outcome measure was the percentage of parents satisfied with information on antibiotic therapy received in the PED, during the physician visit and the educational session [19,23-25]."
0,"Participating sites were randomized to a treatment condition (Native IYG, n=14) or a comparison condition (n=11) featuring a suite of 5 evidence-based Internet-based health promotion programs that were not focused on sexual health."
6,"The secondary endpoints were parent satisfaction about information received in the PED about fever control, parent attitudes about judicious antibiotic use (6 of the 11 questionnaire items on day 14) [32], and outcome of the acute infection."
0,Interviewers will be blind to participants' intervention condition.
3,"The following inclusion criteria were established for this study: being a panel member of respondi; having computer/Internet literacy; having sufficient command of German; being 18 years or older; and having an unhealthy drinking pattern, which was defined as (1) not complying with the guideline recommending no more than 1 glass (women) or 2 glasses (men) of alcohol per day, (2) drinking on more than 5 days per week, (3) having a score higher than 7 on the Alcohol Use Disorders Identification Test (AUDIT) [49], or (4) currently trying to become pregnant, drinking alcohol while pregnant or breastfeeding (in relation to pregnancy), or trying to get one’s partner pregnant (for men)."
0,• Teen parent (under 20 years old).
14,The nature of the trial meant that participant blinding was not possible.
0,Adult men with biochemically and genetically proven X-ALD without contra-indications for the use of BF were eligible for inclusion.
14,All outcomes were self-reported using validated measures.
0,"Classes consisted of an introduction to the weekly theme, pain-relieving or settling-in relaxing poses, a programme of seated and standing practices, educative postural advice, breath work, concentration activities, and 5 to 15 min of relaxation."
8,"The required sample size (n = 76) was determined a priori, based on the ability to detect a difference (Δ) between the treatment groups equivalent to the previously determined minimum clinically important difference (MCID) of 0.5 points for the SSS symptom severity scale [19], and assuming a standard deviation of 0.56 [20], [21] with power set at 90% (alpha 5%), and allowing for a drop-out rate of 20%."
0,Distraction and alertness were assessed with a cross-modal visual-auditory oddball task.
3,"We recruited adults who had physician diagnosed type 2 diabetes for at least 6 months and were receiving one or more oral hypoglycaemic agents, had an HbA1c between 7.5% and 11% and who were willing to sign an informed consent."
0,"Measurements of the fluid status were performed by a single well-trained nurse, using a portable whole-body bioimpedance spectroscopy device, the BCM (Fresenius Medical Care, Bad Homburg, Germany)."
3,"We excluded patients who were unwilling to use insulin, previously or currently using insulin (confirmed by the patient's medication records), had a history of ketoacidosis (confirmed by the patient's healthcare records), were pregnant, worked night shifts, had renal impairment (serum creatine of ≥ 124 mmol/L for females or ≥ 133 mmol/L for males; confirmed by the patient's healthcare records), were clinically unstable (based on the pharmacist's judgement), were unwilling or unable to attend follow-up visits or felt to be unlikely to adhere to study procedures due to cognitive limitations (based on the pharmacist's judgement), severe psychiatric disorders or alcoholism (confirmed by the patient's healthcare records)."
0,"Cost parameters were assigned to be log-normally distributed whilst probability, rate and utility parameters were assigned to beta-distribution [65]."
6,The primary outcome measure was the change in HbA1c from baseline to week 26.
0,The corresponding author had full access to all of the data and the final responsibility to submit for publication.
6,"Secondary outcomes included proportion of patients achieving target HbA1c (defined as HbA1c ≤ 7.0%), changes in oral hypoglycaemic agents, quality of life and patient satisfaction using Audit of Diabetes—Dependent Quality of Life (ADDQoL), Diabetes Treatment Satisfaction Questionnaire (DTSQ) and Diabetes Treatment Satisfaction (Change) Questionnaire (DTSQc), persistence on insulin glargine (% still taking insulin at the end of follow-up), number of insulin dosage adjustments per patient, number of hypoglycaemic episodes."
0,The seven variables to be included in the DRS have been derived from our previous reports.
8,"With a sample size of 80 patients and the following assumptions, an SD of 1.1 and a two-sided α of 0.05,7 we calculated 90% power to detect a mean decrease in HbA1c of 0.4%."
0,"Finally, one hundred twenty-seven apparently healthy subjects who agreed to participate in the study were enrolled."
8,"Since this a pragmatic, practice-based trial, the sample size was inflated to 100 to account for possible losses to follow-up."
0,All ESD procedures were performed in a room dedicated to upper gastrointestinal endoscopy and fully equipped for advanced cardiac life support.
3,"Patients were eligible if they attended regularly the Neuroendocrine Tumour Clinic, Royal Liverpool and Broadgreen University Hospitals, and were known to have autoimmune chronic atrophic gastritis, hypergastrinaemia, raised serum CgA, and multiple type I gastric NETs, and were otherwise in good health."
0,A satisfactory heart rate response is achieved on reaching 85% of the maximum predicted heart rate [12].
3,"Exclusion criteria included: previous gastric surgery; treatment with somatostatin analogues; Zollinger-Ellison syndrome; prolonged QTc interval; and pregnancy, lactation or steroid contraceptive use in females."
0,In the next step the narrative data was combined into meaningful and understandable units which were labeled as codes [37].
16,"We analysed the outcome measures by the nonparametric Wilcoxon signed-rank test using SPSS version 20 as not all the data were normally distributed, and accepted p<0.05 as significant."
0,Figure 2d provides a timeline view of when robotic assistance or BMI control were responsible for translation and grasp velocities.
1,The protocol for this trial and supporting CONSORT checklist are available as supporting information; see Checklist S1 and Protocol S1.
0,Partial response was defined as a decrease in the number of genital or oral ulcers at the current and previous study visits compared to the baseline number of ulcers.
1,"This was a phase I, single centre, placebo-controlled, double-blind, dose-escalating study of the safety and preliminary immunogenicity of OPAL-HIV-Gag(c) in HIV positive adults receiving stable ART."
0,The green and purple lines represent the upper and lower bounds of the 95% confidence intervals.
16,The Mann-Whitney U test was used to compare median values for immunogenicity testing between different weeks for both IFNγ ELIspot and ICS assays and for comparing percentage change of lymphocyte counts to Baseline.
0,"Briefly, MA-CORD WIC intervention components included 1) training of WIC providers in best practices and consistent delivery of MA-CORD target behavior counseling and health messaging across sectors; 2) development of MA-CORD WIC provider resource and training materials; 3) incorporation of MA-CORD patient and family educational materials into WIC participant counseling; and 4) linkage of WIC providers to local MA-CORD clinical and community obesity prevention initiatives and enhanced healthy weight clinic referrals."
16,The Spearman rank correlation coefficient was determined to test correlation of IFNγ ELIspot to ICS assays.
0,"This was a non-randomised, multicentre, open-label, single-arm phase I/II trial of the Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT) trial consortium."
1,"We did a one to one parallel group individual patient randomised controlled trial in two hospitals in Nottingham (catchment population 675 000) and Leicestershire (catchment population 1.1 million), East Midlands, UK."
0,"Twenty four (24) Caucasian women were included and randomized in 2 groups (Figure 1 showing the Flow Chart) and enrolled by CEVAC, who has been responsible for the sample work up of the collected materials: A low dose (LD) group (10 µg/dose) and a high dose (HD) group (50 µg/dose)."
1,The trial protocol has been published.10
0,The average estimated time investment is 1 h a week to complete a module and 30 min per day for homework (e.g. keeping a daily hot flush/night sweats diary and relaxation exercises).
3,"Patients were eligible if they were discharged from an acute medical unit within 72 hours of attending hospital, were aged 70 or over, and were identified as being at heightened risk of future health problems (defined by a score of at least 2/6 on the Identification of Seniors At Risk tool11 12 13)."
0,Each hospital will follow its own antibiotic prophylaxis protocol for the type of implant insertion procedure for the ORIF group.
3,"Exclusion criteria were not being resident in the hospital catchment area, lacking mental capacity to give informed consent and without a consultee, any exceptional reason cited by acute medical unit staff why patients should not be recruited, and participation in other related studies."
0,"To remain consistent with public health recommendations for exercise, light intensity exercise minutes were not included in the exercise measures (Haskell et al. 2007)."
8,"Using pilot data in which the mean number of days spent at home at 90 days was 63 (SD 23), we calculated that a sample size of 200 in each group would have 90% power to detect a clinically important difference of 7.5 days in the mean number of days at home between the two groups at a 5% significance level."
0,"The exclusion criteria included pregnancy or lactation, history of hypersensitivity to any component of the vaccine, active malignancy receiving chemotherapy or radiation, other immunocompromised conditions besides HIV (e.g., solid organ transplant), received immunosuppressive (e.g., corticosteroid ≥ 0·5 mg/kg/day) or immunomodulating treatment in the last six months before screening visit, had renal insufficiency (creatinine clearance <30 mL/min), decompensated cirrhosis (Child-Pugh class C) [19]."
8,"To account for loss to follow-up, we set a total sample size of 420 participants."
0,"The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript."
3,The target group of this study included teachers working in primary (US grades 1–6) and secondary (US grades 7–12 plus 1 year) schools in Hong Kong who could read Chinese or English.
0,"The MRI sequence method used for wall depiction was a 3-dimensional, fat-suppressed, dark-blood, turbo spin-echo sequence with variable flip angles (Sampling Perfection with Application-optimized Contrast with different flip angle Evolutions [SPACE]), which was previously described by our group.16,17"
3,We recruited the primary or secondary schools as clusters.
0,"This data set was not statistically analysed, but allowed the investigators to check the adherence and to provide additional counselling."
3,"Participants were daily smokers 18 years of age and older living in Ankara, Turkey."
0,"For patients who received FOLFOX (folinic acid + 5-FU + oxaliplatin) or OFF (oxaliplatin + folinic acid + 5-FU), data were combined because information regarding dosing and schedule were unknown."
3,"Additional eligibility criteria included: owning a mobile phone and having sent or received at least 1 text message in the past year; seriously thinking about quitting in the next 15 days; and not having a chronic or serious illness defined as emphysema, heart disease, or lung disease (because this population would likely require a different type of intervention)."
0,Only authors MRS and GJ had access to raw data; processed data released by the IDMC and TSC were available to all coauthors.
8,We targeted a sample size of 150 participants for feasibility reasons based on the project budget and timeline.
0,"The obtained number was multiplied by 40, assuming 8000 leukocytes per μL of blood, to gain an approximate parasite count."
3,"Included patients were people aged ≥3 presenting with acute sore throat (two weeks or less of sore throat) and an abnormal looking throat—that is, erythema and/or pus—as in our previous studies in primary care12)."
0,"Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Barbara Ann Karmanos Cancer Institute, Detroit, MI; Cleveland Clinic Foundation, Cleveland, OH; Duke University Medical Center, Durham, NC)."
3,"Exclusion criteria were non-infective causes of sore throat (such as aphthous ulceration, candida, drugs) and inability of patient or parent/guardian to consent (such as dementia, uncontrolled psychosis)."
0,"However, based on the fact that local control seems to be dose-dependent, all types of salivary gland malignancies in the head and neck will probably benefit from high-LET radiation."
8,"The sample size was calculated using methods published by Hayes and Bennett [19], assuming 11% incidence of diarrhea among children in the control group based on previous study [20], 80% power, 10% drop out, 95% confidence interval and design effect of three from clustering."
0,"Three-dimensional orientations of 7 body segments of interest (pelvis, thighs, shanks, feet) were obtained by tracking trajectories of markers placed according to a common commercially available kinematic model (Plug-In-Gait, Vicon, Oxford, UK)."
8,"Accordingly, we aimed to enroll 18 clusters per arm with 24 children under the age of five years per cluster followed for 16 weeks (which would provide 6921 person weeks of observation in each group) to get sufficient power to detect 40% reduction in the incidence of diarrhea in the intervention group among children under-five years of age."
0,"In the current project, the stepped-wedge design confers two benefits: we can (a) extend implementation support to the maximal number of facilities and (b) enhance information from the formative evaluation of our implementation process."
3,Patients were ≥18 years old with a biopsy-proven lymphoma that had relapsed after or was refractory to one or more prior chemotherapy.
0,Blood pressure was measured via automated cuff after 10 minutes of rest at the beginning of each visit.
3,"Patients had to have measurable disease of ≥2 cm by computed tomography scan, Eastern Cooperative Oncology Group performance status (ECOG PS) 0–2, creatinine clearance ≥50 ml/min, absolute neutrophil count ≥1500 cells/mm3, platelets ≥60 000/mm3, and adequate organ function."
0,Paramedics administered the treatment solutions as the initial resuscitation fluid given within 4 hours of the incident.
16,"Analyses were descriptive in nature, and no formal statistical comparisons were made."
0,"As one study has demonstrated that mothers stress in the NICU decreases with KMC [86], and as there is a plausible relationship between maternal cortisol levels and infant reactivity [87], there is an interest in studying maternal stress levels over time."
1,"The Pediatric Vaccine (PedVacc) 001 study was a single-centre, phase I, open, randomized, no treatment-controlled study of candidate HIV-1 vaccine MVA.HIVA compared to no treatment control group."
0,Forms were used to record information regarding one-on-one visits as well as individual contacts.
1,"Randomization was generated by the Centre for Statistics in Medicine, University of Oxford using simple random sampling."
0,Histogram-matching [15] is a histogram-based intensity normalization method that transforms the histogram of an image so that it is a match to the histogram of a reference image.
3,This study enrolled patients (aged ≥18 years; BMI ≤45 kg/m2) with inadequately controlled type 2 diabetes (HbA1c ≥7 to ≤10%) despite a diet and exercise program and a stable regimen (unchanged for ≥12 weeks prior to randomization) of metformin immediate release plus a sulfonylurea.
0,"For the projected sample (134), we estimate that the analyses will have a power to detect effect sizes of 0.25."
8,The sample size of ten per group was proposed to receive the Ad35.CS.01 vaccine to obtain preliminary safety information on a small cohort of subjects before proceeding to subsequent larger trials.
0,Duplicate differential cell counts were performed in a blinded fashion under 400× magnification (40× lens and 10× eyepiece).
8,The study had 80% power to observe at least one adverse event associated with the vaccine if the true event rate were 10%; however the study was not powered to formally compare dosage-related immune responses.
0,"Since 1984, the Medical GOPHER system, a network of computer workstations, has allowed physician order entry and other direct interactions between computer and physician [33]."
6,The primary outcome measure was the patient’s score (out of 3) on questions about their discharge instructions.
0,Oxygen was provided in accordance with current guidelines.12 16
6,"The secondary outcome measure was patient rating (on a 10-point scale) of the value of the videos overall, and in specifically improving discharge instruction comprehension (both measured in patients who viewed a video)."
0,Consecutive participants were recruited between July 2012 and June 2014 for the two main trials.
8,Complete outcome data is expected to be available on 112 patients per group (224 in total).
0,Finally the ring was removed from the mould.
8,This gives 80% power to detect a standardised difference of 0.375 (equivalent to a change in HADS-A of at least 1.5 when standard deviation is assumed at 4) assuming a type 1 error rate of 5%.
0,"Finally, we examined whether restricting viral respiratory infections to people aged ≥45 years substantially altered the interpretation of our results."
3,"All the enrolled patients were at least 18 years-old, HIV-1 infected adults with a CD4+ count <200/µL and/or CD4+ recovery ≤25% and HIV-RNA constantly <50 cp/mL who had been experiencing a HAART regimen for at least one year."
0,During the interview the subject simultaneously reads the question on the computer screen and listens to it read aloud through headphones.
4,The study setting is the NICU of a tertiary-level Canadian hospital specializing in women and children’s health.
0,"The following QCA parameters will be calculated: reference vessel diameter, minimal lumen diameter, per cent diameter stenosis (difference between the reference vessel diameter and minimal lumen diameter/reference vessel diameter ×100) and late lumen loss (difference between the postprocedure and follow-up minimal lumen diameter)."
4,"Enrollment began in July of 2012, and is expected to be completed within 42 months of initiation."
0,"For subjects with no reported post-baseline tumor assessment, irPFS will be censored on the day of first dosing."
10,"Group assignment will be determined using a password protected website, where randomization is in permuted blocks and participants will be stratified by gestational age (less than or greater than/equal to 32 weeks gestational age at birth) in order to ensure equal distribution across groups for all ages."
0,"Inclusion criteria for the substudy were treatment with chemotherapy in doses of 75 mg/m2 or more of epirubicin and docetaxel, respectively, and scoring pain of 4 or greater on a visual analog scale (VAS)."
3,"The study population will be recruited through the Can Reduce website, several websites from local outpatient treatment centers, and from nightlife prevention websites."
0,The materials were developed together with teachers and pre-tested in a group of six-year-old children and their parents.
3,"In addition, advertisements will be placed in internet-forums and (commuter) newspapers."
0,ECGs were performed at baseline and before cycle 2.
3,"Patients are eligible if they (1) are ≥18 years, (2) have ≥3 medications of any kind prescribed by their physicians, (3) have mean blood pressure ≥130 mm Hg systolic or ≥80 mm Hg diastolic if they have diabetes or ≥140 mm Hg systolic or ≥90 mm Hg diastolic if they do not have diabetes, (4) have a Mini‐Cog Exam43 score ≥3, (5) are primarily responsible for administering medication, and (6) do not intend to move or change their usual source of medical care during the next year."
0,"Blood counts were measured on Sysmex XE 2100 or XE 5000 (Sysmex, Europe) with reagents from the supplier."
3,Patients who are non–English speaking are not eligible.
0,"Asthma symptoms were rated on a scale from 1 to 5, with higher scores indicating less asthma control."
3,Participants were recruited via local media advertisement.
0,"We classified asthma according to current treatment at time of immunisation, using the British Thoracic Society (BTS) and Scottish Intercollegiate Guidelines Network (SIGN) guidelines.18"
3,"Inclusion criteria were selected to represent the typical participant in preventive training: Age 30-60 years, Body mass index 25-35 kg*m-2, untrained status (sedentary profession and physical inactivity ( < 1 hour*week-1 regular activity; VO2max < 45 ml·min-1·kg-1, no history of competitive training), non-smoker for at least 1 year, no history of relevant diseases or disorders that would interfere with the intended training (fasting blood glucose concentration < 6.1 mmol*l-1, resting blood pressure < 150/95 mmHg)."
0,AE data (treatment‐emergent AEs [TEAEs] and serious AEs [SAEs]) and vital signs were collected at each study visit.
16,All statistical analyses were performed using SAS software and all tests were two-sided when applied.
0,"Follow-up times were three and six months from baseline (after treatment and three months after treatment, respectively)."
16,Statistical significance for all comparisons was determined at P<0.05.
0,Burden will be measured using the Zarit Burden Interview (ZBI) which is a 22-item validated self-report questionnaire developed to examine subjective burden of caregivers of people with dementia.
8,"A sample of 270 in each arm was chosen so that, after allowing for 15% loss to follow up and using a significance level of 0·05, the following could be detected: a reduction by half in the proportion overall admitted under the MHA with 90% power (from 30% to 15%); a proportionate reduction for a pre-specified subgroup of interest, Black patients, with 80% power (from 40% to 20%), assuming that the overall sample would yield a subsample of 91 Black patients per arm."
0,"Nurses, GPs, patients and the research team remained blind to product allocation until all analyses had been completed."
6,Data were collected at baseline and 18-months after randomisation.
0,"For interrater reliability, we compared the Korean CAM-ICU ratings between the two nurses by κ coefficient."
6,"The primary clinical and economic outcome was admission to hospital under the MHA, which was gathered from and validated between the following sources: case notes, the local Patient Administration System, MHA Office data, and interviews of patients and care co-ordinators."
0,"If eosinophils were not seen at low power, systematic scanning of the entire sample using the × 20 objective (field diameter 1.25 mm) was undertaken."
6,The MM in Delphi as described in this article is designed to deliver information about needs in pharmacotherapy and to trigger activities to reduce these needs.
0,Intracohort patient dosing was staggered by at least 24 hours after the first 4 patients in the prior cohort had been dosed; study drug administration to the remaining patients in a cohort was staggered by at least 2 hours between patients.
17,"In order to explore the consistency of the treatment effects with respect to baseline pain intensity (moderate versus severe pain) and type of anesthesia (spinal versus general) patients received for the surgery, subgroup analyses were performed for the 2 co-primary endpoints."
0,The CP activity is proportional to the rate of formation of reaction product.
3,"Adults (aged ≥ 18 years) with T2DM and insufficient glycemic control (HbA1c ≥7% and ≤10%) were eligible for inclusion in the study if they had received an unchanged dose of metformin immediate release (IR) (≥1500 mg/day, or the maximum tolerated dose, or the maximum dose according to the local label) for ≥12 weeks prior to randomization and met the inclusion and exclusion criteria listed in Table 1."
0,"Symptoms of poor mental health were assessed using a standardised tool (SRQ-20), integrated into the health section of the questionnaire, which was developed by WHO [16] and has been validated in a range of populations [17]."
3,All participants provided written informed consent prior to screening.
0,"Potential risk of AD is rare with a frequency < 1 % and include infection, deep vein thrombosis (DVT), arthralgia, headache, joint effusion/swelling, nasopharyngitis."
1,"A randomised, controlled, equivalence trial at two tertiary hospitals (Austin Health and Alfred Health) in Melbourne, Australia."
0,The relaxation session lasts 15 minutes and it needs only a chair to be performed.
3,"To be eligible for enrolment, participants must be greater than 40 years of age, with a diagnosis of COPD based on an FEV1/FVC ratio of < 70% [3] and a smoking history (current or former) of a minimum of 10 packet years."
0,No formal sample size calculations were performed.
3,"Participants will be excluded if they have 1) diagnosis of asthma, 2) attended a pulmonary rehabilitation program within the last 2 years, 3) experienced an exacerbation of COPD within the last four weeks or 4) have other comorbidities which will prevent participation in an exercise training program."
0,"Diagnostic criteria of arterial hypertension, dyslipidemia and glycemia were based on the current guidelines of professional societies (Box 1)."
6,Rate of histological complete response after double reading by two different pathologist.
0,Twelve of these were specialists.
6,"Mobidity, sphincter preservation rate, overall and disease-free survival."
0,"A secondary outcome on prompt effective treatment, defined as the proportion of febrile patients seen at a registered drug shop who receive appropriately targeted ACT treatment within 24 hours of onset of malaria symptoms, was included in order to evaluate the effect of the intervention on access to prompt, effective treatment."
4,"Healthy male and female volunteers were recruited through advertisement at public institutions in Holstebro, Denmark."
0,"Participation was limited to one adult (age 18 or older) per household, selected based on the next birthday if multiple adults were present."
14,"Blinding the participants or the investigators to allocation group will not be possible, however the outcome assessors and the trials statistician will be blinded to the participants study allocation."
0,Ongoing HIV risk assessments and prevention counseling were offered to volunteers during the trial.
14,"The trials statistician will have access to unblinded data, but will prepare results without knowledge of allocation to randomization coding."
0,Most patients were treated with a four-field technique; use of intensity-modulated radiotherapy was allowed for centres per approval by their group's principal investigator.
8,"To detect significant differences between three groups (MBSR Intervention I and II, and non-MBSR): 50 participants per group (150 participants in total) are needed in order to achieve a statistical power of 80%."
0,"In addition, we annually review the proceedings of conferences with a focus on contraception to become aware of any ongoing or future trials on the subject."
8,The power calculation was based on alpha of 0.05 and expected mean effect size difference between the groups (difference in change between baseline and 3 months follow-up) being at least 1 unit at HAD-scale.
0,"Because we were unable to identify a manufacturer capable of compounding both active lozenges containing more than 1 g of xylitol and indistinguishable placebo lozenges, our choice of a 5 lozenge/day regimen represents a compromise between increased assurance of achieving a therapeutic dose and practicality."
3,Patients were potentially eligible if they had symptomatic DVT and/or PE.
0,An independent nurse who was responsible for the randomization then contacted the exercise coach at each center to inform about group allocation.
3,"The major ineligibility criteria were: a therapeutic dose of low-molecular-weight heparin, fondaparinux, or unfractionated heparin for more than 48 hours; more than a single dose of a VKA; treatment of the current episode with thrombectomy, a vena cava filter, or fibrinolytic therapy; any contraindication listed in the local labeling of enoxaparin, warfarin, or acenocoumarol; or a creatinine clearance <30 ml/min."
0,"Randomization was performed by UCB, GP and AH by opening opaque, sealed envelopes (prepared by TJ) containing a note of the initial diet with equal proportions of envelopes for both diets."
14,"Blinding of intervention team, nursing and medical staff was not possible in this trial; Nurture Specialists had to know to whom they were to administer the intervention, and the study staff had to know from which mothers certain data were to be collected."
0,CMR analysis will be both visual and quantitative following international recommendations [66].
14,"Blinding of the mothers was also not possible, given that all mothers were in the same NICU and knew in advance their group assignment."
0,"Volunteers with clinical suspicion of malaria at routine follow-up, or at any time during the study, had blood smears."
8,"To detect a change from 50 to 60% in the proportion of patients having a yearly follow-up consultation for their chronic disease (with 80% power at the 0.05 level of significance), a total of 816 patients with 408 in each group would have to be included in the study."
0,"Results were communicated to physicians via an inbox message to use at their discretion taking into consideration other factors (e.g., clinical presentation, cardiovascular risk factors, concomitant medications, insurance, PCI complexity) in making antiplatelet therapy decisions."
8,"With a design effect of 1.6, we would need 1,306 patients for the study."
0,SL provides emotional support and validation of patients' experiences and is based on a nondirective person-centred counselling approach (See Table 1 for content and structure of each therapy).
3,"Sample inclusion criteria were: a) female, b) 18 years of age and older, c) caring for a family member who has a diagnosis of advanced cancer and has been referred to palliative care and /or is receiving palliative care services, d) home address is a rural postal code, and e) English speaking."
0,"We excluded patients less than 18 years of age, with a core temperature of less than 34°C upon presentation after ROSC, a history of abdominal surgery, peritonitis or currently undergoing peritoneal dialysis, active uncontrolled bleeding or coagulopathy, a known history of receiving thrombolytic medication in the previous six weeks (treatment with other anticoagulant medications, such as those required for percutaneous coronary intervention (PCI) or ST-segment Elevation Myocardial Infarction (STEMI) treatment, is not an exclusion), known significant concomitant illness with a life expectancy of less than one year, known enrollment in another study, or pregnant patients."
3,"Exclusion criteria were a) women who were cognitively impaired as determined by the recruitment team at the site, b) women otherwise unable to participate, in the opinion of the recruitment team and c) women caring for a family member who has a diagnosis of advanced cancer as well as dementia."
0,"Our intervention was implemented at 2 sexual health clinics, 1 in northern California (Oakland), and 1 in southern California (Hollywood)."
6,"Our three main outcomes of interest were 1) the participant-reported most important attribute (“Which ONE feature of prostate cancer screening is most important to you?” chosen from the four attributes above), 2) the post-task testing preference, based on a question that included two unlabelled options described in terms of the key decision attributes and designed to mimic screening or no screening options - we call this “unlabelled test preference” (Figure 1); and 3) a single post-task question about intent to be screened with PSA, based on a Likert scale (from strongly disagree to strongly agree, with agree and strongly agree considered as positive intent to be screened) - we refer to this as the “labelled test preference”."
0,"Calgary, Canada) blinded to glycaemic status."
6,Figure 1 Unlabelled test preference question.
0,"To measure midazolam and 1-hydroxy-midazolam, 0.2 mL of plasma was mixed with 25 μL of IS working solution, which contained midazolam-d4 and 1-hydroxy-midazolam-d4, and a liquid–liquid extraction procedure was used to isolate the analytes."
14,Health care professionals and participants will be aware of the allocation arm but blinded to the results of any former assessment.
0,"Myocardial infarction was defined by the presence of two of the following three criteria: specific cardiac enzymes more than twice the upper limit of normal; history of chest discomfort for at least 30 min; or the development of specific abnormalities (eg, Q waves) on a standard 12-lead electrocardiograph."
14,Health care professionals who are outcome assessors will be blinded to participants’ allocation and former assessment.
0,"Fourty-one individuals (48–85 years, mean 68±8; 13 women) gave written informed consent and participated in this double-blind, placebo-controlled and randomized study."
8,"The participants self-reported sickness absence will be analysed as a dichotomous measure indicating whether the participant has had no sickness absence (0 days) because of musculoskeletal troubles or has had sickness absence during the last three months (1–7 days, 8–30 days, >30 days)."
0,"Therefore, the Type I error rate, α, can be set higher than in traditional superiority trials (eg 0.1–0.2) [64]."
8,"Assuming that 15% or less of the health care workers in the TPA group and 50% of the participants in the REF group report they have had sickness absence within the last three months, a sample size of 22 individuals in each group will be required to achieve greater than 80% statistical power (one-sided, alpha = 0.05)."
0,"After surgery, routine blood investigations (full blood count, urea and electrolytes, liver function tests and C-reactive protein) were measured 1 and 7 days both before and after operation."
3,"Prior to pharmacokinetic analysis in rats, we demonstrated the radiation dose distributions in a head and neck cancer patient to show the dose-painting concept that low dose area generously deposited around high-dose target volume."
0,"Participants will then be randomised using block allocation with a block size of four, to receive either movement control or general exercise."
16,We used the software programs SPSS 19 and 20 for the statistical analyses.
0,"GlaxoSmithKline K.K. (Tokyo, Japan) provided only the reformulated diluent for Flolan used during the treatment period."
16,"We used linear mixed models statistics for the analyses of the main outcome variable, and chi-square and Fisher's exact tests for secondary outcomes of categorical data, and blinding validation analyses."
0,"In this first introduction to the techniques, we used detailed instructions and handed out copies with the written instructions to the participants, so that they could follow the text while we explained the techniques."
8,"The trial was designed to detect a minimal 35% difference in the number of participants reporting any improvement (very much better, much better and a little bit better on the PGI-I) between the experimental and control conditions, assuming a rate of improvement in the control condition as high as 20%, with 80% power and α 0.05 two sided (n=34)."
0,"Fatty acid methyl esters were formed by acid hydrolysis, and were analyzed by capillary gas–liquid chromatography on a GS2010 Gas Chromatograph (Shimadzu, Duisburg, Germany) equipped with a SP2560, 100-m column (Supelco, Bellefonte, Pennsylvania, USA) using hydrogen as carrier gas."
8,Using an inflation factor of 1.65 to account for an anticipated maximum intracluster correlation (ICC) of 0.05 and unequal cluster size yielded a recruitment target of 56 participants per group.22
0,"This approach is described by Ritchie and Spencer [20] and Pope et al., [21] and is broadly as follows: • Data familiarization: reading of complete interview transcripts, listening to original audio-recordings and use of field notes; • Identifying a thematic framework: key issues, concepts and themes are identified and an index of codes developed; • Indexing: whereby the index generated through identification of the thematic framework is applied to all data; • Charting: a summary of each passage of text is transferred into a chart to allow more overall and abstract consideration of index codes across the data set and by each individual; • Mapping and interpretation: understanding the meaning of key themes, dimensions and broad overall picture of the data and identifying and understanding the typical associations between themes and dimensions; The charting process provides an opportunity to code data from numerous vantage points, by demographic factors, such as gender or age, by personality characteristics, such as looking specifically at people who are highly anxious compared to those who are not, or by medical aspects, such as those with a particular condition compared to those without."
8,"A priori sample size calculation for stage 2 indicated 15 patients per group were required in order to detect a significant difference of 25% in IPAQ [29] between the intervention and control group (Effect size d = 1, alpha = 0.05, beta = 0.08)."
0,"We also recorded the mean, minimal and maximal blood glucose readings during the intervention period, the standard deviation (SD) and coefficient of variation (CV) of blood glucose, and the total and daily doses of insulin."
10,"Assuming an average of 10 individuals per group, the project leader generated a random sequence of 20 sessions through an online program, with the criterion that the occurrence of both interventions had to be balanced (i.e., 10 sessions per intervention)."
0,"This approach spreads brief intervention over sessions, allowing the BHC more time to negotiate a change plan with the patient."
10,"When more participants signed up for the trial, one last session was randomly allocated by the online program to the hypnosis intervention."
0,"Further, we expected slightly lower “Feel Drug” ratings for AMP compared to the other drugs, but elected not to increase the dose of AMP, as there was little information available on safety of higher doses in healthy, non-stimulant abusing participants."
14,The hypnosis and relaxation therapist was informed via text message by the project leader after the first part of the therapy session about which intervention he was about to perform.
0,"This sham acupuncture modality has also been adopted in our previous studies [11-13], without any problems encountered."
14,The participants remained blind with regard to their assigned intervention until the end of the therapy session.
0,The CARDIPP-R comprises a re-investigation of the cohort four years after the completion of the baseline examination.
1,"A placebo-controlled double blind, randomised clinical trial (RCT) using a parallel arm design (Figure 1)."
0,"Clinical measurements includes: Neurological assessment: sensibility, motor function, reflexes, Spurling’s test, neuro-dynamic tests; Active range of motion of the neck in three planes [25] and cervical kinaesthesia (the ability to reproduce the neutral head position from 30° cervical rotation with the eyes closed) [26] as measured with a plastic helmet known as a “cervical range of motion device” [27]; Anterior and posterior neck muscle endurance in seconds in a supine and prone position [28]; Isometric hand grip strength as measured with the Jamar Hand Dynamometer [29]; Static and dynamic clinical balance: static clinical balance as assessed with the Sharpened Romberg test, with eyes closed and the non-dominant foot in front of the dominant foot [30]; dynamic clinical balance as assessed by the patient walking in a figure eight [31]."
1,Figure 1 Trial flow diagram.
0,"For example, if a user is stationary for 50 minutes, MyBehavior will generate a “stationary” activity entry into the life log with a 50-minute duration."
3,"Eligible patients were male or female between 18 to 80 years of age who had been receiving a normal dose of a statin (atorvastatin 20 mg/d, rosuvastatin 10 mg/d, simvastatin 40 mg/d, pravastatin 40 mg/d, pitavastatin 4 mg/d, fluvastatin 80 mg/d, or lovastatin 40 mg/d) for the control of LDL-C levels for at least 8 weeks before screening and had a fasting TG level at 2.3-7.0 mmol/L."
0,"For evaluation of in vivo leishmanicidal activity of CP2, female BALB/c mice (20 to 25 g; 4 weeks old; CEMIB, UNICAMP) were subcutaneously inoculated at the right hind-footpad with 107 infective promastigotes of L. amazonensis in 10 μl of PBS (early stationary phase of growth)."
3,"Main exclusion criteria included hepatic dysfunction with elevations of alanine aminotransferase (SGPT) or aspartate aminotransferase (SGOT) >2 times the upper limit of normal (ULN); renal impairment as defined by serum creatinine ≥179 μmol/l; unexplained serum creatine phosphokinase (CPK) >2 times ULN; poorly controlled hypertension (resting systolic blood pressure ≥ 180 mmHg and/or diastolic blood pressure ≥ 110 mmHg at 2 consecutive visits); pregnancy; breast-feeding; women of childbearing potential not using chemical or mechanical contraception; history of alcohol or drug dependence; history of an acute coronary syndrome within 6 month of screening; uncontrolled diabetes; hypothyroidism; New York Heart Association class IIIb or IV heart failure or with a left ventricular ejection fraction known to be <30%; history of receiving therapies with other non-statin lipid-modifying drugs (e.g. fibrates, niacin, or fish oils) within 2 months; or history of adverse events associated with test agents."
0,"Long working hours, a stressful urban lifestyle, and a cultural tradition that does not emphasize the importance of direct acknowledgment and active engagement with family members posed barriers for positive intra-familial relationships (29)."
16,Specific statistical methods used are noted in each Figure Legend.
0,This was repeated until pain was felt in the calf musculature.
16,"qRT-PCR fold change was calculated as; , when this quotient was <1, the negative of the reciprocal value was calculated as described [23]."
0,A thematic framework was developed by reviewing the notes developed during the familiarization process and identifying key themes and subthemes to create a hierarchical framework.
3,"Patients 18 years or older with confirmed advanced solid tumors were eligible if they had progressed after standard therapy, or if no standard therapy was available for them; had Eastern Cooperative Oncology Group performance status ≤1; surgery or chemotherapy within the previous 4 weeks; ≤3 prior lines of cytotoxic therapies (arms 1 and 2 only); residual toxicity from prior treatment grade ≤1; adequate bone marrow, renal, and hepatic function; and fasting serum glucose ≤1.1× the upper limit of normal and hemoglobin A1c (HbA1c) ≤8%."
0,"Furthermore, to increase the stability of the baseline measurement, tinnitus specific assessments (THI and TQ) will be performed three times (at the baseline visit and two times during the baseline week before the first treatment session), and the average over three measurements will be used as baseline value."
3,"Patients were excluded if they were diabetic and on antidiabetic therapy, pregnant or breastfeeding, receiving oral corticosteroids, had any condition(s) that would impede drug ingestion or absorption, or had other significant coexisting medical conditions."
0,Glucose metabolism was observed before treatment start and compared with profiles after combined treatment.
3,These are shown in table 2.
0,"Availability of at least one pre-operative imaging by CT, MRI, and/or PET-scan was required."
3,"Table 2 Inclusion and exclusion criteria In addition, 20 asymptomatic controls without known cardiac disease will undergo baseline assessment to allow determination of age and sex-matched normal ranges for MPR, diffuse myocardial fibrosis and exercise capacity."
0,"The SPOC questionnaire is a validated self-administered, 27-item questionnaire that measures patient's illness beliefs."
4,"Approximately 200 participants were recruited at each field center, using newspaper, radio, and television advertisements and direct mailings to age‐eligible residents living in the community."
0,"During sedation, the patients were monitored with five-lead electrocardiogram, pulse oximetry, invasive blood pressure measurement, and central venous pressure measurement."
4,"Participants were also recruited from health fairs, senior centers, medical clinics, and churches."
0,"The remaining load (0.25) was considered to include absence from work due to vacation, sickness, participation in seminars and educational courses, and others."
5,"Patients received gefitinib (250 mg day−1 orally) administered continuously until objective disease progression, intolerable toxicity or discontinuation from the study for another reason."
0,"With the peak and plateau pressures measured during inspiratory hold, RAW was calculated as the difference between these pressures, divided by inspiratory flow."
5,"Upon disease progression, patients were offered subsequent anti-cancer treatment at their physician's discretion."
0,The intensity of strengthening exercises aimed to be 12 repetitions maximum (RM).
3,AMPLE trial design and patient eligibility criteria have been previously described.19
0,"The primary outcome measured in GIHU004 was the occurrence of at least one grade 3 or higher adverse event including signs/symptoms, laboratory toxicities and clinical events possibly, probably or definitely related to study treatment as judged by the Principal Investigator or the site investigators during the 28 days after DermaVir administration."
3,"Patients met the 1987 American Rheumatism Association (ARA) criteria for RA, had active disease for ≤5 years despite MTX therapy and were naive to biologic therapy.20"
0,Grade refers to the severity of the AE: grade 1: mild AE; grade 2: moderate AE; grade 3: severe AE; grade 4: life-threatening or disabling AE; grade 5: death related to AE.
1,"SMARTER is a prospective, randomized, open-label, blinded-endpoint (PROBE) trial comparing two strategies to increase physical activity among overweight/obese adults followed for DM2 and/or hypertension."
0,"Rescue therapy initiated will be determined by the investigator as clinically appropriate, either up titration of current anti-hyperglycaemic agents (AHA) or the stepwise addition of non-insulin AHA(s) and then insulin therapies."
1,Allocation is concealed with an intervention to allocation ratio of 1:1.
0,"The gross tumor volume (GTV) was defined as gross tumor on CT, MRI and/or PET."
1,"Between September 2009 and February 2011, a randomized, controlled, parallel-group trial was performed at Linkoping University Hospital (Linkoping, Sweden)."
0,"However, patients with prior biologic anti‐TNF therapy for ≥8 (etanercept, adalimumab, golimumab, certolizumab pegol) or ≥14 (infliximab) continuous weeks (or shorter duration if patient was intolerant of anti‐TNF therapies) were eligible for enrollment in the PSUMMIT 2 trial."
1,"The study was approved by the regional ethical committee of Linköping University, diary number M10-80."
0,Approval for the research was granted by UBC-Providence Health Care Research ethics board.
3,"Patients with age of at least 4 years, confirmed HIV-negative, parasitologically-confirmed non-severe VL, were enrolled in three centres: (1) Gondar University Hospital, Amhara Regional State, Northern Ethiopia; (2) Arba Minch Hospital, Gamo Gofa Zone, Southern Nations, Nationalities and Peoples Regional State, Southern Ethiopia; and per protocol amendment (3) Ministry of Health Hospital, Kassab, Gedaref State, Eastern Sudan from May 2009 to September 2010."
0,"Immediately before the discontinuation of remifentanil, all patients received 1 mcg/kg of fentanyl."
3,"Exclusion criteria were signs/symptoms of severe VL (patients who were very weak, unable to walk, bleeding, jaundiced, suffering from sepsis and other concomitant infections/illnesses); anti-leishmanial or unlicensed investigational treatments within six months; underlying chronic disease such as severe cardiac, pulmonary, renal, or hepatic impairment; serum creatinine outside the normal range; liver function tests more than 3 times the normal range; platelet count less than 40,000/mm3; known alcohol abuse; pregnancy or lactation; concomitant acute drug usage for malaria and bacterial infection; pneumonia within last 7 days; known hypersensitivity to AmBisome® or amphotericin B; any other condition which may invalidate the trial."
0,"Patients aged ⩾18 and ⩽65 yr, with a primary diagnosis of recurrent MDD according to DSM IV-TR criteria, a current MDE ⩾3 months’ duration (confirmed using the Mini International Neuropsychiatric Interview (Lecrubier et al., 1997)) and a Montgomery-Åsberg Depression Rating Scale (MADRS) total score ⩾26 at screening and baseline visits were eligible for inclusion in the study."
3,"Patients recruited to the DRAGON study were treatment-naïve, chronically infected with genotype 1 HCV, aged 20–70 years and had plasma levels of HCV RNA ≥5.0 log10 IU/mL at screening."
0,"Those who, in addition, fulfill the following criteria will be invited to participate in the outcome evaluation of the trial: resident in Goa for the subsequent 12 months; speak one of the three primary study languages (Konkani, Marathi, English); and do not suffer from a serious impairment (hearing, speech, cognition) which interferes with participation in an interview."
3,"Key exclusion criteria included: (1) presence of liver cirrhosis or hepatic failure, or other liver disease, (2) infection/co-infection with HIV-1, HIV-2, hepatitis B or nongenotype 1 HCV, (3) malignant tumor within 5 years prior to study, (4) HCC, (5) meeting conditions that required caution with PegIFNα-2a or RBV treatment, (6) any clinically significant disease, (7) organ transplant, and (8) defined laboratory abnormalities during screening."
0,"The study took place in two of the most endemic provinces, Bandundu and Kasai Oriental, at five HAT treatment facilities operated by the national HAT control program (Programme National de Lutte contre la Trypanosomiase Humaine Africaine, PNLTHA): Bandundu, Dipumba, Katanda, Kwamouth and Ngandajika and one treatment facility operated by the BDOM/KIKWIT (Bureau Diocesain d'Oeuvres Médicales) and supervised by the PNLTHA: General Hospital of Yasa Bonga."
1,"CTA-HF is a multicenter, multinational, randomized controlled trial that is currently recruiting 250 patients from 15 sites across Canada and Finland (see Additional file 1) over 4 years, randomized to CTA versus ICA (n = 125 per group) as the first test to define coronary anatomy in patients with heart failure."
0,Participants will be instructed to perform the test for as long as possible to ensure a true maximal attempt.
1,This research study has approval from each participating center’s institutional research ethics board.
0,This cluster randomised control trial is registered with ClinicalTrials.gov (NCT00996528).
4,"The SWPBIS project will be implemented in six K–8 public schools in North Philadelphia, PA, a low-income area that has the second highest level of food insecurity in the country [83]."
0,"This component will focus on working with ministry of health officials and hospital administrators in improving health system management, especially since integration of appropriate referrals between the health clinics and the hospitals will be a component of ultrasound training."
4,"The ethnic makeup of students is approximately 60% Latino, 30% African American, 10% other minority."
0,"The trajectories of 19 markers were then placed on anatomical landmarks, including both anterior superior iliac spines (ASISs), the sacrum and the lower extremities."
3,"All patients had a diagnosis of schizophrenia or schizoaffective disorder, as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) or Fourth Edition, Text Revision (DSM-IV-TR), were between the ages of 18 and 75, and had at least 1 olanzapine LAI injection [13]."
0,"During phase I (months 1 to 6), participants randomized to the intervention attended weekly on‐site group meetings at an exercise center, during which group support and self‐regulatory skill instruction were employed to help participants adhere to home‐based walking exercise."
3,"Exclusion criteria included significant suicidal or homicidal risk; pregnancy or breastfeeding; acute, serious, or unstable medical conditions; or substance dependency (except nicotine or caffeine) within the past month."
0,"We follow the SCORE working group's definition of a 10-year cardiovascular mortality < 5% for ""low"" risk, and ≥ 5% for ""high"" risk in patients with no history of cardiovascular disease, corresponding with the 20% dividing line commonly used in cardiovascular morbidity tables [19]."
14,"All study investigators, biostatistician, data collectors (study interviewers and medical assistants who measure weight and blood pressure at the medical facilities), health care providers, and RPSC staff are blinded as to group assignment."
0,All the tympanograms were evaluated by two study physicians (ML and AR) who were blinded to the results of the otoscopic examination.
14,Treatment group assignment is only known by the programmer of the study database.
0,"We categorized LVH by ECG using a binary (yes/no) variable by one or both of the following15: (i) sum of the R wave in lead aVL and depth of the S wave in lead V3 > 2.0 mV in women and >2.4 mV in men and (ii) strain pattern in at least one of the following leads: I, II, aVL, or V4–V6."
16,The primary efficacy analysis of PFS by local investigator assessment required 528 PFS events to achieve 90% power to detect an HR of 0.74 (26% risk reduction) using a log-rank test and 2-look Lan-DeMets group [18] sequential design with O’Brien–Fleming-type boundary at a one-sided cumulative 2.5% significance level; one interim analysis was conducted after observing 60% of events (previously reported) [16].
0,Eligibility screening occurred by telephone followed by face-to-face interviews.
16,"Based on the magnitude and stability of the EVE treatment effect over time, as well as lower-than-expected event rates, final analysis after slightly fewer events than planned (i.e., 510 events) was considered appropriate."
0,"The postpartum version of FOBS is worded as “How do you feel right now when thinking about giving birth again,” with the anchor words calm or worried and no fear or strong fear."
8,"Five hundred participants in each group (1,000 total) will be required to have an approximate 90% probability of detecting as significant (at the two-sided 5% level) a 0.3% difference between the ISM and AC group in the mean HbA1c change at visit 5 compared to baseline, with an assumed standard deviation of 1.25% and a loss to follow-up of 25%."
0,Fig. 1 Study Design.
8,"This sample size will also provide 85% power to show an 11% difference between the two groups in percentage of subjects reaching or maintaining the risk target (LBGI ≤2.5 and HBGI ≤5), considering 50% of subjects arriving to target in the standard group."
0,Results are provided to the mother for all clinical samples collected.
8,"Based on the primary outcome of decisional conflict [23], to detect an effect size of 0.5 [17] with a minimum power of 0.80 for a 2-sided significance level of 0.05 and independent sampling, the target sample size required was 402 parents (134 parents per arm) from 42 clusters to achieve 360 parents (120 per arm) completing the study."
0,"Twenty children were not included in the crossover because recurrent BTX was not indicated (n = 14) or due to their request (clown, n = 2; standard, n = 4)."
8,This estimate took into account 10% attrition and clustering effects within GP practices of a sample size inflation factor of 1.9 using an ICC of 0.1 and an estimated 10 parents per cluster [19].
0,Parents were contacted and gave additional written informed consent for the completion of questionnaires.
16,"Differences in participants’ demographic characteristics and baseline decisional conflict score across the three trial arms were assessed using one-way ANOVA (age of parent, age of child, decisional conflict) and chi squared analysis (relationship to child, ethnicity, marital status, education, employment)."
0,The first author will conduct and record all interviews.
1,"This study was a randomized, open-label, multi-dose, two-arm, cross-over trial, conducted in Vietnamese patients with HIV-associated tuberculosis - Clinical trial registry number: NCT00651066."
0,"Each individual was assessed using a battery of tests eight times during the first year of stroke, at 3, 10 days, 3, 4, and 6 weeks, and 3, 6, and 12 months after the onset of stroke (36)."
8,"Based on the area under the curve (AUC0-24) for rifabutin determined in previous studies [19], it was estimated that a sample size of 12 participants had a power of 80% to detect a 20% relative change between the geometric means of the AUC0-24 for the participants taking rifabutin without antiretroviral therapy and the AUC0-24 for the participants taking rifabutin when combined with antiretroviral therapy."
0,"During the 2 week recruitment period, a research nurse worked full-time at the PHCC to facilitate patient recruitment, collect patient data, and support PHCC staff."
8,"To provide a target of 12 evaluable patients in each arm, because patients with low CD4 cell counts recruited into the study might experience high mortality and morbidity resulting in a high attrition rate, it was decided that 32 patients should be enrolled (16 in each arm)."
0,"The protocol of this study, including a priori hypotheses and criteria, is described in detail in a previous publication [31]."
6,The primary composite outcome measure was the change in the numbers of all reminders triggered in the target population over 12 months of individual follow-up.
0,"After administration of the MSCs or placebo at day 0, patients were assessed daily at days 1, 3, 5, 7, 14, and 28 (or until hospital discharge or death, whichever occurred first)."
6,"As secondary outcome measures, we explored the changes also after three and six months of follow-up."
0,All patients had measurable disease refractory to standard or investigational treatments.
1,"This post hoc analysis evaluated data from the previously reported 12-week multicenter, randomized, double-blind, parallel-arm ZETELD study (ClinicalTrials.gov identifier NCT00418834; protocol number 112) [9]."
0,"All antibodies were purchased from BD Biosciences, San Jose, CA (PerCP-CD45, Clone 2D1; Pacific Blue-CD3, Clone UCHT1; PE-Cy7-CD4, Clone SK3; APC-H7-CD8, Clone SK1; FITC-CD69, Clone FN50 APC-CD195 (CCR5), Clone 2D7/CCR5 and PE-CD38, Clone HB7) and titrated under assay conditions to determine an optimum saturating dilution."
1,"The investigational review boards of each participating study site reviewed and approved the protocol and amendments, and all subjects provided written informed consent prior to performance of any study procedure."
0,"The capillary density, defined as the number of perfused capillaries per mm2 of skin area, was assessed by high-resolution intra-vital color microscopy (Moritex, Cambridge, UK) using a video microscopy system with an epi-illuminated fiber optic microscope containing a 100-W mercury vapor lamp light source and an M200 objective with a final magnification of 200×."
6,"Endpoints to evaluate the pharmacologic activity of CLP included stool weight, fecal content of sodium, potassium, calcium, magnesium and phosphorus, and urine content of sodium, potassium, calcium, magnesium and phosphorus."
0,The modelling was performed in Stata using the ‘xriml’ macro Stata module [77] with a cubic spline.
6,"Safety and tolerability evaluations were based on frequency and severity of adverse events, clinical safety labs and vital signs."
0,Assessment and treatment visits.
3,Subjects could be included only if they satisfied the following inclusion criteria: (1) 18 years of age or older; (2) diagnosis of MDD with HAM-D 17 ≥ 17; and (3) on a stable dose of the existing medication or no medication for 1 month or longer prior to the study.
0,Cronbach’s α for this score was 0.87 (18).
3,"Subjects were excluded from study participation if any of the following exclusion criteria applied: (1) Diagnosed with another primary Axis I illness; (2) recent history of or current substance abuse; (3) clinically significant medical illness, including any thyroid disorders; or (4) known pregnancy and/or lactation, or intent to become pregnant during the study."
0,"These exercises were designed to increase heart rate, strength and flexibility by engaging all major muscle groups, although heart rate was not routinely monitored."
16,"The quantitative data from the registration and evaluation forms were analysed with descriptive statistics using SPSS, version 20."
0,"We also estimated the mean expenditure in the last month across all households, including those who spent nothing."
16,"Qualitative data, resulting from the open questions on the evaluation forms and the interviews with the nurses, was classified into categories based on the contents of the answers."
0,"Army Human Subjects Research Review Board, Office of the Surgeon General, the U.S."
8,"The sample size was powered to detect a two day mean delay in patency in the immunized group compared with the infectivity controls (80% power, α = 0.05, one-sided).31"
0,Serum samples diluted 1/200 in PBS-T-10% NGS were added in duplicate and incubated for 2 h at room temperature.
8,"We are seeking to detect a mean KASQ improvement two scores (8%) in the intervention arm and have estimated that with a power of 80% and significance level of p < 0.05, allowing for 15% attrition, deduced from previous studies, 144 participants will be required."
0,"Concentrations of norepinephrine (NE), epinephrine (EPI), and dihydroxyphenylglycine (DHPG) were measured by batch alumina extraction followed by high‐performance liquid chromatography for separation with electrochemical detection and quantification.11"
6,The primary study outcome measure was change in HbA1c from randomization to 12 months of follow-up.
0,"We also will ask whether eating habits in the past month were typical, the proportion of meals prepared and/or eaten together, and who completed the FVS and BSQ2 for the child."
6,"Secondary outcome measures included BMI and blood pressure, along with several self-management behavioral measures (e.g., foot care) from randomization to 12 months of follow-up."
0,"All TMA samples were tested at the US Naval Medical Research Unit-6 Bacteriology Laboratory in Callao, Peru, and HIV and syphilis testing were conducted at the Impacta laboratory."
1,"This was a prospective, multicentre, randomised, double blind, placebo controlled, parallel group trial of 3 years’ duration."
0,"Since the breathing mask is only loosely fitting, ambient air would have enough access to prevent suffocation."
1,"The study protocol was approved by the ethics review board of the Pitié-Salpêtrière Hospital (Paris, France)."
0,Ability to travel to clinic (i.e. individuals able to travel outside their home) 4.
3,Study participants are adults between 18 and 75 years old with a diagnosis of type 2 diabetes taking glycaemia lowering oral and/or injectable medications.
0,"The study endpoints were postoperative nausea and vomiting, and pain measured by the VAS and the need for additional analgesic and antiemetic drugs."
3,"Exclusion criteria are people on corticoid therapy and/or with a debilitating coexisting medical condition such as dialysis, mental illness, cancer; residents of long term care facilities; pregnant women; and people incapable of telephone communication in Dutch."
0,Informed consent was obtained from the patients or substitute decision-makers if patients did not have capacity to consent.
1,"Pilot randomised controlled trial (RCT) with economic evaluation comparing peer support in addition to care as usual with usual care alone following discharge, with follow-up at one month and three months post-discharge."
0,"We will consider parametric GLMMs for continuous, binary and count outcome data."
3,Diagnosed mental illness; approaching discharge/extended leave; age 18–65.
0,The study group consisted of seven patients with type 1 diabetes attending the National Center for Childhood Diabetes of Schneider Children's Medical Center of Israel.
3,Considered a serious risk to others; alcohol or drug dependent or primary diagnosis of substance use; serious personality disorder; pregnant or caring for children.
0,A household census was conducted at baseline and endline to create a list of pregnant women and mothers with infants <6 mo of age.
1,The study is designed as a prospective randomized controlled trial.
0,Screening of possible participants was performed by a formalized telephone interview.
6,"Neck pain intensity, arm pain, headache, and dizziness, all measured with a Visual Analogue Scale (VAS) (0–100 mm) [34,38]; Pain distribution, measured on a drawing, where the patient indicates symptom locations [39]; Self-efficacy in daily activities, measured with the Self-efficacy Scale [40]; Symptom satisfaction, related to neck problems (how would the patient feel about experiencing the current neck symptoms for the rest of his/her life), rated on a seven-grade scale [41]; Psychological and psycho-somatic distress, measured with the Distress and Risk Assessment Method (DRAM) [42]; Coping strategies, measured with the Coping Strategies Questionnaire (CSQ) [43]; Work capability, measured with the Work Ability Index (WAI) [44]; Sick-leave, measured as the number of days off work; Health related quality of life, assessed with the EuroQol five dimensions self-report (EQ-5D) and Current health status, measured with the EuroQol vertical VAS (0–100 mm) [45]; Impact on social relationships, measured with the West Haven Multidimensional Pain Inventory, Swedish version (MPI-S), the MPI-S for impact on significant others, and open questions [46]."
0,"In addition to the eligibility criteria above, the study also aimed to ensure that at least 40% of participants at each site were of each gender."
8,"This was a pilot study, with sample size being resource-driven in terms of available participants in a reasonable time-frame, for which no formal statistically based sample size estimate was applicable."
0,"Participating health facilities with labour wards included Modilon General Hospital, Yagaum Hospital, and the health centres in Alexishafen and Mugil."
8,A minimum of 21 participants from two recruitment sites was deemed appropriate to compare the devices and to measure recruitment rates for each site.
0,"Participants recorded the occurrence of intrusive traumatic memories in daily life by putting ticks in a box for the relevant day in which the intrusive traumatic memory occurred, or marked “zero” if they experienced no intrusive memories in that day."
3,"Patients are excluded from the virtual ward admission if they refuse to provide consent, or are unable to participate (e.g. language barrier)."
0,County hospitals were located at a median distance of 27 km (Guangdong: Range 3–63 km; Yunnan: Range 4–113 km) from the children’s township of residence.
3,Patients with symptomatic persistent AF7 (>7 or <7 days requiring electrical or pharmacological cardioversion) refractory to at least one class I or class III antiarrhythmic drug were recruited.
0,As functional parameter of cerebrovascular microcirculation we aim to measure in parts of the cohort the neurocognitive status by Montreal Cognitive Assessment (MoCA) and Clinical Dementia Rating (CDR).
8,"The study was powered for adherence and depression outcomes according to our initial work in HIV (17), which had effect sizes in excess of 1.0 for these outcomes."
0,"At 30 hours after transfection, cells were lysed and the luciferase activities were measured and normalized against Renilla luciferase using the Dual-Luciferase Reporter Assay System (Promega, Madison, WI, USA)."
8,"The recruitment goal was 100 completers, which would have allowed for an excess of 95% power to detect an effect size of 1.0 for adherence and depression with a general linear model (GLM) ANOVA approach for the posttreatment effect."
0,The system uses pneumatic finger probes which assess digital volume changes accompanying pulse waves.
3,"Eligible subjects were male, aged 30 to 65 years, and characterized by a metabolic syndrome when meeting all of the following criteria [11]: increased waist circumference (Indian descent ≥90 cm, Western European descent ≥102 cm), blood pressure ≥130/85 mmHg or use of antihypertensive drugs, fasting glucose >5.5 mmol/l–11.0 mmol/l and fasting insulin level ≥10 mU/mL."
0,Post-operatively subjects went to the first stage post anesthetic care unit (PACU 1) until they met discharge criteria.
3,"Subjects were considered not eligible in case of history of somatic illness, including neoplasm, endocrine or neurologic disorders, active infection, unstable weight 3 months prior to inclusion or recent surgical procedure within 3 months of the study initiation; respectively systolic and diastolic blood pressure of ≥160 mmhg or ≥100 mmHg, impaired kidney function (eGFR <60 mL/min/1.73 m2 as evaluated by MDRD method) or impaired liver function (ALT or AST >3×ULN) at screening."
0,"Regarding the procedures in the CT group, all the dentists will receive explanations about the preparation of the cavity according to partial caries removal philosophy and also about the manufactures’ specifications of the materials used."
4,"The study will be conducted in three cardiac rehabilitation facilities in three NHS Boards across the UK: NHS Highland, Highland Heartbeat Centre, Raigmore Hospital; NHS Wales, University Hospital of Wales and Maindy Sports Centre, Cardiff; NHS Forth Valley, NHS Hub at the Peak sports and leisure complex, Stirling."
0,"In comparison with usual care, is the AIMS-intervention preferable in terms of costs and utilities during the remaining life expectancy of the study population?"
1,This pilot study was an assessor-blinded randomised controlled trial.
0,They are constructed referring to the ACC/AHA statements on AF performance measures19–21 integrating recommendations from the most updated ACC/AHA guideline and Chinese statement for AF.7 22
1,"As a pilot study, the sample size of patients was fixed at 45 patients based on practical considerations and all patients who consented to participate in this study were enrolled."
0,"IVUS imaging was performed with a 20 MHz 2.9 F, phased-array IVUS catheter (Eagle Eye; Volcano Therapeutics, Rancho Cordova, CA, USA) after administering intracoronary nitroglycerin (200 mg)."
3,"Healthy males and females from 10 to 25 years of age, inclusive, were eligible to participate in the study."
0,"Briefly, aliquots (100 µL) were transferred to BAN50-coated (specific for the N-terminal portion of human Aβ1-16) 96 well microplates and incubated overnight at 4°C."
3,"Individuals were excluded from participation for the following reasons: if they had used any other investigational drug or vaccine within the previous 30 days; if they were receiving immunosuppressive medication or had an immunocompromising condition; if they had previously received a meningococcal vaccine or had a history of meningococcal infection; if they had received tetanus toxoid containing vaccine within the previous month; if they had an allergy to any of the vaccine components; if they had received immunoglobulin or blood products within the 3 previous months or planned administration during the study period; if they were female and pregnant, planning to become pregnant, lactating, or unwilling to use effective contraceptive during the study; if they had a bleeding disorder; if they had a serious chronic infection or congenital defect; if they had any neurological disorder; or if they had an acute illness at the time of enrollment."
0,"We will use the mean of available measures in the 12 month period after intervention completion for SBP, LDL, A1c, and FRS."
3,"Study inclusion criteria were men and women 18–50 years of age, without evidence of active TB, positive tuberculin skin test (TST+) [≥5 mm induration] and Quantiferon TB Gold positive result."
0,"Briefly, the baseline and post-endotoxin PET and CT scans were coregistered."
3,"Additional inclusion criteria in the HIV-positive group were: HIV antibody positive, CD4 count ≥350 cells/mL and clinically stable subjects if on anti-retroviral treatment."
0,"While all intervention participants attended study visits for counseling, reimbursement data were available for only 238 out of the estimated 504 visits because participants did not submit invoices for reimbursement of visit co-pays."
14,"Within the DREAM trial, it will not be possible to blind dentists, study personnel, and statisticians."
0,We also educated patients concerning the symptoms of CRBD.
6,"Primary outcome is the overall antibiotic prescribing rate of the intervention group and the control group measured at T1, thus measured in the interval between months one to six after intervention."
0,These were all retained in the study cohort.
6,A number of secondary outcomes will be analyzed for the subgroup of patients suffering from odontogenic infections (see below).
0,"The second call of the weight management intervention (call 2 for simultaneous, call 8 for sequential) was delivered by an RD and covered topics on calorie reduction strategies and the rationale for why and how to reduce caloric intake."
1,A two-arm prospective RCT was conducted.
0,"Also travel time to therapy or outpatient clinic and related costs will be considered, on the basis of 2 months recall."
1,"Study approval was received from The Ottawa Hospital Research Ethics Board (# 2006724-01H) and the trial was registered (ClinicalTrials.gov, NCT00743951)."
0,The use of routine data meant that it was necessary to exclude a small number of participants.
3,Eligible knee osteoarthritis patients were those with access to a television with a VCR or DVD player.
0,"Conventional size–based radiological criteria using RECIST may not be the optimal method of assessing response to chemotherapy, especially with a regimen integrating bevacizumab) [37, 38]."
3,"Those with inflammatory arthritis, previous TJA, uncorrected hearing or visual impairment, or unable to read, or understand English, were excluded."
0,"In patients for whom prophylaxis was recommended but with contraindication to antithrombotic treatment, a mechanical prophylaxis method was recommended, namely by means of compression stockings or intermittent pneumatic compression devices."
1,For participating centres see the UPBEAT trial website: http://www.medscinet.net/upbeat/.
0,Costs were recalculated to year 2012 prices using the Swedish consumer price index [17].
6,"The primary outcome is expressed as the percentage ScO2 change from baseline, with baseline defined as rest prior to spinal anesthesia (time 0 min)."
0,"Norway has a fully publicly funded health system, and these data should therefore cover any hospital admission, and any use of nursing home and home health care."
6,The secondary outcomes variables (maternal hemodynamics and fetal heart rate) were also expressed as the change from baseline and all observations were continued until the end of surgery.
0,"Based on this assessment the officers assigned the beneficiaries into three categories: Category 1 included individuals who were likely to RTW within three months; category 2 included individuals who were unlikely to RTW within three months, but who were able to participate in activities that may facilitate RTW."
3,"The study will be limited to nulliparous and multiparous women during the first stage of labour with a cervical dilatation between 2 to 9 cm, a singleton pregnancy at term (≥ 37 weeks’ gestation), and an OP position diagnosed by ultrasound."
0,"Participants (mean age = 40.6) were mostly (93 %) first generation, and generally low income with 69 % reporting an annual household income below $30,000."
3,"Women under 18 years old, or who have a limited understanding of French, or who have attempted hands and knees’ positions previously during the first stage of labour."
0,"An additional benefit of C (θ) as a cost function is that it is convex and thus a global minimum will always exist, which can easily be determined with a gradient descent algorithm."
8,We calculated that a sample size of 438 women (219 per group) will be needed to obtain a power of 80% with a two-tailed significance of 0.05 to show a statistically significant difference in the incidence of the main outcome measure.
0,To monitor fidelity a random selection of 10% of the audio-recorded sessions were reviewed by the lead author and evaluated based on adherence to curriculum scripting and activities.
8,"We hypothesized that the difference between groups in the proportion of fetuses rotating in anterior position one hour after randomisation will be 10% (10% in the control group versus 20% in the intervention group), a difference that we consider to be clinically significant."
0,"If x+1<x, then the following day was classified as a decrease."
8,"This pilot study aimed to recruit 30 participants in total, 15 into each group."
0,The primary outcome was assessed by a relative risk combining the low-risk group and the medium-risk group and comparing these to the high-risk group in terms of good outcomes.
8,This number was based upon the recommendation that a pilot study for which there is no prior information upon which to base a sample size calculation should aim for 12 participants in each group [13].
0,Parents gave written informed consent for their infant to participate in the study.
3,"The inclusion criteria were severe TBI defined as Glasgow Coma Scale (GCS) score ≤8 at the time of sedation and intubation, age between 15 years and 70 years, arrival at Umeå University Hospital within 24 hours from the accident, and cerebral perfusion pressure (CPP) ≥10 mmHg at first measurement."
0,"The sphere diameters (D) were therefore converted into particle edge lengths (p) with the following equation:It was also assumed that only the cells through which the fracture plane passes were ruptured (i.e., the surface of ruptured cells created by fracturing the almond) and therefore released their contents, as observed previously (6)."
3,"Exclusion criteria were pregnant or lactating women, known bleeding diathesis, known allergy to epoprostenol, penetrating head trauma, or being discharged alive from the ICU within 72 hours."
0,The PETiT and SF-12 assessments were administered at baseline and at six weeks.
8,"As described previously [34], we aimed for a sample size of 74 participants in each arm of the trial, based on α = 0.05 and β = 0.20 and an inter-cluster correlation (ICC) = 0.03 to detect a difference of 10 (SD 15) mmHg in SBP between the study arms after 6 months."
0,We took a 1-point increase on the 10-point VNRS for pain as non-inferior for the gel compared to powder.
8,We assumed an ICC of 0.03 on the basis of previous experience and the literature [43].
0,Written informed maternal consent was obtained from all participants.
3,"The target population was school pupils leaving school for work, vocational training or with no definite plans for their future, according to their plans during their final term at school."
0,The research pharmacist held the numbered code list containing the identity of the solution used in each syringe until the study had officially ended and data analysis was completed.
3,"173 eligible men aged forty years and over with untreated ED (score < 22 on the IIEF-5 (International Index of Erectile Function)), and no other cardiovascular risk factors were randomised to receive 40 mg simvastatin or placebo once daily for six months."
0,"These variables were insurance status (insured vs. uninsured), preferred language (Spanish vs."
3,"Exclusions were based on participants’ medical and drug history and those considered by the GP to be unsuitable, such as significant CVD risk requiring statin treatment."
0,"Finally, for patients with available data, physicians compared the overall effect and onset of action of moxifloxacin against the antibiotic used to treat the previous episode of AECB."
16,The primary analysis of the data from this trial has been reported previously [6] using the original MED-QoL questionnaire [16].
0,The TS subjects were examined at baseline (Visit 1) and two subsequent follow-up visits (Visit 2 and 3) over a 10 year period using CMR and transthoracic echocardiography (for aortic valve morphology) [7].
1,Taking Healthy Steps is a randomized controlled clinical trial for Veterans with COPD across the U.S.
0,Participants were initially randomised to four equal sized treatment groups; one group received standard support and three received standard support plus combinations of two interventions.
1,"The coordinating center is located at the VA Center for Clinical Management Research in Ann Arbor, Michigan."
0,"Therefore, a ratio of “1” indicates typical development."
3,"We included adult patients (18 years+) admitted to the surgical department after stoma creation no matter whether the stoma was a colostomy or an ileostomy, irrespective of whether it was expected to be permanent or temporary, and regardless of reason for creation of the stoma."
0,"EPI coverage in the study area is relatively low: 55% of children receive all three doses of the diphtheria-tetanus toxoid-pertussis-hepatitis B-Haemophilus influenza type b vaccine (PENT) and oral polio vaccine (OPV), 48% receive the measles vaccine and only 38% receive all the essential vaccines in the programme [29]."
3,"Patients, who withdrew their consent to participate."
0,CD138 immunohistochemistry was performed using rat anti-mouse CD138 antibody and biotin goat anti-rat immunoglobulin (BD Pharmingen) with streptavidin-HRP and DAB staining.
16,All patients who signed informed consent and received at least one dose of GC1008 were included in the analysis of AEs and response.
0,"The evaluable patient set (EPS) comprised patients from the FAS who had a known 28-day cure status, i.e., those who completed the study at least until day 28, or were considered failures before day 28 for reasons other than premature withdrawal."
16,"Analyses included the proportion of patients achieving complete response (CR), partial response (PR) or SD, duration of response, and progression-free survival (PFS)."
0,"If these prove insufficient to lower CVP to a level < 5 cmH2O, the Trendelenburg position and administration of nitrocompounds may be used in addition."
3,"Eligibility requirements for the STC trial were intentionally broad and included age (18 years of age or older), completion of primary treatment at least four weeks prior, but not more than 5 years before joining the study, diagnosis with only one cancer and no recurrence, access to the Internet, and ability to read English."
0,Cell-free supernatants were used for p24 and HIV-1 RNA measurements.
1,"In this international, multicenter, double-blind study (NCT00863655), patients were randomized in a 2:1 ratio to EVE (10 mg/day) or matching PBO plus open-label EXE (25 mg/day)."
0,One hundred people from Primary Healthcare Centers in Málaga begun this research and seventy-five subjects completed the study.
1,"Randomization was stratified by documented sensitivity to previous hormonal therapy and the presence of visceral metastasis [3].The primary end point was PFS; secondary end points included objective response rate, overall survival, and safety."
0,"Concentration of α-tocopherol in serum was measured by High Performance Liquid Chromatography at the Research Centre for Diabetes, Duesseldorf, Germany."
1,"This was a phase III, double blind, randomised placebo controlled trial."
0,Antecubital veins at the elbow level were not allowed to be punctured due to the high risk of early dislodgment of the catheter during flexion/extension movements of the arm.
1,Details of the protocol are described elsewhere.34
0,On the exposed liver the needle electrodes (1.2 mm in diameter with 4 cm non-isolated tip length) were inserted into the metastasis under US guidance.
1,"Clinical trial, multicenter studies randomized, controlled, and randomized into two parallel groups."
0,Participants also recorded unsolicited adverse events and serious adverse events occurring within 21 days of vaccination.
8,"Accepting a 0.05 Alpha risk and a beta risk of 0.2 in a bilateral contrast, it is required to have 67 patients in the control group and 67 in the intervention group (total: 134), to detect a difference equal to or greater than 600 steps/day (1/2 SD) between the 2 groups."
0,"Three levels of participation existed: the unit of randomisation was the maternity unit, midwives were participants at the level of the intervention, and we measured trial outcomes for women receiving maternity care."
8,It is assumed that the common standard deviation is 1200 steps and it has estimated losses of a 5% follow-up rate.
0,The log2-ratio of the methylated to unmethylated intensities (M-value) was used for association testing [55].
6,Primary endpoint: Primary endpoint was the change in HbA1c after 24 months of treatment.
0,Oral and written consent from all participants was obtained.
6,"Secondary endpoints: Secondary endpoints were glycaemic control assessed by mean HbA1C and mean blood glucose profile; change in BMI-Z-score; change in FEV1% predicted and safety assessed by antibiotic therapy, incidence of adverse events, number of hypoglycaemic episodes, all symptomatic hypoglycaemia, hypoglycaemia that necessitates the help of other persons, hypoglycaemia with unconsciousness or coma and number of blood glucose levels below 50 mg/dl in relation to all blood glucose measurements."
0,"Men and women aged 50 to 80 years were recruited in 245 sites in the United Kingdom (UK), Scandinavia, and China and were eligible if they had a history of myocardial infarction, cerebrovascular disease (ischemic stroke or transient ischemic attack), peripheral arterial disease (intermittent claudication or noncoronary arterial surgery or angioplasty), or diabetes mellitus with other evidence of symptomatic coronary disease."
6,"The primary endpoint is the change in glucose tolerance from baseline (measured by AUC for the PG excursion following a 4 h 75 g OGTT) to follow-up at week 16 or to last observation, if study participation is stopped earlier."
0,Table 1 Summary of measures assessing potential maternal mediators Maternal knowledge of child feeding intervention messages
6,"Secondary endpoints include changes of dysglycaemia (IFG, IGT, combined IFG/IGT or diabetes), changes in body weight, waist circumference, blood pressure, secretion of incretin hormones, insulin sensitivity and β cell function, evaluated by homoeostatic model assessment, DEXA scan (body composition), lipid profile, liver function and measures of quality of life, daily functioning, severity of the psychiatric disease and alcohol consumption (in patients with alcohol consumption at baseline) from baseline to follow-up at week 16 or to last observation, if study participation is stopped earlier."
0,"The SUS was developed by Brooke (1996) as a system usability tool, which has been widely used in the evaluation of a range of systems (Brooke, 2013)."
6,"Primary outcomes included 1) Positive predictive value and false positive rates for initial positive surveillance test results or symptoms suggestive of possible recurrence, 2) subsequent resource use for patients with both true and false positives, and 3) whether curative resection of recurrent disease was possible."
0,"It included general range of motion (ROM) exercises that served for warm-up and cool down purposes, followed by 4 stretching/mobilization and 4 strengthening exercises (concentric and isometric contractions) of the cervical and upper thoracic spine, principally flexion/extension, lateral flexion and rotation of the cervical spine."
6,"Secondary outcomes included time from initial detection to confirmation of recurrence, number needed to test per curative resection of recurrence, and cost per curative resection of recurrence."
0,Intervention providers only are also surveyed about their impression of the ADAPT tool components.
1,In the first part of the study we compared patients with PM/DM with age- and gender-matched healthy controls.
0,Therefore the radio-therapy will be applied in 5 weeks.
1,The controlled part of the study was a hypothesis-driven randomized controlled trial evaluating effects of a supervised 12-week endurance exercise program compared to a non-interventional control group.
0,"Efficacy was evaluated in the full analysis set consisting of patients who received at least one dose of pralatrexate, had a post baseline efficacy assessment and met major eligibility criteria, including PTCL confirmed by central review."
6,The primary outcome was change in Disease Activity Score in 28 joints (DAS28) score (calculated as DAS28-CRP = 0.56 * sqrt(tender28) + 0.28 * sqrt(swollen28) + 0.70 * ln(CRP) + 0.014 * global health (GH) and DAS28-ESR = 0.56 * sqrt(tender28) + 0.28 * sqrt(swollen28) + 0.70 * ln(ESR) + 0.014 * GH).
0,"Cluster randomized controlled trials are more effective at preventing contamination, but more susceptible to biases than trials randomizing individual subjects [54, 55]."
6,"Other prespecified outcomes included individual components of the DAS28 score, including tender and swollen joint count, patient-reported GH based on 1- to 100-mm Visual Analogue Scale (VAS) rating and acute-phase reactants (CRP, ESR); level of inflammatory cytokines IL-6 and TNF-α; change in functional capacity determined using the modified Health Assessment Questionnaire (MHAQ) [32]; and change in insulin resistance determined by the homeostatic model assessment for insulin resistance (HOMA), calculated as (fasting glucose [in mmol/L] × fasting insulin [in μU/ml])/22.5 [33]."
0,"During the add-on intervention periods, the participants continued to attend traditional rehabilitation treatment including physical therapy, occupational therapy, and/or speech therapy."
16,"We calculated means, standard deviations and frequencies to describe the participants and experimental groups."
0,"Following the manufacturer’s instructions, fluorescent magnetic beads (R&D Systems, Minneapolis, MN) coated with IL-17 and IFN-γ antibodies were added to each sample."
16,"Inferential statistics include t-tests, analysis of variance, and Pearson chi-square analysis (2-tailed significance)."
0,"All care was delivered by GHESKIO clinic staff, and the same providers (physicians, nurses, social workers, pharmacists, and field workers) cared for both groups."
6,The following disease outcomes were assessed: (1) radiological damage - the onset of new erosions at 24 months and modified Larsen scores; (2) disease activity - disease activity scores on a 28-joint count (DAS28); (3) disability- Health Assessment Questionnaire (HAQ); (4) QoL- SF-36 physical (PCS) and mental (MCS) component summary scores and EuroQol.
0,"Heparin-plasma and urine samples, stored at −80°C before the assay, were used to assess inulin and PAH by colorimetric assay after preparation with p-dimethylamino-benzaldehyde for inulin [14] and trichloroacetic acid and indole-3-acetic acid for PAH [15]."
1,"STEAL was an open-label, prospective, randomized, non-inferiority study that compared simplification of current NRTIs to fixed-dose combination TDF-FTC or ABC-3TC over 96 weeks in 357 adults with plasma HIV viral load <50 copies/mL [17]."
0,"Children were also excluded if they were already receiving treatment for SAM from another center, if they had medical difficulties precluding normal feeding (for example, severe cerebral palsy), if they had known pre-existing renal disease, asthma, hypersensitivity to salicylates or if they were on medication known to interfere with the action of the study drug."
6,The outcome measures tested in the study are summarized in Table 3.
0,• A removal is a procedure where the entire original system configuration is removed with or without replacement.
8,The study will be powered on the primary outcome of mean SBP assessed at the individual level.
0,Texts of the SCP were based on pilot-tested patient education material from the Dutch Cancer Society.
8,"Based on a sample of 4,800 individuals in 120 clusters (townships/villages), an intra-cluster correlation coefficient (ICC) of 0.02 and a standard deviation for SBP of 15 mmHg, the study has 80% power (with two-sided alpha = 0.05) to detect a 1.6 mmHg net difference in pre-post change of SBP and 90% power to detect a 1.9 mmHg net difference in pre-post change of SBP between intervention and control arms."
0,"Safety end-points included incidence of adverse events, the percentage of patients who exceeded the haemoglobin threshold of ≥130 g/l, and the percentage of patients who withdrew from the study because of disease progression."
8,"To address the effectiveness of the Pac-Ifico Programme, a clustered sample size was estimated with an alpha error of 0.05 and a power of 80%, assuming an intraclass correlation coefficient (ICC) for the primary endpoint equal to 0.01."
0,Application of ALGEE (as described above) was measured by asking respondents to describe narratively what they would do to help the individuals in the vignettes.
8,"According to these assumptions we estimated that 10 hospital wards, with cluster size equal to 25 pre-intervention and 25 post-intervention patients corresponding to overall 500 patients, would be sufficient to detect an absolute decrease in the primary endpoint from 20% to 9%, corresponding to an odds ratio of 0.4."
0,Anonymous cohort polling precluded matched analyses.
6,The primary outcome was to assess the effects of vitamin D supplementation on differential gene expression as determined by microarray analysis of alveolar macrophage messenger RNA (mRNA).
0,Other data are registered in the SCRCR protocol.
6,"Gene expression was compared between placebo and treatment groups, as well as a paired analysis pre- and post-supplementation within the group treated with vitamin D."
0,"This is considered a minimal risk study, which includes state quitline services that are currently available to eligible callers, and adds a video-based intervention to two-thirds of the sample."
4,The variables will be assessed according to Table 1.
0,All participants provided written informed consent.
6,"Taking into account the recommendations of Barlow [57] and following analysis of the results of two recent meta-analyses [1,5], the following outcomes were defined (see Table 2)."
0,The other inclusion criteria were ≥20 % of total sleep time spent in the supine position during polysomnography (PSG) with MAD and unchanged body mass index (BMI ± 1 kg/m2) between diagnostic PSG and inclusion in the study.
1,"The study was a single-center, randomized, placebo-controlled, double blinded, trial."
0,The primary outcome of the study is SPT; the secondary outcome is symptoms (asthma and atopic dermatitis); while the tertiary outcome is immune responses (both IgE levels to allergens and cellular immune responses that represent both innate and adaptive immune reactivities).
1,After inclusion subjects were allocated to treatment via computer-generated randomization in blocks of ten and received 3000 IU (75 μg) cholecalciferol daily or placebo for 6 months.
0,"In order to accuratelylocalize bilateral BL33, a line is drawn between the two posterior superior iliac spines (PSIS) which cross over at point A of the spinal column."
4,"Patients were consecutively recruited from the Dialysis Department and Outpatients’ Clinic of Renal Diseases, Holstebro Hospital All patients in our dialysis department were screened for participation."
0,These three articles were thus excluded.
16,Statistical analyses were performed using R 3.01 with software package CMPRSK and SPSS software 19.0.
0,"Because an element of each intervention is classroom-based and results may reflect classroom-level processes, independent observers also assess the emotional climate of the classroom and teachers’ support of children’s self-regulation (fall and spring) via the Caregiver Interaction Scale [88] and the Supports for Social-Emotional Growth Assessment [89]."
8,"Based on 24–36 h in-patient pilot (10,12,28), we anticipated that overnight closed-loop insulin delivery could increase the percentage nighttime glucose was between 70 and 144 mg/dL by a mean 24% (SD 29%)."
0,Mothers were counseled on the risks and benefits of exclusive breastfeeding.
8,We calculated that 16 participants would provide 80% power at the 5% level of significance to detect such difference between sensor-augmented pump therapy and overnight closed-loop insulin delivery.
0,Data presented here are from patients enrolled at the NIH.
6,Overall survival will be measured from the date of surgery to the date of death or to the end of follow-up (5 years).
0,"MACE were defined as a composite of death, MI, unplanned revascularization, or stroke at 1 year."
6,"Efficacy (3-year and 5-year recurrence-free survivals) and localization of recurrence, morbidity, and quality of life."
0,"The following were considered acceptable indications for additional non-invasive testing with another modality: (i) Negative initial test, but high clinical suspicion of CAD; (ii) inconclusive initial test result; and (iii) positive initial test, but low clinical suspicion (suspected false positive)."
3,"The following criteria will exclude patients: prior malignant tumors with detectable signs of recurrence, gastric stump adenocarcinoma, presence of comorbidities, notably serious chronic diseases or organ failure, pregnancy or breastfeeding, contraindication to any drug contained in the chemotherapy regimen, life threatening toxicity before surgery, distant metastases (liver, lung."
0,"However, long-term Epo-treatment can induce epileptic seizures in medically ill patients with chronic renal failure and past history of seizures [49]."
3,"ovaries, etc.), tumoral infiltration of the head or body of the pancreas, patients presenting an adenocarcinoma of the cardia Siewert I or II, existence of any macroscopic peritoneal implants, patients with clinically significant ascites (> 500 cc) even if cytology is negative for cancer cells, in the absence of other non-malignant causes of ascites."
0,The presented data are anonymized and risk of identification is low.
4,Objective physiological as well as patient reported outcomes are collected at baseline and at the end of the intervention (6- 8 weeks).
0,"The follow up will take place in the primary care centre of the participant, with their own GP and nurse."
4,The guidance strategies will be given to construction companies.
0,"Abbreviations: DXA, dual x-ray absorptiometry; mt, months; oGTT, oral glucose tolerance test; pQCT, peripheral quantitative computed tomography; SCCR, Swiss Childhood Cancer Registry; T0a, initial baseline visit; T0b, second visit for baseline assessments; T3, assessment after 3 months; T6a and T6b, first and second visit of assessments after 6 months; T12a and T12b, first and second visit of assessments after 12 months Ethics"
4,Inclusion criteria of the construction companies are: 1) less than 50 employees (small and medium enterprises within the Dutch construction industry); 2) performing physically demanding work; and 3) having the potential to improve the use of ergonomic measures among their workers to reduce work demands/risks for work-related musculoskeletal disorders.
0,"At the three measurement points of the study, participants will complete questionnaires asking about sex, age, marital status, highest educational level, household income; their current, past and family history of hypertension, history of other chronic conditions and diseases, current pharmacological treatments, food intake, tobacco and alcohol consumption."
3,The research population includes all construction workers (i.e. blue collar workers) within the participating companies.
0,"Tetrabenazine data were collected from the published clinical trial results and from the FDA-approved prescribing information [3, 12]."
4,The study was conducted in an area around a middle-sized town in Northern Sweden.
0,This single item instrument asked participants to indicate how much their hearing-related quality of life changed in the past year.
4,The intervention was based at the hospital.
0,"The consent process for the families starts with a pre-enrollment information session conducted by a genetic counselor, which includes an overview of study logistics, basic genetics education, review of types of reportable results, and a discussion of risks and benefits."
16,"All results are presented as mean value ± SEM, unless specified."
0,"We further classified occurrences of either nausea or vomiting as significant adverse events (grade 3–4), or persistent (grade 1–2, leading to treatment discontinuation) and moderate events (grade 1–2, without treatment discontinuation)."
16,"Significance of difference between any two groups was determined by two-sided Student's t-test, and a final value of P < 0.05 was considered significant."
0,The 25-item Interpersonal Processes of Care (IPC) survey measured how patients’ perceived the quality of their relationship with their providers over the past 12 months.
16,"Data analysis used SPSS 16.0 (SPSS Inc, Chicago, IL, USA) and included (1) descriptive numbers and percentages of patients who received SWAP-DM2–assisted prevention and newly diagnosed prediabetes and diabetes; and (2) comparison, using chi-square tests for percentages or t tests for quantitative ratings, between the baseline and 6-month follow-up assessments in terms of improvements in delivery of essential prevention procedures, knowledge about diabetes, lifestyle management practices, body mass index (BMI), and blood pressure, etc; and (3) narratives of qualitative data."
0,"Measurements commenced at a distance of 5 m, with the 5.0 line optotypes of the chart and the eyes of the tested children approximately at equal height."
6,"Renal involvement at one year was defined as haematuria on microscopy greater than 5 red blood cells per high powered field, red cell casts, proteinuria greater than 0.3 g/l, hypertension greater than 90th percentile for age and gender [19], or renal insufficiency indicated by an elevation in serum creatinine."
0,"To design a group-sequential trial, we need to choose 3k−1 values (Vi,ℓi and ui, with the subscript for ℓ running only to k−1, since ℓk=uk), such that (3) and (4) are satisfied."
6,"Acute gastrointestinal complications were defined as gastrointestinal bleeding requiring transfusion or fluid resuscitation, intussusception, perforation or need for operative intervention."
0,"Table 1 Number of fractures, fracture incidences, and incidence rate ratios (IRR) per school year during the 8-year study period We registered objectively verified incident fractures through repeated evaluations of the regional computerised radiographic database that has records of all radiographs within the region."
3,"Eligibility criteria were age ⩾18 years, colorectal adenocarcinoma, inoperable metastatic or locoregional RECIST measurable disease, no previous chemotherapy for metastases, WHO performance status 0–2 and good organ function (Maughan and Meade, 2010)."
0,"Dimensionless NRI reflects the unweighted net movement of all patients regardless of final diagnosis (range, −2 to +2)."
3,Written informed consent for both molecular testing and randomisation was required.
0,Insulin was administered at a rate of 1 mU/kg/min i.v.
4,"Headmasters at the selected schools will be contacted by a research team member, who will provide details about the study and invite the school to participate."
0,Excess substrate was removed by rinsing with tap water.
4,"A nurse-led outpatient respiratory clinic in a large 600-bed general hospital in South West Wales, that serves an urban and rural population of around 600,000."
0,The primary analysis compared the difference in the mean total Ottawa Scale score between the PICOPREP TD and DBD regimens based on an analysis of covariance (ANCOVA) controlling for time of colonoscopy (AM/PM) and country.
14,"Due to the nature of the interventions, the intervention providers and participants cannot be masked in this study."
0,The organizational structure and resources of each participating primary care practice will be characterized at the beginning of the project to assist in the understanding and interpretation of implementation differences across the sites.
14,"However, the licensed dental professionals who perform the annual oral health screenings are blinded to group assignment."
0,"Temporary discontinuation of study drugs not exceeding 3 weeks is permitted for thrombocytopenia (platelet count less than 50 × 109/L), a bleeding event, or if the patient must undergo any invasive procedures."
16,Continuous variables are presented as mean ± standard deviation (SD).
0,It turned out to be so feasible that the KLASS group has continued to use it till now.
16,Categorical variables are presented as frequency and percentage.
0,"Inotropes were not used in patients with two or more of the following conditions: existing coronary heart disease or angina pectoris, presence of diabetes mellitus, impaired renal function, or stroke in the patient’s history (Kristensen et al. 2014)."
14,Professionals implementing the intervention are not blinded to the assignment group.
0,The present investigation was conducted as two separate trials for safety reasons.
14,"However, data extraction will be performed centrally by computer technicians not involved in the study and data will be treated by research personnel after anonymisation."
0,"The second-level analysis used these contrast images in a new GLM from which generated statistical images, that is, SPM t-maps across all subjects and between subject groups."
1,"The trial is a cluster-randomised controlled trial with three arms: Universal arm (with a universal offer to participate in Triple P - Positive Parenting Program, level 2); Universal Plus arm (with offer to participate in Triple P - Positive Parenting Program, level 2 as well as level 3, and level 4 group); and Services as Usual arm."
0,The F-specific IgG or IgA antibody titer was calculated for each serum sample using a simple linear regression using log10 transformed relative luminescence units and log3 transformed sample dilutions.
1,The trial runs from 2013 to 2017.
0,The effects of exercise on immunologic and inflammatory parameters and factors relevant for cancer prognosis and GvHD will be investigated and compared to the progressive muscle relaxation group.
5,"Four oils with different n-9: n-6: n-3 ratios were selected as the intervention; conventional canola oil (6:2:1), high oleic canola oil (31:6:1), DHA-enriched high oleic canola oil (6:1:1), and a flax oil and safflower oil blend (1:1:1)."
0,"After the study drug initiation, the use of any additional antihypertensive was discouraged during the first 30 min."
5,"The fatty acid composition varied noticeably among treatment oils (Table 2), allowing comparison of the effects of n-3 fatty acids, ALA and DHA, n-6 fatty acid, LA, and n-9 fatty acid, oleic acid."
0,"Microvascular dysfunction was defined as an abnormality in one or more parameters that reflect distinct properties of the microcirculation: increased microvascular resistance (IMR ≥25)), impaired coronary vasodilator reserve (CFR <2.0), and impaired microvascular vasodilator capacity (RRR <2.0) [7,13,23]."
5,"GPs could prescribe any treatment, including antibiotics and other drugs for the cough (e.g., cough mixture) and additional medication if deemed necessary."
0,Cell isolation was performed as described before [14].
5,"They were told that medication should be prescribed after the clinical examination (and after the CRP test in the intervention group), without waiting for chest radiography results."
0,Immunohistochemical staining will also be performed for blood vessels and capillaries as per standard methods.
3,Eligible patients were men and women ≥20 years of age with type 2 diabetes being treated with pioglitazone (15–45 mg/day) as monotherapy or in combination with other oral AHA.
0,"Four students were excluded based on baseline values suggestive of diabetes (three with FPG ≥126 mg/dL and one with A1C ≥6.5%), leaving a sample size of 3,980."
3,"Major exclusion criteria included: history of type 1 diabetes, recent treatment with insulin, the presence of progressive diabetes complications, unstable cardiovascular disease or uncontrolled severe hypertension, increased serum creatinine (>132.6 μmol/L in men or >114.9 μmol/L in women), increased alanine aminotransferase or aspartate aminotransferase >2‐fold the upper limit of normal, hemoglobin <110 g/L in men or <100 g/L in women, or body mass index (BMI) <18 or >40 kg/m2."
0,"These patients were recruited from the PREVENRIM, a CKD prevention clinic at the Interdisciplinary Nucleus of Studies, Research and Treatment in Nephrology (NIEPEN) of the Universidade Federal de Juiz de Fora, Brazil (UFJF)."
8,"Sample size was calculated to detect a clinically important difference of 3.5 points in mean change from baseline to six months in the primary outcome measure, severity of depressive symptoms."
0,"The primary outcome measure was physician-diagnosed asthma ever, obtained by a parent-reported questionnaire at age 6 years."
8,"Using a standard deviation of 9.0 as a conservative estimate, a sample size of 105 was estimated to be sufficient to address this primary outcome (two-tailed alpha = 0.05; beta = 0.20)."
0,Costs per day for each level of care in the Australian health care system in 2014 (Table 1) were supplied by the Royal Melbourne Hospital Finance Department (22) and converted to US dollars using the purchasing power parity of 68.54 cents per Australian dollar for 2014 (23).
3,Men and women aged ≥20 years with type 2 diabetes mellitus receiving voglibose treatment (0.2–0.3 mg three times daily) as monotherapy or in combination with other OHAs were eligible to participate in the study.
0,"The valves sizes available for this study were 17, 19, 21, 23, 25, 27 and 29."
3,"The main exclusion criteria included: type 1 diabetes, recent treatment with insulin or pioglitazone, presence of progressive diabetic complications, unstable cardiovascular disease or uncontrolled severe hypertension, increased serum creatinine (>1.5 mg/dL in men, >1.3 mg/dL in women) or increased alanine aminotransferase or aspartate aminotransferase more than twofold the upper limit of normal, hemoglobin <11.0 g/dL in men or <10.0 g/dL in women, or body mass index (BMI) <18 kg/m2 or >40 kg/m2."
0,"The study sample included participants assigned to the intervention arm only, as the control group received no intervention."
16,"All statistical analyses were conducted using IBM SPSS Statistics, version 21 (IBM Corporation, Chicago, IL)."
0,"Total RNA was isolated with the RNeasy Isolation kit with on-column DNase I treatment (Qiagen, Germany) and reverse-transcribed using the cDNA Synthesis Kit (Biorad, Hercules, CA)."
16,A p-value < 0.05 was considered statistically significant.
0,The primary controller for the console (Wii Remote) can be used as a handheld pointing device which detects movement in three dimensions.
8,A power calculation was carried out to estimate the number of practices to be included to detect the effect of the implementation programme in changing providers’ advice giving behaviour and is described elsewhere [23].
0,"Randomly selected (without replacement) weekly samples of 250 of these 5,743 individuals were then sent letters beginning in February 2010 and ending in November 2010 that were signed by the clinic medical directors and the principal investigator (FW) inviting them to participate by calling the IHAMS project office."
8,We intended to recruit 80 general practices.
0,"For hypothesis tests, two-tailed P values <0.05 are considered statistically significant."
1,This paper reports on the internal pilot trial of a parallel-group RCT with a 1:1 allocation ratio.
0,"The specific attitude and belief scale together with the trial intervention arm were held constant within the model, followed by the manual iterative elimination of nonsignificant potential confounders using backward elimination 36 until all remaining covariates were significant within the model."
3,"All patients admitted acutely to Oslo University Hospital with a hip fracture (a femoral neck fracture, a trochanteric or a sub-trochanteric fracture) were eligible for inclusion."
0,"The active and placebo drug components of capsules were packaged identically into numbered treatment packs, each containing 40 mg atorvastatin (Pfizer, Sandwich, UK) or placebo."
3,Patients were excluded if the hip fracture was a part of a high energy trauma (defined as a fall from higher than one meter) or if they were moribund on admission.
0,"The antioxidant enzymes activities (CAT, SOD, and GPx) were determined in the fresh samples and the methods used to measure these activities have been previously described [15–17]."
8,"With a significance level of 1.67% fixed for each of the three 2 × 2 comparisons (Bonferroni correction to maintain an overall significance level of 5%), we needed 118 evaluations for each format to demonstrate an effect size of 0.5 on the numeric scale with a power of 90% for each 2 × 2 comparison."
0,"The study design was based on the British Medical Research Council framework for development and evaluations of Randomised Controlled Trials (RCT) for complex interventions [29, 30], and has been described in detail elsewhere [31]."
8,"Because we expected that each participant would read a single abstract, we needed to include 118 participants per arm (354 in total)."
0,Maximum plasma concentration (C max) and time to C max (t max) were the observed values.
8,A priori analysis provided a sample size estimate of 18 per group which would allow 80% power to detect a difference for mean permeability between 0.015 and 0.045 assuming a standard deviation of 0.03.
0,"Investigators accessed patient randomization through the study website and assigned the randomization to participants who remained blind as for treatment arm.Eligible patients were randomly assigned in a 1:1:1 manner to (i) standard dual-chamber pacing (Control DDDR Group), (ii) atrial preventive pacing, aATP, and MVP (DDDRP + MVP Group), and (c) DDDR with MVP (MVP Group).Device programming"
3,"Our study is based on participants from the Danish part of the MONICA study [21], the Diet, Cancer and Health (DCH) study [22] and the INTER99 study [23], each of which are described in the following."
0,• Point prevalence at each follow up and prolonged abstinence at 8 weeks and 6 months.
3,Eligible patients were those who required mechanical ventilation within the last 24 hours and were expected to need mechanical ventilation for more than 24 hours.
0,Fetal growth ultrasound at 34 weeks.
3,"Patients were excluded if they were younger than 18 years-old, were pregnant, needed deep levels of sedation (intracranial hypertension, status epilepticus, hypothermia after cardiac arrest, severe asthma exacerbations, and severe hypoxemic respiratory failure (PaO2/FiO2 ratio < 50), were not expected to survive for more than six months (for example, metastatic cancer, NY functional class IV heart failure, Child C hepatic cirrhosis, oxygen-dependent chronic obstructive pulmonary disease), were previously cognitive impaired (for example, advanced dementia), or were readmitted to the ICU after participating in the trial."
0,"Women were recruited from September 2007 through November 2009 at nine Norwegian hospitals from both urban and rural populations, handling total of 8200 births annually."
6,The primary study outcome was ventilator-free days in 28 days.
0,This is a single blinded clinical trial.
6,"Secondary outcomes were ICU and hospital mortality, ICU and hospital length-of-stay, incidence of delirium, delirium and coma-free days in seven days, percentage of time on target SAS, self-extubation and reintubation, accidental removal of catheters, tracheostomy rates, total sedatives doses per patient, differences in hemodynamic and ventilator variables, SOFA score, nurse workload and level of psychological stress six months after ICU discharge."
0,"This SD was used to generate random data for all probe sets and all subjects by drawing random numbers from the following distribution, N(0,si), where si indicates the estimated SD of the genes in Cluster i (A or B)."
1,A quasi-experimental design was used to evaluate the PCRM-CI.
0,Dual antiplatelet therapy interruption was defined as any interruption of aspirin and/or clopidogrel more than 14 days.
1,Comparisons were made between two groups of inpatients undergoing MSK rehabilitation post-hip fracture: those receiving usual care (control group) and those receiving the PCRM-CI intervention (intervention group).
0,The 50-mL drink consisted of an aqueous solution of 14C-EC (specific activity 14.5 μCi μmol−1) and delivered 60 mg (207 μmol) of EC and 300 μCi (660 × 106 dpm) of radioactivity.
4,"Participants for both groups were recruited from two Ontario Community Hospitals: Site I, a 40-bed unit in a 500-bed hospital, and Site II, a 20-bed unit in a 120-bed hospital."
0,Those in either the placebo or the antioxidant treatment arm received simvastatin if their LDL-cholesterol exceeded 140 mg/dl.
6,A primary outcome was the change in spatiotemporal parameter.
0,This endoscopy could be performed at initial diagnosis or after a course of treatment with either topical steroids or dietary elimination.
6,"In particular we recorded: the gait velocity assessed by mean velocity (m/s), which measured the rate of change of position, recorded in meters per second; the cadence (step/min) that measured the number of steps taken in a given period of time, which was then converted into the number of steps taken per minute; the step length (mm) that measured the average distance (mm) between two successive placements of the same foot; the stride length (mm) that measured the average distance (mm) between two successive placements of the same foot, the step width (mm) that measured the medio-lateral distance between the two feet during double support; the stance time (stride %) that measured the duration of the stance phase; the swing time (stride %) that measured the duration of the swing phase and the double support (stride %) that measured the duration of double support."
0,"Once informed consent was obtained, participants were randomly allocated to one of the three groups using a stratified randomized block design."
1,"We performed a prospective, randomized, controlled, parallel group trial in STEMI patients enrolled at a single center between March 11, 2012, and November 21, 2012."
0,"Tolerability of the IM/EP procedure (assessed as pain and graded as none, light, uncomfortable, intense, severe and very severe) was monitored at 4 pre-determined timepoints (prior to, immediately after, 10 and 30 minutes after each IM/EP) using a standardized questionnaire which was administered in the clinic during the immediate post-injection observation period."
1,The trial was a proof-of-concept trial nested in a larger prospective cohort study (10).
0,The overall duration of the study is therefore 17.5 years.
8,"Based on a clinical audit in our hospital and a literature review (4–6), we estimated that the incidence of no-/slow-reflow (TIMI flow grade ≤2) during primary PCI would be 40% in selected patients with ≥1 of our predefined risk factors and 10% in the deferred PCI group."
0,"Postprandial sCD14 and IL-6 were original secondary outcome measures, whereas all other outcomes were exploratory."
8,A minimum of 84 patients (42 per group) would provide 85% power to reject the null hypothesis with a type I error of 0.05.
0,"A few conditions, that is, urinary retention (n:12) and uncomplicated urinary tract infection (n:18), were excluded due to lack of preoperative information on voiding difficulties, postoperative intermittent catheterisations, and chronic urinary tract infection."
1,"A single center, two-armed, parallel-group, observer-blinded randomized clinical superiority trial."
0,"Data, collected through multiple channels, are stored on a secure research platform that is housed on Georgetown University’s servers [10]."
1,The participants were enrolled at the trial cite in Copenhagen (Denmark).
0,Enzyme was added (2.5 µl) and the reaction was allowed to run for 30 min at 41 °C.
16,"Because of the low number of patients infected with HCV G4 in this study, no statistical analysis was performed and data were summarized descriptively."
0,"The details of the study design and objectives have been published previously (10,11)."
3,"After obtaining written informed consent, we studied 88 patients, American Society of Anesthesiologist (ASA) grade I-III aged 18-80 years, who required orotracheal intubation for ear surgery."
0,"Patients were excluded if they had clinical evidence of active brain metastasis or clinically serious concurrent disease, pre-existing peripheral neuropathy more than Grade 1, concurrent hormonal or immunotherapy, or other malignancies within the last 5 years that could affect the diagnosis or assessment of breast cancer."
3,"Exclusion criteria were a known or suspected difficult airway, such as mouth opening < 3.5 cm or Mallampati score 4 or Cormack grade 3 and 4; obesity; disease of the larynx or vocal cords; hoarseness before surgery; and a preexisting severe vocal cord pathology discovered at videolaryngoscopy by an ear-nose-throat (ENT) physician before surgery."
0,Answers are graded on 7-point Likert scale which gives a total score ranging from 3 to 21.
6,The box lists all the primary and secondary outcome measurements.
0,Trial enrollment samples with Kalon index values between 0.90–1.49 were classified as indeterminate HSV-2 status.
6,Accelerometer assessed mean time per day spent doing moderate/vigorous physical activity Accelerometer assessed mean time per day spent in sedentary activity Self reported (validated questionnaire) servings of fruit and vegetables consumed per day Secondary outcomes
0,An oral glucose tolerance test (OGTT) was performed with the administration of 1.75 g of glucose per kilogram of body weight with maximal dose of 75 g.
6,The primary objectives of this study were to determine the safety profile and tolerability of Sb when administered in conjunction with TMZ and RT and to establish the MTD of this combination.
0,"Exclusion criteria include contra-indications to CMR imaging or to adenosine, poor renal function (eGFR < 30), LVEF < 30%, PCI within the last 6 months, and previous CABG."
6,"Secondary objectives were to evaluate pharmacokinetics (PKs), tumour response and survival."
0,"All patients had an initial assessment of response—including MRD response by BCR-ABL transcript monitoring or clonal immunoglobulin (Ig)/T-cell receptor gene rearrangement quantification—at the end of induction phase 1, which did not affect treatment decision."
3,"Eligible patients had centrally confirmed HER2-positive locally recurrent, unresectable, or metastatic breast cancer without prior chemotherapy or biologic therapy for their advanced disease."
0,"Patients were eligible if they were ≥15 yrs, had a self-reported illness history of 72 hrs or less and were suspected of having dengue."
3,Patients with current clinical or radiographic evidence of CNS metastases were excluded.
0,The control group were provided with Accu-Chek Nano® meters and trained on their use at baseline and reinforced at week 1.
6,Tumor assessments were based on RECIST and carried out every 9 weeks.
0,"Once basal blood flow was restored, the SNP infusion was continued for the remainder of the study to produce an “NO clamp” as described previously.24"
6,Adverse events were monitored continuously and graded according to NCI-CTCAE v3.0.
0,"Weighted mean glucose and potassium over 0–4 h on days 1, 14 and 28 and maximum glucose and minimum potassium were other safety end points."
3,"Five thousand participants were selected from 56 512 postmenopausal women in the control arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS,14 ISRCTN22488978)."
0,"If one of the adverse events listed above was observed, ICU nursing was equipped with bedside algorithms designed to manage the adverse event."
3,The mean age of women invited was 69.6±6.1 years (range 57–85).
0,"Participants in all three groups had access to the same treatment program, a Swedish translation and adaptation of the Dutch program Therapy Alcohol Online, developed by the Jellinek Clinic [15, 23]."
3,"We selected patients from 225 primary care practices registered between January, 1997, and March, 2010, who were aged 30 years or older at study entry (the index date), who had been registered with their practices for at least 1 year before the index date and had no previous diagnosis of cardiovascular disease."
0,"At the end of the after-school program, or when a student left the early, the research assistant removed each accelerometer and noted time of removal."
3,Appendix p 9 shows the study flow diagram.
0,without an stable dosage (at least three months prior the beginning of the study).
16,Sample size was driven by the dose-escalation scheme and descriptive statistics were employed.
0,"UCB-PATS PM2.5 monitors (described below) were placed 1.5 m above the ground and 1 m away from the stove and, whenever possible, at least 1.5 m from windows and doors by suspending the monitors from the roof beams."
3,"Participants were required to be (i) biologically male, (ii) living in either Tijuana or San Diego County, (iii) at least 18 years old, (iv) report having purchased sex for money, drugs, shelter or goods in the last 4 months, (v) test HIV-negative at baseline, and (vi) agree to receive antibiotic treatment for Chlamydia, gonorrhea, and syphilis if they test positive (to allow us to differentiate incident from prevalent cases at follow-up)."
0,These corresponded to four standardized activities (1 hour/activity).
3,"Additionally, clients must have reported having had unprotected vaginal or anal sex with a FSW in Tijuana at least once during the previous 4 months."
0,"The characteristics of the test have been previously described [17,20]."
4,Practices in South London were recruited via the Greater London Primary Care Research Network (PCRN-GL).
0,So far (August 2015) nearly 550 participants have been enrolled.
4,"To be included, the practice had to keep a register of patients with CHD for the Quality and Outcomes Framework (QOF)[17] and be willing to liaise over patients in the PC arm when necessary."
0,"A, With the conventional approach, patients were classified according to their baseline C‐reactive protein (CRP) level alone (top)."
14,Participants were asked at the beginning of each follow up interview not to mention whether they had been in contact with other study staff.
0,"In part 1 of the study, we will develop a stakeholder based Cardiovascular Health Education Program (CHEP) that is to be used to educate patients at risk of CVD who are enrolled in a private health insurance plan in rural Nigeria."
14,The statistician was also kept uninformed of allocation status.
0,"At the conclusion of each session, the program printed 2 documents: 1) an “Educational Worksheet” for participants with questions for self-reflection, harm reduction tips, and local resources (Figure 1); and 2) a “Cueing Sheet” for providers, which offered an at-a-glance summary of the patient's risk profile and readiness to change, and suggested risk-reduction counseling statements (Figure 2)."
5,"Treatment and dose adaptation were as described previously (see also legend to Table 2) [14, 15]."
0,Antimalarial treatment was given when there was an unequivocal rise in parasite densities indicating recrudescence but before a return of signs or symptoms (see the supplemental text).
14,"It is not possible to blind the participants to their actual treatment allocation, since participants are aware whether they initiate preoperative exercise and whether their postoperative exercise starts two or six weeks after surgery."
0,"Given the severe baseline HRQL impairment present in our population, and that larger improvements may be expected in individuals with lower baseline scores, we used a score of 5 as the MCID threshold [20]."
14,"All study personnel collecting data and doing the statistical analyses of the data are, however, blinded to the patient allocation, and the patients are strictly informed not to reveal their group allocation to the test personnel."
0,We excluded those with major mental or physical illness that was likely to impair their capacity to change lifestyle behaviour or assimilate new information.
1,"The present double-blind, placebo-controlled, two-group study was registered at the International Standard Randomised Controlled Trial Number Registry (registration no."
0,"Figure 1 Course structure, content, and techniques of the integrative cessation program for tobacco and cannabis co-smokers."
1,ISRCTN37927591; http://controlled-trials.com/ISRCTN37927591).
0,"In addition, 11 patients had missing glucose status at baseline (4 in the control group and 7 in the surgery group) and they were excluded."
14,"Apart from the independent statistician at the National Perinatal Epidemiology Unit who generated the sequence, all study personnel and the participants were blinded to allocation."
0,"In addition, the Beck Depression Inventory (BDI) was used to screen participants for conjoint depression as per exclusion criteria [38]."
8,"The software PASS 11 (NCSS, Kaysville, UT, USA) was used for sample size calculation."
0,TPO-Ab concentrations > 35 kU/l at 36 weeks gestation were regarded as antibody positive.
8,Group sample sizes of 2 × 30 patients achieve 81% power to detect a difference in CIPNM sum score of 1.5 between the intervention group (estimated score of 4.0) and the control group (estimated score of 2.5) given standard deviations of 2.0 and at a two-sided significance level (alpha) of 0.05 using a Mann-Whitney test assuming that the actual distributions are equal.
0,"Only index teeth were examined according to the following criteria; healthy periodontal status (code 0), bleeding on probing observed (code 1), calculus detected during probing (code 2), pocket 4–5 mm (code 3) and pocket ≥ 6 mm (code 4)."
6,Pre-defined postoperative complications for each patient (see Additional file 1) were recorded for up to 28 days after surgery from the patient record and by visiting patients on the ward by the investigators.
0,"The study was not designed as a longitudinal study, but rather as a cross-sectional prospective study, in order to maximise the number of follow-up tests completed (at 3 and 5 years) by patients within the period of funding."
6,Length of hospital stay in days was obtained from the patient record.
0,All 95% confidence intervals (CIs) were calculated using the Clopper-Pearson method.
6,The primary endpoint was the occurrence of hyperchloraemic metabolic acidosis within 48 hours.
0,Primary and selected previous renal transplant recipients (non-immunological causes of graft loss) age >18 were eligible for study participation.
6,"The secondary outcomes were electrolyte status, ICP, rate of ICH episodes, volume of intravenous fluid, duration of vasopressor therapy, duration of mechanical ventilation, length of ICU stay and death in the ICU."
0,Volunteers consumed a low-fat and low-protein meal the evening before each visit and drank only low-nitrate water (Buxton Mineral Water; Nestlé Waters UK).
3,"Preterm infants of 31+6 weeks' gestation or less (based on the first day of the last menstruation), were eligible for enrollment after admission to a neonatal intensive care unit (NICU) during the first 24 hours after birth."
0,"Before study initiation, we developed a standardized classic Yang style tai chi protocol for fibromyalgia based on the literature.33"
3,"Exclusion criteria were major congenital malformations, clinical syndromes, or chromosomal abnormalities."
0,"Some team leaders and psychiatrists saw the REFOCUS intervention as an opportunity to establish the team's identity and creditials as a Recovery team, and/or provide the vehicle to enhance team-working."
6,"The primary study outcome was CO at 24 hours after study entry, which was measured by TTE as described above."
0,"In addition, the heads of the medical departments were asked to inform their medical staff about the study."
6,"Secondary outcome parameters included SmTDI, E/E′ ratio and TAPSE, overall fluid balance, blood pressure, acid-base status, electrolytes, renal and liver function tests, need for mechanical ventilation (including noninvasive), ICU and hospital lengths of stay and 28- and 90-day mortality."
0,"Before administration, the frozen solution was thawed and a 0.9-mL aliquot of the rhBSSL solution was transferred to 90 mL of the preterm formula (PF study) or PBM (PBM study) to give a final concentration in the feed of 0.15 g/L, representative of the physiological concentration found in breast milk (27)."
8,Sample size calculation was computed on the basis of MFI data.
0,"To model the healing process, we have developed both a level set approach similar to Javierre et al. [33] and an Agent-Based Model (ABM) to model the healing process."
8,A total of nine patients per group was shown to be sufficient to detect a statistically significant change in MFI of 0.4 (standard deviation = 0.3) after blood transfusion with a power of 80% and an alpha error of 0.05.
0,The first day of the LMP was obtained prospectively by village health workers during biweekly home visits to distribute supplements and monitor pregnancy status.
6,"Outcome measures were both functional tests (gait speed, walking endurance, mobility, balance) and self-reported questionnaires (fatigue, health-related quality of life and walking ability)."
0,"The safety and tolerability of the treatment was assessed in trial participants by clinical history, insulin use, physical examination, temperature, blood pressure, heart rate, 12-lead electrocardiograms, blood glucose, HbA1c, clinical laboratory tests, and adverse event (AE) recording."
6,"All measures were assessed the week prior to treatment (T0), the week after the end of TOCT (T1) and the 3 months home-based training program (T2)."
0,This question was the same as what was used in NSHAP.
8,"To detect a 10-mmHg difference in systolic blood pressure between the randomized groups with the standard deviation set at 20 mmHg and a two-sided p-value of 0.01 and 90% power, 480 patients would have to be screened and 240 randomized, assuming 50% screening failures."
0,We selected each hospital based on the following considerations: its capacity for performing both PCI and CABG; its position as a top-3 highest volume hospital for CABG and PCI in the located province or direct-controlled municipality; the study team's prior experience with participating in a clinical study; overall representation of geographic locations across the country; and the feasibility of conducting the study at the given site.
8,"Assuming a baseline-adjusted between-group difference of 10 ml/min/1.73 m2 in eGFR and a standard deviation of 20 ml/min/1.73 m2, 100 patients randomized per group should be sufficient to reach 0.05 significance with 95% power."
0,In this study those who answered yes were classified as frail.
16,"All statistical calculations, including deriving means and SD, categorical data tests (that is, Chi square or Fisher’s exact test), and correlation analysis based on Pearson statistics were conducted with SAS 9.3 (Cary, NC, USA)."
0,"The inclusion criteria were symptomatic multivessel coronary disease, preserved left ventricular function, and the presence of coronary lesions (70% of stenosis) amenable to angioplasty."
1,This pragmatic randomised controlled trial (RCT) (hereafter referred to as the Occupational Therapy Evidence-Based Practice (OTEBP) trial) employed a matched pair design.
0,"The ELASTO-GEL hypothermia cap is a medical device available in Europe (European Directive 93/42/EEC) and US, (Icewraps, Escondido, CA, USA) made of a seamless flexible material containing a glycerin-based hydrogel that remains flexible even at very low temperatures (− 30 °C)."
1,"This design controls for potential confounders by grouping participants into pairs based on a blocking variable (in this case, knowledge about EBP) and randomly assigning each participant in the pair to one of two interventions [15]."
0,All statistical analyses were conducted using SAS (version 9.1).
1,"The X:IT study will be evaluated by means of effect, process, and health economic evaluations."
0,"Sukuta village has an estimated population of 17,000 (2003 census)."
1,We used a cluster randomized controlled design for the effect evaluation of the intervention.
0,The following approach will be used to handle missing data in analysis models.
4,"This study took place at 11 outpatient clinic sites specializing in diabetic foot care across the U.S. (two each in Pennsylvania, Illinois, California, and Arizona and one each in Ohio, Texas, and Colorado) and included academic medical centers, Veterans Affairs clinics, and private practice podiatry clinics (Supplementary Appendix 1)."
0,"As in the MEG study, the subject viewed two concentric circles."
4,All site principal investigators (PIs) were clinicians with significant experience managing diabetes-related foot problems and had prior experience conducting clinical trials.
0,We were also interested in whether certain population subgroups would be more or less responsive to our intervention.
1,"To achieve its primary objective, this study had a nonblinded, randomized crossover design, with each patient participating in random order in two 40-h outpatient admissions: 1) experimental involving integrated CLC and 2) control using OL CGM-augmented insulin pump treatment."
0,"Limited internal rotation of the hip (<30° with hip flexed to 90°), pain on FABER and/or FADIR.40"
1,"Both the CLC and OL admissions of the study used the DiAs system running in closed-loop or OL mode, respectively."
0,The primary objective of this study is to assess the feasibility of conducting of an adequately powered study of similar design.
14,The randomisation takes place after the baseline assessment and is concealed from the project assistants.
0,2 years Duration of each patient's participation
14,"Blinding of hospital physiotherapists, the rehabilitation centre officer in charge of distribution to rehabilitation and patients to the trial condition is not possible."
0,"During telephone contact, the following activities will take place: calls 1 and 2 will be interviews with subjects to verify they still meet the original non-medical inclusion criteria and to record which cigarette products are currently being smoked, reasons for any change in current cigarette product smoked since the previous timepoint and self-reported daily consumption; call 3 will be to remind subjects of their visit 1 appointment and determine whether they have changed their cigarette product; call 4 will be to remind subjects to collect part-filter tips and urine on day 11."
16,"If not indicated otherwise, data represent results for assays performed in triplicate, with error bars to represent standard errors from the mean."
0,"The rationale and design of this randomized, double-blind, non-inferiority study (Clinicaltrials.gov Identifier: NCT01101009) have been described before [11]."
16,All box plots and linear regressions performed using the R statistical package.
0,The score ranges from 0=maximum disability to 100=no disability (higher score indicating less fatigue).
6,Four indicators of sexual behaviours were considered: 1) sexual activity (i.e. at least one sexual intercourse) in the past year; 2) multiple partnership (i.e. at least two sexual partners) in the past year; 3) unprotected sex at last intercourse in the past year; and 4) risky sex (defined as unprotected sex with a partner of HIV negative/unknown status) at last intercourse in the past year.
0,Group facilitators will complete a standard content checklist after each group session to record the degree to which the intervention was delivered.
3,"Out of the 219 individuals screened, 54 patients with type 2 diabetes (with disease duration of more than 1 year) treated by oral hypoglycaemic agents (both men and women), age 30–70 years, BMI 27–50 kg/m2 and HbA1c 6–11.8% (42–105 mmol/mol), met all the inclusion criteria, gave their written informed consent and underwent randomisation."
0,"At the launching the ELP was promoted at the homepages of the DMA as well as DSAM, the ELP was mentioned in the weekly journal of DMA (Ugeskrift for Læger) as well as the journal of DSAM (Practicus)."
3,"Exclusion criteria comprised alcohol or drug abuse, pregnancy or lactation, unstable medication or weight in the last 3 months, a diagnosis of type 1 diabetes and the presence of a cardiostimulant."
0,"In addition, organizational aspects of the HCs as well as of the nutrition services are recorded through interviews to managers."
16,"Comparisons of changes in PI, GBI, PPD (%) and PAL (%) both within and between the groups were performed using the chi-square test."
0,"Total OCA was calculated for each observation by summing the molar‐based concentrations for OCA, glyco‐OCA, and tauro‐OCA."
16,"Intragroup comparison for mean PPD, mean PAL, mean HbA1c and mean CRP were assessed with the paired sample t-test whereas intergroup comparisons for the same variables was accomplished using an independent sample t-test."
0,"Therefore, our intervention represented a pragmatic step down approach (i.e. from in-person sessions to telephone calls to postcard prompts), that could feasibly be employed by cancer care nurses in routine clinical practice."
3,"Key inclusion criteria were as follows: Women aged ≥18 years with histologically or cytologically confirmed locally recurrent breast cancer or MBC; measureable disease according to RECIST v1.1; HER2-negative disease as determined by immunohistochemical staining (0 or 1+) or by fluorescence in situ hybridization (FISH) (subjects with a HER2:FISH ratio of 1.8:2.2 were eligible); life expectancy ≥24 weeks; Eastern Cooperative Oncology Group (ECOG) performance status of 0–2; at least 12 months since prior neoadjuvant or adjuvant (neo/adjuvant) chemotherapy ended; at least 2 weeks since prior radiotherapy or endocrine therapy was finished or discontinued, with complete recovery from the effects of these interventions; and adequate renal, bone marrow, and liver functions."
0,"Immediately prior to the 6, 12, and 18 Month interventions, parents/guardians will be requested to update information on contraindications to Duraphat® varnish."
3,"Key exclusion criteria were as follows: prior chemotherapy, biologic therapy, or investigational therapy for locally recurrent breast cancer or MBC (prior endocrine therapy was permitted); prior malignancy (other than carcinoma in situ of the cervix or non-melanoma skin cancer) within 5 years; prior exposure to >360 mg/m2 doxorubicin or >720 mg/m2 epirubicin; inflammatory breast cancer; preexisting neuropathy of grade >2 (according to the National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events [CTCAE] version 4.0)."
0,Serum samples will undergo metabolomics analysis using proton nuclear magnetic resonance spectroscopy (1H-NMR) [39].
5,"Eribulin mesylate (1.4 mg/m2 [equivalent to 1.23 mg/m2 eribulin]) was administered as a 2- to 5-min intravenous (IV) infusion on Days 1 and 8 of a 21-day cycle (premedication to prevent hypersensitivity was not required, antiemetics were allowed as per institutional guidelines)."
0,The presence of worms was verified by worm actin PCR.
5,"Dose reductions were implemented as follows:The dose was reduced to 1.1 mg/m2 if one of the following occurred during the previous cycle:absolute neutrophil count (ANC) <500 cells/mm3 for >7 days despite use of growth factor, recovered to grade ≤2;ANC <1,000 cells/mm3 with fever or infection despite use of growth factor recovered to grade ≤2;any grade 3 or 4 non-hematologic toxicity that returned to grade ≤2 within 7 days.The dose was further reduced to 0.7 mg/m2 if there was a recurrence of grade 3 or 4 toxicity despite dose reduction to 1.1 mg/m2."
0,"This was a randomized controlled trial for comparing the treatment of dysentery with ciprofloxacin and gatifloxacin in Vietnamese children (controlled trials number ISRCTN55945881) (HV and SB, unpublished data)."
8,"For the purposes of sample size calculation, infusion time and SD data from our previously completed DRT trial19 were used as nuisance parameters."
0,Each woman in the groups approached for this study met with a staff member to go through the participant information sheet and those who agreed to participate and demonstrated understanding of the study procedures were invited to sign the consent form.
8,"The POWER procedure in SAS(r) V.9.2 statistical software was used to calculate a required sample size of 16 to detect a mean difference of 0.2 mL/s (deemed significant based on clinical experience of investigators), with power 0.9 and α=0.05."
0,Only patients that are withdrawn from the study at the request of parents or caregivers will be replaced.
14,"Although the investigators and participants were aware of the vibratory stimuli, they were blind to the primary and secondary movement outcomes being measured, as those were automatically recorded by the device and only available at the end of the trial."
0,"Costs were listed per batch, and information was gathered on the mean batch size."
14,The statistical analysis was performed blinded for experimental or active comparator status.
0,"Genotype at 906,600 (869,161 autosomal) loci was ascertained using the Affymetrix Genome Wide Human SNP Array 6.0 (Affymetrix) and the Birdseed algorithm; calling was performed in batches [31]."
4,"Patients with CKD were recruited from the Outpatient Clinic of Nephrology and Hypertension, Holstebro, Regional Hospital Jutland West."
0,"Safety was monitored by the Alliance Data and Safety Monitoring Board (DSMB); the majority of the voting DSMB members are not affiliated with the Alliance, and voting quorums for a DSMB meeting require that the majority of voting members not belong to the Alliance."
4,"Healthy participants were recruited by advertisements in local newspapers, in the area of Holstebro, Denmark."
0,"Exclusion criteria included severe liver or renal disease, abnormal liver or kidney function tests, a history of malignant disease or other defined conditions including Barrett’s esophagus, esophagitis, pancreatitis, uncontrolled diabetes mellitus or severe cardiovascular or cerebrovascular disease."
16,"Statistical analyses of experimental data were done in GraphPad Prism 5.0 (GraphPad Software Inc., San Diego, CA, USA) unless otherwise indicated."
0,Participants were considered eligible for the study if they expressed availability for at least 60 min and a willingness to participate.
1,"We will complete a multicenter double-blind, placebo-controlled randomized superiority clinical trial of oral Mg++ citrate supplementation."
0,Custom code was used to compute joint torque commands to execute the decoded endpoint velocity commands.
6,"The individual components of the composite perinatal outcome -- preterm birth before 37 weeks gestation, stillbirth after 20 weeks gestation, neonatal death before 28 days after birth, or SGA birthweight under the 3rd percentile – are listed in Table 2."
0,Participants receive a $40 gift card after completing this assessment.
6,"The individual components of the composite maternal outcome -- preeclampsia or eclampsia arising before 37 weeks gestation, severe non-proteinuric hypertension arising before 37 weeks gestation, placental abruption, maternal stroke during pregnancy or ≤ 7 days after delivery, or maternal death during pregnancy or ≤ 7 days after delivery – are listed in Table 2."
0,Set up deviations > 3 mm are corrected prior to radiotherapy.
11,Participants will be randomized in a 2:1 fashion to either Mg++ citrate or placebo.
0,Doses of 0.5 and 2.0 g or matching placebo were administered once daily for 28 consecutive days.
11,Block randomization will be used to ensure a balanced number of participants in each group at any time during the study.
0,All parents or legal guardians provided written informed consent on behalf of their children.
1,"This pilot study was a three-arm, parallel group, randomized controlled trial."
0,92 cards will be printed with Group II (cryokinetic ice application).
8,"We planned to include 32 subjects (16 in the OMT group, 8 in the sham OMT group and 8 in the usual care group)."
0,Treatment compliance was assessed by the unused returned drugs and empty packages.
8,"Because this study was a pilot study in a rare disease, there was no formal calculation of sample size; nevertheless, this sample was expected to be sufficient to identify a difference of one standard deviation between the mean VAS for pain in the OMT group versus the two other groups with 1−β = 80% and α = 5%."
0,"The CABG surgery and perioperative medication and monitoring management were standardized according with the 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery (Hillis et al., 2011)."
6,The primary outcome was correction of severe anemia (to hemoglobin >6 g/dl) at 24 hours.
0,Responses are directly entered into a computer program that determines general eligibility for the first baseline evaluation.
6,Secondary outcomes included: (1) meeting criteria for additional transfusion (development of profound anemia (hemoglobin <4 g/dl) or hemoglobin 4 to 6 g/dl with new markers of severity (impaired consciousness or respiratory distress)) from eight hours post randomization; (2) serious adverse events defined according to Good Clinical Practice [16] and including suspected pulmonary edema (bilateral basal crepitations with hypoxemia (oxygen saturations <90%); biventricular heart failure (severe tachycardia (<12-months-old: >180 beats per minute (bpm); 12-months to 5-years-old: >160 bpm; >5-years-old: >140 bpm) plus an increasing liver size) or suspected transfusion reaction; (3) mortality through 48 hours and 28 days post-admission; and (4) redevelopment of severe anemia (hemoglobin <6 g/dl) or mortality at 28 days post-admission.
0,cEPC counts will be expressed as percentage of total PBMC in each patient.
1,"We conducted a multi-method study: a pragmatic stepped-wedge cluster- randomized trial, ethnographic observation and in-depth interviews, and an economic evaluation."
0,"Safety evaluations in the four studies included the assessment of adverse events (AEs), clinical laboratory parameters, vital signs, electrocardiograms, and physical examination findings at regular intervals."
1,A stepped wedge design [15] was selected for the trial in order to retain the power of randomization while offering all facilities enrolled in the trial exposure to what was believed to be a desirable intervention and to enable delivery of the intervention to these facilities by a small study team.
0,These assessments were performed at the same times as the episodes of PONV assessments.
6,"To assess intervention impacts on both the primary outcome and intermediary behavioral processes, INSIGHT data collection includes measures divided into the following categories: Anthropometrics and Biological Specimens, Infant/Child Behavior, Parenting, Maternal Psychosocial Variables and Behavior, Family Context, and Background/Demographics/Covariates."
0,"This instrument has been validated for use in patients with Gouty Arthritis [28,29]."
6,"As detailed in Table 2, many of the measurements are assessed repeatedly."
0,Acne severity was also evaluated by the patient.
3,"The following exclusion criteria were applied: (a) hysterectomized women with a history of pre-malignant lesions (AGUS ASCUS, LSIL, HSIL), carcinoma in situ or cervical-uterine cancer, HIV positive or other causes of immunosuppression (since these women follow a specific protocol); (b) non residents in the area for more than 6 months."
0,"As in LWSS 1, a family member or informal caregiver could opt to participate and provide data with the participant’s agreement."
6,The primary endpoint was the carotid plaque lipid content presented as LRNC volume and %LNRC as measured by MRI.
0,Dose-proportionality analysis was conducted using data from the SAD and MAD studies.
6,The secondary endpoint was the plaque burden presented as PWV.
0,Questions using a 5-point Likert scale were employed to evaluate the participants’ satisfaction with the educational video before and after the educational session.
1,"This open-label, randomized (1:1), double arm, multicenter, non-inferiority, conversion study was conducted at three transplant centers in Korea from April 2010 to June 2012."
0,"Accurately assessing limb‐related morbidity and procedure‐related need for reintervention is of paramount importance in a trial comparing revascularization strategies, particularly in light of remaining questions regarding treatment durability."
1,The study protocol was approved by the Institutional Review Board at all participating centers to ensure that study procedures were in accord with the Helsinki Declaration.
0,Participants were randomly assigned to the test or the control group by the use of computerized center-specific randomization lists.
3,The study inclusion criteria were an age between 20 and 65 years and recipient of a primary kidney transplant from a deceased or living donor between 15 and 65 years of age.
0,Interviews were conducted by members of the research team experienced in conducting research with children (ZM and MH).
3,The study exclusion criteria were receipt or scheduled receipt of an organ transplant other than a kidney or scheduled receipt of a kidney from a non-heart beating or ABO blood group incompatible or lymphocyte cross match positive donor.
0,Fig 1 Flow-chart of the study cohort.
3,"Inclusion criteria for this trial included: (a) age ≥ 45 years, (b) persistent leg, buttock, or groin pain, with or without back pain, that was relieved by lumbar flexion, (c) persistently symptomatic with unsuccessful response to at least 6 months of conservative treatment, (d) diagnosis of moderate LSS, defined as 25% to 50% reduction in central canal, lateral recess, or foraminal diameter compared to adjacent levels, and radiographic evidence of thecal sac compression and/or nerve root impingement by either osseous or non-osseous elements, and/or hypertrophic facets with canal encroachment, (e) Zurich Claudication Questionnaire Physical Function score ≥ 2.0, (f) able to sit for 50 minutes without pain and to walk ≥ 50 feet, and (g) able to provide voluntary informed consent and to comply with the study procedures."
0,Baseline assessments were performed in the 24 hours before the first fraction.
3,"Exclusion criteria included: (a) LSS at three or more levels, (b) concomitant surgical procedure required, (c) grade II or greater spondylolisthesis, (d) unremitting back pain in any spinal position, (e) significant lumbar instability, defined as ≥ 3 mm translation or ≥ 5° angulation, (f) active systemic disease that may affect the welfare of the patient, (g) vertebral osteoporosis or history of vertebral fracture, (h) body mass index ≥ 40 kg/m2, (i) previous lumbar spine surgery, (j) pregnant or lactating female, and (k) any disease or condition that, in the investigator’s opinion, may affect subject safety or confound trial outcomes."
0,All subjects signed an informed consent prior to participation.
3,"Subjects who met the inclusion criteria were aged between 18 and 60 years, had body mass index between 20 and 30, reported regular bowel movements (self-reported 1-2 bowel movements per day), and used appropriate birth control methods (for female subjects)."
0,"To ensure adequate calibration, 3 TOF measurements were performed; when these 3 measurements differed >5%, the TOF-watch was recalibrated."
3,"The exclusion criteria were known hypersensitivity to the ingredients of the investigational product, history of or concurrent endocrine disorders, use of other weight management products, use of antidepressants, uncontrolled hypertension, history of or concurrent gastrointestinal diseases, bariatric surgery, history of eating disorder, use of medications/products that could affect gastrointestinal function, pregnant or nursing, or excursions of safety parameters."
0,"Plasma vitamin C concentrations and vitamin C and oxalic acid urinary excretion were measured during the infusion and over the following 4 hours as previously described [26,45]."
1,"The design is a multicenter, controlled, cluster-randomized, nonblinded clinical trial to evaluate the effectiveness of an intervention related to the prescription of cholesterol-lowering drugs in primary prevention, compared to usual clinical practice."
0,Patients whose splint therapy was ended successfully were allowed to apply splint wearing again if they felt a need.
4,"All individuals attended in 283 primary care center (PCC) managed by the ICS, which cover a population of 5.8 million urban, semi-urban, and rural residents of Catalonia."
0,Table 1 Distribution of primary site of tuberculosis infection and number of patients in dose-finding trial.
14,"Due to the nature of the intervention, GPs in the intervention group cannot be blinded to their group assignment."
0,"The main outcome measure for the economic evaluation was HRQoL, using QALYs, which were derived from EQ-5D-3L utilities (measured on a continuous scale and time under observation)."
14,"However, the researcher responsible for data analysis will be blinded to study group assignments."
0,The definition of clinical pneumonia (Figure 1) was based on Benin's adaptation [17] of WHO's generic IMCI guidelines [4].
16,Safety data from the three trials were pooled and analysed for all patients who received ≥1 dose of study medication and included at least 1 post‐baseline safety assessment (safety population).
0,"Key exclusion criteria included treatment for DC on the selected joint within 90 days of enrolment, taking an anticoagulant within 7 days of the first injection, and having another chronic disorder affecting the hands."
16,"Descriptive statistics were used, with categorical variables summarised using counts and percentages and continuous variables summarised using mean, standard deviation, minimum, and maximum."
0,"The intra‐class correlations (ICC) for within‐assay variability for IGF‐I, IGF‐II, IGFBP‐2 and IGFBP‐3 were 0.86, 0.91, 0.95 and 0.88; the ICCs for between‐assay variability were 0.66, 0.84, 0.81 and 0.71, respectively."
1,SWAP is a pragmatic cluster randomised controlled trial with two parallel arms and incorporates economic evaluation and linked qualitative interviews.
0,"Risk accuracy was measured with regard to two types of risks: 1) lifetime population breast cancer risk: a risk within plus or minus 10% of the communicated risk was defined as accurate, and 2) the woman’s own lifetime risk of getting breast cancer as compared to the counseled risk: a risk within their estimated risk category as provided by the risk counselor was defined as accurate."
1,The unit of randomisation is the general practice with data collected from individual participants.
0,Randomization of subjects with non-atopic asthma was restricted to ensure that a minimum of 160 subjects with atopic asthma were included in the study.
3,Adult smokers were recruited to participate in this study.
0,"The intervention design, formative evaluation and feasibility study for ASSIST were undertaken over a two-year period [18]."
3,"To be eligible for this study, individuals had to meet the following inclusion criteria: (1) current daily smoker, (2) interested in quitting smoking in the next 30 days, (3) have a mobile phone with SMS text messaging capability, and (4) use SMS text messaging at least once monthly."
0,The membranes were then washed with TBST three times and incubated with horseradish peroxidase-conjugated secondary antibody (Applygen Gene Technology Corp).
12,Placebo and acetaminophen tablets were provided by McNeil Consumer Healthcare and were identical in appearance.
0,"All-cause mortality was compared at 14 days (the median duration of treatment with anidulafungin) and at 28 days, by using the Fisher Exact test."
12,Study medications were packaged into 1-week supplies by a researcher not involved in subject management or data collection.
0,Peak extension torque was measured at 60° of knee flexion.
1,"This was an independent, investigator-initiated, multicentre, pragmatic, randomised, open, blinded-end point, parallel group study conducted in Japan (NCT00131846)."
0,"According to Section 2.-(1) of the Danish Act on a Bioethics Committee System and the Processing of Bioethics Projects, the project was defined not to be a bioethics project and as a result did not need approval from the Scientific Ethical Committee for the Capital Region of Denmark (May 14th 2007, Journal no.: H-A-2007-0019)."
4,This study was conducted in Japan at hypertension clinics of 106 sites including general practitioners’ offices (n=61) and teaching hospitals (n=45).
0,Informed written consent was obtained in all cases.
4,"All members of committees for this Diuretics In the Management of Essential hypertension (DIME) study and the DIME investigators who participated in the study settings, data collection and management are listed in the online supplementary appendix."
0,Participants were also asked to indicate time of each eating occasion.
12,We developed a web-based minimisation system that was controlled by the data centre and effectively concealed the assignment sequence from investigators assessing and recruiting patients.
0,"Management was carried out by a combination of allied health professionals, predominantly clinical nurses in the hospital who were aware of allocation to telemonitoring or control group and who liaised with primary care teams."
1,"This was a prospective, multicenter, randomized, open-label, two-period, two-sequence crossover study performed in 12 study centers in Germany."
0,"We conducted a cluster randomised controlled trial, where all general practices in Denmark were randomised to an intervention group or to a control group by means of the unique provider number of each practice."
1,It was designed to assess the number of patients with RA preferring the MTX prefilled pen to the prefilled syringe after 6 weeks of treatment.
0,"The FFQ report includes daily estimates of macro-nutrients, major micro-nutrients, and servings per day of key food groups and has been validated against a 24-hour dietary recall (i.e., no significant differences were observed in estimated energy, protein, fat and saturated fat intakes between the FFQ and one 24-hour recall)."
3,● Between one and three previous admissions (including the current admission) in the previous 12 months from the date of discharge with COPD as the primary or secondary documented reason for hospitalisation; ● Referred to the COPD discharge service; ● Willing to consider using Telehealth as part of the discharge plan; ● Able to communicate in English and read English (a requirement of the technology); ● Have a telephone landline in the home (a requirement of the technology).
0,Potential participants completed an eligibility screening questionnaire and provided consent.
3,"● Cognitive impairment to the extent that it impedes ability to participate; ● Other significant impairment(s) which restrict ability to participate; ● Existence of co-morbidities which require ongoing intervention from other community services; ● More than three hospital admissions for COPD within the prior 12 months; ● General practitioner (GP) identifies that person is unsuitable to participate (e.g., due to a mental health condition which could affect outcome measurements)."
0,"Chuna treatment, which is a kind of manual therapy consisting of relaxation and mobilization of the lumbar joint sand back muscles using an Ergo Style TM FX-5820 Table (Chattanooga Group, TN), will be conducted during every treatment visit."
6,"The two co-primary outcome measures were:The proportion of participants re-admitted to hospital with COPD during the 8-week intervention and 6-month follow-up, determined using SUS data on hospital readmissions; andChange in self-reported health-related quality of life at baseline, 8 weeks, and 6-month follow-up through application of the SGRQ [20]."
0,"Furthermore, both FES are closely connected with clinics (PRIME in New Haven and CEDAR at Boston) directed by Co-Investigators on this grant that are part of the NIH-funded North American Prodrome Longitudinal Study (NAPLS)."
6,"The secondary outcome measures were:The proportion of patients requiring unscheduled healthcare support for the 8 week intervention period and 6-month follow-up, determined through analysis of SUS data and patient-completed diaries of GP visits; andCost-effectiveness through quality adjusted life years (QALYs) estimated from analysis of EQ-5D-3 L [21] data, GP visit data, SUS data, and the COPD discharge team’s patient contact records."
0,"The patient has to take nine dowels from a tray, one at a time, as fast as possible and place them in a pegboard."
8,Sample size was based on a suggested sample size of 12 patients per group for proof-of-concept trials [32].
0,"Upper limits for E max for changes in heart rate, body temperature, and diastolic and systolic blood pressure were set to 100/min, 2 °C, 50 and 80 mm Hg, respectively."
8,"Taking into account of dropping out, we planned to enroll 40 participants per group."
0,The ‘low‐dose’ ACEI/ARB stratum also included patients who were ACEI/ARB‐naïve.
16,No formal statistical analysis of safety/tolerability was planned.
0,Chronology of all measurements is shown in Table 1.
16,A Student's t-test for paired data (two tailed) was applied to PK data and a Wilcoxon signed-rank test was performed for PD data to determine statistically significant differences.
0,The RIFLE category FAILURE is defined as a relative increase in serum creatinine ≥ 200% (3.0 fold) or an absolute value ≥354 μmol/L (accompanied by an acute increase ≥44.2 μmol/L) or a reduction in urine output of ≤0.3 mL/kg/hr for ≥ 24 hours or anuria for ≥ 12 hours.
12,Study participants and study coordinators were not blind because of the tangibility of the study food (see Table 6).
0,"The pressure sensor was placed below the estimated height of the participant’s right atrium, with the participant lying at an angle of approximately 45°."
12,"However, investigators and laboratory staff were blinded until the final statistical analyses were conducted."
0,This study was registered at Clinicaltrials.gov: NCT01811420.
3,"Chinese women will be eligible to participate if they are:≥18 years of age,willing to undergo the qigong intervention,available for all testing points,receptive to random allocation, andconfirmed to have been abused by an intimate partner within the past three years based on the Chinese Abuse Assessment Screen (C-AAS)."
0,Patients with no visible or definitive lesions underwent a mucosal biopsy during baseline endoscopy for histologic confirmation of reflux esophagitis.
3,"Chinese women will be excluded if they:have participated in qigong training or other mind–body interventions within the previous 6 months,have serious medical conditions that might limit their participation in qigong exercise (based on our previous experience, such conditions include cancer, severe obesity, narcolepsy, major depressive disorder, and schizophrenia),have psychiatric disorders,use medication or other psychological intervention for stress, orhave been abused by someone other than their intimate partner."
0,"PAXgene tubes can be kept at room temperature for up to 24 h, and then are frozen at −20 °C, until shipped on dry ice to the Ischemia Care CLIA laboratory (Blue Ash, OH) where the ISCDX testing is performed."
1,This prospective study has been approved by the Medical Ethical Review Board of the VU University Medical Center.
0,"Cooperating centres received detailed study guidelines, informal information via telephone, recruitment material and the manuals themselves."
1,"The study is investigator-sponsored, independent of industry and is registered at clinicaltrials.gov under number NCT01895673."
0,The Kessler-10 scale (K-10) was used to measure non-specific psychological distress during the month preceding the interview.27
3,"This study was conducted in accordance with the Declaration of Helsinki and Japanese Ethical Guidelines for Clinical Research, and was approved by the Institutional Review Boards of each participating institute."
0,"If the infant fulfilled the criteria for colic (as above), he/she was included."
1,"We conducted a longitudinal comparative study to compare the changes of biomedical measurements, observed cardiovascular events and cardiovascular risks at 12 months follow-up using a difference-in-differences approach between the RAMP-DM group and the usual care group."
0,"Sachet count method was used to determine subject compliance, with a rate of 85–100 % considered acceptable [14]."
1,"Exploratory randomised trial of the effectiveness and acceptability of the wellbeing intervention for common mental health symptoms in (a) elder patients (b) patients from ethnic minority groups, compared to treatment as usual (TAU)."
0,"After voluntarily providing signed informed consent, participants completed a questionnaire regarding sociodemographics, history of illicit drug use, and medical conditions including prior MRSA infections or SSTI."
8,"We estimated that 50 participants in each trial would be sufficient to assess feasibility, and estimate effect size for future trials."
0,Thick and thin films were stained with Giemsa and counted per 200 white blood cells or 2000 red blood cells.
5,A school-based family-focused pilot intervention focusing on reducing children’s sedentary behaviours in school and at home was developed and implemented over a six-week period.
0,The section was collected on a one-hole copper grid with a Formvar supporting membrane and stained with uranyl acetate and lead citrate.
6,"Measurements were conducted according to standardised protocols [27], and data were collected before (September/October 2011) and after the intervention (November/December 2011)."
0,"The study was approved by the Medical Research Ethics Committee, Faculty of Medicine Universitas Indonesia and informed consent was obtained from all participants."
6,The children completed questionnaires during school time and received the parent questionnaire in a closed envelope to take home for completion by one of their parents.
0,"The trial and informed consent forms were approved by all applicable ethics and regulatory committees: The Protection of Human Subjects Committee of FHI360, the US Food and Drug Administration, the ethics committee (EC) of the University Hospital of Antwerp, the Institutional Review Board of ITM, the Kenyatta National Hospital/University of Nairobi Ethics and Research Committee, the Republic of Kenya Ministry of Health (MoH- Pharmacy & Poisons Board), Kilimanjaro Christian Medical Center Research EC of Tanzania, National Institute for Medical Research of Tanzania, London School of Hygiene and Tropical Medicine EC, Tanzania Food and Drugs Authority, Medunsa Campus Research and EC of South Africa, University of the Free State EC and Medicines Control Council of South Africa."
3,Patients were enrolled into the study if they met the following inclusion criteria: aged ≥40 years; current or ex-smokers with a smoking history of >10 pack-years; post-bronchodilator FEV1 < 80% of predicted normal; and post-bronchodilator FEV1/forced vital capacity (FVC) <70%.
0,"These indices, except MAGE, were calculated for every 6-h block to obtain the measures according to the period of the day."
3,"Key exclusion criteria were: significant disease other than COPD (defined by the investigator as a disease that may put the patient at risk by participating in the study, influence study outcomes, or cause concern with regards to the patient’s ability to participate in the study); history of asthma; history of myocardial infarction within 1 year of the screening visit; and unstable or life-threatening cardiac arrhythmia within the past year."
0,"At least 250,000 total events were acquired in the lymphocyte gate and the data analyzed using the following software packages: FlowJo Version 8 (Treestar Inc., Ashland, OR, USA), and PESTLE and SPICE (courtesy Mario Roederer, Vaccine Research Center, NIH, USA) software."
3,"Outpatients undergoing elective laparoscopic abdominal or gynecological surgery who required general endotracheal anesthesia for ≥30 minutes were eligible for randomization if they met these criteria: ≥18 years of age, American Society of Anesthesiologists (ASA) physical status I to III, and ≥2 of the following PONV risk factors: female, nonsmoker, and history of PONV and/or currently prone to motion sickness."
0,"The evaluation of the SPACE study is split into three main parts: 1) quantitative evaluation of physical activity, physical fitness, and determinants for physical activity, 2) anthropologic evaluation of the intervention effect in two schools, and 3) process and health economic evaluations of the intervention."
3,"Exclusion criteria included chemotherapy within 4 weeks or emetogenic radiotherapy within 8 weeks of study entry; body mass index >40 kg/m2, use of investigational drugs within 30 days of study entry; use of drugs with potential antiemetic efficacy; or any nausea, vomiting, or retching within 24 hours prior to anesthesia."
0,"For example, meetings in the intervention clusters may include government officials and hospital and health center administrators, obstetric providers (physicians, nurse midwives, auxiliary nurse midwives), and, where applicable, community or traditional birth attendants, and health workers."
6,"Primary endpoint of the study is given by changes in the overall score of the Hamilton Rating Scale for Depression (HDRS [44]), from baseline (V0) to week 8 (v1) for each of the treatment groups."
0,The delivery will be measured by asking the instructors to what extend they have followed the specific intervention activities in accordance to the defined criteria written in the intervention protocol (they will fill out a questionnaire after each activity).
6,The primary outcome is the proportion of regular smokers (smoking at least one cigarette per week) assessed by self-report at 24 months (final follow-up).
0,We recommend reducing your body weight and waist circumference to a healthy normal range because you have a genetic variation that can benefit by reducing these two obesity markers (...).
3,"Criteria for inclusion in the study are: 1) patient age above 7 and less than 70 years, 2) renal biopsy diagnostic for IgAN based on immunohistologic staining for IgA that is greater than or equal to staining for IgG and IgM after the biopsy report has be evaluated by one of the study pathologists (entry into the study does not depend upon any specific time interval between the time of the renal biopsy and the time of entry), 3) ability to swallow the oral medications used in the study, 4) signed informed consent by subjects ≥ 18 years of age, and parent/guardian of any subject < 18 years of age with a subject aged ≥ 7 years to <18 years of age also signing an age-appropriate assent form, 5) urine Pr/Cr ratio ≥ 0.6 for males and ≥ 0.8 for females prior to randomization, 6) for female subjects of childbearing potential a negative pregnancy test one week prior to starting lisinopril, and again less than one week before starting MMF or placebo."
0,"Specifically, for each village j, the pre-treatment distributions of kth treatment is ."
3,"Criteria for exclusion from the study are: 1) clinical and histologic evidence of systemic lupus erythematosus, 2) well-documented history of Henoch-Schönlein purpura (previous non-specific abdominal pain or rash does not exclude a subject), 3) cirrhosis, chronic active liver disease, hepatitis B, hepatitis C, 4) history of significant gastrointestinal disorder (e.g.: severe chronic diarrhea or active peptic ulcer disease, 5) HIV, 6) any systemic infection or history of serious infection within one month of entry 6) ANC < 2000/mm3, 7) HCT < 28% (anemic subjects may be reevaluated after the anemia has been treated), 8) estGFR < 40 ml/min/1.73 m2 at time of randomisation (it is acceptable for the estGFR to fall to less than 40/ml/min1.73 m2 during treatment with MMF or placebo provided the level prior to randomization is still ≥60% of the pre-entry value), 9) known contraindication to the administration of MMF, OMACOR® or lisinopril (or losartan if used instead of lisinopril), 10) other major organ system disease or malignancy except skin cancer fully excised more than 5 years prior to entry, 11) current or prior treatment with MMF or azathioprine, 12) pregnancy or breast feeding at time of entry or unwillingness to comply with measures for contraception, 13) current or recent (within 30 days) exposure to any investigational drug."
0,No treatments were altered based on observations made during this study.
3,"Women between 30 and 70 years of age, with histologically confirmed endometrial hyperplasia according to WHO94 classification and D-score (see Additional methods) were eligible; excluded were women with hypersensitivity to progestin, active genital infection, a history of genital or mammary cancer, undiagnosed vaginal bleeding, liver disease, serious thrombophlebitis, or pregnancy."
0,"Exclusion criteria were history of other malignancies, age < 18 years, pregnancy or breastfeeding, diabetes mellitus, or considered unable to cooperate."
16,Data are presented as mean ± S.E.
0,If it remained nonnormally distributed then nonparametric analysis was used.
16,Comparisons between two groups were performed using Student's t-test.
0,The number of positive lymph nodes in TME patients will be assessed.
3,We include females aged 60 years and older with a distal radius fracture.
0,"The trial is also in agreement with the Helsinki Declaration from 1975, which was revised in 1983."
8,"Using a power of 90%, p value of <0.05% (95% for one-sided CI and 90% for two-sided CI) a total of 310 events of hypokalaemia are required to reject the null hypothesis."
0,"We screened 103 subjects, males and females, between the ages of 18–75."
14,"Since the study intervention is a surgical procedure, investigators and patients cannot be blinded for treatment allocation."
0,"Data were analyzed by SPSS for windows version 18 (SPSS Inc., Chicago, IL)."
14,Investigators who are responsible for the analysis of primary and secondary outcomes (adjudication of clinical events) are blinded for the treatment group.
0,"Prior to completing the throwing and catching task, each participant was calibrated to the eye-tracker using nine locations on the wall to which he/she were required to throw the ball against."
8,"A sample size of 500 per group was calculated to provide an estimated 86.4% statistical power to show meaningful differences in LOS, provided that the mean and standard deviation (SD) LOS were similar to those found in a previous study with similar outcome measures (mean [SD] of 8.75 [12.18] days in the quetiapine IR group compared with 6.91 [5.70] days in the quetiapine XR group) [11]."
0,Absolute lymphocyte count was obtained from a complete blood count and differential as measured by an accredited clinical lab.
1,Cluster trials are appropriate to evaluate interventions targeted at health professionals.
0,The MFI scales each rate symptoms from 4 (low) to 20 (high).
1,Thus Support and Assessment for Fall Emergency Referrals 1 (SAFER 1) was a cluster trial with paramedics as the unit of randomisation.
0,"In addition, blood sample collection for ADA was done for all patients at pre-dose and 7 days after injection during the first step and at pre-dose and 14, 28 days after the injection in the second step."
4,We recruited patients at two UK study sites from November 2009 until October 2010.
0,They were asked to rate ‘how was today’s session for you’ on a 5 point scale (1: awful to 5: great).
4,"Delays in implementing a national information technology programme [25] reduced these from three to two: Site one, an urban centre where we recruited paramedics from four ambulance stations; and Site two, where we recruited paramedics from nine stations across a mixed urban and rural area."
0,"The Longitudinal Follow-Up (LFU) program is a prospective follow-up program [16] in COPDGene using automated telephone and web-based surveys every 3–6 months to monitor incident exacerbations, comorbidities, and death [15]."
6,"Effectiveness – proportion of participants left at scene without conveyance to an Emergency Department and proportion referred to falls services Safety – proportion of participants with adverse events (harm) up to one month (999 call, Emergency Department attendance, emergency admission to hospital, or death); Cost-effectiveness – comparison of costs of implementation of CCDS for paramedics and its benefits in the form of patient utility modelled over 12 months."
0,"In addition to patients' characteristics, we collected the data on mRS before the onset of the stroke, NIHSS score, the time from onset of symptoms or stroke to receipt of medical care, the use of intravenous rt‐PA, and the classification of the stroke."
8,The study sample size calculations have already been described.14
0,Quality control is performed on control libraries using Qubit fluorometric measurement (Life Technologies) and Caliper LabChip XT microcapillary gel electrophoresis.
1,The prospectively collected medical records of a cohort of AMI patients were reviewed to assess the occurrence of chest pain and ischaemic atherosclerotic disease in any arterial bed in the 90 days prior to AMI.
0,"A research team was trained to measure height to the nearest 0.1 cm, using a stadiometer, and weight to the nearest 0.1 kg, using electronic weighing scales which were calibrated daily."
3,"Eighty end-stage renal disease patients starting CAPD from dialysis centers of 8 hospitals of the Catholic University of Korea, College of Medicine were enrolled from June 2007 to February 2009."
0,"Finally, in all three countries, detoxification, if necessary, is offered before treatment."
3,"Exclusion criteria included bedridden status, dependency on tube feeding, advanced liver cirrhosis, and current malignancy."
0,All participants were asked to record their daily steps (see below) and fill out monthly medical symptoms questionnaire forms.
8,"The sample size was based on a power analysis to detect a 30% difference in proportion of patients with less than 50% reduction of RRF between two groups (α=0.05, 1-β=0.8)."
0,"Many hospital-wide policies, such as on nutrition, mental capacity, infection control, end of life care, continence, falls prevention and medicines management are of great relevance to patients with delirium and dementia, and these are promoted on an ongoing basis."
8,This resulted in a sample size of 39 patients in each group.
0,"This study was a prospective, two-center cohort study of 50 consecutive patients."
3,"This analysis includes women who participated in three multi-centre trials at sites in KZN: Methods for Improving Reproductive Health in Africa (MIRA) trial [12], conducted in rural Umkomaas and Botha’s Hill; Microbicides Development Programme (MDP) Feasibility study in preparation for Phase III Microbicide Trials [13], in semi-rural Tongaat and Verulam; and HIV Prevention Trials Network (HPTN) Site Preparedness study (HPTN 055) for future implementation of Phase 2/IIb/III HIV Prevention Studies [14], in an urban area in Durban and in a rural district of Hlabisa."
0,cfPWV was calculated by dividing the measured distance between the carotid and femoral sites of pulse wave capture by the time between the foot (initial sharp upstroke) of the carotid pulse wave to the foot of the femoral pulse wave.
3,Study populations were described elsewhere in detail [12-14].
0,"From each patient, 5 to 10 random colonies grown on modified MRS agar were individually inoculated into MRS broth medium (Oxoid, Basingstoke, United Kingdom) for 2 days, at 37°C under anaerobic conditions (Anaerogen® Oxoid, Basingstoke, United Kingdom)."
1,"This was a prospective, multicentric, randomized, open-label, comparative Phase III study."
0,"Myocardial protection was achieved using antegrade, cold, St."
8,"Using Optimal Design software,24 we determined that a sample size of 252 schools with a minimum of 10 students for each school conferred 90% power, with an α of 0.05, intraclass correlation of 0.15, and explained variation by covariates (R2) of 0.50, to detect a difference of 0.20 standard deviations in endline math score between intervention arms and the control group."
0,It includes a central monitoring activity for efficacy and safety and an on-site monitoring.
16,Between-group comparisons were performed using a 2-sample t test with unequal variances.
0,The coronary artery flow velocity waveform appears as a complex of a small wave in systole and a large trapezoid wave in diastole (Figure 6A).
3,All pregnant women and their home- or facility-born live births within participating clusters will be eligible for enrollment in this study.
0,"A total dose of 42 Gy in 15 fractions over 3 weeks was prescribed to the same target volumes as the conventional arm: chest wall in case of MA or whole breast in case of BCS, and to the supraclavicular, infraclavicular and axillary nodes in case of pN1 status."
6,The primary outcome measure was change in fasting insulin at 6 months.
0,"In addition, African Americans are less likely than Caucasians to opt for hip or knee replacements [47] and more likely to manage OA through home remedies that often have little to no evidence of effectiveness (such as copper bracelets or herbal medicines) [48]."
6,"Pre-specified secondary outcomes were 6-month change in body weight, HOMA-IR, glucose, waist circumference, blood pressure, total and HDL- cholesterol, triglycerides, leptin, and adiponectin."
0,RNA was extracted from untreated cells using RNeasy Mini Kit (Qiagen).
14,"It was not possible to blind study participants to their allocation to stimulation and, for ethical reasons, we did not use a placebo for micronutrients."
0,The second group was a control group that consisted of patients with no systemic disease from the Periodontology Clinic of the School of Dentistry at UFJF.
14,"However, testers and interviewers were blind to the treatment status of participants."
0,"Two annual refresher campaigns (4 weeks in duration) are offered using in-person sessions, email or other Internet modalities to offer different approaches to appeal to different participants."
5,"The intervention scheme adapts and simplifies international and applicable national clinical guidelines for hypertension and cardiovascular disease management for use by local CHWs to manage cardiovascular high-risk patients in an easily implementable, low cost, and medically effective way [23, 40]."
0,"Primary and secondary outcome measures, occurrence of any serious adverse event and occurrence of any non-serious adverse event were presented to the DMC under blinded codes for the 2 arms of the trial."
5,"Local CHWs will be trained to provide basic monthly follow-up care to identified high-risk patients, and refer them to higher level healthcare facilities when necessary."
0,Upper half of the diagram (unloaded): biological agent-based model of the wound healing; lower half of the diagram (loaded): mechanical model of the breast.
16,"In both studies, all enrolled patients who received at least one dose of romidepsin were included in the safety analysis."
0,"We will use the fixed-sequence procedure starting with the primary outcome and followed by the secondary outcomes, and the exploratory outcomes ordered according to descending power (see Table 2)."
16,"In the analysis of treatment-related grade ≥ 3 AEs by patient characteristics, the percentages of patients with common AEs in various patient subgroups were compared by Fisher’s exact test, with P < .05 demonstrating significant differences in AE rates."
0,"The primary outcome was time to first cardiovascular event after diagnosis of diabetes, including cardiovascular mortality, cardiovascular morbidity (non-fatal myocardial infarction and non-fatal stroke), revascularization and non-traumatic amputation."
8,"A sample size of at least 84, divided into three groups, provides a power of 80% to detect the minimum effect size that was observed previously in a cardiovascular population13 with a two-sided α-value of 0.05."
0,"Blood samples from all subjects were collected immediately prior to the injection (H0), and at 3 (H1), 8 (H2), 12 (H3), 18 (H4), and 24 (H5) hours after the injection."
3,Participants recruited from England who returned the study-entry questionnaire prior to 2 July 2010 (censorship date—see ‘breast cancer notification’).
0,Cultured fibroblasts from a skin biopsy were analysed to verify oligonucleotide-induced splice switching of exon 51 in all patients.
3,Women recruited from Northern Ireland and Wales were excluded as HES was only available for women residing in England.
0,We considered patients to have side effects of moderate severity if they reported the symptoms for more than half of the time during the previous month.
1,"This was an open-label, multicenter study conducted from October 30, 2007, to January 22, 2008, at 2 medical clinics in Fukuoka and Tokyo, Japan."
0,All potentially eligible women were supplied with study information in the antenatal period and given time to consider participating.
1,"The Institutional Review Board of Kyushu Clinical Pharmacology Research Clinic 2-13-16, Jigyo, Chuo-ku, Fukuoka approved the study."
0,"The changes in I-QOL scores were analyzed using an ANCOVA model that included terms for baseline scores, treatment, site, and baseline incontinence severity."
1,"This is a case–control, cross-sectional study, which compares pain (frequency, severity and interference) and PPTs in adolescents with CFS to a comparable group of healthy adolescents."
0,"This included referrals registered by the GPs, duration of pain, GPs’ assessment of improvement in patients’ symptoms, as well as tertiary outcomes which included a description of how many patients were scored with The STarT Back Tool by the GPs, how often the GPs assessed their quality report, and a process evaluation (tertiary outcome) of GPs’ skills, beliefs, and behaviours and the patients’ beliefs and behaviours [9]."
1,"The study is part of the NorCAPITAL project (The Norwegian Study of Chronic Fatigue Syndrome in Adolescents: Pathophysiology and Intervention Trial; Clinical Trials ID: NCT01040429), which explores possible mechanisms of CFS, the effect of low-dose clonidine treatment and patients’ experiences in adolescents with CFS.15"
0,Passive case monitoring (PCD) for malaria episodes was conducted at the health facilities within the study area throughout the study period.
6,The primary outcome of this study was to assess the mortality of the futhan group and compare it to the mortality of the no-anticoagulation group.
0,The primary objective of the study was to determine whether lung cancer screening with CAD chest x-rays reduces the incidence of symptomatic advanced lung cancer compared to no screening in a high-risk population.
6,"The secondary outcome was to evaluate filter life span (overall filter, filter containing clot at exchange, filter changed due to clotting), transfusion, and adverse events."
0,The population is ethnically heterogeneous but the indigenous inhabitants are Basoga.
3,Healthy participants (male and female) aged 19–40 years were enrolled.
0,It also reduced the likelihood of spillover effects between treated and untreated children within a household.
3,"Exclusion criteria were as follows: previous administration of any influenza vaccine including any A/California/7/2009 (H1N1)v-like virus vaccine, administration of any vaccine within 30 days before first vaccination, use of investigational or nonregistered products, confirmed or suspected immunosuppression, receipt of immunoglobulins or blood products within 9 months preceding the study, and known or suspected allergy to any of the vaccine constituents."
0,Postdialytic BP was measured once in a non-standardized way (clinical routine) and was not used for adjustment of antihypertensive medication and dryweight assessment.
14,"Participants were blinded to group allocation, i.e. neither group was told that this was a trial about self-weighing; the information sheet informed patients that it was a trial about losing weight."
0,A two‐group chi‐squared test with a 0.05 two‐sided significance level will have 80% power to detect the difference between a group 1 proportion of responders of 0.30 and a group 2 proportion of responders of 0.80 (odds ratio 9.33) when the sample size in each group is at least 15 subjects included in the study.
14,Independent researchers measured participants’ weight at three months.
0,"Following drug addition, the plate is incubated for 30 min at 37° C in a 5% carbon dioxide humidified atmosphere incubator."
6,Primary birth outcomes were birth weight and rates of low birth weight.
0,The instrument measures the intensity of the light to quantify a measure of each analyte.
14,"Patients were told that the study was to compare two different ways of giving information about possible test results and treatments but not what the two formats were (pamphlet and discussion), or that one (the pamphlet) was considered to be the control arm."
0,"A detailed list of foods was given to each participant to allow appropriate dietary choices without imposing restrictions on the total consumption of fruit, vegetables, and beverages (i.e., the total consumption of fruit and vegetables was not restricted; the recommendation was simply made to modify the types of these foods consumed)."
14,Staff treating patients in the RACPC appointment were not informed of treatment group allocation.
0,The composition of SQ-LNS was the same for the four intervention formulations except for their zinc content.
3,Patients eligible for inclusion in this study were male and female adults aged 40 years or older with a diagnosis of moderate COPD according to the spirometric classification of the “Global Initiative for Chronic Obstructive Pulmonary Disease” (post-bronchodilator forced expiratory volume in one second (FEV1) <80% and ≥50% of the predicted normal value and a post-bronchodilator ratio of FEV1 to forced vital capacity (FVC) <70%) and a smoking history of at least 10 pack years.
0,"We present the baseline characteristics for the first 40 subjects who have enrolled and initiated on-site HCV treatment through June, 2010): Of these, 21 were randomized to the mDOT arm and 19 to the TAU arm."
3,"Key exclusion criteria were a respiratory tract infection or exacerbation within 6 weeks prior to study entry, a history of asthma or any corticosteroid use (inhaled or systemic application) within the last three months prior to study entry, any other concomitant lung disease, or any clinically significant condition which in the opinion of investigator might compromise patient safety or compliance, interfere with evaluation, or preclude completion of the study."
0,Peripheral edema was defined as an increase of 10% or more in ankle circumference from baseline combined with pitting edema.
16,Results are described primarily with descriptive statistics.
0,"For allocation of the patients, we used a computer-generated list of random numbers in blocks of six (two patients allocated to each group) generated by an independent researcher at the local university."
16,Correlation between recruitment status and the date last updated was assessed with one-sided Mann-Whitney U-tests using R 3.0.2 [26] on Mac OS X 10.9.
0,All analyses were performed with R ver.
1,"ANHELTO 1 (Study 1222.51)14 and ANHELTO 2 (Study 1222.52)15 were replicate, 12-week, randomized, double-blind, parallel-group, multicenter trials to assess the efficacy and safety of 12 weeks of once-daily coadministration of tiotropium 18 μg (via the HandiHaler®) and olodaterol 5 μg (via the Respimat® inhaler) compared to once-daily coadministration of tiotropium 18 μg (via the HandiHaler®) and placebo (via the Respimat® inhaler)."
0,The mean value of the uninjured contralateral wrists was 21.3°.
1,"The studies were registered with Clinical-Trials.gov, identifying numbers NCT01694771 (ANHELTO 1) and NCT01696058 (ANHELTO 2)."
0,"As a group, the Cohort A individuals receiving placebo (PBS without adjuvant) were sero-positive at baseline but did not mount serum responses to the vaccine antigens [37], therefore sera from this group were not included in further analyses of cross-reactive Ab responses."
8,"On the basis of our prior study, an estimated sample size of 230 total patients will provide 90% power, with a one-tail α = 0.05, and standard deviation of 13 mmHg to detect a 5.0 mmHg difference between two arms in change on systolic blood pressure at 3-month follow-up from baseline, with a 1:1 allocation of 115 to each treatment arm."
0,"Moreover, the weekly meetings consisted of group dialogues about both on-going practice and topics related to stress biology and stress reduction."
8,We assumed a 20% of participants lost to follow up and thus a total of 287 participants should be recruited.
0,The order of these two sets was randomized over the two test days.
3,Five healthy men were recruited through local advertisement and provided written informed consent.
0,"Next, a translator who had not seen the original questionnaire back-translated the combined translation into German."
3,The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)–National Institute of Arthritis and Musculoskeletal and Skin Diseases Institutional Review Board approved the study: Impact of Chronic Cold Exposure in Humans (ICEMAN).
0,"Exclusion criteria were clinical or laboratory signs of severe malaria,2 inability to tolerate oral drugs, or having received any other antimalarial treatment within 14 days before admission."
16,"All statistical analysis was performed using PASW Statistics for Windows, Version 18.0."
0,"Other exclusion criteria included a diagnosis of asthma, extensive bronchiectasis, sequelae of tuberculosis, pleural thickening, or restrictive diseases."
3,"Participants in the study were primarily recruited through advertisements in newspapers, but also from previous clinical or epidemiological trials."
0,VSCs were identified by characteristic retention times and were quantified via comparison of their peak area with that of dilutions of standards.
3,"In brief, the inclusion criteria were age 30–65 years, body mass index (BMI) 27–40 kg/m2, and two diagnostic criteria for metabolic syndrome as outlined by the International Diabetes Federation [28], except type 2 diabetes."
0,"Pregnancy in a patient or patient’s partner was to be reported as an SAE, even if no AE occurred in the mother or child."
3,"The following inclusion criteria were adopted: (a) diagnosis of unipolar major depression (clinical diagnosis, guided by DSM-IV criteria); (b) an episode of DSH in the previous 12 months; (c) inadequate response to at least two antidepressants given sequentially at an adequate dose for an adequate time for the current depressive episode; (d) uncertainty about which treatment arm would be best for the participant; (e) age 18 or above; (f) to sign written informed consent."
0,"If the target were absent, participants would click on the “None” button."
3,"The following exclusion criteria were adopted: (a) a primary diagnosis of any concurrent Axis I disorder (according to DSM-IV criteria) other than major depression (by contrast, any concurrent DSM-IV Axis II disorder was not an exclusion criterion); (b) previous exposure to lithium associated with lack of efficacy or adverse reactions; (c) clinical conditions contraindicating lithium (i.e., thyroid or kidney disease/abnormalities); (d) pregnant/lactating women and women of childbearing potential not practicing a reliable method of contraception."
0,"Serum, plasma samples and whole blood will be collected and stored for analysis in our core biomarker facilities."
3,"Study participants were healthy HIV-1-seronegative men and women with a history of consensual rectal anal intercourse, willing to abstain from vaginal and rectal sex during active protocol phases."
0,Informed consent was obtained by the researchers from all participants after detailed written and verbal information was provided regarding the study and its procedures.24
3,"Female participants were required to be using an acceptable form of contraception (e.g., barrier method, IUD, hormonal contraception, surgical sterilization, or vasectomization of male partner)."
0,"The biomarkers were measured by Crescendo Bioscience (South San Francisco, California, USA)."
6,The primary endpoint was the effect of the ATII infusion on the standing dose of norepinephrine that was required to maintain a MAP of 65 mmHg.
0,Changes to medication were ultimately left to the investigator’s clinical judgement.
6,"The secondary endpoints included the effect of the ATII infusion on urine output, serum lactate, cardiac output, and 30-day mortality."
0,"The following variables were adjusted for in our analyses: age, sex, race/ethnicity (White; Chinese; Black; or Hispanic), education (less than high school; high school or vocational school; college, graduate or professional school), study site, scanner type, annual family income (categorized as $24,999 or less; $25,000 to $49,999; $50,000 to $74,999; and $75,000 or greater), cigarette smoking status (categorized as current; former; never), second-hand smoke exposure (in hours per week) and physical activity level (METS*minutes/week of moderate or vigorous activity)."
16,Between-group baseline variables were compared using one-way analysis-of-variance (ANOVA) for continuous outcomes and chi-squared tests for dichotomous ones.
0,Over the first month the duration of the aerobic activities were gradually increased.
6,"In addition to collecting demographic and smoking-history information, measures assessing understanding of the educational material were collected at the baseline assessment."
0,CRP was measured in all patients in the biomarker sub-study (n = 740).
6,"Assessment of the participant's recall and interpretation of their test result was performed at the first follow-up call, while questions about their desire to quit smoking and smoking behaviour were administered at the baseline assessment, first and second follow-up calls."
0,The 360QS technology was tested within a research project for childhood obesity in Qatar called ”Adaptive Cognitive Behavioral Approach to Addressing Overweight and Obesity among Qatari Youth” (ICAN Study) [4].
6,"The primary outcome was the FBF response to the intrabrachial administration of incremental dosages of dipyridamole, after treatment with eplerenone, compared to placebo."
0,"The model also predicts that there would be drug, placebo, and drug*placebo interaction effects on drowsiness and mouth-dryness, only placebo effect on nausea, and no drug or placebo effects on itchiness."
6,"Secondary outcomes were the FBF response to the intrabrachial administration of incremental dosages of dipyridamole with concomitant administration of caffeine, and the FBF response to incremental periods of arterial occlusion."
0,"Participating patients fill out a questionnaire at baseline (the start of treatment, defined as day 1), then daily until day 15 and a final questionnaire at day 29."
1,"TOP is an ongoing, open-label, multinational, multicentre, prospective, observational study conducted in clinical practice settings in Europe, Australia, Canada and Argentina."
0,"The overall HAQ-DI score is on a scale of 0–3, zero indicating no disability and 3 indicating complete disability [9]."
1,"Patients receive natalizumab 300 mg intravenously over approximately 1 h, every 4 weeks."
0,"Fasting blood samples were collected (typically between 7 and 9 am) at weeks 0, 8, 14, and 22."
1,"This is a multicentre, prospective observational study of consecutive patients undergoing emergency intraperitoneal surgery that will be carried out by participants during 14-day, consecutive time periods of the individual participant's choice during a 5-month study period window."
0,Participants and study design are described in detail in S1 Text and S1 Fig (Flow chart).
4,Clinical data with regard to baseline characteristics and outcome are collected during hospital admission using a standardised case record form (CRF).
0,"Underlying chronic restrictive cause of respiratory acidosis, such as severe chest wall abnormalities."
4,An independent monitor checks all endpoints and at least 10% of the CRF data with on-site source data.
0,"AMG 208 plasma concentrations were determined by liquid chromatography-tandem mass spectrometry from samples collected predose, 0.5, 1, 2, 4, 8, 24, and 48 or 72 hours after dosing on day 1, and pre-dose, 0.5, 1, 2, 4, 8, 24, and 48 hours on day 28."
6,The list below represents the full range of outcomes relevant to the five intervention pairs being evaluated.
0,Baseline assessment consisted of recording of demographic and disease-specific characteristics of participants to identify differences in prognostic indicators between the two intervention groups.
16,A detailed Statistical Analysis Plan (SAP) will be developed and agreed by the Study Steering Committee (SSC) before the analysis is undertaken.
0,"Fig. 2 Suggested algorithm for the management of patients with breast cancer diagnosed during pregnancy Regarding anticancer treatments, surgery can be safely performed at any time during the course of gestation and should follow the same guidelines as for non-pregnant cases."
1,We recruited patients with advanced cancer referred to BIS into a Phase III mixed-method single-blind pragmatic fast-track (waiting list) RCT of BIS versus standard care (November 2008 to January 2012).
0,"The GT3X+ has been found valid for the assessment of physical activity in healthy adults [35, 36] with an inter-instrument correlation coefficient between 0.90 – 0.99 [37] and an intra-instrument coefficient of variation of ≤2.5% [38]."
1,Ethical approval was given by by Cambridgeshire 2 NHS REC (Ref:08/H0308/157); RCT registration at ClinicalTrials.gov NCT00678405 and Current Controlled Trials ISRCTN04119516.
0,Exploratory efficacy measures included reduction in frequency of moderate or severe headache days.
8,"A sample size of 60 randomised patients (26 analysed per arm, allowing for dropout) provided 80% power to detect a 2-point difference in mean distress at two-weeks between groups (SD = 2.5, alpha = 5%), with increased precision anticipated from adjustment for baseline."
0,All eligible randomized patients will be included in the analysis (intent-to-treat).
4,The data collection consists of text messages and questionnaires.
0,Eligible patients who have signed a consent form to take part will be randomised by an administrative assistant at the University of Southampton with no prior contact with the patient.
4,At baseline the participants also received physiological health measures for describing the health of the population.
0,"These sensory assessments will be carried out following the protocol defined by Klingels et al. [34], which has been shown to be reliable in this population."
1,Patients participate in an initial open-label treatment period of 21 days of CNV1014802 using 150 mg three times daily.
0,This primarily consists of regular follow up visits (as advised by their neurologist) with their stroke neurologist.
1,Responders are then randomized to 28 days of CNV1014802 150 mg three times daily or placebo.
0,Treatment utilization was determined via automated enrollment records.
3,All practices were asked to identify patients with dementia by using electronic searches of their clinical record system updated by manual checks of the resulting list by medical and nursing staff.
0,The group interviews indicated that most parents understood the benefits and the therapeutic role of PA for their children.
8,"For a statistical power of 80%, a random error of 5% and a response rate of 30% in the treatment group in comparison with the placebo group, and a 50% reduction in symptom scores after the second day of follow-up in the placebo group, the sample size was calculated as 132 patients (66 in each group) [22]."
0,"All others are defined as ""non cases""."
8,"To account for a possible loss to follow-up of 10% of the volunteers, 146 patients were included in the study (73 in each group)."
0,bolus dose of 30 mg of ketorolac was administered upon request from the patient or when the VNRS pain score was ≥ 6.
1,"This is a prospective observational cohort study of patients with, or at risk for, HF."
0,"However, cost and logistical limitations prevented us from extending implementation beyond the compound."
1,"This is a randomised, double-blind (practitioner-patient blinding), placebo-controlled study performed in a single centre including four arms: treatment with penetrating needles (penetrating treatment), treatment with skin-touch placebo needles (skin-touch placebo treatment), treatment with no-touch placebo needles (no-touch placebo treatment) and control with no treatment (no-treatment control) [23-29]."
0,Figure 1 Determination of rotational mismatch between femoral and tibial component.
6,Improvement of neck/shoulder stiffness score immediately and 24 hours after the treatment are primary outcomes.
0,"A total SBT score of ≤3 points indicates low risk, and patients with a total score ≥4 points in combination with <4 points on the psychosocial subscale (item 5–9) are at medium risk."
6,"Practitioners’ and patients’ guesses at treatments and their confidence in their guesses and, pain and de-qi felt during treatment by the patients are secondary outcomes."
0,"The patients from the PBO + MTX group, who received rescue therapy, were designated escapers."
17,"The proportion of patients achieving a ≥2-g dL−1 increase in Hgb at any time from baseline to Week 5 and the mean change in Hgb from Baseline to Week 5 were also analyzed in five predefined subgroups based on the patients' primary underlying cause of their IDA, as attributed by the investigators (i.e., patients with abnormal uterine bleeding (AUB), cancer, GI disorders, postpartum anemia, or other conditions [e.g., patients with nutritional deficiency, heart failure, and rheumatoid arthritis])."
0,"Waist circumference was measured using a non-elastic flexible tape measure, 4 cm above the umbilicus."
1,"Controlled, pragmatic, randomized clinical trial with an intervention and control group that will not present differences in any studied characteristics a priori."
0,"The electrophoretic characteristics of LDL-c were assessed by non-denaturing polyacrylamide gradient gel electrophoresis, using serum obtained at baseline and at week 12, stored at −70°C [22]."
1,"All medium to large size HCCs from the area will be offered participation and randomly allocated, 7 to the intervention group and other 7 to the control group."
0,"Gene ontology (GO) terms under the categories of biological processes, cellular components, and molecular functions with top three counts of genes included during DAVID analysis were retrieved."
1,We conducted a cohort study nested in a randomised controlled trial.
0,"The interassay coefficient of variation values for samples with low autoantibody levels were 11% (IAAs), 18% (GAD antibodies), and 16% (IA-2As).Statistical analysis"
1,A random group of GPs were offered a technological upgrade consisting of direct access to chest LDCT combined with a simple Continuing Medical Education (CME) meeting on lung cancer diagnosis.
0,"The same experienced investigator, who was blinded to the statuses of the individual patients, performed all of the measurements."
3,"Inclusion criteria included patients at least 18 years of age presenting with CIA (irrespective of chemotherapy cycle) associated with solid tumours, lymphomas or myelomas and eligible for treatment with an epoetin alfa biosimilar."
0,"This phase IIb, open, randomized, controlled study was conducted between December 2006 and February 2013 in two centers in the Philippines (Research Institute for Tropical Medicine in Muntilupa City and Philippine General Hospital in Manila) and one center in Saudi Arabia (King Abdulaziz Medical City in Riyadh)."
3,"Exclusion criteria included absence of chemotherapy treatment, presence of any contraindications for epoetin, hypersensitivity to any of the treatment components, previously confirmed pure red cell aplasia (PRCA), uncontrolled hypertension, lack of access to anti-thrombotic prophylaxis, or involvement in another biosimilar epoetin study."
0,All blood and breast milk specimens were stored below -80°C until testing.
4,"The Mexican Social Security Institute (MSSI) includes offices for primary, secondary and tertiary health services as well as facilities designed to develop PA programs (sports fields, gyms, pools and outdoor spaces for PA) called Social Security Centers (SCC)."
0,Blood samples were collected for biochemical analysis at baseline and 3 months after PT.
4,The SCC have specialized staff to guide and assist on promotion and practice PA in all potential participants.
0,"All samples were run in duplicates, and the average concentrations were used for statistical analysis."
3,"The inclusion criteria are: • women 18–45 years • a singleton pregnancy • 6–14 weeks of gestational age • viable pregnancy • delivery planned in the hospital where the study is performed The exclusion criteria are: • < 18 years or > 45 year • multiple pregnancy • known diabetes or treatment with metformin • non-viable pregnancy (miscarriage) • chronic medical condition (uncontrolled hypertension, severe heart disease, severe chronic liver disease, severe chronic kidney disease, chronic infections such as HIV and hepatitis) • bariatric surgery • gastro-intestinal surgery changing the absorption of glucose (e.g."
0,"During the 3rd visit, the radiography, sonography, PPM test, WOMAC index and compliance of study medication intake results were assessed by doctors."
8,"We estimated needing 150 participants in each arm using the test for paired means, based on a moderate effect size (0.50), 80% power, a two-tailed 5% significance level, a design effect of 1.5, and an expected dropout rate of up to 50% (due to frequent cross-border movement)."
0,"Exclusion criteria were: inability to obtain informed consent, care pathway anticipating admission elsewhere than to ICU following surgery, severe visual impairment impeding ability to recognize self in mirror, physical or communication barriers likely to impede effective administration of study procedures, severe mental disability likely to impede assessment of delirium, and history of psychiatric illness previously requiring hospitalization."
8,"We used 1.5 for the design effect as indicating a moderate effect, given that we had no similar studies to compare to."
0,The study was inspected and approved with minor comments by the Danish Medicines Agency before initiation (approval no: 2612-3851).
6,The primary endpoint was pain during 45 degrees flexion of the knee at 4 hours postoperatively.
0,We will also interview a subset of clinicians and administrators to contextualize and extend findings from the quantitative data collection.
6,"Secondary endpoints were pain at rest and during flexion of the knee (calculated as area under the curve, 1–8 h and at 24 h), cumulative morphine consumption (0–24 h, 0–8 h and 8–24 h), number of vomiting episodes, ondansetron consumption and degree of nausea and sedation (mean value 1–8 h and 24 h)."
0,Thermal energy comes from absorption of mechanical energy.
4,"Participants were recruited through service providers and agencies serving individuals who are homeless and mentally ill in Vancouver, including shelters, drop-in centers, street outreach workers, hospitals, police, and courts."
0,The content of the letter incorporated both a reminder and educational element based on a similar study using a mailed educational reminder for colonoscopy screening16.
4,"An effort was made to locate individuals throughout Vancouver, while recognizing that the majority of visible homelessness and related services were concentrated in one area."
0,All AEs will be followed up until resolution.
6,Methods used for tumor assessments and clinical outcomes have been published previously [10].
0,"Participants included in the CCAT group were also undergoing standard treatment; in addition, the participants received the CCAT training program that lasted for 4 weeks (20 sessions, five times a week, each session lasts approximately 60 minutes)."
3,"Eligible patients will meet all the following inclusion criteria: (1) Men or women aged 50 years and older (with no upper age limit); (2) Fracture of the femoral neck confirmed with anteroposterior and lateral hip radiographs, computed tomography, or magnetic resonance imaging (MRI); (3) Operative treatment of displaced fractures within 4 days of presenting to the emergency room, or operative treatment of undisplaced fractures within 7 days of presenting to the emergency room; (4) Patient was ambulatory prior to fracture, though they may have used an aid such as a cane or a walker; (5) Anticipated medical optimization for operative fixation of the hip; (6) Provision of informed consent by patient or a legally appointed representative; (7) No other major trauma (defined as an Injury Severity Score >16); and (8) Low energy fracture, in the judgment of the attending surgeon."
0,Data queries are managed by a single data manager.
3,"We will exclude patients meeting any of the following criteria: (1) Patients not suitable for internal fixation (i.e., severe osteoarthritis, rheumatoid arthritis, or pathologic fracture); (2) Associated major injuries of the lower extremity (i.e., ipsilateral or contralateral fractures of the foot, ankle, tibia, fibula, knee, or femur; dislocations of the ankle, knee, or hip; or femoral head defects or fracture); (3) Retained hardware around the affected hip; (4) Infection around the hip (i.e., soft tissue or bone); (5) Patients with disorders of known bone metabolism except osteoporosis (i.e., Paget’s disease, renal osteodystrophy, osteomalacia); (6) Patients with a history of frank dementia that would interfere with assessment of the primary outcome (i.e., revision surgery at 24 months); (7) Likely problems, in the judgment of the investigators, with maintaining follow-up (i.e., patients with no fixed address, report a plan to move out of town, or intellectually challenged patients without adequate family support); and (8) Exclusion of a patient because of enrolment in another ongoing drug or surgical intervention trial will be left to the discretion of the attending surgeon, on a case-by-case basis."
0,The patients will continue taking their usual medication to control TS symptoms or associated comorbid pathologies.
6,"Mothers completed a self-administered questionnaire at baseline, when children were approximately four months of age."
0,"Specifically, diastolic dysfunction was defined as E/Ea≥15, or 8<E/Ea<15 with any of the following: LAVI>40 mL/m2 or LVMI>149 g/m2 (male) or LVMI≥122 g/m2 (female).24, 25"
6,"Data was collected regarding the child’s birth date and birth weight, as well as mothers’ education level, self-reported pre-pregnancy height and weight (utilized to calculate maternal BMI), and birth date (utilized to calculate maternal age at childbirth)."
0,During the open extension study from three to four years the treatment strategy continued to aim at tight synovitis control.
6,Changes in baseline DLL measures at 12 months postoperatively in both groups.
0,"The remaining two specimens from the lesser curvature of the antrum and body were used for the rapid urease test (CLO test; Delta West, Bentley, Australia)."
6,"The primary endpoint was prepatent period, defined as the time between challenge and first positive thick blood smear."
0,"To assess treatment fidelity, six tapes, chosen at random, were rated on the Cognitive Therapy Scale–Revised33 by an independent clinical psychologist experienced in CBT for psychosis."
6,"Secondary endpoints were parasitemia and kinetics of parasitemia as measured by qPCR, adverse events and immune responses."
0,"Both sensitivity analyses were adjusted for the baseline covariates pregnancy intention, gender, age, education level and acceptability."
3,"This study is part of an epidemiologic survey of epilepsy conducted in 2008, in which 738 people of all ages had active convulsive epilepsy, defined as at least two unprovoked convulsions, with one in the 12 months prior to being assessed.12"
0,The cut-off of 40% was used to ensure that all stenoses in the intermediate group i.e 50 -70% were interrogated with the pressure wire.
3,Recruitment of PWE involved in this study started in August 2009.
0,"The preprandial and basal amount, respectively, took up to 50% of integral dose."
16,"For the statistical analysis of data, JMP v9 software was used (SAS Inc.)."
0,Strategies to foster agency support for evidence-based chronic disease prevention in partnership with public health practitioners.
3,● Established critical limb ischaemia ● Insulin dependent diabetes mellitus ● Active leg ulceration ● Open fractures ● Serious concomitant disease - metastatic disease or terminal illness ● Clinically substantial degenerative or inflammatory arthritis (in the ankle) ● Unfit for general anaesthetic ● Cognitive impairment - Mini-Mental State Exam (MMSE) of under 16/30 [27] ● Patient unwilling to give informed consent.
0,"If available, free breathing single‐shot LGE images with steady‐state free precession readout were also acquired."
1,This research is conducted as a parallel randomized clinical trial with follow-up.
0,Further advances in immunologic assays will occur and may be utilized.
1,The study subjects are randomly allocated into intervention and control groups.
0,"For the isometric test, the lower leg position was fixed at 60° of knee flexion and subjects were instructed to perform a maximal force voluntary contraction of the knee extensors."
1,This was a prospective randomized trial conducted in four ICUs at Bellvitge University Hospital from 1 January 2006 to 28 February 2009.
0,"Body length was measured to the nearest 1 mm on a Harpenden neonatometer (Holtain, Crymych, UK)."
1,The study protocol was approved by the Ethics and Clinical Research Committee of Bellvitge University Hospital.
0,The idea for a ‘buddy system’ or peer support on discharge was suggested by the service user researcher on a previous study [35].
6,"A blinded research nurse performed standardized height/weight assessments at PCP sites and administered questionnaires, i.e., demographics, depression, stress, use of antidepressant medications."
0,Automatically generated emails requested participants to complete a brief follow-up questionnaire and included a hyperlink to Web-based questionnaires.
3,"A population of 49 healthy, male and female, non-smoker volunteers (age 18 to 50 years) was screened, after a written informed consent was obtained from each subject."
0,The best overall response was the best response recorded from the start of the treatment until disease progression/recurrence (taking as reference for PD the smallest measurements recorded since the treatment started).
3,They were excluded if they used drugs within 2 weeks or over-the counter medication.
0,All volunteering women included used a combined oral contraceptive (COC) pill upon inclusion and were instructed to continue their COC for the duration of the study to avoid withdrawal bleeding.
1,A qualitative study exploring factors influencing the engagement of GPs in insulin initiation in a context where a support program is provided and exploring factors relevant for future program development.
0,Balance data were collected at baseline and after week four (12th session).
4,Participants will be recruited from the pediatric kidney transplant clinics at participating centers and their affiliated adult clinics over a 30-month interval.
0,Using the information on costs and benefits an incremental economic analysis comparing the tailored exercise intervention to treatment as usual will be undertaken to estimate mean cost-effectiveness.
4,"The recruitment goal of 176 participants accounts for up to 15% drop out, with the aim of having at least 150 participants complete the study."
0,Table 4 Proportion of subjects with pneumococcal polysaccharide antibody concentrations >5.0 µg/mL in vaccinated and control villages following vaccination with 1 dose of PCV-7 or serogroup C meningococcal conjugate vaccine (data from CS1–CS3 combined).
1,This is a prospective cross-sectional study which was carried out between March and June 2013 at the Radiology Departments of Aga Khan University (AKU) and Dow University of Health Sciences (DUHS).
0,"Nintedanib was taken orally twice daily at three dose levels (100 mg, 150 mg, and 200 mg twice daily)."
3,"We recruited adult Pakistani patients > 18 years of age who presented to the participating centers for MRI of the Brain for indications other than transient ischemic attack (TIA) or stroke (e.g. headaches, epilepsy, rhino sinusitis etc.)."
0,These notes will be collated and analysed as a source of information for the process evaluation.
3,"Subjects were required to have no history of stroke or TIA, confirmed by a negative result on the Questionnaire to Verify Stroke-free Status (QVSFS)."
0,According to Shi et al. [39] the use of control probes during background correction minimize false discovery rate (FDR).
1,"Multicentre, randomised, masked, parallel controlled trial."
0,Detection of the subgenus Viannia applied the primers 5′-GGGGTTGGTGTAATATAGTGG-3′ and 5′-CTAATTGTGCACG-3′.
1,"This study is a pragmatic, randomised controlled clinical trial (RCT) of parallel groups."
0,A fourth group of never smokers was included for baseline comparisons.
1,This is a multicenter prospective cohort study.
0,"Heart rate, the incidence of angina attacks (within the previous week), and the frequency of use of short-acting nitrates (within the previous week) in patients were documented at baseline and after 1 and 4 months."
8,"Assuming an expected response rate of 55% that is 20% higher than the threshold response rate (35%), 45 patients were determined as necessary to demonstrate that the lower limit of the two-sided 90% confidence interval (CI) of the response rate would exceed the threshold response rate with a power of 80%."
0,"Blood samples (40 mL for ELISpot and 30 mL for ICS) were taken at baseline, on day 29 of cycle 1 and subsequent even‐numbered cycles and, whenever possible, 28 days after the final dose for those who terminated the trial after cycle 1."
16,Continuous variables were summarized as mean ± standard deviation (SD) or median (interquartile range).
0,"The approach has the advantage that less stringent assumptions are made, not only with respect to the covariance structure, but also to the mechanism underlying the missing observations."
8,"We calculated that to have an 85% chance (at a two-tailed 5% significance level) of detecting a difference of five percentage points between the intervention and control groups (3–8%) with respect to OB prevalence at baseline of the EdAl study,18 354 participants would be required in each of the participation groups."
0,The patients were instructed to return the cards 21 days after the vaccination for follow-up.
8,"Allowing for an attrition rate of up to 10%, we aimed for 393 participants in each group."
0,Patients with no prior renal dysfunction who fulfilled any of the criteria below were recorded as having de novo AKI and are referred to hereafter as AKI.
4,"Participating centers are Brest, Rennes, Nantes, Lille, Angers, Tours, Vannes, (France) - public funded specialist mental health services for adults in the Western and Northwestern regions of France."
0,"Educational materials, including posters, flyers, and educational displays, will be made available at worksites."
3,"- Age between 18-35 years; - Male, in order to avoid hormonal influences during the experimental period, especially concerning gingival inflammation; - No relevant medical conditions that could interfere on the periodontal health; - Willingness to comply."
0,"All study data were collected, reviewed, and edited by staff at each study site."
3,- Probing pocket depth >3 mm and/or clinical attachment loss >2 mm at any site; - Antibiotic and/or anti-inflammatory therapy within 3 months prior to baseline examination; - Oral mucosal lesions; - Smokers; - Need for antibiotic premedication; - History of hypersensitivity to CHX; - Any condition device that could act as plaque retentive factor (carious lesions; inadequate restorations; dental implants; orthodontic appliances; fixed or removable prostheses).
0,PWPs were supported by a clinical trial team member or therapists working within their IAPT service during fortnightly supervision sessions lasting up to 30 min.
11,Randomization is performed by the NTNU web-CRF solution with separate blocks and stratification to age and gender for each collaborating hospital.
0,The UTT strategy tested in TasP trial had two main components: (i) repeat home‐based HIV testing (both arms) and (ii) immediate ART initiation (intervention arm).
11,Randomization of a new patient in one of the participating hospitals will generate a coded message to the project group with information of treatment and inclusion number for this hospital.
0,"The QALYs for each participant were calculated by multiplying the time spent in different states of health by the utility score associated with each state, assuming a linear change in utility between time points."
14,Participants were blinded to the study’s hypothesis.
0,"“I'm at my best” to “I'm at my worst”), dizziness (“no dizziness at all” to “more dizzy than ever”) and sleep quality (“worst night's sleep ever” to “best night's sleep ever”)."
14,"They were informed that they were participating in a study on the interpretation of abstracts of systematic reviews, but they were not aware that they were randomized to assess an abstract with or without a limitations section."
0,The primary goal was to ensure that the redesigned study addressed an important research question using a methodologically rigorous design without compromising student safety.
1,"This is a randomized, double-blind (patients and physician), placebo controlled multicenter study, which will be conducted in North America (Canada and United States) and Europe (Belgium, Switzerland and Germany), with an aim to enroll approximately 1,400 patients to evaluate the overall study hypothesis."
0,"Safety assessments include adverse events, monitoring for progression to AML, and second primary malignancy."
16,Data was collected and presented at household and cluster level as the study aimed at assessing the effectiveness of the repellents at the community level.
0,Nutrition counselling was provided by dietitians but was not delivered on the basis of SOC as it was in the IG.
16,Individual level data was not collected.
0,"For later timepoints, this window was increased to 2 h, and extrapolation beyond the last PK measurement was allowed for up to 20 min."
1,This Phase I open label clinical trial designed to evaluate the safety and tolerability of LGG in 10–15 elderly volunteers was requested by the FDA.
0,Patients were also monitored carefully for the development of adverse events (AEs) during treatment with MK-2206 in combination with trastuzumab; AEs were graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events version 3.0.
1,"Oversight and monitoring prior to and during the conduct of this study was provided by an independent Data Safety Monitoring Board (DSMB), FDA/CBER, under IND 14377 and NIH/NCCAM Office of Clinical and Regulatory Affairs."
0,"Subjects will also complete visual analogue ratings of appetite, anxiety, stress and sleepiness, and measurement of fasting and postmeal hormones and metabolites over the study visit.32 63"
6,"The occurrence of serious adverse events, defined as any event which resulted in death, was life-threatening, required initial or prolonged hospitalization, resulted in disability, or required intervention to prevent permanent impairment or damage to a volunteer (http://www.fda.gov/medWatch/report/DESK/advevnt.htm), or adverse events (including an abnormal laboratory or physical examination finding, symptom, or disease) defined as a new Grade II–IV toxicity using the FDA's Guidance for Industry: Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventative Vaccine Clinical Trials (Protocol S1), that were possibly/probably/highly probably related to administration of LGG."
0,"The NEI grid divides the conjunctiva into six regions: far temporal, temporal-superior, temporal-inferior, nasal-superior, nasal-inferior, and far nasal; the intensity of staining in these regions was scored by the investigator using the NEI 0–3 scoring system."
8,A sample size of 10–15 subjects was requested by the FDA for this Phase I study.
0,"Added sugar (servings/day) was calculated from the 7-items selected from the National Health and Nutrition Examination Survey Dietary Screener to capture consumption in the past month including sugar-sweetened beverages, chocolate or candy, pastries, desserts or ice cream [24]."
8,"We elected to study 15 subjects to have a 66% probability of detecting at least one serious adverse event and an 88% probability of detecting two or more serious adverse events, based on the binomial distribution."
0,"Patients with body mass index values between 18 kg/m2 and 38 kg/m2 and plasma HCV RNA levels of >10,000 IU/ml at screening were included."
16,"In accordance with recommendations for the analysis of pilot trials,11 12 a formal power calculation was not carried out, the data analysis is descriptive and statistical comparisons between the randomisation groups have not been undertaken."
0,All SMRs presented herein were computed in this manner.
3,"Patients met the following key inclusion criteria: age ≥18 years at baseline visit; ACR classification of RA, symptom onset of ≥6 months; active disease at baseline (≥3 swollen joints, DAS28≥3.2); no prior ETN therapy or any other TNF inhibitor; an indication for ETN as per approved product monograph; able to continue MTX and received a dose of ≥15 mg/wk (or 10 mg/wk if intolerant) for ≥12 weeks, with the dose being stable ≥4 weeks before the baseline visit; and ability to access ETN with private or public insurance."
0,"The downstream purification, final formulation and vial filling of pSB-728mR plasmid were completed, and the final lot was released."
3,Key exclusion criteria included prior biologic treatment or any investigational therapy within 4 weeks of initiation of study medication or during the study period.
0,The normal value was defined as greater than 315 μg per kg per h in a previous study of healthy controls27.
1,"The study design was a two-arm cluster randomized controlled trial with a block design, taking primary care practices as units of clustering, with measurements at baseline and at follow-up in independent samples of patients."
0,"Kaplan-Meier curves were calculated for shock reversal, and the comparison between the groups was performed with the log-rank test."
1,The study protocol was published elsewhere [13].
0,"Under these circumstances, a linear relationship between gadolinium and MR signal was obtained (11)."
14,Functional outcome examiners are blinded to participant treatment assignment.
0,"Inclusion criteria were ≥ 18-years-old, ability to read, write and speak French, prostate cancer diagnosis, treatment with surgery and/or radiotherapy."
14,The physical nature of the treatments prevents blinding of participants and providers to treatment assignment.
0,Contractile reserve was defined as the maximum percent increase in LVFS within 5 minutes after isoproterenol.
4,"Outcome measures are collected through self-report questionnaires, interviews, and blinded functional assessments (see Table 4 for data collection schedule)."
0,"The acute treatment phase for behavior therapy lasted eight weeks and was conducted weekly; core elements of treatment included: 1) psychoeducation about the nature and treatment of TTM; 2) awareness training, in which participants were taught to become more aware of pulling behavior and pulling urges; 3) stimulus control, in which barriers to pulling were created based on participants' report of high-risk situations; and 4) competing response training, in which participants were taught to engage in behaviors that were physically incompatible with pulling."
4,"Patient flow characteristics (i.e., number evaluated, disqualified, etc.) are monitored according to the Consolidated Standards of Reporting Trials (CONSORT) guidelines for standardized reporting of clinical trials [[48]]."
0,"Outcome and safety data collection were completed by 30 October 2006, and 2 March 2007, respectively, and unblinding occurred on 8 March 2007."
8,"For sample size estimation, previous randomized, controlled trial studies, conducted in CTS patients receiving carpal tunnel injection, suggested that 26 subjects per group would provide 90% statistical power and a 5% significance level by two-sided tests to detect a significant decrease in the Boston CTS questionnaire score from 1.6 to 2.0 [21, 22]."
0,The HEALD intervention was based on a previously pilot-tested self-management program in this patient population [22].
8,"To compensate for a 15 to 20% dropout rates, we recruited 30 subjects per group."
0,The planning target volume (PTV) was created by expanding the CTV by 5 mm in all directions except by 3 mm posteriorly [9].
8,"We estimated that 300 patients would achieve at least an 85% power to detect a 15 percentage point or greater improvement in the proportion of patients who continued their medication and took it for at least 22 of the previous 28 days at a 5% level of statistical significance, assuming an adherence rate of 70% in the control group [4] and 20% loss-to-follow up."
0,"Groups with at least eight eligible families (English-speaking, first-time parents) who provided written, informed consent, were randomized to either the intervention or control arm."
1,"The study was designed as a mono-centric, three armed, open label, randomized (1:1:1), controlled, phase IIb trial with tissue biopsy [19] without any amendments to the protocol after trial start."
0,"The National Curriculum was operating in all schools throughout the intervention and follow-up period, although independent schools and academies were not obliged to follow it."
6,The primary outcome measure was whether or not an eligible trial patient received an eye exam within 90 days of their first FP visit during the one-year period following the mail-out.
0,"Pre and post-vaccination sera were tested for rSBA for each meningococcal serogroup as previously described,34 and for antibodies against tetanus toxoid with an enzyme-linked immunosorbent assay (ELISA).35"
6,"Because the PEMs specifically addressed the issue of insured eye exams for patients with diabetes younger than 65 years, a secondary analysis examined the impact of patient age on the uptake of eye exams."
0,Table 2 Summary of experimental data obtained from the same study groups Statistical analysis
5,"At weeks 0, 2, 6, and 14, participants received infliximab 3 mg/kg in 0.9% NaCl or 0.9% NaCl alone."
0,"Sessions began with a review of the participants’ records since the previous session and discussion of successes and challenges to goal achievement, followed by a review of the previous session."
5,Patients continued to receive their standard dose and regimen of disease modifying antirheumatic drugs (DMARDS).
0,"A first exploratory analysis of biomarker data (see below), that is, cEPC and sVEGF blood levels, will be carried out at the time of analysis of the primary end point."
3,"Eligible patients were men with histologically or cytologically confirmed adenocarcinoma of the prostate and castrate levels of serum testosterone (<50 ng/dl), with ≤2 prior chemotherapy regimens, including ≥1 containing docetaxel."
0,The study was approved by the South and West Devon Research Ethics Committee and done in accordance with Good Clinical Practice guidelines.
8,This was an observational and descriptive study to assess the safety and immunogenicity of ChAd63 CS and MVA CS.
0,"Before the participants’ randomisation, we recorded their baseline measurements, quality of life (with the SF-36 (short form 36) and EuroQol EQ-5D questionnaires), intensive care experience (ICE score), and mood disorder (HADS (hospital anxiety and depression scale) score).9 25 26 27"
8,"The sample size (n = 24) was chosen to allow determination of the magnitude of the primary outcome measures, especially of serious and severe AEs, rather than assessment of statistically significant differences between groups."
0,Participants agreed to participate in the study by signing an informed consent form.
3,Complete patient inclusion and exclusion criteria are provided in Table 1.
0,This study was conducted according to the Declaration of Helsinki and approved by institutional review board of Severance Hospital (IRB No.
8,"The sample size was determined based on the following assumptions for the primary endpoint: a mean ASAS-NSAID score of 100 in both groups at baseline, and mean scores of 50 and 80 in the etanercept/etanercept and placebo/etanercept groups, respectively, at week 8."
0,We used the former for analyses and the latter to check if the 24-hour recall method yielded representative data for the usual dietary pattern.
8,"A target sample size of 39 patients per treatment group was estimated to provide a between-group difference of 30 for change from baseline to week 8 in the ASAS-NSAID score, assuming a standard deviation of 40 and based on at least 90% statistical power and two-sided testing at α = 0.05."
0,"Briefly, ChAd63 ME-TRAP was grown in suspension HEK293 cells and purified by caesium chloride density-gradient centrifugation."
3,"After approval by the local School of Medicine and University Hospital Center Ethics Committee and written informed consent, 148 consecutive patients (male, n = 105 (70.9%); female, n = 43 (21.9%)), scheduled for elective cardiac surgery (ECS) procedures requiring CPB between July 2010 and January 2011 were recruited."
0,"We conducted a single-center, double-blinded, randomized clinical trial as a substudy of “Efficacy and safety of pitavastatin and atorvastatin: a 12-week, randomized, double-blinded, active controlled study in high risk patients with hyperlipidemia” (registered at ClinicalTrials.gov, NCT01386853)."
3,"Excluding criteria were: age younger than 18 years, urgent procedure, administration of antiplatelet agents other than aspirin and clopidogrel, patients with inaccurate antiplatelet therapy administration documentation, patients with off-pump cardiac surgical procedure, and patients requiring surgical exploration for excessive bleeding due to obvious surgical bleeding with a bleeding vessel identified."
0,The study lasted 14 weeks and had two arms: intervention (Web-based app) and control.
1,"This prospective, observational study was conducted between October 2008 and October 2010 as part of a single-blind randomised controlled trial investigating effectiveness of deep breathing exercises [14] where no significant differences were detected."
0,Experimental protocols were approved by the University and Medical Center Institutional Review Board and voluntary written informed consent was obtained from each participant.
1,Ethical approval for this study was granted in 2008 by the Local Research Ethics Committee (South Birmingham) following approval from the local clinical governance department (REC number H1207/79).
0,"Physicians can click on the highlighted medication to view medication compliance within the last 6 months, drug details and cost, and can click a button to switch patients to the recommended therapy."
16,Mean item and domain discomfort scores of the GSRS were calculated together with the corresponding 95% confidence intervals (CIs).
0,"All procedures were performed by dedicated, trained research assistants."
6,The primary outcome measure of the SIRFLOX study is a comparison between treatment arms of PFS.
0,"Consequently, if oral or genital ulcers persisted after the first month of treatment, anakinra was increased to 200 mg daily."
6,Secondary outcomes will include: PFS in the liver; OS; tumour response rate (liver and any site); health-related quality of life (HRQoL); toxicity and safety; and liver resection rate.
0,•Embolectomy: Occlusion of cerebral intra-arterial vessel technically accessible for endovascular embolectomy <4½ hours after stroke onset or awakening; or <6 hours if based on penumbra assessment (as defined by local treatment protocols).
1,The trial design was a parallel-group study with balanced randomization 1:1.
0,Mothers and fathers were independently assessed at the same time using questionnaires.
3,"All the children in the fourth and fifth grades in the 20 selected schools were considered eligible for study inclusion if they met the following criteria: a) literacy in Spanish; b) lack of serious learning difficulties or of physical and mental disorders identified by parents and teachers, which could impede participation in the scheduled activities, and c) absence of any chronic disease that, as judged by their pediatrician or family doctor, would preclude participation in MOVI-2."
0,"To increase the amount of practice that the instructors have using SDT and MI in the current study, the intervention exercise instructors will be encouraged to utilize these techniques within their other exercise classes and within their daily life."
3,The collaboration of a family member who would respond to questionnaires on lifestyle was also required.
0,"The research assistant will circulate a monthly update to review progress relative to the project plan, highlighting any issues that need to be addressed."
4,The study included all U.S.
0,"HIV testing and treatment was proposed to all participants and performed according to national guidelines [36], which include cotrimoxazole prophylaxis for people infected with HIV."
4,"VA facilities (sites) that were required by the VA National Policy Directive [38] to assign a designated VA mental health provider to implement Re-Engage, with the adaptive implementation trial focusing on sites that did not initially implement Re-Engage in response to receiving 6 months Standard REP alone."
0,"After adherence counselling, if – according to the nurse’s judgement - the person understood the implications of lifelong ART, he/she will be offered to start ART immediately."
6,"Physical assessments and interviews were carried out to obtain data, including age, sex, anthropometric data (weight, height, body mass index [BMI]), smoking habits (number of cigarettes/day and years of smoking), number of existing comorbidities, spirometry data (forced vital capacity [FVC]% predicted, FEV1% predicted, and the FEV1/FVC ratio), clinical data, and demographic data."
0,Mood was measured four times a day using ten- or seven-point bipolar Likert scales designed to comprehensively assess the main dimensions of subjective state (happy–sad; angry–calm; anxious–composed; disgusted–satisfied; tired–energetic; restless–relaxed; hungry–full; thirsty–not thirsty; intoxicated–sober; ill–well).
6,The outcome measures were obtained at baseline and after 3 months of WBV treatment for the WBV group as well as after the 3-month washout period for the control group.
0,New biopsy forceps were used for each anatomically different location to avoid cross-contamination.
3,"Male and female participants were considered for inclusion, if they were between the ages of 40 and 60 years and had a body mass index (BMI) between 24 and 27 kg/m2, normal blood pressure or minor hypertension (<140/80–90 mmHg), blood CRP >3 mg/L, LDL >130 mg/dL, elevated triglycerides (>200 mg/dL), HDL <40 mg/dL, and fasting glucose <100 mg/dL."
0,"Based on research supporting post-training consultations [28], clinicians began weekly telephonic group consultations with the IMR trainer."
3,"Participants were excluded if they had a diagnosis of or symptoms consistent with cardiovascular disorders (e.g., angina, shortness of breath), diabetes mellitus, renal failure, infectious or inflammatory disorders, active allergies, tobacco use, consumption of more than two alcoholic beverages per day, use of any supplements within 30 days prior to the initiation of the study, or use of statins, anti-hypertensive, anti-hyperlipidemia, anti-inflammatory, or anti-diabetic medications."
0,"The subjects, investigators and study staff involved in study conduct or data management were blinded to the identity of the treatment assignments throughout the course of the study."
1,"The design is a double-masked randomised placebo-controlled trial, with embedded substudies to explore mechanism of action of metformin, in a population of ∼400 obese pregnant women (figure 1)."
0,We compared individual items measured on the MPSS or other rating scales with Mann-Whitney-U test.
1,Figure 1 Flow chart of participants in the trial.
0,"uKS levels (normalized to creatinine) were measured by liquid chromatography followed by tandem mass spectrometry (Pacific BioLabs, Hercules, CA) (see Supplementary Appendix S3 online for schedule of assessments) (12)."
6,The primary objectives of our pilot study were to evaluate the feasibility of a larger randomized trial in current cardiac surgical practice in which individual surgeon preferences have been suggested to play a large role in choosing grafting strategies [1].
0,Prespecified cutoff levels that had been determined in 187 patients with stage I disease (≥ 65 for ERCC1 and ≥ 40 for RRM1) were used to categorize specimens as high or low expressors for each marker (Fig. 1).16
6,Feasibility was defined as our ability to recruit more than 20% of eligible patients and assess completion of CT-coronary angiography in greater than 80% of patients at 6 month follow-up.
0,The protocol is registered at clinicaltrials.gov (NCT00669084).
1,This study analyzed 110 subjects in the 4th year of follow up who were included in the longitudinal LOD-DIABETES study (NCT01065155) [31].
0,The supernatant was removed and the sediment was diluted and washed with 10 ml of erythrocyte lysis buffer.
6,"A detailed description has been published elsewhere regarding how the clinical data were collected, the anthropometric measurements were made, blood pressure was recorded, TOD was assessed, and the analytical parameters were obtained [31]."
0,"An agreed on method of contraception for each participant, was documented as part of eligibility."
6,The primary endpoint of this study was comparison of the change in COPD symptoms assessed by the CCQ questionnaire between the intervention and control group at 26 weeks.
0,The letters of invitation included an explanation that agreement to take part in the workshops would include a formal evaluation.
6,"Secondary endpoints included comparison of the changes in SGRQ score, spirometric lung function, BODE index, and exacerbation frequency at 26 weeks between the 2 arms."
0,All statistical analyses were done in SAS Enterprise guide 4.3 and the level of statistical significance was p<0.05.
4,The timing of data collection activities is outlined in Table 1 and described in more detail below.
0,"Anticoagulation during treatment was maintained by continuous citrate dosage (ACD-A, anticoagulant citrate dextrose, formula A; Fresenius Kabi, Bad Homburg, Germany) at a volume/citrate ratio of 1:25, and sodium heparin (1000–1500 IU/h, Heparin Immuno, Immuno AG, Vienna, Austria)."
16,"This paper describes the full, registered patient population, including all patients who signed the informed consent documents, up to the point of surgery."
0,The family doctors recruited the patients and assessed them for comorbidity of depression for stratification of the sample.
1,A randomised controlled pilot study with nested quantitative and qualitative process evaluation.
0,"The intervention was tested using a parallel-groups, nonblinded, randomized design."
14,"The researcher and participants were aware of group allocation at the 4 month and 12 month follow up points, but not at baseline."
0,"During Period 1, all subjects received dolutegravir 50 mg day−1 for 5 days."
14,"The rest of the research team, including the nurse or phlebotomist taking blood, the participants’ care team and the statistician were blind to group allocation until the allocation codes were unlocked following analysis."
0,"The RSSearch® Patient Registry is managed by the Radiosurgery Society®, a non-profit professional medical society."
12,"Within each stratum, stroke services were not informed of their intervention allocation until all stroke services within that stratum were recruited to take part in the trial."
0,Confidentiality was ensured at all levels of the study.
12,"However, when two sites required substitution (one site withdrew due to the pressure of other changes within the stroke service and another site was found to have a throughput of only 120 stroke patients per annum) the rest of the stratum were already aware of their allocation."
0,"The determinants, for both promoting and inhibiting the behavior are also described in this step."
3,"We included children and adolescents who were: (1) Diagnosed with any acute myeloid leukemia (AML), relapsed acute lymphoblastic leukemia, stage 3 or 4 Burkitt’s lymphoma/leukemia or about to receive autologous or allogeneic haematopoietic stem cell transplantation (HSCT); (2) Expected to be an inpatient for at least three weeks after initiation of chemotherapy or conditioning; and (3) Ages 7 to 18 years at enrollment."
0,SMT: spinal manipulation therapy Neuromuscular and kinematic acquisition
3,"Exclusion criteria were as follows: (1) Features present to an extent that would preclude compliance with yoga (as assessed by the attending physician): a) motor disability, b) cognitive disability, c) cardiopulmonary symptoms, or d) known compression fracture resulting in disability; and (2) Parent or patient cannot understand English."
0,"Microscopic evaluation was performed using the Comet Assay IV image analysis system (Perceptive Instruments, Suffolk, UK)."
16,Feasibility was defined as the ability to deliver at least 60% of the planned three times weekly yoga sessions over the evaluation time frame in at least 70% of participants.
0,"Participants were asked to be as descriptive as possible when identifying features to be included (e.g., ideal design, wording, colors, formatting, etc.) Small groups were asked to share at least three new ideas with the larger group."
16,We had planned to enroll a minimum of 10 and a maximum of 20 patients to allow modifying the program in the event significant barriers were identified.
0,"ETT size 7.0 internal diameter (ID) was used for female patients and 7.5 ID for male patients (Mallinckrodt Medical, Athlone, Ireland)."
6,"The primary outcome was time to shock resolution, defined by vasopressor weaning."
0,"Much of this work is undocumented and therefore this study will satisfy Phase 0 of the MRC Framework of Complex Interventions, by documenting a theoretical basis to this study."
6,"Secondary outcomes were the followings: ventilator-free days at day 28, number of days with greater than normal plasma lactate, pulmonary edema (that is extravascular lung water index (ELWI) >10 ml.kg-1 PBW) or organ system failure (that is SOFA ≥6) from inclusion to end of study, ICU length of stay, and mortality at day 28."
0,Global assessments by the subjects at 13 weeks and subject and physician global assessments at 26 weeks were obtained.
6,The primary outcome of this study was to evaluate the effect of chocolate on endothelial function by FMD and on walking distance in PAD patients.
0,"At visit 3, i.e. 1 week after study drug initiation, a third 12-lead ECG is recorded and vital signs, blood count and blood chemistry were assessed (Fig. 1)."
16,"The data were analyzed using one-way ANOVA for repeated measures to evaluate the significance of the changes in biological and psychological parameters between baseline and post-treatment, and by two-way ANOVA for repeated measures to evaluate the differences in the psychological and biological data in the three groups."
0,"In addition to participant blinding at recruitment, outcome assessors (assessing accelerometry and bioimpedance) were blinded."
16,The Spearman test was used to evaluate the correlations between basal and final changes in the psychological and biological scores.
0,Some participants had suggestions for improvements to the visual aids which were incorporated prior to the start of the RCT.
3,"To be included, patients should meet all of the following criteria:Resident in Barakaldo or Bilbao seen in the treatment rooms of the PC health centres of the Ezkerraldea-Enkarterri and Bilbao health region of Osakidetza, for MWCAged between 40 and 100 years of age of either sexChronic venous insufficiency corresponding to C6 on the CEAP classificationVascular ulcer that does not respond to conventional treatment in 2 monthsNormal blood test results in terms of platelet and red blood cell counts and haematocritOne or two ulcer together whose area is equal or less than 20cm2Patients with a negative analytical on syphilis, Hepatitis B, Hepatitis Cand HIV I/IIAnkle Brachial Index ≥0.8 and ≤1.5"
0,"This was a phase IIIb, multicentre, randomized, two‐arm, parallel‐group, open‐label, 16‐week trial conducted at 24 sites in Italy and Spain (NCT01787383)."
3,"Patients will be excluded if any of the following apply:Being pregnant or breastfeeding, or a woman of fertile age not using contraceptive methodsChronic use of immunosuppressants or antiretroviral drugsPatients with syphilis, Hepatitis B, Hepatitis Cand HIVClotting disordersChronic infectious diseasesTreatment with radiotherapy or chemotherapyHistory of cancerActive infection or fever at the beginning of the studyABI below 0.8 or above 1.5"
0,Response to treatment was measured and defined according to WHO guidelines [22].
16,"Safety and efficacy data were summarized by descriptive statistics and reported using the safety population, which comprised patients who received ≥1 dose of eltrombopag or placebo."
0,"To better handle comparisons of compositional data, the centered log ratio transformation described by Aitchison (28) and adapted to microbiome data (29, 30) was used and then tested using an analysis of variance with FDR multiple-testing corrections."
1,The present study is is a parallel-group randomized controlled trial.
0,"In the postanesthesia care unit (PACU), six trained nursing staff provided standardized monitoring and administered fluids, analgesics, and antiemetics."
1,"Further details of the study methods are available in the trial protocol (Mantzari, Vogt, & Marteau, 2012b).2"
0,We collected additional data from local hospital records on follow-up ultrasound scanning done within medical imaging departments and surgery for abdominal aortic aneurysm.
3,"Participants were one thousand 16- to 18-year-old girls: 500 had not yet received an invitation to attend the vaccination program (first-time invitees), and 500 had previously received an invitation to get vaccinated, but had failed to attend the first vaccination appointment (previous nonattenders)."
0,Patients were identified and screened and enrolled in the study following informed consent and their oncologists' approval.
3,"All girls lived in Birmingham, United Kingdom, and (a) were registered with general practitioners within the BEN and Heart of Birmingham Primary Care Trusts; (b) were eligible to be vaccinated through the participating community clinics (Sutton Cottage, Partners in Health, and Dove Medical Centre); and (c) had not been vaccinated against HPV before."
0,The primary exposure variables were numbers of risk alleles according to the SNPs being investigated.
9,"Two interim analyses were planned to be conducted, when approximately 70 and 85 % of the targeted 237 participants had experienced an osteoporotic hip fracture event."
0,Values are means and standard error of the mean (SEM) unless indicated otherwise.
9,"To adjust for multiplicity, an alpha spending function was used for the interim and final analyses, such that p values of approximately 0.007, 0.018, and 0.046 were required for the first and second interim and final analyses, respectively."
0,"The right V was performed as follow: (i) 100-cm Vicryl no. 1 was thrown to form two nearly equal parts (each 50 cm) on a blunt semicircular 70-mm needle, the curve of the needle was straightened."
6,Primary outcome measures were the prevalence (likelihood) of the health services utilization (i.e. utilization of hospital emergency service or admission or consultation with primary care doctors per subject) during the last episode of illness.
0,Grade 3 intensity for all other AEs was defined as preventing normal everyday activity and/or causing parents/guardians to seek medical advice.
6,Secondary outcome measures were the monthly rates of doctor consultation (number of visits to the doctors over the past 4 weeks per subject).
0,Stopping rules were built into this study based on the number of observed serious adverse events.
6,The primary outcome measure was total postoperative complications of grade II and above (moderate to severe)16.
0,"All Geisinger clinics include a pharmacist trained in the management of common chronic conditions, such as dyslipidemia, diabetes, and hypertension."
6,"Secondary outcome measures were 30-day postoperative mortality, length of postoperative hospital stay, change in forced expiratory volume at 1 s (FEV1) measured by spirometry on day 5 compared with preoperative value, and postoperative hypotensive episodes."
0,"A successful global response was defined as both clinical success (cure – resolution of signs and symptoms of Candida infection, or improvement – significant, but incomplete, resolution of signs and symptoms of Candida infection) and microbiological success (eradication – negative follow-up culture for Candida species, or presumed eradication – follow-up culture was not available and clinical response was defined as cure or improvement)."
16,"Analyses were performed using GraphPad Prism 6.0 (GraphPad Software, Inc., La Jolla, CA) on a Macintosh Quad-Core Intel Xeon computer running OS 10.10 (Apple; Cupertino, CA)."
0,"While the acute phase of the study can last a maximum of 12 weeks, participants enter the stabilization phase as soon as they meet full-remission criteria."
16,A two-tailed p value of < 0.05 was considered to indicate significance.
0,"Both the Fitbit Flex app and the online program included tracking of physical activity, sedentary activity, and dietary intake progress; setting realistic individualized goals; monitoring progress related to reaching the goals; providing tips for everyday activities; and having interactive apps related to improving weight status and maintaining healthy weight."
1,"This study was a three-arm, open-labelled, randomized, controlled, non-inferiority trial comparing the efficacy, safety and tolerability of ASAQ and DHAP to AL in children aged six to 120 months following a 42-day follow-up period."
0,Instrument developers have demonstrated that SF-12 and SF-36 summary scores are comparable [25].
8,"A power calculation based on a 1 m/sec reduction in aortic PWV post-treatment, a standard deviation of 1.5 m/sec, a significance of 0.05, and a power of 0.8, gave a sample size of 29 patients per group.23"
0,"This risk model included the following factors: apolipoprotein B-to-A1 ratio, smoking, second-hand smoke exposure, hypertension, HbA1c, abdominal obesity, physical inactivity, diet, and psychosocial factors."
8,"Given likely attrition, we aimed to recruit 35 patients per arm."
0,"Thus, the model appropriately addresses the primary and secondary aims of the study, i.e., whether placebo effect-1 is different from placebo effect-2 and whether interaction model-estimated drug effect is different from conventionally estimated drug effect."
4,Patients participated in the study from October 2006 to July 2012.
0,The parents and children return their consent forms and the PQs to a sealed box in the waiting room before the doctor’s appointment.
4,Patients were recruited from vascular labs and vascular clinics from the University of Oklahoma Health Sciences Center and the Oklahoma City VA Medical Center.
0,The subject was then asked to inhale as far as possible which estimated at least 90% of the subject’s vital capacity (VC) followed by holding their breath for 10 seconds without straining.
1,"The LIPOGAIN study was a 7‐week, double‐blind, parallel‐group, randomized trial, carried out in Uppsala, Sweden from August through December 2011."
0,Working solutions were prepared by diluting DAPI 1:38 000 in phosphate-buffered saline.
1,The details of the study design and protocol have been previously reported.6
0,"The main goals of body psychotherapy as a treatment for negative symptoms in chronic schizophrenia are: to reconstruct a coherent ego structure through grounding and bodily awareness; to strengthen self-referential processes as a prerequisite for safe social interaction and reality testing; to widen and deepen the range of emotional responses to environmental stimuli; to improve boundary demarcation, enabling differentiation between self and other; and to help patients explore a range of expressive and communicative behaviours with the aim of reducing emotional withdrawal and improving prosocial capabilities Each session comprised five discrete sections."
6,Overall survival will be measured from the date of randomization to the date of death or to the end of follow-up (2 years).
0,The results were very similar (data not shown).
6,"Progression-free survival, quality of life, toxicity of chemotherapy, response of the primary tumor and metastatic disease to chemotherapy, time to disease progression, rate of secondary curative resection, postoperative morbidity and mortality, rate of patient not eligible for postoperative chemotherapy (arm A), primary tumor related complications and rate of emergency surgery with post-operative morbidity and mortality associated (arm B)."
0,"Net joint moments at the knee were calculated with an inverse dynamics procedure (Braune and Fischer 1987), normalized to body mass and the anatomical joint coordinate system described by Grood and Suntay (1983)."
3,"Age of 18–70 years old.Histologically confirmed diagnosis of stage IV breast, gastrointestinal or non-small cell lung cancer and an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1.Usual first line chemotherapy treatment for the type of cancer in question.Adequate renal and liver function and blood parameters."
0,The primary objective was to detect at least a 50% decrease in PBMCs proviral DNA levels in the intensified group and a calculation of at least 8 patients needed in each arm was done.
3,"Brain metastases.High risk of fracture (bone metastasis).Decompensated heart disease, uncontrolled hypertension (systolic blood pressure >200 or diastolic blood pressure >110 mm Hg), heart failure (New York Heart Association Class II or greater), or constrictive pericarditis.Other health problems in which physical exercise is contraindicated, at the discretion of the researchers.Regular physical activity (150 min of moderate or 75 min of vigorous physical activity/week)."
0,The wind-up ratio (WUR) was examined using ten repetitive pinprick stimuli (1 Hz) compared to a single pinprick stimulus with a force of 256 mN.
3,"All clients, aged > = 5 years, presenting to be tested for HIV in the study sites were invited to participate in the study."
0,"Of approximately 4300 women who were eligible for the trial, 679 were approached and 303 agreed to participate."
3,Study participants underwent informed consent procedures and had a written consent form signed by the participant or the guardian.
0,"The analysis included 2,579 singleton live children."
17,"For the primary outcome only, interaction terms were added to the regression model to test whether the intervention effect varied between: men and women; different age groups; different BMI cut-offs; different disability levels; different levels of confidence in ability to exercise; and those taking part as a couple versus those taking part individually."
0,"Other predictors included were: age, gender, type of stroke, stroke severity, upper extremity functioning 3 days poststroke and functional dependency at discharge (Modified Rankin Scale (mRS)), shown in table 1."
3,"Inclusion criteria were: 1) Hematological malignancies confirmed histologically and not rapidly progressing; 2) Theoretical indication for a myeloablative allo-HCT, but not feasible because of age, patient refusal, or comorbidity, or planned tandem autologous/allogeneic HCT; 3) age ≤ 75 years of age; 4) HLA-identical sibling donor or 10/10 HLA –A, −B, −C, −DRB1, −DQB1 allelic matched related or unrelated donor fit to (and willing to) give G-CSF mobilized peripheral blood stem cells (PBSC), and 5) Signed informed written consent."
0,Regular follow up was carried by the consultant physician in the unit.
3,"Main exclusion criteria included: 1) HIV positivity; 2) Non-hematological malignancy(ies) (except non-melanoma skin cancer) < 3 years before allo-HCT; 3) Life expectancy severely limited by disease other than malignancy; 4) Administration of cytotoxic agent(s) for “cytoreduction” within three weeks prior to initiating the non-myeloablative transplant conditioning (Exceptions were hydroxyurea and imatinib mesylate); 5) CNS involvement with disease refractory to intrathecal chemotherapy; 6) Terminal organ failure, except for renal failure; 7) Uncontrolled infection; 8) Karnofsky Performance Score <70%; and 9) Previous radiation therapy precluding the use of 2 Gy TBI or 8 Gy TLI."
0,Extra visits in between week 2 and week 3 will be recorded in the case record form and extra diaries and NRT will be issued to the participants to cover their delay period.
6,The primary endpoint was the 180-day incidence of grade II-IV acute GVHD.
0,"The secretions collected were then weighed in the same way as for the control group, and weight values were recorded on a data collection sheet."
6,"Secondary endpoints included: 1) hematopoietic (whole blood and T-cell chimerisms) engraftment and incidence of graft rejection; 2) Incidence of grade I-IV and III-IV acute GVHD; 3) Incidence of chronic GVHD; 4) Quality and timing of immunologic reconstitution (that will be reported in a separate analysis [23]); 5) Incidences of infections; and 6) incidence of relapse (RI), nonrelapse mortality (NRM), progression-free survival (PFS) and overall survival (OS)."
0,Households in the control group received no intervention.
4,Eligible clusters which refer to low-cost public subsidised flats with a common facility area or hall suitable for exercise sessions and with at least 100 residents aged 60 years and older will be invited to participate in this study.
0,Content development began with a review of informed consent forms from previously conducted FXS clinical trials.
4,"These participants included those who had daily work, whether, shift-work, casual employment or self-employed."
0,"Training, in-home intervention orientation, and multimodal behavioral intervention procedures parallel procedures described in the MBI arm below."
8,"An a priori sample size estimate indicated 284 participants (142 per group) would be sufficient to detect a difference of 1 body mass index point with a two-sided 5 % significance level and a power of 80 %, given an anticipated dropout rate of 10 %."
0,"The study protocol was approved by the Ethics Committee of the Thomayer Hospital and Institute for Clinical and Experimental Medicine in Prague, Czech Republic."
1,"This was a prospective, randomized, double-blind placebo controlled trial of escitalopram in the prevention of PTSD symptoms in traumatized adults with full or partial ASD."
0,"In this single center, open label, randomized, parallel group clinical trial, patients with newly diagnosed type 2 diabetes not currently receiving antihyperglycemic medications were recruited."
1,"We conducted a pilot, randomized, double-bind, placebo-controlled study with crossover design of a single dose of intranasal insulin or sterile saline in T2DM and healthy older adults (FDA-IND 107690; www.clinicaltrials.gov NCT01206322)."
0,"Participants in the Internet arm were also invited to participate in a discussion forum facilitated by intervention staff, had the opportunity to email questions directly to the intervention staff, and received customized progress reports every 6 weeks by email."
1,"Details of the study protocol have been reported, and intranasal insulin administration was safe without affecting systemic glucose levels (10)."
0,"Children accompanied caregivers to meetings, and many aspects of the curriculum involved interactions with children."
3,"Eligible individuals were between the ages of 18 to 40 years, normal weight (body mass index 18.5 to 24.9 kg/m2), sedentary (defined as less than four 20‐minute episodes of moderate or vigorous intensity physical activity in the prior 4 weeks), had no medical conditions requiring ongoing treatment, and taking no medications other than oral contraceptive pills for birth control."
0,"Participants who submitted at least 80% of exercise and symptom data during the run-in and chose to proceed with the study were scheduled for baseline testing (spirometry, incremental cycle, and 6MW tests, as well as questionnaires) and randomly allocated to MOBILE-C or MOBILE-SM."
3,"Exclusion criteria were pregnancy or plans to become pregnant in the next year, tobacco use, anemia, any sleep disorder, and inability to follow the study protocol."
0,"The trial is planned to be finished during the 1st quarter of 2017 (last patient out; LPO), 1.25 years after LPI."
3,"Patients were eligible for inclusion if they were (1) intubated or tracheotomized, (2) undergoing assisted mechanical ventilation, (3) considered (by the attending physician) to be able to tolerate a short period of spontaneous breathing (not having passed spontaneous breathing trial prior to study) and (4) awake."
0,Two-sample t tests (for unequal size groups) were used to compare each condition across groups.
3,"The exclusion criteria were (1) age <18 years; (2) history of esophageal varices; (3) gastroesophageal surgery in the previous 12 months or gastroesophageal bleeding in the previous 30 days; (4) coagulation disorders (international normalized ratio >1.5 and activated partial thromboplastin time >44 seconds); (5) history of acute central or peripheral nervous system disorder or severe neuromuscular disease; (6) history of leukemia, severe chronic liver disease, solid organ transplantation, malignant tumor (because of their immunocompromised state and increased risk of infection); or (7) severe cardiac disease (to avoid provocation of hemodynamic instability)."
0,Fig. 1 Flow diagram showing the patient flow of the trial Statistical Analysis
1,"The prospective study analysed the effect of a MPP, integrating physical land-based TE, adapted swimming and health education, as a treatment in patients with CNNSP for 8 weeks."
0,"For village j (j = 1, … 24), we assumed a population of size N j, taken from the number of children aged 0–5 years found in the census at the time of treatment k (k = 1, 2, 3 corresponding to baseline, 12 and 24 months)."
1,The protocol for this trial and supporting TREND checklist are available as supporting information; see S1 TREND Checklist and S1 Protocol.
0,Leg ad-/abduction: planet drive—avoid touching oncoming cars (D).
8,"A priori sample size calculation indicated 81 patients were required to detect a minimum important difference of 10.5 points in NDI score [32] (effect size d = 0.28, alpha = 0.05, beta = 0.08)[33] using G*Power 3.1 software."
0,"Prior to the initiation of liraglutide, if the HbA1c was ≥7.5% (58 mmol/mol), then no reductions were made in dose of insulin, while if the HbA1c ranged from 7 to 7.5% (53 to 58 mmol/mol) and was ≤7% (53 mmol/mol) then the basal and preprandial insulin doses were reduced by 10% and 25%, respectively."
8,"As a pragmatic approach, we decided to included as many patients as possible during the pre-planned recruitment period, which is why the final sample ended up being 175 patients."
0,The brochure also included a participant testimonial and a lengthier description of why weight-gain prevention is important.
3,"The following inclusion criteria were applied: a) a unilateral frozen shoulder, defined as greater than 50% limitation of passive ROM relative to the nonaffected side in one or more of three movement directions (i.e., abduction in the frontal plane, forward flexion in the sagittal plane, or external rotation in 0° of abduction) with a hard end feel [5,22]; and b) symptoms that had lasted for at least 3 months."
0,"Briefly, fecal samples (375 μl) fixed in 4% paraformaldehyde (pH 7.2) overnight at 4°C were then centrifuged at 1500 × g for 5 min, washed twice with phosphate buffer saline (PBS 0.1 M, pH 7.0), re-suspended in a mixture of PBS/99% ethanol (1:1 v/v) and stored at −20°C for up to 3 months."
3,"The following exclusion criteria were applied: a) previous manipulation of the affected shoulder under anesthesia; b) other rheumatic conditions involving the shoulder (e.g., rheumatoid arthritis, ankylosing spondylitis, or osteoarthritis); c) fracture or dislocation of the affected shoulder; d) previous shoulder surgery; e) Hill-Sachs lesion, severe osteoporosis, or malignancies in the shoulder region); f) neurologic deficits affecting shoulder function; g) disorders of the cervical spine, elbow, wrist, or hand; h) a history of allergy to lidocaine; i) pregnancy or lactation; and j) corticosteroid injection in the affected shoulder during the preceding 4 weeks."
0,"The bLf iron saturation was about 20–30% as detected by optical spectroscopy at 468 nm on the basis of an extinction coefficient of 0.54 (100% iron saturation, 1% solution)."
4,Approximately 14 days before the nine-year follow-up session questionnaires were sent to the families [31].
0,"In patients who underwent diverting ileostomy, anal sphincter function was evaluated after stoma repair."
4,Parents and children were requested to report QoL independently.
0,"These trials were carried out in 33, 25, and 11 countries, respectively."
3,"We enrolled 142 patients with HeFH (n = 103) and HoFH (n = 38) taking maximally tolerated lipid-lowering therapy who had successfully completed a Phase 3 placebo-controlled mipomersen trial [NCT00607373-HoFH, n = 38 (86%); NCT00706849-HeFH, n = 94 (82%); NCT00794664-HeFH, n = 9 (100%)] had an acceptable safety profile [no significant liver blood test abnormalities that met stopping criteria or intolerable injections site reactions/flu-like symptoms (FLS)], no new or worsening conditions that interfered with study completion, and were willing to limit alcohol consumption to moderate amounts [males, 2 drinks (20 g) per day, 8 drinks (80 g) per week; females, 1 drink (10 g) per day, 4 drinks (40 g) per week] for the study duration."
0,Adverse events (AEs) were evaluated during each study visit through communication with the patients.
1,Cluster randomized clinical trial.
0,Subjects completed the protocol at either the Waisman Center (n = 19) or Boston Children’s Hospital (n = 11).
1,The PHCC will be the unit of randomization.
0,$ needed number with and without drop-out/loss-to-follow up The randomization process is concealed from those responsible for recruiting patients using central telephone randomization.
6,The main outcome variable is quality of life as measured by the WOMAC index [26].
0,"Table 1 Participant characteristics Breakfast and lunch were identical and both meals consisted of bread, margarine, salami slices, cheese, jam, and semi-skim (1.5% fat) milk."
6,"Secondary outcomes are: pain [27], weight, physical activity [28] and nutrition [29]."
0,"Additionally, those in the intervention group were asked to record their Walking for Health participation—including date and location of walks attended—on a simple form."
6,"We defined the use of ACEI/ARB therapy as prescription of either agent at any point during the hospitalization, as obtained by medical record abstraction."
0,"Before the first VRE session, D rated himself as having low confidence, 2 (on a scale of 0 to 6); his parent rating was also 2."
6,We also assessed the specific type of ACEI/ARB used during hospitalization using the medication that was administered first.
0,The MRC Clinical Trials Unit coordinated the trial in the UK and analysed the data.
6,"The efficacy outcomes evaluated for this study were (1) the primary efficacy composite endpoint of cardiovascular death, MI, or stroke, and (2) individual component endpoints of cardiovascular death, all MI events, all stroke events and all-cause death."
0,"Patients in the IG, will be invited for following activities during the first three sessions of the PA program at the SCC: 1) Select and enroll in their PA group."
6,All outcomes were ascertained through 30 months.
0,The allocation was concealed until knowledge of the assignment was required operationally to implement the intervention.
16,"Initially, differences between the conditions for baseline demographics were assessed using χ2 and t tests."
0,"Scoring systems evaluated were the Acute Physiology and Chronic Health Evaluation (APACHE)-II score [2], the simplified Acute Physiology Score (SAPS)-II [3], the Mannheim Peritonitis Index (MPI) [4,5], the Multiple Organ Dysfunction Score (MODS) [6], the Sepsis-related Organ Failure Assessment (SOFA) score [7], and the APS, the physiological part extracted from the APACHE-II score [2]."
16,Differences in weight loss outcomes were assessed in terms of BMI at baseline and 12 months follow-up and change in BMI using t tests.
0,We assessed adolescent eligibility through a screening conducted before participation.
16,"This was a non-interventional study, using a descriptive analysis approach to assess clinical management, clinical outcomes and healthcare resource use."
0,Current smoking was recorded using the Nicotine Dependence Questionnaire [25] and alcohol use by the Alcohol Use Disorders Identification Test (AUDIT) [26].
3,"All subjects were required to be ≥18 years old and have a clinical diagnosis of symptomatic OH associated with Parkinson disease, multiple system atrophy, pure autonomic failure, dopamine-β-hydroxylase deficiency, or nondiabetic autonomic neuropathy, plus a documented decrease of ≥20 mm Hg SBP or ≥10 mm Hg diastolic blood pressure within 3 minutes after standing."
0,"However, the Mtwara Rural district differs in numerous ways from the other five districts included in the study, for example, by not having a hospital."
3,"Key exclusions were for pre-existing sustained severe hypertension (≥180/110 mm Hg while sitting), atrial fibrillation or other significant cardiac arrhythmia, current use of tricyclic antidepressants or other norepinephrine reuptake inhibitors, current use of antihypertensive medication (except short-acting agents at bedtime), or use of vasoconstrictive agents within 2 days before baseline."
0,"An array of demographic parameters, clinical and paraclinical stroke characteristics and outcome information was collected."
8,"In the absence of previous data, we empirically chose as clinically meaningful a 1.6 units change from randomization to end of study in OHSA item 1 (dizziness/lightheadedness) score, with an SD of 2.5 (see the online-only Data Supplement for a more detailed rationale)."
0,"In protocol 2, FAO-supported LEAK (FAOL) respiration was determined through the addition of palmitoylcarnitine (25 μmol/L) and malate (2 mmol/L)."
8,"On this basis, we predicted that a sample size of 41 subjects per treatment group would have 80% power (0.05, 2-sided significance level)."
0,Participants were encouraged not to modify their daily activity or achieve any specific step count goal or daily activity level.
16,"Mean, standard deviation [SD] and proportions were used to describe time lapse, the flow of applications and meeting or not prerequisites or study criteria for applicants and candidates."
0,Antibody responses to CS were measured by an IgG ELISA performed at the WRAIR International Reference Center for Malaria Serology (Supplementary Materials) [34].
6,"We aimed to assess rates of death, dependence (measured according to patient-reported modified Rankin scale scores), and recurrent subarachnoid haemorrhage after neurosurgical clipping or endovascular coiling as part of the tertiary objectives of ISAT."
0,"Phase-contrast cine images of ascending aorta (AA) were obtained in axial plane at the level of the right pulmonary artery with ECG gating (repetition time/echo time, minimized; flip angle, 20 degrees; field of view, 340 × 340 mm; matrix, 256 × 256; maximal velocity encoding, 150 cm/s, through plane; slice thickness, 8 mm; number of phases, 50; temporal resolution, 30 ms; and number of averages, 2)."
1,The TACIT (tumour necrosis factor inhibitors against combination intensive therapy) trial was an open label pragmatic randomised two arm non-inferiority trial carried out over 12 months in multiple centres.
0,"If differences in coding arose, the coders discussed them and reached a consensus."
1,"A randomized, placebo-controlled, double-blind, double-dummy, superiority, three-arm trial with a six week follow-up study was conducted."
0,"The effectiveness of an intervention that increases the PA in PWD/CG pairs has also not been evaluated, which can be particularly important, although it is not possible to estimate in which of the two groups (patients or caregivers) there will be a greater impact from the intervention."
14,"Participants, the homeopathic doctor, the psychologist, and the statistician remained blinded from the identity of the three treatment groups until the end of the study."
0,"Infants eligible for study vaccination were between 6 and 7 weeks of age at the time of enrollment, generally healthy, free of contraindications to receipt of rotavirus vaccine, born at full term (≥36 weeks of gestation), not underweight (ie, <2000 g), the only child <16 weeks of age living in the compound, and had not previously received rotavirus vaccine."
14,The psychologist assessed the severity of the symptoms and kept the HRSD scores strictly confidential in a close envelope every follow-up until the end of the study.
0,Website use in period 1 was determined as at least 1 website visit within the month after the email was sent to promote website use.
4,"We collected the following variables from patients excluding those under 18 years of age.We collected baseline patients’ characteristics: age, gender, body height and weight, Acute Physiology and Chronic Health Evaluation (APACHE) II score, admission categories (medical or surgical), admission diagnosis (cardiovascular, respiratory, neurologic, renal, operation, etc.), and co-morbidities (hypertension, diabetes mellitus, cardiac disease, liver disease, respiratory disease, kidney disease).Blood urea nitrogen (BUN), SCr and eGFR values were measured the day of the radiologic study, immediately prior to the administration of CM (baseline), and thereafter at 24 hours, 48 hours, 72 hours, and on the ICU discharge day and hospital discharge day."
0,"A typical township in the study comprised about 17 villages and included 25,000 people with at least one village doctor providing basic health services in each village."
4,"UO was also measured at the same time periods.We investigated variables suspected of being risk factors for CA-AKI based on previous studies: the type of radiologic tests, the volume of CM, mean arterial pressure (MAP) and hemoglobin (Hb) values at the point of contrast use, preventive measures (N-acetylcysteine and isotonic crystalloid) before and after CM administration, whether RRT was applied, and whether diuretics were used after contrast administration."
0,"NVivo 10 software was utilized to assist in the coding and analysis the process (QSR International, Australia) [54]."
1,"Randomised, parallel-group clinical trial in which a group of hypercholesterolaemic patients, undergoing a combined intervention targeted at improving treatment adherence and degree of lipid control as complementary measures in support of the intervention at the GP’s practice, will be compared to another group of hypercholesterolaemic patients who will solely receive routine GP care."
0,"We included patients who (i) were ART naive, (ii) had microbiologically confirmed tuberculosis, or conformed to WHO clinical definitions for HIV-associated TB with response to treatment (iii) had no evidence of Rifampicin resistance or MDR, (iv) were diagnosed with paradoxical TB-IRIS based on a validated consensus case definition [2]."
5,"Participants in the intervention group will be supplied with: a) printed matter containing information on the disease and its management (this will be handed out at each of the follow-up visits); b) mobile-telephone text messages containing guideline summaries, reminders of forthcoming appointments and/or arrangements for making new appointments in the event of non-attendance (in the periods between visits); and, c) self-report cards to check compliance with recommendations (across the entire follow-up)."
0,Twenty-six adolescents were allocated to the control group and received the computer-based sham.
5,"Both groups, intervention and control, will receive routine recommendations from their GPs, in accordance with current European clinical practice guidelines on the management of hypercholesterolaemia and cardiovascular risk (European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: Fifth Joint Task Force of the European Society of Cardiology and other societies and Guidelines for Management of Dyslipidaemias: the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology and the European Atherosclerosis Society)."
0,"In this study, HFMD was defined as the occurrence of blister-like eruptions in the mouth or on hand, foot, or buttock, accompanied by fever in the absence of measles, rubella, chicken pox, other febrile eruption disease, or allergy."
2,"At the time of registering the trial protocol, a basic analysis plan was written."
0,The AIx is the difference between the second (P2) and the first (P1) systolic peaks expressed as a percentage of the pulse pressure (PP) and calculated as: ((P2-P1)/PP)*100.
2,"This has been followed when writing the current detailed plan, with some additions made, namely: details of variables to adjust for in analyses, rules for dealing with missing data, sensitivity analyses, meta-analysis and details of how the ancillary analyses will be performed."
0,"It was only at this point that participants who declined to take part in the randomised trial, because of a strong preference either for remaining on medical treatment or for undergoing surgery, were informed about, and given the opportunity to take part in, the preference study."
3,"Patients had to have been willing to give informed written consent and be able to adhere to dose and visit schedules 18 to 50 years of age, of either sex and of any race Clinical history of significant ragweed-induced AR/C of two years’ duration or more with or without asthma (diagnosed by a physician) and have received treatment for the disease during the previous RS Positive skin prick test response to Ambrosia artemisiifolia (wheal size ≥5 mm larger than saline control) at the screening visit Positive for specific IgE against Ambrosia artemisiifolia (≥IgE Class 2 [≥0.70 kU/L]) at the screening visit."
0,Oestradiol measurements are necessary for the identification of women with premature ovarian insufficiency.11
3,"Clinical history of symptomatic seasonal allergic rhinitis and/or asthma having received regular medication, owing to another allergen during or potentially overlapping the RS Clinical history of significant symptomatic perennial allergic rhinitis and/or asthma having received regular medication due to another allergens to which the subject is regularly exposed Received an immunosuppressive treatment within three months prior to the screening visit (except steroids for allergic and asthma symptoms) Clinical history of severe asthma History of asthma requiring medium- or high-dose inhaled corticosteroids History of anaphylaxis with cardiorespiratory symptoms History of chronic urticaria and angioedema Clinical history of chronic sinusitis during the two years prior to the screening visit Current severe atopic dermatitis Female subject who was breastfeeding, pregnant, or intending to become pregnant Previous immunotherapy treatment with ragweed allergen or any other allergen within the five years prior to the screening visit History of allergy, hypersensitivity or intolerance to the ingredients of the medicinal products (except for Ambrosia artemisiifolia), rescue medications, or self-injectable epinephrine History of self-injectable epinephrine use AR/C, allergic rhinitis with or without conjunctivitis; IgE, immunoglobulin E; RS, ragweed pollen season."
0,Cotrimoxazole was given to women with CD4 counts <200 after November 2003 [14].
9,"No deleterious effects of the intervention, such as a reduction of influenza immunization among healthcare personnel, were anticipated as a result of participation in the trial."
0,"In both jumps, the distance from the starting line to the heel was measured."
9,"As such, no interim analyses or stopping rules were used."
0,Nodal groups at risk of harbouring occult metastatic disease received a biologically equivalent dose of either 50 Gy in 25 daily fractions (conventional radiotherapy) or 54 Gy in 30 fractions (IMRT).
10,"Given the short recruitment period with uncertainty about the willingness of organizations to participate in the trial, as organizations indicated their willingness to participate, they were allocated to the intervention or control group using block randomization."
0,There was no specified minimum number of supervised scans required before independent practice was allowed at any of the three participating hospitals.
10,A random number spreadsheet in blocks of two was generated in Microsoft Excel.
0,"Additional postal questionnaires are sent to the patients in the months that they do not visit the hospital (1, 2, 4, 5, 7, 8, 9, 10 and 11 months after randomization), and again 18 months after randomization."
12,"A research associate generated the allocation sequence, which was placed in sealed envelopes in the order generated in Excel."
0,"Additionally, there are 3 scales with a total of 15 items that pertain to parent-focused concepts: Parental Impact-Emotional, Parental Impact-Time and Family Cohesion."
12,"As organizations indicated their participation, they were randomized based on the date and time stamp of the completed registration form."
0,Patients will be informed and treated by their treating physician.
3,ICU patients were eligible if they were ≥18 years of age and had an AKI requiring CRRT according to the kidney-failure criteria of the RIFLE definition [13].
0,Peripheral blood samples for DNA extraction were collected at the time of recruitment.
3,"Patients were excluded if they had active hemorrhagic disorders or severe thrombocytopenia (<50 × 109/L), a history of heparin-induced thrombocytopenia, severe liver failure defined as a factor V <20%, or were on the waiting list for liver transplantation."
0,Study participants were patients aged 18 and up who visited the PHCCs and were identified and diagnosed by a GP with a new episode of mild/moderate depressive disorder [14].
1,This was a prospective matched case-control study designed to compare HIV replication and progression of clinical disease between patients co-infected with HIV and Wb infection and patients that were HIV-positive but without Wb infection.
0,"Ex vivo thrombin generation potential was investigated by the CAT assay, performed according to the manufacturer’s instruction (Thrombinoscope BV, Maastricht, The Netherlands)."
6,The primary outcome was the difference in mean fasting glucose levels by POC testing before breakfast between the supplement and no-supplement groups.
0,Individual lipid species were quantified based on the ratio of signal intensity for target compounds to the signal intensity for an assigned internal standard of known concentration.
3,"Participants were included when fulfilling the following criteria: age over 65 years, able to stand with or without walking aids, classified as being only lightly dependent on nursing care according the BESA classification level 0, 1, 2a, living in the Canton of Berne and a having a score >22 in the Mini-Mental Status Examination (MMSE) Test."
0,"Further, this study does not consider mortality or hospitalisation as primary outcome measures, rather it focuses on functional capacity and quality of life as the key factors to attempt to improve in these patients."
3,"Exclusion criteria were: visual disturbancesb, lower or upper leg prosthesis, acute joint disease, acute thrombosis, acute fractures, acute infections, acute tissue damage, acute surgical scars or alcohol abuse."
0,"Hence, session 1 was designed to include all required content, in case participants were then lost to program, and sessions 2 and 3 could be optional."
4,"The study was conducted in the respiratory therapy area in the emergency department of a district hospital, Hospital Nacional San Bartolo, in Ilopango, El Salvador, during August and September 2012."
0,Weekly diaries were used in combination with the activity monitor to indicate what physically active and targeted sedentary behaviors the child was engaging in during the last week of each phase of the experiment.
4,All patients presenting to the respiratory area with an asthma exacerbation and a physician’s order for nebulised salbutamol were screened by the study physician for eligibility.
0,Blood samples were collected directly on admission at the emergency department and stored at −70 °C.
16,"All descriptive statistical analyses were carried out using SAS statistical software version 9 or higher (SAS Institute, Cary, NC), unless otherwise noted."
0,"The Feeling Scale (FS) [39], a single-item 11-point measure (-5 = very bad, +5 = very good), corresponds with the valence component of Russell’s circumplex model of affect [40] and has been used as a measure of general affect during exercise [41]."
16,Time-to-event data were summarized using the Kaplan–Meier methods.
0,"Parasite clearance curves were derived from these parasite counts [29], and parasite clearance half-life was calculated using the Parasite Clearance Estimator (http://www.wwarn.org/research/parasite-clearance-estimator)."
3,Infants were eligible if they were born at any of the study sites prior to 32 completed weeks of gestation.
0,"All subjects provided informed, written consent prior to the clinical trial which was approved by the Hammersmith and Queen Charlotte's Research Ethics Committee (08/H0707/99)."
3,"The exclusion criteria were: 1.) lack of informed consent, 2.) outborn, 3.) any major congenital malformation, or 4.) death in the delivery room."
0,"Thus, in all practices, the EBQI-designed CCM model was part of routine care before recruitment for the randomized evaluation began [19]."
6,The primary endpoint for testing the efficacy of intervention was colonization status of newborns’ nostrils after 7 days of intervention (decolonization of the infants’ nostril from multi-drug resistant Staphylococcus).
0,The laboratory safety tests included tests for the following: red blood cell count (RBC); white blood cell count (WBC) with differential count; platelets; hematocrit (Hct); hemoglobin (Hb); erythrocyte sedimentation rate (ESR); blood creatinine level; aspartate aminotransferase (AST) level; alanine aminotransferase (ALT) level; gamma glutamyltransferase (γGT) level; blood fibrinogen level; activated partial thromboplastin time (aPTT); and lipid panel.
6,"Birth weight (measured at birth using digital scales with 5 gram precision), gestational age (according the the last menstrual date), type of delivery (vaginal/cesarean section), sex (male/female), birth weight for gestational age (classified according to Alexander’s curve) [21], 5th min Apgar score and need for resuscitation (at delivery room) and antibiotic use (from birth to the end of data collection) were compared between groups."
0,"To achieve this, the group exercise sessions are designed to be as attractive and pleasurable as possible."
8,"A sample of 248 participants (124 participants per group) was required to detect significant group differences on the primary outcome, HbA1c, for a two-group and repeated measures design."
0,"The order of treatment was randomized using a three x three orthogonal Latin square design, as specified in Jones and Kenward [23]."
8,"These calculations were based on equal group sizes, an attrition rate of 30%, 80% power to detect differences at the P=.05 significance level (two-sided), with correlations between measurements of .70, and an effect size of 0.21 standard deviation units."
0,Three example interim analyses are shown in Fig. 1.
6,Increase in HCV antibody testing rate in prisons following introduction of DBST.
0,"The ImageJ Software will be used to measure the length of the telangiectasia treated, residual telangiectasias, and hyperpigmented spots."
3,All job consultants working with the project were offered the chance to participate in focus group interviews.
0,"The medical history and the body mass index were assessed at visit 1, and non‐fasting blood samples were drawn to determine the HbA1c levels (visits 1, 8 and 12)."
3,"Due to practicalities, selection differed between municipalities, but in all sites the key persons in the project were included."
0,"In brief, 100 µL of mononuclear cells derived from peripheral blood was immunostained with monoclonal antibodies against human CD31/FITC, CD3/PE-Cy5, CD19/PE-Cy5, CD34/PE-Cy7, CD14/APC Cy-7 (BD Pharmingen, UK), VEGFR2/PE (R&D System, Minneapolis, MN, USA), and the appropriate isotype control antibodies (BD Pharmingen, UK)."
3,"History of recurring or persistent hypotension in the past 1 month Pregnant woman Severely hypertensive patients (SBP > 180 mmHg and/or DBP > 115 mmHg) Severely hypotensive patients (SBP < 100 mm Hg and/or DBP < 60 mmHg) Paradoxically hypertensive patients whose BP increases by more than 20% of baseline during dialysis (in the past 1 month) History of recent myocardial infarction or unstable angina (within the past 6 months) Significant valvular disease, i.e. severe aortic stenosis and moderate-severe mitral regurgitation Patients with end stage organ disease e.g."
0,"The LTQ-Orbitrap was operated in a data-dependent mode, that is, one MS1 scan precursor ions followed by CID (collision induced dissociation) and HCD (high energy collision dissociation) MS2 scans of the three most abundant doubly or triply protonated ions in each MS1 scan."
3,"COPD, recent or debilitating CVA Patients with Left Ventricular dysfunction, Chronic Heart Failure and older age group more than 70 years Patient with recent stroke (within the past 6 months) History of known arrhythmia Participation in another clinical intervention trial Unable to consent Dialysis hypotension may occur in one of three clinical patterns: (i) acute (episodic) hypotension defined as a sudden drop of systolic blood pressure below 90 mmHg or of at least 20 mmHg with accompanying clinical symptoms, (ii) recurrent – as detailed above but prevailing in a minimum 50% of dialysis sessions, and (iii) chronic, persistent hypotension in which interdialytic systolic blood pressure is maintained at less than 90–100 mmHg."
0,No harmful side-effects from participating in reminiscence groups have been documented [7].
16,Data from all patients who received one or more doses of drug were included in the analyses.
0,"Glucose metabolism was assessed during the 2-step clamp with the continuous infusion of 6,6-[2H2]glucose infusion (Cambridge Isotope Laboratories, Inc."
16,Descriptive statistics were used to analyse and present the data.
0,"Briefly, ischemia and reactive hyperemia were induced by inflation of a BP cuff around the forearm to 50 mmHg above the subject’s supine SBP for 5 min followed by rapid deflation."
3,"Non-intubated patients suffering from hypercapnic (PaCO2 ≥ 45 mmHg) acute respiratory failure, hospitalized in the ICU, equipped with an arterial line and requiring NIV could be included in the study if they had no major hemodynamic instability, no facial lesion preventing the use of the naso-buccal sensor, and no cognitive disability or psychiatric disease liable to interfere with NIV."
0,Patients are instructed not to reveal details that may cause the research assistant to deduce which treatment they are receiving.
3,"To note, as only patients admitted in the ICU and already equipped with an arterial line could be included in the study, the NIV treatment monitored in the study was usually not the first NIV treatment delivered to the patients."
0,"A single-blind, cluster-randomized controlled trial was conducted to test the hypothesized benefits of CDS support for asthma management."
6,"As this study aims to assess the effect of anthelmintic treatment on whole-body insulin sensitivity, our primary outcome is a change in insulin resistance as assessed by HOMA-IR between both treatment arms after one year of treatment."
0,"On discharge, MLU midwives visited at home, and/or provided telephone support, up to the seventh postpartum day, when care was transferred to the Public Health Nursing service."
6,"Secondary outcomes are changes in body mass index and waist circumference, fasting blood glucose, 2 h-glucose levels after oral glucose tolerance test, HbA1c, serum lipid levels, immunological parameters, and efficacy of anthelmintic treatment."
0,"In both countries, compounds consist of multiple households (typically 3–10 in Bangladesh and 1–4 in Kenya), usually comprising blood relatives, who share a common courtyard."
1,"The Dolphin studies are double-blind randomised placebo-controlled trials of supplementation with a combination of DHA, choline and uridine."
0,BMI was computed as kg/m2.
1,Two cohorts will be recruited:Dolphin 1 (D1): Optimising nutrition to improve growth and reduce neurodisabilities in neonates at risk of neurological impairment and Dolphin 2 (D2): Optimising nutrition to improve growth and reduce neurodisabilities in children with suspected or confirmed cerebral palsy.
0,Analysis was done by intention to treat.
3,"Eligible patients (≥18 years of age) had a diagnosis of RA23 (6 months–10 years), LDA/MDA at screening and baseline (defined by CDAI >6 and ≤16, ≥2 tender joints (28-joint count, TJC), ≥2 swollen joints (28-joint count, SJC) and either erythrocyte sedimentation rate (Westergren-ESR) ≥28 mm/h or C-reactive protein (CRP) >10 mg/L)."
0,"To further account for recall bias, lists of possible services were presented (e.g., every outpatient service was addressed specifically in the questionnaire)."
3,"Patients must have received mono or combination DMARD therapy (MTX, leflunomide, sulfasalazine and/or hydroxychloroquine) for ≥6 months (dose stable ≥2 months) prior to baseline, with corticosteroid dose stable >1 month (for exclusion criteria, see online supplementary material)."
0,CMR guided RHC procedures were performed under moderate sedation.
1,"ACCURE Trial (Netherlands) - A multicenter randomised clinical trial aiming at patients with an established diagnosis of ulcerative colitis and a disease relapse within 12 months prior to randomisation, medically treated (for treatment with immunomodulators and biologicals a wash out period of 3 months before inclusion is required) until full clinical and endoscopic remission has been achieved as defined by the Mayo score."
0,Initially all patients were diagnosed as having painful bone metastases requiring RT.
1,"ACCURE-UK Trial (UK) - This parallel study is a randomised external pilot and feasibility study utilising a matched overall study design, including the same patient population, intervention, and outcome measures."
0,"For QTc determination, two common QT correction (QTc) methods were used."
3,Patients are eligible for both trials when they meet the following inclusion criteria:Aged ≥ 18 years.Histologically confirmed diagnosis of UC.Disease relapse within 12 months prior to randomisation.In remission on 5-ASA or after a wash out period of at least 3 months after treatment with immunomodulators and biologicals (if given).Clinical (Mayo score <3) and endoscopic (Mayo score 0 or 1) remission at time of randomisation.Negative stool culture and C.
0,"This was an open‐label, three‐period, single sequence study in male patients with mild‐to‐moderate hypertension aged 18–65 years."
3,"Patients will be excluded when:A prior appendectomy has been performed.Previous major abdominal surgery that may prevent safe and straightforward appendectomy has been performed.Any suspicion of Crohn’s disease is present.A toxic megacolon or severe ongoing colitis is present at time of randomisation.Diagnosed with active extra-intestinal infections, liver or kidney failure, major lung or heart co-morbidity."
0,Patients aged 18–75 years with a diagnosis of adult-onset RA for at least 6 months and <15 years were eligible for inclusion in the study.6
4,The present study is a secondary analysis of a previously published randomized controlled trial [13].
0,Participants in the online condition had full access to the web page content and online therapist during the course of the study.
4,"We recruited 350 patients from September 2003 through May 2007 at an outpatient back care centre in Copenhagen, Denmark."
0,"procedure RareCover (S, Q) Set repeat Set Select that maximizes Xcorr while return Xcorr ."
1,This is a 12 month follow-up multicenter observational prospective controlled trial comparing patients that receive antidepressant drugs with those who do not.
0,"The room lights were dimmed to less than 30 Lx from approximately one hour before the saliva collection was commenced until waking in the morning, and participants were advised to take precautions to prevent contamination with food."
1,The study was approved by the Clinical Research Ethics Commitee of the Sant Joan de Déu Foundation (CEIC Fundació SJD; Reference Number: EPA-24-12) and the Clinical Research Ethics Commitee of The Jordi Gol i Gurina Foundation (CEIC IDIAP; Reference Number: 5013 – 002).
0,Adverse events were reported at weeks 2 and 4 of treatment and week 4 of the post-treatment follow-up period.
16,The analysis will be done according to the intention to treat analysis (all the patients will be included in the analysis in the group to which they were allocated independently of the treatment they finally received.
0,"For the two study visits, participants attended the department between 1445 and 1730 hours."
1,"A single-blind, randomized controlled trial to compare TAU alone with TAU and a psycho-educational intervention comprising six booklets delivered fortnightly to participants alongside follow-up phone calls."
0,"The caloric intake was possibly adjusted according to patients’ caloric needs, with lipids in the form of a powder composed of medium chain triglycerides, as well as omega-3, and long chain triglycerides (Ketoneural Lipid Complex, Medi-Diet s.r.l., Aprilia, Italy) with nutraceutical integrators (3)."
8,"The sample size was estimated based on previous research which showed a change in the knowledge score of 2 points post-treatment [11,32]."
0,Directly measured osmolality was assessed in molal units (mOsm/kg) and calculated osmolarity produced molar units (mOsm/L) making terminology comparing the two measurements complex.
8,"Taking into consideration a power of 80% and significance level of p < 0.05, allowing for 15% attrition, deduced from previous studies, we estimated 144 participants would be required."
0,"CHARM included Government of India FP information, education and counseling (IEC) materials used in the public health system to provide basic FP knowledge and positive outcome expectancies as well as contraceptives [23]."
6,"Primary outcomes were number of cigarettes smoked and volume of smoke inhaled per cigarette, as measured by a smoking topography monitor (number of cigarettes smoked was confirmed with a self-report measure)."
0,"Secondary objectives of the study comprised assessment of the response rate, resectability, progression-free survival and overall survival as well as toxicity of the RCT regimen."
6,"Secondary outcomes were self-reported ratings of motivation to quit smoking (as measured by the Quitting Contemplation Ladder), the cigarette taste test, experience of smoking, experience of using the pack, rating of pack attributes, rating of the health warning, changes in behaviour, and attitudes to plain cigarette packs."
0,"Within each level, Social cognitive theory (SCT) provides guidance for specific behavior change strategies."
3,"Eligible patients comprised all those who were receiving hemodialysis at a participating facility as of January 1, 2008, and who satisfied any of the following inclusion criteria: intact PTH (iPTH) level of ≥180 pg/mL or treatment with intravenous vitamin D receptor activator or oral active vitamin D receptor activator."
0,"Details of PHC therapy optimization are discussed below; in general, the pacing sequence consists of 8 to 13 beats with the shorter atrioventricular delay followed by 1 to 3 beats with the longer atrioventricular delay."
3,Patients undergoing hemodialysis for <3 months were excluded.
0,"Selected sputum was weighed, and samples greater than 0.15 g were mixed with 0.1% DTT on ice in a ratio of 4:1 and processed as previously described to obtain a cell pellet [12]."
1,"This randomized controlled study on the effects of 12 week- cognitive training on changes of cortical thickness in healthy elderly participants was conducted between June 2011 and May 2012 at Samsung Medical Center in Seoul, Republic of Korea."
0,"SWABIMS is a multi-centre, randomized, parallel-group, rater-blinded Phase IIb-study conducted in eight hospitals in Switzerland."
1,This trial was registered at “ClnicalTrials.gov” as NCT01596205.
0,"The randomisation schedule is minimised according to ethnicity, parity (0 versus ≥ 1), age, BMI (BMI 30-34.9 kg/m2versus 35-39.9 kg/m2 and >40 kg/m2) and centre."
16,"Data were analyzed using SPSS version 20.0 using paired sample T-test and the χ2 test, where p < 0.05 would be considered significant."
0,Biomarkers of the endothelial function.
16,Shapiro-Wilks and Friedman’s non-parametric test were used to test the validity of the pain and symptom severity VAS scores.
0,"As specified in the study protocol (Fig. 1), the accuracy analysis required a minimum monitoring time of 48 h or at least 12 comparative readings."
8,"The sample size calculation was based on the primary outcome, RTW, and is reported elsewhere [15]."
0,In our study we used m = 2 and r = 0.15.
3,Potential participants must meet the inclusion criteria of (i) DSM-V diagnosis of schizophrenia of schizoaffective disorder (ii) at least a mild level of depression as measured by scoring 14 or more on the Beck Depression Inventory-II [17] (iii) aged between 18 and 65 (iv) have a sufficient understanding of spoken English to engage with assessments and clinical intervention (v) are able and willing to provide informed consent (vi) do no exhibit an organic impairment which is considered to be the primary diagnosis and (vii) do not exhibit a learning disability.
0,"Randomization was performed centrally and was stratified according to HCV genotype (2 versus 3), baseline HCV RNA level (≤800,000 IU/mL versus >800,000 IU/mL) and study centre."
6,The primary aim of the study was the ability to recruit an adequate number of patients (n = 50) in a nine-month-period without excessive (more than 20%) protocol violations.
0,"Here, the trial would be stopped for inefficacy at the third interim analysis Note that if for any reason one wishes to avoid stopping early for efficacy at analysis i, for some i<k, then it is straightforward to impose ui:=∞ before solving for a and V1."
6,"Secondary outcomes included improvement in PaO2 and OI at 60 ± 15 minutes and four ± two hours after study aerosol initiation; need for ECMO; death; combined outcome of need for ECMO or death in the first 120 days of life; need for supplemental O2 at 28 days of life; duration of INO, mechanical ventilation, supplemental oxygen, and hospitalization; and occurrence of intracerebral hemorrhage, intraventricular hemorrhage, periventricular hemorrhagic infarction, cystic leukomalacia, areas of low attenuation in the white matter (edema or ischemia), atrophy, and ventriculomegaly."
0,"If these agents were used during trial participation, the study drug was to be (temporarily) interrupted and restarted as soon as the prohibited drug was discontinued."
1,"The Pediatric Vaccine (PedVacc) 002 study was a single-site, phase I/II, open, randomized, controlled trial of candidate HIV-1 vaccine MVA.HIVA compared to no treatment."
0,"The intervention - 40–60 minutes per session, twice a week, for 12 weeks - started as soon as the patient was allocated to the IG."
1,The primary outcome was MVA.HIVA vaccine safety.
0,"Two slides from a single stool sample were examined by the Kato Katz method, as previously described [26], and infection intensity categorised as undetected, light (0-99 eggs per gram (epg)), moderate (100-399 epg) or heavy (> 400 epg)."
14,"The study was blinded with respect to the treatment allocation for subjects, investigators, coordinators and sponsor."
0,"In France, the condition for reimbursement by the national health system was a length of use of 3 or more hours per night over a 5 month period."
14,The dose cohort was not blinded.
0,"Second, we initiated a validation process for fitness centers and supermarkets."
6,"The primary outcome was the effect of experiential learning on the reduction of dental plaque, gingivitis and caries as compared to the traditional lecturing method."
0,A 12-month maintenance intervention phase follows in which interventionists continue leading some sessions and trained rehabilitation staff assume responsibility for delivering part of the intervention.
6,"Secondary outcomes were the improvement of oral health knowledge, behavior and attitude, as reported from the questionnaires in children following the EL program compared to those who did not (TL program)."
0,The study and its Informed Consent form have been judged by the Committee to be ethically and scientifically satisfactory as well as correct and adequate to the aims.
3,"Inclusion criteria for the present study were: diagnosis of ocular hypertension (OH), primary open-angle glaucoma (POAG), pseudoexfoliative glaucoma or normal tension glaucoma, according to the definitions of the European Glaucoma Society Guidelines [21]; no previous treatments to reduce IOP and no treatment with any BAK-preserved eye drop for at least 6 months before the study; no fluorescein staining at baseline and no observable signs of ocular surface disease."
0,Calls lasted approximately 15–20 min and were guided by standardised phone call scripts.
3,"Exclusion criteria for the present study were: unwillingness to sign informed consent; aged <18 years; any ocular condition that was of safety concern or interfering with the study results; any ocular condition requiring the use of eye drops during follow-up (i.e., dry eye); closed/barely open anterior chamber angles or history of acute angle closure; ocular surgery or argon laser trabeculoplasty within the last year; ocular inflammation/infection occurring within 3 months prior to pre-trial visit; presence of the following ocular conditions: dry eye, moderate–severe blepharitis, Rosacea, Sjogren syndrome, pterygium or use of contact lens(es); hypersensitivity to BAK or to any other component of the trial drug solutions; any corneal pathology; diabetes at any stage; other abnormal condition or symptom preventing the patient from entering the trial (need for more than 1 IOP-lowering treatment), according to the investigator’s judgment; refractive surgery patients; women who were pregnant, of childbearing potential and not using adequate contraception or nursing; inability to adhere to treatment/visit plan."
0,Basal (V0) and maximal (Vmax) respiration rates were recorded in the presence of pyruvate/malate (10 mmol/L) or palmitoyl-l-carnitine (40 μmol/L).
1,A pilot feasibility RCT of exercise rehabilitation was conducted in survivors of critical illness with ICU-AW with a nested parallel observational cohort study of post–critical illness patients without ICU-AW.
0,Injection 2 occurred on Day 8 and was administered at the study clinic by the patient using the prefilled pen following training provided by the clinic site Trainer/Observer.
1,"Because of the pilot, feasibility nature of the study, there was no a priori calculated sample size."
0,Patient outcome is assessed 6 months after injury using the GOSE questionnaire.
1,"The study utilizes, after one year and a half piloting, a quesi-RCT (randomized controlled trial) design and involves 4320 high risk individuals selected, via rapid risk assessments (RRA) and detailed risk assessments (DRA), from about 72,000 farmers aged 35 or older in 36 administrative villages randomized into equal intervention and delayed intervention arms."
0,Subjects continued consuming their usual diet; no dietary advice or guidance was provided during the course of the study.
1,"The intervention arm receives baseline and semiannual follow up evaluations plus eCROPS-CA for 5 years; while the control arm, only the same baseline and follow up evaluations for the first 5 years and eCROPS-CA starting from year 6 if the intervention is proved effective."
0,"Defined as the average dose prescribed according to a representative sample of prescriptions and the costs were calculated on the basis of the actual dose administered and the purchase price to the institution by the pharmacy, without inclusion of administration costs."
6,"The study uses 5 types of outcome and process measures to assess intervention efficacy and sustainability, i.e., diagnosed type and stage of cancers, cancer-related KAP (knowledge, attitudes and practices), easy biophysical indicators, intervention compliance and acceptance of eCROPS-CA (Table 1)."
0,"Salbutamol was the only rescue medication permitted throughout the study, although not within 6 h prior to the start of each visit."
6,"In addition, the study also collects related social demographic variables e.g., age, gender, ethnicity, migration patterns, marital status, education."
0,The median of three measurements was recorded for analysis.
6,The primary measure of the incidence study is psychotic caseness as ascertained by SCID (Kiddie SADS for adolescents who are 13–17 years old) assisted by the PANSS interview.
0,"To be included in the sampling frame for the study, the veteran: (1) had one or more primary care clinic visits at the VAPHS UD in the 12 months before enrollment, (2) was at least 18 years of age at the time of enrollment, and (3) was overweight or obese with a body mass index (BMI) ≥25 kg/m2 calculated based on the most recent height and weight recorded in the medical record."
6,The primary endpoint was the quality of bowel cleansing.
0,The secondary aims will be examined as follows.
6,"Secondary endpoints were patient tolerance, and patient compliance, polyp detection rate, and cecal intubation time and rate."
0,The serum samples were frozen at −20°C or below until analysis.Safety and tolerability evaluation.
4,"Only partners of the women in the intervention group are asked to complete questionnaires regarding problems with sexuality and intimacy (male partner: IIEF [85], female partner: FSFI [86]), and relational functioning (PAIR Inventory [87], MMQ [84]) at the same points in time as the participants."
0,Values of the area under the concentration-time curve (AUC) were estimated using the linear trapezoidal rule with linear interpolation.
16,Descriptive statistics were performed.
0,Hybridomas were generated from the lymph node cells that had been subjected to 2 rounds of amplification with CD40L-stimulation.
16,The areas of the intervention and control sites for each child were not identical; therefore differences were calculated as percentages: Changes in the areas of the control and intervention sites each week were calculated as change in proportion of area related to baseline area.
0,"Hence, children with particularly high prevaccination antibody may have had subclinical measles infection and be at higher risk of dying."
1,"This is a multicenter controlled randomized clinical trial in four parallel groups: a) healthy lifestyle psychoeducational program, b) focused program on positive affect promotion, c) brief intervention based on mindfulness and d) improved treatment as usual (ITAU) group in primary care."
0,"Initially, subjects received 200 mg oral capsules SG1002 or placebo twice daily (BID) for 7 days (visit 1, days 0–6); then increased to 400 mg SG1002 or placebo BID for 7 days (visit 2, days 7–13); then increased to 800 mg SG1002 or placebo BID for 7 days (visit 3, days 14–21)."
6,"The primary outcome measures were as follows:Difference in recruitment in each site (A, B and C) from 1 month pre-intervention to 1 month post-interventionDifference in recruitment in each site (A, B and C) from 3 months pre-intervention to 3 months post-intervention The secondary outcome measures were as follows:Change in adherence to trial procedure (defined as providing eligible women with the trial information booklet during the antenatal period) in each site (A, B and C) from 1 month pre-intervention to 1 month post-intervention.Change in adherence to trial procedure in each site (A, B and C) from 3 months pre-intervention to 3 months post-intervention."
0,"the PSS-14 perceived stress questionnaire, which was validated for the Greek population [55] and collected at baseline; and 4."
6,The 1 month and 3 month timeframes were chosen to assess short- and long-term effects of the intervention.
0,PCR products were directly sequenced using the Applied Biosystems PRISM dye terminator cycle sequencing method (Perkin-Elmer Corporation).
3,"The eligible study population will consist of all consecutive adult patients who are planned for elective implant removal following fracture treatment of the foot, ankle and/or lower leg."
0,Amplification was performed at 55 °C and 45 cycles.
6,"The CaMEO Study modules included validated instruments and surveys as well as original items developed based on the results of focus groups, expert opinion, and pretesting among target respondents."
0,"Prior to the administration of study drugs the field worker asked the mother/guardian and checked the health card to determine whether the child had received antimalarials during the previous 2 weeks and if so, the study drugs were not administered to avoid repeating a treatment with SP."
1,"We conducted a randomized, double-blind, placebo-controlled, crossover study comparing the analgesic efficacy of amitriptyline tablets to inactive placebo tablets, with a three-week washout period between interventions."
0,All time intervals were measured using preset timers.
8,"To detect a clinically meaningful reduction in the intensity of peripheral neuropathy of 2 units on an 11-point NRS [10,13,24], assuming 90% power, 5% level of significance and assuming common variance in the two crossover periods of 2, we estimated that 56 individuals would be required."
0,The questionnaire and recommended processing codes are available in http://www.mrc-epid.cam.ac.uk/research/resources/.
8,"We assumed a loss to follow-up of 10%, thus increased the sample size to 62 participants in each of the ARV-naive and ARV-user groups."
0,Take the logit function of this weighted difference.
4,"The study was conducted in 2 sites in north-western Ethiopia: a MSF supported health centre in Abdurafi, Amhara Region and a hospital in Humera, Tigray Region."
0,Written informed consent was obtained from both parents or guardian.
4,The populations included residents as well as high numbers of migrant workers who were present seasonally.
0,"Patients with symptoms requiring a rescue antiemetic—nausea score ≥4 on an 11-point Numeric Rating Scale (NRS), retching or vomiting, or patient request—within 6 hours of PACU admission were given the randomized drug within 10 minutes of investigator determination of necessity."
3,"All clients, aged > = 5 years, presenting to be tested for HIV in the study sites were offered participation in the study."
0,A random intercept will be utilized to account for natural variation in baseline blood lead measurements among hunters.
3,All study participants underwent informed consent procedures and had a written consent form signed by the participant or the guardian.
0,Data will be analysed according to an intention-to-treat approach.
8,"The sample size calculation is based on a 20 % effect size of VO2 peak , which is comparable to the effect reported by Frederix et al. in their Telereab II study [9]."
0,"At all health facilities, envelopes were arranged and allocated sequentially."
8,"In order to attain a minimal power of 95 %, at an alpha error probability < 0,05; 140 patients should be recruited when taking into account a dropout rate of 30 % during follow-up."
0,The institutional review boards of each participating centers approved the studies.
3,"The VBS eligibility criteria are the same as in the PDI/RDS study described above, with the following exceptions: VBS participants must reside in the core HRA (not the larger HRA), and those with previously diagnosed HIV are ineligible."
0,Eligibility for cancer screening and “up-to-date” status will be based on the USPSTF recommendations in effect at the time of the office visit.
3,"Thus, the VBS eligibility criteria are: aged 18-60 years; sexually active (vaginal and/or anal sex) with at least one opposite sex partner within the previous year; reside in the core HRA’s seven zip codes; African American/Black or Latino/Hispanic race/ethnicity; comprehend English or Spanish; unknown or negative HIV status; not actively psychotic based on valid screening instrument."
0,To establish the effectiveness of the pragmatic weight loss and exercise intervention appropriate data are collected to address the question of cost-effectiveness.
8,"Parasitologic failure rate among pregnant women treated with SP was 11% in 2004, double the failure rate in 1996 (5%) [14]."
0,"We initiated a multicentre, cluster-randomised trial in India on Sept 1, 2009, to find out whether two doses of quadrivalent HPV vaccine would be as effective in inducing non-inferior immune response and in preventing persistent vaccine-targeted HPV infection and cervical neoplasia as three doses."
8,"Allowing for the possibility that failure rates had increased, a sample size of 300 women was determined to be sufficient to estimate the proportion of failures with a 95% confidence interval (CI) width of 0.10, assuming a 20% failure rate, and allowing for approximately 20% loss to follow-up [15]."
0,DNA was extracted from the sections using the DNeasy Tissue and Blood kit (Qiagen) and from blood using the EZ1 system (LifeTechnologies).
1,"The project utilizes an initial formative research process to understand inefficiencies in the current Option B+ care cascade, to guide identification and prioritization of key workflow modifications and the development of an enhanced adherence and retention package."
0,"We calculated the proportion of synovial tissue in every voxel using P=(I−mf)/(ms−mf) truncated to [0, 1], where I is the voxel intensity, and mf and ms are the means of the intensity distributions of fluid and STV, respectively."
1,"These two components, described in detail below, are bundled into a defined intervention implemented and evaluated across six health facilities utilizing a stepped wedge randomized controlled trial (with the health facility as the unit of randomization)."
0,Office of Human Subjects Research Protection.
8,Following the primary hypothesis (1a) we assume a FPR of 0 and the study is planned to include approximately 400 patients among whom 125 had a good neurological outcome.
0,"Consequently, with α=0.05 and power of 80%, we were required to enrol 138 infants."
8,Based on these assumptions a 95%-confidence interval (using Wilson’s method) of FPR will be 0-3%.
0,Figure 1 Study design Settings and locations
1,"This study used qualitative, semistructured interviews to explore and understand participant experiences of dizziness self-management using booklet-based VR alone or with telephone support."
0,"NGAL neutrophil gelatinase-associated lipocalin, S.K+ serum potassium, S.Cr."
4,"Participants are recruited through local newspaper advertisements that are designed to target individuals who might score high on internal disinhibition and included phrases such as, “Do you have trouble controlling your eating when you are stressed?” and, “Would you consider yourself an emotional eater?” In addition, to recruit a more diverse sample, direct mailing are used."
0,Details of the design are reported elsewhere [39].
4,Recruitment materials with pictures of men and people from a variety of racial and ethnic backgrounds and using the term “stress eating” (rather than emotional eater) are sent to zip-codes with higher representation of minorities.
0,The analysis of linear regression in the resistive component of the impedance in the frequency range between 4 and 16 Hz was used to determine the intercept resistance (R0).
12,"After giving written informed consent and filling in baseline measures, the patients will be randomly assigned to the ""early palliative care"" group or the ""standard care only"" group using sealed envelopes prepared using a computer program by FRH co investigator not involved in the inclusion of the patients, in a 1:1 ratio without stratification and with randomized block sizes ranging from 4 to 6."
0,The primary outcome was the percentage of days over a twelve-week period on which the correct number of doses of main glucose lowering medication was taken each day as prescribed.
16,"To compare baseline characteristics and study outcomes of the patients between groups, Fishers’ exact tests, chi-square tests and the independent-samples t-test or the non-parametric equivalent Mann–Whitney u test will be used."
0,"For all of our analyses we used SIF1LED 375 nm[0.6, 0.2] and SIF14LED 456 nm[0.4, 0.8], which were examined previously in genetic association studies of SIF in DCCT/EDIC10 and represent the lowest (SIF1=375 nm) and highest (SIF14=456 nm) light-emitting diode (LED) excitation wavelengths examined in the DCCT/EDIC study."
5,Subjects were randomly allocated to one of three different foreskin hygiene techniques (ratio 1:1:1): (1) control arm: subjects instructed to follow the current hygiene instructions of standard washing with soap and water during a daily shower; (2) soap arm: subjects instructed to clean the foreskin with soapy water once a day using a syringe; and (3) chlorhexidine arm: subjects instructed to clean the foreskin with diluted chlorhexidine (1%) once a day using a syringe.
0,Standard diet advice was given by a dietitian and/or specialist doctor.
5,"The trial staff included 2 physicians, 4 procedure nurses, 3 smelling nurses, and 2 coordinators."
0,"Finally, the intended ‘blinding’ in terms of the topic of the intervention was checked among the participants by formulating the following open question ‘Do you have any idea on which clinical topic this study focused on?’."
6,"The primary outcome is mortality, with a secondary outcome of any reintervention, both within 30 days of randomization."
0,"The personal control item was significantly correlated with diabetes self-efficacy (r = 0.61, p < 0.001) and lower HbA1c (r = −0.30, p < 0.01) [19]."
6,"Following the review of initial results, 24 h mortality also was assessed."
0,The subjects walked for 14 m to account for potential acceleration and deceleration effects.
3,"Age 18–78 years, BMI >30 with metabolic syndrome (NCEP ATP III), CKD stage 3 with proteinuria less than 3.5 g per day, with a blood pressure <140/90 mmHg/."
0,"The elimination rate constant, λz, was calculated as the negative of the slope of the terminal log‐linear segment of the plasma concentration–time curve."
3,"Fructose intolerance, BMI < 18, presence of diabetes mellitus, symptomatic gout defined as an acute inflammatory arthritis in the last 3 months, or presence of chronic inflammatory diseases (including systemic lupus erythematosus - SLE, chronic inflammatory bowel disease, and rheumatoid arthritis) or use o immunosuppressive treatment, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), or allopurinol."
0,There was a slight delay in trial registration due to administrative oversight.
1,"This is a single-center, parallel, randomized, double-blinded, sham-controlled trial, conducted in the Laboratory of Functional Electrostimulation at the Federal University of Bahia (Salvador, Brazil)."
0,Fertile without effective contraception.
1,"This study will include descriptive and analytical steps designed to investigate the neurobiological aspects of patients with ADHD, and the response of inhibitory control parameters to tDCS."
0,Oral and depot medication costs were calculated drawing on the Prescription Cost Analyses.[23] Each study medication code was assigned to the corresponding British National Formulary chemical name.
3,"The inclusion criteria for the study are (1) the ability to understand and sign the informed consent form, (2) a diagnosis of ADHD according to DSM-IV-TR and the Adult Self-Report Scale (ASRS), (3) resident of Bahia, and (4) ≥18 years old."
0,The pedal rate was set at 50–60 revolutions per minute using a metronome set at 100 bpm.
3,"Patients who meet the following criteria will be excluded (1) major psychiatric disorders such as schizophrenia and bipolar disorder, (2) inability to understand the questionnaires applied (cognitive impairment score of ≤24 on the Mini-Mental State Examination) or illiterate, and (3) abuse of psychoactive substances or alcohol, except nicotine and caffeine, during the last 12 months."
0,Eighty-six percent (n = 660) completed the T2 assessment.
1,"The study was a feasibility study with a randomised design to assess the fidelity, feasibility and acceptability of the short-listed VBIs identified in Stage 1."
0,"In January-February 2010, we were able to recontact 109 of the subsample participants for the second interview."
4,The study was conducted in three NHS general practices in urban areas in the east of England.
0,Fig. 1 Consort diagram for HOME Plus study Measures
4,"The study was approved by the NRES Committee East of England - Cambridge Central (REC reference: 12/EE/0200), and research governance approval was obtained from NHS Cambridgeshire (Re: LO1183VBI)."
0,Interim analyses are planned after 1/3 and 2/3 of the patients included reach the end of the follow-up period to allow for an early stopping of the study (or accrual of patients in a specific treatment group) due to rejection of the null hypothesis.
1,HOPE is an ongoing 2.5-year multi-centre observational prospective cohort study with seven study visits and data entry points (t0-t6) and a follow-up period of 12 months.
0,A summary score ranging from 0 (worst performers) to 12 (best performers) is calculated by summing the three component scores.
1,The primary endpoints are completion of the follow-up period or patient death.
0,Witnessed written consent or thumbprint was obtained from every patient participating in the study.
4,Study centres collect data prospectively following the data acquisition timeline in Table 2.
0,No virus was added to untransduced T cells.
4,Visits t0 to t2 take place at ICUs; visits t3 to t5 at the neurorehabilitation centres; and visit t6 at the location of residence of the patient 12 months after day 0.
0,6.00 and p < 0.05 were considered statistically significant.
3,"Inclusion criteria were as follows: Age ≥ 18 years; inception of maintenance HD within the previous 3 to 18 months; predialysis Hb level between 8 and 12 g/dl; LV volume index (LVVI) < 100 ml/m2, and predialysis diastolic BP (DBP) < 100 mmHg."
0,"Clinical and methodological heterogeneity hampers the interpretation of pooled statistical analyses, although evidence from the multiple systematic reviews suggests that multifactorial interventions reduce the rate of falls (number of events) but not the risk of falling (number of fallers)."
3,"Exclusion criteria were as follows: Clinical evidence or history of symptomatic cardiac failure or ischemic heart disease; daily prednisone dosages ≥ 10 mg; medical conditions that are likely to reduce epoetin responsiveness, including uncorrected iron deficiency; concurrent malignancy; blood transfusion in the preceding month; therapy with cytotoxic agents; seizure in the preceding year; hypersensitivity to intravenous iron; and current pregnancy or breastfeeding."
0,"We obtained permission from an original study investigator (B Leelarthaepin, coauthor) and approval from the Office of Human Research Protection to recover, analyze, and interpret de-identified SDHS data stored on a 9 track magnetic tape."
1,"This study was a randomized, double-blind, multicenter, active-drug-controlled, phase III clinical trial to compare the efficacy and safety of Neuronox versus BOTOX in the treatment of post-stroke upper limb spasticity."
0,"Based on our previously reported experience [17], a positive response was defined as an increase by ≥ 40 spots from baseline."
1,"It was conducted at 5 university hospitals (Seoul National University Hospital, Bundang Seoul National University Hospital, Seoul National University Boramae Hospital, Asan Medical Center, and Ilsan Dongguk University Hospital) in the Republic of Korea between March 2011 and January 2012."
0,Iterative reconstruction (Adaptive Iterative Dose Reduction or iDose4) was used to reconstruct images.
16,Details on statistical analysis can be found in the online-only Data Supplement.
0,Patients and care givers were also supplied with comprehensive written information to support the information given at counselling sessions and courses and a log book in which they could write information and thoughts about their daily life.
1,A double-blind randomized controlled trial of oral celecoxib or placebo following tonsillectomy or A&T in children was conducted in a Canadian pediatric tertiary care centre.
0,This was to reduce the possible disadvantages of being in the placebo group.
1,The study protocol was approved by both the institutional ethics review board and Health Canada.
0,prior to the measurements.
3,Children (age 2-18 yr) scheduled for elective surgery were enrolled over a three-year period (2009-2012).
0,"Overall parent resource empowerment increased by 0.25 points (95% confidence interval [CI], 0.21–0.30) over the 1-year intervention period."
3,"Exclusion criteria included patients with extremes in body mass index (< 10th or > 95th percentile), abnormal renal or hepatic blood work, moderate-to-severe OSA documented in a sleep lab, any contraindication to NSAIDs, allergy to sulfonamides, risk of pregnancy, recently received CYP2C9 inhibitors or inducers, language barrier to English or French, and parent/participant cognitive impairment."
0,This does not occur with the SJ.
8,"Because there were few relevant previous studies available, we estimated an approximate sample size on the basis of the number of patients with dizziness visiting the emergency department (ED) of Changhua Christian hospital."
0,We conducted IDIs with 10 Thai and Vietnamese FEWs.
8,We planned to enroll a total of 60 participants with 30 in each group to conduct this pilot study.
0,"Since a log-rank test statistic for intervention effect calculated for a simulated stepped-wedge trial (Z SW) will generally always be lower than the corresponding statistic (Z E) for a parallel group trial, because allocation ratios of patients to intervention or control status for parallel group trials remain equal while for stepped-wedge trials they are usually unequal, except at the mid-point of the stepped-wedge design, the z-score in the stepped-wedge trial formula (Z β above) was divided by a published estimate of Z E/Z SW (i.e., 1.2) prior to extrapolating the z-score to a power estimate [26]."
1,"The Intra-Peritoneal Vacuum Trial was a single-center, parallel-group RCT that intraoperatively allocated adults to the ABThera versus Barker's vacuum pack in a 1:1 ratio after abbreviated laparotomy."
0,"On the rare occasions on which an assessor became unblinded due to overt disclosure by a participant, we used an alternative assessor for all subsequent assessments."
1,Trial methods were prespecified in a previously published protocol10 that was registered online at ClinicalTrials.gov (identifier NCT01355094) and approved by our local research ethics board.
0,The resulting solution was further diluted (final dilution 5 times) in PBS and assayed.
8,"As clinical data are lacking concerning the effect of negative pressure peritoneal therapy on the inflammatory response after abbreviated laparotomy, estimates were unavailable for sample size determination."
0,The health states were converted into a single index value using the UK value set.
8,We therefore obtained funding to randomize 45 patients.
0,"When parent and child attended the well-child centre allocated to the intervention group, the professionals used a brief assessment form regarding asthma-like symptoms and ETS exposure during the regular visits at age 14, 24, 36 and 45 months."
3,"The study population for this analysis was restricted to women enrolled in the MNHR, aged 24 years or less, who gave birth to infants of at least 20 weeks’ gestation and weighing 500g or more."
0,The tenets of the Declaration of Helsinki were followed throughout this study.
3,"The study period included women enrolled with deliveries January 2010 through December, 2013."
0,"CD4 count was measured in TasP clinics using a commercial point-of-care CD4 test (Alere PIMA device tool, Alere Inc, Waltham, Massachusetts)."
6,"EIBF was defined as initiation of breastfeeding within one hour after delivery, based on the maternal report, at the perinatal visit, of how soon after birth the child was given breast milk."
0,Sources of healthcare funding or non-funding of all patients were identified at the time of entry in the study and continuously thereafter.
6,"Exclusive breastfeeding at 42 days of life was defined as the baby having received no other food, liquids, or substances (exclusive of medication, immunizations, ORS drops, or vitamin supplements) other than breast milk at the 6-week follow-up visit."
0,The RA will review the electronic ED medical records of patients according to these lists and determine which patients are potentially study eligible.
1,"The iPACK-HD trial is a randomized, double-blind (subjects and physicians), placebo-controlled, Phase II, multicenter study which will be conducted in North America (Canada and United States)."
0,"Spots were visualized by adding BCIP/NBT (Sigma-Aldrich), scanned and counted using the AID ELISpot reader (AID Autoimmun Diagnostika GmbH, Germany) to determine the number of spots/well."
1,"In this study, incident (within 6 months) hemodialysis patients with ESKD are randomized to receive 10 mg of phylloquinone three times per week or matching placebo after each dialysis session for 12 months."
0,(iii a) Women who had indicated they were interested in advice and wished to become pregnant within a year were sent a risk-assessment questionnaire they could return to their GP.
3,"Patients were enrolled in the study if they had typical symptoms and signs of CTS, such as positive Tinel’s sign, Phalen’s test, numbness, or tingling in at least two digits of the hand, and were confirmed with CTS by electrophysiological tests."
0,"During the 12-week trial, subjects ingested one of the three astaxanthin doses (zero, six, or 12 mg) capsules with an appropriate amount of water once daily after breakfast."
3,"Patients who had conditions mimicking CTS, such as cervical radiculopathy, polyneuropathy, brachial plexopathy, thoracic outlet syndrome, had previous wrist surgery, or received steroid injections for CTS, were all excluded."
0,SPE cartridges were pre-washed then conditioned with 3.5 mL with 0.1% acetic acid in 5% methanolic water.
8,"There are no published studies investigating ultrasound-guided PRF for CTS, and our research is a preliminary and novel study in this field."
0,A Cox regression analysis with backward selection was performed to analyse the independent predictors of short-term and long-term mortality.
8,"Therefore, no previous study could be referenced before designing the experiment and deciding the number of patients."
0,"For lysis of erythrocytes, samples were incubated with 500 µl FACS Lysing solution (Becton Dickinson) for 15 min in the dark at room temperature."
1,The trial design has been published in full [22].
0,"The physician described the subject’s demographic and general clinical characteristics, the main medical and surgical history and any current treatment if those pathologies were still present, and any previous antidepressant, anxiolytic or neuroleptic treatments."
1,"Participants were randomized (1:1) to receive either 12 weeks add-on group-based CR or ST in an evaluator-blind, between-groups design."
0,Figure 2 Fluid management in Vigileo group.
1,We conducted a feasibility RCT comparing CCBT with physiotherapy in four NHS Musculoskeletal / Physiotherapy Services in England between September 2010 and December 2013 (see [9] for details).
0,It also provides a summary print-out that can be taken to one's visit with his or her doctor.
1,"The study was approved by The National Health Service ethics committee, and at university level at Royal Holloway, University of London."
0,"Total RNA from liver biopsy was extracted using Trizol reagent according to the manufacturer instructions (Invitrogen, Carlsbad, CA, USA)."
3,Three eligible male participants with post-stroke left hemiparesis participated in this study after providing informed consent.
0,Study participants were undergraduate students from one university in the central region of China.
3,Demographic data and lesion types for participants are provided in Table 2.
0,First measurement was performed during screening visit to avoid training effects during study visits.
16,"Descriptive statistics were used to summarize the results according to HT use, reasons for use of HT, reasons for stopping HT, use of CAMs, and perceived helpfulness of CAMs."
0,Histones and proteins acetylation on PBMC will be done as additional surrogate pharmacodynamic markers of VPA activity at different time points during and after treatment.
6,The final health outcome of the cost-effectiveness analysis is the number of CRBSIs avoided and the cost-effectiveness criterion is the cost per patient with CRBSI avoided resulting from chlorhexidine dressing use.
0,"Analysis (Arista Laboratories, Richmond, VA) consisted of methanol extraction of groups of cut cigarette tips (n=5 ± 1) from the study subjects as well as calibration cigarettes."
3,"The study population consisted of students who attended the following basic courses (vocational clusters in brackets):Car mechanicsCarpenter, bricklayer, painter or plumber (Construction)Electrician, data technician or frontline PC supporter (Electricity and information and computing technology (IT))Media graphic designer, graphic technician, web integrator or sign writer (Media production)Zookeeper, landscaper, farmer or greenhouse gardener (Agricultural) Shaping the Social is designed to accommodate the fact that this was a heterogeneous population considerably more diverse than, for example, a typical Danish high school population."
0,As shown in b plasma cells (PC) displayed a CD38high CD138int phenotype with low CD19 and CD45 expression indicative of an immature plasmablast (PC) population.
3,"Patients were aged 18–50 years with documented grass pollen-related ARC for at least the two previous grass pollen seasons, a positive skin-prick test (wheal diameter >3 mm) to 5-grass-pollen-mix extract, Phleum pratense (timothy grass)-specific serum IgE ≥0.7 kU/L, and a retrospective rhinoconjunctivitis total symptom score (RRTSS) ≥12 (on a 0–18 scale), based on the most severe days in the grass pollen season preceding enrolment."
0,"The study partners developed a memorandum of understanding, engaged in formal capacity building activities (e.g., trainings on human subjects research, study protocols, quality control and translation of study documents for populations with lower literacy), and formed a community advisory board to provide structure and oversight of the partnership and research study."
3,"Exclusion criteria were ARC symptoms during the grass pollen season due to allergens other than grass pollen, asthma requiring treatment with more than a beta-2 agonist, or presence of any other disease that might affect the participation or outcome of the study."
0,"In each school, two 8th grades and two 9th grades were randomly selected and all students in those grades were invited to participate in the study."
6,"Secondary outcome measures included total opioid dose, opioid side effects, patients satisfaction with pain management, proportion of study period in moderate/severe pain (that is, with visual analogue scale >44 mm), proportion of study period spent sleeping, and length of hospital stay."
0,We will estimate and test differences in continual measures of disease activity using random-effects linear regression models adjusting for the levels of clustering and compare mean changes in scores between the T2T and UC groups.
6,"Secondary outcome measures included total opioid dose, out of range vital signs, patients satisfaction with pain management, proportion of study period in moderate/severe pain (that is with visual analogue scale >4.4 cm), proportion of study period spent sleeping, and length of hospital stay."
0,"The protocol was approved by the Institutional Review Board of the Icahn School of Medicine at Mount Sinai (New York, NY) and the Ethic Committee at St Mary’s Hospital (Manchester, UK)."
1,"This was a 12-week randomized, double-blind, placebo-controlled clinical trial conducted at Chung Shan Medical University Hospital (CSH-2012-C-023)."
0,"After genotyping of the AMPD1 rs17602729 variant (also known as 34C > T and Cys12Arg), we selected 10 subjects with the heterozygous (CT) genotype."
1,"The study employed a repeated cross-sectional observational design embedded within a cluster randomised controlled trial, with the school as the unit of randomization [17]."
0,The Symptom Checklist (SCL-90) is a self-report symptom inventory of psychopathology.
8,The sample size of this pilot study has been estimated based on determining the proportion of patients failing oral antibiotic treatment.
0,All participants were recruited on the basis of the following strategies.
8,"Using a 95% CI for the proportion of patients failing oral antibiotic treatment, a margin of error of 0.05 and an expected proportion of 10% based on an educated guess, and two recent studies15 16 suggesting that at least 6.8%, and up to 20% of ED patients with cellulitis fail initially prescribed antibiotic therapy, the required sample for the pilot study would be at least 152 patients."
0,"DCs endocytosis was evaluated by incubating 106 cells with 1 mg/ml FITC-dextran (FITC-Dx) (Sigma, St Louis, CA) for 60 min at 37°C."
14,Both patients and investigators were blinded to the treatment allocation.
0,"From these results, there now exist strong data validating the magnitude of theoretical robustness for a number of social-cognitive constructs to predict (or not predict) stage transition."
14,"The same efficacy assessor (LC) performed all skin scores and physician global assessments at baseline and week 24, and remained blinded to safety assessments throughout the study."
0,Each textbook-based MCQ was designed to be answered within 90 seconds and was preselected according to the results of item analysis.
4,"The study will be based on around 20–24 study participants who were randomly assigned to the SMILE (UK) control group, and the precise sample number will depend on when sampling saturation has been achieved and the condition that no new issues or explanations are elicited by further interviews [36]."
0,"The latter was analyzed in those receiving study medications (uzara versus ibuprofen) as “modified intention-to-treat” or “per protocol”; a non-randomized, observational comparison."
4,"Participants will be selected purposively to achieve a study group that is inclusive in terms of differences in gender, age, ethnicity, severity of seizures, and depression score."
0,"Data were analysed using descriptive statistics, with categorical variables presented as absolute values and percentages and continuous variables as means with standard deviations (SD)."
6,"The main outcomes were the 8-week changes in blood lipids, glucose metabolism, BP and uric acid concentrations."
0,"CT26 mouse colorectal carcinoma (CD73low) cells, 4T1 mouse breast carcinoma cells (CD73high), MDA-MB-231 (CD73 high) human breast carcinoma."
6,"In addition, we assessed changes in the prevalence of MS, body weight, body composition, gastrointestinal symptoms and hormonal characteristics of PCOS."
0,"Although the validated ELISA assays used gp120 Env proteins from laboratory-adapted HIV-1 strains, consensus gp140 envelope sequences show greater similarity to the vaccine strains."
8,"We assumed that the LMR and CB diets would be associated with a mean (s.d.) 8-week decline in triacylglycerol (primary outcome) of 0.3 (0.5) and 0.6 (0.5) mmol/l, respectively (25)."
0,Female 4 week old Wistar rats were given daily 3.0 milligram per kilogram body weight sirolimus (N = 4) or vehicle (N = 4) by gavage feeding.
8,At least 90 patients had to complete the study in order to attain a power of more than 80% (α=0.05) to reveal this possible difference.
0,"Exclusive breast feeding increases the risk of ID, but controversies exist about whether iron supplementation in this population should be recommended."
5,"After signing the informed consent form, women were given the antibiotic or anti-fungal treatment followed by EcoVag® vaginal capsules."
0,"In addition, due to their potential role in our pathophysiological model, a number of genetic variants have been preselected from a search on the SNP NCBI database and Hapmap: (i) variants with a phenotypic expression and/or associated with functional alterations related to asthma and (ii) variants related to asthma and with an allele frequency > 10%."
3,Only women who completed the full vaccination course in the primary study were eligible for inclusion in this extended LTFU study.
0,"For each of the 40 cycles, we imputed missing values and bootstrapped the complete data set."
3,Inclusion and exclusion criteria for the primary study were previously described.41
0,• The Brief Illness Perception Questionnaire (B-IPQ) assesses perception of illness by asking patients for their own belief about their condition [34].
1,"The NAT2 study was a double-blind, prospective, randomized, parallel, comparative trial in patients with early AMD in the study eye and neovascular AMD in the fellow eye, receiving oral DHA or placebo over 3 years."
0,Families in this Combined arm group that are identified with a child ‘at risk’ at age two years will be offered the Family Check-Up.
1,The assessment of incident CNV in the study eye was the primary efficacy endpoint.
0,All planning was performed using the Eclipse Treatment Planning System v12 (Varian Medical Systems).
1,"STRATEGIC-1 is an international, open-label, randomized, multicenter phase III trial comparing two standard therapeutic strategies in patients with unresectable RAS wild-type mCRC."
0,All patients on treatment will have an additional follow up visit at week 8.
1,A full list of the participating institutions is displayed in Additional file 1: Table S3.
0,"Table 1 Baseline predictors associated with categorical improvement after 6 Months and 12 Months of treatment with OLAI At the second step of modeling, reported in Table 1 under the ‘Stepwise multivariate logistic regression’ heading all baseline variables that were identified as potentially significant (p < 0.1 in the single factor model) were simultaneously included in a multivariate model for stepwise selection of covariates based on significance cut-off of p < 0.1 entry into the combined model."
1,This study was a single-blinded randomized placebo-controlled trial (RCT) involving 12 treatment sessions over 3 months.
0,"Omollo et al. [7] proposed the following estimate for p210: where is the median unbiased estimate of p [6], with and being estimated by maximum likelihood from the 2×2 table of cure status at the two time points."
1,The study presents an unregistered outcome based on prospective data collection during an otherwise registered study.
0,"Quantitation of total serum IgG antibodies against HspB5 was performed by standard ELISA on plates coated with HspB5, using peroxidase-conjugated rabbit anti-human IgG (Sigma Aldrich, St."
14,"After each treatment session, the participants completed the de-blinding questionnaire administered exclusively by a blinded external trained independent party with no involvement from the clinical investigator, i.e., providing a dichotomous “yes” or “no” answer as to whether active treatment was received."
0,"As described previously, median 68% (IQR 48–77) of the hours for medical care at the ward were covered by PAs [15]."
14,"This response was followed by a second question regarding how certain they were that active treatment was received on a 0–10 numeric rating scale (NRS), where 0 represented absolutely uncertain and 10 represented absolutely certainty1415."
0,The final step was in-stent balloon dilation.
6,The outcome measures included the rate of successful blinding and the certainty in the participants’ beliefs in both treatment groups.
0,○ Hypertension: ▪ systolic blood pressure (SBP) ≥140 mmHg ▪ diastolic blood pressure (DBP) ≥90 mmHg ▪ receiving antihypertensive medication.
16,Results are expressed as standard deviation if not otherwise indicated.
0,"Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), hs-CRP, apolipoprotein (Apo) A-I, Apo B, and triglyceride fasting plasma levels were determined by a central laboratory."
16,"Values of p ≤ 0.05 were considered statistically significant, as determined by the ANOVA test, the two-tailed unpaired Student t test, or the Wilcoxon rank-sum rank test where appropriate."
0,"The features of the consultations that is consultation time, the amount of nurse communication, and the amount of lifestyle discussion as well as the patients’ readiness to change were identified by the judges during the rating of the videos."
16,"Data were processed with SPSS version 22 for Mac and statistical analysis was made using descriptive statistics and repeated measures ANOVA, p values <0.05(two-tailed) were regarded as significant."
0,"For sample size calculation, exponentially distributed survival times are assumed to calculate the hazard ratio under the alternative."
3,"In order to participate in the study, women will be required to meet the following inclusion criteria: age 18–<41 years; body mass index 18–30 kg/m2; eligibility for controlled ovarian stimulation and ART treatment (including ICSI); anticipated and/or confirmed POR to stimulation, using criteria aligned with the 2011 ESHRE Bologna criteria,11 that is, at least two of the following three features: advanced maternal age (40–41 years); a previous cycle with ≤3 oocytes retrieved with a conventional stimulation protocol; and/or an abnormal ovarian reserve test (ORT) characterised by an anti-Müllerian hormone level (AMH) greater than or equal to the lower limit of assay detection to 1.3 ng/mL (inclusive); access to motile, ejaculatory sperm (including donated and/or cryopreserved sperm); and no treatment with clomiphene citrate or gonadotropins for ≥1 month prior to screening."
0,Individual participants were randomized in a 1:1 ratio to receive either PfAMA1-FVO/Alhydrogel® or tetanus toxoid at the time of vaccination.
3,"Specific exclusion criteria include: primary ovarian failure; preimplantation genetic screening or diagnosis; two episodes of POR after maximal stimulation; history or presence of tumours of the hypothalamus or pituitary gland; history or presence of ovarian enlargement or cysts of unknown aetiology; presence of an ovarian cyst >25 mm on the day of randomisation; presence of confirmed or suspected Grade III–IV endometriosis; presence of unilateral or bilateral hydrosalpinx; abnormal gynaecological bleeding of undetermined origin; malformation of the sexual organs incompatible with pregnancy; contraindication to being pregnant and/or carrying a pregnancy to term; currently pregnant; presence of a clinically significant concurrent medical condition (eg, diabetes) that would compromise participant safety or interfere with the trial assessments; known infection with HIV or active hepatitis B or C virus (including in the male partner); history or presence of ovarian, uterine or mammary cancer; known allergy or hypersensitivity to human gonadotropin preparations or to compounds structurally similar to any of the other medications administered during the trial; substance abuse that would interfere with the trial conduct; use of testicular or epididymal sperm; and/or participation in another ART clinical trial within the preceding 30 days."
0,Species identification and antimicrobial susceptibility testing (microbroth dilution test) followed standard operating procedures according to Clinical and Laboratory Standards Institute (CLSI).
3,The study population has been previously reported.3
0,Radiographic non-progression was defined as mean change from year 2 through 5 (OLE years 0 through 3) in mTSS (ΔmTSS) of ≤0.5 units.
3,"Inclusion criteria included Japanese women (≥5 years post-menopause) and men who were ambulatory, ≥55 years old, able to use the pen injection device correctly, and at high risk of fracture defined as at least one of the following criteria: 1) BMD at lumbar spine L2–L4 <80% of young adult mean (YAM) (based on the Japanese Normative Female Database)11 with a minimum of one prevalent vertebral fragility fracture; 2) BMD at L2–L4 <70% of YAM and age ≥65; or 3) BMD at L2–L4 <65% of YAM and age ≥55."
0,Willemse et al. found that primary care patients with sub-clinical depression can benefit from self help manuals for MDD [52].
5,Women in the intervention arm attended 12 weekly 90-min group sessions (8–10 women and one facilitator).
0,Other subjects were LTFU between delivery and the 42 day visit (LTFU-after).
5,"Two bilingual, trained healthcare providers delivered the intervention."
0,Written informed consent was obtained from all participants before enrolment.
1,"The OptEC trial, hence the internal pilot study was a multi-site, pragmatic, placebo controlled, superiority randomized trial [1]."
0,Participation is based on written informed consent from all physicians.
16,"Nrf2 target gene data were analyzed with Sigmaplot 12.0 (Systat, Inc., San Jose, CA) by student’s t-test or by one way-analysis of variance (ANOVA) followed by Duncan’s Multiple Range post-hoc test with significance set at p < 0.05."
0,"Between October 2013 and February 2015, all candidate patients were approached in random order within each municipality (Viladecans and Gavà were grouped together because they are adjacent municipalities)."
16,Analysis will take place within this package and SPSS.
0,"Social skills training will be conducted using a standardized treatment manual, appropriate for this age range."
16,Dummy tables for this analysis are prepared before recruitment of the first patient (Table 5).
0,"During the placebo lead-in period, patients received single-blind placebo for up to 14 days corresponding to the time in screening of 10±4 days."
16,No formal power calculations have been performed.
0,"While blinded during the conduct of the study, GSK was unblinded at the time of data review with the independent physician."
16,"Means, medians, standard deviations, and basic statistical analysis were performed using the GraphPad Prism 6 software (GraphPad Software, CA, USA)."
0,"After initial attempts using nurses to approach patients were unsuccessful, physicians were asked to approach appropriate patients directly to determine if they might be interested in the study."
8,"Planned recruitment was up to 300 patients (≤150 adults), with a minimum of 200, which would provide at least 134 evaluable patients based on an estimated 33% rate of dropouts and exclusions from the evaluable immunogenicity population between visits 1 and 6."
0,"An inventory of sports equipment (balls, rackets, nets, etc.) at each school was undertaken and the school coordinator was consulted about enabling students to have access to the equipment during their free-time at school."
8,"Owing to slow recruitment, particularly for the pediatric population, the protocol was amended to allow for enrollment of >150 adults to ensure the sample size."
0,"The aim of Girls Active is to provide a support framework for schools to review and change their PA, PE and school sport culture and practices with the support of the YST and a hub school."
8,Sample size was determined by estimating the number of OOR events based on the prior study assuming a Poisson distribution in these and a 20% reduction in the intervention group with 80% power and 5% significance level.
0,"If necessary, this visit may take place in the first term of the child’s first year in Primary school."
8,"This resulted in 15 patients per group, and our target was to recruit 40 patients altogether."
0,"Second, the language used in the slides that originated from the WCWHC was modified to address both partners."
6,The primary endpoint of this study was stroke volume before the intraoperative start of the liver resection.
0,"Approximately 150 new adult patients visit our specialised clinic each year, of whom 23% are diagnosed with CRPS-1.18"
6,"Secondary outcome measures were all determined with the study period of 8 postoperative days and included intra- and postoperative haemodynamic parameters, blood losses, the cumulative frequency of organ dysfunctions (cerebral, pulmonic, renal, abdominal, cardiovascular), infections, satisfaction of the patients (pain levels), (serious) adverse events and hospital length of stay and time treated in the intensive care unit."
0,Tracheal extubation was performed when standard extubation criteria were fulfilled.
8,"We evaluated if the application of rectal indomethacin had better results than placebo for the prophylaxis of PEP, with a known incidence of PEP of 25 % in high-risk patients and about 7.5 % in the study group [1, 2]."
0,"If willing to participate, clinical-demographic information was collected by phone and an appointment for baseline neuropsychological assessment was scheduled."
8,"By calculating the sample size for the comparison of proportions with desired errors α of 0.05 and β of 0.20, a minimum sample size of 80 patients per group was obtained."
0,The study was conducted in the morning hours during fasting before surgery.
1,"This was a prospective, single group, longitudinal study design."
0,"Plasma volume before the first apheresis was estimated from each patient’s weight, height, and hematocrit [27] (http://lipid-apherese.info/plasmarechner.htm; accessed 05.08.2016)."
1,"Ethical approval for this study was obtained from The Joint Bridgepoint Health – West Park Healthcare Centre – Toronto Central Community Care Access Centre – Toronto Grace Health Centre Research Ethics Board, and all participants provided written informed consent prior to inclusion in the study."
0,Capsules which varied from the standard thermometer by >0.5°C were discarded.
1,"The Ossébo study is a multicentre, balanced, two arm, parallel group, randomised controlled trial.11 12"
0,All data were linked through the GP ID and aggregated at the level of the general practice.
1,"It applied a pragmatic approach13 14 and aimed to assess the effectiveness of the intervention under real world conditions with existing community resources (instructors, settings)."
0,"The SLN procedure was initiated the day prior to the surgery using 4 subareolar injections of rhenium sulfur colloidal and technetium (99mTc) (0.4 ml, 22 MBq (595 μCi), Cis bio international®, France)."
1,"We planned a two-centre, assessor concealed, prospective randomized clinical trial conducted in Norway and Finland."
0,"ECL assays for plasma total Aβ (aa18–35), total Aβ42 (aa28–42), and free Aβ (aa1–22) were developed by GlaxoSmithKline (Table A in S1 File and S1 Fig.)."
1,The trial was approved by the institutional board in Norway (2011/947/REK Vest) and Finland (EETTMK:10/2012).
0,"Psychopathology, GAF, self-efficacy and quality of life measures were re-evaluated at a 12 weeks follow-up in both samples."
5,"Patients were randomized into two groups: a control group receiving traditional fluid therapy and a group with a goal-directed fluid therapy (GDFT) regimen guided by an arterial pressure-based cardiac output device (LiDCOrapid, LiDCO Ltd, London, UK) to measure SVV [11]."
0,There was a wide variety of exercises that the teachers could choose from.
5,"For more details of the study protocol, see Additional file 1."
0,"All the outcome assessments and the EMDR sessions will be conducted at the Department of General Internal Medicine and Psychosomatics, University Hospital Heidelberg, Germany."
6,The primary outcome measure was LOS in the hospital after surgery defined as the number of nights spent in the hospital after the day of surgery.
0,The qualitative study adopts an approach based on the analytical principles of Grounded Theory.
6,"Secondary outcome measures included: intraoperative packed red blood cell transfusion, number of packed red blood cells transfused per patients transfused, average lowest intraoperative hemoglobin value, average intraoperative mean arterial pressure, central venous pressure, cardiac output and SVV, incidence of unplanned mechanical ventilation for more than 6 hours after surgery, incidence of postoperative complications, LOS in the intensive care unit (defined as the number of nights spent in the intensive care unit after the day of surgery), readmission to the hospital within 30 days after hospital discharge, and 30-day postoperative mortality (Table 1)."
0,We only report the issues not identified through questions A and C above.
4,The study was conducted at a large academic primary care practice in the Midwestern United States.
0,Participants were also free to explore and download apps on their own.
4,"The practice provides primary care to approximately 130,000 patients."
0,"Bioluminescence was performed using a Xenogen IVIS-100 imager (PerkinElmer, Waltham, MA)."
6,"The primary outcome of the study was change in plasma CoQ10 parameters (total CoQ10 levels, CoQ10 levels relative to cholesterol levels, levels of oxidized (ubiquinone) and reduced (ubiquinol) CoQ10, and the fraction of reduced CoQ10 (reduced CoQ10/total CoQ10 levels))."
0,Patients who agreed to participate gave their written informed consent.
6,"Secondary outcomes included were: 1) assessment of vascular endothelial function via vascular endothelial growth factor (VEGF) and VCAM-1 measurements, 2) assessment of inflammation via IL-2, IL-6, IL-10, and tumor necrosis factor (TNF)-α measurements, 3) assessment of mitochondrial injury via cytochrome c levels and DNA markers, and 4) assessment of clinical outcomes (length of ICU and hospital stay, and in-hospital mortality)."
0,PEFR measurements were assessed for reproducibility by completing a minimum of three acceptable manoeuvres (based on American Thoracic Society/European Respiratory Society guidelines) with the two largest FEV1 measurements not varying by more than 0.15 L.
3,"Eligible individuals were at least 6 years of age at the time of enrolment, were HIV-infected with a CD4+ T-cell count at least 200 cells/μl and a viral load less than 50 000 copies/ml obtained on the most recent two occasions within 6 months before first vaccination; received a stable dose of HAART for at least 6 weeks before first vaccination, or were not receiving any antiretroviral therapy; and were naive to any licensed or experimental pneumococcal vaccine."
0,"However, no combination of drug-eluting stents with bare metal stents was to have been performed."
3,"Individuals were ineligible if they had active AIDS-related illness, including opportunistic infection or malignancy, previous anaphylactic reaction to any vaccine or vaccine-related component, or a history of culture-proven invasive disease caused by Streptococcus pneumoniae within 12 months before enrolment."
0,"The haematocrit (packed cell volume), haemoglobin and blood cell count were measured at all time intervals."
6,"The primary outcome measures for this study were (1) change (i.e. difference) in KAAI between the neutral shoe condition and the assigned wedge condition, measured by biomechanical gait analysis, and (2) change in pain during running over the six-weeks measured by cVAS."
0,Cleaning was performed every 12 hours until extubation (if <7 days) or up to 7 days after recruitment.
6,"Change scores were quantified as % change, since this method is less biased by baseline scores [36]."
0,"The physical activity intervention consisted of moderate-intensity- walking (with a 150 min goal per week), and strength, flexibility and balance training, in supervised clinical centres and at participants' homes."
1,"This is a two-armed, single centre, comparative, randomized controlled trial, comparing two conditions: a) a self-administered Internet-based intervention (SII) and b) usual medical care (UMC)."
0,"Doses of topotecan were increased, according to a modified Fibonacci schedule, to 2.5, 3.0, 3.5, and 4.0 mg/m2 (Table 1)."
1,"The study will be conducted following the CONSORT statement (Consolidated Standards of Reporting Trials, http://www.consort-statement.org) [30, 31] and CONSORT-EHEALTH guidelines [32]."
0,A thick blood film was declared negative only after examination of 100 high power fields (HPF).
4,"The study was conducted at seven sites: Carolinas Rehabilitation, Carolinas Health Care System in Charlotte, NC (lead site); Indiana University School of Medicine and Rehabilitation Hospital of Indiana in Indianapolis, IN; Kessler Institute of Rehabilitation in West Orange, NJ; Spaulding Rehabilitation Hospital and Harvard Medical School in Boston, MA; TIRR Memorial Hermann in Houston, TX; The Ohio State University in Columbus, OH; and University of Washington in Seattle, WA."
0,"Secondary outcomes include parent report of day time sleep problems, infant crying problems and feeding problems."
1,The present study is a triple masked randomized controlled trial.
0,"Details of the study design, the recruitment results and the implementation of the intervention have been published elsewhere [5,6]."
3,"Postpartum women diagnosed with severe preeclampsia, after completion of therapy with magnesium sulfate, with spontaneous diuresis and greater than 50 ml/h."
0,"When a patient is randomised for the PCT group, PCT will be measured at base-line called the T0-serum sample (T0: as close to initiation of antibiotics as possible, at least within 24 hrs)."
3,"Women with superimposed preeclampsia, or that used diuretics before admission to the intensive care unit (ICU), with acute or chronic kidney disease, diabetes mellitus; collagen disease; sickle cell anemia, patients with hemodynamic instability or with hypokalemia (K < 3.0 mEq/L) or patients with contraindications to the use of furosemide or unable to consent were excluded."
0,Blood samples were collected in ethylenediaminetetraacetic acid (plasma separated within 60 min by centrifugation) and serum tubes and stored at −70°C in plastic freezer vials.
16,"We used the SAS statistical package (version 9.0.0, 2002) both for the proportion of variance of the dependent variable (VAS) that is accounted for by the independent variable (MDI) within a regression analysis using R2 > 0.50 as goodness of fit [23] and for the intercorrelations between the depression scales in terms of Pearson coefficients [24]."
0,Nursing home stay or residence was indicated by a yes/no variable.
16,The weighted Kappa was used when testing the corresponding cut-off points between VAS and MDI [25].
0,"Subsequently, the supernatant was added to the internal standard (iso-caproic acid)."
3,This study concerned the 1141 patients included whose hospitalization lasted 2 or more days.
0,"The intervention, ‘Men & Women in Partnership Initiative’, was developed to influence inequitable gendered attitudes, behaviours and expectations among men—with the ultimate aim of reducing intimate partner violence."
3,The results of patients whose hospitalization lasted only 1 day (n=949) are reported in Multimedia Appendix 1; the organization of the discharge process after these very short stays was logically analyzed independently of those of longer duration.
0,We will ask service members their intervention preferences and obtain feedback on a planned WBI.
3,"The inclusion criteria for patients were initiating insulin glargine or requiring the titration of an existing insulin glargine dose, English or Spanish speaking, the most recent HbA1c value at or above 8%, able and willing to inject insulin, and able and willing to provide informed consent."
0,"In Denmark there are at present no standard procedures or standard treatments when it comes to patients with HE, and the participants in the control group are not considered to be treated worse than 'usual standard care'."
3,"The exclusion criteria were patients on short-acting insulin, on systemic glucocorticoids, with sustained serum creatinine at or above 1.5 mg/dL for men and 1.4 mg/dL for women, with documented hypoglycemia unawareness, and with type 1 diabetes."
0,Current drug treatment and knowledge of target BP. 4.
3,"This was a double-blind, randomized, placebo-controlled study with 34 subjects who were recruited based on inclusion and exclusion criteria."
0,"All available management costs per unit were adapted from Diaz et al., [13] whereas strict costs from interventions were calculated from the Reproductive and Sexual Health Primary Care Unit (ASSIR) [14] (Table 2)."
3,The study population consisted of 16 healthy subjects (placebo: n = 9; XOS: n = 7) and 13 Pre-DM subjects (placebo: n = 6; XOS: n = 7).
0,"Dose titration up to 0.08 mg/kg BID was allowed if there were no improvements in metabolic parameters, and a reduction in target dose was permitted if tolerability became an issue."
6,"Primary endpoints including safety and tolerability of the different prime-boost regimens, secondary endpoints assessing the qualitative and quantitative immune responses elicited by the different prime-boost regimens and ancillary endpoints were pre-defined."
0,"Tissues were quickly dissected, immediately frozen on dry ice, and stored at −80°C."
8,"In order to detect a decrease with 33 % in the cumulative incidence of wasting assuming a baseline incidence rate of wasting of 0.26 per child-year [9] with a Type I error of 5 %, a statistical power of 90 % and a minimum follow-up time of 24 months, assuming a coefficient of variation K of 0.25, we calculated that 16 clusters of 50 households per cluster are necessary per study arm [34]."
0,Syringe contents were masked using opaque tape to ensure that the subject was blinded.
8,This calculation takes into account an anticipated 25 % drop-out.
0,Adults ≥18 years old with nOH diagnosed using a documented decrease of ≥20 mmHg in systolic blood pressure (SBP) or ≥10 mmHg in diastolic blood pressure (DBP) within 3 min of standing were eligible for enrollment.
6,RTW was operationalised as not receiving sickness benefits and measured by register data from the municipalities’ job centres.
0,We constructed a decision tree in Excel 2013 to model the care pathways of the young people in the trial and to assess the costs and effects in 2 years associated with the two active interventions and PAU.
6,Time to full RTW was defined as the period (in days) between randomisation and not receiving any sickness benefits for at least 4 weeks without partial or full sickness absence recurrence.
0,Patients will be excluded from the study at their own request or the request of their legal representative.
1,This study used baseline data from 450 randomly selected patients with established (multi-episode) psychosis recruited as part of the National Institute for Health Research-funded study: Improving Physical Health and Reducing Substance Use in Severe Mental Illness; a randomized controlled trial (IMPaCT RCT) (Gaughran et al. 2013).
0,"Fatigue syndromes (Methylphenidate, Erythropoietin, transfusions); 3."
4,"The study took place in community mental health teams (CMHTs) in five Mental Health NHS Trusts, covering urban (Lambeth, Southwark, Lewisham, Croydon, Greenwich, Bexley, Bromley) and rural (Staffordshire, Somerset and Sussex) boroughs across England (Gaughran et al. 2013)."
0,"Eligibility was restricted to those who reported having access to the Internet for personal use, who had a working email account that they used at least once a week, and who did not have a health condition that conflicted with eating fruits and vegetables."
3,Table 1 Inclusion and exclusion criteria for recruited patients
0,"They were scored by the BioClinica Corporation (Newtown, Pennsylvania, USA) using the Sharp score as modified by van der Heijde and colleagues (vdH-S).14"
3,Inclusion and exclusion criteria are summarized in Table 1.
0,Information on safe places for walking and exercise was provided.
3,Eligible patients were >55 years of age and postmenopausal for at least 1 year (women who were not postmenopausal were not eligible for inclusion).
0,Recruitment was also done in-person by WIC staff members.
3,"The patients were also required to have the following: either BMD T-score ≤ -2.5 in at least one anatomic site (lumbar spine, total hip, or femoral neck) or prior non-pathological fragility fracture (of the spine, wrist, humerus, or clavicle) and BMD T-score ≤ -1.5 in at least one of the same anatomic sites; 25(OH)D levels ≥8 ng/mL (20 nmol/L); no prior hip fracture; no abnormal finding of clinical significance (no pronounced medical history other than osteoporosis, including as follows: history of malignancy <5 years prior to signing study consent, with melanoma, leukemia, lymphoma, or myeloproliferative disorders of any duration leading to exclusion; uncontrolled primary/secondary hyperparathyroidism; malabsorption syndrome; history or evidence of metabolic bone disease other than osteoporosis or abnormal serum calcium or phosphate); no treatment with specific drugs for specified time periods (including past oral bisphosphonate or recombinant parathyroid hormone); and no contraindications to alendronate, calcitriol, or vitamin D."
0,Data are expressed as median and interquartile ranges.
1,Parallel randomized trial of two groups.
0,A rating manual was developed based on the manual devised for those providing the intervention (so called 'self-help coaches') which defined specific tasks to be carried out in session 1 and in sessions 2 to 10 (the manual is available from the authors).
6,The primary outcome measure was LV diastolic function measured as peak early diastolic tissue velocity (e’).
0,"Inclusion criteria specified men and non-pregnant women, age 40–85 years, with primary OA of at least one knee, and a flare of pain after withdrawal of prior therapy with either an oral NSAID or acetaminophen (used at least 3 days per week during the previous month)."
6,"Secondary outcome measures were LV late diastolic tissue velocity (a’), LV early diastolic filling velocity (E), LV late diastolic filling velocity (A), LV filling pressure (E/e’), E/A-ratio, deceleration time (DT), isovolumic relaxation time (IVRT), LV global strain and strain rate, LV peak systolic tissue velocity (S’) as well as resting heart rate, blood pressure, circulating glucose, triglycerides, total cholesterol, LDL-cholesterol, HDL-cholesterol, C-peptide, total antioxidant status (TAS) and high sensitive c-reactive protein (hs-CRP)."
0,The two studies were pooled and efficacy calculated by contrasting vaccine illness incidence rates with those observed in placebo recipients (Table 6).
3,"Liver resections <1 segment Wedge resections (<3) Liver cirrhosis on histology Coagulopathy (INR > 1.2, platelets < 150,000 × 103/μl) Hypertriglyceridemia (>5.0 mmol/l) Hypersensitivity or allergy to Omegaven™ or any fish oil or lipid emulsions Known allergy to egg protein Pregnancy Nursing women Renal failure (estimated GFR < 30 ml/min/1.73 m2) Medication impairing platelet aggregation Study product Omegaven™ is a fish oil-based lipid emulsion approved for parenteral nutrition provided by Fresenius Kabi (Swissmedic approval number: 54750)."
0,Direct costs were estimated per week per child for human resources and consumables in rupees for the treatment under three regimens.
3,Both study drug and placebo (0.9 % saline) are administered in 100 ml equally shaped bottles with a maximum infusion rate of 0.5 ml/kg/hour on the evening before surgery and during surgery.
0,"The VOICE-D study stage 2 (detailed in [19]), enrolled former VOICE participants assigned to active study product arms."
1,We conducted a prospective cohort study to compare the risks of developing cardiovascular complications and all-cause mortality over 3 years between people with diabetes managed under RAMP-DM and those receiving usual primary care.
0,"All participants gave their written, informed consent."
6,The primary outcome was the difference between groups in baseline plasma levels of biological markers.
0,"The nature of this approach means that small sample sizes are preferred, and homogeneous groups are purposively selected according to important variables [32]."
6,"Secondary objectives were: to describe RAGE soluble forms (sRAGE, esRAGE) and ligands (HMGB1, S100A12, AGEs) pulmonary and plasma levels during the first 6 days after ARDS onset, as compared with measurements in controls; to report venous-to-arterial differences and alveolar-to-arterial ratios in sRAGE, esRAGE, HMGB1, S100A12 and AGEs levels; to test their correlation with CT-scan lung morphology and ARDS severity; to test their prognostic values in ARDS."
0,"Saliva samples were taken 15 min before (−15) and 60 min after (+60) administration of study medication, directly after stimuli presentation (+90) and after heroin intravenous (+120)."
3,"Eligible patients were at least 18 years old and had a diagnosis of Stage IV esophageal, gastroesophageal (GE) junction adenocarcinoma or squamous cell carcinoma with measurable lesions showing radiographic progressive disease on ≤2 prior chemotherapy regimens in the metastatic setting (or ≤3 prior regimens including perioperative chemotherapy or chemoradiotherapy)."
0,We followed the Guideline for Reporting of Evidence-based practice Educational interventions and Teaching (GREET) statement to describe our educational intervention (Figure 2) (26).
3,"Other eligibility criteria included Karnofsky Performance Status (PS) of at least 60 (requires occasional assistance, but is able to care for most of personal needs) and adequate organ function."
0,Secondary assessments were analyzed using a fixed-sequence hierarchical gatekeeping procedure to control the overall type 1 error rate.
4,"This is a diagnostic accuracy study in ambulatory care (defined as general practice, paediatric outpatient clinics or ED)."
0,Generation of the random allocation sequence was prepared by an independent person and randomization was performed by the first author.
6,"Primary outcomes will be: 1) for mothers: a) adequate weight gain at the end of the pregnancy based on IOM 2009 [30]; b) adequate glycaemic control at 24-28 weeks of pregnancy according to ADA 2011 (having fasting plasma glucose (FPG) levels <92 mg/dl or 2-h values in the oral glucose tolerance test (OGTT) of <153 mg/dl) [22]; 2) for infants: adequate weight, length and BMI growth during the first year of life according to WHO 2006 [31] (Table 2)."
0,"The trial compared the combination therapy of clopidogrel and aspirin (clopidogrel at an initial dose of 300 mg, followed by 75 mg/day for 90 days, plus aspirin at a dose of 75 mg/day for the first 21 days) versus placebo plus aspirin (75 mg/day for 90 days)."
6,"Secondary outcomes will be divided into: i) implementation outcomes (number of midwives and dietitians per PHCC, compliance to protocol by health personnel, time allocated to the actions of the interventions, etc.) and ii) participant compliance outcomes (attendance to dietitian's clinic, attendance to PA sessions, etc.)."
0,T1 mapping was performed using the Modified Look-Locker Inversion recovery sequence for the assessment of diffuse myocardial fibrosis.
8,"The sample size was estimated based on the hypothesized effect sizes using existing data, and the likely rates of study drop-out (20 %)."
0,"The study participants will be members of a pre-existing, national online survey panel."
8,"Assuming that currently 50 % of Chilean women meet Institute of Medicine (IOM) weight gain recommendations [32], that we have six intervened and six control health centers, two-tail α p < 0.05; 80 % power and an intraclass correlation coefficient of 0.008 % [33] (based on cluster design of the study), we will need to recruit 200 women in each PHCC (n = 1200 per arm to obtain a final sample size of 960 per arm) to detect a 20 % difference in the achievement of IOM weight gain recommendations between intervened and control women."
0,A specific evaluation is also planned of the benefit of the treatment on the reduction of fatal and non-fatal coronary and arrhythmic events.
1,This study is designed as a nonrandomized clinical trial (quasi-experimental pre- and post-test design with a control group).
0,"As delivery mode (caesarean or vaginal) was the primary trial endpoint, a short-term hospital stay is sufficient to capture all meaningful differences in costs and clinical outcomes between intervention and control arms."
1,"We are looking for empirical evidence for the general investigation hypothesis: treatment adherence, healthy lifestyle, quality of life and weight control of obese adolescents are positively influenced by this intervention program."
0,BMD was then assessed at 12 and 24 months during scheduled follow-up visits.
1,This pilot trial used a randomised trial design and mixed methods [16] described previously [17].
0,"For 1 week prior to each particular CID, ~70% of the food was provided with detailed daily meal plans to ensure a standardized dietary pattern for all participants."
1,"We sought to address the objectives by (1) reporting numbers of participants invited, screened, randomised and uptake to randomised allocation and those completing follow-up, exploring experiences of PWPs inviting participants and exploring understanding and acceptability of study recruitment procedures with participants; (2) reporting completed data collection at baseline and follow-up; (3) reporting descriptive statistics related to the planned outcomes of a future study; (4) assessing variability in the number, length and frequency of support sessions provided by PWPs; (5) exploring views and experiences of delivering the intervention with PWPs and participants who received at least one treatment session, and collecting recorded sessions between PWPs and participants to measure fidelity to the intervention protocol."
0,"A formal validated quality of life instrument was not utilized in this phase 1-2a study; however, an informal questionnaire was administered at baseline and on day 1 of each treatment cycle to assess key MDS clinical symptoms."
6,The primary end point was the percentage change from baseline to final on-treatment in proteinuria with pentoxifylline compared with the placebo group.
0,"Data were analyzed using the Barcrawler sequencing pipeline (E.D. unpublished data), with a maximum sensitivity of 0.1% (additional details are provided in the Supplementary Methods)."
6,"Secondary end points included the percentage change of albuminuria and the mean change of eGFR, serum Cr, fasting glucose, HbA1c, HOMA-IR, hs-CRP, and serum TNF-α from baseline to final on-treatment."
0,Participants were assessed individually.
6,The primary outcome from this study is the proportion of patients who experience a postoperative major in-hospital complication or death (composite outcome).
0,The content in the TW is on the patients relation to others (score 4 on Item 15 and 4 on Item 16).
6,"Secondary outcomes include: the proportion of patients who experience each component of the primary composite outcome (in-hospital mortality, intensive care unit admission, vascular complications, serious infections, protracted delirium); the proportion of patients who die or are readmitted within 30-days of initial discharge; length of hospital stay; discharge location; requirement for an alternative level of care upon discharge; quality of life; functional, cognitive and nutritional status; and health care resource utilization and costs."
0,Linear mixed models taking into account the clusters (child-class-school) will be used to evaluate differences in the primary and secondary outcome variables.
1,"This is a two-center, randomized, cross-over trial with a 12-week wash-out period in between intervention periods (Fig. 1)."
0,"Among these, 45 patients did not have data on cost for the index hospitalisation cost, so they were excluded from cost analyses."
1,Ethical approval has been granted by the medical ethical committee of the VU University Medical Center (VUMC).
0,"At the end of surgical procedure, anesthesia was discontinued."
3,"The inclusion criteria consisted of either a diagnosis of depression by a psychiatrist or less than 13 points on the WHO depression scale [24], informed consent, and having free time on Thursday mornings during the intervention period."
0,"We will also carry out an Economic Evaluation through the Client Service Receipt Inventory [24], which will be administered at baseline and 12 weeks into the trial."
3,"Exclusion criteria consisted of undergoing in-patient treatment during either the intervention or the waiting periods, acute suicidality or psychosis, or a strong medical contraindication against sport, determined by a GP or psychiatrist."
0,Individual maximal oxygen uptake () was determined as previously described [30].
3,"Patients were enrolled into the study if they met the following inclusion criteria: age ≥40 years, current or ex-smokers with a smoking history of >10 pack-years, diagnosis of COPD, post-bronchodilator forced expiratory volume in 1 second (FEV1) of ≥30% predicted normal and <80% predicted normal, and a post-bronchodilator FEV1/forced vital capacity (FVC) <70%."
0,"Patients were treated with a 10-day oral course of prednisolone, starting 2 days before surgery at 1 mg/kg (70–100 mg) for 7 days and then reduced to 40 mg for 1 day, 20 mg for 1 day, and 10 mg for 1 day."
3,"Key exclusion criteria were as follows: a significant disease other than COPD (defined by the investigator as a disease that may put the patient at risk by participating in the study, influence study outcomes, or cause concern with regard to the patient’s ability to participate in the study), history of asthma or a total blood eosinophil count of ≥600/mm3, history of myocardial infarction within the past year, unstable or life-threatening cardiac arrhythmia or hospitalization for heart failure within the past year, marked prolongation of QT/QTc interval (QTc interval >450 ms), and experience of any respiratory infection or COPD exacerbation 6 weeks prior to the baseline assessment."
0,The scale demonstrated acceptable reliability at all time points (α = 0.72–0.75) and past studies have demonstrated construct validity among African American populations [78].
1,"This study was designed as a blinded, single-centre, parallel group feasibility RCT with a 1:1 allocation ratio (see Additional file 1 for CONSORT checklist)."
0,"Fresh PBMC collected 12 days previous to the CHMI were plated into duplicate wells at 4 x 105 cells in complete RPMI-1640 medium (cRPMI; Gibco, Invitrogen) supplemented with 10% FBS."
3,Patients referred for a primary elective AAA repair as an EVAR or open procedure were eligible to take part.
0,Safety assessments were completed at every visit.
3,"Patients taking sulphonylurea oral hypoglycaemic drugs or nicorandil, which are known to influence preconditioning, were excluded [24, 25]."
0,"The allocation of students involved in this study is shown in Fig 1, including those offered interventions after screening."
6,"The study outcomes were as follows:Number of patients referred for elective AAA repair and the number and proportion eligible for the trial.Number of eligible patients approached to participate and reasons for non-approach.Number and proportion of eligible patients approached who consented to participate and reasons for non-consent.Success of blinding those not involved directly in administering the intervention.Impact of the intervention on delivery of care and time taken for anaesthesia (defined as the time from when the patient entered the theatre suite until surgical knife to skin).Participant follow-up to 6 months, numbers and reasons for loss to follow-upCompleteness of clinical outcome data and frequency of the these events, in particular, indices of acute renal injury within the first 48 hours after AAA repair, as defined by the AKIN criteria [26]; cardiac events, namely myocardial infarction (MI), new arrhythmias, electrocardiogram (ECG) changes and raised troponin T levels in the period prior to discharge; and complications, including stroke and death, up to 6 months after surgery.Staff and participant views on the intervention and study conduct."
0,Written informed consent is obtained from all patients before enrollment into the trial.
14,"With the exception of the in-theatre anaesthetic team who administered the intervention, everyone (participants, surgeons, nursing staff and research nurses) was blinded to the intervention received."
0,Trials where muscle movements were identified were removed.
16,"Continuous variables were summarised using the mean and standard deviation, and categorical data were summarised as a number and percentage."
0,"The six researchers comprised three midwives (researchers 1, 2 & 6 as labelled in results below) and one nurse (researcher 3) all with extensive experience of providing behavioural support for smoking cessation in pregnancy, plus one nurse (researcher 4) and psychologist (researcher 5) without previous experience of providing this support."
16,Participants were grouped by treatment allocation (intention to treat).
0,"Based on the experiences gained with the implementation in the trial period, it was estimated that it would be necessary to have an administrative officer employed to ‘run’ the telehealthcare solution, should it be implemented in routine practise (coordinating activities, contract supervision, etc)."
6,"The primary outcome of the phase II study will be swallowing function, measured using the 19-item composite MDADI score at 12 months post-treatment."
0,"Participant recruitment began on 5/15/04 and enrollment occurred between July 16, 2004 and July 31, 2008."
6,The primary outcome of the planned phase III study will be overall survival (OS).
0,Flares were based only on items that were new and were confirmed by the central review and adjudication committee.
1,This was a two-arm pilot cluster randomised controlled trial.
0,Capsule counts upon bottle return at the end of the intervention were used to determine compliance to the supplementation.
16,This noninferiority trial design utilized a difference of −1 day (noninferiority margin) in DSN in cycle 1 as the largest acceptable difference between the biosimilar compared with reference treatment.
0,In patient gene expression analysis
16,"TAC chemotherapy induces a median DSN of 7 days in breast cancer patients receiving no G-CSF treatment [8], while G-CSF treatment reduces the mean DSN to 1.4 days [95% confidence interval (CI) 1.07–1.69] [9]."
0,DEBIO1143 plasma concentrations were measured using a validated LC–MS/MS assay.
6,"Because of the design of the trial, we defined two primary endpoints (1) the number of measures taken against comorbidities in order to evaluate the comorbidity programme and (2) the percentage of patients in whom DMARDs was intensified, initiated and/or changed in order to evaluate the self-assessment programme."
0,"The recipes were prepared by Master of Science in Food, Science, and Nutrition students and staff from the department of Food Science and Nutrition under the guidance of the study investigators and community coordinator."
6,"As secondary endpoints, in the comorbidity programme, we evaluated the number of actions taken in the four subgroups (eg, CV, infection, cancer and osteoporosis); in the self-assessment programme, we evaluated the changes in DAS28-ESR and RAID."
0,This is a logical consequence of the different perspectives and experiences that exist among and within local teams which reflects the societal diversity.
8,"For the overall study, sample size calculation was performed for the main outcome variable (a health care quality score), as shown in the methods paper [22]."
0,"As is the case with all investigations, the potential for methodologic limitations may exist."
8,No specific sample size calculation was performed for the referral quality outcome reported in this paper.
0,The rs129679860 SNP was genotyped with a custom TaqMan genotyping assay (Applied Biosystems) on DNA isolated from whole blood samples.
16,"The AUC for the treatment groups were compared using confidence intervals to draw conclusions on possible superiority, non-inferiority or equivalence of efficacy."
0,With these assumptions a sample of n = 40 patients (n = 20 per drug group) has a statistical power of 86% to detect a clinically relevant difference in RAVLT total scores between the two treatment groups at an alpha level of 5% (2-sided test).
16,"The two-sided Wilcoxon-Mann–Whitney U-Test at α = 0.05 was applied in the analysis of antibody responses using SPSS Version 14.02 (SPSS Inc., Chicago, USA)."
0,"Oral examinations were performed at women's household with subjects seated, and the examiner used a headlamp as source of illumination, mouth mirror and a CPITN periodontal probe in line with the WHO instructions."
1,This multi-center pilot intervention trial studied participation in a jogging program for patients with schizophrenia.
0,"The movement time, measures of velocity, and smoothness have previously been proposed in literature as key kinematic variables for end-point performance in individuals with stroke (17, 27)."
1,"In our 2 × 2 between-subjects design, patients were recruited from two types of wards with different degrees of autonomy (quasi-experimental variation) and allocated to two conditions (intervention vs. control; experimental variation)."
0,"In order to quantify the number of parasites in blood, a 10 fold serial dilution of 106 to 10 in vitro cultured parasites/ml was used as reference and processed and analysed with NASBA."
3,"Inclusion criteria included: aged 18 or older, previous histological diagnosis of RCC, documented evidence of metastatic disease on contrast-enhanced CT and/or MRI within 30 days with at least one measurable lesion, [10] and suitable candidacy for standard sunitinib therapy for metastatic RCC as determined by the treating oncologist."
0,Continuous treatments were started 10 min before occlusion till the end of the 120 min reperfusion period.
3,"Exclusion criteria included: pregnancy or lactation (a negative pregnancy test was required for premenopausal females); renal insufficiency; known allergic or hypersensitivity reactions to previously administered radiopharmaceuticals; HIV positivity (as a precaution due to potential toxicity observed with 3'-deoxy-3'-fluorothymidine (alovudine) in therapeutic trials of HIV positive individuals [31]), and the requirement of monitored anesthesia sedation for PET scanning."
0,Thirty-eight percent of transcripts were read and coded by two different team members.
3,"Eligible patients were adults (≥18 years) with biopsy-proven ATTR amyloidosis and mild-to-moderate neuropathy; Karnofsky performance status ≥ 60 %; body mass index 17–33 kg/m2; adequate liver and renal function (aspartate transaminase [AST] and alanine transaminase [ALT] ≤ 2.5 × the upper limit of normal [ULN], total bilirubin within normal limits, albumin > 3 g/dL, international normalized ratio ≤ 1.2, serum creatinine ≤ 1.5 ULN); and seronegativity for hepatitis B virus and hepatitis C virus."
0,"Endpoints were derived from the raw profiles, except for t Early 50% GIRmax, t Late 50% GIRmax, GIRmax and t GIRmax, which were derived from GIR profiles smoothed by local regression (LOESS) using a smoothing factor of 0.1 in order to achieve a robust calculation of these endpoints."
3,"Patients were excluded if they had a liver transplant; had surgery planned during the study; were HIV-positive; had received an investigational drug other than tafamidis or diflunisal within 30 days; had a New York Heart Association heart failure classification > 2; were pregnant or nursing; had known or suspected systemic bacterial, viral, parasitic, or fungal infections; had unstable angina; had uncontrolled clinically significant cardiac arrhythmia; or had a prior severe reaction to a liposomal product or known hypersensitivity to oligonucleotides."
0,We did not implement either of these components as it would have added greatly to the cost and we wanted to test a delivery model that we thought could be more easily funded for roll-out.
6,The primary endpoint was safety of the transgastric implant evaluated by endoscopy examination 3 months after implant.
0,A fixed effects model is likely to be preferable if the purpose of the model is only to provide predictions on the sample of data itself [12–14].
6,"The secondary outcomes were: the frequency and seriousness of all adverse events; the percentage excess weight loss (%EWL) measured at each follow-up visit up to 27 month, assessment of eating behavior with the TFEQ and quality of life with the Moorehead-Ardelt II at baseline and 12 months, and measurement of trends in exercise with the implanted 3D accelerometer during the first 12 months."
0,The RR was recorded only in the breathing group with the same setup.
1,"This post hoc analysis evaluated data from the previously reported multicenter, randomized, double-blind, 5-arm, parallel-group VYMET study (NCT00409773; protocol number 107) that was designed to assess the lipid-altering efficacy of ezetimibe/simvastatin and atorvastatin in subjects with metabolic syndrome and elevated cardiovascular risk [14]."
0,"To check for reproducibility of measurements, the intraobserver mean percent error (the absolute difference between two measurements divided by their mean) was calculated from 10 randomly selected studies 15 days later, analyzed by the same blinded echocardiographer who performed all measurements."
1,"The protocol was approved by the institutional review board or ethics committee of each participating study site, and all patients provided written informed consent."
0,"P. falciparum accounts for more than 95% of the malaria infections [24] with mosquitoes of the Anopheles gambiae complex being the major vector [25] with an EIR of 0.65–0.79 infectious bites per person per night [24], [25]."
1,"This multi-centre pragmatic randomised controlled non-blinded parallel arm trial assessed the effect of breathing training delivered over three 1 hour-long sessions at weekly intervals, or during a single session in the management of patients with refractory breathlessness due to intrathoracic cancer."
0,"MELD is a scoring system for assessing the severity of chronic liver disease based on the patient's values for serum bilirubin, serum creatinine, and the international normalized ratio for prothrombin time (INR)."
3,Inclusion criteria for the pilot RCT (and anticipated inclusion criteria for any future definitive RCT) were as follows:Clinical diagnosis of SUI or stress-predominant MUI.Women must state that their family is complete.Women should have undergone a course of pelvic floor muscle training (± other non-surgical treatments for their urge symptoms) with inadequate resolution of their symptoms.Both the woman and her treating clinician should agree that surgery is an appropriate and acceptable next line of treatment.
0,"For this integrated analysis, data were included from patients who were randomized to double-blind treatment with droxidopa or placebo in 3 clinical trials (ie, each individual full analysis set) [10–13]."
3,"Exclusion criteria for the pilot RCT (and anticipated exclusion criteria for any future definitive RCT) were as follows:Symptomatic utero-vaginal prolapse requiring treatment.Previous surgery for urinary incontinence or pelvic organ prolapse.Urodynamic investigation within the last three years.Neurological disease causing urinary incontinence.Current involvement in competing research studies, for example, studies of investigation or treatment of urinary incontinence.Unable or unwilling to give competent informed consent."
0,a “medium” effect [33].
1,"This was a multicenter, open-label, parallel group study conducted in France (10 sites)."
0,"Each training session lasted 60 min, and the training was held for a total of 15 sessions with 5 days per week for 3 weeks."
5,"After central randomization participants were assigned to either an intervention group including a pediatrician visit every 3 months, a nurse visit intercalated every month and phone calls every 2 weeks after each visit; or to the control group with a pediatrician visit only every 3 months."
0,"At time 120 min, a primed constant (9.0 pmol · kg−1 · min−1) infusion of insulin (Human Regular Insulin; Eli Lilly, Indianapolis, IN) was started and continued until 240 min."
6,The primary outcome was the evolution of the rate of A1C during the 12 months of follow-up.
0,"The protocol was approved by the Biomedical Research Ethics Committee based at the University of KwaZulu-Natal, the Medicines Control Council in South Africa and the US Food and Drug Administration."
6,"Secondary outcomes were participants’ acceptance of the disease, evaluated by visual analog scale (VAS) (0 mm “I cope very well with my diabetes,” to 100 mm “I cope very badly with my diabetes”), the number of hypoglycemic or ketoacidosis episodes having required hospitalization, evaluation of A1C rate over time in each group, adolescents’, parents’ and nurses’ satisfactions evaluated by 6 questions.."
0,Refresher training of the interviewers on methods to collect data and anthropometric measurements were repeated every 3 month.
2,The authors made the following major changes to the initial study protocol: age range of eligibility was changed from 18–35 years to 18–40 years to reach a larger segment of the population; the criteria for classifying wound infections after circumcision was modified to be more specific and user friendly; and the initial enrollment number approved by the IRB was increased from 525 to 575 subjects.
0,"The mobile phone-based intervention had three components: use of the Fitbit Flex (6 months), participation in the iStart Smart for Teens online educational program (3 months), and receipt of biweekly text messages during the maintenance phase (3 months; see Figure 1)."
6,The primary outcome of this study was the uptake/acceptability of VMMC as measured by the proportion of men who agreed to be circumcised after being offered.
0,"However, enrollment at those sites (50 children with complete vaccination data) was considered insufficient to yield meaningful VE estimates; UK data were not combined with data from US sites because children were recruited in a different setting."
6,"Secondary outcomes were the number and percentage of adverse events by severity (mild, moderate, severe) and the proportion of clients satisfied with the procedure."
0,"HR in the upright position was measured immediately after getting up by pulse palpation or an automated blood pressure monitor, and ΔHR was calculated as the difference between HR in the upright and supine positions."
4,"The study was conducted at the MacMobilize Laboratory at McMaster University, Hamilton, Ontario, Canada."
0,Patients with severe interstitial lung disease were excluded from the study.
4,"The intervention was implemented at a private yoga studio in downtown Hamilton, Ontario, Canada."
0,"We obtained self-reported age (years), gender, race/ethnicity, and education level (eg, some high school or high school graduate)."
1,Randomized double-blind crossover controlled.
0,"Despite this assumption, the ingredients were not independently verified, and thus, exact contents cannot be confirmed."
12,The sequence was concealed by a computer interface.
0,This will ensure that education is not a confounding variable in the study.
14,Participants could not be blinded to intervention assignments.
0,"Additional inclusion criteria were HbA1c of 7.5% to 12.0% (59‐108 mmol/mol) and fasting plasma glucose (FPG) <15.6 mmol/L (<280 mg/dL) at screening, and HbA1c of 7.0% to 10.5% (53‐91 mmol/mol) at randomization."
14,"However, outcome assessors were blinded to intervention assignments."
0,It was hypothesized that the response rate in the control group would be 0.30 and that a response rate of at least 0.45 would indicate that a combination was sufficiently promising to be included in further studies.
3,Patients receiving >1 L of IV fluid the day prior to SIRS qualification were excluded.
3,"Also excluded were those who had cardiac surgery (part of another study), a diagnosis of end-stage renal disease, or receipt of any colloid or hypertonic saline."
0,ASQ has not been published in Danish.
3,"All eligible patients were 18 years or older with clinically detectable local and/or regional melanoma (of cutaneous, mucosal or unknown primary site of origin)."
0,All patients from sites where the suspicion of fraudulent activity could not be rejected during the telephone interview were excluded from analysis.
3,The Institutional Review Board of the University of Pittsburgh approved the study and the written informed consent that was obtained from all patients participating in the study.
0,The results of study 1 informed the decision on level and type of incentive in study 2.
3,We enrolled mechanically ventilated patients over 18 years of age during the first 72 hours after ICU admission who were expected to remain in the ICU and on mechanical ventilation (MV) for more than 3 days and who were receiving at least 20 % of their target calories as enteral nutrition.
0,"Extensive process evaluation will also be performed to document reach, dose and fidelity of the intervention trial."
3,"We excluded those patients with unstable fractures that may have resulted in limitation of bed mobility, those who were pregnant, those with gastrointestinal ostomy (colostomy, ileostomy or jejunostomy) or any gastrointestinal disease associated with diarrhea, those with chronic liver disease, neuromuscular diseases, spinal cord injury, severe hemodynamic instability, survival expectancies of less than 24 hours, those under palliative care and those previously included in the study."
0,Differentially expressed transcripts identified by SAM analysis were further analyzed using weighted gene co-expression network analysis (WGCNA)[25].
3,Extremely low birth weight infants cared for at Children’s Memorial Hermann Hospital between the ages of 10 and 21 days were eligible for inclusion if they were ventilator-dependent and their respiratory index score (mean airway pressure X fraction of inspired oxygen) [22] was ≥2.0 and stable or increasing or if the respiratory index score was ≥3.0 when improvement was noted in the previous 24-hour period.
0,"If the window closes without an MI session being completed, the participant must wait to chat with her MI counselor until the next window opens."
3,The exclusion criteria and data and safety monitoring plan have been reported previously [21].
0,"Immediately after blood collection in Lithium-heparin tubes, whole blood samples were stimulated in vitro with a pool of 15-mer peptides overlapping by 11 amino acids and covering the CSP antigen in RTS,S (1.25 µg/ml), medium (negative control) or phytohemagglutin A (PHA, positive control), in the presence of anti-CD28 and anti-CD49d antibodies (BD Biosciences, Belgium)."
1,"The study was performed as a randomized, controlled, open-label, clinical prospective double-center interventional study, at two tertiary medical care university hospitals in Germany (Charité, Universitätsmedizin Berlin (3200 Beds), Klinikum der Universität München (KUM) (2244 beds))."
0,"25 Hz, which gives 140 colours which are then mixed according to spectral content to give one map similar to the RGB mode of TV pictures)."
4,Patient recruitment methods for CANVAS (ClinicalTrials.gov Identifier: NCT01032629) have been previously described [20].
0,Investigational New Drug application for purified human pancreatic islets (PHPI).
16,The log-rank test for survival and ANOVA or Kruskal–Wallis for comparison of treatment groups were used.
0,"Prognostic factors for efficacy outcome measures were determined using a backward stepwise selection procedure, and was carried out separately for OS, PFS and ORR."
16,"Differences between groups were analysed with Chi Square test or Fisher’s exact test using SPSS software, version 20 (IBM Corporation Armonk, New York, United States)."
0,Each item is scored from 1 to 4 for a possible score range from 3 and 12 points [12].
16,"The 95% Confidence Interval (95% CI) was calculated using RStudio, Version 0.98.1062, 2009–2013 RStudio, Inc."
0,"It is the largest randomized controlled trial to date (2,000 randomized patients) to compare RBC transfusion strategies following cardiac surgery."
1,"A self-administered cross-sectional survey was conducted to assess eligibility for inclusion in a trial, to collect health-related data, and to collect baseline trial data."
0,"As participants progress in the program, they will continue to monitor their activities including the use of activity tracking device, depressive symptoms, and quality of life."
1,"The CiQ trial, which has been described in detail elsewhere,6 is a randomised controlled trial of a five-session SCSO case-worker delivered smoking cessation intervention for socially disadvantaged smokers."
0,"Patients with any forms of secondary hypertension, known or suspected unilateral or bilateral renal artery stenosis, severe hypertension (seated clinic DBP >119 mmHg), those with a recent (within 6 months) history of major cardio-, or cerebrovascular event, clinically significant cardiac conduction defect, left ventricular outflow tract obstruction/aortic valvular disease, severe renal impairment (calculated glomerular filtration rate (cGFR) <30 mL/min/1.73 m2) were excluded."
6,The primary outcome variable was the performance in the pseudoword reading test measured in terms of accuracy (percentile of number of errors).
0,"Serum levels of blood glucose, insulin, high-sensitivity C-reactive protein (CRP), total cholesterol, HDL-cholesterol, and triglyceride were assayed enzymatically (Bayer) using an ADVIA 1650 auto-analyzer (Bayer)."
6,"The secondary outcomes variables were performance in: - pseudoword reading test measured in terms of speed (z score of reading seconds); - reading words and text, measured in terms of accuracy (percentile of number of errors) and speed (respectively z score of reading seconds and z score of syllables per sec); - phonological knowledge, in particular in phonemic blending task (number of correct answers); - auditory attention (number of correct answers); - verbal short term memory and working memory, respectively in digit span forward and backward and in WISCIII QI Freedom from Distractability index, (raw scores and scaled scores); - temporal processing through rhythm reproduction task, (raw score), tapping task (coefficient of variations) and temporal anisochrony threshold (ms)."
0,Stable patients revealed no signs of ongoing ischemia based on electrocardiographic characteristics or persistent chest discomfort.
5,"In this study, LC strategies were applied and compared with the standard education in CR at three hospitals in the western part of Central Denmark Region (Table 1)."
0,Urine was also collected over 72 hours postdose for PK assessment of orteronel in urine.
5,Detailed components of education strategies is available in the study protocol [8].
0,The secondary objective was to measure plasma and CSF concentrations of nimodipine; these will be reported separately.
12,Concealment of intervention allocation was achieved by giving responsibility for sequence generation and allocation to a statistician independent of the running of the trial.
0,"Biopsies were fixed in neutral buffered formalin, processed and carefully orientated and embedded in paraffin wax."
12,"Completing the screening and consent process prior to sequence generation minimised selection bias, thereby ensuring that decisions were not influenced by the assigned intervention."
0,"Therefore, for each of the data sets collected at all measurement points, differences in outcome variable between the 2 regions will be tested using multiple MANCOVAs, entering various indicators of case mix as co-variates, i.e. age, gender, stroke severity."
1,"An open-label trial was conducted to test the feasibility of distributing by mail a free 12-week supply of bupropion SR (Zyban) or varenicline (Champix, Chantix) to smokers following a visit to a physician of their choice for authorization of the prescription, in conjunction with weekly motivational emails and with a 41-week follow-up period to assess quit outcomes."
0,"For each process, the ten different HCP types involved in the various tasks were grouped into four categories: nursing staff, physicians, pharmacists, and pharmacy assistants."
1,The study was approved by the Research Ethics Board at the Centre for Addiction and Mental Health and was registered as a clinical trial (ClinicalTrials.gov Identifier NCT01023659).
0,"On the morning of the fourth day of dosing, subjects were admitted to the clinical research unit and administered 13C6 leucine through an intravenous catheter as an initial bolus of 3 mg/kg (10 minutes), followed by 9 hours of continuous intravenous infusion at a rate of 2 mg/kg/h."
8,"The number of participants enrolled in each group was determined by the quantity of each medication available for this study, considered sufficient for achieving the primary goal of determining the logistic feasibility of the proposed distribution method."
0,"We chose the PCNE classification, since it has been shown to contain all required aspects to describe and classify DRPs for research and practice purpose [41]."
8,"With a sample size of approximately 500, we could estimate a physician visit rate of 50 % to within a 95 % confidence interval of ±4 %."
0,"Among those for whom the etiology of thyrotoxicosis was GD, only patients who had planned treatment with antithyroid drugs (ATD) were included so that their clinical course could be followed during medical treatment."
1,"A prospective observational study was performed in a primary care setting, with a median of follow up of 3.5 years (range, 2.9–3.9 years)."
0,"Since these classes are often too large for experiential group program delivery, each class was divided into two equal groups of 15 participants (we had twelve intervention groups and six control groups)."
1,This study included 112 subjects from the LOD-DIABETES study (NCT01065155) [29].
0,"For postoperative pain management in hospital, subjects were prescribed paracetamol 1 g i.v."
6,"A detailed description has been published elsewhere of how clinical data were collected, including anthropometric measurements, blood pressure and TOD assessment [29]."
0,"The exercise program was tailored for pregnancy and followed contemporary guidelines [21], including 10 min of warm-up, 40 min combining cardiovascular exercise at moderate intensity and strength training, and finally10 minutes of stretching."
3,Term and near term infants (36–43 weeks gestation) with evidence of neonatal encephalopathy and treated with therapeutic hypothermia at the participating neonatal units will be eligible for recruitment.
0,"Samples with call rate < 99%, cryptic relatedness and sex/ethnic discrepancies were excluded."
6,"The primary outcome is to examine the accuracy of quantitative cerebral MR biomarkers for predicting adverse 18–24-month neurodevelopmental outcome in infants who had neonatal encephalopathy treated with therapeutic hypothermia, in a multicentre setting."
0,"At baseline, eligibility criteria excluded patients with a history of CVD, hypertension, or hypercholesterolemia (9)."
6,"The secondary outcomes are the intercentre variability of proton MRS measurements and the incremental benefits of quantitative MR biomarkers for predicting adverse outcomes when compared with conventional MR assessment and bedside assessments and investigations such as the Apgar score at 1, 5 and 10 min; umbilical cord pH; base deficit and Lac or blood gas pH; base deficit; Lac within 1 h of birth; abnormal aEEG (voltage criteria: upper margin <10 µV, lower margin <5 µV) at 48 h; neurological examination at discharge."
0,Two doses (0.52 g = 2.48 mmoL and 1.56 g = 7.4 mmoL) of L-trp and an isocaloric dose of L-leu (1.56 g = 11.9 mmoL; isocaloric to 1.56 g L-trp) were selected.
1,The trial was designed as a clinical controlled single-blinded randomized trial.
0,Clinical response has not been shown to be a robust surrogate endpoint to predict outcome.
1,"It was registered in ClinicalTrials.gov (NCT01469091), registration date October 27, 2011, and approved by the Danish National committee on Health Research Ethics (H-1-2010-112)."
0,"The primary objective of this study was to evaluate the clinical efficacy of a new protocol for the treatment of L. tropica CL, which consisted of EC followed by MWT in the presence (group I) or absence (group II) of 0.045% DAC N-055 (which equals 5 mM pharmaceutical NaClO2)."
6,Primary outcome: baseline and 1-year follow-up telephone survey response rates.
0,The Control Attitude Scale (CAS) is a tool consisting of four items designed to measure an individual’s perceptions of control over their cardiovascular disease.
6,Secondary outcome: the cost per subject who had completed both baseline and 1-year surveys.
0,The Clinical Trial Center North and the University Hospital Hamburg-Eppendorf will monitor the study.
5,Participants under the care of teams randomised to the intervention received a financial incentive of £15 from the clinician administering the depot injection immediately after the injection was given.[18] Clinicians and participants were for this reason not blinded to allocation.
0,"Nutrient intakes were estimated with NUTRICA 2.5 software (Social Insurance Institution, Turku, Finland)."
5,The size of payment was intended to avoid creating financial dependency (the maximum amount of income that could be gained from the incentive being £60 every 4 weeks); it was below the amount which could have negatively impacted on the patient’s entitlement to welfare benefits.[16] Intervention participants received these payments in addition to their standard treatment from their assertive outreach or community mental health team for a period of 12 months.
0,"The protocol was approved by each institutional review board, and written informed consent was obtained from each participant or parent, with assent obtained as required."
3,"Patients were recruited from outpatient gastrointestinal (GI) clinics, which represent a subset of all patients with colonoscopy seen in our tertiary care centre."
0,The 3 antenatal clinics each covered a cluster of villages in different geographical regions of West Kiang.
3,Patients ≥18 years of age scheduled for outpatient colonoscopy for whom the gastroenterologist ordering the colonoscopy had chosen to prescribe a polyethylene glycol electrolyte lavage solution (PEG-ELS)-based bowel cleansing preparation (as opposed to a low-volume solution) were eligible for inclusion and recruited by a research assistant.
0,The study design was cross sectional.
8,"Using a non-inferiority design with a margin of 1 in the OBPS, and assuming an SD of 2.6 (based on prior research at our centre), 107 patients would be required in each arm to achieve 80% power and a two-sided α of 0.05."
0,"We used a cohort study design, identifying patients with acute myocardial infarction in four prospectively collected, linked electronic health record sources in England (the CALIBER programme14)."
16,All subjects who received at least one dose of AMG 403 were included in the safety and efficacy analyses.
0,Patients recruited during this phase were randomised to either the usual care arm or to the PhysioDirect arm.
16,"Adverse events, PK, and efficacy endpoints were descriptively compared across the various treatment groups, as the study was not powered to perform formal statistical testing."
0,d)e) Usual dementia care performed by GPs without coaching.
6,"A centralized events committee of cardiac electrophysiologists reviewed and adjudicated all suspected episodes of PoAF, based on documentations including duration, clinical information, and confirmatory rhythm strip or 12-lead ECG."
0,"In the control group, lower segment caesarean section was performed in the classic way."
6,"The primary end point for this analysis is incident PoAF of ≥30 seconds’ duration, with outcomes assessed until hospital discharge or postoperative day 10, whichever occurred first."
0,"Subjects were then asked to fully blink five times, and then the lens was slid back onto the cornea.No action (control): the contact lens was not manipulated in any way."
1,We followed the Cochrane Handbook for Systematic Reviews of Interventions25 and the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines.26
0,Closed envelopes with the randomisation sequence will be prepared and distributed to the participating centres.
1,The review protocol is available at ClinicalTrials.gov (registration number: NCT01363791).
0,"Briefly, all patients met with the renal dietician."
1,Data were collected as part of the Pre-Empt study; a cluster randomised controlled trial with randomisation at the General Practice level [24].
0,The exercise intensity was set at 40% of their VO2max during LIE and 75%VO2max during HIE.
8,The commisioning body predicted that the AWaC centres would recruit 600–1000 participants/year.
0,The Health and Housing Ministries then decided to accept one of the Report’s major recommendations by agreeing to establish a Housing First-type programme for long-term homeless people with severe psychiatric disorders [8].
8,"On the basis of an optimistic 8% effect difference in favour of AWaC versus control (48% vs 40% increased work participation), we calculated that a sample size of 600 in each group would be sufficient to detect statistically significant results."
0,"Participants in this group answered chemoprevention questions at the three-month follow-up, but neither received the DA nor answered any questions about chemoprevention at the time of enrollment, which ensured the inclusion of a control group without previous exposure to chemoprevention information."
3,Patients fulfilling the inclusion criteria (Table 1) were invited to participate.
0,We also recruited carers who were relatives or friends who provided help with activities of daily living for most days of the week.
3,Patients provided written consent after being provided with oral and written information about the protocol.
0,We used data from 2.13 million patients across 225 CPRD practices in England that consented to data linkage.28
6,The primary outcome measure was the difference in plasma ALT concentration.
0,"During the project period, three-hourly network meetings were held quarterly."
6,"Secondary outcome measures included anthropometric measurements, fasting plasma levels of insulin, glucose, lipids, MPO, CK-18 M30, and NAFLD fibrosis score."
0,Table 1 JJ-TRIALS Implementation Strategies Matrix Linear and dynamic applications
14,"Outcome assessors, including the data input administrator, were blind to treatment group at both follow up time points."
0,Healthy controls are defined as children without wheeze or asthma and otherwise applying the same in- and exclusion criteria as mentioned above.
14,The analysis was conducted on a data set in which group allocation was unlabelled.
0,Total sleep time was calculated as the sum of all epochs scored as sleep.
8,"Our sample size calculation of N = 150 per arm provides 80 % power to detect a moderate effect size of 0.50 (Cohen’s d), with an estimated loss of 25 % due to the authors’ experience with dropout in similar settings, the additional expected dropout due to insecurity, and a moderate design effect of 1.5 given authors’ experience and a lack of other studies in the region."
0,"Goal attainment (yes or no), measured every 2 weeks during treatment initiation, was analyzed using mixed-effects logistic regression with time modeled as either the first or the second 6-weeks of initiation."
8,"A difference in gastric emptying time of 30 min between the study groups was considered as statistically significant, as normal solid phase emptying has been shown to fall in the range of approximately 60 min in volunteers [3, 28]."
0,"PPAR-γ was assayed in the nuclear and cytoplasmic fractions of sputum cells using a TransAM™ PPAR-γ Kit (Active Motif, Rixensart, Belgium) and a competitive enzyme-linked immunosorbent assay (ELISA) PPAR-γ kit (Biosources, Inc., San Diego, CA, USA) according to the manufacturers’ instructions."
8,"We calculated that 22 patients in each group would have 90% power to detect a difference in mean emptying time of 30 min, assuming that the common standard deviation was 33 min and using a two-group Student’s t-test with a 0.05 one-sided significance level."
0,Subjects will be given a nominal payment for each data collection visit.
14,"For the telephone bereavement interviews, social workers who are not involved in the study conduct the interviews and are blinded to the study arm of the patient and surrogate (intervention vs control)."
0,"Infarct size, area-at-risk, and MO were expressed as percentages of the left ventricular mass (%LV), given by the sum of the mass of edema, late enhancement, and MO regions for all slices divided by the sum of the LV myocardial cross-sectional mass."
16,"To characterize the study sample and assess the success of randomization, the intervention and control group characteristics were compared using Chi square and two-tailed t-tests as appropriate for categorical and continuous variables."
0,Small-for-gestational-age and large-for-gestational-age births were defined in accordance with Oken et al. (31) and also “within-cohort” as <10th and >90th percentile based on singleton live births without major congenital abnormalities.
3,">18 years, confirmed HIV diagnosis, and receiving care within a participating site."
0,"The treatment outcomes were analyzed for the intent-to-treat sample with the primary outcome being the percent reduction from baseline to endpoint on the HAMD-17 rating scale, using the last observation carried forward (LOCF) method for interpolating final score for those subjects who discontinued before the final endpoint."
3,"Inability to provide informed consent, inability to read and speak English."
0,"The study was not initially registered due to the fact that it is an observational design with education as the intervention that did not clearly meet the criteria for inclusion on ClinicalTrials.gov, and registration was not required by our Institutional Review Board."
1,"The NAILED stroke risk factor trial was designed to be an open, population-based, randomized controlled trial comprising two parallel groups with an allocation ratio of 1:1."
0,Hierarchical linear modeling (HLM) [71] will serve as the basic analysis paradigm in which Enhanced and Core sites are compared.
1,The design of the trial and the intervention evaluated is described in further detail in the published study protocol [21] and we will describe it below in brief.
0,One subject had to be excluded from the S meal due to reported inappropriate behavior the day prior to the test day.
8,"To reliably detect a difference between groups in mean SBP of 5 mmHg, study groups of 180 participants (standard deviation 19 mmHg, mean SBP 140 versus 135 mmHg, alpha 0.05 two-tailed, power 80%) were needed."
0,Each of the three therapists demonstrated a score of 100% accuracy.
8,"To allow for drops-outs, we planned for study groups of at least 200 participants."
0,"The study staff at each facility monitored daily BMV practice sessions when BAs reported for work and signed the logbooks; daily BA checks of availability, cleanliness, and function of resuscitation equipment; regular observation of deliveries; debriefing after every resuscitation; and audits of every perinatal death on a continuous ongoing basis."
1,"An investigator-initiated, single-centre randomised superiority educational trial was previously described in a design article.36"
0,"Of note, because this was a first-in-man study and the human safety profile was as yet unknown, the study protocol specified a number of stopping rules."
6,Primary outcomes measures were the rate of successful biliary cannulation and incidence of PEP.
0,"Surveillance DR mutations (SDRM) were derived from a consensus genotypic definition for identifying transmitted mutations [33, 34] and were assigned from population sequences by the Stanford HIV DR Database CPR tool (v6.0) (http://cpr.stanford.edu) [35]."
6,"Secondary outcome measures were the incidence of bleeding, incidence of perforation, number of attempts at biliary cannulation, and number of unintentional PD cannulations/opacifications."
0,Randomisation was performed at the level of the general practice (stratified by practice size and level of urbanisation).
1,"This was a prospective observational study of 2000 individuals in 3 different groups of the society, and it was approved through expedited review by all participating hospitals’ institutional review boards."
0,Radiographs of the lumbar and cervical spine (lateral projection) were obtained at baseline and after a period of 2 years.
1,A cross-sectional study design.
0,[32] Data analysis
4,"The SMS for Stroke Study was conducted at the Clinical Trials Unit (CTU); Aga Khan University which is a JCIA (Joint Commission International Accreditation) accredited hospital in Karachi, Pakistan."
0,We sought to compare our sample with the national population of veterans.
4,Stroke service is delivered at the center through a 24 h neurovascular team on floor and ambulatory care clinics.
0,"Additional use of medication to treat anaemia, like oral and parenteral iron medication and other types of medication, is allowed in both groups and may be prescribed according to local protocol."
16,"Bootstrap percentile confidence intervals for results from Niger were estimated using R [15], N = 10,000."
0,The CV for repeat measures on PWVc-f was <3% on the same day and 7% in the same subject on different days.
16,CIs for model parameter estimates were obtained from MCMC with 16384 (214) steps after a burn-in including 8192 (213) steps.
0,Free‐text descriptions of the barriers and coaching strategies were extracted.
1,"This was a nested study with a randomised design within a cohort of household contacts exposed to patients with sputum positive tuberculosis in Kampala city, Uganda [32]."
0,The protocols of the constituent studies included in these pooled post hoc analyses were approved by an institutional review board or ethics committee and the studies were conducted in compliance with guidelines for good clinical practice; all patients gave informed written consent to participate.
1,Participants were recruited from May 2011 to January 2012.
0,"Furthermore, a (familiar) history of depression and use of antidepressants were reported."
6,"Secondary measures for clinical measures, mobility (gait and balance), cognition and imaging domains are listed in Table 2."
0,"Specifically, the independent Clinical Events Committee determined whether reinterventions at the target lesion were clinically driven on the basis of objective testing (ankle-brachial index decrease ≥20% or >0.15 in comparison with postprocedure ankle-brachial index) or symptoms of exertional limb discomfort."
1,"We carried out a multicenter, open, controlled, randomized, cluster, two-parallel arm trial (Experimental Group -EG- and Control Group -CG-) with a 12-month follow-up conducted in community health centers of the Spanish National Health System."
0,Patients at risk of CVD were identified as men aged 45 or older or women aged 55 years or older with hypertension.
6,"Variables collected during the visits were: age, sex, marital status, education level, social class, family status, family history of premature cardiovascular disease, comorbidity, current drugs consumption, snuff consumption (smoker, ex-smoker, non-smoker, number of cigarettes/day in case of smokers), and alcohol intake (basic units of alcohol/week), anthropometric data (weight, height, body mass index, waist circumference, blood pressure, heart rate), analytical data (total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, glucose, creatinine, uric acid, GOT/GPT/GGT, glomerular filtration rate), abnormal ECG, cardiovascular risk (SCORE, Framingham) [23, 24], diet (diet questionnaire Mediterranean) [25], physical activity (IPAQ questionnaire) [26], and adherence to medications (Haynes-Sackett and Morisky-Green tests) [27, 28]."
0,Creatinine concentration will be determined to provide an indication of urine collection compliance.
3,Participants were people with MS enrolled in the FACETS randomised controlled trial who had been allocated to the FACETS arm.
0,The BWA was programmed as web application with a technology using the server scripting language php and the database system MySQL.
3,"Inclusion criteria for the trial are described in full in the published protocol and trial papers,26–28 but in brief, included having a clinical diagnosis of MS, fatigue impacting on daily life, and being ambulatory (<8 on the Adapted Patient Determined Disease Steps (APDDS) Scale30)."
0,"The study was composed of two substudies: in substudy 1, DAA-naive patients with GT1 HCV infection without cirrhosis and without the Y93H polymorphism were randomized to 8 weeks of treatment with glecaprevir-pibrentasvir (arm A) or 12 weeks of treatment with ombitasvir-paritaprevir-ritonavir (arm B)."
1,"The study is a retrospective, observational study."
0,"The iStent inject is smaller than the first generation iStent, but functions in the same way to bypass the trabecular meshwork to improve aqueous flow from the anterior chamber into Schlemm’s canal."
4,"Data was collected from the electronic patient records at UNN, including radiological images and scanned or transferred documents from referring hospitals."
0,"Additional secondary end points described in this paper were: mean number of new non-enhancing T2 lesions per patient per scan, mean number of new Gd+ lesions per patient per scan, T2 lesion volume, mean number of new T1 hypointense (non-enhancing) lesions per patient per scan, T1 hypointense (non-enhancing) lesion volume, T1 Gd+ lesion volume, and brain volume determined at yearly intervals."
1,"This was a prospective, parallel arm, randomized, placebo-controlled, blinded trial of iNO versus placebo (1:1 ratio), among children with severe malaria, all of whom were treated with artesunate."
0,"In addition, intracellular and cell surface proteins were removed as being possible contaminants."
1,The trial protocol has been described in detail previously [22].
0,"in their analysis of data from a questionnaire answered by 464 patients with lung cancer (registered in the Alliance for Lung Cancer Advocacy, Support, and Education database from 2000 to 2002)."
3,"This study was a single-center, randomized, open-label, prospective phase II trial."
0,"Previous psychometric research has validated Internet-administration of self-rating scales for depression, quality of life and anxiety.44–46"
3,"Inclusion criteria were metastatic pancreatic adenocarcinoma, presence of at least one measureable lesion, Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2, absolute neutrophil count ≥ 1,500/mm3, platelet count ≥ 100,000/mm3, serum creatinine level ≤ 1.5× upper normal limit, aspartate aminotransferase or alanine aminotransferase level ≤ 5× upper normal limit, adequate samples for histological and mutational analyses, and absence of any other malignancy or serious medical or psychological illness that would preclude informed consent."
0,A detailed list of endpoints is reported in Table 1 and defined in the Additional file 1: Appendix.
3,"Eligible participants are: 1) at least 18 years of age; 2) living with HIV infection; 3) initiated ART in the ≤90 days; 4) food insecure, as measured with the Household Hunger Scale (score ≥2 indicating moderate to severe hunger in the household) [41, 42]; and 5) willing and able to provide written informed consent for the study."
0,"Patients were recruited between December 2006 and September 2010, when the study was prematurely terminated due to slow recruitment as a result of increasing use of robot assisted surgery at all investigational centers."
3,"PLHIV who are severely malnourished (body mass index (BMI) < 16 kg/m2) are excluded from the study, as these individuals require therapeutic nutritional supplementation for nutritional recovery."
0,"In addition, self-reported presenteeism was assessed using some questions from the World Health Organization (WHO) Health and Work Performance Questionnaire (HPQ) [20]."
4,"A comprehensive in-person interview about individual and household characteristics, food security, ART adherence, and health service utilization will be conducted at baseline, 6 and 12 months along with quantification of plasma viral load."
0,"Given that we had a priori hypotheses about the direction in which these variable would change (for example, an increase in weight), we used one-tail significance threshold P<0.05."
4,"Visit attendance, CD4 count, pharmacy pick-up data, and other clinical and prognostic markers will be abstracted from medical and pharmacy records at 0, 6, and 12 months."
0,"Statistical analyses and Kaplan-Meier survival curves were calculated using PASW Statistics 18 (IBM SPSS Statistics, Armonk, NY)."
1,"We performed an open label, dose-escalation study (Fig. 1) to evaluate the safety and tolerability of CoQ10 in HD patients using a commercially available CoQ10 chewable wafer (Vitaline Formulas, Wilsonville, OR)."
0,"Responses were measured after 40 minutes of dark adaptation by sequential stimulation in each eye with white light under low, medium and high intensity conditions (0.04, 0.4 and 10 lux, respectively) [17]."
1,Fig. 1 CoQ10 dose escalation study design.
0,"Access to information will be limited to interviewers and their supervisors at sites of collection, to auditors and data feeders at the collation point and thence to the senior data management officers and principal investigators."
16,The data analysis was split into the GTV volume analysis and position analysis.
0,"2.9.0 were used for data pre‐ and postprocessing, graphical visualization, and model diagnostics.24"
16,"All statistical analysis was performed using Matlab2013b (MATLAB and Statistics Toolbox Release 2013b, The MathWorks, Inc., Natick, Massachusetts, United States)."
0,Patients were randomly allocated in a 1:1 ratio to the MSCs group or control group.
8,The sample size was contingent on the number of Malian subjects enrolled in the PHiD-CV unprimed group in study NCT00678301.
0,The duration of survival is the time interval from the first day of radiation treatment until death of any cause.
8,"As no data or information on the prevalence of vaginal lesions depending on the nature of the vaginal microbiom was available, the sample size was determined to ensure a minimal statistical power of 80% to detect clinically relevant risk factors (relative risk ≥ 1.5)."
0,We hypothesize that DAART will increase rates of viral suppression compared to SAT.
8,"With a hypothesis of 35% prevalence of vaginal lesions and a frequency of BV equal to 10% (both estimated from registry data of the Nîmes University Hospital in 2011: overall prevalence of vaginal tears 38% and BV frequency to 10%), 660 patients were required (with a 2-sided type 1 error rate of 5%)."
0,"At all places, two quiet rooms were used, one for evaluation of primary and secondary outcomes and another for treatment."
8,Detailed sample size calculations for the original trial are described elsewhere.7
0,The study ran from February 2012 until June 2013 in eight municipalities in the Netherlands.
8,We achieved the original intended sample size.
0,Peak intensities were normalized to one of the 8 internal standards added to each sample.
1,"DRAGET is an ongoing multicentre prospective, open, transversal clinical trial with repeated measures."
0,"Each domain contains four descriptors which are rated on a 1–4 scale, and the total BPS value ranges from 3 (no pain) to 12 (most pain)."
8,"The calculation of the sample size for an up-and-down method has not been clearly defined, but a sample size of 20 – 40 for each group is generally considered acceptable [15]."
0,"The patient was excluded from study entry either if the stroke diagnosis could not be confirmed or if the patient was critically ill, had severe dementia, could not be weighed or if there was planned discharge within 24 hours after the first visit by the trial assessor."
8,"Therefore, a total of 30 patients were included for each group in this study."
0,"For each of the test batteries a measure of the overall functioning level, a total equivalent age, is obtained."
16,The change in IOP from baseline to week 12 was analyzed using a mixed model including visit as a fixed effect and patient as a random effect.
0,"To reduce the risk of airway complications during and following tracheostomy, patients with a Cormack and Lehane score ≥ 3 were excluded and received surgical tracheostomy."
16,P values of <0.05 were considered statistically significant.
0,Driving conditions were a straight motorway on weekdays with usually light traffic conditions and in fair weather.
1,"The pilot single-blinded, pragmatic, parallel 3-armed cluster RCT compared the relapse rate at 2- and 6-month follow-ups between recent quitters who participated in group discussion and received reminders (group A: WhatsApp; group B: Facebook) and those who did not (group C: control; allocation ratio 1:1:1)."
0,The median treatment duration was 9.1 months.
1,The study was approved by the Institutional Review Board of the University of Hong Kong / Hong Kong Authority Hong Kong West Cluster (IRB reference no: UW-13-528).
0,"We will disseminate our findings to those currently involved in the management of vertigo and dizziness (e.g. clinical scientists in audiology, hearing therapists, physiotherapists, ENT consultants, neurologists, and audiological physicians) by submitting academic papers to journals such as the International Journal of Audiology and Clinical Otolaryngology, and magazines such as ENT News."
12,The ICSC counselors who screened and enrolled participants were notified of the group allocation on Monday of each recruitment week.
0,"Throughout all treatment phases, vital signs, the occurrence of adverse events and use of concomitant medication was monitored for each subject."
12,Participants were not aware of the allocation sequence.
0,"It refers to the strength of one’s faith in one’s own abilities, and one’s capabilities to complete assignments and achieve goals [29]."
14,"All participants received a specific relapse prevention intervention, but they did not know what the other interventions were."
0,"Cholesterol and triglycerides were analyzed as concentrations, and fatty acids were analyzed as percentage of total fatty acids (by weight)."
14,All assessors of outcomes were blinded to the RCT group of each participant.
0,"Furthermore, the enamel specimens are divided into two subgroups, including sound and artificially demineralized (subsurface lesion) enamel (Figures 3b, c and 4)."
8,"An a priori power calculation indicated that 48 participants were needed per group to detect an estimated difference of HbA1c of 0.65%, assuming a significance level of 5% (two-tailed), a standard deviation of 1.4, and a statistical power of 80%."
0,"(1) Date and time, task (imitation or JA), game number, level number; (2) The reaction time (RT) that corresponds globally to the time used by the child to complete a task."
8,"We overenrolled to allow for attrition, setting our final recruitment target at 65 participants per group."
0,"In the ADT arm, all patients enter the model in the BDFS with ADT state, receiving monthly treatment with goserelin as clinically recommended.8 23"
12,Participants and recruiters were blind to treatment allocation prior to the point of allocation.
0,"Fourteen days (±2 days) after the first treatment, the school nurse conducted another head check on the treated child and completed another Egg/Lice/Scalp Condition Form."
12,No one apart from the telephone contact had access to allocation codes.
0,Patients and CarePartners randomized to mHealth+CP received identical intervention elements described above.
3,Female students of the School of Medicine from the Universidad Miguel Hernández of Elche (Spain) who suffer from PD.
0,"Additionally, we identify potential subjects in the electrophysiology laboratories at each of our participating sites."
4,"A closed-ended questionnaire was used to collect data on a range of factors, including the women’s use of FP, whether they ever had an HIV test, whether the provider offered HIV counseling and testing at current facility visit, other sexual and reproductive health (SRH) behaviors and health-seeking behaviors."
0,"During the trial, we asked all centres to retain their original administration system (mostly the paper based patient’s record) to record information on patients’ rehabilitation programmes."
4,Teams of trained research assistants conducted the interviews using hand-held personal digital assistants (PDAs) loaded with the questionnaire tool that had been translated into Swahili.
0,Experiments were performed blinded with respect to subject status (treated HIV-1 patients or control subjects).
1,"This study was a prospective, interventional, double-blind randomized controlled trial."
0,Wedge biopsies from the right lobe of the donor liver were collected pre-reperfusion (LB1) and 1 hr post-dual reperfusion (LB2).
3,Subjects were recruited from previously healthy children visiting the Emergency Room (ER) and Out-Patient Department (OPD) of Kanti Children Hospital with the following inclusion criteria:Age between 6 weeks and 2 yearsFirst Episode of WheezingMeets Clinical Definition of BronchiolitisClinical severity (CS) scores (Wang et al [26]) between 1 and 9 (Table 1).
0,The two sessions were randomly assigned.
3,"Table 1 Wang et al. clinical severity score Bronchiolitis was clinically defined as per the AAP consensus guidelines [4, 27] as the first episode of acute wheezing in children less than two years of age, starting as a viral upper respiratory infection (coryza, cough or fever)."
0,Exercises were only added to sustain the muscle activating effect of the WB-EMS and were adjusted to the patients’ ability in performing the motion sequence.
4,"The study was carried out in the ER, Observation room (OR) and OPD."
0,"Each finger was tapped for three blocks for a total of nine 30 s blocks, with 30 s rest blocks separating each finger tapping block (Fig. 1a)."
4,Recruitment occurred at the peak of bronchiolitis season in between January 15th to April 15th for duration of 4 months.
0,"The formation half-life (T½for) and the elimination half-life (T½el) were calculated as ln2/kabs and ln2/λel, respectively, where kfor represents the first order formation rate constant and λel is the elimination rate constant."
16,Numerical values are given as means ± SEM.
0,Probability proportion to size of the school and grade populations was used to determine the number of children selected from each school and grade in the two groups.
16,"Statistical analysis was performed using SigmaPlot 12.5 (Systat software Inc., San Jose, CA) and significance was assessed by performing appropriate statistical tests (paired Student's t test or, for multiple comparisons, one-way repeated measure ANOVA followed by Holm-Sidak post-hoc test)."
0,WEMWBS shows high internal reliability (Cronbach’s alpha = 0.93) and one-week test-retest reliability (r = 0.97) in the Spanish population [33].
8,"According to literature, we assumed a mean EDTRS visual acuity of 48 letters and a standard deviation (SD) of 15 letters at baseline.[5, 24, 25] Assuming a clinically relevant between-group difference of 5 letters on the ETDRS chart, we needed to include 282 patients to achieve a power of 80% and a significance level of 5%."
0,Sonidegib concentrations in plasma were measured using a validated liquid chromatography–tandem mass spectrometry method7 with the lower limit of quantification of 25.4 pg/mL.
8,"The CHARMED–Study-Group, however, decided to stop recruitment after 169 patients, because the recruitment proceeded much slower than expected."
0,Participants were provided with four separate tubes and asked to submit two paired simultaneously and spontaneously expectorated morning sputa to the health center laboratory on consecutive days.
14,Research technicians not affiliated with the clinics carried out all assessments at the 3 and 9-month follow-up interviews and were blind to treatment group allocation.
0,"Disposition index (DI) is a product of measures of insulin sensitivity and first-phase insulin secretion which is predictive of conversion to diabetes [28], [29]."
6,"The primary endpoint was progression-free survival; secondary endpoints were overall survival, response by RECIST (version 1.1), assessment of adverse events, and quality of life."
0,The inclusion and exclusion criteria are presented in Table 1.
6,"Samples were also taken for exploratory biomarker analysis (including archival tumour tissue, and blood samples for circulating tumour cells and a panel of angiogenesis ELISAs)."
0,"Images were acquired at × 20 magnification, and the thrombus area was measured using an Ariol image acquisition system (Leica Microsystems GmbH, Germany) by a blinded operator."
3,Adults (age > 18 years) admitted to the ICU and given norepinephrine to treat shock were eligible for inclusion.
0,One prompt was delivered at a random time of day between 9:00 a.m.
3,"Exclusion criteria were moribund status, pregnancy or breastfeeding, infusion of another medication via the central venous port used for norepinephrine administration, absence of healthcare insurance, refusal of the patient or next of kin to participate in the study, pheochromocytoma, and carcinoid tumor."
0,"Hb was measured on each visit (finger-prick capillary blood, HemoCue®)."
8,We believe that a sample size of 30 patients is appropriate for a pilot study and will allow estimation of percentage rates of recruitment and retention to within a SE of at most 10%.
0,"During treatment, blinding of participants and clinicians are naturally impossible."
6,The primary outcomes included volatile anesthetic dose was measured in MAC-hours; intraoperative fentanyl and propofol doses; the intensity of the most severe surgical site pain in the first two postoperative hours on a 10-cmvisual analog scale (VAS).
0,At 0900 h the subjects received a yogurt breakfast (130 g) containing either PinnoThin TAG or placebo (milk fat).
6,"Secondary outcomes included intraoperative ephedrine use, core temperature at the end of surgery, time-weighted mean arterial pressure (MAP), time-weighted heart rate, and nausea or emesis in the PACU."
0,Disease severity was scored by the Scoring of Atopic Dermatitis (SCORAD) index and sensitisation was evaluated by standard prick test (SPT) and specific IgE (sIgE) measurements [14].
1,"We conducted a parallel-group, double-blind, randomized placebo-controlled monocentric study in a tertiary care hospital (Cochin Hospital, Paris, France)."
0,"Due to the early termination of the study, predefined efficacy endpoints could not be evaluated."
6,The primary outcome was 50 % reduction in sciatica pain measured on a VAS (0–100 mm) at day 10.
0,Follow-up fidelity data will be collected throughout the project to document provider skill and intervention adherence.
6,"Secondary outcomes were sciatica pain assessed by a VAS at 2 hours and days 30, 90 and 180; lumbar pain assessed by a VAS at 2 hour sand days 10, 30, 90 and 180; patient acceptable symptom state (PASS) defined as a VAS score <40 mm; and absolute and relative minimum clinically important improvement (MCII) defined as a reduction in VAS-assessed pain ≥15 mm or ≥20 %, respectively, at 2 hours and day 10; Québec disability score; co-interventions; and tolerance at days 0, 10, 30, 90 and 180."
0,This 110-item questionnaire was designed to estimate usual and customary intake of a wide array of nutrients and food groups.
8,"To achieve a 50 % reduction in sciatica VAS pain score between IFX and placebo groups, with an α risk of 0.05, a power (1-β) of 0.80, and predicted improvement in pain scores of 10 % in the placebo group and 60 % in the IFX group, the number of participants needed was 17 in each group (two-sided chi-square test)."
0,"All investigations were carried out at the Department of Clinical Research (Division of Endocrinology, Diabetes and Clinical Nutrition, and Division of MR- Spectroscopy and Methodology)."
8,"With an estimated 10 % of patients lost to follow-up or presenting latent or active tuberculosis, we sought to include 20 patients in each group."
0,"In addition, we will conduct a per protocol analysis using data from participants who received at least a minimum exposure to the interventions and for whom MPR was available at 6 months."
6,"The primary efficacy end point was the mean change in Hgb from baseline to end of treatment (EoT), defined as the last one-sixth of time in the randomized stage (Stage 2) (average of all Hgb values obtained in the window) per patient."
0,CHAQ discomfort index was also rated for each patient by their parent at each scheduled visit using a 21-numbered VAS in 0.5 unit increments anchored by 0 = “no pain” to 10 = “very severe pain.”
8,"The sample size calculation was based on a one-sided α level of 0·0125 to account for two primary end points, an assumed placebo response rate of 40 % and a treatment difference of 10 % in responder rates based on previously published studies("
0,"After the study was approved by the local ethics committee of the Radboud University Nijmegen Medical Centre, 43 healthy male volunteers provided written informed consent."
8,"Further, accounting for a potential 10 % dropout rate and three interim analyses, 580 subjects in each group were required, totalling to 1740 subjects."
0,"Of the 20 enrolled subjects, 18 were Caucasian and 2 were African-American."
1,"The evaluation will be guided by the MRC Framework for the Evaluation of Complex Interventions [18, 19]."
0,Additional study details have been described previously [12].
1,"In the INSPIRE study, the first three phases of the Framework will be completed (i.e., from pre-clinical phases to phase II – an exploratory trial) as outlined below and in Figs. 1 and 2."
0,The patients stayed in the PACU for not more than 2 h and were then taken to the intensive care unit (ICU) of the Department of Neurosurgery.
1,Open randomized controlled prospective clinical trial with subsequent development of a conception of evolution of AS based on systematic review of scientific databases.
0,"Exclusion criteria consisted of statin or digoxin use upon presentation, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels more than three times the upper limit of normal or creatine phosphokinase level more than four times the upper limit of normal."
6,The primary efficacy endpoint of the study was the complete recovery from AS diseases.
0,"Therefore a number of 50 subjects to be enrolled per group was considered sufficient to reach the goal accounting for a certain degree of drop-out rate reported in previous studies on the effects of probiotics [34, 54–56]."
6,"The secondary efficacy endpoint of the study was data imaging methods (doppler-ultrasound, computed tomography scans) and measurement of clinical status presence."
0,"After 24 h, the water-resistant film was removed by stripping and a new layer was applied."
3,The population enrolled (E7389-G000-301; ClinicalTrials.gov identifier: NCT00337103) has been previously described [12].
0,"Lesions that became smaller than 5 mm × 5 mm were recorded as ‘too small to measure’, and given a default value of 0 mm × 0 mm (SPD nadir of 0)."
3,"In brief, women (aged ≥18 years) with histologically or cytologically confirmed breast cancer, who had received ≤3 prior chemotherapy regimens (≤2 for advanced and/or metastatic disease) including prior therapy with an anthracycline and a taxane, were eligible for study inclusion."
0,Clinical malaria was selected as the primary endpoint for this trial.
16,"Organ effective periods estimated at S1 and S2, as well as tumor- and organ-absorbed doses for each schedule, were compared using the Wilcoxon statistical test."
0,The initial session focuses on the purpose of the ILC program and on identifying thoughts and behavior related to ASPD.
16,"For each patient, Spearman statistical tests were conducted to evaluate whether S1-absorbed doses were able to predict absorbed doses during S2."
0,The BCTQ is a disease-specific status scale that incorporates both a symptom severity scale and a functional scale.
3,"Enrolled patients (either sex, aged ≥18 years) had an MDS diagnosis (de novo or secondary) as per French–American–British (FAB) classifications, an International Prognostic Scoring System (IPSS) score ≥0.5 within 30 days of randomization, and an Eastern Cooperative Oncology Group (ECOG) performance status score of 0–2."
0,"Following the baseline interview, dyads eligible and willing to participate are randomized (see data analytic considerations) to the TAP-VA treatment group or an attention control group."
3,Key exclusion criteria included: a diagnosis of AML; a history of prior malignancy; a viral or bacterial infection that was not controlled by concomitant anti-infective therapy; and an inaspirable bone marrow.
0,"If focus and microorganism of infection is not clear, steps will be: A) Empirical sepsis treatment, B) Empirical sepsis treatment with anaerobic and gram positive coverage, C) Empirical sepsis treatment with anaerobic and gram positive coverage and/or fungal treatment."
1,"Pragmatic, blinded, parallel-group, superior, randomised, placebo-controlled trial."
0,"Thoracic kyphosis was measured using a Dualer Electric Inclinometer (North American Fork, Utah), and followed a previously established protocol [23]."
4,"Subjects were invited to participate in the trial during hospital visits, through trial posters on bulletin boards in hospitals, newspaper and Internet advertisements."
0,The trial was registered on the ISRCTN register (ISRCTN27934462) on 02 August 2013.
8,Sample size calculations were performed to determine the number of participants needed to detect effect sizes based on minimal clinically important differences in the SCORAD index.
0,"Eligible studies included randomized trials where dietary pulses constituted the majority (>50%) of the intervention, with a ≥3-week follow-up,16 and an adequate comparator of equivalent caloric value (isocaloric)."
8,Results showed that 42 patients were needed in this two-treatment parallel-design study to detect a treatment difference with a two-sided 0.05 significance level and a probability of 81% if the true difference in SCORAD between interventions was 8.7 units [15].
0,Patients planned for neoadjuvant systemic therapy (NAST) may be included in this trial in case all inclusion criteria are met.
1,"This study was a two-arm, individually randomised controlled trial (RCT)."
0,"The patient will be seen by the geriatrician and the nurse for CGA at baseline (after randomization and before treatment initiation), as well as 6 and 12 months after randomization."
1,"1:1 randomisation (stratified by age, sex, and ethnicity) was set up by an independent statistician using a computer generated list and was conducted remotely."
0,According to our institutional protocol all patients with suspected GERD undergo 24 h-pH-impedance monitoring (24 h-pH-MII).
1,"This study was a parallel group randomized controlled trial, which utilized blinded outcome assessors, and an intention-to-treat analysis."
0,The study was approved by the Arizona State University Institutional Review Board.
1,"After meeting the eligibility criteria for the study, participants were randomly allocated by the primary researcher to two experimental groups according to a computer-generated block randomization."
0,"After inclusion in the study and baseline assessment, participants will be assigned to the GI group or to the NGI group depending on their baseline scores at the GI Severity Index [60], as previously described."
4,"Center of Chronic Pelvic Pain and Gynecologic Endoscopy of the Universitary Hospital, Ribeirão Preto Medical School, University of Sao Paulo."
0,"The active layer of the stent’s dual-layer coating includes the fluoropolymer PVDF-HFP [poly(vinylidene fluoride-co-hexafluoropropylene)], which is the coating polymer on the Promus Element coronary stent (Boston Scientific),17,18 and the antiproliferative agent paclitaxel at a nominal concentration of 0.167 µg/mm2.19"
10,"Block randomization, consisting of ten blocks of six subjects each, with three patients in each group of treatment, was generated online (http://www.randomization.com)."
0,"As shown in Table 1, 9 of the 13 major recommendations advocated by the PREDIMED intervention diet [20] were almost identical to those in the Med-South Diet."
3,"Inclusion criteria were adults ≥18 years of age, requiring endotracheal intubation ≥3 h needing an endotracheal tube sized 7 or 8 mm."
0,Table 2 Contacts schedule for each participant in the intervention group.
3,"Exclusion criteria were cognitive dysfunction (i.e., inability to understand and fill out the study questionnaires), transmissible blood disease, multi-resistant bacterial colonization, current or continuous treatment with immune modulating therapies, e.g., systemic (or inhalation) use of cortisone or non-steroid anti-inflammatory drugs (NSAID), on-going respiratory infection, as well as deficient poor skills in writing and or speaking Swedish."
0,"The FLU-PRO is a 32-item daily diary assessing influenza signs and symptoms across 6 body systems: Nose (4 items), Throat (3 items), Eyes (3 items), Chest/Respiratory (7 items), Gastrointestinal (4 items), and Body/Systemic (11 items)."
1,"This was a phase 3, multicenter, randomized, double-blinded, placebo-controlled, parallel-group study (http://www.clinicaltrials.gov; NCT01441440) and a long-term, open-labeled, extension study (http://www.clinicaltrials.gov; NCT01485887) to evaluate the efficacy and safety of venlafaxine ER 75 mg/day (fixed dose) and venlafaxine ER 75–225 mg/day (flexible dose) compared with placebo."
0,Study drug was supplied in a monthly subject medication kit/carton bearing a two‐part detachable label.
1,"The double-blinded study comprised a 2-week screening period, an 8-week treatment period, and a 2-week tapering period."
0,"They were selected by their communities and trained for 6 d by council health management teams, who were trained in turn by regional health teams."
16,We conducted Fisher exact tests to assess whether providing a letter of intent during proposal development was associated with subsequent participation.
0,"In addition, the health educator goes over the principles of behavioral skills training, asks the patient to choose the first target behavior, and assists the subject in developing an action plan."
16,Results were considered significant if p ≤ 0.01.
0,"Additional evaluations included coagulation parameters, whole blood flow cytometry, and ECG."
6,The mapping of assessment domain to measurement is detailed in Table 1 and the schedule of measurements is illustrated in Table 2.
0,"Eligible subjects underwent a 2- to 4-week, open-label, placebo run-in period (Figure 1) during which background glucose-lowering therapy was continued unchanged."
6,All measures are validated.
0,"We aimed to enroll 200 men from in and around Homa Bay town, using the locater information in the stored study files from the field study."
3,"Eligible patients were ≥30 years old, l-dopa responsive, met UK Parkinson's Disease Society Brain Bank diagnostic criteria, and had severe motor fluctuations defined as ≥3 hours of daily off time at baseline (confirmed by the PD symptom diary), despite optimized treatment with available PD medications."
0,The epithelial cells selected by their green fluorescence were relocated and analyzed for vitality.
1,"This is a multicenter, randomized, controlled, crossover, open, phase IV clinical trial, which compares the effect of two different formulations of paracetamol (effervescent or non-effervescent tablets) in the blood pressure of hypertensive patients after 3 weeks treatment (coded EUDRACT 2010-023485-53)."
0,"Images were reconstructed using the following filters, slice thicknesses and spacing: standard, B31f, and B kernel; 0.625, 0.75, and 0.90 mm slice thickness; 0.625, 0.5, and 0.45 mm slice interval for General Electric Medical System, Siemens, and Philips scanners, respectively [29]."
1,The washout period between the two treatment periods is approximately 1 week (minimum 3 days).
0,"Occlusion was not deemed present if external mechanical obstruction (e.g., kinking of the external CVC components) was evident."
4,"The study will be conducted in Primary Care, with the participation of 13 primary care centers in Catalonia and Euskadi."
0,"For a desired statistical power of 80% to detect a hazard ratio of 0.44 for time to next suicide attempt between treatment groups, with a two-sided alpha level of 0.05, a total sample size of n = 116 was required."
4,The study protocol was approved by the Ethics Committee of IDIAP Jordi Gol and the rules of good clinical research practice will be followed.
0,The scans were analyzed with the latest QDR software for Windows V11.2.
8,"49 patients are required to detect a difference in systolic BP equal to or greater than 2 mmHg in 24-h systolic BP detected by ABPM (minimum difference with relevance in clinical practice), with a standard deviation of the mean difference of 4.5 mmHg (14), and for a crossover design."
0,The protocol was reviewed and approved by an independent ethics committee or institutional review board (IRB) at each participating center and all patients gave written informed consent prior to participation.
8,"An alpha error of 5 % and beta error of 20 % in a two-tailed test, and maximum loss rate of 15 % is assumed."
0,"The study was an outcome assessor blinded, cluster-randomised controlled trial with the class as the unit of randomisation."
4,"Before treatment, data was gathered about gender, age, education level, employment status, and pain duration."
0,"sCD14 and MCP-1 were measured by R&D Systems using a solid phase sandwich ELISA with a human sCD14 and human C-C chemokine ligand type 2/MCP-1 Quantikine ELISA kit, respectively (R&D systems)."
4,"Additionally, fear of movement/reinjury was assessed using the Tampa Scale for Kinesiophobia (TSK: [27])."
0,"If cough-related BIS elevation occurred, cough management was performed as described below, rather than increasing the dose of propofol."
8,The sample size calculation was based on an expected proportion of responders of 80% in the PEPT group14 and 50% in the CONV group.27
0,"RNA was reverse transcribed into cDNA by using High-Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA, USA)."
8,"Given an α of 0.05 and a power of 80% for a one-sided χ2 test, 62 patients had to be included when using a 1:1 randomisation."
0,"The Local Ethics Committee (De Videnskabsetiske Komitéer for Københavns og Frederiksberg Kommuner, Københavns Kommune) approved the trial: H-KF 307413."
16,See online supplementary text.
0,"The drop-out rate was expected to be less than 20%, based on the documented good tolerability of nutraceutical combination."
16,Data were analysed for the following populations: intention-to-treat (ITT): all randomised subjects; modified ITT (mITT): all randomised subjects who received at least one dose of study medication (this was also the Safety Analysis Set); and potential completer (PC): all subjects who were randomised ≥52 weeks prior to atacicept 150 mg arm termination.
0,"Table 2 Primary and key secondary endpoints The primary efficacy endpoint is the percent change in non-HDL-C from baseline to week 24, using all values regardless of adherence (intent-to-treat [ITT] approach)."
16,More details of the statistics used are provided in the accompanying supplementary materials.
0,"The CDM was carried out at the workplace, with two team members who had examined the patient."
6,"All the measurements and questionnaires were administered by the same expert interviewers, who were blinded to the allocated study group in both sessions (baseline and at the end of the intervention)."
0,Drafting the clinical question using the PICO format 4.
3,"One hundred and nine (109) primigravida, healthy pregnant women were recruited between 8 and 15 weeks’ gestation (mean gestation at recruitment was 10.5 +/− 1.3 weeks) at routine antenatal booking appointments."
0,"The BMQ-Specific evaluates representations of specific medication prescribed for the patient, in this case antidepressants."
3,"Women with medical or obstetric complications or risks were excluded from participation (in line with American College of Obstetricians and Gynecologists (ACOG) guidelines [33]), i.e., contraindications to being physically active; multiple gestation; under 18 years old, BMI under 19."
0,"One thousand bootstrap data sets were generated by repeated random sampling with replacement from the NONMEM input data file, and the final NONMEM model was fitted to the bootstrap data sets."
1,This was a cross-sectional descriptive study of catatonia in NS patients in Northern Uganda and an open label pilot study of using one or two doses of lorazepam as a catatonia test.
0,"ANCOVA was performed on primary and secondary outcomes variables to ascertain the effects of age, gender, BMI, center, total energy, macronutrients, and dietary fiber (PROC MIXED)."
3,"Young people aged 10–21 years, who fulfilled the NS diagnosis according to the consensus definition by international NS researchers [4], who presented with two or more catatonic items from a list of ten preselected common catatonia symptoms coined the Kampala Catatonia Panel (see section on assessment of catatonia) and whose caregivers gave written informed consent, were consecutively recruited."
0,Compensation was performed in FlowJo using beads (BD Biosciences) that were single stained with each of the antibodies in the 5 panels.
3,"Children without a caregiver to provide the history of the child, a history of having used a benzodiazepine drug in the past 48 h, or having a concurrent acute illness (e.g. febrile illness, pneumonia) at time of assessment were excluded."
0,Six of the eight channels were utilized for primary samples and two were used for reference samples created by combining aliquots from each primary sample in the study.
6,Our primary outcomes were: (a) the proportion of children and adolescents with NS who met clinical criteria for pediatric catatonia; and (b) a positive catatonia test (>50 % reduction in catatonia symptoms and signs) on the responses of the children and adolescents with NS and catatonia to test doses of oral LZP.
0,"The list included allergic reactions (tachycardia, fever, skin eruption, leukocytosis), local complications (haematoma, local infection at the site of bone marrow aspiration and thrombophlebitis at the site of injection), clinical features suggestive of vascular obstruction (tachypnoea, oliguria, peripheral vascular insufficiency, worsening of stroke) and systemic complications (septicaemia, increased SGOT, SGPT or rise in blood urea, creatinine levels) and development of epileptiform discharges in brain by EEG."
3,Adults (≥18 years of age) with active RA despite stable MTX therapy for >12 weeks were eligible to enrol in CAMEO.
0,"Measurements of all intakes (ORS, food, and water) and output (stool, urine, and vomit) were summarized for every six-hour period of the study until discharge."
3,"Patients met the 1987 American Rheumatism Association criteria for RA [12], experienced RA symptoms for ≥6 months, had active disease at baseline (defined as three or more swollen joints and DAS28-ESR ≥3.2), had not received prior therapy with a biologic, had an indication for etanercept per the approved product monograph [10], were able to continue MTX and had received a dose of ≥15 mg/week (or 10 mg/week if intolerant) for ≥12 weeks with a stable dose for ≥4 weeks before the baseline visit and were able to receive etanercept with private or public insurance."
0,A diet record was started and continued for the following 3 days.
1,"This was a single-centre, parallel group, RCT."
0,Table 5 Case definitions of secondary efficacy endpoints The case definitions have been selected to be consistent with usual practice wherever possible to allow generalizability of trial findings and comparability with other interventions.
1,Parents were individually randomised to either the intervention or treatment as usual (TAU) arm with an allocation ratio of 2:1 in favour of the intervention.
0,(Adapted from Perera et al. 2007).
8,"Consistent with pilot studies, no power analysis was conducted."
0,The ratio of OD260/230 should be larger than 1.8.
8,We aimed to recruit a minimum of 12 participants in the TAU group based on suggested guidelines for pilot studies.30
0,"Subsequently, families were prompted by email each month to complete the asthma control survey."
14,"Owing to the nature of the trial, participants could not be blind to their allocation."
0,Participants had access to additional information about PA and tips online on their personal Food4Me account.
14,"There was one researcher recruiting, delivering the intervention, and assessing outcomes and thus it was not possible for them to be blind to intervention allocation."
0,Further details of the trial recruitment procedures are provided elsewhere [30].
1,This is a randomized double blinded placebo-controlled non-inferiority trial with parallel assignment and treatment allocation ratio of 1:1.
0,"Then, the workload was increased by 30 W for females and 40 W for males every 3 min until maximum volitional exhaustion."
3,"Source: Data Management Unit, Department of Pediatrics and Child Health Aga Khan University Inclusion and exclusion criteria"
0,The studies were conducted according to the International Conference on Harmonization Guidelines for Good Clinical Practice.
3,"Children 2–59 months old, visiting primary health clinics (PHC) run by Aga Khan University (AKU) with following eligibility criteria are included (Table 1)."
0,"The theoretical base and mechanism of action of behaviour change counselling was strongly linked to research on the process of motivational interviewing,55 where it has been confirmed in a number of studies that a less confrontational style is more likely to evoke “change talk,” which in turn predicts a better outcome."
5,Children in the reference arm receive the WHO regimen of oral Amoxicillin in two divided doses for three days using WHO Integrated Management of Childhood Illnesses (IMCI) recommended weight bands [26] (Table 2).
0,Response definitions were according to Response Evaluation Criteria in Solid Tumors (RECIST) 1.1.
5,Children in the comparison arm receive pharmacologically inert placebo similar in appearance in two divided doses for three days.
0,"The study protocol was reviewed and approved by the Ethical Committee of the Faculty of Medicine, Pharmacy and Dentistry, University of Bamako, Mali and by the Ethics Committee of the London School of Hygiene and Tropical Medicine."
6,The primary outcome will be cumulative treatment failure at or before day 3 (Table 3).
0,"Ultimately, if the participant regained capacity, they were asked for their permission to retain data already collected."
6,"Secondary outcome includes treatment adherence, new onset infectious co-morbidity, severe and non-severe adverse event, relapse, pneumococcal and viral carriage and cost of treatment."
0,Clients will undergo a series of physiological tests in order to assess their metabolic health and physical functioning.
1,"A prospective, randomized, international multicentre trial including 69 patients was performed according to a standard protocol to compare computer-assisted TKA using either a mini-midvastus (MIS group) or a medial parapatellar approach (conventional group)."
0,Fig. 1 Flowchart of the patients in this study Anesthesia management
1,"Patients in 3 centers (Maastricht, Zwickau, Adelaide) with end-stage osteoarthritis of knee were randomized to either an MIS group with dedicated instrumentation or a conventional group."
0,"Grade 3 general reactions (solicited or unsolicited) were defined as those that prevented normal daily activity, or in the case of fever an oral temperature >39.0°C."
6,The primary endpoint of this trial was the area under the plasma concentration–time curve (AUC(0–12)) for ticagrelor during the first 12 h after the administration of the LD.
0,Adults aged 18 years and older were eligible for enrolment.
6,"Secondary endpoints included AUC(0–12) for AR-C124910XX, AUC(0–6) for ticagrelor and AR-C124910XX, maximum concentration of ticagrelor and AR-C124910XX for 12 h (Cmax12), time to Cmax (tmax) for ticagrelor and AR-C124910XX, platelet reactivity index (PRI) assessed by the vasodilator-stimulated phosphoprotein (VASP) phosphorylation assay, area under the aggregation curve (AUC) assessed by multiple electrode aggregometry (MEA), P2Y12 reaction units (PRU) assessed by VerifyNow, percentage of patients with high platelet reactivity (HPR) 2 h after the LD of ticagrelor assessed with VASP, MEA and VerifyNow, and time to reach platelet reactivity below the cut-off value for HPR evaluated with VASP, MEA, and VerifyNow."
0,"Other secondary endpoints in the hierarchical testing procedure were ACR50 response, CFB in HAQ-DI and CFB in mTSS, all at Week 52."
8,"Since there was no reference study examining the pharmacokinetics of ticagrelor in patients presenting with STEMI or NSTEMI, we decided to perform an internal pilot study of approximately 30 patients (15 for each arm) to estimate the final sample size."
0,"Serum glucose, hemoglobin, leukocytes, platelets, total cholesterol, high density lipoprotein and low density lipoprotein fractions, uric acid, C‐reactive protein, troponin I, creatine kinase–MB fraction, serum urea, and creatinine (estimated glomerular filtration rate, [eGFR], by CKD‐Epi formula) were recorded at admission, before PCI."
8,"Based on the results obtained from the analysis of the first 33 enrolled patients, and assuming a two-sided alpha value of 0.05, we calculated, using the t-test for independent variables, that enrolment of 68 patients would provide an 80% power to demonstrate a significant difference in AUC(0–12) for ticagrelor between the study arms.13"
0,"In the elaboration of the therapy plan, it was decided to perform more sessions with exercises E3 and E7, setting a focus on compliance identification during grasping as well as the coupled training of forearm rotation and grasping, which were identified as the exercises corresponding best to daily activities."
6,"All analyses were carried out using the full analysis set, thus permitting a paired analysis of results."
0,"Pentobarbital was administered in accordance with the protocol established by Eisenberg and coworkers [10], using a loading dose of 10 mg/kg over 30 minutes followed by a continuous perfusion of 5 mg/kg per hour for 3 hours."
1,"This was a multi-center (9 sites in Korea) open-label, single-arm, phase 4 study conducted from April 2012 to October 2012."
0,"The distribution of providers by site designation (intervention or control), facility type (hospital or laboratory), and participant role can be found in Table 1."
16,"Where applicable, the data were analysed by Student's t-test and p<0.05 was considered statistically significant."
0,Instruction and practice in administering the survey instruments would also take place.
16,All error bars indicate ± standard error of the mean (SEM).
0,"A total of 251 individuals were randomized to receive either oral methadone (n = 111), injectable diacetylmorphine (n = 115) or injectable hydromorphone (n = 25), the latter two on a double blind basis."
1,"Viral surveillance time-series regression models were used to estimate the number of persons consulting a GP for influenza-attributable respiratory disease in England in each season (July in the index year through June the following year), from 1995 to 2009, stratifying by age, risk status and vaccination status (www.clinicaltrials.gov: NCT01520935)."
0,Adjuvant glycoprotein IIb/IIIa inhibitors were used wherever needed.
1,"Seasons after July 2009 were not included as we were concerned to establish the normal or average seasonal burden of influenza, which was disturbed by the pandemic experience in summer 2009."
0,"This means a number of patients, initially presenting with septic shock, could improve to sepsis or even better between days 3 and 8, while patients with sepsis on day 1 could develop a septic shock on day 3 or 8."
8,"As this was a feasibility study, a prospective sample size calculation was not conducted."
0,We used the list of 14 methodological issues (as the best available) to categorize and assess the extent to which each issue was addressed (or not) in this feasibility study with pilot trial.
8,"We aimed to recruit 80 stroke participants across the four sites over 14 months, which appeared realistic given the teams’ referral rates."
0,"• The mean Oswestry Disability Index score, as well as the mean improvement, will be compared between groups across all study visits."
6,Data were collected in participants’ homes by research assessors blinded to group allocation.
0,CRP was measured on an IMMULITE 2000 automatic system (Siemens Healthcare Diagnostics).A total of 6 spot urine samples (1 before and 1 96 h after each of the 3 test supplement administrations) were collected from each study participant and were stored at −25°C until analysis.
6,"Clinical outcomes were collected at baseline (within 2 weeks from starting rehabilitation), 6 weeks and 12 weeks after baseline."
0,"An indwelling IV catheter was inserted on that day, and blood samples were obtained at 0730, 0745 and 0800 h for baseline determinations."
17,"We repeated the two subgroup analyses performed in the original trial, among the two groups of patients that were hypothesised to derive greater benefit from surgery: (1) patients with less severe radiographic disease (KL grade 2), and (2) patients reporting mechanical symptoms of catching and/or locking.10"
0,"Patients were required to have at least one hospital blood glucose (BG) >180 mg/dL and, if on insulin, the outpatient insulin dose needed to be ≥0.5 units/kg/day."
3,People with CRC were recruited from three UK hospitals with CR facilities and considered for inclusion if they were 18 years old and over and had been diagnosed with primary CRC and were in the recovery period postsurgery (they could still be receiving adjuvant therapy).
0,"The FOThyr study was a prospective, multicentre, single‐blind trial, with patients enrolled at 13 sites in France."
3,"People with CRC were excluded if they had advanced disease, failed clinical/risk assessment for rehabilitation and were deemed unsafe to participate in exercise classes, had severe cognitive impairment or were unable to communicate in English since this is the language used in CR in the UK."
0,"Intracellular analysis of IL-2(MQ1-17H12) (BD Biosciences), IL-4(8D4–8), IL-17(EBIO64CAP17), IFNγ(4S.B3) (eBioscience, San Diego, CA, USA), and TNFα(Mab11) (Dako, Glostrup, Denmark) was performed after fixation and permeabilization, using Fix and Perm reagent (eBioscience)."
6,"Trial outcomes used to assess the feasibility and acceptability of the intervention were consent rate, reasons for declining to participate, adverse events, intervention adherence, evaluation of training."
0,"Randomisation was performed in Stata, at a single point in time, by the study statistician (KH)."
8,"The aim of the study was not to provide a definitive estimate of treatment effect, so we did not have a formal sample size calculation."
0,"For enzalutamide, an additional pharmacokinetic analysis was based on the sum of enzalutamide plus N-desmethyl enzalutamide (i.e., composite of enzalutamide active moieties)."
8,"Rather, we estimated that we would recruit 66 participants in a given time period."
0,The FRAT-up fundamental hypothesis is to consider the fall risk as being directly related to the subject’s exposure to known risk factors.
1,"The MOVES trial was a phase IV, multicentre, non-inferiority, randomised, parallel-group, double-blind study."
0,"On diagnosis, volunteers were treated with a 3 day curative course of oral Malarone (atovaquone/proguanil 250 mg/100 mg) where each dose was directly observed in clinic."
1,"Patients were recruited consecutively by physicians in public or private practice at sites in France, Germany, Poland and Spain (see online supplementary table S1 for a list of investigators by study site and country)."
0,"Routine community surveillance for influenza was conducted in the Kamalapur area throughout the trial period, as previously reported [9], and included RT-PCR detection of influenza as well as antigenic characterization, as described above."
16,The sample size was estimated on the assumption of a 78% non-failure rate for the ETN50 group (based on the findings of a previous study15).
0,Seeds were collected by researchers from plants identified as R. rosea and confirmed by DNA testing.
16,Full details of statistical methodology are provided in the online supplementary text.
0,It was administered using a nasal spray device delivering 50 μL per actuation.
4,"Inclusion criteria This work involved surgery patients receiving TPN during the calendar year of 2013 and 2014 in Cancer Hospital/Institute, Chinese Academy of Medical Sciences."
0,The median age at genotyping for infants diagnosed with HIV in the first six weeks of life for the cohort was 29 days (interquartile range [IQR]: 22–43 days).
4,Exclusion criteria Patients were excluded with one of these criteria: (1) TPN not being the unique nutrition source; (2) TPN duration shorter than 2 days; (3) use of anti-tumor drugs after surgery; (4) no surgery.
0,The fifth wave is now ongoing.
6,"The primary efficacy outcome was the mean sum of pain intensity differences (SPID) throughout 8 h after the first dose (SPID8 corresponds to the area under the pain intensity difference vs time curve during 8 h post-dose).Secondary PI-related end points during the SDP and MDP included the following: mean PI-VAS scores, mean SPID at rest, mean percentage of theoretical maximum SPID (% max SPID) at rest, percentage of PI responders (achievement of a mean PI-VAS <40 at rest), and worst pain on movement."
0,Table 2 Adequate perioperative intravenous antibiotic prophylaxes.
6,"The PAR-related end points over SDP included the following: mean PAR-VRS scores, mean total pain relief (TOTPAR), and percentage of TOTPAR responders (achievement of at least 50% of theoretical maximum TOTPAR; ≥50% max TOTPAR)."
0,Subjects were fasted on study days.
8,"A sample size of 600 patients and a significance level of 0.05 were required for a power higher than 85% to detect the differences in change of SPID8 between dexketoprofen/tramadol and each single component.A standard deviation of 94 mm h and a between difference of at least 35 mm h was assumed based on data from a previous phase II study (Scartoni S and Nizzardo A, unpublished observations)."
0,"Secondary clinical outcomes were the components of the primary outcome, cardiac death, target lesion revascularization (TLR), target lesion failure (TLF) defined as the composite of cardiac death, target-vessel MI, and ischemia-driven TLR and definite and probable stent thrombosis."
3,"Only stage-IV colorectal cancer patients were recruited, because of feasibility of metastatic lesions follow-up."
0,We have used the Michie et al. [23] CALO-RE taxonomy to detail the behaviour change techniques used in the intervention (Appendix 1).
3,Criteria for inclusion and exclusion of patients are presented in Additional file 1: Table S1.
0,"The ENGAGE AF‐TIMI 48 trial was a 3‐group, randomized, double‐blind, double‐dummy multinational trial that compared 2 dosing regimens of the oral factor Xa inhibitor edoxaban with warfarin in 21 105 patients with AF (NCT00781391).17"
3,"AS patients aged 18–75 years meeting the 1984 modified New York classification criteria [14] for ≥3 months prior to screening, with Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score of ≥4 (range 0–10) and a visual analogue scale score for spinal pain of ≥4 (range 0–10) were eligible for the PLANETAS study."
0,The secondary objectives are: To analyse the quality of life of patients with locally advanced pancreatic cancer treated with Cyberknife combined with S-1;To demonstrate the potential factors associated with the safety and prognosis of patients with locally advanced pancreatic cancer after radiochemotherapy.
3,"Patients were permitted to receive both oral glucocorticoids (equivalent to ≤10 mg daily prednisolone) and nonsteroidal anti-inflammatory drugs, if they had received a stable dose for ≥4 weeks prior to screening."
0,Only patients with three technically acceptable measurements based on slightly modified ATS/ERS criteria were included in final analysis (Additional file 1).
1,"The protocol was designed as a nonrandomized, off-label phase II study of alemtuzumab in subjects with T-LGL (Figure S1, page 1)."
0,"A second laser scanning system (confocal scanning laser ophthalmoscope, cSLO) operates simultaneously and allows recordings of topographic confocal images, including modalities such as near-infrared reflectance, fundus autofluorescence or angiography."
1,"The protocol was approved by the Institutional Review Board of the National Heart, Lung, and Blood Institute and is registered at ClinicalTrials.gov as NCT00345345."
0,"No post-reconstruction technique, such as smoothing or partial volume correction, was applied to the images."
1,"The study design is a 3-month, parallel group randomized controlled trial in which young men were allocated (allocation ratio 1:1) to receive either no intervention (control group) or objectively measured, continuous feedback on their PA."
0,A sample was considered positive when rRNA and/or DNA were detected.
1,The primary outcome measure was change in time spent in intensities of MVPA and sedentary activity.
0,"Fig. 3 Descriptive statistics on work status in valid % of multidisciplinary intervention group (MI) and brief intervention group (BI): proportions fully returned to work (f-RTW), partly returned to work (p-RTW) for both groups at each month for 24 months follow-up Ethical Considerations"
8,"A total of 36 participants (18 per arm) was estimated to provide 80% power at α=.05 to detect a difference of one weekly exercise session between the arms at week 12, assuming a standard deviation of 1.1 session."
0,Home Monitoring transmissions were reviewed by the nurse within two working days upon HM notifications of critical events flagged for attention.
8,"We anticipated a dropout rate of 15%; hence, we aimed to include 42 participants (21 per arm) [34,42]."
0,"Randomisation was stratified according to ward type, which was possible because of the coincidental even number of wards for each type."
6,The primary outcome was infant attentiveness to parent.
0,JL and NH then developed a coding frame that captured cross-cutting themes together with the descriptive data needed to allow a ‘thick description’ [20] of the findings to be provided to readers that was sensitive to contextual factors.
6,"Secondary outcomes were atypical infant behaviour, parent-child interaction, direct and parent-reported language, event-related potentials to vowel change, attention disengagement, and adaptive function."
0,"In case of lanreotide-associated toxicity, the dose will be reduced with 30 mg until symptoms disappear."
6,"For this study, the primary clinical outcome of interest was the results of the head CT scan (positive/negative) among patients with the first blood sample drawn within 6 h of injury."
0,All blood samples were drawn from the arterial line and analysis was performed in the hospital laboratory.
1,The study is designed as a RCT using a combination of quantitative and qualitative methods.
0,"By checking boxes, the doctor verified with a patient and indicated which home medications were to be reordered, suspended or discontinued (F1V)."
1,A health economic evaluation will be performed alongside the RCT.
0,Participant baseline and delivery data were collected by face-to-face interview and abstraction from medical records using standardized forms (Additional files 1 and 2).
3,Study participants will be enrolled consecutively from Aarhus University Hospital (OUH) and Odense University Hospital (AUH) in Denmark.
0,"Patient‐reported outcomes concerning weight‐related quality of life, binge eating, and sexual function were assessed but are not reported in this article."
4,"Program leaders and their coordinators will recruit women via flyers, community bulletin boards, social media, radio, direct mail postcards, and newspapers, as well as through churches, health care providers, human services, and “word of mouth.”"
0,"After a screening period of up to 21 days, eligible patients entered a 7-day baseline assessment phase followed by a 24-week treatment phase."
4,Recruitment of Aim 2.1 subjects will occur directly following the Aim 2 subjects’ baseline assessment.
0,An intent-to-treat (ITT) approach was used.
3,"The inclusion criteria of ShockOmics are:SOFA score > 5First blood sample and first hemodynamic measurements available within 16 h from admission to the ICUInformed Consent available: the consent will be requested to the patient, or to its relatives in case of altered consciousness, and signed by the physicians responsible for ShockOmics in the ICU."
0,"Inflammation is part of the healing process as well as a side-effect of the radiotherapy treatment on tissue [17, 18]."
3,"Delayed consent may be asked according to local rules and regulations in case the relatives were unavailable at the time of potential enrollment The exclusion criteria of ShockOmics are:Risk of fatal illness and death within 24 hPatients already enrolled in other interventional studiesMore than 4 units of red blood cells transfusedPatients receiving plasma or whole bloodActive hematological malignancyMetastatic and/or active cancerImmunodepression, including transplant patients; patients infected by the human immunodeficiency virus (HIV+); constitutive immune system deficiency; any immunosuppressive therapy, including oral and parenteral corticosteroids (aerosols are allowed)Patients with pre-existing end stage renal disease needing renal replacement therapy."
0,"From January 2011, real-time quantitative PCR (RQ-PCR) was used to identify the PML/RARa fusion transcript [20]."
16,Agreements between the conventional and ThinPrep cytology and the two study histopathologists were analysed by the McNemar test using R program version 3.1.2.
0,Below we describe each of these domains and provide key citations that support their relevance to our intervention development goals.
16,All 95% confidence intervals were computed using the R binom package and a p value < 0.05 was considered statistically significant.
0,"We considered patient was ready for surgery when a minimal composite score of 14 points was achieved, provided the sensory block score was equal or superior to 7 of 8 points."
12,The sequence was concealed by a computer interface.
0,The completed data forms will be entered onto data entry screens in Portuguese.
12,Each patient's allocation was revealed on logging in to the study’s secure website.
0,By standard protocol in this centre all patients treated via TFA received a collagen‐based vascular closure device.
14,"Blinding was not possible in this study, but the data collectors were not aware of the arm to which each patient had been allocated."
0,"Practitioners who expressed interest were posted a letter and the study information sheet, presented on one A4 sheet as opposed to multiple pages, for ease of reading."
6,"The primary endpoint was the percentage of late cancellation, defined as cancellation the day before surgery or on the day of surgery."
0,All reactions were plated in triplicate and beta actin (known as ACTB) was used as a housekeeping gene.
6,Secondary endpoints were the following: - The percentage of cancellations the day before surgery; - The percentage of cancellations on the day of surgery; - The percentage of conversion to conventional hospitalization.
0,The two antibodies used for this sandwich assay were directed against the N- and C-terminal region of the liraglutide molecule.
8,"A standard sample-size approach, based on a two-sided alpha risk of 5% and a statistical power of 95%, would have required 1193 subjects per group to detect a minimal clinically important difference of 6% in the cancellation rate between the intervention and control groups (4% in the intervention group and 10% in the control group)."
0,"Individual PK parameters were obtained by noncompartmental methods using Phoenix WinNonlin 6.3 software (Pharsight Corporation, Sunnyvale, CA, USA)."
8,"Taking into account erroneous inclusions and clustering due to a center effect, the estimated number of patients to be enrolled was increased by 70%, to 2045 patients per group."
0,This will be provided before study commencement.
3,"Eligible participants were SOT recipients with at least one rejection of a transplanted heart, lung, kidney, liver or pancreas recorded in the HES inpatient database between 1 October 2009 and 31 October 2010, and considered acceptable for research in the CPRD (ie, with no break in their records, and with information available on year of birth, registration date and gender).30"
0,"When comparing the active interventions, yoga served as the reference group."
3,"Participants also had to have an HES and CPRD follow-up covering the 180-day period preceding 1 October 2009 (ie, back to 4 April 2009) to contribute to the analyses, with no interruption in their permanent CPRD registration between 4 April 2009 and the end of follow-up (ie, 31 October 2010, death or withdrawal from the database)."
0,"Because logistic regression gives odds ratios (ORs) rather than RRs, the adjusted estimates are given as ORs."
8,The power calculation was based on a previous study of the research group37 and clinical experience.
0,"Safety assessments included vital signs, chemistry and hematology results, transfusion requirements and monitoring for adverse events."
8,"The sample size of 400 participants per study arm were based on assumptions of a baseline intention to use condom if new partner of 60%, with a power of 80% to detect differences of 10 percentage points between intervention and control group at a significance level of 5% (356/study arm IG/CG, a dropout of 10% and missing values=400)."
0,"A total of 24 patients, with BMI >40 kg/m2 and metabolic syndrome according to the Adult Treatment Panel III classification were invited to participate in the study (see online appendix at http://care.diabetesjournals.org/cgi/content/full/dc09-1833/DC1)."
6,The two primary clinical endpoints of the study were the change in gastrointestinal symptoms score using the IBDQ and the change in rectal bleeding score (Question 22) in the IBDQ between baseline and 12 months (panel).
0,"The final protocols, amendments and informed consent documentation were reviewed and approved by the Institutional Review Boards and/or Independent Ethics Committee of each study centre (see Acknowledgements for details)."
6,"Secondary clinical endpoints were adverse effects (bowel dysfunction) assessed according to LENT SOMA scales of radiation injury, clinical assessments of gastrointestinal symptoms according to the 11 questions selected from the CTCAE gastrointestinal scale (version 4), and patient self-assessments of quality of life recorded by the EORTC QLQ-C30 core questionnaire and QLQ-CR38 colorectal module between baseline and 12 months."
0,"Briefly, an insoluble delipidated pellet (mean recovery per biopsy was 7.2 mg; i.e., 92 %, range 72–100 %) was digested enzymatically and sequentially with collagenase, peptidase, pronase, and aminopeptidase as described [15] in order to release acid sensitive AGEs and LW-1 without destruction."
6,The primary outcomes were all-cause ICU mortality and hospital mortality.
0,The study timeline can be found in Figure 1.
6,"Secondary endpoints included the development of severe sepsis during the ICU stay, ICU and hospital LOS, and MV duration."
0,The mixtures were further diluted in buffer (to yield 800–1000 colonies on control plates) and plated on agar enriched with trypticase soy broth.
8,It was anticipated that up to 60 subjects would be needed for screening to enroll 45 subjects.
0,"To identify anti-inflammatory prescriptions, the PDR was searched for the ATC codes for bDMARD (L04AA and L04AB), NSAID (M01A), methotrexate (L04AX) and sulfasalazine (A07EC01)."
8,"Thirty subjects were required to complete the study and, per agreement with the FDA, a minimum of six subjects were to be assigned to each age group (5–12 years and 13–17 years), as well as a minimum of six subjects per dose level (30, 60, and 100 mg/kg/day)."
0,"All the sessions were audio-recorded and later transcribed, after which data were analysed using the thematic analytic approach [25]."
1,The VIPAR (Internal Plate Fixation versus Plaster in Complete Articular Distal Radius Fractures) trial is designed as a multicentre randomised controlled trial that will randomise between open reduction and internal plate fixation (intervention group) and closed reduction and plaster immobilisation (control group).
0,VA was letter scored with 0.02 logMAR assigned to each letter.
1,Patients will be recruited in 15 Dutch hospitals.
0,"Details of the study methods have been reported elsewhere [18], [20], [21]."
14,Randomisation status will not be blinded since the assigned treatment involves a surgical procedure.
0,"Immediately following exercise, a blood sample was taken, with subsequent samples at 15, 30, and 60 min postexercise."
3,"Of the 270 participants included in the previous study [6], 218 participants were weighed and measured at T2 (mean age = 11.13 y; SD = 0.76 y; grades 5–6; mean BMI = 18.31; SD = 2.73, BMI range =13.65–30.83) from six different primary schools in the Netherlands; 51.4 % of the participants were boys."
0,Target-lesion revascularization was not included in this secondary end point because it was unknown whether statins are effective in preventing restenosis and/or thrombosis of lesions treated at prior percutaneous coronary intervention.
3,"Using international cut-off scores [24], among the children in this follow up study (T2), 12 children were underweight, 170 children were normal weight, 33 children were overweight, and 3 children were obese."
0,"Using CVI42 (Circle Cardiovascular Imaging Inc.), an area of at least 10 pixels in the remote normal myocardium was used as a reference value for the normal signal intensity."
1,"The study employed a randomised, double-blind, placebo-controlled, parallel groups design with energy metabolism, and cerebral hemodynamics during cognitive tasks being measured following a single dose (Day 1) and after eight weeks (Day 56) supplementation with one of two multivitamin/mineral supplements or placebo."
0,Costs of the care provided to the patients will also be compared to the cost of usual care in the control group.
1,In this exploratory study both the metabolic and CBF parameters were considered primary outcomes and all other measures secondary outcomes.
0,"The leading ethical committee (ERC Jessaziekenhuis) coordinated the process, collected feedback and granted approval on 26th of February 2014 (BE24320149544)."
3,"At each clinical intervention site, study subjects were selected if they met the following criteria: 1) they were 18–75 years of age; 2) they met study criteria for diabetes before study enrollment (13,14); 3) they had received clinical care at a designated clinic or medical center involved in this study for at least 15 months before study enrollment; and 4) they were prescribed a new class of medication (not filled in the past 180 days) for A1C, BP, or LDL cholesterol uncontrolled at the time of medication prescription (A1C ≥8% [64 mmol/mol], systolic BP [SBP] ≥140 mmHg, or LDL cholesterol ≥100 mg/dL)."
0,Patients participating on an outpatient basis were to receive study drug infusions and all other study activities by home health care or have the ability to return to the study center.
1,"Randomised controlled trial (RCT) with participants individually allocated to one of two weight maintenance programmes: comparator (brief maintenance support call and leaflet provided) or brief maintenance support call, leaflet plus text intervention that encouraged regular self-weighing."
0,"In this article, we estimate and validate the 13 logistic models and their prediction power using combinations of 12 sets of predictor variables of tumor characteristics (tumor type, Nottingham score and mitotic counts), tumor pathological variables (tumor characteristics and receptor status of triple-negative, HER2 and ER), five pairs of hemoglobin predictor variables of tHb, oxyHb and deoxyHb only, tHb and oxyHb (tHboxyHb), and tHb and deoxyHb (tHbdeoxyHb), without tumor pathological variables and with these variables."
1,For trial design see Fig. 1.
0,"To limit the effect of day-to-day fluctuations in cognitive performance, healthy elderly were recruited."
1,In this prospective multicenter outcome study data were collected during the inclusion phase of an ongoing randomized controlled clinical trial (RCT) in a multi-center setting described in detail elsewhere [50].
0,Because of the expected further advances in molecular microbiological approaches the methods will be specified later.
3,The main inclusion criteria for the study were (1) HIV-1-infected persons ages 18–60 years; (2) receiving combination antiretroviral therapy for a minimum of 12 months; (3) documentation of HIV-1 RNA levels below the limits of quantification for at least 6 months; (4) CD4 cell counts >200/mm3 for at least 1 year.
0,The confirmatory analysis of the primary endpoint will be done using a group sequential analysis plan that is based on the number of observed events.
3,"The main exclusion criteria included (1) HCV antibody positivity; (2) history of clinically significant cardiac, gastrointestinal, hepatic, renal, pancreatic, neurologic, or autoimmune disease; (3) positive rheumatoid factor or anti-dsDNA antibody; or (4) initiation of ART within 12 months of documented HIV-1 seroconversion."
0,"In addition, indicator variables for county and counselor will be included in all regression models to account for the stratification of the randomization by county and counselor."
8,We designed the pilot to give a precise estimate of the proportion of subjects complying with screening.
0,The injection volume was 5 μL.
8,A study size of 4000 and therefore 2000 in the intervention arm would enable us to estimate 80% compliance with a 95% CI not exceeding ±2%.
0,"The clinical research was reviewed and approved by GSKs internal review panels and Independent Local Research Ethics Committee located in Brent, London, United Kingdom."
3,"A 5-year lung cancer risk of ≥5%, based on the LLPv2 risk prediction model,7 8 10 men and women aged between 50 and 75 years old, ability to provide fully informed written consent."
0,"During Phase II, the draft FAST was administered to a new set of adult patients using the cognitive interviewing method."
3,"Inability to give consent, comorbidity which would unequivocally contraindicate either screening or treatment if lung cancer were detected, thoracic CT performed within 1 year preceding the invitation to be screened, inability to lie flat."
0,"The following aspects will be discussed: techniques and strategies to follow through the action plan, review of the action plan, review of the assessment of results, assessment of results and prevention of relapse."
2,There was one protocol amendment that provided detailed microscopy instructions for examining blood and CSF for the presence of trypanosomes and determining WBC count in CSF.
0,"It will be calculated as the quotient of the number of cases with bpCR in VAB (“Category B”) and residual tumor in surgical specimen (false negative VAB results), divided by the total number of cases with residual tumor in either specimen (VAB and / or surgical specimen)."
2,"The amendment also detailed randomization of pregnant and lactating women in a separate strata, and provided additional clarifications and administrative changes."
0,The control group was treated with EVD + UT therapy.
7,There were no changes to any of the outcomes.
0,Fig. 2 Example of food tray before and after meal Weekend clubs: actigraphy sensor
14,"The study was open-label, since pafuramidine is administered orally and pentamidine is administered intramuscularly."
0,"Participants were considered to be diabetic, hypercholesterolemic or hypertensive if they had previously been diagnosed as such, and/or they were being treated with antidiabetic, cholesterol-lowering, or antihypertensive agents, respectively."
14,"However, the sponsor was blinded to treatment assignments."
0,"The exclusion criteria were (1) no risk of abnormal bleeding tendency or bleeding disorder (normal coagulogram, serum creatinine < 2.0 mg/dL, stop nonsteroidal anti-inflammatory drugs and antiplatelet drugs more than 7 days; and (2) no contra-indication for TXA use (no active intravascular clotting process, no acquired defective colour vision, no subarachnoid hemorrhage, no hypersensitivity to TXA, and no any of history of serious adverse effects, thrombotic disorder and hematuria)."
14,There was no blinding in the studies due to the different routes of administration.
0,Table 1 Study inclusion and exclusion criteria Catheter ablation strategies
14,Phase 2a and Phase 2b-2 were non-controlled studies.
0,"Three distinct types of forms were used at enrolment, daily in the hospital and at each visit respectively."
1,"This was a two arm, pragmatic, cluster randomised trial, with general practices as clusters allocated in a 1:1 ratio to each arm."
0,"Proton T1-weighted magnetic resonance imaging (MRI) was used to visualize the cross-sectional area (CSA) of the thigh and calf using a 1.5 T whole body Siemens Magnetom Vision System, as described previously [24]."
8,"To achieve 90% power with a 5% significance level, assuming an intracluster correlation of 0.024, 100 practices were required to identify a 7.5% relative increase in vaccine uptake from 54% to 58%.18"
0,Body weight did not influence the PK of KB003.
8,"To account for differences in the number of eligible patients per practice and dilution of the intervention effect through potential contamination between arms, we chose to recruit and randomise 150 practices to the study.11"
0,Cohen’s d was bias corrected [32].
3,In this trial were included male and female subjects who met the following criteria:ambulatory adult patients affected by knee OAdiagnosis according to the ARA (American Rheumatism Association) criteriaage > 40 yearsdisease activity assessed by the Lequesne Knee Index ≥ 7.0 at T0disease activity assessed according to the VAS at T0 ≥ 4 cm and persistence of pain in the knee for at least the last 3 months.radiological degree II-III according to the Kellgren-Lawrence scalepatients able to comply with study procedures.
0,"Population PK data were available for analysis from five of the six studies (Merck protocols PN052 [deferred arm only], PN060 [immediate arm only], PN061, PN062, and PN068)."
3,"Patients who met the following criteria were excluded:presence of comorbidities (rheumatoid arthritis, spondyloarthritis, connective tissue disease, polymyalgia rheumatica, gout, Paget’s disease, septic arthritis, fractures, osteonecrosis, and fibromyalgia)patients with skin or subcutaneous tissue infection in the area of the joint to be treatedpatients who had used oral, parenteral or intra-articular corticosteroids in the 3 months prior to the T0 visitpatients taking topical analgesics that may interfere with the evaluation of the studypatients on anticoagulant therapy or suffering from thrombocytopenia and/or coagulopathypatients with allergy to products of porcine origins."
0,"After thawing and vortexing, 10 μl aliquots of the pernasal swabs in SMGGB were streaked onto horse blood agar, chocolate agar, gentamicin blood agar (5 μg/ml), and bacitracin chocolate agar (300 μg/ml)."
8,"Since these were embedded studies, in which there were practical constraints around the timing of implementing the interventions in different trial centres, we did not derive a formal sample size calculation a priori."
0,"Potential participants were excluded if they were assessed as having severe psychiatric illness, dementia, severe drug addiction, or inability to communicate in the official language of the country."
8,"Instead, sample size was determined by these constraints."
0,The safety sample included all participants who were randomized and consumed at least one sachet of study product.
6,"The primary outcome was a composite of index type 1 myocardial infarction, or type 1 myocardial infarction or cardiac death at 30 days."
0,"Serum Leptin, resistin and adiponectin: will be measured by ELISA technique."
6,The secondary outcome was 1-year survival from myocardial infarction or cardiac death following the index presentation.
0,"Determination of the mean percentage of bacterial vitality in each field required sections with a minimum area of biofilm of 250 μm2, and the mean percentage of bacterial vitality of the biofilm was calculated for the corresponding sample and for each biofilm layer."
6,The primary outcome was the proportion of patients with PCR-corrected adequate clinical and parasitological response (ACPR) at day 42 [15].
0,"Briefly, the brachial artery was imaged in longitudinal section, 5 to 10 cm above the antecubital fossa, using high‐resolution ultrasound (GE Vivid 7; General Electric Healthcare Technologies)."
6,"Secondary outcomes were the proportion of patients with PCR-corrected ACPR at day 28, crude or PCR-uncorrected ACPR, early treatment failure, parasite, fever and gametocyte clearance times, haemoglobin recovery and the rate and severity of adverse events."
0,We also generated a reference case as follows.
6,The primary endpoint was the occurrence of any type of breast cancer (including ductal carcinoma in situ).
0,No prior treatment for systemic JIA aside from NSAIDs or short-term (less than 2 weeks) GC were allowed.
6,"Secondary endpoints included the occurrence of invasive oestrogen receptor-positive breast cancer, all-cause mortality, and adverse events."
0,GS and PD were scored separately on a 0–3 semiquantitative scale (as used in RA studies 6) for each joint imaged.
16,"Immunologic readouts were analysed using Prism 5 software (GraphPad, San Diego, CA)."
0,"All study drug modifications including initial doses, participant-initiated and/or protocol-mandated interruptions, substitutions, and permanent discontinuation and reasons for modification were assessed at each visit."
16,"Two-tailed P values, using Wilcoxon Matched Pairs Test for paired analyses comparing individuals’ responses to their own baseline values and Mann Whitney for inter-group comparisions are reported, with differences considered significant if p<0.05."
0,Wald tests were used for the p-values and confidence intervals from the logistic regression and chi-square tests were used to compare frequencies.
1,The JIKI trial was a multicenter proof-of-concept non-comparative trial conducted in four Ebola treatment centers in Guinea.
0,Anxiety was assessed with the Generalized Anxiety Disorder 7-Item Scale GAD-7 (see Additional file 1) [17].
1,"The study will be a two-site, four-arm, 6-month, parallel-group randomized controlled trial with a follow-up to 9 months."
0,"Prior to inclusion, all patients were assessed with a knee arthroscopy procedure to grade and assess the cartilage lesion area and the surrounding cartilage and to exclude other reasons for the knee symptoms."
1,VCU is the primary site with Penn State University (PSU) College of Medicine serving as the secondary site.
0,"Separate baseline, efficacy, and safety analyses will be done for the induction and maintenance phases of the study."
4,"The study will be conducted in HIV clinical sites across Australia, including general practice clinics, public hospitals and sexual health centres."
0,"At follow-up patients have a general physical exam, evaluation of current cardiac medications, echocardiography, 6-minute walk test, assessment of quality of life, blood tests, and device check according to standard of care guidelines."
16,All statistical analyses will be conducted using Stata 13 [54] according to the pre-specified plan below.
0,Study measurements were started when the physician in charge made the decision to give i.v.
16,All of the primary and secondary outcomes are measured at the individual level and therefore we will use Generalised Estimating Equations (GEEs) to allow for the clustering due to randomisation at the doctor level.
0,Thematic categories were identified in initial interviews which were then tested or explored in subsequent interviews where disconfirmatory evidence was sought [16].
8,"The planned sample size for this study was 400 participants, powered to detect differences between treatment groups in the point prevalence (7-day cigarette avoidance) at the completion of treatment (week 12)."
0,"3) A psychosocial assessment, also telephone administered, which included measures adapted for the target population [40]."
8,"Group sample sizes of 200 in each group would achieve at least 80% power to detect an absolute difference between 7-day cigarette avoidance rates of 10%, if avoidance rates are 12% and 22%, using nicotine gum and snus,9 respectively, using a two-sided Z test and significance level of 0.05."
0,Participants were randomized 1∶1 to receive either escitalopram 10 mg or placebo.
1,"This was a prospective two-arm, parallel, open randomised controlled trial with a 1:1 allocation ratio."
0,"To meet the criteria for a stable emulsion, the drop had to remain intact on the water surface for 3 minutes."
1,The protocol with full details of the study design has been published elsewhere.13
0,"Any child who experienced an episode of malaria and was treated was not considered at risk for the next 21 d, which were deducted from the child's time at risk."
3,The study includes type 2 diabetic patients with preserved kidney function (estimated GFR (eGFR)>45 mL/min/1.73 m2) and normoalbuminuria (urine albumin to creatinine ratio (UACR)<30 mg/g in two of three consecutive morning urine samples).
0,The purpose of this call was to establish a therapeutic alliance and to clarify the participants’ need for support.
3,"Participants who are eligible, according to the inclusion and exclusion criteria at the screening visit, can be included in the trial (table 1)."
0,"In the questionnaire participants rate the greatest emotions experienced during the media experience (anxiety, disgust, anger, fury, surprise, relax, happiness, sadness) on a 7-point likert scale •Slater-Usoh-Steed Presence Questionnaire (SUS, [34]): The Presence Questionnaire was used to assess the level of presence experience during media exposures."
1,"A quasi-experimental study was conducted in two public hospitals in different areas of Hong Kong, with one assigned as the ‘control’ and the other as the ‘experimental’ hospital."
0,"Pre-specified safety assessments included evaluation of clinically notable anemia, defined as new onset of grade ≥ 3 anemia in patients who were transfusion-independent at baseline, new onset of transfusion dependence in patients who were transfusion-independent at baseline, or a 50% increase in transfusions from baseline in patients who were transfusion-dependent at baseline."
1,"The two hospitals have similar paediatric specialties, settings, and medical and nursing care."
0,This method uses a voxel-wise and cluster volume joint-probability threshold to establish a cluster-wise false-positive cluster detection level.
14,The study design precluded either the mother giving birth or the nurse-midwife performing the intervention being blinded.
0,"Central Ethics Committe, agency for Medecines and Medical devices, Zagreb, Croatia."
14,"Physicians performing neonatal examinations, staff members responsible for collection of blood samples and background data, and laboratory staff performing analyses of blood samples will be blinded to each infant’s allocation group."
0,Adjuvant chemotherapy is preferably started within six to eight weeks after primary surgery and at a maximum of 12 weeks after primary resection.
16,"The Statistical Package for Social Sciences (SPSS; Chicago, IL) version 22.0 will be used for statistical analyses of the quantitative data."
0,Reading reaction time was recorded by the voice key.
16,A range of analyses are required to report the reliability and validity of the translated CARES version.
0,"Base on the manufacturer's guidelines, the test is considered: positive if Nil ≤8.0 IU/ml, TB Antigen minus Nil ≥0.35 IU/ml and ≥25% of Nil value; negative if Nil ≤8.0 IU/ml, TB Antigen minus Nil <0.35 IU/ml and Mitogen minus Nil ≥0.50 IU/ml, or if Nil ≤8.0 IU/ml, TB Antigen minus Nil ≥0.35 IU/ml and <25% of Nil value, and Mitogen minus Nil ≥0.5 0IU/ml; and indeterminate in any other cases."
3,"Between July 2002 and March 2006, 105 European patients fulfilling the classification criteria for SLE,7 aged ≥14 years, suffering from biopsy-proven proliferative WHO Class III, IV, Vc or Vd glomerulonephritis and displaying ≥500 mg/24 h proteinuria were randomised in the MAINTAIN Nephritis Trial, after having signed informed consent."
0,Seropositivity was defined as an antibody level greater than or equal to the assay threshold: 8 ELISA units (EU)/mL for HPV-16 and 7 EU/mL for HPV-18 [26].
3,"This investigator-initiated study was conducted according to the Good Clinical Practice guidelines of the European Medicines Agency, did not receive external funding, and was registered at ClinicalTrials.gov (NCT00204022)."
0,"If BP was > 160/105 mm Hg, axitinib was to be stopped and then restarted at the next lower dose when BP returned to < 150/100 mm Hg."
16,"While the study is intended to provide long-term outcomes, the performance endpoints are not statistically powered."
0,"At baseline, and after 10 and 52 months, dietary counselling was given to all patients."
16,"For purposes of this study, we provided paired comparison results for LVEF, 6MWD, and the KCCQ results at 6 months as compared to baseline, using the paired t-test."
0,Whole blood (300 μL) is installed in a fixed disposable cuvette with a rotating pin.
3,The campaign mainly targeted the general population.
0,The Northern Shanghai Study (NSS) was an ongoing community-based prospective study.
3,"Since general practitioners and paediatricians received ad hoc information on antibiotic resistance and had an active role in designing the campaign and in using brochures and posters in their surgeries, they may have been sensitised to appropriate antibiotic prescribing."
0,All patients are irradiated in a prone position on a belly board with a CT-planned three-field technique with megavoltage photons ≥ 6 MV.
8,"A sample size of 60 study participants in each CVC arm and 30 study participants in the EFV arm was proposed to provide a preliminary evaluation of the safety and efficacy of CVC, and to sufficiently detect an 18% difference in the proportion of patients with HIV-1 RNA less than 50 copies/ml at week 24 (primary end point) between groups (P = 0.05; t-test for two independent proportions; 80% power; 80% EFV rate) or −0.92 log10 copies/ml difference between each CVC group and the corresponding active control group in HIV-1 RNA (SD = 1.4, P = 0.05; 80% power; t-test with nonparametric adjustment to the normal distribution)."
0,"In the experimental group, we invited midwives who admitted women in labour to participate in the study."
8,Sample size statistics are based on Power Analysis and Sample Size 2008 software.
0,"Any adverse events (AEs) that occurred during the period from administration of the first dose (day 1) to the follow-up visit (1 week ± 3 days after the last dose of study drug intake) were reported, whether or not the event was considered to be treatment related."
17,"When we analyzed our initial cohort of patients with ALF [19], we noticed that patients with a HBV or a AIH-related ALF behaved differently from the others in terms of PR slope H0H72 (-0.02±0.07 vs 0.30±0.26, p<0.001) and mortality (76.9 vs 36.0%, p<0.001) (Bertrand Nalpas, personal communication), a result not reported in our publication [19]; this result fitted well with reports showing that HBV ALF mortality was higher than that with hepatitis A or E infections [21, 22] and other showing that as AIH related ALF respond poorly to corticosteroids so patients should be systematically placed on the list for transplantation [14]."
0,We dichotomized the responses to each question that assessed the perceived influence of the intervention and used the chi-square statistic to test for differences.
17,"Hypothesizing that it could be the same in the present prospective study we scheduled to perform a secondary analysis of ALF-5755 efficacy on the specific subgroup of patients with HBV-AIH related ALF, if possible since we could not anticipated the number of patients satisfying this condition who will be included."
0,"Thus, FDG-PET/CT scans are planned at baseline and on day 11 (+/- 2) in patients enrolled in phase II study, to validate the ability of early metabolic change to predict TRG and outcome."
6,The primary efficacy endpoint for this study was the change from baseline in weekly average of daily trough (pre-dose and pre-rescue bronchodilator) AM PEF over the 12-week treatment period.
0,"The Smoking Issues section provided 5 pages on health effects of smoking and quitting, depression, stress, secondhand smoke, and coping with the challenges of quitting smoking for the lesbian, gay, bisexual, and transgender community."
6,"Secondary efficacy endpoints were: PASAPQ scores and inhaler quickness satisfaction score at week 12, the change from baseline in weekly average of daily PM PEF, trough (AM pre-dose and pre-rescue bronchodilator) FEV1 over the 12-week treatment period, and percentage of symptom-free and rescue-free 24-hour periods during the 12-week treatment period."
0,"An ESS score ≥16 was also considered to define severe EDS in sensitivity analysis (see end of ""Statistical analyses"" paragraph)."
16,All statistical analyses were performed using a one-tailed paired T-test or one-way ANOVA with Prism software (GraphPad).
0,The incidence rates for subsequent disease were calculated with case counting starting 60 days after cervical surgery or diagnosis of vulvar or vaginal disease.
3,Patients aged ≥40 and <85 years and having elective or urgent CABG with CPB and cold blood cardioplegic arrest for CABG were eligible.
0,The Institutional Review Board at the Harvard T.H.
3,"Exclusion criteria were the following: left ventricular ejection fraction ≤30%, previous pulmonary embolism requiring warfarin for ≥3 months, previous cardiac surgery, NYHA class IV, cardiogenic shock, chronic renal failure requiring dialysis, treatment with corticosteroid or immunosuppressive drug, severe chronic obstructive pulmonary disease, lung pathology, previous radiotherapy, or body mass index >35."
0,The concentration of alkaline hematin was obtained by assay in a spectrophotometer at 546 nm with the appropriate NaOH as a blank.
3,The study included 34 patients with stroke.
0,The fatty acid composition of each lipoprotein fraction was measured as previously reported [17].
3,"The inclusion criteria were chronic unilateral stroke (>6 months poststroke), an initial Fugl-Meyer Assessment (FMA) score between 20 and 50 [33], able to perform ≥10° of wrist extension with extension of at least two fingers >0° and <10° and with thumb abduction ≥10° [34], without excessive spasticity in any of the UE joint (modified Ashworth scale ≤3), without UE fracture within 3 months or painful arthritis, and Mini-Mental State Examination score ≥22."
0,Plasma P. falciparum histidine-rich protein 2 (PfHRP2) was assessed by enzyme-linked immunosorbent assay (Cellabs) from an EDTA plasma sample on admission.
1,"This is a cross-sectional study of a random sample of people with established psychosis, recruited at baseline to the NIHR funded Improving Physical health and reducing substance use in Psychosis (IMPaCT) randomised controlled trial (RCT) [20]."
0,Serum chemistry profiles were analyzed by using standard techniques at the clinical laboratories of the University of Wisconsin Hospital and Clinics or Boston Children’s Hospital.
3,Patients were required to have measurable (RECIST version 1.0) metastatic adenocarcinoma of the pancreas.
0,Adult patients (18 years or older) with histologically confirmed low- or intermediate-grade advanced (unresectable or metastatic) pNET and radiological documentation of disease progression in the 12 months before randomization were eligible.
3,Additional eligibility criteria included a Karnofsky performance status (KPS) ≥70 and bilirubin ≤upper limit of normal.
0,Figure 1 Flow chart of randomisation groups.
1,"Patients were randomized 1:1 (stratified by KPS, presence of liver metastases, and geographic region) to receive nab-P 125 mg/m2 plus Gem 1000 mg/m2 on days 1, 8, and 15 every 28 days for 56 days or Gem alone 1000 mg/m2 on days 1, 8, 15, 22, 29, 36, and 43 every 56 days (cycle 1) and then on days 1, 8, and 15 every 28 days (cycle ≥2)."
0,"Self-reported questionnaires are filled out by the students with PFPS at baseline, 3, 6, 12 and 24 months after inclusion in the study."
1,It was a prospective randomized controlled single blinded trial conducted over a six-month period from October 2011 to March 2012.
0,Vials were single use only and did not contain preservative.
1,There was no change in protocol during the study.
0,Table 4 Visits When starting medication at baseline and when increasing the dose after two weeks a special safety measure is taken.
1,"This was the first prospective, multicenter, observational, non-interventional study in Chinese postmenopausal women [HR (+) and EBC] undergoing adjuvant treatment with AIs."
0,The result was a dataset cleaned for blink and heartbeat artifacts.
1,There was no intent to intervene in the current treatment of the recruited patients (NCT01144572).
0,"Depressive symptoms were assessed using the BDI, Version II© (BDI-II) [19], which has a range of 0 to 63, with each item rated on a 4-point Likert-type scale ranging from 0 to 3."
3,Participants included children meeting the following eligibility criteria: aged 4 to <17 years with T1D duration of at least 1 year and in good general health.
0,"Plasma glucose was clamped at 5.5 mmol with an insulin infusion rate of 40 mU m−2min−1, and whole-body insulin sensitivity was determined during the last 30 minutes of the 180-minute clamp (13)."
16,All data were expressed as a mean of values ± standard error (SE) or ± standard deviation (SD) and differences between groups were analyzed using non-parametric Mann-Withney's U test.
0,Table 2 The group were divided by UACR Pre-therapy detection
16,Differences were considered significant at p ≤ 0.05.
0,Fig 1 Schematic diagram of the intervention design and treatment outcomes.
1,We studied the inclusion process of children screened to be enrolled in the MONOD ANRS 12206 project until their confirmed inclusion with EART initiation.
0,This list will be complemented if needed and according to the circumstances on the field.
1,Eligible children were initially included in a 12-month therapeutic prospective cohort with a twice-daily EART combination (zidovudine (AZT) or abacavir (ABC))+lamivudine (3TC)+lopinavir/ritonavir (LPV/r) in addition to cotrimoxazole prophylaxis and therapeutic education (teaching the caregiver how to comply with the daily dosages and hours of treatment).
0,"Creatinine (mg/dl), urea (mg/dl), glucose (mg/dl), insulin (mU/l), C-reactive protein (mg/l), alanine aminotransferase (U/l) and potassium (mmol/l) were measured using standard laboratory techniques."
8,A formal power calculation was precluded by absence of data on the efficacy of fluvoxamine in the treatment of fatigue associated with PBC or PSC.
0,Final consensus on nonunion will be determined by the Central Adjudication Committee.
8,"In order to detect an effect similar to the expected therapeutic effect of fluvoxamine in depression (25% improvement in the placebo-group and 75% in the fluvoxamine-group), with a power of 80% and assuming a drop-out rate of 5%, it was calculated that 40 patients needed to be recruited (Stata 5.0, Stata Corporation, College Station, Texas, USA)."
0,Patients who met all eligibility criteria were enrolled and sequentially assigned an allocation number into one of the two groups.
1,Controlled before-after (CBA).
0,"Specific responsibilities of the study coordinators included (a) the verification, along with the study monitors, of the completeness and accuracy of the case report forms, (b) analysis of the data in collaboration with the investigators, (c) support of the publication and presentation of the study results, and (d) preparation of the adverse event report forms and supporting information for evaluation by a member of the Safety Monitoring Committee, composed of three expert cardiologists who did not participate in the trial and were unaware of the random patient assignment to the active vs. the control group."
3,"All the 48 participants, aged 18 to 52 years old, were free of significant medical problems and received the same clinical, psychiatric, neuropsychological, and MRI assessments."
0,Patients were followed up for 28 days after the end of treatment for monitoring of adverse events (AEs) assessment.
3,"The patients fulfilled DSM-IV-TR criteria for childhood and current ADHD diagnosed by the corresponding author and further confirmed with the semistructured Conners’ Adult ADHD Diagnostic Interview as described in the DSM-IV (Multi-Health Systems Inc.) (Conners et al., 1999) for current ADHD, and the modified adult version of the ADHD supplement of the Chinese version of the Schedule for Affective Disorders and Schizophrenia–Epidemiological Version for past and current ADHD (Ni et al., 2013a, 2013b)."
0,Those who preferred to answer the questionnaire online received an email reminder after approximately 2 weeks if they had not yet completed the online questionnaire.
16,Two-tailed Fisher’s exact test was performed to evaluate the associations of individual CNV segments and case-specific CNV loci with ASD.
0,"Following this, medical detailing visits were scheduled for a time and date convenient for each of the clinics and the visiting nephrologist."
16,Student t test was used to compare the messenger ribonucleic acid (mRNA) expression level between the two groups.
0,"To minimize the drop-out and non-response levels, participants are reminded through several channels in case questionnaires or samples are not received in time."
1,"AMPLE (NCT00929864) was a 2-year, phase IIIb, randomised, investigator-blinded study."
0,"The NHS has a duty of care to participants treated, whether or not the participant is taking part in a clinical trial, and the NHS remains liable for clinical negligence and other negligent harm to participants under its duty of care."
1,"Biologic-naïve patients with active RA and an inadequate response to MTX were randomised to 125 mg subcutaneous abatacept weekly or 40 mg adalimumab bi-weekly, both on background MTX.10 11"
0,It has been estimated that the study's inclusion period will take approximately two years.
6,Efficacy outcomes up to day 729 were assessed according to baseline anti-CCP2 IgG status and concentration quartile.
0,The time of the first organ dysfunction was retrospectively estimated according to objective data such as blood gas analysis when the patient was enrolled.
6,"Outcomes were adjusted mean change from baseline in Disease Activity Score 28 (C reactive protein; DAS28 (CRP)) and Health Assessment Questionnaire Disability Index (HAQ-DI) over time, percentage of patients achieving DAS28 (CRP) <2.6, ACR/EULAR remission rates defined by Clinical Disease Activity Index (CDAI; ≤2.8) or Simplified Disease Activity Index (SDAI; ≤3.3) criteria and ACR 50/70 response rates."
0,"Patients were randomized 1:1 to receive either atorvastatin 80 mg orally or no additional atorvastatin, along with standard clopidogrel 600 mg loading dose immediately prior to beginning of ad hoc PCI in the catheterization laboratory."
3,"Eligible subjects were aged ≥50 years with mild to moderate AD, according to National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association (NINCDS-ADRDA) criteria and Mini Mental State Examination (MMSE) scores of 16-28."
0,"At least 63% (n = 25) of the preselected and interested persons were expected to be recruited 12 weeks after discharge, and at least 80% (n = 20) of the study participants should complete the study in accordance with the trial protocol.(II)Appropriateness of assessments Assessments to investigate the efficacy of the intervention were tested at all three points in time to learn more about the instruments’ suitability for this special patient group."
3,Subjects receiving symptomatic treatment for AD were required to have been on stable doses for at least 12 weeks prior to Baseline visit.
0,"The public health system comprises a network of dispensaries, health centres and hospitals offering a varying quality of care [22]."
8,The estimated number [30] of patients required for the study was 40 (n = 20 in each group).
0,"This training session was conducted by program members in a participatory manner and included active, dynamic, small group discussions and presentations in order to enhance content absorption and to help create new classroom strategies focused on health issues [9]."
8,"The minimum difference in NRS pain evaluation between memantine and placebo groups at three months was 1.6 (standard deviation equals 1.5), estimated from published data [41, 42], with two-sided type I error α = 0.05 and β = 0.10."
0,"From a previous pilot study in 16 COPD subjects, the 1-year repeatability of IL-6 averaged 0.34±1.68 pg/mL."
1,"This was a European Union (EU) based multicentre, retrospective nested case–control comparison of individual patient data collected from electronic medical records and/or administrative databases available at the participating institutions."
0,"Positive or equivocal tests were further analysed using the Aptima CT mono-specific platform assay, which has a different target to the Aptima Combo-2."
1,"Centres using the intravesical administration of combined HA+CS, in the countries where ialuril was already registered and on the market (ialuril received a CE mark for this indication in 2009), were identified and invited to take part in the study."
0,Morbidity was recorded by using a questionnaire which evaluated general symptoms of upper and lower respiratory tract infections and gastrointestinal infections in the previous 3 or 4 days.
4,"General patient demographic characteristics, diagnosis and treatment information were collected on the basis of a predefined form designed on the input obtained from collaborating centres during a workshop held in July 2013."
0,Details about the recruitment procedure and the samples are described in detail elsewhere [28].
4,An intuitive electronic system was implemented (Advice Pharma Ltd) to record and store data on a secure remote server provider.
0,"The CAU occupational therapy sometimes included some form of group intervention, addressing for example daily living skills, social skills or creative activities, while some occupational therapists offered individual therapy only."
3,"Patients with NVAF who started dabigatran treatment from December 12, 2011 to November 30, 2013 were registered at 1042 study sites in Japan."
0,"After 6 months, we assume no more than 10% of control patients will have started a study medication."
3,"This report is based on the data from the case report forms (CRFs) collected up to September 17, 2014."
0,"As the PCT intervention arm should be non-inferior, in terms of safety (mortality), in comparison to the standard treatment, the non-inferiority margin for PCT guided antibiotic management regarding 28-day-mortality is set on 8%."
16,Descriptive statistical methods were used for analyses.
0,Written informed consent for participation in the study was signed or thumb-printed by each respondent.
16,Data are expressed as mean±standard deviation (SD) or percentage.
0,The number/symbol of each child will be sent by the computer by the registration model in CREN which is based on the distribution by learning classes.
6,"The primary objectives of this study were to compare the effectiveness of once- and twice-daily colchicine dosage regimens regarding control of disease symptoms, reducing disease severity assessed using the modified Mor scoring system [21], and laboratory findings indicative of inflammation, such as ESR, CRP, and SAA."
0,"The patients could receive fewer than the maximum of four treatment sessions for safety reasons, at the patient’s request, or because the clinician or patient judged that therapeutic success had been achieved."
6,The secondary objective of the study was to evaluate the safety and tolerability of the drug and research whether once- and twice-daily dosage schemas are clinically similar with regard to side effects.
0,Flow-cytometry analysis scatter plots to assess EPC number.
6,Primary outcomes were differences in the evolution of cytokines using the CytoSorb™ adsorber for HA during cardiopulmonary bypass.
0,The Khan Academy modules’ design and style were suggested for use in the iStart Smart for Teens modules by the pilot study’s advisory board members.
6,"Secondary outcomes were differences in LPS-induced release of TNF-α; differences in the expression of HMGB1; changes in serum CRP or procalcitonin (PCT) concentrations; differences in the need of fluid components (crystalloid and colloid solutions), blood products (erythrocytes, fresh frozen plasma, and platelets), or catecholamine treatment; and changes in BIA, length of ICU stay, and 30-day mortality."
0,"QT intervals were measured in each ECG lead from the onset of the QRS complex to the end of the T wave, defined as a return to the T-P baseline."
4,"Preoperative patient data (age, weight, height, sex, BIA, European system for cardiac operative risk evaluation [EuroSCORE], diagnosis, preoperative myocardial infarction within 24 hours [MCI], history of asthma bronchiale, chronic obstructive pulmonary disease [COPD], insulin or non-insulin-dependent diabetes mellitus [IDDM, NIDDM], history of chronic kidney disease [CKD], dialysis, left ventricular ejection fraction [LVEF], stable and unstable angina pectoris, cardial decompensation, peripheral arterial obstructive disease [PAOD], and arterial hypertension), surgery-related factors (kind of operation, duration of anaesthesia and surgery duration of CPB and aortic cross-clamp [AoCC], unplanned insertion of assist devices, amount of fluids [cristalloids or colloids], need of catecholamines [noradrenalin, dobutamin, levosimendan, vasopressin, or milrinon], and need of blood products [erythrocytes, fresh frozen plasma, or thrombocytes] or coagulation factors [fibrinogen, prothrombin complex concentrate, desmopressin, or recombinant factor VIIa]), intraoperative diuresis and postoperative data (use of catecholamines, BIA, length of stay on intensive care unit [LOS-ICU], length of mechanical ventilation, or need of extracorporeal membrane oxygenation [ECMO]) were collected by a case report form."
0,"Patients with no history of outcomes of interest prior to cohort entry were included; those with a gap of ≥24 months between cohort visits were excluded, due to uncertainty about their prednisone exposure during that period."
6,The primary outcome measure was visit attendance defined as the proportion of participants attending their follow-up visit for repeat HIV testing within two weeks of the scheduled date.
0,Only 1 digit was to be treated.
6,"Since the aim was not to measure timelines of attendance, we assumed that the effect of reminders is the same whether delivered before the appointed date or after a missed appointment, hence the outcome could be compared across in-person and phone reminders subgroups despite this asymmetry in the timing of reminders."
0,"The number of patients allocated to the different doses (close to their prescribed doses) was: 6 to instant-release tablets (IR-T) 10 mg, 3 to IR-T 20 mg, 7 to slow-release capsules (SR-C) 20 mg, and 4 to SR-C 40 mg."
6,"The primary endpoint of this study was return to the OR or ventriculostomy outside the OR due to intracranial hemorrhage, edema, or acute obstructive hydrocephalus within 48 hours."
0,Flow analysis was performed as previously described [16].
6,"Secondary endpoints were time to extubation after surgery, the rate of ordered emergency head CT scans within 48 hours postoperatively, timing of CT imaging after surgery, duration of surgery (defined as the time in minutes from skin incision to skin closure), and mortality within 30 days after elective craniotomy."
0,"This study was conducted in collaboration with Maya Health Alliance (MHA), a primary care organisation working in rural Maya communities."
8,"Using electronic data delivered from the Ministry of Health, the 30-day readmission rate for the hospital was estimated to be 13%."
0,A written informed consent form was obtained from all potential recruits at the time of inclusion.
8,We calculated that a sample size of 240 in each group would have 90% power and a significance level of 5% to detect a clinically relevant reduction of 20% in the readmission rate in the intervention group versus the control group as found in a previous Danish randomized controlled trial on follow-up intervention [21].
0,"A 4-hour fast followed study drug administration, and there was a 7-day or longer washout between treatments."
1,This study was designed as a parallel randomized controlled trial.
0,Participants were recruited by advertisement at a university campus among people who showed an interest in better understanding their every-day behaviors and well-being.
1,This trial report followed the CONSORT guidelines11.
0,"This larger dose of morphine was chosen for the perceived acuity of pain produced by an intubation; a larger dose may be more effective to decrease the struggling by infants during the procedure, which is caused by pain."
8,We calculated that 16 participants were required per group to provide 80% power (Standard Deviation of 0.36 for Rosen score) based on Vordemvenne et al.12.
0,The exercise intervention in the BETA Trial was restricted to aerobic exercise only.
8,"The sample size was calculated using Graphpad Statmate (GraphPad Software Inc., San Diego, CA, USA)."
0,"Therefore, all descriptive statistics are presented with mean ± standard deviation unless otherwise specified."
4,"The setting of the study is the Department of General, Endocrine and Transplantation Surgery within the Medical University of Gdansk, Poland."
0,"The trial protocol was approved by the Institutional Review Board of the International Vaccine Institute (IVI) in Seoul, Korea, the AHRI/All Africa Leprosy, Tuberculosis and Rehabilitation Training Center (ALERT) Ethics Review Committee (AAERC), the National Health Research Ethics Review Committee (NHRERC), and the Food, Medicine, and Healthcare Administration and Control Authority of Ethiopia (FMHACA) in Addis Ababa."
1,"Before participants were enrolled in two different dietary models (Mediterranean diet and Low fat diet) from CORDIOPREV study, they received an oral fat tolerance test using a weight-adjusted meal (0.7 g fat and 5 mg cholesterol per kg body weight) with 12 % saturated fatty acids (SFA), 10 % polyunsaturated fatty acids (PUFA), 43 % monounsaturated fatty acids (MUFA), 10 % protein and 25 % carbohydrates (CHO)."
0,The adverse outcomes of interest were defined the same as the definitions of adverse events in a large multicenter cohort study – the Thai University-Based Surgical Intensive Care Units Study (THAI-SICU study) – and standard definitions.8–10
1,"Meal preparation was performed by a group of nutritionists with olive oil, skimmed milk, white bread, cooked egg yolks and tomatoes."
0,A-Part® Gel is absorbed and undergoes renal excretion within approx.
16,"For associations of clinical and patient characteristics with paradoxical responses, we used t-tests or Mann-Whitney U tests for accordingly and Χ2 tests for categorical variables."
0,"Fig. 2 Screenshot of the tasks in V+ conditions with additional map of haptic elements: The visual environment displays sound icons (e.g., a bell or hands clapping) within sound zones (SZ), and a grey square that marks the center zone (CZ)."
16,"For testing the association of genetic mutations and variants with paradoxical responses, we used a binary logistic regression analysis with the occurrence of a paradoxical response as the dependent variable."
0,"IOP was assessed by palpation through an ophthalmologist, who had no previous knowledge about the measured GAT- and ORA-IOP."
8,"Using an estimate of SD for a log10-transformed endurance time of 0.213 s, a sample size of 75 patients per treatment group will provide a power of 80–90% to detect an improvement of 25–30% in endurance time between tiotropium+olodaterol 5/5 μg versus placebo from ESWT."
0,Household contacts were determined to be healthy by history and physical examination and had resided in the same residence as the BL/LL leprosy index case for at least 6 months duration and within 6 months of this study.
8,No sample size calculation was performed for activity variables.
0,"Health coaches also addressed barriers and potential solutions with participants, and helped them target higher goal settings or select new goals when participants attained them."
8,"We estimated that a trial among a minimum of 2266 patients would allow us to detect a 25% reduction in attendance with RTIs (20% vs 15% requires 906 per group, with completed outcomes or 2266 allowing for 20% loss to follow-up; for α=0.05 and β=0.2), and a 0.2 standardised effect size for continuous outcomes."
0,"In the OGTTs, blood samples to measure glucose, C-peptide and insulin concentrations, and urine to measure glycosuria were collected for 300 min."
1,"A cluster-controlled observer-blinded design was used in line with Medical Research Council (MRC) recommendations,21 where the intervention targets health professionals in order to study the subsequent impact on patient outcomes, protecting against contamination across trial groups where patients are managed within the same setting.22"
0,The moderator then verbally polls each panel member individually regarding whether any particular exclusion criterion is met or requires discussion or clarification and tallies the poll results.
1,"Qualitative interviews, focus groups and ethnographic methods were used to investigate staff experiences and transfer of training to the workplace."
0,All children were instructed to wear the monitor continuously during the day.
4,"Data collection tools consisted of six questionnaires including (1) demographic variables, (2) the FCEM, (3) the 36-Item Short Form Health Survey (SF-36), (4) the perceived stress, and (5) State and (6) Trait Anxiety questionnaires."
0,Platelet immunostaining was performed in a manner designed to minimize sample manipulation and artefactual ex vivo activation.
4,"In addition to questionnaires, results of serum creatinine, ejection fraction as measured on echocardiography, and cardiac catheterisation and stenting were also recorded."
0,Results yielding a p-value less than 0.05 were deemed statistically significant.
3,"At DCCT baseline, the 13- to 39-year-old study cohort included a primary prevention cohort with 1–5 years’ diabetes duration, no retinopathy based on 7-field stereoscopic fundus photography, and <40 mg/24 h of albuminuria."
0,The design and conduct of the study complied with good clinical practice in accordance with the Declaration of Helsinki and all local requirements.
3,"The secondary intervention cohort had 1–15 years’ duration, minimal to moderate nonproliferative retinopathy, and <200 mg/24 h of albuminuria (9)."
0,"The comprehensive model integrated all components of the interdisciplinary care model with an enhanced rehabilitative program, fall prevention, nutrition consultation, and management of depression."
1,The analyses presented in this paper are cross-sectional comparisons of 71 older adults enrolled in a six-month proof-of-concept single-blinded randomized trial of exercise.
0,"The cUTI microbiologic modified intention-to-treat population included all randomly assigned patients with cUTI with ≥1 dose of study drug and ≥1 uropathogen at baseline, regardless of susceptibility to study drug."
1,"All participants had mild cognitive impairment primarily due to vascular burden in the brain (i.e., mild vascular cognitive impairment)[26]."
0,"Insulin was assayed using a commercial 125I labeling radioimmunoassay (Human insulin RIA kit, Linco Research, Inc."
16,"Statistical analyses were performed using the Spearman correlation and Mann–Whitney U test as appropriate for the data with Prism 5.0 (GraphPad software Inc., SD, California) or R 3.1.2 (http://www.r-project.org)."
0,"All patients are put on osteoporosis medication, such as bisphosphonates together with supplemental calcium and vitamin D."
16,Statistical significance was set at P < 0.05.
0,"Charles, MO) concentrations were transferred to the laboratory at room temperature, centrifuged, and serum was stored at −80°C until run in a single batch at the end of the trial."
1,"We conducted an open, randomised controlled study from August 2011 to September 2012 at the Singapore General Hospital on patients receiving the transitional care programme versus patients receiving the usual care."
0,"The primary efficacy (immunogenicity) end points following vaccination were the proportion of subjects who achieved seroconversion, defined as a pre-vaccination (day 0) hemagglutination inhibition (HI) antibody titer of less than 1:10 with a post-vaccination titer of > 1:40 at day 28 (case 1) or a pre-vaccination (day 0) titer of > 1:10 with a ≥ 4-fold increase in antibody titer at day 28 (case 2), and the proportion of subjects who achieved seroprotection, defined as an HI antibody titer of > 1:40 at day 28 following vaccination."
1,Consented patients were randomised in blocks of six and allocated in a 1:1 ratio to either the transitional care intervention or the control group.
0,These endurance capacity tests were conducted until task failure.
1,"PROACT‐4 was a prospective, open‐label, blinded‐endpoint (PROBE) randomized, clinical trial."
0,"Of the 4927 patients who completed the baseline measurement, 317 intervention patients and 293 control patients were excluded because they already met the minimum recommended levels of physical activity, as confirmed in the baseline physical activity assessment performed by research nurses."
1,Patients were randomized in the prehospital setting 1:1 into POC‐Troponin or usual care (UC) groups.
0,"In brief, non psychotic MDD (DSM-IV criteria) patients with age between 18 and 75 years were enrolled from primary care or psychiatric outpatient clinics and a current 17-item Hamilton Depression Rating score of ≥14 by independent raters was obtained."
14,"Patients, EMS personnel and physicians treating the patient were aware of the allocated arm; however, outcome assessors, the adjudication committee, and data analysts were blinded to the allocation."
0,The arrows show 12 cases reclassified as controls and 6 controls reclassified as cases during the interview.
4,ReLApsE is an investigator initiated trial designed and carried out by the German-Speaking Myeloma Multicenter Group (GMMG).
0,"The fiber bundles were gently placed into the respirometer chambers (Oxygraph-2K; OROBOROS Instruments), and after a stable baseline was reached, two assay protocols were run in duplicate at 37°C and between 230–150 nmol/mL O2 in buffer Z with blebbistatin (25 μmol/L) (Supplementary Fig. 1)."
4,"The trial setting is multicentric with 16 participating study sites located in Germany: Helios Hospital Berlin-Buch; Charité Campus Benjamin Franklin, Berlin; Community Hospital Bielefeld; University Hospital Bonn; Klinikum Chemnitz GmbH; University Hospital Düsseldorf; University Hospital Essen; Evangelisches Krankenhaus Essen-Werden gGmbH; Goethe University, Frankfurt; Katholisches Krankenhaus Hagen gGmbH; Asklepios Klinik Altona, Hamburg; Heidelberg University Hospital (trial sponsor); University Hospital Cologne; University Hospital Mannheim; Maria-Hilf-Krankenhaus Mönchengladbach; University Hospital Tübingen."
0,"Safety was assessed by monitoring AEs during the trial (from initiation of study treatment until at least 28 days after the last dose of OTSGC-A24), by clinical laboratory tests, recording vital signs, 12-lead electrocardiography, and performance status."
4,"Participants were recruited from the Mbarara Regional Referral Hospital (MRRH) in southwestern Uganda, which cares for ∼10 000 HIV-positive individuals."
0,All subjects performed the two tests with a rest period of 14 days in-between (Figure 1).
4,The region is largely rural and approximately one-quarter of homes have electricity.
0,Malaria was defined as the presence of fever and a positive blood smear microscopy result.
1,TARDIS is an international collaborative multicenter parallel‐group prospective randomized open‐label blinded‐end‐point phase III controlled trial.
0,"To assess the impact of fingolimod treatment on disease activity over time, an exploratory analysis, using a model similar to that developed by Rio et al,4 was performed."
4,"In May 2013, we placed advertisements in four community newspapers and sent emails to relevant groups (e.g., health professional associations) and placed posters in the local neighborhood library and community center."
0,Table 1 Resources and unit costs used for cost calculation Unit costs
3,"For inclusion in this study, patients must fulfill the following requirements preoperatively1: pathologically proven adenocarcinoma2; primary tumor located at the rectum up to 12 cm above anal verge (all enrolled patients were confirmed to this item after rigid proctosigmoidoscopy before nCRT)3; fecal continence maintained well before nCRT4; long-course nCRT (1.8 Gy/day, 5 fractions per week, and a total dose of 50.4 Gy/28 fractions + 2 cycles of concurrent chemotherapy with radiotherapy [5-fluorouracil {5-FU}, 400 mg/m2 (i.v.) 1 hour before radiotherapy and leucovorin, 20 mg/m2 (i.v.) immediately before each dose of 5-FU on days 1–5 and days 29–33])5; temporary stoma during SPS at 6 to 10 weeks after nCRT6; adequate organ functions7; and written informed consent."
0,"The Stages of Implementation Completion (SIC) [10] measure was developed to evaluate completion, speed, and quality of implementation progress in both the CDT and IND conditions."
3,"Exclusion criteria are as follows: fecal incontinence before nCRT2; previous diverting stoma before SPS due to obstructive lesion, bleeding, fistula, and so on3; active infectious disease requiring systemic therapy4; and pregnant women."
0,"For Western blotting the following secondary antibodies were used: anti-mouse IgG1-HRP conjugate (Santa Cruz Biotechnology, Dallas, TX); ECL rabbit IgG-HRP linked whole antibody (from donkey; GE Healthcare Life Sciences, Piscataway, NJ)."
6,"A detailed description has been published elsewhere regarding how the clinical data, drugs therapy, anthropometric measurements, and analytical parameters were obtained from patients [18]."
0,"In addition, the study was registered at www.clinicaltrials.gov (ID no."
3,"Patients were eligible for enrollment if they were aged 50–88 years with a diagnosis of probable AD and had an MMSE score of 16–26, inclusive, and a screening MRI scan consistent with AD."
0,The family and outside clinician were notified if the adolescent’s depressive symptoms increased.
3,Inclusion and exclusion criteria were similar to those used in the 301/302 studies [3] and are listed in Additional file 2.
0,"BSIFs are invasive, and therefore, the use of IDIFs was investigated."
5,Both groups will attend an initial 60-min session comprising the following content: CPGs—what they are and where to find them; information on and presentation of the GuiaSalud website and a link to the guidelines library; and instructions for downloading guidelines.
0,The vital statistics and information on emigration was obtained from the Population Register Centre.
4,"As planned in the ESCAPE protocol, at the end of each of the five consultations per patient dedicated to cardiovascular prevention, GPs in the intervention group were asked to write in the case report form the answer to the following open-ended question:If the therapeutic targets recommended in the guidelines for this patient were not reached (blood pressure, LDL-cholesterol, HbA1c, and low-dose aspirin for diabetic patients) and you did not change the medication, could you tell us why?"
0,Neurological status at discharge was assessed by review of the medical records and was classified by degree of reported disability and discharge destination.
4,This led to the collection of up to five responses per patient.
0,"The current clinical trial includes preventative measures to increase safety, such as pre-inclusion evaluation and clearance by the personal physician, educational content on the website about the proper shoes and socks to wear, and weather-related recommendations."
6,The primary outcome for this trial was the change in antibody titre from baseline pre-vaccination to one month post-vaccination at the individual level.
0,A poster summarizing the study protocol was visible at all times on every unit.
6,"Secondary outcome measures were cytokine and steroid hormone levels, as potential underlying mechanisms of any effect of time of day and/or gender on vaccination response."
0,"Scores range from 0 (unable to complete 5 chair rises within 60 s) to 4 (able to complete 5 chair rises in ≤11.1 s) [15, 16]."
1,The NEUROS study is a prospective two-arm randomized controlled multicenter clinical trial with a follow-up period of 12 months per patient.
0,Videos from 5 different sites (at least 10 sec/site) were recorded at both time points with adequate focus and contrast and every effort was made to avoid movement and pressure artefacts.
3,Patients undergoing TME for rectal cancer presenting at one of the participating hospitals.
0,"The CNI is a deprivation index based on sociodemographic factors, including percentage of older adults living alone, children under age 5, unemployed people, people with low educational status, single parents, high mobility and foreign-born people."
3,Histologically confirmed rectal cancer (≤ 16 cm from anal verge) Suitable for radical surgery TME Age 18-90 years Informed consent Exclusion criteria
0,"EMG electrodes are attached over the paraspinal muscles of the participant bilaterally at the L3 level and connected to an EMG amplifier (Delsys, Inc."
8,"Based on CSF determinations of Aβ1–42, Aβ1–40, and Aβ1–38 with a similar enzyme-linked immunosorbent assay (ELISA) method (Janssen, unpublished data), the CV of percentage change from baseline was estimated to be ~13 %."
0,These competitive training grants are awarded to trainees who are researching an area of heart failure and are collaborating with/mentored by another team member.
8,A sample size of five completers per group was expected to produce two-sided 95 % confidence intervals with 16 % precision compared with natural fluctuation of around 15 % in the reference study (ClinicalTrials.gov NCT01556217) and was considered reasonable for precise estimation of mean.
0,"Traditionally, FHR is routinely monitored by the attending midwife using a Pinard fetoscope."
16,Patients with >42 days between the pre- and post-vaccination sample dates were excluded from all analyses.
0,"HRQoL outcomes were assessed using version 4 of the FACT-P instrument completed before randomization, and at weeks 13, 17, 21, and 25, and every 12 weeks thereafter while the patient remained on the study treatment [6]."
16,"A logistic regression model (odds ratios [OR] and 95 % confidence intervals [CIs]) was performed to evaluate the relationship of baseline factors (i.e. protective antibody level, MTX dose, concomitant steroid use, and age) to the primary endpoint and the proportion of patients achieving protective antibody levels (concomitant steroid use only)."
0,BM will be aspirated from the posterior iliac crest of all patients under general anesthesia during the renal transplantation.
1,We performed a multicenter prospective controlled cluster-randomized trial in community and academic hospitals.
0,All dairy products needed to control dairy and calcium intakes were provided to participants in the APMD and HPHD groups and were generously donated by Agropur Dairy Cooperative (Table 1).
3,We prospectively enrolled all consecutive patients over 40 years old presenting to the emergency department of the participating sites for acute medical illness and requiring hospitalization in a medical ward.
0,"Fig. 1 The RAPAEL Smart Glove™ system and the task-specific games of this system The training games in the SG system are categorized according to the intended movements as follows: forearm pronation/supination, wrist flexion/extension in the vertical plane, wrist flexion/extension in the horizontal plane with gravity eliminated, wrist radial/ulnar deviation in the vertical plane, wrist radial/ulnar deviation in the horizontal plane with gravity eliminated, finger flexion/extension, and complex movements."
3,"Patients were excluded from analysis if they were hospitalized for less than 48 hours, if venous thrombosis or pulmonary embolism was diagnosed within 48 hours following admission (in order to rule out any VTE that had occurred before hospital admission), and if they received anticoagulant treatment at a therapeutic dosage for another reason than acute VTE at the admission and/or during hospitalization."
0,The tumor bed was identified by the metallic clips positioned at the time of surgery.
8,"With the study design assuming 30 participating centers divided into two groups of 15, an intra-cluster correlation of 0.01, a 5% combined rate of VTE or major bleedings in the control group, a total of 16,170 patients with 8,085 in each group were required to detect a 1.5 percentage absolute difference between the two groups, with 3.5% in the intervention group, at a power of 80% and significance level of 5%.[13] Considering that approximately 15% of patients would be hospitalized for less than 48 hours and 5% would be lost to follow-up, we planned to enroll a total of 20,000 patients."
0,Symmetry lines were drawn manually to separate the hemispheres.
4,Data were collected from all participants using standard CRFs (case report forms) and interviewer-administered questionnaires.
0,"Overall, two dose reductions for toxicities were allowed; if dose reduction was required for the third time, the treatment was discontinued."
4,"The 2 arms were compared in regards to the following parameters: Procedure operative time (device placement through device removal for the PrePex arm) or first cut to last suture for the surgical arm, including administration of anaesthesia; preparation time; pain and or discomfort at key time points pre-, during, and post-procedure assessed by the Visual Analogue Scale (VAS); clinical AE rates, defined as: site bleeding, penis-diffused hematoma, penis-diffused edema, incision site infection; device-related AE rates defined as: necrotic process did not initiate, device did not remain in situ for the full 7 days (mild events considered common to any MC procedure were not counted as AEs, whereas the AE totals include events graded as moderate or severe events in keeping with the PrePex MC Classification of Adverse Events and Device Hazards, Version 01, Dated Jan 18 2012); participant and partner satisfaction (the healing process, no complaint of pain, husband/partner involvement in routine activities of daily living during the healing period) based on a 5-point scale ranging from ‘not at all satisfied’ to ‘extremely satisfied’; time to complete healing based on treating physician’s objective wound status evaluation by scores of different wound parameters, such as exudate/tissue type; difficulties and complications during procedure based on operator reports; and cost of procedure based on cost-analyses related to training, personnel, time, infrastructure, tools, and materials."
0,"Comparison between studies is difficult, due to variations in dosages, treatment protocols, evaluation methods, injection technique (single versus multiple sites), rating scales, and definitions of improvements."
14,Participant teams could not be blinded to receipt of an intervention.
0,"Blood samples were collected early morning after an overnight fast using heparin, serum and EDTA tubes (Greiner Bio-One, Kremsmunster, Austria)."
14,"Data collection was blinded and used a standard electronic system that extracted data from the general practice electronic health records and, to minimise bias, all data were collected using full anonymisation using electronic data extraction queries suitable for the different types of general practice computer systems used in England [25]."
0,"Seven to fourteen days later after a second randomization and another baseline QST, in the first study arm of the second study block capsaicin was applied for 15 min and then the lidocaine/prilocaine plaster was applied for 60 min (as described above, Cap/LA-group)."
1,"A controlled trial will be conducted involving a random assignment of clusters (patients registered with the same primary care physician) to two study groups: a) control group undergoing usual care; and b) treatment group, where participants will undergo a program for the integrated management of chronic pain and depression (Fig. 1)."
0,Students logged on using only their student IDs.
3,"Patients were men and postmenopausal or surgically sterile women 18–80 years of age with gout according to preliminary criteria for the classification of the acute arthritis of primary gout,16 inadequate urate-lowering response (sUA ≥6 mg/dL on ≥2 occasions ≥2 weeks apart) to allopurinol monotherapy 200–600 mg daily for ≥6 weeks and sUA ≥6 mg/dL at screening."
0,"Second, the test sample displayed a significantly higher number of IFN-γ positive CD8+ CD3+ cells than the negative control by the Chi-square test, provided that the number of IFN-γ positive CD8+ CD3+ cells in the test sample was at least twice that in the negative control and the difference of these two numbers was at least 0.1% of the total CD8+ CD3+ population."
3,"Main exclusion criteria were history of documented or suspected kidney stones; active liver disease or clinically significant hepatic dysfunction; history of cardiac abnormalities; long-term use of salicylates >100 mg daily, thiazide diuretics (except ≤25 mg hydrochlorothiazide), losartan, azathioprine, mercaptopurine, theophylline, intravenous colchicine, ciclosporin, cyclophosphamide, pyrazinamide, sulfamethoxazole or trimethoprim; uncontrolled hypertension; serum creatinine (Cr) >1.5 mg/dL or creatinine clearance (CrCl) <60 mL/min by Cockcroft–Gault formula using actual body weight (during the study, this protocol was amended to use ideal body weight) and body mass index >48 kg/m2."
0,We use the Trimbos and iMTA questionnaire on Costs associated with Psychiatric illness (TiC-P) [68] to collect data on direct and indirect costs from the patients.
1,A prospective observational study was carried out in the primary care setting with a follow-up of 4 years.
0,"Cox proportional hazards regression was used to estimate anticipated improvement in the hazard ratio [HR] for successful vasectomy for the fascial interposition group versus the non-fascial interposition group, controlling for age and for surgeon experience (three surgeon groups based on prior experience with fascial interposition)."
1,This study analysed 112 participants who were included in the LOD-DIABETES study (NCT01065155).15
0,"All patients received albuterol/salbutamol, to be used as needed throughout the run-in and treatment periods; no other asthma medications were permitted."
3,Male and female adult patients (smokers and non-smokers) with a GINA-compliant diagnosis of asthma for at least 6 months and treated with the same anti-asthmatic drugs in the last 4 weeks before enrolment were eligible for study participation.
0,"EGFL7 Recombinant Protein, Novus H00051162-P01 4 μl and Dako Flex buffer K8007 200 μl were used along with 1 μl of the anti-EGFL7 antibody in a 1 : 200 dilution."
3,Patients suffering from critical conditions and illnesses that might have interfered (according to the doctors’ judgment) with the study purposes were excluded.
0,"Spearman rank correlations coefficients (rho) were calculated between these instruments and the following clinical variables: age, volume voided per micturition (mL/24 h), daily incontinence episodes, daily urgency episodes, daily micturition episodes, daily incontinence urgency episodes, number of daily nocturia episodes and weekly incontinence episodes."
3,"Eligible subjects were aged at least 18 years, fulfilled the College of Rheumatology/European League Against Rheumatism classification criteria for SSc [2], had at least moderate skin thickening (modified Rodnan skin score [MRSS] [27] ≥2) in at least one area suitable for a repeat skin biopsy, had B cell counts in peripheral blood of ≥50 % LLN at screening, had forced vital capacity (FVC) of ≥55 % predicted and diffusing capacity for carbon monoxide (DLco) of ≥40 % predicted."
0,The institutional review board of each participating center approved the treatment protocol before the initiation of enrollment.
3,"Subjects were not eligible if they had pulmonary hypertension requiring treatment, scleroderma renal crisis within the previous year, significant malabsorption, Herpes zoster infection in the previous 3 months, a history of severe viral infection, active hepatitis or human immunodeficiency virus (HIV) infection, or evidence of active or latent tuberculosis without appropriate treatment."
0,Cells were then suspended in PBS with 10% DMSO (Sigma-Aldrich) and cryopreserved at -80°C.
1,"The study design involved repeated baseline and intervention phases, with each of eight consecutive periods lasting two weeks: A: Baseline: standard 300 ml glass used B: Larger 370 ml glass replaced standard glass A: Standard 300 ml glass used C: Smaller 250 ml glass replaced standard glass B: Larger glass A: Standard glass C: Smaller glass A: Standard glass The primary outcome was the daily volume of wine (ml) purchased in ‘Larger glass’ and ‘Smaller glass’ intervention periods compared to baseline (all ‘A’ periods)."
0,The operating surgeon for tracheostomy determined the size of the tracheostomy tube.
6,The primary outcome was a significant transfusion within the first post-traumatic 48 h defined by a transfusion of at least six RBC units.
0,The test consists of four series of matrices.
6,The secondary outcomes were: 1) blood lactate concentration to determine the agreement with the POC capillary lactate measurement; 2) a significant transfusion defined by at least four RBC units within the first 48 h; 3) the allocation of transfusion according to abnormal (≥3.5 mmol/l) or normal (< 3.5 mmol/l) capillary lactate concentration on admission.
0,The minimal detection concentration was 0.5 pmol l-1.
4,"Baseline medical information (clinical status, cardiac, respiratory, and orthopedic data) was collected at the first visit and any notable recent medical issue was documented at follow-up."
0,"Consistent with the logic model (Figure 1), the evaluative approach will focus both on the implementation of the intervention and the measurement of its effects by using a mixed methods design [46] to evaluate health interventions [47]."
4,"Magneto-inertial data were analyzed using specific software developed by Sysnav Company using MatLab® (R2009b, The MathWorks, Natick, MA)."
0,"Total mRNA was subjected to qRT-PCR using 2× PCR master mix (Super Array, Valencia, CA, USA) and the ABI PRISM7900 system (Applied Biosystems, Foster City, CA, USA)."
1,A 2 × 2 factorial randomized controlled prevention trial will be conducted to compare two nutritional strategies: a multi-nutrient supplement and a food-related behavioral change (FBC) intervention.
0,"The CSI-SF is chosen because it contains 16-items, is quick and has been shown to be reliable for measuring coping strategies [64]."
1,A total of four intervention groups will be created: (1) placebo supplement group; (2) placebo supplement + FBC group; (3) multi-nutrient supplementation group; (4) multi-nutrient supplementation + FBC group.
0,The Chinese government uses in-hospital death or withdrawal from the treatment as a composite quality measure for hospitals.[16] Statistical analysis
16,PATENT-1 and CHEST-1 were not designed to show statistically significant differences in subgroup populations; the subgroup data presented here were therefore analysed descriptively.
0,"Over half (67.79%) report some to a lot of difficulty paying for basics, and have an average of 6.6 health conditions with more than a third having diabetes (42.8%), high blood pressure (78.8%), high cholesterol (58.2%), and arthritis (76.4%)."
16,The incidence of VTE was summarized using descriptive statistics.
0,"However, a correction factor embedded on a population level did not allow us to differentiate between differences resulting from the analytical quantification assay method and the biological matrix (for HPLC-UV, the lumefantrine venous and capillary matrix as well as the desbutyl-lumefantrine venous matrix; for LC-MS/MS, the desbutyl-lumefantrine capillary matrix) (13)."
16,Treatment comparisons were made using the χ2 test and the 95 % confidence interval was calculated.
0,Improvement in mood and quality of life at the end of the program will be measured using standardized instruments that are described in detail in the protocol.
6,"The primary endpoint of this study was the occurrence of post-operative symptomatic lymphocele, which was defined as the absence of aspiration or a unique or iterative aspiration global volume of lymphocele ≤ 60 cc in the 28 days after the intervention or a systematic aspiration volume ≤ 120 cc on the 28th day."
0,"VO2peak was assessed during both IWTF procedures using indirect calorimetry (Cosmed K4b2, Cosmed, Italy) as indirect calorimetry is considered the gold standard in assessing VO2 in a clinical setting [15]."
6,"Secondary endpoints were the total quantity of lymph drained up to the time of drain removal, duration of drainage, daily drainage volume, aspirated volumes of lymph, local healing, infections, fever, length of hospital stay and length of time to onset of adjuvant chemotherapy."
0,The ultimate objective of the national strategy is to reduce stunted growth among children <2 y old from 45% to 30% nationally.
3,"Inclusion criteria comprised the following: patients treated in primary care with a diagnosis of diabetes (International Classification of Diseases 10th edition codes; E10, E11, E13, E14) and receiving treatment with liraglutide [Anatomical Therapeutic Chemical (ATC)-code A10BX07] or sitagliptin (ATC-code A10BH01) who were judged to have T2D, age ≥18 years, treatment with liraglutide or sitagliptin started between January 2010 and December 2013 (date of first prescription purchase = index date), a minimum of 180 days’ history within the database before their index date, and at least one HbA1c and body-weight measurement after 180 days’ therapy (defined as 180 days −60/+180 days, always choosing the observation closest to 180 days)."
0,Probes with less than three beads for methylated or unmethylated channel or with detection P > 0.01 were set to missing.
3,Exclusion criteria comprised the following: current or previous cancer; end-stage liver disease; end-stage renal failure; history of gestational diabetes; or previous GLP-1RA or DPP-4i use other than described in the inclusion criteria.
0,"Blood was centrifuged at 3,000 rpm for 15 minutes, and urine at 2,000 rpm for 5 minutes."
3,"Eligible study patients at screening were previously diagnosed with T2D, at least 18 years of age, presenting with T2D to a study site as part of normal medical care, and receiving any commercially available initial insulin therapy for at least 3 months, with or without any combination of approved noninsulin anti-hyperglycemic agents (AHAs) (e.g., metformin)."
0,Fasting glucose and lipids were measured as previously described [42].
3,Patients were considered ineligible if they were receiving intensive basal-bolus therapy or had initiated insulin at a dose of three injections of mixed insulin.
0,"The method also includes calibration in 6 points.[18] IL-6 was determined using ELISA method (Quantikine, R and D, Minneapolis, USA)."
6,The primary endpoint of our study was the successful eradication of H pylori.
0,"Although increasing the volume of injectate above 50 μL would likely contribute to tissue destruction, it might also lead to sporozoites being trapped within the injectate and unable to be distributed systemically."
6,We also conducted additional analyses on adverse events during the therapies.
0,"Supplementary to the standard Chair Rise Test (CRT) on stable surfaces, test trials were also recorded while standing on a foam pad (AIREX©)."
3,Men who were 50–75 years old and diagnosed with prostate cancer were eligible if they were scheduled to undergo laparoscopic radical prostatectomy.
0,"Briefly, this equation was developed using second trimester fetal biometry measurements from a single ultrasound examination among women with certain LMP dates in the INTERGROWTH-21st project."
3,"Exclusion criteria included any history of abdominal or pelvic surgery, hypersensitivity or an allergic reaction to the study material, pelvic lymph node dissection at the same time as prostatectomy, the presence of surgical site infection or contamination, a history of a medical disease causing bowel adhesion, or a history of severe drug allergies."
0,A key feature of pragmatic trials is that the participants reflect the population for which the treatment is intended.
1,Feasibility and economic evaluations are part of an ongoing open-labeled noninferiority randomized clinical trial (Clinicaltrial.gov id.
0,Lab technicians assessed malaria and HIV infection status with rapid tests.
1,"In this trial, specialist telemedicine visits versus traditional specialist visits for headache sufferers were compared."
0,"In the cases in which PEEP exceeded 5 cm H2O, it was gradually decreased by 2 cm H2O every 6 hours until a value of 5 cm H2O was reached."
3,"A convenience sample of obese patients (defined as a body mass index (BMI) of >30 kg/m2), with or without chronic ventilatory failure, was recruited following referral to the sleep and ventilation unit, or during assessment for possible bariatric surgery."
0,The data collectors placed at each of the study’s healthcare facilities will obtain written informed consent from all participants at enrolment into the study.
3,"Exclusion criteria included: being currently on any drug that might potentially stimulate/depress respiration, a diuretic or a theophylline; being diagnosed with obstructive lung disease (defined as an FEV1/FVC ratio <70%); or the presence of other severe comorbidities, for example, congestive cardiac failure, primary central nervous system or neuromuscular diseases, and untreated hypothyroidism; or being currently on treatment with continuous positive airways pressure (CPAP) or non- invasive ventilation."
0,"The exercise prescription in both groups was consistent with the recommendations of the ACMS [15], with 45 min bouts at 2 times a week for 16 weeks."
1,"A Phase I, randomized, double-blind, dose-escalation study was conducted at Saint Louis University (SLU), following Declaration of Helsinki principles and approved by SLU and Aeras Institutional Review Boards."
0,"Upon enrolment at the initial dental visit, the children were assigned to dental students in the undergraduate or graduate pediatric clinic for their required clinical care."
3,"After giving written informed consent, 24 HIV-negative, BCG-naïve, mycobacteria-naïve, 18–40 year old healthy subjects were sequentially assigned to study groups."
0,"This technique consists on applying alternating electric currents of 800 μA at 50 kHz with the aid of Ag/AgCl source and sensor electrodes to obtain R, Xc, and phase angle (i.e., the arc tangent of the ratio of reactance to resistance transformed to degrees)."
1,"This study was a randomized, double-blind, placebo-controlled, parallel-group, clinical trial."
0,"In order to measure the progression of the different parameters collected during the three visits (mobility, amyotrophy, deformation, effusion, and pain on palpation), we will conduct a longitudinal analysis of the data in two stages by ANOVA for repeated data followed by a post-hoc Tukey-Kramer test and using mixed models (or random effects models) [19] that will allow the measurement of the intrasubject correlation by taking into account the effects of the subject and time (‘random intercept’ and ‘slope’ effects)."
1,Subjects and all study staffs were blinded to treatment group assignments.
0,The IWQOL-Lite is used to assess obesity-specific HRQL [23].
1,"As presented elsewhere [16], OTEMTO® 1 (1237.25; NCT01964352) and 2 (1237.26; NCT02006732) were two replicate, double-blind, placebo-controlled studies."
0,A detailed report regarding the safety outcome of the studies will be published after completion of the studies.
1,"Patients were randomised to one of four treatment arms to receive once-daily tiotropium + olodaterol 2.5/5 μg, tiotropium + olodaterol 5/5 μg, tiotropium 5 μg or placebo, all delivered via the Respimat® inhaler."
0,"In non-geriatric populations (≤65 years), such as our study sample, the threshold that suggests a “probable case” of cognitive impairment when the score is less than 27 points."
3,"Patients of any cancer entity meeting the following inclusion criteria were eligible to participate in the study: receiving out-patient therapy (acute or maintenance therapy) or finished this therapy not longer than 6 months ago, being ≥ 18 years, being below the current guidelines to be moderate active at least for 150 min per week, and being able to follow the study instructions."
0,The cut-offs for advanced fibrosis (F3 = numerous septa without cirrhosis) and cirrhosis (F4) were ≥9.5 kPa and ≥12.5 kPa respectively.
3,"Exclusion criteria were: planned rehabilitation or inpatient treatment during the next 8 weeks, wound healing not completed, bone metastases, and serious comorbidities or comorbidity-related limitations."
0,The primary efficacy end point was changes in serum phosphorus levels from baseline to the end of the chewing period.
16,Analysis of pre-treatment and post-treatment biomarker analytes was performed using paired student-t tests.
0,"However, some clarifications for the procedure were made concerning which person would be best suited to inform the families about the study and to ask for informed consent."
1,"We performed a meta-GWAS of skin intrinsic fluorescence (SIF) on directly genotyped and imputed single nucleotide polymorphisms (SNPs) from individuals with T1D of European ancestry from two studies, DCCT/EDIC and WESDR."
0,"DNA extraction from fresh frozen tissue and formalin-fixed, paraffin-embedded specimens was carried out using the DNeasy Blood and Tissue Kit (Qiagen, Manchester, UK) according to the manufacturer's instructions."
1,"Then, association of the identified locus with SF was investigated in two other studies, LonGenity and LifeLines, including mainly ND subjects with a subset of subjects with T2D (Table 1, Supplementary Table 1, and Supplementary Fig. 1)."
0,The cut off arbitrary limit was defined as at least 30% reduction of myoma volume as indicator for good response.
8,"Br2 (http://www.utstat.toronto.edu/sun/Software/BR2/), which implements a bootstrap-based bias-reduction method to correct for the effect of the winner’s curse in GWAS (29), was used to calculate bias-reduced effect sizes for the SNP identified to be associated with SIF1 in DCCT/EDIC (threshold for significance was 1E-5 for suggestive association)."
0,"Visits at 18 months were analysed for those patients who had completed all the follow-up forms, while the mixed-linear model also included incomplete responders."
8,"Subsequently, the corrected β for the identified SNP was used to estimate the required sample size to detect the effect of the identified locus among T2D and ND subjects assuming that the SNP effect is similar to its effect in T1D subjects, using QUANTO, version 1.2.4 (http://biostats.usc.edu/Quanto.html)."
0,"Samples were analyzed at an external laboratory (Pharmaceutical Product Development, LLC, Richmond, Virginia, USA)."
1,This study is a prospective study nested within the Newhints cluster-randomised controlled trial.
0,"In Poland, children received a single dose of hepatitis B vaccine at birth, according to national recommendations."
6,Two main indicators were used to measure newborn access to care: referral compliance defined as the percentage of families who took their babies to health facilities after CBSV referrals and overall care seeking defined as the percentage of newborns taken to a hospital/clinic among those reported by the mother in the first surveillance visit (usually up to 56 days) after birth as having had severe illness.
0,Estimates of the malaria burden in the absence of vaccination and the potential impact of vaccination were made for 42 countries in sub-Saharan Africa.
1,"A cross-sectional health facility assessment was conducted to study health worker competence in emergency obstetric care, and linked to population-based surveillance data on place of birth."
0,"If diagnoses of trauma or accident were present for the same hospital admission, the ICH event was classified as traumatic."
8,"To detect a reduction in infarct size from 20 to 15% of LV mass, assuming a standard deviation of 10%,18–22α of 0.05 and two tailed, with 80% power, a total of 192 patients were required."
0,Items were summed to create a total self-efficacy score (range 9 to 90).
8,Allowing for a drop-out rate of 20% between PPCI and CMR resulted in a final sample size requirement of 240 patients.
0,Individuals who reported that they have diabetes did not have an OGTT and were classified as known T2DM.
16,The difference in day 15 steady-state everolimus exposure (AUC0–24 and Ctrough) between patients with and without dose reductions was tested with an unpaired t test.
0,Both interviewers had a strong background in the use of qualitative methods and were trained to use specific interview procedures for this study; both were unfamiliar with any members of the ED staff.
16,The relationships between day 15 everolimus exposure (AUC0–24 and Ctrough) and stomatitis and pneumonitis were evaluated using a four-level ordered logistic regression in SPSS version 20.0 (IBM).
0,"Accordingly, the fees for some services varied for each woman in the trial and were applied individually at the record level."
1,"This single site, randomised, open label, parallel arm, phase 1b trial was conducted at City of Comprehensive Cancer Center (COH), Duarte, CA, USA."
0,"The mother-infant pairs were scheduled to be interviewed at 3, 6, 12 and 24 weeks after birth, with an additional follow-up interview between 18 and 24 months of age."
1,"The study was approved by the local institutional review board (IRB 12022), and the Food and Drug Administration (FDA, investigational new drug BB-13124, held by COH) before initiation of enrollment."
0,The limits of agreement in the Bland-Altman figures were defined at a distance from the mean of 1.96 times the standard deviation of the differences.
3,"We screened healthy, male volunteers between 18 and 50 years of age, with a body weight between 60 and 100 kg, and a body mass index between 19 and 30 kg/m2, as detailed in Supplementary Methods."
0,"Analgesia in maintained using Ropivacain (40-50 mg/h), again."
3,"Male subjects aged between 18–65 years, weighing at least 50 kg, with a body mass index between 19–32 kg/m2, and in good general health as determined by medical history, clinical examination, 12-lead electrocardiogram (ECG), and clinical laboratory tests, were eligible for the study."
0,Fig. 1 Information-Motivation-Behavioral Skills model as a theoretical framework for the trial Study sites and recruitment feasibility
3,Screening was conducted within 30 days prior to the first dosing.
0,These materials were returned to study staff at the end of the vacation.
3,"The key inclusion criteria were as follows: age 20–55 years with body mass index (BMI) in the range 18.5–24.9 kg/m2 and good general health as determined by medical history, clinical examination, 12-lead electrocardiogram (12-lead ECG) and clinical laboratory tests."
0,"To facilitate the generation of reproducible data, analytical runs were organized into batches."
3,The screening procedure was conducted within 30 days prior to the first dosing.
0,"Briefly, it was determined that a sample size of 30 subjects was needed to provide at least 90% power to show non-inferiority of IGSQ scores compared to a pre-determined, non-inferiority criterion based on mean IGSQ scores from several previous studies [51, 52] conducted in similar infant populations."
1,"The feasibility study was a non-randomized, parallel arm, cluster allocation of two polyclinics: one clinic to the intervention group and one clinic to the usual care (control) group."
0,"In addition to the safety and tolerability analyses performed to address the protocol-specified objectives, statistical analyses were also performed on the efficacy data from this extension study (Fx-006)."
1,"The trial protocol was approved by SingHealth IRB, and registered at clintrial.gov NCT02330224."
0,"Over three years, the two studies recruited 530 women undergoing a first trimester abortion and 501 women undergoing a second trimester abortion."
3,"All individuals aged 40 years or older who were Singapore citizens or Permanent Residents visiting the recruiting polyclinic at least twice during the last one year with a diagnosis of hypertension and uncontrolled BP (systolic BP 140 mmHg and above, or diastolic BP 90 mmHg and above)."
0,Linking of all national registries with the CPR-number is therefore possible at the individual level [11].
3,"Active systemic illness including fever, hospitalization during prior 4 months, clinically unstable heart failure, advanced kidney disease (estimated CKD-EPI glomerular filtration rate (GFR) < 40 ml/min/1.73 m2 or nephrotic range proteinuria (i.e., 3 g/day or more)), known advanced liver disease, pregnancy, or any other major debilitating disease or mental illness that precluded validity of informed consent [7]."
0,Urinary measurements are performed by the laboratory at arrival.
1,SPLASHY is a prospective cohort study including children during early childhood within two sociocultural areas of Switzerland (German and French speaking part).
0,"Among the 362 individuals screened for the study, 44 (12%) were ineligible (Figure 1)."
1,"The project uses a multi-site approach including four research groups recruiting child care centers within five cantons of Switzerland (Aargau, Bern, Fribourg, Vaud, Zurich) which together made up 50 % of the Swiss population in 2013."
0,Treatment codes were revealed only after locking of the database at trial’s end.
4,This prospective single-center observational study was performed during a 9 months period in 2013/2014 in an 18 bed neurosurgical ICU in a tertiary teaching hospital.
0,"Of these, 104 persons responded."
17,"Subgroup analyses were performed post-hoc, and included: assessment of ORR in chemotherapy-naïve versus previously treated patients, and in paclitaxel-naïve versus paclitaxel-pretreated patients; comparison of DCR between patients with a > 10 % decrease in EBV-DNA from baseline after cycle 1 versus those with a ≤ 10 % decrease; and analysis of PFS in patients with ≤ 30 %, > 30 to < 50 %, and ≥ 50 % tumor regression (defined as the maximum decrease in the sum of the longest diameters of target lesions), and in patients with complete EBV-DNA clearance at any time during treatment versus those with non-zero trough EBV-DNA."
0,"Follow-up measures will include items such as a repeat of the NEMS, The Food Trust stock assessment, photographs, and customer survey."
17,Estimations and comparisons of PFS between the 3 dose cohorts and the exploratory subgroups were carried out by Kaplan-Meier methodology using a log-rank test.
0,The first (lowest) p-value has to be less than 0.05/3 (0.0167) to be significant and permit continuation to the other t-tests.
1,"The study was a randomised, placebo-controlled, double-blind intervention trial conducted over a twelve-week period (Sheffield University Breakfast Study – SUBS)."
0,"Key exclusion criteria included: (1) known or suspected hypersensitivity to trial products or ECG electrodes; (2) participation in another clinical trial 90 days before screening; (3) a QTcF interval (the Fridericia heart rate [HR] corrected interval) [13] of > 450 ms; (4) hypotension (systolic blood pressure [SBP] of < 90 mmHg or diastolic BP [DBP] of < 50 mmHg) or hypertension (SBP > 140 mmHg or DBP > 90 mmHg) or HR of < 50 beats per minute (bpm) or > 90 bpm; (5) a history of seizures, epilepsy, syncope, cardiac arrest, cardiac arrhythmia or Torsade de Pointes, atrioventricular block or structural heart disease; (6) a family history of long QT syndrome; (7) a family history of sudden cardiac death."
1,This phase 2 clinical trial (NCT00137852) was a single arm study evaluating the efficacy and safety of perioperative celecoxib and neoadjuvant chemoradiation with weekly cisplatin plus irinotecan followed by surgery in locally advanced esophageal and gastroesophageal junction cancer patients.
0,"The diabetes case–control comparisons also included additional adjustment for obesity (at first clinic visit), total cholesterol, statin use (at first clinic visit) and hypertension (at first clinic visit)."
4,VA administrative and health care utilization data were obtained from the VA National Patient Care Database.
0,All endpoints were pre-specified prior to unblinding the data.
4,Survey data were collected at baseline and 1-year follow-up.
0,"Serum free fatty acids (FFAs) were determined using a commercial kit (Wako Chemicals, Neuss, Germany)."
3,"Eligible participants included English-speaking parents or guardians (subsequently “parents”) of children aged 6-12 years, who received treatment at a participating practice, had an asthma diagnosis at the time of recruitment, and had an office visit during the past 12 months."
0,● Aged between 18–65 years.
1,"VITAL (ClinicalTrials.gov, NCT00634049) was a phase 3, open-label, nonrandomized trial conducted in 34 medical centers worldwide that evaluated the efficacy, safety, and outcomes of patients treated with ISAV for dimorphic fungi, emerging molds and yeasts, or invasive aspergillosis in the setting of renal impairment."
0,The Ad35-GRIN vaccine and placebo were both administered intramuscularly in 0.5 mL.
1,Only patients infected with cryptococcosis and dimorphic fungi are presented in this report.
0,"During the scheduling process, individuals were assigned to either the comparison or intervention group by a computer-generated process using simple randomization."
16,"VITAL Study—patient characteristics, antifungal exposure, outcomes, AEs, and mortality were summarized using descriptive statistics."
0,The questionnaire and full details of the results have been reported in the original publication [8].
16,Deaths were considered failures for all DRC assessments.
0,"This duration measure, although semi-quantitative, showed adequate validity and frequently used in published studies [26, 32, 33]."
14,All study personnel except the biostatistician are remaining blind to the group assigned until after eligibility is determined.
0,"Written informed consent was obtained from all participants prior to enrollment in the study; the study protocol, informed consent, and patient information were reviewed and approved by the Ethics Committee of the Thomayer Hospital and Institute for Clinical and Experimental Medicine in Prague, Czech Republic on November 9, 2011."
14,"Afterward, the PIs discloses the assigned Pp code and provide their information to the appropriate RA for the assigned intervention to begin."
0,Plasma LX4211 levels were quantitated using liquid chromatography with tandem mass spectrometric detection.
3,"Eligible subjects were healthy adult volunteers aged 18–55 years (male) or 18–44 years (female), with a body mass index of 18–30 kg/m2 and a total body weight >50 kg (110 lb)."
0,"The Health Assessment Questionnaire (HAQ) assesses functional ability for eight subscales: arising, common daily activities, dressing and grooming, eating, grip, hygiene, reach and walking."
3,"Subjects with evidence or history of clinically significant hematologic, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease (including drug allergies, but excluding untreated, asymptomatic seasonal allergies at time of dosing) or any condition possibly affecting drug absorption were excluded from the study."
0,Patients evaluated as having glenohumeral internal rotation limitation in our outpatient clinic were eligible for participation in the study.
16,"The change from baseline in primary biomarker endpoints (biomarkers of AEs and biomarkers of anti-inflammatory activity) for each prednisone dose was compared with the change from baseline for placebo, using a repeated-measures crossover analysis of covariance model containing effects for sequence, period, time, dose, time by dose interaction, and subject within sequence (as random effect), as well as baseline as a covariate."
0,Individual variation in plasma glucose and insulin concentrations during the clamp were taken into account in the calculation of the insulin-mediated glucose disposal (M) (19;21).
16,"For comparison with placebo, the least squares mean difference, standard error, 95 % confidence interval, and P value were reported."
0,"The biomarker selection was primarily based on a systematic literature review, searching PubMed with terms related to cardiac device infections and bacterial endocarditis."
6,"The primary outcome is a composite defined as the occurrence of one or more of the following: pregnancy loss, preterm birth, birth injury, moderate/severe respiratory distress, neonatal hypoglycemia, and NICU admission > 24 h."
0,Details on the BAT are published elsewhere [12].
6,"The secondary outcomes include the individual components of the composite as well as the incidence of large for gestational age infants defined as greater than the 90th percentile for weight, based on the National Canadian fetal growth standards for singleton boys and girls [31]; congenital anomalies; cord blood gas pH <7.0; hyperinsulinemia as measured by elevated cord blood c-peptide > 1.7 ug/L; sepsis; hyperbilirubinemia; shoulder dystocia; fetal fat mass as measured by neonatal anthropometric analysis [32]; maternal weight gain; maternal insulin doses; maternal glycemic control as measured by HbA1c and capillary glucose measurements; maternal hypoglycemia defined as mild (<3.6 mmol/L (65 mg/dL)), symptomatic and asymptomatic or requiring treatment), or severe (loss of consciousness or confusion requiring assistance); incidence of pre-eclampsia, and/or gestational hypertension; number of hospitalizations prior to admission for delivery; the duration of hospital stays for the mother prior to admission for delivery and associated with delivery; rate of caesarean delivery; duration of hospital stay for the infant."
0,Geometric mean titers (GMTs) and seroprotection rates (defined as HI titers ≥1∶40) were the main outcome measures.
1,"The MEDIACONNEX study will be a simple blinded, parallel-group multicenter randomised controlled trial (RCT) conducted in eastern France."
0,This analytic approach has been proven feasible in several previous report from our group [9–11].
1,It will compare a program of usual care plus SMS to one of usual care only provided to adolescents who attempted suicide and who receive treatment in a pediatric and adolescent psychiatry unit at a hospital in eastern France (ClinicalTrials.gov no.
0,We used the prone ventilation endotracheal tube in one group of subjects.
4,"Centers of inclusion will be CHU Besançon, CHU Dijon, CHR Metz-Thionville, CHU Nancy, CHU Reims, and CHU Strasbourg."
0,The Balloon Analog Risk Task (BART) was a measurement of the individual’s risk-taking behavior [32].
4,The University Hospital of Nancy will supervise the study and the evaluations will be carried out by the Clinical Investigation Center.
0,The cobas® 4800 SR2 System Software v2.0 and EGFR Analysis Package Software v1.0 were used for tissue analysis.
3,Potential participants will be identified from both primary and secondary care in Leicestershire using electronic databases.
0,Our study had two scenarios for treatment sessions.
3,All patients meeting the inclusion and exclusion criteria (Table 1) will be invited for screening and those who remain eligible after screening will proceed to visit 1–6 as outlined in Additional file 1: Appendix 3.
0,"The SF-36 general health scale score will be the main focus of interest, as this represents a secondary outcome in the trial."
14,The study was single-blinded (investigators and gastroenterologists) since the placebo aqueous solution was not identical to the PEG 3350 ASC.
0,"The following patients were excluded; coronary revascularization within the index procedure or planned in the next month, acute coronary syndrome or cardiogenic shock, use of strong inhibitors of CYP3A, use of inducers of CYP3A, liver cirrhosis, severe renal insufficiency (creatinine clearance <30 ml/min/1.73 m2), or baseline corrected QT interval >500 ms."
6,"The primary outcome was the proportion of patients with recurrent haemorrhoids at 12 months after procedure, derived from the patient's self-reported assessment in combination with resource use from their GP and hospital records."
0,"Diagnosis and treatment of CRPS-1 is performed by the multidisciplinary CRPS outpatient team, including a surgeon, a rehabilitation physician, a physical therapist, an anaesthesiologist and a research nurse."
6,"Secondary endpoints assessed at 6 weeks and 12 months were: symptom severity (assessed with an HSS adapted from Nyström and colleagues),13 incontinence inventories (assessed using the validated Vaizey faecal incontinence score),10 pain (assessed using a 10 cm VAS), surgical complications, need for further treatment, persistent symptoms at 6 weeks, and health-state utility based on the EQ-5D.10"
0,The transfusion rate was analyzed using a zero-inflated Poisson model.
3,"Inclusion criteria for participation in MOSAIc were age ≥18 years; diagnosis of T2DM; presentation to a study site as part of usual medical care; use of any commercially available initial insulin therapy for at least 3 months with or without any combination of approved non-insulin oral antidiabetic drugs (OADs) (e.g., metformin); and sufficient understanding of the primary language of the country to complete study surveys."
0,Participants were randomized to receive PCV7-PCV7-23vP or 23vP-PCV7-PCV7 or PCV7-23vP-PCV7 with vaccines given 6 months apart.
3,Exclusion criteria were participation in another medical research study; use of intensive basal-bolus therapy (basal insulin in addition to three prandial doses); or initiation of insulin treatment with three daily injections of mixed insulin.
0,[28] The study was designed with a sample size of 100 patients to allow estimation of this change rate within an exact binomial 95 % confidence interval half-width of 9 %.
1,"A workplace-based cluster RCT will evaluate the intervention, incorporating nested behavioural economic experiments, and process evaluation."
1,The study protocol is developed using the MRC framework for complex interventions [28] and SPIRIT guidelines [29] and was successfully tested in a pilot study [27].
0,GPs who did not respond to the original letter received a reminder phone call.
14,"The test assessors were blinded to group allocation, and long pants or neoprene sleeves were worn by participants over both knees to hide possible surgical scars and preserve blinding of group allocation."
0,"The secondary end point included 1) the frequency rate of each clinical symptoms such as fever, rhinorrhea, nasal congestion, sore throat, cough, sputum, dyspnea, diarrhea, nausea, vomiting, headache, and myalgia 2) symptom duration; and 3) severity of symptom (total symptom score)."
14,The statistician was blinded to group allocation during the analysis.
0,"The standardized technique of neuromonitoring of the RLNs was used, including indirect vagal response evaluation at the beginning and at the end of the operation (IONM = L1 + V1 + R1 + R2 + V2 + L2) according to the recommendations formulated recently by the International Intraoperative Monitoring Study Group [12]."
6,"Tumor response was assessed by investigators and independent central review (RECIST v1.1) every 6 weeks for the first 24 weeks, and every 8 weeks thereafter [10]."
0,All participants provided written informed consent.
3,"Children aged 1–5 years were eligible if they had: (i) physician-diagnosed asthma, based on clinical signs of airflow obstruction and reversibility [3, 19]; (ii) URTIs as the main exacerbation trigger, reported by parents; (iii) ≥4 parent-reported URTIs in the past 12 months; and (iv) ≥1 exacerbation requiring oral corticosteroids in the past 6 months or ≥2 in the past 12 months."
0,"As the instructors were already practicing dancers, the content did not focus on any dance-specific skills but instructors had time to work together and share ideas and rehearse different choreography."
3,Exclusion criteria included: extreme prematurity (<28 weeks’ gestation); high risk of vitamin D deficiency; other chronic respiratory disease; disordered calcium or vitamin D metabolism; oral medications interfering with vitamin D metabolism; or vitamin D supplementation greater than 1000 IU/day in the past 3 months.
0,The last observation carried forward approach was selected for the primary analysis on the basis of U.S.
1,"We conducted a multicenter, 1-day point, cross-sectional study on the practice of MV among patients with brain injury in China."
0,The Anxiety Disorders Interview Schedule for DSM-IV was used to discriminate between anxiety disorders and for determining the primary and secondary diagnosis based on the participant’s responses and severity scores on measures of symptoms.
1,The study was performed at 11:00 a.m.
0,Changes in medication intake were recorded by the therapist.
3,"Adult patients with brain injury, including traumatic brain injury, stroke (ischemic stroke, spontaneous intracerebral hemorrhage, and subarachnoid hemorrhage), postoperation with intracranial tumor, hypoxic-ischemic encephalopathy, intracranial infection and idiopathic epilepsy, and receiving MV for at least 24 h, were enrolled in the present study."
0,"The hexokinase method colorimetrically measured NADP to determine fasting and postprandial glucose concentrations in sera using a clinical chemistry analyzer (Hitachi 7600 Autoanalyzer, Hitachi Ltd., Japan)."
3,"Severe brain injury was identified using a Glasgow Coma Scale (GCS) ≤8 points.[20] The exclusion criteria included age <18 years, undergoing a spontaneous breathing trial with a T-piece, or participating in another MV trial during the study period."
0,The study has been under discussion and development for over two years.
3,"Eligible adult patients who presented to the Intensive Care Unit (ICU) with septic shock as defined by the International Sepsis Definitions Conference criteria[12] from December 1, 2012 to November 30, 2013, were assessed for possible enrollment according to the inclusion criteria: (1) fulfillment of two of the four systemic inflammatory response syndrome criteria; (2) systolic blood pressure (SBP) no higher than 90 mmHg, mean arterial pressure (MAP) no higher than 70 mmHg, 40 mmHg SBP reduction from baseline (after a crystalloid-fluid challenge of 20–30 ml/kg of body weight over a 30-min period), blood lactate concentration of 4 mmol/L or more, or oliguria; and (3) EGDT criteria were not met (central venous pressure [CVP] no higher than 8 mmHg, MAP no higher than 65 mmHg, urine output no higher than 0.5 ml·kg−1·h−1, or central venous oxygen saturation no higher than 70%)."
0,Back-translation is a quality control step to demonstrate that the target language version does not have a different content or conceptual basis which would compromise psychometric properties and reduce data quality.
3,The exclusion criteria included the following conditions: EGDT not met within 6 h after the EGDT standard procedure treatment; below 18 or above 90 years of age; pregnancy; if over 24 h of time elapsed after septic shock onset; chronic liver disease; terminal stage of disease; brain death; other types of shock; brain injury; or iodine or ICG allergies.
0,The program is delivered in one-on-one sessions between the mother and an intervener.
3,"The study population included nonsmoking male and female volunteers from 18 to 55 years of age with a body mass index between 18.5 and 30.0 kg/m2 who were judged to be healthy based on a medical history, electrocardiogram (ECG), laboratory evaluation, physical examination, vital sign measurements, pulse oximetry, spirometry, radiography, being capable of providing consent, and having normal lung function (forced expiratory volume in 1 second [FEV1] ≥ 80 % of predicted and FEV1, forced vital capacity >70 %)."
0,It was carried out with either the head of the facility's joint maternity/newborn ward or the most senior nurse/midwife available at the time of the interview.
8,"The sample size of 12 subjects per cohort is a number commonly used in first-in-human studies, and it was judged appropriate to achieve the study’s objectives."
0,The initial resting period as well as the following warm-up phase were equal to CON.
8,A total of 36 subjects were recruited into the study.
0,"Data were used from a randomized clinical trial conducted in 12 neonatal intensive care units, 11 in the United States and 1 in Austria from mid-2007 to late-2008 [1]."
3,Participants were aged over 18 years of age.
0,"Patient-centred outcomes from the TTM trial were also assessed; all-cause mortality through to the end of the trial, and the composite of poor neurological function or death at 180 days, as evaluated with the Cerebral Performance Category (CPC) scale 3–5 and the modified Rankin scale (mRs) 4–6."
3,"Exclusion criteria were contraindication to MRI or ferumoxytol infusion, any systemic inflammatory comorbidity (eg rheumatoid arthritis), renal failure (estimated glomerular filtration rate <30 mL/min), pregnancy, breastfeeding and women of child-bearing age not ensuring reliable contraception."
0,"DB double-blind; HAE hereditary angioedema, LTP long-term prophylaxis; OLE open-label extension."
16,"Data are given as the mean, or best estimate, and SD."
0,COPDGene is a multicenter study that aims to improve classification of COPD phenotypes as well as determine the genetic background of this disease.
16,Differences were evaluated by the Wilcoxon matched-pair test.
0,Mortality was defined as death within 90 days after surgery.
3,Patients suffering from untreated localized mild-to-moderate chronic periodontitis were initially included into the study [14].
0,Results of subject and control serum were converted from OD values to STF2-specific IgG using the standard curve and adjusted for dilution.
3,The inclusion and exclusion criteria are summarized in Table 1 and depend on time of inclusion.
0,The authors confirm that all ongoing and related trials for this drug/intervention are registered.
4,"The setting was the general community of Scotland, UK, specifically the health board areas of Greater Glasgow and Clyde, Lothian, Tayside, Lanarkshire and Borders."
0,"–.52) felt ready to participate in an ISCP (10.1% responded “yes”, and 22.9% responded “yes probably”)."
4,"Recruitment was from multiple sources within the general community, Down Syndrome Scotland, Local Authorities, and National Health Service clinical services."
0,This trial was initiated in September 2013 and completed in May 2016.
3,Down syndrome Aged 50 years and over Exclusion criteria
0,"When the patient was unable to exercise or when the ECG stress test result was indeterminate, a pharmacological stress test using dipyridamole was carried out [4,7,21]."
6,Recruitment and retention:Numbers screened and recruited each monthThe proportion of participants retained 12 months after randomisationThe number of participants recruited per base general population size Secondary measures
0,"The PL intervention used here aimed to help students feel more informed and knowledgeable about where and how they could find opportunities for PA, which might result in enhanced self-efficacy and a greater sense of agency regarding the adoption of ‘healthy behaviours’."
1,This is a sub-study of a multicenter randomized controlled trial in women with FM (ClinicalTrials.gov identification number: NCT01226784) [32].
0,". The inclusion criteria were: gestation ≥34 weeks at birth; age <7 days, post-ductal arterial line, and an A-aDO2 of 400 to 600 on two blood gases at least 30 minutes apart."
1,The present sub-study aimed to investigate the effects of resistance exercise on multidimensional fatigue in women with FM.
0,"The children's mean BMI percentile was 95.2%, which is also classified as obese."
6,"The patients were referred to a baseline examination which included a tender-point examination [2] by a physician, performance-based tests of physical capacity conducted by physical therapists, and a battery of self-reported questionnaires [32]."
0,The interventions were all delivered over four group sessions (held once a week) by nine occupational therapists (OTs) in two hospital centres.
1,"CPP FAP-310 is an ongoing, randomized, double-blind, active-controlled, Phase III trial evaluating the efficacy and safety of CPP-1X/sulindac combination therapy versus each as monotherapy during a 24-month treatment period among individuals with FAP [15]."
0,"A Type-I error rate, commonly referred to as is the probability of rejecting a null hypothesis when the null hypothesis is actually true."
1,Patients are assessed endoscopically every 6 months for evidence of polyposis progression (vide infra).
0,"For NRAS, mutation analysis was performed using the NRAS Mutation detection kit (EntroGen) on an LC480 platform (Roche)."
8,"With 90 % power and 5 % significance (two-sided test), a sample size of 140 per group will be required to detect a 19 % increase (from 55 % to 74 %) in the proportion of participants with a minimum improvement in VA of ≥10 EDTRS letter score."
0,Samples were coded and the patient identification only released upon completion of microbiome and metabolomic analyses.
8,The target sample size has been inflated to 300 to allow for a 7 % dropout rate.
0,"This was a 52‐week, open‐label, randomized, parallel‐group trial with an active control (combination therapy with two OADs), designed to evaluate the safety and efficacy of liraglutide in combination with an OAD (glinide, metformin, α‐glucosidase inhibitor or thiazolidinedione) in patients with type 2 diabetes."
16,"The flow of participants will be displayed in a Consolidated Standards of Reporting Trials (CONSORT) diagram, as shown in Fig. 1."
0,"Investigators who have already undergone training in implantation of the control disc will be selected for participation; however, for any participating investigator who has not performed at least three prior control implantations, up to three nonrandomized control implantations may also be performed prior to enrolling randomized subjects into the study."
16,The number of protocol deviations with reasons will be reported.
0,"Primary end-points were a 5% reduction in BMI or waist circumference, and improved energy expenditure (physical activity expenditure >10 MET-hour/week)."
1,"This pilot study was a prospective, randomized, controlled trial conducted in New Delhi, India."
0,"Criteria for the evaluation of safety included a comparison of pre-treatment to during-treatment laboratory tests; assessment of the occurrence, severity, and duration of all adverse events and serious adverse events, with the investigator’s assessment of causality; and a comparison of pre- and post-treatment physical examinations."
1,There could be significant differences in environmental cleanliness and bacteriologic profile in the community and hospital settings; study subjects from both the settings were included in order to have a representative sample.
0,"Using a ALOKA α10 with a 3.5 MHz probe, echocardiography was performed."
1,This was an individually randomised controlled trial.
0,A secondary per protocol on-treatment analysis would exclude any patients found to be invalid after randomisation or who had cross-over in treatment during follow-up.
1,"We randomised students with a 2:1 allocation ratio, a decision based on the need to reduce costs [25]."
0,Another study involved a control group of 94 and an experimental group of 37 [28].
6,"The primary outcome is all-cause mortality assessed on 6th of April 2017, 10 months after inclusion of the last patient."
0,"The items are inspired by different existing scales that have been successfully applied in recovery studies such as the Recovery Experience Questionnaire [15], the Subjective Vitality Scale [67,68], the Energy at Work Scale [69] and the Restoration Outcome Scale [70]."
6,Secondary outcomes are listed in Table 2.
0,"The sample was drawn from the adult Danish population (18 years or older) using the Danish Civil Registration System, which contains information on gender, age, address, citizenship, and marital status for each individual (each Danish resident has a unique personal identification number) [27]."
3,"All patients presenting acutely to the ED and have blood work done including hemoglobin, C-reactive protein and creatinine within 6 h of registration are included."
0,The clinical attachment level is calculated by the DCC using these two recorded measurements.
3,"Patients presenting in Pediatric, Gynecological or Obstetric units are excluded."
0,"Also, comparison will be made between participants’ demographic, pain/disability and quality of life characteristics."
6,All patients underwent contrast-enhanced 1.5 T MRI of the clinically most active wrist and hand (metacarpophalangeal joints 1–5) at baseline and at 6-month intervals thereafter; the same wrist/hand was imaged at each designated visit (see online supplementary material).
0,"Plasma lipids, glucose, hemoglobin A1c, and C-reactive protein are collected after an overnight fast."
6,MRI assessments were evaluated at baseline and up to month 18; only patients with baseline and postbaseline MRI assessments were included (see online supplementary material).
0,Tumor response was defined as the best overall response rate (BORR).
3,We enrolled children in general good health without significant medical history into the study.
0,"This will count twice a T cell that responds to any of the 10-mer overlap regions that occur in two pools with adjacent peptides, as each pool contains non-overlapping peptides."
3,"Children were excluded if they fulfilled any of the following criteria: active, planned, or recent activity in another clinical study; receipt or planned receipt of antiviral medication within 2 mo or any vaccine within 4 wk before first trial vaccination and up to 4 wk after trial vaccination; receipt of any blood product in the preceding 3 mo that may interfere with assessment of immune response; immunodeficiency (any cause); history of central nervous system disorder or disease, including seizures; chronic illness that may interfere with trial conduct or completion; administration of systemic corticosteroids for more than 2 consecutive weeks within 4 wk preceding vaccination; febrile illness or moderate or severe acute illness or infection up to 3 d before vaccination; thrombocytopenia or bleeding disorder contraindicated for vaccination with the same administration route, or receipt of anti-coagulants within 3 wk of inclusion; known hypersensitivity to any vaccine components; history of flavivirus infection or vaccinations (including JE)."
0,"A sensitivity analysis was performed to confirm that the results were similar when including only participants with follow-up data (as compared to the intention-to-treat analysis), and the conclusions were the same."
1,"To reach the study aim, a multicentre prospective cohort study is set up among women visiting Dutch STI clinics."
0,Height and weight were measured at enrollment and at every clinic visit using a Seca 354 Digital Baby Scale and Seca 416 Infantometer.
5,"In the intervention clusters, HIV-positive individuals were informed during home-based HIV testing that they would be provided ART irrespective of CD4 count and clinical stage."
0,"The reference standard for rejection status was the histology-based rejection grade (using the ISHLT 1990 grades: 0, 1A, 1B, 2, 3A, 3B, or 4) for heart tissue obtained from an EMB performed on the same day as the collection of blood for the GEP test.8"
5,"In the control clusters, HIV-positive individuals were informed that ART would be offered according to the criteria of the national South African guidelines: CD4 count ≤ 350 cells/μl, World Health Organization (WHO) clinical stage 3 or 4, or coinfection with multidrug resistant or extensively drug-resistant tuberculosis."
0,"This impacted design and the user experience, necessitating an interface optimized for tablets and continuous Internet connection."
16,Graphs depict group means and standard deviations.
0,The medial hinge is measured on the initial radiographic examination.
16,"Inter-group comparisons were made using one-way or two-way analysis of variance (ANOVA) and the Tukey post hoc test (GraphPad Prism 6, San Diego, CA)."
0,"Each GTO sub-team created a “GTO Planning Team” of HUD-VASH staff (led by a designated point of contact) and the GTO TA staffperson (SM, in Pittsburgh) who lead the sub-team through the GTO process."
3,All interview participants were recruited from the OPTI-SCRIPT study between January and July 2013.
0,"Two nuclear medicine physicians blinded to the treatment groups made the FDG uptake measurements, and the 2 measurements were averaged."
3,"The lead study GP in all 21 participating practices, in both the intervention and control arms, was asked to participate in a semi-structured interview, 17 of whom were available for interview (two were on leave and two were unable to schedule an interview within the study time frame)."
0,"Details of the algorithm for contour selection and calculation of left ventricular mass, systolic and diastolic variables have been previously published [20]."
16,Data were analyzed using GraphPad Prism v6 (GraphPad Software) and are presented as mean and individual data points.
0,Death and readmissions were modelled separately as these outcomes are valued differently and incur different resource utilisation.
16,"One-way ANOVA was used for multiple comparisons and post hoc analysis using Dunn’s multiple comparisons test was used to compare pre-freeze, post-thaw, and 4-day culture, where significance was set at p < 0.05."
0,"For this national study, approvals for data collection and analyses were obtained from a central institutional review board (New England Institutional Review Board) for private practice sites participating within Corrona."
1,"A multinational and multicentre retrospective, observational cohort study which will involve the collection of data on hospitalised patients from 1 January 2013 to 31 December 2014."
0,"If AF terminated as a result of CFE ablation, an attempt was made to reinduce AF using the same standardized protocol detailed in the first paragraph of this section."
8,We aimed to recruit a total of 50 participant groups.
0,Findings were shared with informants of the FGD and IDIs and checked for correctness to ensure accurate reporting.
8,This sample size was chosen based on the recommendations for feasibility studies by Sim and Lewis.19
0,"Both in the videos as well as during the execution of the tasks, all the material is placed on dark surface to highlight the contrast and facilitate the focus on the activity, in particular for those with a visual and/or attention problem."
4,The participating teachers delivered the Social Stories within the mainstream classrooms.
0,"In general, if the tumor was smaller than 1.5 cm in its longest axis, electrodes with 2.5 cm active tips were used using the “no-tumor-touch” technique [34]."
4,Professional educational and Child and Adolescent Mental Health Service (CAMHS) clinical staff associated with the research team delivered the training in Social Stories in a CAMHS setting.
0,The list of each approving ethics committee and IRB is provided in Table S1.
14,"Blinding of the participants (inclusive of teachers, parents and children) was not feasible due to the nature of the intervention."
0,All subjects gave informed consent.
14,Members of the study team responsible for the statistical and economic analysis were kept blind to group allocation.
0,The sensory or motor onset time were considered when Scale 2 was achieved for all 5 or 4 nerves.
3,Patients: (1) diagnosed with type 2 diabetes for at least 5 years; (2) with an estimated GFR≥30<90 mL/min/1.73 m2 confirmed with repeat testing over 3 or more months calculated by the abbreviated Modification of Diet in Renal Disease (MDRD) study equation;27 (3) persistent macroalbuminuria with spot urine albumin-to-creatinine ratio (UACR) ≥300 mg/g confirmed by at least two consecutive first morning void urine samples; (4) aged between 35 and 80 years; (5) on a stable dose of antidiabetic drug including insulin for 12 weeks and (6) on a stable dose of ACE inhibitor or angiotensin receptor blocker for 12 weeks will be recruited.
0,Each subject gave written consent for their participation.
3,"Patients: (1) with a known history of glomerulonephritis, polycystic kidney disease, systemic lupus erythematosus or any suggestive evidence of non-diabetic glomerulopathy; (2) with a known history of kidney transplant; (3) with concurrent severe disorders of the heart, brain, liver and haematopoietic system, tumour, mental disorder; (4) deranged liver function; (5) with poorly controlled blood pressure; (6) with a known history of intolerance or malabsorption of oral medications; (7) uncontrollable urinary infection; (8) experiencing pregnancy and (9) participating in other clinical trials within 30 days will be excluded."
0,"After washing, antibody-coated beads were incubated with test sera or heat-inactivated (negative control) serum, washed, and then stained with biotinylated anti-C3d antibody and phycoerythrin-conjugated streptavidin as described above."
16,"Data were analyzed and graphed using Prism (GraphPad Software, La Jolla, CA)."
0,[20] 3) The study has limited power to evaluate clinical events such as need of dialysis or death.
16,Individual data sets were compared using Student’s T-test and analysis across multiple groups was performed using ANOVA with individual groups assessed using Tukey’s comparison.
0,"Careful monitoring of enrollment numbers during the first phase of recruitment (October-December 2011) made it clear that an additional 4 communes would be needed in order to reach the target sample size of >5,000."
1,"The ARCTIC trial was a 24 month randomised, open label, parallel group clinical strategy study conducted at 11 centres in Norway (four rheumatology departments at university hospitals, six regional/community hospitals, and one private practice) in compliance with the Declaration of Helsinki and the International Conference on Harmonization Guidelines for Good Clinical Practice."
0,The vessel’s diameter was measured at the same point with resting measurement at least twice and the maximal diameter was again defined (diameter during reactive hyperemia).
1,The study was conducted and analysed according to the protocol and the statistical analysis plan (see appendix).
0,"Another questionnaire collected information on sociodemographic variables, lifestyle, and family history data."
16,"Mean changes in SM levels from baseline to 26 weeks were measured by computer morphometry and assessed for statistical significance (P<0.05) using the unpaired Student t test (GraphPad PRISM, version 5.0, GraphPad Software)."
0,There was no automated SpO2 data inflow into the electronic medical record (neither in the OR nor outside the OR).
8,"We calculated the sample size required for evaluation of coagulant factor VIII activity (two sided test, α=0.05, β=0.90) and determined that 23 participants would be required to observe an increase of 15 IU/dL (150 IU/L) or more (assuming a correlation between the difference in measurements at the two time points of 0.7)."
0,All slides were coded and examined in blinded manner.
8,"Taking into account possible dropouts, we determined that overall 24 participants would be required."
0,"Concerning the prognostic role of CTCs, the absolute amount of CTCs at baseline, every increase or decrease between each step of the treatment, and the highest value of CTCs of all measurements during the treatment (maximal CTC values) were analyzed."
8,An initial sample size of 50 participants (n = 25 per group) was determined to be adequate to evaluate the feasibility of the tailored tobacco intervention approach.
0,"At the baseline visit, a complete medical history was obtained including data related to perinatal period, SMA diagnosis and genetic confirmation, family history and hospitalizations in relation with SMA as well as previous and concomitant diseases."
8,"Because enrollment accrued more quickly than anticipated, a total of 63 rural smokers were ultimately enrolled and randomized to treatment conditions."
0,"Unless other evidence was available, we considered as nonpathogenic the isolation (at any concentration) of the following microorganisms in lower respiratory secretions: viridans-group streptococci, coagulase-negative staphylococci, Neisseria spp, Corynebacterium spp, and Candida spp."
1,"ORTHODIAB is a French collaborative multi-centre randomized, open label trial, with a blinded end points evaluation by an adjudication committee according to the Prospective Randomized Open Blinded End-point (PROBE) method [19]."
0,"On the day of the cardiac catheterization procedure (Day 2), patients were given 1mg of midazolam and 50 µg of fentanyl for presedation ; blood pressure readings were taken as indicated in Figure 1 with the patient in the supine position."
3,"Based on the United Nations’ definition of the elderly [28], this post-hoc subgroup analysis included all patients who were aged ≥ 60 years at trial entry."
0,"Additionally, patients need to be deemed clinically and medically appropriate for treatment acceleration by the rheumatologist-investigator and willing to have their therapy escalated as appropriate."
3,The 60-year cut-off point for age was also chosen to allow for sufficiently large patient numbers in each of the treatment groups.
0,"Anonymised data on key baseline characteristics (age, gender and Index of Multiple Deprivation) of those who were invited but did not participate are compared with those who did participate."
1,"The Tysbari Pregnancy Exposure Registry (TPER; referred to as the Registry) was a global, observational, exposure registration and follow-up study of pregnant women with MS or CD."
0,"As a point of delivery for the Italian National Health System, each LHU has an information network that routinely measures expenditure related to the dispensing of medications to registered patients."
1,The Registry collected information routinely documented in the patient and infant medical record with no Registry-required interventions or procedures conducted.
0,"Care for the patients' concomitant diseases, most prominently heart failure, was provided by specialists as clinically indicated; however, they had no role in the study."
16,"Weighted Kappa coefficients, along with 95 % CIs, were calculated to assess the intra-examiner repeatability for MLSI (IxA) assessments at each visit."
0,"The trial was carried out in compliance with the clinical trial protocol, the principles of the Declaration of Helsinki, the ICH‐GCP, and with applicable regulatory requirements and Boehringer Ingelheim standard operating procedures."
16,"Repeatability was deemed to represent excellent replication if the kappa coefficient was greater than 0.75, fair to good replication if the value was between 0.4 and 0.75 inclusive and poor replication if the value was below 0.4."
0,"All subjects were seen in group sessions monthly for an American Diabetes Association–approved diabetes education program given by the study coordinator, in which adherence to medications was also stressed."
16,"Data are presented as mean ± SD and differences between means were analyzed with the Student’s T test using Microsoft Excel software (Redmond, WA, USA)."
0,"3+ was defined as strongly positive, 2+ intermediate, 1+ weakly positive, and 0 as negative."
16,Differences were considered significant at P < 0.05.
0,The data we collected via pop-ups were stored in a national database for general practice.
14,"Due to the nature of the intervention, participants, service providers, and research staff involved with collecting and assessing outcome data will not be blinded (i.e. they were aware of group assignment to either the intervention or the TAU group) for the duration of the study."
0,"To explore the impact of including the unvaccinated cohort in the unexposed pregnancies, we estimated the miscarriage risk after excluding pregnancies in the unvaccinated cohort."
5,"Intervention materials included a letter describing results of their DXA (lowest T-score and interpretation [OP, low BMD or normal]), a graphic portrayal of their 10-year probability for a major osteoporotic fracture (using FRAX®; https://www.shef.ac.uk/FRAX/), and a bone-health educational brochure."
0,"For the purposes of this study, a potential caregiver is defined as a person living inside or outside of the patient's household who has at least monthly contact with the patient, either by phone or in person, and is willing to help the patient manage his/her symptoms."
5,"These materials have been described elsewhere [27, 28]."
0,-Health problems (WONCA ICPC-2).
3,Three groups of subjects classified by their fasting and postchallenge glucose tolerance status (2-h post–75-g OGTT) (and balanced for gender) were studied.
0,The anterior preoptic ROI extended from the anterior-most tip of the anterior commissure to the anterior-most tip of the infundibulum.
3,"NGT subjects had a fasting glucose <100 mg/dL and postchallenge <140 mg/dL; prediabetes mellitus (PDM) subjects had impaired fasting glucose (≥100 and <126 mg/dL) and impaired glucose tolerance (≥140 and <200 mg/dL); subjects with T2DM had fasting glucose values of 126–270 mg/dL and HbA1c 6.5–10.0% on a stable dose of metformin monotherapy (500–2,000 mg/day)."
0,"in Seattle, Washington, which complies with all provisions of the United States Public Health Service Policy on Humane Care and Use of Laboratory Animals (NIH Publication No."
8,"We estimated that a sample size of ten patients per group was required to detect an effect size of 0.6 with a power of 80 %, assuming a balanced allocation to treatment groups, and a 5 % type I error probability."
0,"A clinical malaria episode was defined as presence of P. falciparum parasites in a blood smear plus any sign or symptom suggestive of malaria including: current fever (axillary temperature ≥ 37.5°C) or history of fever in the last 24 hours, and/or pallor, and/or arthromyalgias and/or headache, and/or history of convulsions [32]."
8,"The sample size calculation was based on a pilot study that tested eight participants at Hoehn and Yahr stages 1 and 2, indicating a difference of 0.2 s between pre- and post-training on reaction time in the LOS test."
0,"Exclusion criteria included any abnormal findings at the screening examination; clinically relevant comorbidities including gastrointestinal, hepatic, renal, cardiovascular, metabolic, central nervous system, immunological or hormonal disorder; history or evidence of a blood disorder; and subjects unable to refrain from smoking during hospitalization (or a current smoker >10 cigarettes/day or equivalent)."
8,"Based on this difference, a sample size calculation indicated that 20 participants would be sufficient for 85 % power (α = 0.05)."
0,All-cause mortality is a tertiary outcome.
6,Response assessments were performed every 8 weeks in ERIVANCE BCC and every 8–16 weeks in the EAS.
0,The inter-reader variability was 4.7%.
6,"Adverse events (AEs) were assessed on a monthly basis in both trials and graded according to National Cancer Institute Common Terminology Criteria for Adverse events, version 3.0."
0,"A total of 10,935 patients were screened, and 600 eligible individuals were recruited to participate."
1,A randomised crossover trial was conducted to compare the effects of 24 h high added fructose and high added glucose feeding (20 % of daily calories) in men of BA compared with men of WE origin.
0,Authorization to conduct the study was sought from the relevant administrative and health authorities in the study area.
1,"Fasting and post-prandial circulating TG, non-esterified fatty acids (NEFA), glucose, insulin and C-peptide were measured in 9 BA and 11 WE participants over a 24-h period on two separate days, during which they consumed three isocaloric, mixed nutrient meals accompanied by beverages sweetened with either 100 % fructose or 100 % glucose (Additional file 1: Table S1), in a randomised crossover fashion."
0,"Acquisition parameters were 128 × 128 pixels matrix, 64 frames over 360°, zoom 1.0, pixels size of 2.67 mm, 35 s per acquisition view and total imaging time of 20 min."
3,Male subjects aged 5–16 years with DMD resulting from a mutation correctable by treatment with drisapersen were eligible for inclusion in the original dose-escalation study (EudraCT 2007-004819-54).
0,"This study was conducted at RITM, Manila, the Philippines, from May 2016 to Feb 2017."
3,"Inclusion and exclusion criteria, which have been described previously [22], are summarized in the Supporting S1 Methods and S1 Results."
0,"Insulin (Actrapid HM; Novo Nordisk, Bægsvard, Denmark), in concentration of 50 IU in 50 mL 0.9% NaCl, was continuously infused through a central venous catheter by the Perfusor Space syringe infusion system (BBraun, Melsungen, Germany)."
1,"A waitlist RCT design was used to examine the feasibility, acceptability, and effectiveness of the iPeer2Peer program in adolescents with JIA."
0,One dose reduction in the following cycle was allowed if a DLT or similar toxicity event occurred.
1,"This study is planned as a multi-centre, prospective, observational, blinded (for physiological and surgical outcome assessments) observational cohort study, funded by the National Institute for Health Research for Patient Benefit Programme (PB-PG-0609-18262), approved for all NHS sites by the Dyfed Powys Research Ethics Committee (11/WA/0072) and registered with clinicaltrials.gov (NCT01325883)."
0,Table 2 Critical structures and threshold doses Long-term follow-up
1,"The study is to be conducted in four United Kingdom based NHS hospitals including; University Hospital Southampton NHS Foundation Trust, University Hospital Aintree NHS Foundation Trust, Lancashire Teaching Hospital and South Tees Hospital NHS Foundation Trust (above ethics number covers all four NHS sites)."
0,"The regression and mediation analyses were stratified by age (6–11.9 and 12–17.9 mo) because important motor and mental developmental milestones are achieved after 12 mo of age, so variance due to age could overwhelm other predictors."
3,All patients listed to undergo NAC/CRT followed by elective UGI cancer resection (oesophagectomy and gastrectomy) are eligible for inclusion.
0,We fixed biopsy samples in 10% neutral-buffered formalin and embedded them in paraffin before staining with hematoxylin and eosin.
3,"Exclusion criteria are: inability to give informed consent, under 16 years of age, non-resectable disease, inability to perform CPET or bicycle exercise due to known contra-indication, and patients who declined surgery or neoadjuvant cancer treatment, or who received non-standard neoadjuvant cancer treatment."
0,"For phenotypic stains, peripheral blood mononuclear cells (PBMCs) were thawed and stained for two surface panels and an intracellular panel."
8,The sample size for the IDOCC study was determined based on the primary process measure for the trial (adherence) as presented elsewhere [11].
0,"Adults with type 2 diabetes were enrolled if they were 18–75 years of age, had an A1C of 7–11%, and had a BMI of 25–37 kg/m2."
8,"For this secondary analysis, the clinical outcome was assessed in all participating practices using population-level data, and no additional a-priori sample size calculation was carried out."
0,"A Dutch and French version of the Edinburgh Depression Scale (EDS), a validated 10-item scale, is used to measure depressive feelings during the pre- and postnatal period [45–47]."
14,The assessor was blinded to the participants’ group allocation.
0,"Eco-Social Development Organization (ESDO), an NGO contracted by WFP, was responsible for the field implementation of the transfers, including distributing monthly food and cash transfers, delivering nutrition BCC training sessions, and performing routine monitoring and reporting activities."
14,This “blindness” was assessed as the assessor wrote down on each participant’s data sheet her opinion about what kind of treatment the participant received and her opinions were compared with the randomization codes after the end of the study
0,The difference between baseline and follow‐up RAL readings described the changes of the clinical attachment level (gain or loss of tooth supporting tissue).
1,A qualitative study using a phenomenological approach was conducted from May 2012 to January 2013.
0,"Raters coded each consultation four times: once for treatment fidelity, twice for motivational interviewing (global ratings followed by behaviour counts) and once for therapeutic alliance."
1,"A random sample of 42 children aged 10–13, with 17 from families in the three highest monthly household income districts (high-income families) and 15 from the three lowest monthly household income districts (low-income families) were chosen from the previous study conducted by Ho and colleagues [5]."
0,"Classical oncological parameters such as Eastern Cooperative Oncology Group-performance status (ECOG-PS) [10], tumor characteristics (tumor molecular subtype according to the St."
8,"The sample size calculation was based on the quality sum score assessed by the consulting physicians; the results indicated that we needed at least 191 patients in each group to achieve 90 % power to detect non-inferiority using a one-sided two-sample t-test, a standard deviation equal to 1.0 and a 5 % significance level."
0,"Training began with the 1-back task, and the training level was upgraded by achieving 90% accuracy twice in succession."
8,"The margin of non-inferiority was set at 0.30, as a difference in sum score between the groups ≤ 0.3 was rated as not clinically relevant using a questionnaire with five-level questions (1–5)."
0,"The RCRI was developed and tested in patients undergoing elective procedures; thus, we will exclude from our analyses patients who underwent urgent or emergency surgery."
4,"Physicians from about 50 centres (hospitals and physician practices), all experienced in the management of FXS, participated in the study."
0,"To ensure data quality and participation, project staff will supervise the whole data collection process keeping track of the accrual rates over time."
4,"Specialists from other disciplines were also involved, such as child/adolescent psychiatrists, general psychiatrists, or physicians in social paediatric centres."
0,Study participants with two failed Xpert results were managed based on the liquid culture results.
16,Table 2 Statistical findings shown as change from baseline at week 8 and 12 Secondary outcome measures
0,Participants felt they had greater understanding of diabetes and its risk factors as a result of the course and the visual aids employed.
8,No formal sample size calculation was performed because this was a single-arm OLE trial and the primary objective was evaluation of safety and tolerability.
0,"As is common in cluster randomized trials [27], patients were unaware of the assignment to trial arms."
8,The number of patients enrolled in this trial was dependent on the number of patients completing the double-blind acute trial and was expected to be ≥280 patients (approximately 70 % of patients enrolled in the acute trial).
0,"In case exercise goals were not met, the study subjects were instructed to book an appointment with the physical activity advisor."
6,Efficacy endpoints were absolute IOP values and reduction from baseline (RFB) in IOP.
0,"Although it was not necessary to have tailored text in the sexually active male module to address why it was important for them to know how to use condoms, the issue of motivation did need to be addressed."
6,"Safety endpoints included AEs, vital signs, corrected decimal VA, conjunctival hyperemia assessment, slit-lamp examination, ophthalmoscopy, photographs, visual field assessment, gonioscopy, and pachymetry."
0,Group B was instructed in NW once by the same specially trained instructors in a single one-hour session.
16,"One-way between groups analysis of variance (ANOVA) (the statistical package IBM SPSS; version 22) compared the overall as well as the contrast differences in mean scores on quality of life, self-esteem, anxiety and depression within the at-risk groups."
0,To determine whether BI reduces the length of stay in hospital 4.
16,"Multiple regression analysis assessed the degree of relationship between anxiety and depression on quality of life and self-esteem, controlling for gender and grade-level within each symptom group."
0,The resistance training will be performed at public gyms during two supervised sessions per week.
6,The primary outcome was a composite of prolonged ICU length of stay (≥ 48 hr) and death from any cause within 30 days of the operation.
0,"However, commencement of the intervention was done as soon as the patient been randomised into one of the study group."
6,"The secondary outcomes included high-sensitivity cardiac troponin T (cTnT) measured six hours post-ICU admission, hospital and ICU lengths of stay (based on the times the participants actually left the hospital and the ICU—i.e., not when they were fit for discharge), duration of tracheal intubation, inotrope or vasopressor usage in the ICU at any time, prolonged (≥ 12 hr) inotrope or vasopressor usage, peak postoperative serum creatinine, new-onset hemodialysis, new-onset atrial fibrillation, use of an intra-aortic balloon pump (IABP), perioperative stroke, and ICU readmission."
0,"Nonblinded assessors performed the ultrasound scans; however, the evaluators measuring MLT were blinded to patients’ group assignment."
14,"The exercise assessments (baseline, 6 months and 1 year) are performed at a different facility by different staff than the supervised exercise training team."
0,HIV testing was performed on all study participants.
14,The cardiac MRI interpreter is blinded to the group assignment.
0,"These questionnaires will be based on both the Dutch translation of PACIC [40,41], and the CQ index [42], and adapted to our program."
1,"This 12-week, open-label, noncomparative, observational study of bimatoprost 0.01 % in consecutive patients with OAG (including NTG) or OHT (ClinicalTrials.gov identifier: NCT01814761, registered on March 18, 2013) was conducted between May 2013 and August 2014, in accordance with the Guidelines for Good Clinical Practice and all applicable Taiwanese laws."
0,BMI was calculated as body weight in kilograms divided by the square of height in meters (kg/m2).
8,"Based on the results of a clinical trial [13] of ORS solution in severely malnourished children with acute watery diarrhoea (the mean ± SD duration of diarrhoea was 66.4 ± 32.3 h), we anticipated a 25% reduction in diarrhoea duration in children receiving PHGG-added ORS."
0,"The research nurse who retrieved outcome data was masked to randomisation, and the concealment strategies were that the nurse was in a separate office during clinic, the administrator randomly assigned the patients, and the use of a masked follow-up database."
8,Considering 5% level of significance and 80% power and 5% drop out the sample size was estimated to be 63 in each group.
0,A single blinded cluster randomized controlled study with 45 clusters was conducted between January 2009 and December 2011.
1,"The study relied in the comparison of three independent samples, in three experimental conditions: 1) control situation with no specific FOP nutrition label on products; 2) intervention n°1: introduction of the 5-CNL as a FOP nutrition labelling on all food products with no additional information for the consumer; 3) Intervention n°2: introduction of the 5-CNL FOP nutrition label on all food products with consumer information."
0,Table 1 Secondary Outcome Measures for BTB Trial BTB Intervention
8,"For the primary endpoint, PID at 8 h, a difference of 1 point on the 11‐point NRS (0–10) between the treatment groups, together with a common standard deviation of 3 was used to calculate the sample size."
0,The protocol for this trial is available as supporting information; see Protocol S1.
8,"With a sample size of 192 per group (768 total), a power of 90% was provided assuming a two‐sided t‐test with α = 0.05."
0,"Briefly, heat inactivated, serially diluted sera, rAd5 luciferase and 1×104 A549 cells (human lung carcinoma) were incubated in 96-well plates."
1,"The effectiveness of the onsite mentoring program was evaluated using a parallel, cluster randomized control study design, with the nurse mentor intervention randomized to facilities and the staff therein."
0,Individuals were excluded from the analysis if they were nonadherent within 48 hours of PK assessment (Section I in S1 Appendix).
1,The trial incorporated pre- and post-intervention surveys to measure the changes in facility readiness and provider preparedness.
0,"The implementation costing method focused on the prospective identification, measurement and valuation of implementation activities."
14,"The study participants were blinded to all of the clinical assessments, including CFR, IMR, ECG, and MRI results."
0,The secondary outcomes are the answers on each of the 13 symptoms as well as the mean score of the six interference items.
14,The observers who analyzed the surrogate outcomes and those who adjudicated the adverse clinical events were blinded to all of the other clinical data.
0,"The study takes advantage of an ongoing initiative to disseminate CBT training in schools in the State of Michigan, the Transforming Research into Action to Improve the Lives of Students (TRAILS) program."
14,There was no blinding in the study.
0,"The relationship between urinary glucose excretion (UGE) and BG was approximated by an idealized threshold relationship: as used previously (11, 12)."
14,The statistician who analysed the data was blinded to group allocation.
0,"The study methodology involved a grounded theory constructivist approach [15], in which hypotheses are constantly reformulated throughout the recursive process of data collection and analysis."
3,"Patients will be recruited from outpatient HF clinics, cardiology departments, rehabilitation units, or primary care in Sweden, Italy, Israel, and The Netherlands."
0,The Familiarity Scale asks about previous experience with each prescribed eating and activity change.
3,"Diagnosed with HF (NYHA I–IV) by a cardiologist according to ESC guidelines1 [independent of EF: both patients with a preserved ejection fraction (HFpEF) and patients with a reduced ejection fraction (HFrEF) will be included].Older than 18 years, no upper age limit.Speak/understand the language of the country where the intervention takes place."
0,"Based on prior research examining the impact of MI, we expect that the intervention will result in improved oral health behavior through improved oral health knowledge, self-efficacy, and an increased sense of the importance of good oral hygiene."
3,The study included patients aged 18–75 years with a body mass index (BMI) between 18 and 40 kg/m2 who had OSA with an oxygen desaturation index (4%ODI) ≥15/hour or with an ODI ≥5/hour plus an Epworth Sleepiness Scale (ESS) >10 points.
0,"Other characteristics were obtained from two questionnaires, the risk-assessment questionnaire referred to above, and a questionnaire assessing knowledge of pregnancy-related risk factors and preventive measures, that was sent to women in the intervention group prior to the first invitation for PCC [19]."
3,"Exclusion criteria were obesity-hypoventilation syndrome, significant airway obstruction, acute or critical illness."
0,"At one year follow-up missing responses for these three groups were six, one, and four, respectively."
3,"From this population, participants aged 18 years and older will be selected based on the following inclusion criteria: presence of CVD (acute coronary syndrome, peripheral arterial disease, an aneurysm of the aorta, or stroke/TIA), diagnosed in the last 6 months by a medical specialist, willingness to remain in follow‐up for a period of one year, and provision of signed informed consent."
0,"Baseline characteristics of included and excluded patients were summarized by means and SD for normally distributed variables, medians and interquartile ranges (IQR) for skewed continuous variables, and numbers (%) for categorical variables."
3,"Exclusion criteria are pregnancy (reported by the patient), severe comorbidity (eg, a mental health diagnosis considered by a physician to be a contraindication), problems with the Dutch language (reported by the nurse), or logistic problems such as lack of computer access."
0,"Mama Mshauri assisted with expediting service provision, enhancing communication between participants and health providers, assisting participants to identify and problem-solve personal barriers to retention and adherence, providing psychosocial support and counseling, and reminding participants of upcoming clinic appointments via phone calls or SMS up to 1 week before scheduled appointments."
16,Unpaired student T-test and Chi-squared test were used to compare continuous and categorical data respectively.
0,"In this study, it will be administered only at the slowest presentation rate of 2.4 s."
1,This was an open-label clinical trial in which participants were randomized to one of three treatments: (1) Lorcaserin 10 mg by mouth twice a day for 12 weeks; (2) LLLT administered for one hour once a week for 12 weeks; or (3) combination therapy with lorcaserin and LLLT for 12 weeks.
0,An overall process evaluation plan was developed for this project.
3,"Eligible patients were adults with moderate to severe CKD (defined as serum creatinine (sCr) at screening of 2.0–5.0 and 1.5–5.0 mg/dL for men and women, respectively) who were not expected to require dialysis or renal transplantation within 6 months of trial entry and who were expected to survive for ≥1 year."
0,(For details of phase 2 see clinicaltrials.gov NCT02655835) The study was a pilot randomized controlled trial of English-speaking adults.
3,All patients were required to have proteinuria or progressive deterioration in renal function indicated by either a urinary total protein to urinary creatinine (UP/UCr) ratio >0.5 at screening or an sCr level that had increased by >10 % at a second evaluation conducted 3 months after screening.
0,The presence of significant hypertension was defined by prescription of antihypertensive medications (angiotensin converting enzyme inhibitors and angiotensin II receptor blockers) using electronic prescription records kept by every practice included in the study.
6,"The primary end point was a triple composite of the time from the date of group assignment to the date of kidney disease progression, as indicated by dialysis initiation, kidney transplantation, or doubling of the sCr level, whichever occurred first."
0,Group members who miss a session receive follow-up from the group facilitator before the next session.
14,"The researcher conducting all outcome assessments was blinded to group allocation of participants, but it was not possible to blind the treating physiotherapists."
0,"Study phases included screening/washout, baseline randomization and measures, and a 4-week double-blind evaluation of LDX versus placebo."
14,Care was taken to conceal the study hypotheses from the participants as well as any clues to their allocation to tailored or non-tailored treatment.
0,Eligibility was checked again during a screening visit at which weight and height were measured.
6,The primary outcome was postprandial glycemic control following each intervention.
0,"We used the NBS Toolbox17 to analyze functional matrices with statistical threshold P=0.01, 10 000 permutations, t-threshold=6, and exchange blocks for paired comparisons."
6,"Secondary outcomes included insulin levels and insulin sensitivity measures after each intervention, and ancillary analyses included RPE and preferred exercise intervention."
0,"The goal of the HE intervention was to improve oral health-related behavior also, but not through a patient-centered dialogue."
16,Repeated measure analysis of variance was used to evaluate the statistical difference between responses of the 3D7 and 7G8 peptides.
0,"To ensure participation of patients with little or no written or spoken English, translation services will be provided as necessary."
16,Proc Mixed of SAS 9.3 was used for this analysis.
0,"Information collected from each participant included family history, lifestyle factors (eg, smoking and alcohol consumption), anthropometric measurements and biochemical studies (eg, fasting glucose, lipid profile and uric acid)."
3,Patients of both sexes and over 40 years of age diagnosed with unilateral symptomatic OA of the knee who met the criteria of the American College of Rheumatology (ACR) [18].Patients who were rated grade II or III on the Kellgren and Lawrence (K&L) radiological scale [19].Patients with symptomatic OA with a global mean pain in the knee >40 mm on a Visual Analogue Scale (VAS) for pain assessment.
0,"All patients, regardless of TE threshold result, received lifestyle advice from the nurses and were given the British Liver Trust ‘Looking After Your Liver’ leaflet."
3,"Women who were pregnant or breastfeeding.Patients with any form of decompensated or uncontrolled heart disease, diagnosed with renal or liver failure, severe infections, decompensated asthma, or a history of either alcoholism or another drug addiction and/or uncontrolled active psychiatric disorder.Patients who were grade I or IV on K&L radiological scale.Patients with bilateral symptomatic knee OA or symptomatic and developing OA in 3 or more joints, including the knee targeted in the study.Patients who have had a prosthesis replaced in the 12 months prior to inclusion.Concurrent joint rheumatisms (history and/or presence of signs at the time of selection) that could give rise to a misinterpretation of the evaluation of efficacy against pain or interfere in the evaluation, such as chondrocalcinosis, Paget’s disease of the limb which is ipsilateral in relation to the affected knee, rheumatoid arthritis, aseptic osteonecrosis, gout, septic arthritis, ochronosis, acromegaly, hemochromatosis, Wilson’s disease, osteochondromatosis, seronegative spondiloarthropathy, mixed conjunctival tissue disease, collagen vascular disease, psoriasis, inflammatory bowel disease.Participants who had a diagnosis of fibromyalgia (either by rheumatologist diagnosis, the 1990 American College of Rheumatology (ACR) criteria [20] or the Modified 2010 ACR (ACR) criteria [21].Patients who performed intense physical activity (daily or almost daily exercise practice).Patients with an osteotomy in the study knee.Arthroscopy in the previous 3 months.Patients with a contraindication for the use of CS.Patients who have used hyaluronic acid (intra-articular hyaluronic acid in the affected knee) during the 26 weeks prior to inclusion.Patients who have received intra-articular corticoid infiltrations in either their hips or knees in the 3 months prior to the intervention.Patients who had received oral corticoids in the 3 months prior to starting the study.Patients who had taken any of the drugs classified as SYSADOA in the three months prior to the baseline visit.Patients who had taken oral and/or topical NSAIDs (including COXIBs) at anti-inflammatory doses during the 30 days prior to the baseline visit.Patients who had used medicinal plants or homeopathic products and analgesic creams or gels during the week prior to inclusion."
0,"Eligibility criteria also included adequate liver, renal, cardiac and bone marrow function; normal electrolytes; normal thyroid function (or on adequate replacement doses); normal LVEF by MUGA or echocardiogram; measurable disease per RECIST 1.0 criteria; and Eastern Cooperative Oncology Group (ECOG) performance status of 0–2."
3,"Mentally competent ambulatory outpatients of any age > 18 years with advanced lung cancer were eligible to participate whether or not they were receiving specific anti-cancer therapy, with the following exceptions: current use of any vitamin D supplement equivalent to > 1000 IU per day, current therapy with any dose of calcitriol, a recent history of extensive sunlight exposure (>30 min of summer sunlight exposure more than 5 days per week), non-fluency in French or English and no capable neutral translator available, current diagnosis of primary hyperparathyroidism, existing nephrocalcinosis, hypercalcemia, current or suspected tuberculosis, histoplasmosis, sarcoidosis or other granulomatous disease, pregnancy, or anticipated death within 2 months."
0,The observation protocols were pre-tested and modified into Finnish context in autumn 2014.
1,"This 56-week, randomised, double-blind, placebo controlled trial (RCT) (ClinicalTrials.gov NCT01616732) was conducted at a tertiary referral centre (Austin Health, Melbourne, Australia)."
0,The patients will be placed in an intensive care unit for at least 24 hours.
1,"The study was approved by the Human Research Ethics Committee, Austin Health (HREC 2012/04495)."
0,"Eight weeks after the commencement of nivolumab, he developed a new enhancing lesion within the right sylvian fissure with surrounding vasogenic edema at the site of initial tumor."
1,A double-blind randomized trial compared the effect of KRTF with the traditional teaching method when learning two ankle joint mobilization techniques (dorsiflexion and plantar flexion with displacement of the talus).
0,No injection was given at a location in which the draining lymph nodes had been removed.
1,Data collection of the study was conducted between 15 September 2015 and 30 November 2015 at a Faculty of Health Sciences.
0,We used practice records to identify eligible patients 18 years or older with a complaint of dizziness during the past two years (box 1).
6,The primary objective was to evaluate the safety and tolerability of nintedanib combined with LDAC to establish a P2RD.
0,All medications were dispensed by the study site pharmacies.
6,Secondary objectives were treatment response and overall survival (OS).
0,We leveraged clinical and genetic data obtained from the GO-FURTHER phase III clinical trial for 436 patients with moderate to severe RA [23–25].
1,A Markov simulation model with a time horizon of 40 years was populated with patient-level data from a 18-months randomized clinical trial in the Belgian primary care setting involving 574 type 2 diabetes patients [13].
0,"At time of evaluation, forty-three of the patients were on anti-diabetic therapy (13 patients were treated with oral anti-diabetic agents and 30 with insulin)."
1,"Belgian guidelines for health economic evaluations were followed in methodology and the Consolidated health economic evaluation reporting standards (CHEERS) in reporting [14, 15]."
0,Apolipoprotein (Apo) B-100 concentrations were measured in plasma by the rocket immunoelectrophoretic method of Laurell [38].
5,"The COACH Program is a risk factor target-driven telephone counselling intervention delivered by diabetes nurse educators, who have followed a one-week training course."
0,Study visits were scheduled to follow a logical sequence to monitor patient safety and compliance with trial requirements.
5,"It consists of five telephone sessions of 30 minutes on average, spread over 6 months, focused on achieving guideline-recommended diabetes treatment targets through regular control of diabetes risk factors including self-monitoring of blood glucose, appropriate lifestyle adjustments and intensification of medication therapy upon a consultation with the patient’s GP [13]."
0,The average measurement time was 20 min.
3,People between the ages of 18 and 75 diagnosed with type 2 diabetes and on diabetes medication therapy were invited into the study by their health insurance fund based on the reimbursement data of glucose-lowering agents in the preceding 12 months.
0,A follow‐up period of up to 6 months would be required to obtain sufficient efficacy and safety data.
3,"Exclusion criteria comprised patients on corticoid therapy and/or with a debilitating coexisting medical condition such as dialysis, mental illness, or cancer; residence in long-term care facilities; pregnancy; insufficient proficiency in Dutch [13]."
0,In the first part of the QUOTE the perceived importance of care-aspects in anxiety and depression are measured.
6,"Incremental cost-effectiveness ratio (ICER), Life Expectancy, Quality Adjusted Life Years (QALYs) and cost of diabetes and its complications."
0,This study consisted of 2 phases: the dose-escalation and expansion phases.
6,"These analyses were performed for the entire cohort as well as for a subgroup of patients with inadequate glycemic control at baseline, i.e. glycated hemoglobin (HbA1c) ≥7%, in line with the clinical trial analysis [13]."
0,"Data allow us to examine differences in underperforming physiologic and neuromotor systems (e.g., low cardiorespiratory reserve, musculoskeletal weakness, balance impairments) and to develop interventions that address these deficits."
3,Patients were recruited from the orthopedic outpatient clinic at Ramathibodi Hospital by orthopedic residents and staff between August 2013 and August 2014.
0,An aliquot of freshly isolated plasma was processed for ascorbic acid analysis.
3,Residents and staff were trained in how to recruit and inform patients about the trial.
0,"Upon hospital arrival, a systemic temperature probe will be placed (i.e., bladder, arterial, rectal) and core temperature will be recorded."
5,"All patients were treated with oral everolimus at a dose of 3mg/m2/day taken either daily or every other day, titrated to achieve target trough blood concentrations of 5 to 15ng/ml, and adjusted per patient tolerability."
0,Table 1 summarises the two intervention programmes.
5,"Treatment continued until all patients had received ≥60 months of everolimus (last patient, last visit) or had discontinued from the study."
0,"Weight was measured in light clothing without shoes using a digital scale (Seca 808; Seca, Hamburg, Germany)."
3,"Eteplirsen studies 4658‐201/202 were approved by the relevant institutional review boards prior to implementation, and informed consent/assent was obtained from each subject and family prior to enrollment."
0,"Five of the six patients reported being advised to ‘lose weight’, ‘change their diet’ or ‘exercise more’ although they were not offered any specific support or advice on how to achieve this in the context of their everyday lives."
3,"Patients eligible for this study were 7 to 13 years old, were able to walk 180 to 440m on the 6MWT, had confirmed out‐of‐frame dystrophin deletion mutations amenable to exon 51 skipping, and were on stable corticosteroid therapy for ≥24 weeks (Tables 1 and 2)."
0,"The RCT comprises an exploratory trial, to complete the modelling and piloting phase of the MRC 4-phased framework [26]."
1,We conducted a one-group pilot study with a pre-post evaluation design to evaluate the feasibility and preliminary efficacy of a human counselor–delivered behavioral intervention incorporating multiple mHealth strategies targeting weight management behaviors among breast cancer survivors (ClinicalTrials.gov NCT02387671).
0,The study was conducted from 25th March.
1,The protocol was approved by the Boston University Medical Center Institutional Review Board.
0,"A total of 20.000 simulations were made from these a posteriori distributions, and the corresponding 20.000 differences θ1 - θ2 were calculated providing an a posteriori distribution of the difference between the proportions: Δ = θ1 - θ2."
1,This study had an exploratory design with a qualitative phenomenological lifeworld approach.
0,"In the second analysis, patients were exposed to at least two checklists and in the third analysis at least three of the four checklists."
1,"Further details regarding study recruitment, inclusion and exclusion criteria, the screening process, randomization, assessments, baseline and follow-up interviews, and institutional review board approval are presented in Part 1 of this study [23]."
0,Child presenting to a study health facility for an initial visit.
3,The study population will be drawn from among the approximately 4000 patients with SCA who are registered at the Muhimbili Sickle Cell Clinic.
0,A positive response was defined as a skin wheal diameter of 3-mm or more compared to negative control.
3,The main mDOT-HuA study inclusion and exclusion criteria are listed in Table 2.
0,Figure 1 Geographical location of the 4 study sites in Maputo Province showing prevalence of malaria at the study start.
1,"A 16 week randomised controlled trial with focus on feasibility and acceptability, and with blinded outcome assessors."
0,Dual X-ray absorptiometry scan and abdominal computed tomography scan at the L2-L3 interspace were performed to obtain anthropometric indices (15).
1,"An open label, randomized control design was used."
0,The control group in this study will be the 0.4-mg folic acid group.
1,"This is a single-center, 5-year follow-up study (MYSTAR-5-YEAR, clinicaltrials.gov NCT01395212) including patients who participated in the MYSTAR trial at the Medical University of Vienna (clinicaltrials.gov NCT00384982) (Fig 1) [5]."
0,Vestergaard Frandsen donated insecticide-treated bednets and water filters.
6,All primary and secondary outcomes are presented in Table 5 below.
0,"Fasta and qual files were then generated, and the primers were removed from the 3′ end of the sequence, allowing one mismatch in addition to primer degeneracies."
1,"Phase II comprised the second stage of the MRC framework14 and consisted of a randomised feasibility study, including focus groups of the multidisciplinary rehabilitation teams, hip fracture patients and their carers."
0,"During the second session, patients in the MIRT-Lokomat group underwent 20-minutes Lokomat® training per day, 5 times a week, for 4 weeks."
1,An anonymous cohort study of all proximal femoral fracture patients was also conducted to assess the feasibility of recruiting a representative sample by comparing the recruited participants with the cohort population.
0,"After the recruiting doctor had obtained informed consent and enrolled the participant, participants were allocated randomly to treatment policy by phone or fax by way of the minimisation method, which was balanced across centre or region and number of seizures at randomisation."
3,"Age 65 years or older Recent proximal hip fracture Surgical repair by replacement arthroplasty or internal fixation Living in their own home prior to hip fracture Capacity to give informed consent, as assessed by the clinical team in the acute hospital."
0,Patients were asked to complete the cost diary up to 26 weeks follow-up.
3,Patients with postoperative delirium were approached if this was resolved prior to discharge from the acute hospital.
0,Tests were interpreted as positive if there was any colouration of the test line.
1,"This was a randomized, controlled, modified Latin square parallel design study with two treatment arms to examine the effects of the inclusion of walnuts in the diets of adults at risk for type 2 diabetes on their dietary patterns over a 6-month period."
0,"A fourth protocol amendment was made on 12 October 2015 to clarify that IRF and intraretinal cysts that, in the Investigator’s opinion, are likely to be recalcitrant to anti-VEGF treatment are not considered in the treatment protocol when making treatment extension decisions to align with standard clinical practice."
1,"After a 4-week run-in period of an ad libitum diet, participants were randomized to one of four possible sequence permutations, and then crossed over following inclusion of 56 g walnuts per day, or walnut exclusion, for 6 months in their diets in random sequence, with a 3-month washout between treatments."
0,"To foster referrals from within the WFBH system, several study investigators made presentations at Internal Medicine and Family Medicine faculty meetings."
16,"Standard statistical methods (Data Supplement) were used to assess significance for associations between ASCO-CAP FISH groups and HER2 protein expression (Friedman tests and χ2 tests) and clinical outcomes (log-rank tests) in BCIRG-00519,25 and BCIRG-006.4,26"
0,"We selected major osteoporotic fracture for this study because it addresses all bones and provides the highest percent risk of the two calculations, which may have more of an impact on a general population with low health numeracy."
3,"Individuals aged from 20 to 60, healthy on the basis of physical examination and routine biochemical and hematological laboratory determinations, with willingness to provide written informed consent and to adhere to the protocol."
0,Samples were measured by high‐performance liquid chromatography with electrochemical detection.
3,"Smoking, intake of antioxidant supplements, aspirin, or any other drug with established antioxidant properties, hyperlipidemia, obesity (body mass index >30 kg/m2), diabetes, hypertension, celiac or other intestinal disease, any condition limiting mobility, life-threatening diseases, or any other disease or condition that would impair compliance."
0,"Some therapy and medical staff work across wards, in particular out-of-hours, or to cover shortages elsewhere, but the additional specialist staff do not."
4,"Participants will be recruited from the general population of Granada, Spain, by using newspaper and tableaux advertisements in civic centers."
0,"Nasal gene expression profiles associated with COPD were identified using a linear regression model with the log2-transformed expression of each gene as dependent variable, and COPD, age, gender, packyears, RNA integrity number (RIN), and the first 4 principal components (PCs) as independent variables."
4,A total of fifty-four individuals (27 males and 27 women) are expected to be recruited in this trial.
0,"As to the frequency of the contacts, most workers suggested about once a month."
1,"This is an observational, single‐center cohort study based on data from the SMURF (Symptom burden, metabolic profile, ultrasound findings, rhythm, neurohormonal activation, hemodynamics, and health‐related quality of life in patients with AF) study.21"
0,"Role-playing offered an opportunity for the HEs to refine their skills in both English and Spanish with a variety of individuals, many of whom they had never met before, and all of whom attempted to approximate the diverse participants the HEs would encounter in the field."
1,"This multicenter, randomized, blinded, sham controlled, parallel group clinical trial was conducted at 43 North American university affiliated academic trauma centres between October 2008 and March 2013."
0,"ADHD patients with an intelligence quotient (IQ) below 70, a past or an ongoing history of either tic disorder, obsessive compulsive disorder, language disorder, learning disorder, convulsive disorder, pervasive developmental disorder, schizophrenia, bipolar disorder, or brain damage, a past history of taking stimulants or atomoxetine longer than 6 months, or a recent history of taking stimulants or atomoxetine during the last 4 weeks were excluded from the study (Hong et al., 2015)."
1,There were no shared patients between the TRUST pilot study12 and the TRUST definitive trial.
0,"The seminars had preventive aims--for the patients to reflect on how to prevent a new, similar occurrence of sick leave, and for the supervisors on how to prevent work stress-related sick leaves among their employees."
1,"A vignette-based study was conducted as an extension to a multicentre, pilot randomised controlled trial."
0,"Hence, patients randomized to sequence 1 participated in the study for 22 weeks and patients randomized to sequence 2 participated for 20 weeks."
1,Its aim was to explore consistency and variability of eligibility assessments made by those involved in screening hospital notes and communications to identify patients for recruitment.
0,We assigned members from the same household to receive the same information (n=6).
6,Major cardiovascular events are defined as:Sudden cardiac death (SCD) defined as a sudden pulseless condition out of the hospital (most probably due to arrhythmia).
0,"We carried out a four group (2×2), parallel, factorial randomised controlled trial among callers to the English National Health Service smoking helpline, which assists smokers who live in England."
6,"The primary objective was to assess the tolerability, safety and efficacy of prophylactic treatment using biosimilar filgrastim in patients receiving cytotoxic chemotherapy for cancer, with an emphasis on patients undergoing in-patient treatment."
0,Date of notification of the enrolling site was recorded on the “Step 0” enrollment forms.
6,The secondary objectives were to describe the characteristics of patients being treated with biosimilar filgrastim; the treatment modalities using biosimilar filgrastim; and the characteristics of participating physicians and their prescribing practices with regard to G-CSF.
0,"For the Putting Life In Years RCT, mail-outs were also sent via an existing cohort study (the South Yorkshire Cohort) to individuals who were willing to be contacted regarding future research [29]."
8,"The study population size was calculated considering a LVEF of 65 (±5) % in the control group, as previously reported [18]."
0,"The dose was adjusted with regard to postprandial (2 hours after meal) glucose levels: The dose should be adjusted by about 10–20%, approximated to full or half units (see Figure 2)."
8,"Assuming a clinically relevant reduction from 65 to 55 % in the TBI group, with a two-sided type 1 error of 0.05 and a power of 80 %, 20 patients per group were needed to detect this difference."
0,"Secondary end points were PFS, OS and safety."
8,"As a pilot trial, the primary consideration for the sample size is the ability to inform the feasibility of a full-scale study."
0,We chose these landmarks as they are easy to recognize from the endoscopic image.
8,"We propose a sample size of 50 adults in each treatment group for a total sample size of 100, while stratifying for participants with either myeloma or any other haematological malignancy."
0,Women who fulfilled the inclusion criteria and agreed to participate in the study were asked to provide a written inform consent.
4,"De-identified demographic, office visit and vaccination data were derived from EMR data extractions performed by the UPMC Center for Assistance in Research using the eRecord and from a similar EMR extraction by staff of the SPUR-NET for the Houston sites."
0,"Data will be generated from focus groups, in-depth semi-structured interviews, medical records, questionnaires, clinical and anthropometric measurements and blood biochemistry."
4,"A longitudinal data base was created with only those patients who had a visit each year during all three years, creating a cohort of individuals who would have been patients of the practice during the entire study period."
0,"The second page reported recent site-specific activities (e.g., competition results, co-worker testimonials)."
16,"Changes in RQLQ and IgE were compared to the first time point (T0; before first herbal plaster) via a paired Student’s t-test and a Mann Whitney U-test, respectively."
0,"μ Refused surgery (n = 7), re-operated upon with a fusion (n = 2)."
4,Trinity Health is one of the largest multi-institutional Catholic health care delivery systems in the nation.
0,"GoTaq Flexi DNA Polymerase (Promega, Madison, WI) was used as thermostable DNA polymerase."
4,"Committed to those who are poor and underserved in its communities, Trinity Health serves people and communities in 21 states with 124 continuing care locations, and 91 hospitals, of which five Michigan hospitals were included in the study."
0,"Additional file 1, panel c, shows an FSC-SSC dot plot to show how each population was defined on the basis of size and granularity."
3,Subjects 20 years or more in age with documented H pylori infection (as described below) were eligible for enrolment.
0,"Physical activity was measured using the ActiGraph GT3X+ accelerometer (Pensacola, FL, USA) [32]."
3,"Subjects with any one of the following criteria were excluded from the study: (1) history of gastrectomy, (2) previous eradication therapy for H pylori, (3) pregnant or lactating women, (4) contraindication or previous allergic reaction to the study drugs, (5) use of antibiotics within 4 weeks and (6) severe concurrent diseases or malignancy."
0,The safety population included all patients who received at least one dose of the study treatment; patients were analysed according to the treatment they received.
3,"Eligible participants were category 2 beneficiaries between 18-65 years, who were asked to meet at the municipal jobcentre for their first interview after sickness absence."
0,"AUCgluc60 was defined as the area under the curve from 0 to 60 min after glucose ingestion, the period during which plasma glucose concentration increases."
3,Participants were included between 1st January 2011 and 1st June 2012.
0,"In contrast, for Cohort B the preprocedural A-MSCT derived, recommended CAA was used for the first aortic root angiogram."
3,"Subjects enrolled in the registry included individuals of any age who used pnfC1-INH for any reason, irrespective of regionally approved product indication."
0,"The letter provided the URL to the data collection page, but also contained a paper-based version of past week drinking and the health service utilisation questions."
4,"After baseline information was collected during screening, subjects used diaries to record pain intensity (rated at 15 minutes, 30 minutes, 1 hour, and 2 hours after treatment), attack duration, rescue medication use, AEs, device perceptions, and blinding questionnaire responses for each attack."
0,"Women agreeing to participate, should they choose to deliver at home, were asked to contact the field worker after the onset of labor."
6,"Potential prognostic factors were assessed by means of the CINS questionnaire at baseline assessment (t0) which included Norwegian versions of instruments, covering a broad range of factors including demographic variables, physical variables, individual- and work related psychological variables and social support."
0,The anterior and posterior vessel walls are delineated (A).
3,CF Individuals older than six years were included with persistent S. aureus airway cultures one year before recruitment.
0,"Thirty minutes after the baseline blood sample a primed continuous infusion of [2H5]phenylalanine (0.05 μmol·kg−1·min−1; 2 μmol·kg−1 prime; Cambridge Isotopes Laboratories, Andover, MA, USA) was started."
4,"The study was conducted in a Community Psychiatric Service (CPS) in the New Territories, the largest geographical region of Hong Kong SAR, China."
0,Both patients and PCPs will be notified of positive screening results for all patients assessed.
4,"The multi-disciplinary community psychiatric team provided both crisis intervention and longer-term, recovery-focused community psychiatric services for people with different types of mental health problems."
0,"When the costs of condition specific procedures performed were unavailable, we applied day reference costs for gynaecology patients."
6,The primary endpoint was the change in BCVA from baseline to month 6 in patients treated with DEX implant.
0,The intervention has been described in detail elsewhere [7].
6,"Key secondary endpoints included characteristics of patients treated for RVO-related ME with or without DEX implant, and the following endpoints in patients treated with DEX implant: treatment methods; RVO treatments and procedures administered; change in BCVA from baseline at each follow-up visit; percentage of patients with at least 15-letter improvement in BCVA from baseline at each follow-up visit; AEs during the DEX implant injection procedure and throughout follow-up validated by an ophthalmology specialist and coded using MedDRA version 16.1; mean IOP at each visit; and changes in quality of life from baseline to months 4 and 24."
0,"For quality assurance and equilibration, a calibration block was scanned each morning."
6,Secondary outcome measures include:All-cause mortality within two years of follow-up.
0,Written informed consent was obtained from caregivers for each different activity.
6,"In addition, we will assess mortality in the period between three months and two years after inclusion in patients who were alive at three months of follow-up.Improvement according to the classical dichotomizations of the mRS at two years including mRS 0–1 (excellent outcome) versus 2–6; mRS 0–2 (independency) versus 3–6, and mRS 0–3 (moderate good outcome) versus 4–6.First new major vascular events between three months and two years of follow-up.The quality of life using the EuroQol EQ-5D-3L questionnaire."
0,Tumor volume was calculated by the formula length * width * height / 2.
17,"Subgroups will be analyzed with an interaction term for each subgroup by treatment allocation and reported as subgroup-specific estimates with 95% confidence intervals, displayed in a forest plot."
0,Data on level of sedation were not collected.
16,The total amount of Cal/BD foam used during the study was evaluated according to three baseline disease assessments: the extent to which a patient’s BSA was affected by psoriasis vulgaris; PGA; and mPASI.
0,This masking process could be compromised through contact with treating clinicians but knowledge of referral origin was reduced by accommodating researchers in a different part of the building from the clinical team.
16,The proportion of patients achieving treatment success was stratified according to body weight and body mass index (BMI).
0,"Determination of PWV was done at the Department of Physiology, Linköping University Hospital, Linköping and at the County Hospital Ryhov, Jönköping, as described previously [19, 20]."
3,Children studied were a subset of the Kansas University Docosahexaenoic Acid (DHA) Outcomes Study (KUDOS; NCT00266825) cohort [17].
0,"Flavanol monomers and O-methylated metabolites were analyzed using a Hewlett-Packard 1200 series HPLC (Hewlett-Packard, Palo alto, CA, USA) equipped with diode array and fluorescent detection."
3,Both the research protocol and informed consent adhered to the Declaration of Helsinki and ethical approval was obtained from the University of Kansas Institutional Review Board (HSC #11406).
0,Maternal height and pre-pregnancy weight in the Registry had differential missing rates that did not permit these to be included in this analysis.
6,The study assessor who collected the outcome measurements was blinded to the study hypotheses and group allocation.
0,Worms were incubated for 4–6 days and F1 growth compared between wells with and without CX-5461.
16,"Descriptive statistics were used to summarize the demographics, baseline characteristics, clinical outcomes, microbiological outcomes, and genotypes of patients, and 95% confidence intervals (CIs) were calculated by the Wilson score methodology to compare the relapse rates at LFU."
0,"Table 1 Follow up and contacts with health professionals The TB DOTS facilitators and primary care doctors will be given a training course (using training manual) on the ""five steps to quit"" programme on the use of desk-guide and focusing on[30]: • The scientific basis of the intervention • Techniques to enquire about the status of tobacco use • Providing brief advice on the benefits of stopping its use through visual images • Approaches to assess nicotine dependence and motivation to quit • Using this motivation to propose various treatment options explaining their pros and cons • Training in the use of available pharmacotherapies and other cognitive-behavioural strategies • The procedure for follow-up and other technical and organisational aspects."
16,"Statistical analyses were performed using SAS version 9.1 (SAS Institute Inc., Cary, NC)."
0,"Patients with clinically stable, GOLD stages III and IV flow limitation and chronic hypercapnic (prolonged hypercapnia during daytime at rest without oxygen or ventilatory support for at least 3 months), aged ≥40 years, were eligible for this study."
16,"All the analyses were descriptive and performed using SAS® 9.4 software (Cary, NC, USA)."
0,No neuromuscular blockade was used.
6,"Study outcomes included PHiD-CV effect on S pneumoniae colonization (including all pneumococcal serotypes, vaccine serotypes, non-vaccine/non–vaccine-related serotypes, and vaccine-related serotypes, particularly 6A and 19A) and other bacteria (NTHi, Moraxella catarrhalis, and Staphylococcus aureus).Study outcomes also included all-cause AOM and all-cause AOM with antimicrobial prescription."
0,Details of the vaccination schedules have been described earlier [11].
6,"We assessed effectiveness in reducing the number of children reporting ≥1 AOM episode, and in reducing the occurrence of all AOM episodes."
0,"Endotoxin core antibodies (EndoCAb) IgM and IgG were measured by ELISA as previously described [39,40]."
1,"We conducted a multi-journal, two-arm parallel group, randomised trial to assess the impact of the WebCONSORT tool compared to a control intervention on the completeness of reporting of randomised trials submitted to biomedical journals."
0,Measurements and calculations obtained were in accordance to standard procedures recommended by the American Society of Echocardiography.
1,"The study obtained ethics approval from the University of Oxford Central Research Ethics Committee, Oxford, UK (MSD-IDREC-C1-2012-89) and is registered on ClinicalTrials.gov (NCT01891448)."
0,Hepatobiliary adverse events (AEs) were defined as any AE with a MedDRA (ver.
3,"Couples were eligible if patients, with a willing partner able to speak and read English, met the following criteria: had a diagnosis of type 2 diabetes for >1 year (diagnosis confirmed by medical record and/or A1C level); baseline A1C level of ≥7.5% (58 mmol/mol); ≥21 years of age; able to speak and read English; in a self-defined committed relationship for ≥1 year; no severe medical or psychiatric conditions that might interfere with participation; and telephone access."
0,LV mass is calculated as the product of myocardial density and myocardial volume.
5,"After a screening visit (within 30 days of baseline), patients were centrally randomized using an interactive voice response system/interactive web response system in a 1:1 ratio to one of two sequences of adalimumab [either the 40 mg/0.8 mL or 40 mg/0.4 mL formulation at visit 1, followed by the other formulation at visit 2 in a blinded manner (Fig. 1)]."
0,"If the monitor is still not returned after 6 weeks, the participant is randomised."
5,The timing of the second visit was based on the regularly scheduled doses of adalimumab required by the patient’s prescribed on-label dosing schedule (eow or ew).
0,"The primary outcome was the incidence of composite outcome, consisting of completed suicides and suicide attempts that required admission to an emergency ward for critical care."
4,"Each data collector received training for data collection and was required to use an adapted standardised protocol for data collection, an optimised version of the one used in the Hutchinson Smoking Prevention Project, which was discussed with and provided by the original authors.19"
0,The protein intensities are log2-transformed and normalized by subtracting the median intensity in each column/sample.
8,The sample size was calculated after conducting a pilot study on 5 participants.
0,Nausea or vomiting was treated with 4 mg of intravenous ondansetron.
8,It was found that sample of 14 participants was enough to reject the null hypothesis between test and placebo at probability power of 0.95 and 0.05 type I error probability (see additional file 1).
0,"Also, we added an additional table to the questionnaire containing the following respite services: day care (replaced from another table), night-time care (community-based or residential), short-stay, day sitting service, and in-home respite care (type Baluchon)."
14,"The surgical team, including who applied the dressing, the laboratory technicians who processed the samples and the microbiologist were blinded to patient grouping."
0,The objective of using personal feedback coaching based on a mobile app and a wearable activity tracker is to lose weight for a healthy lifestyle.
14,It was not possible to blind patients and the surgeon who assessed SSI.
0,Compliance was further assessed through trough VPA levels.
8,The study size was based on the main outcome mortality.
0,Adherence was assessed based on clients’ visit attendance and self-reported meal replacement consumption.
8,"With 6000 children and a mean MUAC of 14.55 cm (SD = 1.3 cm) by 9 months of age, we would be able to show a difference of 0.1 cm in MUAC with a power of 80% and a significance level of 0.05."
0,This study was conducted according to the principles expressed in the Declaration of Helsinki.
8,The sample size of 75 patients (25 in each arm) was calculated assuming an SD of 0.25 with the aim to detect a minimum difference of 0.2 logMAR units at the 5% significance level (two-sided) with 80% power.
0,The results of presence/absence of calculus and stain index24 were analyzed by Kappa-statistics.
14,The research orthoptist who delivered the treatment was aware of the patient allocation but not of visual acuity measurements which were performed by an independent orthoptist who was masked to the treatment allocation.
0,Study implementation begun after intervention-facility providers were certified as attaining a pre-determined minimum level of clinical skills.
14,"The test assessors were blinded to group allocation, and long pants or neoprene sleeves were worn by participants over both knees to hide possible surgical scars and preserve blinding of group allocation."
0,"Following the protocol amendment, all the participants yet to receive the booster dose, received the licensed DTPa-HBV-IPV/Hib formulation."
14,The statistician was blinded to group allocation during the analysis.
0,The final protocol and informed consent documentation were reviewed and approved by the Institutional Review Board(s) (IRB) and/or Independent Ethics Committee(s) (IEC) at each of the investigational centers participating in the study.
16,"We used descriptive statistics (frequencies, median/mean, and/or range) to summarize data on reach parameters (computer access, connectivity, and bandwidth) and implementation (program errors and technical issues)."
0,"With this process, besides generating the allocation sequence, the PI was be able to enrol participants, assign them to the intervention and also follow them up without compromising the allocation concealment and the blinding/masking."
16,"Regarding youth engagement, for each parameter we calculated the percent of youth who rated each program favorably, and the range of ratings across all 6 programs, from lowest to highest."
0,"If knee pain increased by 2/10 points from pre-exercise pain on a Visual Analog Scale (VAS) during any exercise, participants were instructed to ask for a modification to alleviate discomfort."
1,The study is designed as a two arm randomised controlled non-inferiority trial comparing B-CBT for adult depression to treatment as usual (TAU) with an economic evaluation alongside.
0,Significance testing was then performed between modalities using an ANOVA test combined with a Tukey multiple comparison test [23].
1,The present trial is part of the national project ENTER located and coordinated from the Center for Telepsychiatry and is additionally affiliated with the EU-study E-COMPARED [28].
0,"The only difference from the procedures described in the 2009 [14] paper, wherein research assistants either called or emailed those who did not submit follow-up data after the automated email contact, was that in the present study we did not use live follow-up."
3,Patients were aged ≥18 years with a diagnosis of PDPN due to type 1 or type 2 diabetes mellitus for ≥1 year prior to the screening visit.
0,"After culture at 37°, 5%CO2 for 60 h, the culture were pulsed with 1 µci of [3H]TdR for 12 h before harvesting the cells using a semi-automated sample harvester."
3,Key criteria for inclusion and exclusion are presented in Table 1.
0,"The cDNA synthesis control (UniSp6) was added in the reverse transcription reaction, giving the opportunity to evaluate the RT reaction."
16,"All analyses were done on SPSS for Windows (Release 11.5.1)-statistical package (SPSS Inc., Chicago, Illinois)."
0,"Surgery should be performed 8–12 weeks after termination of chemotherapy, and a minimum of 8 weeks after the final dose of bevacizumab."
3,We approached 238 students without prior statistical training to recruit the necessary 184 students who agreed to participate.
0,"Data will be collected through observation of health worker practices at baseline, midline and end line."
3,"(See power calculation below) Students attending the University of Hamburg (health sciences, biology and sports), a vocational college (health and nursing) or taking part in an in-service training (nursing and public health) were informed about the timing and content procedure of the study during their courses."
0,"Muscle will be obtained with the percutaneous needle biopsy technique (Bergstrom needles, DePuy Co., Inc., Warsaw, IN)."
8,"Accepting an alpha risk of 0.05 in a two-sided test with 243 subjects in the first group (normal weight) and 175 in the second group (obesity), the statistical power was greater than 99% to recognize as statistically significant a difference of means (97.9 of FVC% in normal-weight group and 87.8 of FVC% in obesity group)."
0,The data for the current analyses are from the KAN-DO (Kids and Adults Now – Defeat Obesity!) study and its supplemental study about the role of the family in the development of healthy habits.
8,"Moreover, accepting an alpha risk of 0.05 in a two-sided test with 243 subjects in the first group (normal weight) and 303 in the second group (overweight), the statistical power was 98% to recognize as statistically significant a difference of means (97.9 of FVC% in normal weight group and 92.8 of FVC% in overweight group)."
0,Data analyses will be completed using an “intention-to-treat” principle (Montori & Guyatt 2001).
4,Participants will be recruited from the inpatient unit and day hospice at an 18-bed specialist palliative care unit in Northern Ireland.
0,"All five components contribute to the score equally, yielding overall scores ranging from 0 to 500."
2,Any protocol amendments will be discussed firstly with the university’s Research Governance to assess if they constitute a minor or major amendment.
0,Children’s group topics paralleled those of the parent but were more game-like to educate them in a developmentally-appropriate and engaging manner.
2,Approval will then be sought from the ORECNI before any amendments are implemented.
0,"Sixty-five (19.9%) participants did not provide a (valid) email address, and 2 (0.6%) participants reported being younger than 18 years."
8,"The primary objective of this feasibility study was to determine the feasibility of the program, thus we focused on determining the number of participants that we could recruit over the 6 months at the study site, to provide information on the number of sites and time needed to recruit the sample required for the RCT."
0,Baseline HR was measured at the end of an average 4‐week washout of antihypertensive drugs (HR1).
8,"We also thought the 6-month time frame would generate a sample of between 20 and 40 participants, the size that Hertzog [77] found sufficient for pilot and feasibility studies that varied in terms of purpose, desired precision, and effect sizes."
0,Participants allocated to the two intervention groups (the Prosdex group and the paper version group) and the first control group (named the “questionnaire control group”) were asked to complete a questionnaire.
1,"We performed a randomized, double-blind, placebo-controlled, crossover trial collecting baseline and follow up measures of self-reported acute organophosphate poisoning symptoms and PchE activity in Nepali farmers randomized to either Group A (farmers spray with organophosphate in their first spray session and placebo in their crossover spray session) or Group B (farmers spray with placebo in first their spray session and organophosphate in their crossover spray session)."
0,"Patients with a previous history of malignancy in the past 5 years (except for non-melanomatous skin or in-situ cervix carcinoma) and those with previous or concomitant illness or treatment that, in the opinion of the investigator, would interfere with the trial treatments or comparisons were excluded."
1,The data presented was gathered by the principal investigator and a local partner over a 2-month period from September to November 2014.
0,"Surrogate parameters of pulmonary and cardiovascular events are a decline in oxygen saturation (SO2) to less than 90%, a rise in exCO2 > 50 mmHg, or a respiratory rate < 6/min; heart rate less or more than 20% of the baseline rate or occurrence of an arrhythmia; blood pressure less or more than 20% of the first pressure measured."
3,Subjects with non-traumatic (spontaneous) ICH attributed to cerebral small vessel disease and not due to a macrovascular cause such as an aneurysm or AVM were candidates for this trial.
0,"The strains used in this test were V. cholerae O1 strain T19479 (El Tor Inaba), X25049 (El Tor Ogawa), and O139 strain CIRS 134-SR."
3,"After obtaining written, informed consent, all patients age 18–80 years old with spontaneous, non-traumatic, supratentorial ICH ≥20mL, Glasgow Coma Scale (GCS) score ≤14 or NIH Stroke Scale (NIHSS) score ≥6, a historical modified Rankin Scale (mRS) score of 0 or 1, whose ICH remained the same size for ≥ 6hrs and who satisfied all other inclusion/exclusion criteria listed in the Supplemental Appendix (page 4) were randomized."
0,"The workbook contained background information, an overview of the course structure and content, and work sheets to reflect on personal reasons for cessation and develop and write down personal strategies."
3,"Eligibility criteria included patients 55 years or older, with a best corrected visual acuity (BCVA) worse than 20/40 secondary to wAMD due to active subfoveal choroidal CNV demonstrated by leakage on fluorescein angiography (FA), or the presence of fluid on spectral domain optical coherence tomography (SD-OCT)."
0,All sera will be batch analyzed in duplicate.
3,"The vast majority of patients had previously received anti-VEGF therapy, and a washout period for the anti-VEGF was not required prior to the baseline visit."
0,T cells were isolated from Ficoll separated PBMCs by negative selection using the Pan T Cell Isolation Kit II (Miltenyi Biotec).
3,"Eligible participants lived in South Africa, were Vitality members aged 18 years or older with a diagnosis of type 2 diabetes, were not yet enrolled in HF, and were registered on the Vitality website (reflecting internet access and an available email address)."
0,All analyses were performed in a central laboratory.
3,Vitality members with type 2 diabetes were identified based on billing codes for diabetes along with any pharmacy codes for oral hypoglycaemic medications (not prescribed to patients with type 1 diabetes).
0,"Therefore, body size is a confounding factor that needs to be normalised for when analysing associations between EE variables and metabolic outcomes [17]."
1,"The study was a single-center, one-visit, single-blinded trial in people with type 2 diabetes, investigating skin PF, pain, and SBP during needle insertion into the subcutis on the abdomen with different needle designs."
0,Women presenting for the first time in labor were not enrolled.
8,"We have calculated that a sample size of 102 infants is necessary to detect a difference of at least 2.5 days in time to full enteral feeding, assuming a SD of 4.5 days (two-tailed α = 0.05, β = 0.20)."
0,The open‐label as‐treated population included all 100 mg mavrilimumab–treated patients in the open‐label extension study.
8,The SD value is based on an retrospective analysis of time to full enteral feeding in infants with GA <32 weeks and/or BW <1500 g admitted to our NICU in 1998.
0,"The validity of recordings was determined by a third party (Biomedical Systems, Brussels, Belgium), blind to treatment allocation."
6,"The primary outcome of the trial was aneurysm growth rate over 2 years, estimated from the sequential AAA diameter measurements (external diameter measured in the longitudinal plane)."
0,"Assessments were performed by a single rheumatology research nurse in each center, independent of the US examinations."
6,"Secondary outcome measures include: changes in BP; the composite outcome of time taken for the aneurysm to reach the 5.5 cm diameter threshold, referral for elective surgery or AAA rupture; drug intolerance; and drug compliance."
0,"Data was prepared and analysis performed using FlowJo v8.8.6 (Treestar Inc,), Pestle v1.6 and Spice v5.05 (Mario Roederer, Vaccine Research Centre, NIAID, NIH)."
6,The primary endpoint was the proportion of patients clinically cured at the TOC visit in the co-primary CE and MITT populations (see Supplementary data for definitions).
0,"To assess the depth of anaesthesia, BIS® A-2000™ (Aspect Medical Systems, Natick, MA, USA) was attached to the forehead, and an INVOS®5100B cerebral oximeter (Somanetics, Troy, MI, USA) was applied for monitoring of rSCO2."
6,Secondary endpoints included the following: clinical response at TOC in the microbiological MITT (mMITT) and ME populations; clinical and per-pathogen microbiological response at TOC (ME population); clinical relapse and reinfection or recurrence at the LFU visit; the PK profile of ceftaroline fosamil 600 mg administered as a 2 h iv infusion every 8 h; and safety.
0,"In the frequency-domain, vagal (parasympathetic) activity is the main contributor to HF variability, whereas both vagal and sympathetic activity contributes to LF variability [32]."
6,"Patients were evaluated at baseline, 6 weeks, and 12 weeks after the beginning of the treatment protocol with the original English version of the validated Victorian Institute of Sports Assessment-Achilles (VISA-A) questionnaire."
0,"The time till the presentation of a > grade 2 toxicity is another, but secondary, endpoint."
6,"The VISA-A questionnaire scores range from 0 to 100, with higher scores corresponding with less pain and increased activity."
0,Linguistic translation and cultural adaptation was achieved through the standard protocol.6
8,"To detect a 0.50 effect size when comparing the change in the primary outcome between two groups with 80% power using a two-tailed 0.05 hypothesis test, and considering a 0.6 correlation between repeated measures in two time points, 50 patients per group were needed.[40] However, the study ended after recruiting 50 participants when funding was received to continue the study as a multicenter RCT with slightly different participants’ criteria (Trial registration NCT01610908)."
0,Clusters were excluded if they had ongoing special health programmes or immunisation activities that could bias the study outcomes.
1,A multicenter randomized controlled trial with two parallel groups was carried out with a follow-up period of 12 months (the EVIDENT II study) [20].
0,"The Human Adipokine panel assesses adiponectin and resistin with assay sensitivities ranging from 2.2-11 pg/mL, the Human Circulating Cancer panel contains leptin, FGF2, prolactin and VEGF with sensitivities ranging from 3.6-42.8 pg/mL, and the Human High Sensitivity panel contains IL-4, IL-6, IL-10 and TNF-α; with sensitivities ranging from 0.11-1.12 pg/mL."
1,"Assessments were made at baseline and after 3 months between January 2014 and December 2015, with evaluation at 12 months in 2016."
0,"After screening for eligibility and informed consent is obtained, patients are randomised in a 1:1 ratio into one of the following study arms: • Resection of the primary tumour followed by systemic therapy (experimental arm) • Systemic therapy alone (control arm) Patients are randomised stratified for centre using a web-based, central randomisation and registration system http://www.randomizer.at."
6,The primary efficacy end point was the effect of statin on the change in the ratio of low frequency (LF) to high frequency (HF) with 48‐hour sleep deprivation compared with the baseline value.
0,The video files were copied from the camera to an external hard drive and named with the participant ID number and recording date.
6,"Secondary efficacy variables were the frequency of PACs and PVCs, the standard deviation of N–N intervals (SDNN), and levels of total cholesterol, triglyceride, high‐sensitivity C‐reactive protein (hsCRP), interleukin 6, superoxide dismutase, and malondialdehyde (MDA; an indicator of oxidative stress)."
0,The lactation consultant will also be available for additional support when requested by the participant up to 6 months postpartum.
8,"A sample size of 568 participants per group was originally planned with the expectation that this number would provide 85% power to detect a 40% reduction in the incidence of hypertension for participants in the chlorthalidone/amiloride group, assuming a cumulative incidence rate of 14% in the placebo group, with 2‐sided α=0.05."
0,"After placing the patient in the sniffing position (head extended and neck flexed), the chin was gently pressed down and a lubricated i-gel was inserted gently towards the hard palate until resistance was felt."
8,The sample size was rounded to 625 per group to compensate for losses during follow‐up.
0,"Within a stratum, communities were randomly selected from those eligible with probability proportional to size."
3,"Individuals aged >6 months with a body weight >5 kg with slide-confirmed P. vivax monoinfection, parasite density between 250 and 100 000 parasites/µL, and axillary temperature ≥37.5°C or history of fever in the last 48 hours were considered eligible."
0,"The passive leg raising manoeuvre (PLR) was performed by a leg elevation up to 45° with the trunk in the horizontal position, inducing haemodynamic changes by transferring blood towards the central compartment."
3,"Eligible patients from study sites in the United States and Puerto Rico were 18 years of age or older; were using a reliable method of birth control; had a diagnosis of plaque psoriasis for at least 6 months prior to baseline; had at least 10% body surface area of plaque psoriasis, a static Physician's Global Assessment score of at least three, and a Psoriasis Area and Severity Index (PASI) score of at least 12 at both screening and baseline; were candidates for phototherapy and/or systemic therapy; and were willing and able to self‐administer (or have an assistant inject) the study drug and have blood drawn for PK sampling."
0,"Methods for obtaining wearable and SPO2-R data are reported elsewhere [18], and in the Supplementary Content (see Additional file 1)."
3,"Patients were ineligible if they had erythrodermic, generalized pustular or guttate forms of psoriasis; were pregnant or breastfeeding; recently received any systemic, biologic or non‐biologic therapy or topical psoriasis therapy; were concurrently using biologic therapy; were positive for human immunodeficiency virus, hepatitis B or hepatitis C or had any other active or recent infection; or had an uncontrolled cerebrovascular condition, unstable medical condition and/or any significant, uncontrolled neuropsychiatric disorders."
0,A group of healthy volunteers were studied in a single session as controls.
3,Patients (age 20–75 years) with hypertension (blood pressure ≥ 140/90 mm Hg or currently on antihypertensive medication) and dyslipidemia (defined in accordance with the National Cholesterol Education Program Adult Panel III (NCEP-ATP III) [11] or currently on lipid modifying medications) were included.
0,"Parents were recruited through key persons within Somali associations, social services, schools and a family centre (a meeting place for parents living in the city)."
3,"Exclusion criteria were a mean sitting SBP (siSBP) ≥ 180 mmHg at screening visit and/or sitting diastolic blood pressure (siDBP) ≥ 110 mmHg; differences between arms ≥ 20 mmHg for siSBP or ≥ 10 mmHg for siDBP; secondary hypertension; secondary dyslipidemia (nephrotic syndrome, dysproteinemia, Cushing’s syndrome, and obstructive hepatopathy); fasting triglyceride level at pre-randomization visit ≥ 400 mg/dL; history of myopathy, rhabdomyolysis, and/or creatinine kinase ≥ 2× upper limit of normal; history of hypersensitivity to angiotensin receptor antagonist and/or 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors; gastrointestinal surgery or active inflammatory gastrointestinal diseases potentially affecting study drug absorption in the preceding 12 months; uncontrolled (glycated hemoglobin > 9% at pre-randomization visit) or insulin-dependent diabetes mellitus; liver disease (aspartate aminotransferase and/or alanine aminotransferase ≥ 2 × upper normal limit); hepatitis B (including positive test for HBsAg) or hepatitis C-positive; impaired function of kidney (serum creatinine ≥ 1.5 × upper normal limit); human immunodeficiency virus infection; electrolyte imbalance (sodium level < 133 mmol/L or ≥ 145 mmol/L or potassium level < 3.5 mmol/L or ≥ 5.5 mmol/L); retinal hemorrhage; visual disturbance or retinal microaneurysm within the past 6 months; history of abusing drugs or alcohol; ischemic heart disease within the previous 6 months (angina pectoris, acute myocardial infarction); peripheral vascular disease); percutaneous coronary intervention, or coronary artery bypass graft within the previous 6 months; severe cerebrovascular disease within previous 6 months (cerebral infarction, or cerebral hemorrhage); New York Heart Association functional class III and VI heart failure; clinically significant cardiac arrhythmia; or history of any type of malignancy within the previous 5 years; women in pregnancy, breastfeeding, or child-bearing potential without no intention of using a contraceptive."
0,Pairwise comparisons between treatment conditions were conducted and analyzed using Tukey’s procedure to adjust P values for multiple comparisons for each dependent variable.
3,"Eligible subjects were elderly (≥65 years) or younger adult (18–35 years) men and women diagnosed with T1DM ≥12 months before being included in the trial who were treated with multiple daily insulin injections or continuous subcutaneous insulin infusion for ≥12 months (total daily insulin dose <1.2 (I)U/kg/day and total daily bolus insulin dose <0.7 (I)U/kg/day), with glycosylated haemoglobin (HbA1c) ≤9.5% (80 mmol/mol), body mass index (BMI) 18.5–28.0 kg/m2 and fasting C-peptide ≤0.3 nmol/L."
0,"When weighted according to the FIM12 gender distribution (43% male, 57% female), the mean life expectancy for subjects in FIM12, prior to adjustments for discounting and deaths experienced during the trial was 9.9 y."
3,"Subjects were excluded if they had clinically significant concomitant diseases or clinically significant abnormal values in clinical laboratory screening tests, were smokers or were treated with any drugs that might interfere with glucose metabolism."
0,This software makes components of the tailoring program easier to edit and maintain.
14,Research technicians not affiliated with the study clinics carried out all assessments at the follow-up interviews and were blind to treatment group allocation.
0,The comorbidity index was assessed using the Deyo strategy [23].
6,"Outcome measures were assessed at baseline, at post-intervention (immediately after the intervention) and at follow-up (6 months post-intervention; 9 months after baseline) (Fig. 1)."
0,"Patients screening, baseline SPT, blood sampling and baseline challenge chamber session (VCC) occurred in a period of 28 day before treatment was started."
3,"Residents of England aged 16–24 who had received either a positive chlamydia test result or reported unsafe sex in the last year (defined as more than one partner and at least one occasion of sex without a condom), were literate in English and who owned a personal mobile phone were eligible."
0,"The study was prospective, randomized, and open-labeled, and was performed on two parallel groups."
8,The pilot trial was designed to estimate the likely follow-up rate at 12 months.
0,Adipose tissue specimens were collected in RPMI medium and minced into fine pieces using scissors after careful removal of infiltrating blood vessels with forceps and scissors.
8,"If loss to follow-up in the main trial was 20%, a pilot trial of 200 participants would estimate the loss to follow-up with a precision of 6% (ie, a 95% CI of 14% to 26%)."
0,The preparation was available in a 5-ml syringe and was stable for 4 weeks.
3,"The eligibility criteria included (1) histologically confirmed metastatic or recurrent gastric cancer; (2) at least one measurable lesion; (3) an age of ≥18; (4) adequate oral intake; (5) no previous antitumor therapy within 5 years (adjuvant chemotherapy without S-1 was allowed if finished ≥6 months before enrollment); (6) an Eastern Cooperative Oncology Group performance status <2; and (7) adequate bone marrow, hepatic, and renal function."
0,"S. aureus colonization status is known within 72 h after start of first episode of mechanical ventilation and according to the result, the patient qualifies for enrollment.Written informed consent from subject / legally accepted representative within 72 h after start of first episode of mechanical ventilation."
3,"The exclusion criteria included (1) known hypersensitivity to any of the study drugs, or usage of drugs interacting with S-1; (2) serious concomitant conditions; (3) extensive bone, brain, or meningeal metastasis; (4) another synchronous cancer; (5) surgery within 3 months; (6) participating in other clinical studies; (7) pregnant women; (8) subjects with reproductive potential who were unwilling to use an effective method of contraception."
0,"Quantitative data were collected in the intervention arm of an effectiveness trial [7], and measurements were performed by trained nurses in the patients’ homes using a face-to-face questionnaire."
16,"A linear multiple regression model was used to assess the relationship between AUC0–τ normalized to the administered dose/m2 at steady state and age, gender and drug formulation using the lm function in R statistical software package (The R Foundation for Statistical Computing, http://www.R-project.org)."
0,"Peak systolic (s'), early diastolic (e') and late diastolic (a') mitral annular velocities will be measured at end expiration at the septal, lateral, inferior and anterior left ventricular walls with real time pulsed wave tissue Doppler [37]."
16,The statistical methods are described in the Supplementary Materials.
0,"Toxicities are classified by type, grade, duration, onset and relationship to radiation treatment."
1,"The trial was a randomized, double-blind study in two centers comparing the treatment effects of orlistat and polyglucosamine and conducted in accordance with the European Medical Device Directive 92/43/EEC, European harmonized Standard (EN) International Standardization Organisation (ISO) 14155-1, the Declaration of Helsinki and the National Data Protection Act."
0,Postoperative nausea and vomiting (PONV) were minimized by perioperative dexamethasone and ondansetron (8 mg × 2) at day 0–2.
1,"The centers involved in the study were: center 1, the Diabetological center in Dreieich-Sprendlingen, Germany, center 2, the Monitoring Food and Diseases (MAP) in Rende (Cosenza, Italy)."
0,All eligible household members aged 18–32 years were invited to participate.
6,The primary outcome in this analysis was bacterial resistance of uropathogens in children with spina bifida on clean intermittent catheterization to commonly used antibiotics.
0,"Anemia was defined as hemoglobin < 13 g/dL for males, or < 12 g/dL for females."
14,"Due to the nature of the study, GPs and patients could not be blinded to the intervention."
0,"We will recruit individuals who fulfill the diagnostic criteria for SIVCI as outlined by Erkinjuntti and colleagues [22], which requires the presence of both cognitive syndrome (as defined in Section A below) and small vessel ischaemic disease (as defined in Section B below)."
1,"FIND-CKD was a 56-week, open-label, multicenter, prospective, randomized, three-arm study undertaken during December 2009 to January 2012 at 193 nephrology centers in 20 countries (ClinicalTrials.gov NCT00994318) [25]."
0,The hypothesis states an improvement of the progression free survival after 2 years from 75% to 89% (risk reduction by 40% using Rituximab).
3,"The inclusion criteria were: 1) pathologically confirmed colon carcinoma; 2) CT-defined T4 or lymph node-positive resectable CC; 3) no history of previous treatment; 4) obstructive CC treated with defunctional stoma or exploratory laparotomy; 5) age ≥18 years and ≤75 years; 6) Eastern Cooperative Oncology Group (ECOG) perfor-mance status 0–1; 7) no prior chemotherapy or abdominal or pelvic irradiation; 8) life expectancy ≥3 months; 9) no history of CRC; and 10) laboratory analysis showing leukocytes ≥3×109/L with neutrophils ≥1.5×109/L, platelets ≥100×109/L, hemoglobin ≥9 g/dL (5–6 mmol/L), total bilirubin ≤1.5×upper limit of normal (ULN), aspartate aminotransterase (ASAT) and alanine aminotransferase (ALAT) ≤2.5×ULN, alkaline phosphatase ≤1.5×ULN, and serum creatinine ≤1.5×ULN."
0,H&E measures were used as binary predictors (positive score or not).
3,"The exclusion criteria were: 1) tumors within 15 cm of the anal verge determined by sigmoidoscopy, or below the sacral promontory determined by imaging; 2) evidence of distant metastases or peritoneal carcinomatosis by CT scan; 3) colonic obstruction without prior defunctional stroma or stent treatment, or 4) serious medical comorbidity that might hinder neoadjuvant therapy and/or surgery."
0,General ‘resectability’ criteria are shown in Table 2.
14,"Given the different characteristics of SMD, acupuncture, and chewing gum, no blinding was applied to participants or doctors."
0,A flow-chart of the data collection is summarized in Figure 3.
14,"Nevertheless, the nursing staff and statistician were blinded to treatment allocation throughout data collection and analysis."
0,Date of recurrence is defined as the first day of tumor suspicion.
3,"Participants were recruited from the Cataract Service in a consecutive-if-eligible basis, and randomly populated two study groups: a) MoG study group (participants that underwent uncomplicated lens-extraction surgery with MM-VD), and, b) MfG study group (participants that underwent uncomplicated lens-extraction surgery with bilateral multifocal intraocular lens implantation)."
0,Most of the interviews (72%) were conducted face to face in women’s homes; the other 28% were conducted by telephone due to difficulties in reaching participants in their homes.
3,"The exclusion criteria for both groups included preoperative manifest astigmatism above one diopter (D), glaucoma, IOP-lowering medications, former incisional surgery, former diagnosis of corneal or fundus disease, diabetes, autoimmune, mental diseases, or the inability to perform ADL tasks for reasons not related to visual capacity."
0,"The expression level of the 5-gene marker in whole blood and skin was measured using Affymetrix Human Genome U133 Plus arrays (Santa Clara, CA, USA) [25]."
4,"The study is conducted in a diabetes and obesity care centre affiliated with a 400-bed private tertiary care hospital in São Paulo, Brazil."
0,"The study consisted of a washout period (approximately 2 weeks to discontinue from their previous antihyperglycemic agents [AHAs]), and a single-day treatment followed by a washout day and then 14 consecutive days of treatment."
3,Patients with diabetic kidney disease as defined by albuminuria and an estimated glomerular filtration rate >30 mL/min treated within a specialist diabetes service had to comply with all of the following criteria at randomisation: Age: 18–65 years;BMI: 30–34.9 kg/m2;<15 years of history of T2DM;Negative glutamic acid decarboxylase autoantibodies test;Fasting C peptide over 1 ng/mL;Appropriate postprandial C peptide response after a 500 kcal mixed meal challenge.
0,"Inclusion criteria were: i) subjects with a clinician-rated score in the Clinical Global Impression-Severity (CGI-S) scale ≥4 both at screening and randomization visit [22]; ii) subjects who, according to the doctors’ assessment, required medication de novo or were receiving treatment and required substitution or addition of drug treatment with an antidepressant drug."
3,"Autoimmune diabetes or type 1 diabetes; Previous abdominal operations that would complicate an RYGB; Pregnancy or women of childbearing age without an effective contraceptive; Alcoholism or illicit drug use; Severe hepatic disease that may complicate RYGB; Inflammatory bowel disease or malabsorptive syndrome; Major cardiovascular event in the past 6 months; Current angina; Severe psychiatric disorders that would complicate follow-up after RYGB; Use of immunosuppressive drugs, chemotherapy and/or radiotherapy; Uncontrolled coagulopathy; Advanced proliferative retinopathy with or without amaurosis; CKD stage 4 or 5 waiting for renal replacement therapy; Stage 3 peripheral neuropathy; Pulmonary embolism in the past 2 years."
0,"To assess the effectiveness of homeopathic potassium phosphate (Kali phos 6x), an off-the-shelf preparation, for attention problems associated with mental fatigue in healthy adults."
6,"The main outcome is the change in the uACR (intention-to-treat (ITT) analysis) captured as the proportion of patients who achieved nephropathy remission (uACR<30 mg/g of albumin/mg of creatinine) in an isolated urine sample (morning) over 12, 24 and 60 months."
0,"Eligible patients had to satisfy the following criteria: an expected survival of 3 months or longer; no prior chemotherapy; an age of 20 to younger than 80 years; an Eastern Cooperative Oncology Group performance status of zero or one; a histologically confirmed diagnosis of unresectable or advanced gastric adenocarcinoma (including adenocarcinoma of the gastroesophageal junction) or unresectable recurrence; ability to orally intake food and liquids; either measurable or non-measurable lesions as defined by the Response Evaluation Criteria in Solid Tumors (RECIST), version 1.0 (Therasse et al. 2000); and adequate organ functions."
6,"The secondary outcomes are changes in diabetic retinopathy, changes in diabetic neuropathy, use of antidiabetic medication, glycaemic control (defined as FPG<100 mg/dL and HbA1c <6.0% with or without medication), blood pressure control (defined as systolic blood pressure <130 mm Hg and diastolic <80 mm Hg), lipid control (defined as low-density lipoprotein <100 and <70 mg/dL in patients with previous cardiovascular events; high-density lipoprotein >50 mg/dL and triglycerides <150 mg/dL, hepatic fibrosis assessed through intraoperative liver biopsy and control evaluated by postoperative liver elastography, fatal and non-fatal cardiovascular events, quality of life (36-item Short Form Health Survey, SF-36) and diabetic urinary bladder dysfunction (assessed through a questionnaire)."
0,The provincial CDC followed up with diagnosed HIV-positive individuals for CD4 and viral load testing and referred them to the local designated hospital for treatment.
14,Blinding was not possible because of the nature of the intervention.
0,BNP serum levels were transformed by logarithmic correction.
14,"However, investigators in charge of the statistical analysis and laboratory personnel will be blinded to the allocation status of each participant in the trial."
0,Follow-up blood samples will be collected every 6 months postoperatively.
1,This is a 6-year European multicentre prospective cohort study.
0,"On the following Monday, the first internet week was released, and the web administrator released a new week on every Monday thereafter."
1,"The design and publication of this protocol has been performed in line with the ‘strengthening the reporting of observational studies in epidemiology’ (STROBE) guidelines [25, 26]."
0,"For ethical reasons, the patients also had to receive the personalised feedback on alcohol consumption in May 2007, which can be assessed as a minimal intervention, but took place after the physician programme ended."
3,"Live singleton fetus.Estimated fetal weight <600 g and <3rd centile for gestational age as defined by local criteria.Gestational age at diagnosis 20+0 to 26+6 weeks of gestation, based on ultrasound and/or last menstrual period.Informed consent given by the participant and signed consent form completed."
0,All emergency physicians who participated in our study had attended the World Interactive Network Focused on Critical UltraSound provider course.
3,"Multiple pregnancy.Maternal age under 18 years.Known abnormal karyotype at enrolment.Known major fetal structural abnormality at enrolment defined as a lethal, incurable or curable severe abnormality with a high risk of residual handicap [27].Indication for immediate delivery.Women who lack the capacity to give informed consent.Any medical or psychiatric condition which compromises the woman’s ability to participate.Maternal HIV or hepatitis B or C infection.Premature preterm rupture of membranes before enrolment."
0,"In practice, since only a small number of factors are truly informative with respect to the response of interest, univariate or multivariable regression analyses could produce biased or false-positive results."
8,"Considering a 20% recurrence rate within 3 years in most collaborating centres for BC cases specified in Table 2, and a predicted rate of 10% in the high intensity arm, with power of 80% and two-sided alpha of 0.05, the number of subjects are 506 (n = 253 in each arm)."
0,The study was designed to distinguish a favorable true response rate of 24% from a null rate of 5% using a conventional 2-step phase II study design model [14].
1,The CEDAR Study is a naturalistic prospective longitudinal observational study with bimonthly assessments during a 12-month observation period [19].
0,"Due to difficulties in achieving the target RRT dose as a result of high transmembrane pressures in some patients with higher body mass (particularly those randomized to CVVH), the protocol was modified in May 2010 (21 months after randomization of the first patient) such that the total fluid dose was capped at 4,000 mL/hr for both treatment arms, irrespective of the patient's weight."
1,"The overall aim of the CEDAR Study is to assess the scope and quality of clinical decisions in the treatment of people with severe mental illness, and the impact of clinical decision making in routine care on patient outcome."
0,Women were offered screening by the midwife at the booking visit.
1,A randomised clinical trial (RCT) has been designed to assess the effectiveness of behavioural graded activity compared with physiotherapy treatment in patients with chronic non-specific neck pain.
0,"Based on an algorithm that included information about diagnosis, community functioning, and service use, participants were assigned to a “high” or “moderate ” need group [20,21]."
1,"The study design has been approved by the Medical Ethics Technical Commission of the Erasmus MC, University Medical Centre in Rotterdam and is in compliance with the Helsinki Declaration."
0,All the patients read and signed an informed consent approved by the Institution's Ethics Committee Treatment methodology: inclusion criteria were healthy individuals of both sexes.
16,"This Phase I trial was not powered for comparative hypothesis testing and basic descriptive statistics are used to summarise outcome data, demographic and operational information."
0,Hospitalisation rates were assessed for patients who received aripiprazole once-monthly for ≥3 months during Phase B.
3,Eligible participants were 18–65 years old with a body mass index (BMI) between 28.0–34.9 and a waist to hip ratio of ≥ 0.88 for males and ≥ 0.83 for females.
0,VTE and hemorrhagic events were graded according to NCI-CTCAE3.0 criteria [22].
3,"Exclusion criteria were, briefly: diagnosed type 1 or type 2 diabetes or cardiovascular disease, or use of related medication; use of laxatives, fiber supplements or probiotics in the previous 6 weeks; inflammatory disorders and use of immunomodulatory drugs; history of bariatric surgery; use of anti-obesity drugs in the previous 3 months; recent (last 2 months) or on-going antibiotic use; excessive use of vitamin D supplementation; active or recent (last 3 months) participation in a weight loss program or weight change of 3 kg during the past 3 months; pregnant or planning pregnancy within 6 months or breastfeeding women; drug or alcohol abuse; and other reasons identified by the Investigator."
0,Game performance was recorded for each participant in each session.
3,The inclusion and exclusion criteria are depicted in Table 1.
0,The internal opening was not closed before advancing the flap over the internal opening.
3,Table 1 Eligibility criteria.
0,Further samples (10 ml) were drawn 30 seconds and 15 minutes after completion of the tooth extraction in order to determine the prevalence and duration of PEB (Fig 2).
1,"A prospective 2-site parallel intervention trial using mixed qualitative and quantitative methods has been selected to facilitate in-depth exploration of whether and why Fit For Dialysis works (or fails) in a particular setting, and for whom, including the actual degree of adoption and the extent to which the adoption occurred as intended."
0,"During the first night of titration, minimum and maximum EPAPs were determined mainly to abolish obstructive respiratory events."
14,"This is an open trial; blinding of the clinicians, nursing staff, and parents is not possible."
0,Internal consistency was satisfactory in the current sample (McDonald’s ω = .89
14,A blinded endpoint review committee will examine the relevant data collection forms and clinical notes of infants with possible sepsis and NEC and classify them systematically according to predefined criteria.
0,"To facilitate interpretation, normalization was done using reference ranges from one center (ImmuneHealth), as follows: normalized data = Ls + (x−Lx) × [(Us−Ls)/(Ux−Lx)], where x = raw data; Ux/Lx = upper/lower normal limit of the local normal range applicable to x; Us/Ls = upper/lower normal limit of the corresponding reference range."
3,"Patients who were ventilated using PSV for an expected duration of ventilation of more than 24 hours and who had a known or suspected history of chronic pulmonary obstructive (COPD) or restrictive disease, obesity (defined as body mass index (BMI) ≥ 30 kg.m-2), visible asynchronies or suspected intrinsic PEEP, were enrolled in the study."
0,Full-mouth bleeding on probing and full-mouth plaque index had to score ≤25%.
3,"Exclusion criteria were contraindication to nasogastric tube placement, poor short-term prognosis or “Do not resuscitate” order already established and in palliative care."
0,"In addition to the inputs listed in Table 1, we also varied the treatment effect length, the discount rate, and participant transport reimbursement."
16,"For domain scores, intra-individual changes as well as between professional categories were evaluated by paired t-test and analysis of covariance, respectively."
0,"Nutrition knowledge is estimated using items from a national survey, developed by the Netherlands Nutrition Center to assess knowledge of the Dutch dietary guidelines on dietary fibre, fruits, vegetables, calories, fats, and extended with items about potassium and sodium."
16,"Software used were SPSS, version 22 (SPSS)."
0,"Malaria diagnosis is predominantly presumptive, based on the presence of fever, in both public and private health sectors [22],[23]."
6,"Primary endpoints: weight loss over 24 weeks, fasting blood glucose and 2-hour oral glucose tolerance test (OGTT), HbA1c."
0,"Therefore, the aim of the trial is to observe low rates of toxicity with high local doses due to effect of the altered biology of carbon ions on pancreatic cancer cells as well as the superior physical characteristics."
6,"Secondary endpoints were systolic/diastolic BP, blood lipids, blood insulin levels."
0,We enrolled 4 control participants to provide a reference for the SOC alone (Figure 1).
16,There was no statistical analysis.
0,Figure 1 Study design.
16,All patients and results are listed.
0,The staff exposure score had high internal reliability as measured by Cronbach’s alpha 0.72.
3,"Criteria for inclusion in the study are 1) patients above 1 month and less than 19 years of age, 2) end-stage renal disease with manual or automated continuous peritoneal dialysis as maintenance treatment modality, 3) a fill volume approximately of 1100 ml/1.73 m2 body surface area, 4) the most recent episode of PD-associated peritonitis, if any, occurred more than 3 weeks ago, 5) signed informed consent by parent/guardian, with a subject aged > 7 years also signing an age-appropriate assent form."
0,The protocol was reviewed and approved by the Ethical Committee and registered (inter)nationally (Eudract 2008-008300-40; NCT00807313).
3,"Criteria for exclusion from the study are 1) reduced efficiency of peritoneal dialysis due to anatomic anomalies or intraperitoneal adhesions, 2) uncontrolled hyperphosphatemia, 3) severe pulmonary, cardiac, hepatic or systemic disease including any kind of malignancy, and 4) current or recent (within 30 days) exposure to any investigational drug."
0,The study was approved by the Institutional Review Board of the University of California San Francisco and San Francisco General Hospital.
8,We calculated the sample size a priori using the G*Power 3 (version 3.1.9.2) sample size calculation program [33].
0,"Process indicators included: (1) vignette scores, (2) whether or not each of the reasons were mentioned for the delayed discharge of newly delivered babies listed in the PCPNC guidelines and (3) two indicators capturing ENC practices that should be promoted by facilities: percentage of babies born in facilities where breastfeeding was initiated within 1 h of birth and percentage of babies born in facilities where bathing was delayed for at least 6 h based on surveillance data."
8,"We calculated that a minimum sample size of 676 participants in total would be required to detect a small difference (effect size, Cohen d=0.25) between the 2 groups on our primary outcome measure of objective intervention usage, with alpha=.05 and beta=.1."
0,Blood samples were collected after an overnight fast of at least 12 h.
4,"The study centre, testing and exercise clinic are located at Karolinska University Hospital, and Karolinska Institutet, Stockholm, Sweden."
0,"Observation of a patient ended in case of the following events: no follow-up prescription of the agent that was first prescribed at index date in the 180 days after the last prescription, or any prescription of another NOAC or VKA agent different from the agent that was initially prescribed at index date, death of the patient, or end of data availability (30/06/2014)."
3,Inclusion criteria include women (aged 18–70 years) with Stage I-IIIa breast cancer about to start adjuvant chemotherapy.
0,"Participants were assessed at three time-points by a clinician blinded to treatment group: baseline (before randomization and administration of study medication), 2–4 days, and 28–31 days after the administration of study medication."
3,"Exclusion criteria are assessed by study researchers and include patients with advanced disease, patients where physical activity is contraindicated because of safety reasons such as uncontrolled cardiovascular disease, brain or bone metastases, cognitive dysfunction, and patients who do not speak or understand the Swedish language."
0,"Site‐level and regional reports were sent to sites every 3 months, and patient‐level reports were sent to sites every 6 months."
14,"As this is an exercise intervention, participants cannot be blinded to group assignment."
0,The 21 participating families were randomly assigned to the intervention or the control group.
14,"Outcome assessors are not blinded to group allocation, with the exception of assessors of muscle biopsy and blood samples who are blinded to group allocation."
0,"MetS was defined by the National Cholesterol Education Program (NCEP) criteria (8), and a metabolic risk score (z-MetS) was constructed (5,7)."
17,"As patients can choose to use donor oocytes (usually from younger female donors) to overcome age-related infertility problems, the HOPE Registry included the use of both autologous and donor oocytes for cryopreservation."
0,"During exercise, HR is monitored every 3–6 min using a Polar HR monitor (Polar Vantage XL and Polar Vantage NV)."
17,"Because there were differences in the mean age of oocytes cryopreserved in the autologous versus donor oocyte groups and in the slow-freezing versus vitrification groups, additional analyses were conducted in two subgroups to extract more homogenous results from the collected data: donor oocyte subgroup by cryopreservation technique used, and vitrified oocytes by donor or autologous subgroup."
0,A summary of the demographic characteristics can be found in Table 1.
1,"This is a multi-centre, cross-sectional observational cohort study in the Netherlands that aims to include 4,000 patients."
0,The study was registered on clinicaltrials.gov (NCT02044679).
1,"The study has been approved by the Medical Ethical Committee of the Academic Medical Center (AMC), Amsterdam and has been registered in ClinicalTrials.gov (NCT02715141)."
0,"After their email had been validated, users had to complete baseline data questionnaires, including demographic data, a log of past-week alcohol consumption (the TOT-AL) [41], a 5-item health-related quality of life measure (the EQ-5D) [42], and 1 of 4 randomly allocated secondary outcome measures."
8,We calculated that a minimum of 17 participants in each arm of the trial was required.
0,"For the younger age group, internal consistency (Cronbach α) ranged from 0.55–0.96, and was around 0.8, except for some single exceptions."
8,"Our forecast was principally based on the findings of a study in Kosovo [19], therefore, the sample size was calculated for the detection of a 0.4 deduction in the mean score of Harvard Trauma Questionnaire (HTQ), with power of 90 % (1 − β error probability) and statistical significance of P value <0.05."
0,"The latter three were selected because there were relatively few cases of infection on admission on those wards, and it was thought that HAIs would be more accurately observed than at other wards where febrile illnesses such as malaria were more common on admission."
1,"This was a 26-week, randomized, open-label, phase 3b, treat-to-target, exploratory trial in which patients were randomized 1:1 to either IDegAsp BID + IAsp OD ± OADs or IDeg OD + IAsp TID ± OADs."
0,"All volunteers had a normal physical examination, electrocardiography, and routine laboratory values before the start of the experiment."
1,"Participating countries were the USA (n = 26), Malaysia (n = 11), Germany (n = 2), and Turkey (n = 1)."
0,"Subjects were instructed to ingest one pill per day, ideally with breakfast (675 mg per day, for ~90 days)."
8,The sample size calculations were based on the results from a previous RCT on BI in low-back pain [29].
0,a Conductance catheter in position in the left ventricle during an injection of contrast into the left coronary artery.
8,"With a power of 80 % and a significant level of 5 %, the total number of participants needed for this study was calculated to be 300."
0,"In BWL, each member of the dyad will be encouraged to engage in healthy behaviors and weight loss efforts and to serve as a model or cue for desired behavior changes."
4,The RCT was conducted in 10 maternity centres in the UK in order to assess realistic recruitment rates and acceptability across different types of units.
0,"HOMES requires case managers to make separate ratings on mental health, substance abuse, and associated problems for each Veteran using components of the Addiction Severity Index [46] as well as the Global Assessment of Functioning (GAF) [47]."
14,"Owing to the nature of the interventions, it was not feasible to blind outcome assessors, care providers or participants themselves."
0,"After a screening period to determine eligibility, subjects were asked to discontinue all ADHD medications for at least 7 days (28 days if the patient was taking atomoxetine)."
14,"However, the follow-up perineal wound assessments were undertaken by independent practitioners whenever possible."
0,"Thus, the smallest village with 16 registered pregnant women per year was visited every second week only, and the largest village with 163 registered pregnant women was shared by two midwives weekly."
3,"The inclusion criteria were: Diagnosis of DSM IV bipolar affective disorder, currently euthymic (BDI < 12 and YMRS < 8), age 18–65 years, participants engaged with the mental health services for preceding 6 months, able to give written informed consent, resident of the trial catchment area, and ability to speak Urdu/Punjabi/English."
0,"Cells were incubated for 48hrs following staining using the In Situ Cell Death Detection Kit, Fluorescein, (Roche, Mannheim, Germany) in accordance to manufacturer instructions."
3,"The exclusion criteria were as follows: Severe cognitive impairment, currently experiencing relapse (mania, hypomania, mixed or depressive), being actively suicidal, the presence of any comorbid psychiatric illness such as substance misuse or alcohol dependence, according to DSM IV criteria."
0,"The clinical examination and the saliva sampling were performed during the school day; 526 children showed up at the time scheduled for the examination, 208 met the inclusion criteria and were enrolled in the study."
14,"All laboratory-based tests, including UPLC-MS, were conducted and interpreted by technicians blinded to POCT results."
0,"Patients were contacted 3, 12, and 24 months after discharge by telephone calls or in written form."
3,"Infants who fullfilled the following inclusion criteria were considered eligible for participation: full term (>37 gestational weeks), birth weight of > 2500 g, absence of congenital anomalies and medical conditions, EBF at 4 – 6 months of age."
0,"Diet and exercise also raise ACR43, 44, 45, 46; therefore, we collected samples in the fasting state and prior to exercise on the collection day."
3,Infants were excluded if they had started on complementary foods (other foods or liquids than breast milk) or consumed formula.
0,Detailed population description has previously been reported [25].
6,"Secondary outcomes were cardiovascular mortality and cancer mortality, and were available in all cohort studies except NHS."
0,The time the participants required to finish the Grooved Pegboard test with the dominant hand served as an indication of fine motor control [35].
3,"Eligible patients included adults (≥18 years) with ECOG performance status ≤2 and adequate hematological and organ function who presented measurable, symptomatic MM documented by IMWG criteria [1] who had failed ≥2 prior MM therapies."
0,The independent statistician on the trial steering committee selected one allocation at random for each set and randomly assigned intervention or control to the two groups in each set to construct the final allocation.
3,Full inclusion/exclusion criteria are detailed as supplementary material (available online).
0,"At the start of the observation phase, physicians compiled part A of the questionnaire with information on which method the participant intended to use (if any), as well as whether CHC was indicated for this participant and whether the counselling leaflet was used (see Additional file 3)."
16,"Safety, efficacy, and pharmacokinetics were summarized by descriptive statistics."
0,Analysis for this paper was performed for participants for whom complete data-sets of both the clinical and economic measures of interest were available across all time points.
6,The primary outcome of the study was all-cause mortality.
0,"Exploratory endpoints included CZP levels in the infants’ plasma at weeks 4 and 8, anti-CZP antibody levels in the infants’ plasma at birth and weeks 4 and 8, and PEG concentrations in the plasma of mothers, cords and infants."
6,"We identified patients who had died by linkage to the relevant national death registry, with follow-up in New Zealand until 26 July 2012 and in CALIBER until 25 March 2010."
0,The majority of participants (85 %) signed up to participate in the web-based forums.
16,"The median values of the 12-month change (from 12 to 24 months) and 24-month change (from 12 to 36 months) in strain, LV EF and LGE during this open-label extension phase (from 12 to 36 months) were compared between the eplerenone and placebo groups, using two-sample Wilcoxon rank-sum tests."
0,Leukocyte count and albumin were measured in all samples of ascites.
1,The study was a prospective randomized controlled trial that compared the effectiveness of a face-to-face structured patient-specific smoking cessation program conducted by trained ambulatory pharmacists with brief unstructured pharmacist-delivered advice on smoking cessation rates.
0,"On the day of discharge from the hospital the patient was instructed to take oral ketoprofen 100 mg (Lek Pharmaceuticals, Slovenia) in the event of pain."
4,The study was implemented in eight public and private ambulatory pharmacies in Qatar.
0,This standardization will circumvent the need to use discount factors and inflation adjustment for the annual BIA values pertaining to each year of the study.
4,Two pharmacists from each site were invited to participate in the study.
0,Written consent was obtained from all subjects prior to participation and all study activities were performed according to the principles expressed in the Declaration of Helsinki.
8,"For a priori sample size calculation, we assumed a 7-day point prevalence abstinence at 12 months of 3% for the control group and 15% for the intervention group based on the results of one of the previous pharmacist-run smoking cessation studies."
0,The study was performed in accordance with the Guidelines for Good Clinical Practice [3] and approval of local ethics committees.
8,"With a two-sided alpha of 5% and 90% power, a minimum sample size of 118 participants was estimated for each group."
0,"Based on our volunteer’s body composition, presumed VLDL-TG levels, and previous studies performed in our laboratory, we considered average basal VLDL-TG production rates of 60 mmol/min with an SD of Δ values of 10 mmol/min."
3,"The patients had been referred to the NICU for head trauma, including brain hemorrhage, tumors, stroke or meningitis."
0,No formal stopping rules or interim analyses were planned.
3,"They were intubated, mechanically ventilated and sedated with sufentanil plus midazolam or remifentanil using target-controlled infusions [10]."
0,The axillary temperature was measured and the weight of the baby recorded.
1,"All servers of the Western Oporto grouping of health centers counted for randomization, except that serving the center where study authors worked (to avoid possible bias)."
0,"Thus only invited users could participate in, view or hear the videoconferences."
1,The remaining nine servers were randomized into two groups: 1) five servers were randomly allocated to the intervention group and 2) four servers to the control group.
0,"Since FOT would not affect the bronchial tone, it was performed before plethysmography for every patient."
3,All family physicians working and prescribing diagnostic and laboratory tests in the Western Oporto group of health centers (except in those where the authors worked) participated in this study.
0,"The Total Competence scale includes 20 items where parents report the amount and quality of their children’s participation in sports, hobbies, activities, jobs and chores, their friendships, how well the child gets along with others and school functioning."
3,Data of the diagnostic and laboratory tests prescriptions were centrally collected by informatics staff belonging to the Ministry of Health and sent to the research team without patients’ or physicians’ identifications.
0,Our initial version of the booklet was developed in collaboration with the Most Worshipful Prince Hall Grand Lodge of the District of Columbia (Masons) and was targeted to AA men and their spouses [55].
3,"The American Society of Anesthesiologists (ASA) physical status I-III of patients aged >65y scheduled for hip arthroplasty under spinal anesthesia were contacted, informed about the study, and enrolled after written consent was acquired."
0,Patients were blinded to physician global assessments and physicians were blinded to patient global assessments.
3,"Exclusion Criteria: any allergy and contraindication to 6% HES 130/0.4; infections and malignancies; sepsis; history of heart failure or NYHA > III; pre-existing renal failure or Cr >108 μmol/L, BUN >8.3 mmol/L; undergoing dialysis treatment; intracranial hemorrhages; long-lasting intake of any non-steroidal anti-inflammatory agent; inability to understand the study information sheet and provide a written consent for participation in the study."
0,"In this trial, the period of observation for collection of adverse events extends from the time the subject has signed the informed consent document up to study day 56 (end of the trial)."
5,"Patients were randomly divided into one of the two groups: (1) patients in group LR received intraoperative placebo lactate Ringer’s at a dose of 7.5 mL/kg; (2) patients in group HES received 6% HES 130/0.4 at a dose of 7.5 mL/kg during the first hour of surgery, followed by administration of 5 mL/kg lactate Ringer’s until the end of the surgery."
0,Families and birth attendants notify the CHW as promptly as possible after a birth has occurred.
14,The patients and a treating anesthesiologist involved in the perioperative patient management were incognizant of the group assignment.
0,"A soft bulky dressing was placed, but no splint was applied."
14,"Primary and secondary outcomes were measured and recorded by another anesthesiologist responsible for data collection, but not involved in the direct treatment of the participating patients and thus, blinded to randomization."
0,The first patient was included on May 15th 2012 and the last visit of the last patient was November 20th 2012.
1,"We conducted a single-centre, randomized, longitudinal controlled study with an intervention group (gPPC-G) and a control group (CG)."
0,"Briefly, cine-CMR images were acquired in multiple short- and long-axis views using a steady-state free procession sequence."
1,The study was performed between the spring of 2012 and the spring of 2014 at Sahlgrenska University Hospital in Sweden.
0,Effectiveness was defined as the primary endpoint.
1,We conducted a 2×2 factorial randomised experiment to test two levels of subsidy RDT for malaria (fully subsidised and free to the participant vs an unsubsidised test for which the participant paid ∼US$0.50) and two levels of ACT subsidy (current retail price equivalent to no additional subsidy vs an additional subsidy of US$0.60 at the point of sale) on testing and treatment decisions of patients ill with malaria-like symptoms.
0,"To facilitate hypoglycaemia induction, a three-times-higher basal insulin dose was administered at midnight (range of timing ±3 min), replacing the regular basal insulin dose given at 20:00 hours (Fig. 1)."
1,The study was conducted in a rural division of Bungoma County in western Kenya.
0,Amplification products were recovered and PCR fragments incubated at 37°C for 16 h with FokI for identification of the A376G mutation (G6PD*A).
16,R Session information: R version 3.2.0 (2015-04-16) was used for all statistical analysis of data.
0,"Overall, 594 participants (10%) were missing data on household income so education was used instead as a proxy for socioeconomic status."
16,Platform: x86_64-apple-darwin13.4.0 (64-bit) Running under: OS X 10.10.3 (Yosemite) locale: [1] C attached base packages: [1] stats graphics grDevices utils datasets methods base other attached packages: [1] nlme_3.1-120 gdata_2.16.1 loaded via a namespace (and not attached): [1] compiler_3.2.0 tools_3.2.0 grid_3.2.0 gtools_3.4.2 [5] lattice_0.20-31
0,This phase 1 trial was approved by the Medicines and Healthcare Products Regulatory Agency (reference 2010-022381-27) and Oxfordshire Research Ethics Committee A (reference 11/SC/0021).
16,All primary analyses are based on intention-to-treat principles in full accordance with CONSORT guidelines [45].
0,Processed red meat included industrially processed red meat.
6,The primary outcome was mortality rate after admission to the stroke unit.
0,"The change in spastic hypertonia and muscle tone was measured via AS scores for six muscle groups in the LE (hip flexors, hip adductors, knee extensors, knee flexors, plantar flexors and ankle-dorsal flexors) and five in the upper extremities (UE: wrist flexors, elbow flexors, elbow extensors, shoulder abductors and shoulder adductors)."
6,"Secondary outcomes were 30-day mortality, mRS at 3 months, time to involuntary early retirement, prevalence of reduced work ability after 2 years, and percentage of time on social transfer payments during the first 2 years after admission to the stroke centre."
0,"To be included in the project participants • had LBP with or without leg pain > 8 weeks • had averaged pain > 3 during the past two weeks on the 11 point numeric rating scale • had completed four weeks of treatment in the primary sector by a family physician, chiropractor, physical therapist, or a combination thereof • had concluded all examinations, individual and group treatment at the back clinic with at least a 75% attendance rate • were able to read and understand Danish Exclusion criteria were"
3,Patients were included in the study if they had type 2 diabetes and were between 18 and 70 years of age.
0,"Calendar pages were sent back monthly, data were entered and dates of reported falls were tracked."
3,"Individuals were excluded if they had any other form of diabetes, were being treated with insulin or more than one oral anti-diabetic drug, were being treated with any medication with loop diuretics, had a HbA1c level ≥10% (86 mmol/mol), had a FPG level >240 mg/dl, had BP ≥180/110 mmHg, had an estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m2, or had a body mass index (BMI) >40 kg/m2 or suffered from cataract or glaucoma."
0,"The three groups were kundalini yoga, strength training and a minimal-intervention (advice only) control group (CG)."
3,"Key enrollment criteria included the following: 21 to 65 years of age; body weight > 45 to ≤ 110 kg and body mass index 18 to 32 kg/m2; good general health with no clinically relevant abnormalities based on medical history, physical examination, clinical laboratory evaluations, and 12‐lead electrocardiography; surgically sterile or using adequate contraception; not taking medications (other than allowable oral and implanted contraceptives) unless approved by the sponsor and the investigator; and no vaccination within 30 days before baseline."
0,"Detailed study methodology has been reported previously [6, 7]."
1,"The RAMSES study (ClinicalTrials.gov identifier NCT02344901) was planned as a national, multicenter, cross-sectional registry."
0,"The protocol was approved by an Independent Ethics Committee or Institutional Review Board at each study site and the study was conducted in accordance with the ethical principles originating in the Declaration of Helsinki and in accordance with ICH Good Clinical Practice guidelines, applicable regulatory requirements, and in compliance with the protocol."
1,All data for each patient were collected during a single visit.
0,R0 resection rate is defined as the proportion of R0 resection among all TME specimens according to the pathologic results.
1,This is a prospective multi-center longitudinal cohort study of H&N cancer patients who receive high-dose RT.
0,"Figure 1 Schematic of the High-STEACS trial design and linkage of electronic patient record data sources(A) Diagram illustrating how screening, enrolment, adjudication, and follow-up were done by use of linked routine health-care data in Scotland."
6,Our primary objective was to assess the efficacy of PRP in wound/ulcer healing by evaluating the percentage reduction in wound/ulcer size over the 24 weeks follow-up period by visual inspection.
0,KDQOL-36 survey is a kidney disease specific measure of health related quality of life [12].
6,"The secondary objectives included safety and feasibility of autologous PRP injections, time to wound/ulcer healing, improvement in pain or discomfort, and quality of life."
0,"In October 2009, women living in the Shivaji Nagar area were invited to community meetings at which they were informed about the study by the research team."
1,A cluster-randomized trial was performed and a mixed-methods approach was used with the intention to describe and understand quantitative results more in breadth by exploring qualitative views [24].
0,Mucosal biopsies were obtained to quantify tissue levels of UC781 once the method had been optimized.
1,"The intervention group received theoretical and practical training regarding chronic pain among NH residents; over time assessment scales were used, nursing records were reviewed and nurse interviews were conducted to follow the intervention (Fig. 2)."
0,"The acquired data (anatomy, pressure and flow curves) were combined to assess a cardiac energy profile (Fig 2), covering external and internal heart power (EHP and IHP), the power efficiency of the left ventricle defined as a relationship between EHP/IHP*100 [%], and data derived from pressure-volume loops."
1,"A multiple case study design was used starting with an analysis of PFs’ narrative reports to categorize barriers and enablers (Yin, 2009)."
0,"All patients provided written, informed consent before study participation."
1,"This cross-sectional analysis used baseline data from the Genetic Epidemiology of COPD Study (COPDGene®) (ClinicalTrials.gov # NCT00608764), an ongoing multi-center observational cohort designed to identify genetic factors in smoking-related lung disease [22]."
0,It was required that the total daily dose and type of pretrial drug should have remained unchanged for ≥8 weeks before screening.
1,"COPDGene recruited ever-smokers (≥10 pack-year), non-Hispanic White or African American adults, both sexes, who underwent a detailed phenotypic evaluation, including high-resolution chest computed tomography (HRCT)."
0,Households were not eligible if the index patient was treated for asthma or chronic obstructive pulmonary disease or was hospitalized.
3,We enrolled patients with BMI levels ≥35 kg/m2 who were newly wait-listed for adult (age >18 years) bariatric specialty care at the Edmonton or Red Deer clinic.
0,The sponsor remained blinded to treatment allocation as well.
3,"Patients with one or more of the following characteristics were excluded: (1) completed more than four Weight Wise Community Modules (web-based or group session) in previous 3 months, (2) pregnant, (3) unable to read/write/comprehend English, (4) unable to access the web, (5) unable or unwilling to attend in-person sessions, (6) uncontrolled severe personality disorder, active psychosis, active substance dependence and/or major cognitive impairment, (7) deemed unsuitable by the study investigators, (8) participated in concurrent trial related to obesity management, (9) resided more than 1 hour driving time away from Weight Wise clinic or (10) declined to participate."
0,The primary study end point was death from any cause by day 90.
3,Eligible subjects were hospitalized patients aged 18 years or older who had documented ESBL-producing Enterobacteriaceae infections and who received group 2 carbapenems as empirical therapy.
3,"Exclusion criteria were, as follows: treatment with a group 2 carbapenem for longer than 96 h; having active P. aeruginosa co-infection; pregnancy; breast-feeding; having a history of carbapenem hypersensitivity; and having infection caused by carbapenem-resistant Enterobacteriaceae strain."
0,"For each ECG lead, the same observer performed three measurements of the QT and TpTe intervals."
6,"In the main trial evaluating chemoradiotherapy the primary endpoints were complete clinical response at 26 weeks from the start of chemoradiotherapy, acute toxic effects for patients that received chemoradiotherapy and progression-free survival for patients that received maintenance chemotherapy."
0,The session will end with the same 10 min cool down stretches as for the exercise group.
6,"This post-hoc analysis investigated complete clinical response at all three assessments (11 weeks, 18 weeks, and 26 weeks from the start of chemoradiotherapy) as well as progression-free survival and overall survival measured from the time of randomisation."
0,These outcome variables are collected at baseline and 6-month visits by a bilingual study coordinator who is blind to group assignment.
4,"The survey took place in Luwero District, Uganda, from June to July 2012."
0,"Centralised meetings to update investigators were held throughout the trial, included training in wound assessment, and each unit received a site visit on opening, which included training of local investigators."
4,Luwero is near Kampala and has both rural and urban areas.
0,"Plasma glucose and serum insulin were analyzed by standard methods at the Department of Clinical Chemistry, Skåne University Hospital, Lund, Sweden."
1,"This was descriptive, cross-sectional formative research, drawing on a qualitative approach to collect data through semi-structured interviews and focus group discussions with both Option B+ patients and HCWs."
0,All patients who were biopsied during endoscopy at baseline and Day 57 and had two or more biopsy samples available for analysis at both time points are included in the histological analyses.
6,The principal outcome was the overall response rate.
0,"If these participants enter the red zone, they are taught to return to self-monitoring with the reduced calorie intake goal of 1200–1500 or 1500–1800 calories per day."
6,"Response rates to initial and follow-up mailings, and numbers of blank responses were also compared between groups."
0,"MPT was obtained by having the patient sustain the vowel “a” for as long as possible on a single breath, while observing the display of the computerized oscillogram."
16,"The six phases for thematic analysis identified by Braun and Clark [15] were followed; data familiarisation, generation of initial coding, emerging themes, analysis and connecting themes, development and naming of each theme and telling the story of the data in a coherent way."
0,"The secondary efficacy end points were the severity of symptoms, interference with daily life, and level of pain."
16,All statistical analysis was performed in SAS by the Duke Human Vaccine Institute statistical team.
0,Study subjects’ drug susceptibility test results were made available to the treating physicians at each site.
16,The statistical test and p value are recorded where used.
0,"After completing the questionnaires, patients log out and the pseudo-anonymized data will be backed up on a local storage device and securely locked."
1,"The trial was performed as a randomized, double-blinded, placebo- controlled, crossover, dose-response study in healthy subjects."
0,"The exclusion criteria included: 1) with history of uninterested gastrointestinal tract neoplasia; 2) with history of upper GI tracts surgery; 3) with a history of FAP, HNPCC or P-J syndromes or uncontrolled diabetes, hypertension or other chronic metabolic disorder; 4) with eating habits changes in recent 4 weeks; 5) with active GI tracts bleeding in recent 6 months; 6) using any of the following medicine: NSAIDs (nonsteroidal anti-inflammatory drugs), immunosuppressor, antibiotics or probiotics at least 1 month prior to enrollment."
1,"The study consisted of four treatment periods, placebo or tolvaptan 15, 30 and 45 mg, with an intermediate wash- out period of at least 3 weeks to eliminate any carryover effects."
0,Differences were considered significant at P < 0.05.
4,Healthy volunteers were recruited by advertising in public institutions and private companies.
0,The changes in the scores will be calculated by subtracting baseline from follow-up score at each follow-up assessment visit for each patient.
14,"Due to the nature of the intervention, blinding of participants will not be possible as each of them will be aware of the kind of physical exercise they are engaged in."
0,"The target population will comprise male and female patients aged 0‐17 years with an objectively confirmed diagnosis of VTE (eg, deep vein thrombosis, pulmonary embolism, and/or cerebral venous sinus thrombosis)."
14,"However, during data analysis researchers will be blinded to the intervention allocated to each participant."
0,"In the Seasonality Score, the individuals report the effect the changing of the seasons has on them in six areas (sleep length, social activity, mood, weight, appetite and energy level) on a scale of 0 to 4, with 0 being ""no change"" and 4 being ""extremely marked change"" [23]."
2,Changes to the research protocol that impact conduct of the study will be reviewed by the individual institutional review boards.
0,Group allocation into either phase was determined by the time from study onset.
2,Ammendments will also be made to the trial registry as necessary.
0,Discussing problems will not always be rated as symptoms.
16,To investigate the effects of time and time x group interactions for the group of 174 participants we used repeated measures ANOVA in SPSS v.24
0,A randomization schedule for IVRS was generated linking sequential patient randomization numbers to treatment codes.
16,"as our data were complete and the interval between baseline and post-intervention measurements was same for all participants (Liu et al., 2012)."
0,The combined cognitive and physical training sessions were performed in a pseudo-randomized counterbalanced sequence.
1,"RELIEF is a large, multicentre, randomised, international, single blind, pragmatic trial, with patients randomly assigned to either restrictive or liberal fluid groups, stratified by site and by planned high dependency unit (HDU) or intensive care unit (ICU) admission."
0,"ECG was performed at D7, D14 and D21 (and at additional time-points if indicated) and was evaluated by trial physicians."
1,"The Adolescent Morbid Obesity Surgery (AMOS) study is a Swedish nationwide prospective, non-randomised controlled study.17"
0,"The more physically demanding outcome measures were separated to avoid fatigue and so the order of testing for strand A was 6MWT including PCI, MSIS, HHD, MFIS."
1,The study was conducted according to the Declaration of Helsinki with the approval of the Gothenburg regional ethics committee (523–04).
0,"Assuming a difference of 70 mmol*min/L between after consuming WWB or brown beans the previous evening, and a SD of 82 mmol*min/L, with α = 0.05 and 1−β = 0.8, a number of 13–17 participants were required (two-tailed test)."
6,Use of urgent referrals was operationalised as: 1) urgent referral rate per GP (i.e. number of urgently referred patients during six months per GP in the practice) and 2) urgent referral rate per 1000 patients in the practice (i.e. number of urgently referred patients during six months per 1000 listed patients aged ≥ 40 years in the practice).
0,All 38 subjects from the observational study were AA or EA.
6,Timing of urgent referrals was operationalised as: 1) prior contacts (i.e. number of daytime contacts with general practice from urgently referred patients before referral) and 2) primary care interval (i.e. number of days from first presentation in general practice until urgent referral to secondary care) [30].
0,"The participant was asked to finish the task as fast and as accurately as possible, first with the unaffected arm followed by the affected arm."
1,"The Statin Induced Regression of Cardiomyopathy Trial (SIRCAT) was a proof-of-concept, prospective, parallel design, single-center, randomized, placebo-controlled trial conducted at the University of Calgary, Canada, between July 2007 and December 2010."
0,Data from other national registers were available until 31 December 2010 and therefore the maximum follow-up for secondary analysis was 6 years.
1,All subjects and investigators were blinded throughout the study and during data analysis.
0,The content and usefulness of training will be assessed using questionnaires to those in receipt of training.
3,"Patients were eligible for the study if they were ≥18-year-old, and had HCM based on the two-dimensional echocardiography identification of an hypertrophied, nondilated left ventricle (wall thickness with septal-to-posterior wall thickness ratio of ≥1.3:1) in the absence of another cardiac, or systemic disease capable of producing this magnitude of wall thickening.[7] They were ineligible for the study entry if they had (1) ongoing use of statin therapy or intolerance to it, (2) hypertension, (3) a myectomy or septal ablation, (4) use of calcium channel blocker or angiotensin receptor blocker at baseline for <3 months[8] or had a dose change within the 3 months prior to randomization, (5) indication for statin therapy for primary or secondary prevention of coronary artery disease, or (6) current or anticipated indication in ≤1 year for implantable cardioverter-defibrillators or other metallic devices preventing cardiac magnetic resonance imaging (CMR)."
0,"Thus, we had data on the frequency at which each message promoted engagement on the website and the characteristics of the smokers that received these messages."
16,The sample distributions were summarized and described with means and SDs as well as median and interquartile ranges if appropriate.
0,"Visual grading of lung destruction due to emphysema has been shown to be highly dependent on the radiologist performing the analysis, and to be much less consistent than quantitative computer analysis[12]."
16,The significance of differences among groups was analyzed with two-way analysis of variance.
0,"Harvested PBMC from 12-day culture from pts (PRE and POST1 samples) and HD were added to the plates in duplicate at 2.5 × 105 cells/well and cultured with either culture medium alone or with addition of OKT3 (30 ng/ml, BD Pharmingen, San Diego, CA, USA) plus PHA (1/1,000, M form, Gibco) for 24 h at 37°C, 5% CO2."
3,"Adult patients aged ≥18 years were eligible if they had chronic plaque psoriasis for ≥12 months (PASI score ≥12, affected body surface area [BSA] ≥10%, static Physician Global Assessment [sPGA] score ≥3 [moderate to severe]); inadequate response, intolerance or contraindication to ≥1 conventional systemic agent for treatment of psoriasis; were candidates for phototherapy or systemic (including etanercept) therapy; and had no prior exposure to a biologic therapy for psoriasis or psoriatic arthritis."
0,"Amplicons containing LasR P117L or LasR I215S were generated by amplifying the lasR coding sequence from strain 283J or strain 262K, respectively, using primers lasR_KON_pMQ30_3 and lasR_KON_pMQ30_4."
3,"Excluded patients included those with prior failure of >3 systemic agents for treatment of psoriasis; history of known demyelinating diseases such as multiple sclerosis or optic neuritis or history of or concurrent congestive heart failure, including medically controlled, asymptomatic congestive heart failure; other clinically significant or major uncontrolled disease; serious infection; latent, active or history of incompletely treated tuberculosis."
0,Letters were signed personally by the ASSIP therapist.
1,"We performed an open-label randomized controlled trial to assess the effectiveness of InsuOnline as a method for education of PCPs on insulin therapy for diabetes, as compared with a “traditional” onsite educational activity with the same content and same duration."
0,"A cannula was then inserted into an antecubital vein, with a baseline sample of 15 mL obtained and further samples acquired at regular intervals throughout the day."
3,"Subjects were eligible if they were medical doctors with an active register at a regional Council of Medicine in Brazil, were not specialists in Endocrinology or diabetes, were currently working at a public health care unit as a primary care physician (PCP), and were directly involved in the treatment of patients with diabetes in those facilities, with any degree of computer or gaming literacy."
0,The plates were incubated in a blocking buffer for 1 h without shaking and then washed.
8,"In order to detect a minimum standard deviation of 0.5 on the score (percentage of right answers) in competence subscale, with 80% of statistical power at 5% of significance level, we estimated a sample size of 128 subjects (64 in each group)."
0,Blood pressure assessment will also be performed at other times if judged to be clinically appropriate by the study staff.
8,"Taking into account an expected attrition rate of 40% in the game group (about twice the 17% attrition rate observed in the previous pilot study with students and residents [36,37]) and of 20% in the control group, we decided to enroll at least 90 subjects in the game group and 77 subjects in the control group."
0,Patients willing to participate fill out two short questionnaires concerning dyspnoea and exercise tolerance.
16,Statistical methods were primarily descriptive and no formal hypothesis tests were planned or completed.
0,Patients who had complete remission and who presented an increase in the number of blasts (> 5%) at any time were considered to be in Relapse.
16,"Data were summarized and analyzed using Statistical Analysis System SAS® (version 9.1.3; SAS Institute, Cary, NC, USA)."
0,Participants in the SMT group were palpated to determine if each had intersegmental dysfunction prior to manipulating [33].
3,"Eligible participants are pregnant women attending the antenatal clinics from May 2013 to August 2014: With expected due dates before 1 October 2014,Are <37 weeks gestation,Have sufficient English proficiency to verbally answer interview questions,Have 2 or more of 10 risk factors identified by risk factor screening (see Recruitment and eligibility section and table 2), andHave home addresses within the travel boundaries specified by the local councils/regions managing the intervention nurses."
0,"Results were analyzed with Peak Scanner version 1.0 (Applied Biosystems) with discrete peaks being interpreted as unique clones, after adjustment for background levels per experiment."
3,"Women are excluded if they: Are enrolled in the Tasmanian Department of Health and Human Services CU@Home visiting programme (for first-time mothers aged 15–19 years),Do not comprehend the recruitment invitation (eg, have an intellectual disability such that they are unable to consent to entering the study, or have insufficient English to complete face-to-face assessments), orHave no mechanism for contact (landline or mobile telephone, or email address)."
0,"For home deliveries, field assistants residing in the village attended the delivery to collect cord blood and the placenta."
17,"In 26 cases and 26 controls, we undertook a subanalysis of glucocorticoid duration, grouping patients according to duration of steroid treatment, since the data were insufficient to allow for overall exposure to be calculated."
0,"The research physician performed a standard clinical examination, including the assessment of pubertal status."
6,"Although undertaken as a pilot study with study aims to identify the most suitable outcome measure, LOS was nominally selected as the primary outcome measure for this pilot trial."
0,Photo permitted by patient Fig. 2 Diabetic foot necrosis with underlying abscess requiring amputation.
6,"Secondary outcome measures were unplanned (emergency) readmission at 3 months, quality of life (EQ-5D-3L) and UDs."
0,"The research protocol was approved by the medical ethics committee of the Elisabeth Hospital Tilburg, and written informed consent was obtained from all participants (METC Brabant protocol number: NL22258.008.08)."
3,"We enrolled healthy infants using the following inclusion criteria: ≤14 days of age; gestation 37 to 42 weeks; birth weight 2500 to 4500 g; mothers had independently elected, before enrollment, not to breast-feed; exclusive formula-feeding at time of enrollment; and parent/legal guardian informed consent."
0,"This research was approved by the Medical Research Council of Zimbabwe, the committee for the protection of human subjects at the University of California San Francisco and the institutional review boards at RTI International and Pangaea Global AIDS."
3,Exclusion criteria were congenital illness or malformation that could affect growth; significant prenatal and/or serious postnatal disease before enrollment; minor parent(s); parents not expected to comply with study procedures; and current or previous participation in another clinical trial.
0,The workshops were scheduled with a clinic visit.
5,26-week vitamin D supplementation (1200 IU) in obese children presenting with low serum concentrations of 25OHD3 at enrolment to the integrated weight-loss programme.
0,"The sequences were aligned against the P. falciparum 3D7 strain (PF3D7_1343700, PlasmoDB Release 28) using ClustalO [37, 38]."
1,"This post hoc analysis was based on pooled data from four 26-week, placebo-controlled, phase 3 studies (N = 2313) that evaluated canagliflozin 100 and 300 mg in patients with type 2 diabetes (ClinicalTrials.gov Identifiers: NCT01081834, NCT01106677, NCT01106625, NCT01106690)."
0,Participants were aware of group assignments.
1,This was a prospective single-arm phase II trial conducted at 20 centres in Germany registered at clinicaltrials.gov (NCT 00989352).
0,"In several cases, existing tools did not address LifeCourse’s guiding principles (e.g., ongoing interpersonal relationships with care team), and so the team crafted and reviewed its own items to address those aspects."
16,Statistical analysis of BOLERO-1 has been described previously [16].
0,The sample of this experimental RCT was drawn from a homogenous population of patients (N = 112) scheduled for SDS at two public hospital wards in Iceland.
16,"For analysis of the Asian and non-Asian subsets, a non-stratified Cox regression model was used to estimate the hazard ratio for PFS and the 95% CI."
0,Endogenous peroxidase was blocked with 3% hydrogen peroxide.
4,Participants to the study were primarily recruited from those patients that had been referred for PR at University Hospitals of Leicester (UHL) NHS Trust.
0,Provisions are to be made for blinded statistical analysis of data by a statistician who is unfamiliar with the objectives and outcomes of interest.
4,Recruitment was also directly from primary care and community rehabilitation services within Leicester Partnership Trust (LPT) and eligible participants were identified from the research participant database of the Leicester Respiratory Biomedical Research Unit and Pulmonary Rehabilitation Department.
0,"We defined a recurrent stroke as a stroke, using the above definition, in which (1) there was clinical evidence of the sudden onset of a new focal neurological deficit with no apparent cause other than that of vascular origin (i.e., the deficit could not be ascribed to an intercurrent acute illness, epileptic seizure, or toxic effect) occurring at any time after the index stroke; or (2) there was clinical evidence of the sudden onset of an exacerbation of a previous focal neurological deficit with no apparent cause other than that of vascular origin [17, 18]."
1,An open label uncontrolled clinical trial of 40 patients aged 2 to 15 with cerebral palsy was conducted.
0,"When available, the sleep log data were used to identify periods when the participant reported being out of bed (vs. in bed)."
1,The study commenced in April 2014 and completed in August 2015.
0,An identical pre-dinner glucose target was applied for people administering a morning dose of insulin detemir (Table 1).
14,"Due to the nature of the intervention, it is not possible to blind the group assignment to the participants and providers, but we will mask the providers to the study data."
0,Patients expect their physicians to use the best available knowledge in order to make good clinical decisions.
14,"In addition, we will mask the data analysts regarding the group assignment to reduce bias."
0,"Sample size was determined on basis of the primary objective with a t statistic under the assumption of a one-sided t test of size 2.5%, a zero mean treatment difference, and a 1.3% SD for A1C."
8,"We calculated that a total of 44 LQICs would be sufficient to detect a standardised effect size (Cohens d) of 0.5, with a significance level alpha of 0.05, a power of 0.9, an ICC of 0.1 and a mean group size of seven GPs."
0,"This randomized, two-period, two-treatment, two-way crossover, bioequivalence study compared two temozolomide oral formulations (Dralitem® vs."
8,"Anticipating a dropout rate of 10%, we would need to recruit 50 LQICs."
0,The EuroQol 5-Dimensions (EQ-5D 5L) Health State Profile was also used to assess HRQOL.
3,"Eligible patients had HCC diagnosed by core biopsy or appropriate imaging technique [computed tomography (CT) or magnetic resonance imaging (MRI)], measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) version 1.0 with protocol-defined modifications [20], and, unless newly diagnosed and never treated, evidence of progressive disease (PD) by CT, MRI, or bone scan at screening."
0,"Eighty patients were randomly assigned to either the PLLA screw group or the β-TCP screw group on the day of surgery using permuted block randomization [12], and 74 underwent knee computed tomography (CT) immediately and 1-year after the operation (Fig. 1)."
3,"Additional inclusion/exclusion criteria have been previously described (see supplementary Patients and Methods, available at Annals of Oncology online) [21]."
0,Informed consent was obtained from all patients for being included in the study.
3,"Eligible subjects were ≥18 years old with histologically or cytologically confirmed, unresectable and/or metastatic GIST with investigator-assessed objective progression after, or intolerance to, treatment with at least both imatinib and sunitinib; measurable disease (RECIST 1.1); and Eastern Cooperative Oncology Group performance status 0–2."
0,Modification included the position of the patients which was described by Eason and Wyatt either lateral with the side to be blocked uppermost or sitting upright.
1,We designed a cohort study using secondary data from four clinical studies conducted by investigators and collaborators of the Centro Internacional de Entrenamiento e Investigaciones Medicas (CIDEIM) between 2007 and 2013 in three municipalities of Colombia.
0,The phase IV study (www.clinicaltrials.gov NCT01627340) was conducted between 24 July 2012 and 18 December 2013.
1,"The largest study was a non-inferiority trial (Clinical trial registration: NCT00487253) comparing miltefosine and pentavalent antimony in children; the second was a pharmacokinetic trial of miltefosine in children and adults (Clinical trial registration: NCT01462500), the third was an immunologic study of patients treated with pentavalent antimony, and the smallest was an add-on trial evaluation of pentoxifylline or placebo to the antimonial treatment (Clinical trial registration: NCT01464242)."
0,"Levels of PA were measured using the short version of the International Physical Activity Questionnaire (IPAQ-s), validated for the Catalan population [21]."
1,"This first-in-human, multi-center, single arm study evaluated the safety, tolerability, pharmacokinetics (PK), efficacy and pharmacodynamic (PD) effects of rebastinib in patients with CML or AML."
0,SF is a 2 hour informational event for 7th graders taking place in a specialised chest clinic which uses a classic fear approach aiming to reduce smoking prevalence.
1,The study was conducted in accordance with the Declaration of Helsinki and approved by the institutional review boards at each participating institution.
0,"The inclusion criteria were students of both genders, aged 12–15 years who were enrolled in Grades 7–9, attending full-time public schools in Fortaleza, northeastern Brazil (Fig. 1)."
3,"Inclusion criteria were as follows: (i) age 18 years or older; (ii) documented diagnosis of MDS or AML according to the French-American-British classification16 and World Health Organization (WHO) 2008 criteria,17 with IPSS intermediate-2- or high-risk MDS,18 including cases of chronic myelomonocytic leukemia with a white blood cell count less than 13×109/L and refractory anemia with excess blasts in transformation (AML/RAEB-t); (iii) del(5q) by conventional cytogenetics or by fluorescence in situ hybridization in the case of cytogenetic failure, with or without additional chromosomal changes."
0,"Stroke awareness was assessed using the Stroke Action Test (STAT) questionnaire [17], cross-culturally adapted to the Italian context [18], following the methodology described by Beaton [19] and performing pretest evaluation on 30 volunteers to improve clarity and comprehension."
3,"Conventional cytogenetic analysis was performed by analyzing G- and R-banded metaphase chromosomes in at least 20 mitoses, and results were interpreted using International System Cytogenetic Nomenclature; (iv) no contraindication to anthracycline-based intensive chemotherapy; (v) written informed consent; and (vi) negative serum or urine pregnancy test in women of childbearing potential.The trial was approved by the Comité de Protection des Personnes Paris—Ile de France (ethical committee whose approval is valid for all participating French institutions)."
0,A dose of 0.1 ml of leishmanin was injected intradermally on the inner surface to the left forearm.
3,"Eligible patients were aged ≥18 years, had documented CD20+ FL with no prior systemic therapy, were deemed in need of treatment by the investigator, had ≥1 bi-dimensionally measurable lesion (>1.5 cm at its largest dimension by computed tomography scan), had a life expectancy >12 weeks, an Eastern Cooperative Oncology Group performance status of 0–2, and no disease transformation based on lymph node biopsy or re-biopsy within 5 months of the start of treatment.Key exclusion criteria included central nervous system lymphoma, a history of malignancy within 2 years of study entry, and evidence of significant, uncontrolled comorbidities.All patients provided written informed consent."
0,"At baseline, all patients were free of history of CVD, hypertension, and hypercholesterolemia."
6,Testing for all secondary outcomes will be based on appropriate statistical methods and two-way superiority testing.
0,Participants completed a questionnaire before (T1) and immediately after the intervention (T2).
6,"Secondary outcomes will not be tested at the interim analysis, except if the withdrawn rules were met."
0,"In the year prior to each patient’s index screening visit, we identified presence of a psychiatric diagnosis (i.e., psychoses, neurotic, personality and other psychiatric disorders, excluding AOD disorders) and presence of an other chronic disease diagnosis (yes/no) (i.e., Arthritis, Hypertension, Chronic Pain, Diabetes Mellitus, Asthma, Ischemic Heart Disease, Congestive Heart Failure, Stroke/Cerebrovascular Accident, Epilepsy, Parkinson’s Disease, End-Stage Renal Disease, HIV, Osteoporosis, Chronic Obstructive Pulmonary Disease (COPD) (ICD-9 codes available upon request)."
3,Pregnant women were eligible if they were (1) able to speak or read English; (2) willing to be randomized to e-screening; and (3) willing to participate in a follow-up diagnostic interview within 1 week of recruitment.
0,"Of these, 1453 patients (27.28%) declined to participate."
3,"Because the Web-based screening tool was intended to be completed unassisted, it was designed for use by women with varying degrees of computer literacy."
0,"Secondary outcomes were quality of life, serum levels of glucose, glycated haemoglobin, ferritin, total- and high-density lipoprotein (HDL) cholesterol, and triglycerides."
16,The statistical significances between the rates from vitrified/warmed and fresh oocytes were evaluated by z-test with p > 0.05 and 0.01.
0,A multiple regression model was then iteratively developed by retaining variables whose coefficients had P values < 0.05 and coefficients that did not show multicollinearity based on a test of tolerance (>0.1) and variance inflation factor (<10).
6,The primary outcome was the proportion of children alive and with virological suppression (defined as HIV-1 RNA <500 copies/mL) at 12 months post-randomisation; this specific time point was considered regardless of any detectable VL between randomisation and 12 months.
0,Details of the study protocol have been reported previously [13].
6,"Secondary outcomes were virological failure (defined as HIV-1 RNA ≥1000 copies/mL, the commonly used threshold to guide treatment strategies [8]) at 12 months post-randomisation, adverse events, resistance mutation profiles, the clinical-immunological response, the pharmacokinetic parameters, adherence, and cost."
0,Correlations of changes in clinical parameters and serum markers were analyzed with Spearman's rank correlation.
1,"We conducted a secondary analysis of data of all 100 patients enrolled from the African site (Mbarara, Uganda) within the Rifatox Trial [16]."
0,"In a separate 5 randomly chosen children per village, a negative field control was obtained immediately after the initial swab by passing a swab within one inch of the subject's conjunctiva."
1,"Study aims were addressed in the context of a randomized controlled trial to test the efficacy of “Starting Early”, an early child obesity prevention intervention, compared to a standard care control group."
0,"In a previous randomized trial that involved lower limb open fractures [31], the overall rate of re-operations due to infection, wound healing complications and delayed fracture healing was 46%."
1,"This trial was approved by the Institutional Review Boards of New York University School of Medicine, Albert Einstein College of Medicine, Bellevue Hospital Center and the New York City Health and Hospital Corporation and registered on clinicaltrials.gov (NCT01541761)."
0,"After digitally separating the labia, a study nurse advanced a cotton tipped swab through the vaginal introitus towards the posterior fornix and rotated the sample back and forth three times before pulling it out."
4,This study took place in a New York City large urban public hospital and an affiliated neighborhood health center.
0,"Feelings about functioning refers to the ability to communicate with other people in the family and community and the ability to perform daily living activities such as feeding, dressing, and toileting."
3,"Adults (18 to 65 years) with visible and symptomatic varicose veins and Clinical-Etiology-Anatomy-Pathophysiology (CEAP) clinical classification C2-5, with saphenofemoral junction (SFJ) incompetence and reflux (>5 sec) in either the GSV or major accessory veins, were enrolled."
0,Compliance to light therapy is retrospectively measured by lux-meters that were built in the wrist-worn actimeters patients wear during the entire protocol.
3,"Patent foramen ovale (PFO) was initially an exclusion criterion; however, the US FDA agreed with the removal of this exclusion criterion after another study showed that patients with known PFO had no subclinical injury from Varithena-derived intracerebral bubbles.22"
0,"Clinical outcomes including gestational weight gain, birthweight, gestation at delivery, mode of delivery, and any complications including neonatal hypoglycaemia were collected from the clinical record post-delivery."
8,"Sample size was selected to provide 95% power to detect an absolute difference of 0.65 in the change from Baseline at Week 8 on the IPR-V3 scale between the ETA + PEM group (using pooled PEM dose groups) and the ETA + placebo group, assuming a standard deviation of 0.80, using a two-sample t-test and a two-sided α = 0.05 significance level and allowing for ∼10% dropout."
0,The following research activities with 10 % of the whole sample size (about 200 participants) will be conducted during pilot study.
1,Cluster randomization at the site level was used to avoid possible contamination from staff using two different consent forms for START.
0,"The study provides the opportunity to address not only baseline genetic and epigenetic characteristics of the patient blasts with relation to the clinical response, but also mRNA expression and epigenetic changes induced by the treatment."
1,Details of the study design and characteristics of sites and participants have been published previously [20].
0,The programme was designed based on the recommendations for antenatal care from the Danish Health Authority28 and developed using the Intervention Mapping approach.29
14,"By the nature of the intervention, it will not be possible to mask the intervention to clinics and study staffs."
0,"On days 1, 8, 15, 22 and 29, patients will receive Paclitaxel 50 mg/m2 and Carboplatin AUC 2 by intravenous infusion."
14,"However, participants (HIV-infected mothers) will not be informed about the randomization nor the intervention."
0,The IPEC IRB membership includes multidisciplinary representation as well as community representation.
3,Included in the study were healthy adolescents ≥11 to <19 years of age at enrollment who had received the full series of DTaP/IPV vaccines per the country-specific recommendations applicable at the time of vaccination.
0,"For quantification of numbers of OPCs in MS lesions, consecutive 8-μm cryostat sections of MS tissue or tissue from normal controls were stained with Olig2 and NogoA antibodies and numbers of single and double-positive cells in each field of view calculated."
3,"Key exclusion criteria included previous vaccination with any MnB vaccine, vaccination with any diphtheria, tetanus, pertussis, or poliomyelitis virus vaccine within 5 years of the first study vaccination, previous vaccine-related anaphylactic reaction, contraindication to diphtheria, tetanus, pertussis, or poliomyelitis virus vaccine, bleeding disorders, known or suspected disease of the immune system or receipt of immunosuppressive therapy, any significant neurologic disorder, any neuroinflammatory or autoimmune condition, history of culture-proven disease caused by N meningitidis or Neisseria gonorrhoeae, current chronic systemic antibiotic use, or current pregnancy or breastfeeding."
0,"The 120 peptides span the HIV-1 Durban 2005 Clade C Gag protein consensus sequence and were manufactured to current Good Manufacturing Practice as defined by United States Part 21 Code of Federal Regulations by CS Bio, Inc. (San Mateo, CA)."
3,"Patients who had cancer requiring treatment based on exclusive chemotherapy were eligible to be included if they met the following inclusion criteria: age over 18 years, histological diagnosis of cancer, and requiring chemotherapy with curative or palliative intent (planned with 3 separate cures 21 days apart or 6 separate cures 14 days apart)."
0,All samples that did not provide PSQ queries with a 100 % match to library wildtype or mutant sequences were repeated in duplicate.
3,Patients were excluded if they met the following criteria: surgery in the last 4 weeks or radiotherapy in the last 2 weeks.
0,Nevertheless the entire recording and the computer-based automatic artefact rejection were continuously supervised and adjusted by a trained technician [14].
16,"All data were expressed as mean values ± standard error (SE) or standard deviation (SD), and differences between groups analyzed by non-parametric Mann-Withney's test or Student's t test."
0,Sodium nitroprusside was used for women who continued to have very high blood pressure episodes even after other hypertensive drugs were used.
16,Differences were considered significant at p ≤ 0.05.
0,"Non-trauma medical–surgical critically ill patients were enrolled if they were at least 18 years of age, weighed ≥45 kg and were expected to remain in the ICU for at least 3 days."
3,"A convenience sample of families was recruited through advertisements at Ontario Early Years Centres, Boys and Girls Clubs of Hamilton, various licensed daycares, and the Hamilton Public Libraries from May to July 2015."
0,"If answering yes (diagnosed), patients where further asked about their age at the time of diagnosis."
3,"Children were eligible to participate if they were between the ages of 3 years, 0 months and 4 years, 11 months at baseline and must not have been diagnosed with any developmental delay or other health condition that would prohibit safe participation in the program."
0,"Hepatic vein waveforms were described as triphasic, biphasic, monophasic, or not assessed because of severe attenuation."
8,"Our prior data on LQT1 patients7 indicated that a difference of 2000 pmol/L×min in the incrementalAUC(0–30) insulin response between 11 matched pairs would reject the null hypothesis that this response difference is zero with power 0.8, P<0.05."
0,"To control for covariates, i.e., age, gender and side of donor nephrectomy, multivariable logistic regression was used."
8,"With our present data on 11 patients and 22 matched controls and a difference of 2471 pmol/L×min±489, we have a power >0.9, P<0.05 (paired design)."
0,"At follow-up, research assistants were not told the allocation of the household they were interviewing, but questions were included at the end of the questionnaire about whether households received transfers."
1,"This was an exploratory, within-subjects cross-over study."
0,"The study medication was given every two weeks until 33 weeks of gestation or birth, whichever occurred first."
6,"The primary outcome of this study is preterm birth, which will be defined as delivery at or after 20 0/7 weeks and prior to 37 0/7 weeks."
0,"Treatment will be allocated randomly using the following stratification parameters: liver-only versus extra-hepatic metastases (at least 60% of recruited patients will have liver-only metastases); the extent of tumour involvement of the liver (classed as ≤25% or >25% tumour involvement determined by CT scan, and based upon the tumour involvement groupings used by Gray et al. [24]); planned use of bevacizumab with chemotherapy; and investigational centre."
6,"This will be determined based on actual date of delivery in comparison to the projected EDD, independent of whether or not the preterm delivery is indicated or spontaneous."
0,HPA-axis functioning will be assessed through the collection and analysis of salivary cortisol.
3,"Eligible patients were treatment-naive Taiwanese patients, aged 18–65 years, who satisfied all of the following inclusion criteria were eligible to participate: (1) had undergone a liver biopsy within 6 months before entry, the results of which were consistent with NASH, i.e. a combination of steatosis (>5% steatosis), hepatocellular injury and inflammation; (2) displayed an increased serum ALT level, defined as >1.5 times the upper limit of the normal range for at least two measurements within 6 months preceding the study entry; and (3) ethanol consumption of < 20 g/day."
0,"For the FAST and SCOT studies combined, to detect a 50% increase in response to invitation letters at 80% power required 225 letters to be sent for each group."
3,"Patients were excluded from the study if any of the following criteria existed: (1) laboratory or histologic findings highly suggestive of liver disease of other etiologies, such as autoimmune hepatitis, primary biliary cirrhosis, biliary obstruction, hemochromatosis, alpha-1-antitrypsin deficiency or Wilson’s disease.; (2) ALT or AST levels greater than 10 times the normal; (3) abnormal total bilirubin or albumin level, prolonged prothrombin time, or platelet count below the lower limit of normal; (4) decompensated cirrhosis (Child–Pugh class B or C) or overt hepatic failure; (5) Treatment with any drugs known to cause hepatic steatosis (i.e., corticosteroids, high-dose estrogens, methotrexate, amiodarone, calcium channel blockers, spironolactone, sulfasalazine, naproxen, or oxacillin) within 6 months prior to the study; (6) psychiatric condition, previous liver transplantation, or evidence of HCC."
0,"An analysis of variance (ANOVA) was carried out on the log-transformed pharmacokinetic exposure parameters (Cmax, AUC0–last, and AUC0–∞) to assess the bioequivalence of drug administrations (alone or in combination)."
4,"The study took place in five primary schools within schistosomiasis-endemic areas in Wakiso District, Uganda, on the shores of Lake Victoria, between June 2014 and January 2015."
0,"The GCMR website supports uploading of formatted de-identified data fields spanning patient demographics, cardiac histories, CMR metrics including cardiac function, tissue characterization, pulse sequence descriptions and imaging protocols."
4,"Community leaders, district Ministry of Education and Health officials and school staff were consulted and parent-teacher meetings held before the trial started to describe the trial, explain procedures and answer questions."
0,"Before leaving the Glaucoma Clinic, intervention participants received an individualised glaucoma education and motivational support package using BCC from a GSA."
6,The primary endpoint was T cell immunogenicity assessed by ex vivo Ag85A-specific interferon gamma (IFN-γ) ELISpot response.
0,Figure 1 is a simplified model of an intricate system that illustrates user-to-system interactions and software-to-software interactions.
6,"Secondary endpoints were the profile of cytokine responses assessed by multiplex Luminex assay of supernatant following six-day whole blood stimulation, plasma antibody concentrations, and solicited and unsolicited local and systemic adverse events."
0,A non-elastic strap was placed around the ankle and attached to a pressure transducer with an amplifier.
16,Primary outcome measures were compared with values from the preceding 50 conventional procedures using the Mann Whitney U Test.
0,"The samples were run in duplicate on an ABI Prism 7,900 system (Applied Biosystems, Darmstadt, Germany) with internal negative controls and a standard curve."
16,"Statistical analyses were performed with Graph Pad Prism version 5.0, Graph Pad Software, La Jolla, CA, USA)."
0,"(The study commenced in 1999, many materials were disposed of during a subsequent move, and the HRPP did not retain a copy.) All participants were seen at UCSD."
4,The study was approved by the Institutional Review Board for the Massachusetts General Hospital and registered at clinicaltrials.gov/ct2/show/NCT01569243.
0,"To evaluate the effect of baseline status on the change in 25(OH)D, the change in 25(OH)D was plotted (mean ± SD) by baseline 25(OH)D category and analyzed by ANOVA."
4,A total of 98 individuals completed the TTM study of which 46 were assigned to the intervention arm and were contacted for poststudy interviews 6 months to 1 year after the study concluded.
0,Cells were cryopreserved at −150°C or lower using 10% dimethyl sulfoxide.
6,The primary endpoint of the study is the in-segment late loss (LL) at 9 months measured by quantitative coronary angiography (QCA).
0,"The study was conducted according to Good Clinical Practice, the Declaration of Helsinki and all applicable local rules and regulations of Thailand."
6,"The secondary endpoints include angiographic findings such as angiographic success, device success, binary angiographic restenosis, and clinical outcomes such as procedural success, death of all causes, myocardial infarction, target vessel revascularization, target lesion revascularization, and stent thrombosis."
0,"Negative values denote radius being longer than ulna, whilst positive values refer to radius being shorter than ulna."
3,The main eligibility criteria were as follows: locally advanced or metastatic pancreatic cancer; histologically or cytologically confirmed diagnosis of adenocarcinoma; no prior chemotherapy or radiotherapy for pancreatic cancer; age of 20–80 years; Eastern Cooperative Oncology Group PS of 0–1; and adequate main organ function.
0,The choice of antiemetic will be as per local policy.
3,Written informed consent was obtained from all eligible patients.
0,"Pt #006 cells were also incubated with 1/10 diluted sera and bound antibodies (Abs) were detected using FITC-rabbit anti-IgA, G, M (DAKO) and observed by fluorescence microscopy (Olympus BX40 microscope, DP2-BSW software)."
4,"The study was conducted at a community health centre in urban Lusaka, Zambia."
0,Secondary end points also included clinicians’ ratings and patients’ self-ratings on the Clinical Global Impression (CGI) severity and improvement scales.
4,Procedures to develop questionnaires (focus group discussion and key informant interviews) have been previously reported [13].
0,The RCMI method used by study participants was a commercial language line accessed via a landline telephone.
4,"The study was conducted at the Bagcilar Research and Training Hospital Gynecology and Obstetrics Department, Infertility Section."
0,"A translated and adapted SF-12 version one survey was administered to participants at baseline along with a survey that collected data on gender, age, income and rural/urban residence."
4,"Cycle monitoring was done with folliculometry with transvaginal sonography, E2, P4 and A4 measurements."
0,"An MPRI ≤1.8 is considered abnormal,20 and correlates with CRT20 and risk factors.33"
8,No formal sample size calculation was carried out as this was a feasibility study.
0,"Coverage assessments were implemented in Kita in December 2014, before the intervention started, in June 2015 and in December 2015 (10 months after the start of the study)."
8,"We set a sample size of 50 as sufficient to allow assessment of key objectives related to recruitment, retention, willingness to be randomised, data capture, completion rates of outcome measures, mean and standard deviation of primary outcome, and acceptability of the intervention [26]."
0,The sample size was estimated based on the assumption that micronutrient bundle would decrease diarrhea incidence by 15% and episodes of pneumonia by 25% with alpha of 0.05 and 90% power.
1,"This phase 2, multicenter, randomized, double-blind, placebo-controlled study evaluated the effect of teriflunomide as add-on therapy in patients with RMS receiving a stable dose of GA."
0,No other beverages or food were allowed during the cycling time trials and 1.5-h recovery.
1,"After a four-week screening period, patients entered into a 24-week double-blind treatment period; those completing 24 weeks of treatment and still meeting eligibility criteria were given the opportunity to enter a 24-week double-blind extension study, during which patients continued to receive their originally assigned study treatment."
0,Both VIPtot (VIP scores for the predictive and orthogonal components) and VIPpred (VIP scores for the predictive component) were calculated (33).
5,"The intervention was based on standard MBSR, including home practice materials, but without the day retreat at week six; excluded for pragmatic, space-constraint reasons, as well as empirical evidence contesting its necessity [28] (Additional file 1)."
0,The other hemisphere was used for additional histochemical and immunocytochemistry studies and post-mortem imaging studies.
5,"All MBSR classes were led by two experienced physician facilitators and took place at the NHS Centre for Integrative Care (NHS CIC), in Glasgow."
0,"The study was performed in accordance with the International Conference on Harmonisation Good Clinical Practice guidelines and appropriate regulatory requirements, and with approval of Institutional Review Boards at individual enrolling institutions."
8,"Given the aim of this study being to assess feasibility and power estimate for a phase-3 trial, sample size was not based on a power calculation."
0,"Chromatography was performed on an analytical reversed phase LC column (Phenomenex Luna (C18) 100 Å, 30 × 2.0 mm (3.0 μm particles) with gradient elution."
8,"However, based on the advice of a statistician, a working sample size of 50 people was chosen as:Browne [37] has demonstrated that an ‘n’ of 30 is sufficient to allow estimates of sample size for an efficacy trial.Pragmatic reasons including a) the MBSR instructors were used to routinely delivering groups of this size; and b) space constraints meant that a maximum of 25 participants could be accommodated in each group."
0,Patients will be free to leave the study without explanation without any negative consequences on future treatment.
4,Blood samples were obtained and processed for proper storage and shipment per protocol [11].
0,The parent trial is registered on clinicaltrials.gov (NCT00860470).
4,"Data on procedures including bronchoscopy, transthoracic needle biopsy, and surgery were recorded."
0,Written informed consent was obtained from all individuals.
8,"We intended to include 420 early MV-children and 210 controls based on detecting a 10% reduction of pneumococcal colonization among MV-children, from 85% to 75%, with a power of 80% and significance level α = 0.05."
0,"The WRAT-3 Reading subtest assesses single-word reading skill.WAIS-III, Digit Symbol Subtest (3 minutes)."
3,Patients with intermittent claudication and critical lower limb ischemia of atherosclerotic genesis that correlated with stage II–III (a pain-free walking distance [PWD] of <200 m and resting pain) according to the Fontaine–Pokrovsky classification (2004) were enrolled in the study (n = 210) and randomized into either the control group (n = 60) or the treatment group (n = 150).
0,Patients will be screened and randomized from January 2009 until June 2011.
3,"Depending on the anatomy and pathological process involved, patients had atherosclerotic lesions of the following types: (1) proximal—primarily occlusion of the iliac-femoral and popliteal arteries; (2) multilevel—occlusions in the iliac-femoral, popliteal, and tibial arteries; or (3) distal—occlusions or hemodynamically significant stenosis in tibial arteries."
0,"In a systematic review in 2015 [2], pooled correlations were undertaken based on the Fisher’s z transformation of the correlation coefficients, showed that between illness perceptions and depression, blood glucose levels and quality of life were in the range 0.25 to 0.49 for consequences, identity and emotional representations and between - 0.15 to - 0.27 for the personal control item."
8,Manganese deposits prevalence was estimate in the total HHT cohort.
0,VIA-positive women are referred to BSMMU and government medical college hospitals for colposcopic evaluation and management.18–20
8,"For the objective of comparing the presence of neurological affectation in BG-MnIL patients, we calculated a sample size considering an estimated difference of 35% (40% of patients with BG-MnIL would have psychological symptoms and only 5% of those without lesions), power on 80% and alpha 0.05, we estimated 20 patients with BG-MnIL and 20 without it."
0,Concomitant cholecystectomy was performed in patients with preoperative cholelithiasis.
16,All data were summarized using descriptive statistics.
0,"10 µL of thawed, inoculated STGG medium were plated onto a gentamicin blood agar plate and incubated for 18–24 hours at 35°C in 5% CO2."
16,Data are presented as mean ± standard deviation (SD) or as median with 25th and 75th percentile.
0,"The kV setting was determined by weight: 100 kV for subjects <60 kg, 120 kV for subjects ≥60 and <80 kg and 140 kV for subjects >80 kg."
6,The primary outcome in the current study was effects on LVEF after 26-week treatment of exenatide versus insulin glargine in T2DM patients with LV systolic dysfunction.
0,The study was not powered for subgroup analysis by race or menopausal status.
6,"Secondary outcomes were differences in myocardial perfusion and energetics in T2DM patients with LV systolic dysfunction versus healthy BMI-matched healthy controls, and effects on myocardial perfusion and energetics after 26-week treatment of exenatide versus insulin glargine in T2DM patients with LV systolic dysfunction."
0,The trial was conducted under the provisions of the Declaration of Helsinki and in accordance with Good Clinical Practices guidelines set up by the WHO and by the International Conference on Harmonization.
8,QUARISMA was designed and powered to detect differences between treatment groups in the primary clinical endpoint (caesarean sections averted).
0,Treatment machine QA was performed daily and monthly and patient specific QA performed prior to treatment.
8,Sample size calculations were not designed to test cost-effectiveness hypotheses.
0,"At each study contact, parents were encouraged by study staff to present the child to a healthcare facility at any time they felt their child was unwell."
3,"The DCCT enrolled 1,441 subjects with type 1 diabetes, with 711 randomly assigned to intensive therapy aimed at achieving levels of glycemia (HbA1c) as close to the nondiabetic level as safely possible and 730 assigned to conventional therapy aimed at maintaining clinical well-being with no specific glucose targets (1)."
0,"If patients, after reading the patient information, have any questions about our study protocol, they can contact Dr."
3,"Two subcohorts were enrolled: a primary prevention cohort of 726 patients with 1–5 years’ duration of diabetes, no retinopathy, and an albumin excretion rate (AER) <40 mg/24 h on study entry; and a secondary intervention cohort of 715 patients with 1–15 years of diabetes, minimal to moderate retinopathy, and AER <200 mg/24 h."
0,An economic evaluation was undertaken using the participant level data from the trial.
16,"Statistical analysis of 2D-DIGE spot intensity was performed using DeCyder 7.0 BVA or EDA software (GE Healthcare, Uppsala, Sweden)."
0,"Secondary objectives were progression-free survival, overall survival, acute and late toxicity, resectability and patterns of recurrence."
16,Other statistical analyses were performed if appropriate using either an independent sample t tests or an ANOVA with statistical software package IBM SPSS 20.
0,c Geometric mean of the largest number of drinks consumed on occasion across all time points Brief Versus Extended Internet Interventions
6,"The primary outcome was safety and tolerability over the first 84 h of hospital admission as determined by clinical, biochemical, haematological, and electrocardiographic observations according to specific pre-defined local reference ranges."
0,"Simvastatin, mevalonate, ammonium salt of FPP and GGPP were purchased from Sigma-Aldrich Co (St."
6,Adverse events (AEs) and serious adverse events (SAEs) were recorded and monitored throughout the study.
0,"Specifically, a high-resolution T1-weighted sequence was used to acquire 5-mm-thick slices in the transverse plane."
3,Selection criteria for MOR-005 have been previously reported [12].
0,All participants in the DISC06 Follow-up Study provided informed consent.
3,This report was a post hoc subanalysis of the adult patients (≥18 years of age) who participated in MOR-005.
0,The invasive measurements of epicardial and microvascular function were: 1.
16,"Microsoft Excel for Mac (version 15.27) was used to tabulate data and calculate odds ratios, confidence intervals, and perform Student t tests."
0,"The age variable was included in all models with a change point at 24 months, as this was the closest half-year to the mean age of those children who were no longer receiving breast milk (mean = 26.8 months ± 5.8, n = 746)."
1,"This was a phase III, non-randomized, open-label, multi-center study with a single group (Clinicaltrials.gov: NCT01827839) conducted in 2 centers in Canada and 2 centers in the Russian Federation between June 2013 and November 2014."
0,All the study procedures were subsequently conducted during 1 visit at the Clinical and Translational Research Center at the University of Colorado Anschutz Medical Campus.
1,"The duration of the study was approximately 14 months for each participant, (approximately 12 months after the second dose), including 3 study site visits (at Month 0, Month 2 and Month 3) and 2 telephone contacts (at Months 8 and 14)."
0,"Rates of incomplete recovery (relapses associated with subsequent 24-week CDP) over 1 year and over 2 years were compared for all randomized patients according to Year 1 treatment assignment: patients receiving continuous peginterferon beta-1a every 2 or 4 weeks were compared with the overall delayed treatment group (all patients originally randomized to receive placebo), using a Chi-square or Fisher’s exact test."
3,"Patients were aged 18–75 years, had active RA despite MTX treatment, and had inadequately responded or been intolerant to previous treatment with anti-TNF agents (see online supplementary material B and C for details of study methods)."
0,Patients are generally fluid overloaded on the beginning of the week i.e.
16,"The primary statistical analysis was a comparison of AUC0–last and Cmax between CT-P10 and RTX groups, stratifying for region and prior anti-TNF agent status at baseline."
0,We were not always able to determine the space used for every telemedicine visit.
16,The PK of the two drugs were to be considered equivalent if 90% CIs for the ratio of geometric means (CT-P10/RTX) of both primary endpoints fell within the bioequivalence range (80%–125%).
3,"Snakebite victims were enrolled in the study if they gave written informed consent (assent if aged 12 to 18) and had ≥1 sign(s) of neurotoxic envenoming: bilateral ptosis; inability to frown, open the mouth, protrude the tongue, or clear secretions; broken neck sign; skeletal muscle weakness (power < 3 UK MRC scale); gag reflex loss; and paradoxical breathing."
0,"Briefly, a total of 3619 women were screened and 1644 enrolled into the CS trial at the Ikeja and Apapa clinics in Lagos, and at the Central and Peripheral clinics in Port Harcourt."
3,"Those presenting >24 hours post-bite, with a proven viper bite, who had already received antivenom, or were children below 5 years, pregnant or breast feeding women, individuals with a history of neuromuscular disease, known allergy to horse protein, and those with an immediate need for mechanical ventilation were excluded."
0,What is your experience in managing these cases?
16,"Based on an expected response rate of 60% with the telaprevir-based regimen, it was calculated (based on exact binomial distribution and using the Clopper–Pearson formula) that a sample size of 80 evaluable patients would give a 2-sided 95% confidence interval extending 11% above and below the expected observed response rate of 60%."
0,Focus group and individual interview participants were not excluded from participating in the survey.
16,"To allow for up to 30% of patients to have non-evaluable data (i.e., as-treated or observed analyses do not impute missing data) for the primary virologic endpoint, enrollment of 115 patients was planned."
0,"The study milk was consumed by the women both pre- and postnatally, and the children did not receive any probiotic supplementation as a part of this study."
6,"The primary efficacy endpoint was the prepatent period in days defined as time from DVI of PfSPZ Challenge (day 0) to parasitaemia, detected by TBS."
0,"On approval from the IRB, we implemented an option that enabled participants to complete both the full eligibility screening and the informed consent process solely through the app."
6,"Secondary outcome measures were number and severity of adverse events, the pharmacokinetic (DSM265 and DSM450 concentration in peripheral blood over time), and pharmacodynamics profile (parasitaemia over time)."
0,The ASP staff in each intervention ASP will participate in the course programme as described below (table 1).
3,The exclusion criteria were selected to avoid the presence of a contraindication to treatment or diseases affecting biomarkers clearance and to exclude the interference of concomitant painful condition or therapies that may modulate cartilage metabolism.
0,"Upon randomisation, subjects completed five study visits: Visit 3 (Day 1/baseline), Visit 4 (Day 7±1 day), Visit 5 (Day 14±1 day), Visit 6 (Day 28±1 day) and Visit 7 (Day 29±1 day)."
3,Patients meeting to at least one of the criteria detailed in Table 1 were not included in the study.
0,All four of these efficacy secondary endpoints had a P<0.050 in the entire cohort.
1,"This was an uncontrolled pilot study intended to evaluate the feasibility and preliminary effects of a comprehensive, therapist-guided CBT program for alcohol use disorders."
0,"For each arm, 2 men and 2 women were assigned randomly to a dietary sequence consisting of 2 weeks on one defined diet followed by two weeks on another; the remaining 4 subjects were assigned the same two diets in reverse order."
1,A within-group design with repeated measures was used.
0,Serum and products samples were kept at −80°C before being analyzed with the use of the same protocol.
16,All patients who received OCV‐C02 were included in the safety and efficacy analyses.
0,"The second cut-off point, TDC = −0.379, was related to attaining functional status for myogenous TMD (potentially ‘successful’ treatment with a residual level of signs and symptoms), and corresponds to 55% decrease of a single score of pain intensity."
16,"All statistical analyses were done using SAS software (version 9.2) (SAS Institute, Cary, NC, USA)."
0,"When the duplicate T/S value and the initial value vary by >7%, the sample was run the third time and the two closest values were reported."
16,The intent-to-treat (ITT) population was used for efficacy analyses and was defined as all randomized patients who took at least one dose of study medication and had a baseline and at least one post-baseline FEV1 assessment.
0,Participants who had quit smoking at 12 weeks were randomized into 2 groups matched by their level of motivation and level of addiction as per psychometric questionnaire at baseline.
16,The risk of a CID event over time was analyzed using a Cox-Proportional Hazard model with study treatment group as a covariate.
0,"The study was approved by the Research Ethics Committee of Trinity College Dublin (Study reference: 21 November, 2012)."
8,The sample size of 40 patients was based on a similarly sized sample26 where a large measurable reduction in HRSD scores was found after four ECT treatments following ketamine v.
0,"XANTHIPPE (Examining the effect of Ticagrelor on Platelet Activation, Platelet-Leukocyte Aggregates, and Acute Lung Injury in Pneumonia is an investigator-designed and initiated trial) (NCT01883869) was approved by the institutional review board at the University of Kentucky."
8,KANECT ended when the sample size was achieved.
0,VRC01LS vials were filled at a concentration of 100 mg/mL.
3,"Patients are eligible if the following inclusion criteria are fulfilled: 1) Histologically verified primary head and neck squamous cell carcinoma (HNSCC) of the oral cavity, oropharynx, hypopharynx, larynx, or in lymph nodes of the neck from an unknown primary tumor; 2) candidate for curatively intended CCRT (weekly cisplatin during radiotherapy, 66–68 Gy) according to Danish Head and Neck Cancer (DAHANCA) group (i.e. patients with stage III-IV disease, www.dahanca.dk) [31]; 3) performance status (PS) 0–1 (Eastern Cooperative Oncology Group Performance (ECOG); 4) age ≥ 18 years; 5) signed informed consent."
0,"For client-related characteristics, we aggregated data from female sex workers (n = 1,088)."
3,"Exclusion criteria are: 1) Body Mass Index (BMI) < 20.5; 2) comorbidity potentially interfering with attendance or test results, e.g. other cancers, diabetes, prednisolone treatment); 3) tonsillectomy within 1 week before inclusion; 4) psychological, social or geographical conditions that could influence protocol adherence; 5) insufficient bone marrow function (hemoglobin <6 mmol/L, leucocytes <2.5 × 109/L, or thrombocytes <50 × 109/L; 6) diastolic blood pressure < 45 or >95, resting heart rate > 100; 7) signs of ischemia on electrocardiogram; 8) pregnancy."
0,The stemming process refers to extracting the stem or root of words so that words with the same roots such as “book” and “books” fall into the same word subcategory.
3,"Eligible patients reported moderate to severe claudication or ischemic rest pain (Rutherford class 2–4) with angiographic evidence of >70% stenosis within the SFA and/or popliteal artery, 1 or 2 de novo or restenotic lesions with a cumulative length of 30 to 200 mm, and reference vessel diameter of 4 to 6 mm."
0,The costs for each product is given in this dataset and is valued based on a standardised pharmacy consumer price.33
3,Important patient eligibility criteria are detailed in Table I in the online-only Data Supplement.
0,"Worms were classified as newly acquired, young, middle-aged, or old [19]."
6,The primary endpoint was the percentage of dp-ucMGP drop after 4 weeks of vitamin K2 supplementation at a dose of 360 μg /d.
0,There is a great deal of scatter in terms of the population throughout the area because of the large rural area that exists there.
6,"Secondary endpoints were: 1- the correlation between AC-24 score and baseline dp-ucMGP levels, 2- the correlation between baseline dp-ucMGP levels and the other collected variables, 3- the correlation between dp-ucMGP drop and the other collected variables."
0,"Facilitators trained the brigadistas over 1 week before visiting households, and accompanied them for a further month in the field."
3,"From the original cohort of 644 infants, weight and/or length were recorded at birth, at enrolment and/or at the two-year follow-up visit in 642 children (Fig. 1)."
0,The device and endoscope are retroflexed.
3,"Mean age (min, max) was 5.1 months (0.2, 13.4) at enrolment and 24.6 months (17.5, 35.2) at the two-year follow-up visit."
0,"sTREM-1 levels were determined in duplicate using a double antibody sandwich enzyme-linked immunosorbent assay (ELISA) (Quantikine Human TREM-1 Immunoassay kit; R&D Systems, Minneapolis, MN, USA)."
3,"Eligible subjects were healthy, 6 week-old, full-term infants, attending well baby clinics for their first polio vaccinations."
0,"In order to measure cell-free DNA in plasma, the plasma samples were centrifuged at 16,000 g for 10 min to remove any residual cells."
3,Inclusion criteria were medical and surgical ICU patients ≥18 years with an expected ICU stay of ≥5 days and anticipated tube feeding for ≥3 days.
0,"The minimally invasive approach through the right fourth intercostal space with femoral–femoral cannulation for arterial and venous lines was used in 29.4% (n = 25) and 31.4% (n = 27) of patients in the SR and FB groups, respectively."
3,"Exclusion criteria were the presence of contraindications for enteral nutrition or placement of an enteral feeding tube, patients receiving enteral nutrition with ≥75% of caloric goal already administered, restrictions in full intestinal support, parenteral nutrition of any kind unless due to enteral nutrition intolerance, a history of allergy or intolerance to study product components (test or control product), nonfunctional gastrointestinal tract, limited care, and participation in another interventional trial during the last month."
0,Neonatal mortality and morbidity will be specified until date of discharge from hospital.
14,"All sociodemographic, clinical characteristics, food consumption and anthropometric measurements, biochemical markers and cytokines measurements were performed in a blinded fashion by the same single evaluator."
0,The intervention was designed to be used before a visit with the physician who provided the patient’s hypertension care.
8,"Considering a prevalence of 60% of inadequate omega-3 PUFAs intake [26], IFNγ values of 3986 (738) pg/mL at baseline and IFNγ values of 2922 (1275) pg/mL after omega-3 PUFA supplementation [27], and assuming 80% of power and 5% of significance level, the minimum estimated sample size was 40 patients (20 in each group)."
0,The patients were prepared in the supine position with their skin temperature measured on the palms and maintained above 32°C.
8,The sample size was calculated based on an anticipated clinically meaningful mean difference in BMI SDS of 0.1 between the two groups after 2 years assuming a SD of 0.15 in both groups.
0,Sensitivity to the imputed value was explored by using the maximum and minimum costs.
8,"Given a significance level of 5% and keeping statistical power to >80%, at least 37 children in each group were needed to complete the study."
0,"In evaluating rating prediction methods, we used a range of standard performance metrics including root mean squared error (RMSE), Kendall tau-b, and normalized discounted cumulative gain."
3,"In the monotherapy study, eligible patients were Japanese males or females with T2D aged 20 years or older with BMIs ≥18.5 and ≤35.0 kg/m2 and HbA1c ≥7.0 and ≤10.0% confirmed at randomization who were OHA-naïve (diet and exercise only) or had discontinued OHA monotherapy [14]."
0,"All participants were instructed to remove the device during contact sports, water-based activities (swimming, showering, and bathing), and overnight."
3,"In the combination therapy study, eligible patients were Japanese males or females with T2D aged 20 years or older with a BMI ≥18.5 and <35.0 kg/m2 and HbA1c at screening ≥7.0 and ≤10.0% who were taking stable doses of sulfonylureas and/or biguanides [15]."
0,"Short-axis cine images were used to calculate ventricular volumes, mass, and function."
1,"This randomized, double-blind placebo controlled trial of oral cinnamon supplementation on individuals with metabolic syndrome was carried out for 16 weeks after an initial run in period of 4 weeks."
0,"Participants received messages that spanned these categories to provide broad coverage of topics, and to ensure messages were not duplicated."
1,The clinical trial was registered after the recruitment of the participants in ClinicalTrial.gov under the identification number: NCT02455778 (URL:https://clinicaltrials.gov/show/NCT02455778?displayxml=true).
0,"The study was approved by local ethic committees, and informed consent was obtained from all participants before admission to the study."
6,Our primary outcome was the cure rate (the percentage of egg-positive children at baseline who became egg-negative after treatment) resulting from different doses of praziquantel based on the Kato-Katz method.
0,"The Life-ON Project is a prospective, both observational and interventional, multicentre [three sleep centres in Northern Italy (Bologna, Milan, Turin) and one in Southern Switzerland (Lugano)], non-profit, without medicines, cohort study, which will include about 500 women, who will be longitudinally followed from early pregnancy (10–15 gestational week) until 12 months after delivery."
6,The secondary outcomes were egg reduction rate (ERR) and the safety of different doses of praziquantel.
0,"Through a network of posted field workers, we attempt to attend all deliveries occurring in West Kiang."
3,"Child inclusionary criteria included an African American girl, 8 to 10 years old, with Internet access, a personal email address, and a parent or legal guardian willing to participate in data collection; exclusionary criteria included having mental, physical, or medical conditions that limited their ability to participate in data collection activities or taking medications that impact appetite, dietary behaviors, and physical activity."
0,"In practice the majority of schools offered breakfast cereal with milk, toast and fruit juice and either fresh, dried or tinned fruit."
3,"Parent inclusionary criteria included having a child participating in the program, willingness to participate in data collection, and having Internet access and a personal email address; exclusionary criteria included physical restrictions that limited their ability to participate in data collection activities."
0,"Plasma samples were stored at −20°C until shipped and analyzed by the department of Drug Metabolism and Pharmacokinetics at Bayer Pharma AG (Wuppertal, Germany)."
16,"All efficacy analyses were performed on the intention-to-treat population, except for response endpoints (analyzed in the response-evaluable population)."
0,The community readiness score is used to develop appropriate and specific nutrition and physical activity interventions for each community and is used as an adjustment factor in the evaluation of intervention effectiveness.
16,"Time-to-event distributions were estimated using Kaplan-Meier methodology, with log-rank tests and Cox models (alpha=0.05, 2-sided) used for inter-arm comparisons of time-to-event endpoints."
0,"According to national policy, children between 1 and 12 months of age are expected to attend preventive WBCs at the HC on a monthly basis and then attend it every other month up to the age of 24 months."
3,"From 16th April 2014 and 19th December 2015, 25 patients were assessed for eligibility."
0,Patients were enrolled into part A in initial cohorts of three to six patients.
3,Five patients failed screening and were not enrolled.
0,"To increase the testing sensitivity, we repeated the isolation five times and then pooled and concentrated the cfDNA from a total of 4 mL plasma for mutation testing."
14,"The ED and research staff were blinded to the treatment assignment, but the participant and caregiver were unblinded at the time, and after, the patient was randomized into the trial."
0,"This protocol resulted in matches very close to 2 h in duration and with very low variability, while avoiding games played “in time”, which could have led to abnormal playing and have had a negative impact on the player motivation."
14,"During follow-up and retention efforts, the research staff remained blinded to the patient group assignment."
0,"In order to correct for inter-subject variability, each volume of the segmented regions was divided by the total intracranial volume for each subject."
3,"The study (ClinicalTrials.gov, NCT02231619) was conducted at six public sector primary level abortion clinics, including one youth clinic for women under 25 years, in Cape Town, South Africa."
0,The energy requirements were estimated to the nearest 100 kcal/d and used for the development of the diets.
3,"To be eligible for the study, women needed to be clinically eligible for medical abortion using mifepristone with home-use of misoprostol, have a gestational age within 63 days, be 18 years of age or older, willing to receive abortion-related text messages on their phone over the next 14 days, able to give informed consent and willing to attend a follow-up visit at the same abortion clinic 2 to 3 weeks later."
0,The mean cell diameter from samples was calculated from the mean cell perimeter of the three readings.
1,"This was a multicentre, double blind, randomised controlled trial (RCT)."
0,They were randomized at a ratio of 1:1 to either a treatment arm or a comparison arm by opening a sealed envelope which contained a paper with a randomly assigned group number.
16,"Exploratory, descriptive analyses of demographic, safety, and efficacy data were planned based on the treated set (all patients who were dispensed medication and were documented to have taken ≥1 afatinib dose), with two subgroups divided by previous TKI exposure."
0,"They should simulate the problematic motions of the worker, preferably by simulating working situations."
3,"The participants were primary care physicians in British Columbia providing office-based care to patients 65 and over, using the open source OSCAR EMR developed by McMaster University and the OSCAR community (version 12.x) for at least 12 months (this was to provide enough time for medications to be consistently documented in the EMR), and who were part of or willing to be part of the University of British Columbia’s Department of Family Practice Research Network."
0,Blood samples were drawn at vaccination and 4 to 6 weeks thereafter.
3,"Providers who do not provide longitudinal care (eg, walk in clinics) or only hospital care, who do not use OSCAR for writing prescriptions, or who provide care to a younger population (eg, a maternity clinic) were excluded from the study."
0,Chang performed site visit to maintain fidelity.
8,"Sample size was calculated assuming a PIP rate of 20% [10,27,35] and an expected relative reduction of 20% in PIPs (absolute reduction of 4%)."
0,"PAMF research staff assisted participants in signing into an account for the Alive-PD Web-based program, where participants provided their email address and password to the system."
8,"Using a power of 0.8 and alpha=0.05 and estimating that two practices may be lost to follow up, we predicted the need for 12 practices in each arm and 900 encounters per arm with patients 65 years and over."
0,Box 1Study inclusion and exclusion criteria
1,"A prospective, comparative, randomised, single centre trial that included 106 patients was performed to compare MB and FB PS-TKA with patella resurfacing at 5 years follow-up (FU)."
0,"This work was part of the multifaceted, multi-center PATRES (Pan-Scan for Trauma Resuscitation, ISRCTN35424832 and ISRCTN41462125) project that investigates the different levels of diagnostic test research pertaining to the whole-body scan in early trauma care."
1,Patients with end-stage osteoarthritis of the knee were randomised to either an MB or FB group to receive PS-TKA using a standard medial parapatellar approach.
0,The primary outcome measure is disability.
14,"Other than for the random selection process, no blinding was used due to the pragmatic nature of the research question “Is treatment by a homeopath effective for self-reported depression?” No blinding of assessment (statistical analyses) was used, as group allocation would become obvious due to the 1:2 randomisation ratio."
0,We excluded those who did not have a postal address (74) or had been invited to our pilot study (200).
4,"The implementation sites were the University of Alabama at Birmingham (UAB), the University of North Carolina at Chapel Hill (UNC), Johns Hopkins University (JHU) in Baltimore, and the University of Washington in Seattle (UW)."
0,Eligible patients were randomly assigned (1:1) to receive either nimesulide/pantoprazole (one tablet; 100 mg/20 mg) plus placebo twice daily or naproxen/esomeprazole magnesium (one tablet; 500 mg/20 mg) plus placebo twice daily according to a computer-generated randomization code.
4,The institutional review boards (IRB) at each participating site approved this protocol.
0,Four physiotherapists provided the treatments.
14,Study participants and primary investigators are blinded.
0,All patients were placed in the supine position on the operating table.
14,An unblinded investigator will evaluate safety issues.
0,Observations were made by the nurses using digital stopwatches and a checklist to record the time taken for each task.
16,All data are presented as mean ± SEM.
0,"In our study, the repeatability of CFR and IMR was assessed by duplicate measurements 5 minutes apart in a subset of 12 consecutive patients, in line with previous observations (28)."
16,"Statistical calculations were performed using SPSS software (SPSS Inc., Chicago, IL, USA) and included univariate quantitative analysis (independent samples t test, chi–square test, Fisher’s exact test), multivariate linear regression, and correlation analysis (Pearson’s correlation coefficient)."
0,The number of WAJAs per village and village population size were obtained from project records.
6,"The primary end point was a reduction in insulin requirement by ≥50%, while maintaining HbA1c < 7.0% (<53.0 mmol/mol) [5, 10]."
0,EDSS was used to evaluate the potential effects of disease severity on depression outcomes.
6,"The secondary end points included alterations in weight, HbA1c, metabolic indices including stimulated C-peptide and insulin sensitivity as compared to the baseline."
0,"Total (external wall to external wall), luminal, and non-luminal volumes were measured semi-automatically."
1,"See S1 Protocol French version, S2 Protocol English version."
0,"A dietary survey form, a 3-day dietary recall, and a validated Food Frequency Questionnaire (FFQ) were completed by a qualified dietitian or trained study coordinator."
1,"A single center, randomized controlled single blind two arm parallel group trial with a 1:1 allocation ratio evaluation standard information by the surgeon versus standard information by the surgeon plus delivery of a validated standardized information booklet with respect to 10 items questionnaire [12]."
0,"Continuous variables (age, duration of infertility, total motile sperm count, 3rd day FSH, initial and total dose of ovulation induction agent, follicle count and size, and endometrial thickness) were presented as mean ± SD."
1,Quasi-experimental longitudinal field study with an intervention and a control group.
0,An AHI of five or more events confirmed a positive OSA diagnosis.
3,"Adults (aged ≥18 years) with histologically confirmed advanced (unresectable and/or metastatic), well-differentiated, or moderately differentiated (low or intermediate grade) NETs with documented disease progression in the prior 12 months, independent of primary tumor location and functional status, were enrolled in the study."
0,Questionnaire measurements were conducted at baseline and at 24 months of follow-up.
3,A key exclu-sion criterion included patients with baseline glycosylated hemoglobin (HbA1c) >7.0%.
0,"A NanoDrop 8000 Spectrophotometer (Thermo Scientific Pierce, Waltham, Maine, USA) was used to quantify RNA by measuring absorbance at 260 and 280 nm with a ratio ≥1.9."
5,CRRTnet is strictly an observational study and no clinical interventions will be performed.
0,"During Phase I of the trial (months 1 to 6), participants randomized to the intervention attended weekly group meetings led by a facilitator at an exercise center."
5,"In addition, no biosample collection or storage will occur as part of CRRTnet."
0,All samples were run in duplicate.
8,"Due to the observational nature of CRRTnet, a formal sample size calculation was not performed."
0,The EN-assay had a total coefficient of variation (CV) of about 6%; the OPG-assay of 7%.
8,"However, our target recruitment is 2000 patients, which would result in the largest and most detailed collection of CRRT patients to date."
0,This study was designed as part of our previous prospective single‐center registry (NCT00737945).
4,"Participants came from a variety of recruitment sources, with the most common being referrals from a health care organization, Web-based advertising, news stories, advertisements on local public transportation, and word of mouth."
0,The study was registered at clinicaltrials.gov with registration numbers NCT01699009 and NCT01547494.
4,"The remaining participants came from the Google Play Store, research registries, other research studies, social media, fliers, and other sources."
0,"Data were collected in an electronic case-report form (Clininfo, Lyon, France)."
3,"Patients were eligible for enrollment if they had a histologically or cytologically confirmed adenocarcinoma of the prostate that was castration resistant, had not received cytotoxic chemotherapy or abiraterone acetate, had an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 (no symptoms or ambulatory but restricted in strenuous activity), and were asymptomatic or mildly symptomatic per the Brief Pain Inventory Short Form question 3 (i.e., pain score 0–3).[22] Patients with conditions that could lower the seizure threshold (i.e., brain metastases, history of seizure, concurrent medications) or those with a history of chemotherapy were excluded."
0,"Immunogenicity samples were taken at screening, immediately before doses 3 and 4, and 8 weeks after the last dose using an enzyme-linked immunosorbent assay for detection of human antibodies to BIW-8962."
3,"Participants will be physicians that are specialists or residents, have a practice including cancer patients and speak French."
0,Oxygen adaption of both COT and HFOT followed the same standard protocol.
3,"The study was approved by a central ethics committee (Jules Bordet Institute, Cancer Center of the Université Libre de Bruxelles) and all participants will provide written informed consent."
0,"At the 24 and 32 week visits, women in treatment group 1 received SP-IPTp whilst women in treatment groups 2 and 3 were screened with the RDT and, if positive, treated with SP or AS+AQ according to the allocation arm."
8,"Due to the pilot nature of this study, a sample size calculation was not performed."
0,The minimum size required was 3mm diameter.
8,The initial aim of the study was to recruit between 20 and 25 participants because having 10 to 12 participants per group seemed like a sufficient sample size to inform our group of trends in the levels of the biomarkers of interest as a consequence of weight loss.
0,"At 3 weeks, the vitreous body was clear, but the left nerve head had a “soft mound” appearance, and by 3 months the mound was slightly thinned."
1,"The study was designed as a multicenter, randomized, open label, controlled trial to evaluate the efficacy and safety of AmphoB, LAMB and the combination LAMB plus MA, compared to standard treatment with MA."
0,The WTP value was varied between $0 and $100 000.
1,The patient allocation ratio was 1:1:1:1.
0,"Assessment of glycemic control in T2DM patients is currently provided by three measures: HbA1c, an integration of glucose levels over 3 months period, fasting glucose level, and postprandial glucose levels [29]."
1,"The study was a two arm, parallel group pilot randomised controlled trial with outcome assessments at baseline (T1), and subsequent blinded outcome assessment at the end of the intervention (T2) and at 3 months (T3) and 6 months (T4) after the end of the intervention."
0,"These components were education, reminders, feedback, facilities and products, setting norms and targets, social influence and leadership."
1,"A two-site randomized controlled trial (RCT) was completed with community-dwelling MWC users in Québec City, QC, Canada, and Vancouver, BC, Canada."
0,"Interventions that have used the IMB model have been show to effectively improve many health-related behaviors, including antiretroviral adherence [41–43]."
3,≥50 years of ageLived in the communityCould self-propel a MWC an average of 1 h per dayHad self-proclaimed wheelchair mobility goalsWas cognitively able to engage in the WheelSeeU program (Modified Mini-Mental Status Exam (MMSE) score of ≥24) [23] Exclusion criteria
0,for 14 days following each T cell infusion as a source of helper support.
1,"A randomized crossover, experimental longitudinal design was used in this study (see protocol published elsewhere) [20]."
0,"The injured muscle compartment was accessed, scar tissue was debrided and selective tenolysis performed."
1,This article presents the quantitative component of this study.
0,"A total of 1,373 subjects consented to and completed baseline assessments of body composition, including total body BMD (including the head), BMD of the lumbar spine (L1–L4), total hip, and the femoral neck of the hip, using a Hologic fan beam densitometer."
3,"Pregnant femaleAny significant lab abnormality of neutrophil count, hemoglobin, platelets, aspartate aminotransferase (AST), or alanine aminotransferase (ALT) (Defined as Grade ≥ 3 by Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events, Version 2.0, Nov."
0,Questions on usage of smartphone apps for quitting smoking and preferred features in an app were asked.
1,"The study was cross-sectional, multicentric and observational."
0,Toxicity was assessed using the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) version 3.0 (National Cancer Institute 2006).
1,It was conducted between January and June 2015 at resting sites along the Suriname-French Guiana border.
0,Adverse device effect that has resulted in any of the consequences characteristic of a serious adverse event or that might have led to any of these consequences if suitable action had not been taken or intervention had not been made or if circumstances had been less opportune.
3,Patients ≥18 years of age with stable angina or objective proof of ischaemia or patients with acute coronary syndrome (ACS) had to meet the requirements forPCI.10
0,"One of the challenges with worksite health promotion programs is that the company management should “buy in” to the intervention and support its implementation, and also “buy in” to the study and be willing to being placed in the wait-list control arm of the study."
3,Single or multiple vessel stenting was allowed in de novo or restenotic lesions with reference diameters from 2.0 to 4.0 mm.
0,"Owing to the low patient numbers in the IFN to fingolimod switch groups (IFN-switch 0.5 and 1.25 mg), we present pooled data for both the fingolimod doses (IFN-switch group) for efficacy outcomes."
3,"After written informed consent, adult patients with a suspected renal carcinoma limited to one kidney and planned for PN were enrolled in this study."
0,The study protocol was approved by the institutional ethics committee and all patients gave written informed consent for participation in the study.
3,"Among exclusion criteria were CKD, ASA>III, contraindication and known hypersensitivity to the study drugs, pre-existing severe cardiac disease, severe respiratory disease and neurological disease."
0,The study was conducted according to the International Conference on Harmonization Guidelines for Good Clinical Practice and the Declaration of Helsinki.
3,Study participants were considered lost to follow‐up if breastfeeding outcome survey evaluations were not completed within the 1 month study follow‐up period; they were not included in the analysis.
0,Table 2 Intervention components and behaviour change techniques (BCTs) Qualitative longitudinal research
3,"Additional exclusions were made for infants with life‐threatening comorbid conditions, those with previous treatment for tongue‐tie or lip‐tie by another provider, infants born from multiple births, and mothers with previous breast surgery or insufficient glandular tissue."
0,We decided not to make assumptions on sidedness not having previous results about comparison between CBT and BST.
3,"The inclusion criteria are as follows: 1) age between 18 and 69 years; 2) diagnosis of T1DM, T2DM, and/or post-transplant DM (post-transplant DM includes both individuals diagnosed with T1DM or T2DM before organ transplantation and those first diagnosed with DM after organ transplantation); 3) initiation or intensification of insulin regimens, including once-daily basal insulin (including initiation of basal insulin only or basal insulin plus rapid-acting insulin 1 to 3 times per day and intensification to multiple insulin injections from twice-daily premixed insulins or once-daily basal insulin; patients will be eligible unless the insulin regimen was initiated more than 1 month prior to study participation, with insulin dose adjustment education provided by registered diabetes educators); 4) most recent hemoglobin A1c (HbA1c) ≥8.0% based on the National Glycohemoglobin Standardization Program (NGSP) at least 3 months prior to participation (recent HbA1c values measured <3 months prior to screening are permitted); and 5) use of an Android-based smartphone manufactured by Samsung Electronics (Seoul, Republic of Korea; Galaxy S4 or later)."
0,2H2O enrichments were calculated by comparison with standard curves generated by mixing 100% 2H2O with natural abundance 2H2O in known proportions.
3,"Exclusion criteria include the following: 1) initiating twice-daily pre-mixed or intermediate-acting insulin therapy; 2) use of an insulin pump; 3) history of alcohol or drug abuse 1 year prior to participation; 4) history of psychological disorder (e.g., schizophrenia, depression, or bipolar disorder); 5) history of severe visual or hearing impairment; 6) history of active malignancy; 7) pregnancy; and 8) any condition, in the investigator’s opinion, not suitable for enrollment eligibility."
0,Continuous variables were compared between the two groups using Mann–Whitney test.
4,"Participants will be patients diagnosed with T1DM, T2DM, and/or post-transplant DM if they initiate basal insulin or intensify their insulin regimen to a basal-bolus regimen at the tertiary hospitals Samsung Medical Center or Samsung Changwon Hospital in Korea."
0,"On non-training days, one dose was taken in the morning and the second dose in the afternoon."
4,"Individuals who are willing to participate in the clinical trial and who meet the inclusion criteria will receive written information about the study and must provide informed consent, as approved by the ethics committee [Additional file 1]."
0,Those who travelled to other areas and could not be traced for their scheduled follow-up were classified as loss to follow-up and withdrawn from the study.
6,The primary outcome of this study was the change of the total number of VPCs monitored by 24-h ambulatory ECG.
0,"If there was no improvement after fluid bolus, ephedrine (0.5 % Ephedrine, UMC Ljubljana Pharmacy, Slovenia) 5–10 mg (0.01 %, UMC Ljubljana Pharmacy, Slovenia) was instituted to maintain CI between 2 to 3.5"
6,"The secondary outcomes included the changes of LVEF, LVEDD, plasma NT-proBNP level, NYHA classification, 6MWD, and MLHFQ scores."
0,Candidates were contacted by telephone to check any uncertainties in the screening forms and to prevent multiple registrations.
8,"A sample size of 500 patients per group, allowing for a 6% dropout rate, was calculated to provide 90% power to show a statistically significant difference in the primary efficacy end point, using a continuity-corrected χ2 test with an α = 0.05 2-sided significance level."
0,"The tool is linked to the participant’s responses to the diet and physical activity questionnaires, and “remembers” both the individual’s baseline score (eg, for saturated fat), the recommended level for that score, and the participant’s baseline responses to each question."
8,"This calculation was based on the results of a previous study, with a different design, of ER guaifenesin/pseudoephedrine compared with placebo in 605 patients.15"
0,The primary end-point was the change in the time-normalized area under the curve of FEV1 over the period from 30 min to 9 h post-dose (AUC30min/9 h) between V0162 and placebo.
8,"Based on prior studies, we estimated that the risk of RAO would be 5% in the control (60‐minute) group."
0,"Comorbidity was allowed except for conditions with a different treatment indication, for example, autism spectrum disorder, psychosis, bipolar disorder, severe eating disorder, suicidal ideation and substance abuse."
8,"To reduce this risk to 1% with a power of 80% and a type 1 error of 0.05, we required 282 patients in each group."
0,"Four patients out of initial number of 30 patients (3 assigned to placebo and one in TCV) were not included due to withdrawal of their consent or lost to follow up, before the day 1 of the trial."
1,"Data will be gathered at baseline, three, six and 12 months by community data collectors who will be members of the research team."
0,Four of the measures in the questionnaire pack were analysed as comparators for the MGI.
1,"Each of the comparator sites is implementing a program in a “real life” setting, thus providing the opportunity for a pragmatic assessment of the comparative effectiveness of the program models under externally valid and generalizable conditions."
0,"Anesthesia maintenance: this time starts 10 minutes after completion of induction medication administration, and ends when the anesthetic agent delivery stops."
1,This was a prospective observational study undertaken before any intervention in all women enrolled in the parent Women First study during 2013–14 [20] who had anthropometry and completed questionnaires on maternal characteristics and household wealth.
0,"Table S1 Strains, plasmids, and primers used in the study."
1,"The rural sites that provide cohorts for this study are located in Equateur Province, Democratic Republic of the Congo (DRC); Department of Chimaltenango, Western Highlands of Guatemala; Belagavi, North Karnataka, India; and Thatta, Sindh Province, Pakistan."
0,Disease activity and arthritis pain were measured using the Patient’s Global Assessment of Disease Activity (PtGA) and the patient’s assessment of pain visual analogue scales (VAS; 0–100 mm) in which higher scores indicate more disease activity or pain.
8,"In order to ensure a precise estimate of relapses among MB patients, a sample size of at least 278 MB patients in each study arm was calculated."
0,"The EDTA blood was analyzed on the same day with Coulter automated flow cytometer (Beckman Coulter, Fullerton, CA) for a detailed hemogram."
8,"This value is based on an alfa error of 0·05 a betta error of 0·20, i.e., a power of 80%, a ten years relapse risk for the U-MDT group of nine per cent, and a relapse risk of 0·03 in the R-MDT group for the same period."
0,Uncontrolled prevalence report estimate up to 85% of females suffering from cellulite of various degrees.
3,"Inclusion criteria were 1) overweight or class I/II obese (25 – 40 kg/m2), 2) 30 – 70 years of age, and 3) willingness to participate in the two year study."
0,The intra-observer variability of the review process was evaluated in approximately 10 percent of episodes by repeating the review several months later blinded to the results of the first review.
3,"Exclusion criteria were 1) diabetes treated with oral medications or insulin, 2) unstable cardiovascular disease, 3) use of medication that affects body weight, or 4) insufficient motivation."
0,The intervention group assignment will not be altered based on the participant's adherence to the randomly allocated study arm.
1,The SCOT-HEART study was a prospective open-label parallel group multicentre randomised controlled trial that assessed the role of CTCA in patients with suspected angina due to coronary heart disease who attended a cardiology clinic.
0,"In addition, baseline assessment includes detailed initial medical history, measurement of weight and height, blood pressure, capillary A1C for randomization procedure, centralized venous A1C, insulin use, clinic attendance, and completion of baseline patient satisfaction questionnaires."
1,The study design has previously been described4 and the primary findings published.1 2
0,"The key attributes of the potential product formulations were described as follows: vaginal gel – vaginally administered using an applicator, inserted daily or pericoitally; oral tablets – orally administered, used daily; injectables – injected using a needle, administered once every two to three months; vaginal film – vaginally administered using fingers, inserted daily or pericoitally; vaginal ring – vaginally administered using fingers, replaced once a month or less frequently (once every three months); barrier methods (cervical barriers) – vaginally inserted using fingers, used coitally but may be used continuously if removed, cleaned, and reinserted daily; vaginal suppository/tablets – vaginally administered using finger or an applicator, inserted daily or pericoitally; implants – flexible plastic rods placed under the skin of the upper arm, for contraception implants are inserted every three to five years."
16,Differences in pCR rates by mutation and PTEN status were calculated with a corresponding 95% CI and tested using a χ2 test of association.
0,The main effect variable was u-NKCC2.
16,The treatment effect was further examined by performing χ2 tests of association on pCR and mutation status and PTEN status for each treatment arm separately.
0,"On a monthly basis, coaches have the option of participating in a conference call with other HOPE coaches, mentors, and members of the study staff (e.g., principal investigators, research coordinators)."
1,An observational study that analyzed the motor control system by evaluating the performance in a computer task in individuals with CP and in a control group of typically developed individuals.
0,"The three-day diet records, including two consecutive weekdays and one weekend day, were done once before the trial and twice during the trial."
1,"A UK multicentre, prospective, blinded study comparing surveillance intervals determined by NBI-assisted optical diagnosis and histological assessment in patients referred for colonoscopy."
0,Integrating the gyroscopes allow to estimate the short-term attitude variations.
6,"Patient-level test sensitivity was assessed at two thresholds comparing optical diagnosis with the histology reference standard: Presence of an adenoma (including high-risk, intermediate-risk and low-risk findings).Need for surveillance (where some low-risk patients are judged not to require surveillance)."
0,Patients were asked not to exercise in the previous 24 h and to take no medication in the morning of the test.
6,"Additionally, three further definitions of test accuracy were assessed: Exact surveillance interval (precise agreement of surveillance interval by optical diagnosis and histology).Conservative matching (correctly identifying or overspecifying need for surveillance)Error rate (false-positive or false-negative diagnosis of adenoma) In addition to patient-level analyses, factors influencing the accuracy of diagnosis were explored at the polyp level, including patient, organisational, colonoscopist and polyp variables."
0,"To complete the survey, we followed the directions described in the manual available on the Improving Chronic Illness Care (ICIC) website [18]."
3,"Inclusion criteria were as follows: (1) age ≥ 55 years; (2) subjective memory complaints; (3) Clinical Dementia Rating (CDR) scale score of 0.5 (Hughes et al., 1982); (4) sufficient English proficiency at the 8th grade level or higher as determined by the word reading subtest of the Wide Range Achievement Test-4 (Wilkinson, 2006) to participate in MET; (5) capacity to provide informed consent."
0,In deceased patients the cause of death was established from the Swedish death registry and patient files.
3,"Exclusion criteria included the following: (1) current or past Axis I psychiatric disorders, or recent unstable medical or neurological disorders; (2) any disabilities preventing participation in the MET or KY conditions (e.g. severe visual or hearing impairment); (3) insufficient English proficiency; (4) a diagnosis of dementia per the DSM-5; (5) Mini Mental Health Examination (Folstein et al., 1975) score of 24 or below; (6) use of psychoactive medications; (7) participation in a psychotherapy that involves cognitive training; and (8) participants with prior or current training in yoga."
0,Patients were randomized in a 1:1 ratio to receive either methoxyflurane or placebo (sterile normal saline) via a Penthrox inhaler.
1,The study has a cross-sectional design.
0,"Attaching higher sampling probability weights at even intervals mimics the follow-up strategy of clinical trials, while also simultaneously allowing some randomness (just as in real life follow-up examinations, patients often are seen slightly before or after their nominal follow-update)."
1,The data were collected from baseline measurements of a randomised controlled trial (RCT) (EXDEM) that was carried out in Norway in 2012 and 2013.
0,"The trial was conducted at the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam."
5,Combined physical activity and dietary restriction programmes.
0,"However, the specific wording of the questions was tailored to the participants [16]."
6,"Primary outcome measures: body weight, BMI, musculoskeletal function either self-reported function or objective functional performance measures, also, including mobility, joint range of motion (ROM) and muscle strength."
0,"Three Ebola treatment centers were identified before initiation of the trial, all located in rural forested Guinea: one in Gueckedou, run by Médecins sans Frontières (MSF), one in Nzerekore, run by the Alliance for International Medical Action, and one in Macenta, run by the French Red Cross."
6,Secondary outcome measures: pain and QOL.
0,A team of data collectors linked to the HDSS conducted a baseline household survey to establish coverage of maternal and newborn care behaviours and practices.
4,"Using a standardised form (developed by ASA) based on the Cochrane Consumers and Communication Review Group’s data extraction template,33 two reviewers (ASA/AMK) extracted data independently."
0,The supervised exercise program consists of three 45-min exercise sessions a week for 12 weeks.
4,A third reviewer (CAG) checked for consistency and clarity.
0,"Outcome measurements were performed on a daily basis before (baseline period), during (intervention period) and after the interventions (after-intervention period)."
6,"Based on paediatric and adult data that show that early cardiac remodelling precedes global dysfunction, the study will use remodeling parameters (left ventricular posterior wall thickness (LVPWT) Z-score and LV thickness to dimension ratio (TDR)) as markers of early cardiac injury that can identify patients who are at risk for progressive cardiac dysfunction later in life."
0,So the dates of FU were not imposed by the protocol but physicians were encouraged to comply with guidelines.
6,"Thus, the primary outcome measurement in each of the genomics, biomarker and imaging cores is the presence of one or more of the following at 12 months after anthracycline in the Acute Cohort, or at any study time point in the Survivor Cohort:Cardiac remodelling defined as an LVPWT or TDR z-score < −2.0 (or a reduction in LVPWT or TDR z-score by ≥1 standard deviation compared to baseline in the Acute group); orReduced LV EF (<55%) or a drop in LV EF of ≥10% over serial echocardiograms; orSymptomatic heart failure graded using New York Heart Association (NYHA) classification (or Ross heart failure class 2 in infants <2 years old)."
0,Intent to treat analyses (ITT) will be used to examine the primary outcome.
3,"Inclusion criteria were as follows: (i) 18–80 years of age; (ii) clinical diagnosis of osteoarthritis, rheumatoid arthritis, low back pain, or joint/muscle pain; and (iii) chronic moderate to severe pain [defined as a score of ≥4 on the Box Scale-11 (BS-11) pain scale], not adequately controlled with non-opioid analgesics and requiring an opioid for adequate analgesia."
0,Cronbach’s α coefficient of reliability in this study was 0.82.
3,"Exclusion criteria included the following: (i) pregnant or lactating females; (ii) females of childbearing potential who were not willing to use appropriate contraception during the study; (iii) current diagnosis or history of cancer (except basal cell carcinoma); (iv) previous surgery or required surgery; (v) history of alcohol or drug abuse, or behaviors suggestive of addiction or substance abuse; (vi) presence of any contraindication to the study medication; (vii) other chronic conditions that required frequent analgesic therapy; (viii) history of allergy to analgesic agents; (ix) history of prior treatment with study medication; (x) history of opioid treatment; (xi) current or history of steroid treatment; and (xii) deemed unsuitable for participation by the study physician."
0,"Both groups received 12 months of TN and 12 months of SC, only the attribution order varied; (group 1 received TN first and then SC and group 2 received SC first and then TN)."
3,"Patients with confirmed histological diagnosis of cancer/leukaemia and with Karnofsky Performance Score ≥70%, in the age group 10–70 years, with adequate organ functions (serum creatinine <1.8mg/dL, total bilirubin <2mg/dL, liver enzymes within three times of normal limit) and an expected survival >6 months were included."
0,The study variables assessed are summarized in Table 1.
3,"Patients with autoimmune disease, with history of HIV or with any neurological disorders were excluded from the study."
0,"In the first stage, we analyzed the cardioprotective effects of RIPC in a rat model of I/R injury."
3,INSECT focuses on hospitalised patients over 18 years of age who are planned for an elective primary abdominal operation and are eligible for a vertical abdominal incision in order to perform the planned surgical procedure.
0,Participants were instructed to perform the repetitions at an intensity ≥85% HRmax.
3,A detailed overview of all eligibility criteria is given in Table 2.
0,Greater and lesser pelvic flexibility using finger-ground distance 5.
16,"The data was analysed by a blinded assessor, to reduce any biases and increase the rigour with which a de-identified and coded dataset was probed."
0,Isomaltulose has been categorized as “generally recognized as safe” (GRAS) in the USA and has been approved as a food ingredient under the Novel Food regulation in the European Union [9].
1,This was a longitudinal intervention study with repeated measurements.
0,"The exact pathogenesis in the setting of SCD is unknown but it is theorized that the recurrent sickling, increased blood viscosity and vasculature blockade cause stasis, leading to hypoxia and infarction in the affected bone [29]."
1,"Participants were provided with an 8-week ketogenic VLED, followed by 4 weeks of weight stabilisation, and were requested not to change their physical activity levels throughout the study (Supplementary Figure I)."
0,Consensus for LVEF was achieved by an average of the LVEF measurements between two observers in any questionable cases.
4,"The study was conducted from January to December 2014 at five PC centres participating in the larger PsicAP study [28], a clinical trial designed to evaluate the diagnosis and treatment of emotional disorders among PC patients in Spain."
0,Change of mean pH and proportion (%) of time of gastric pH above 4.0 were calculated.
4,"The centres are located in several cities in Spain (two in Valencia, and one each in Albacete, Vizcaya, and Mallorca)."
0,"During this analysis, the axillary area was thoroughly palpated by the surgeon and no nodes showing signs of extensive tumor involvement were identified."
3,"We enrolled subjects aged 45–75 years with symptomatic, moderate-to-very severe COPD (Global Initiative for Chronic Obstructive Lung Disease [GOLD] stage II–IV [1]), receiving standard maintenance therapy and who had ≥2 AECOPD that required oral corticosteroids, antibiotics or hospitalisation in the 12 months prior to screening."
0,"LV endocardial and epicardial borders were traced manually at end-diastole and end-systole on the short-axis cine images to determine the LVEF and end-diastolic LV mass for each slice, and the respective EDV, end-systolic volume (ESV) were obtained from the tracing."
3,"Full inclusion, exclusion and study-stopping criteria are listed in the online Additional file 1."
0,"The electrodes were positioned at the mid-forehead, the left forehead, and the left mastoid after the skin was cleaned with alcohol."
1,"A randomized, double-blinded, placebo-controlled, crossover study was performed in patients with ADPKD before and after NO inhibition using L-NMMA."
0,Bouts of fewer than 10 min were not counted.
1,"To test the difference between tolvaptan 60 mg and placebo, each patient participated in two examination days with an intermediate wash-out period of at least 3 weeks to eliminate any carryover effects."
0,"However, as shown in Figure 1, the participation rate for the intervention group and the control group was around 21%."
4,"Eligible ADPKD patients were recruited from the Outpatient Nephrology Clinic of the Department of Medicine at Holstebro Hospital, Denmark."
0,"In patients without a defined arterial occlusion on pre-treatment CTA, haemodynamics are assessed by TCCS at 60 min."
8,"Based on an intervention to educate every hospitalized patient about the harms of VTE and benefits of VTE prophylaxis, Piazza et al found a reduction in nonadministration from 10.1% to 5.6% or a 45% reduction in nonadministration.[12] Assuming 45 to 50% relative reduction in non-administration in the intervention group, the effect size in form of the odds ratio is between 0.43 and 0.47."
0,"The interventions for housing instability were individually-tailored, contingent on need, and provided by a licensed social worker experienced with resolving housing crises commonly occurring in lower income populations.Acceptance rates."
8,We will have at least 80% power to detect a 60% reduction in odds of missed dose at 0.05 level of statistical significance.
0,‘Something is wrong’ was defined as a subjective gut feeling of the physician that something is out of the ordinary.
3,"To be eligible to participate in the study, an adolescent had to (1) be aged between 13 and 18 years, (2) have a BMI greater than or equal to 85th percentile (as indicated by the CDC growth chart), (3) own a mobile phone, (4) have access to a computer with Internet access, (5) be able to speak and read English, and (6) be a patient at one of the clinics participating in the study."
0,"Formalin fixed samples were sectioned (5 µm) and used for histochemical evaluation of hepatocellular injury, and TUNEL staining as previously described [11]."
3,"Eligible adolescents also had to be in good health, be free of acute or life-threatening disease, and be able to engage in activities of daily living such as attending school."
0,A flow chart presenting the different steps from inclusion until treatment is presented in Fig. 1.
16,Data were analyzed by ANOVA followed by Bonferroni post-test using GraphPad Prism version 4.02 (GraphPad Software).
0,Incremental values were calculated by subtracting the pre-infusion value from all post-infusion values for a given visit.
16,Data are presented as average ± SE.
0,"Before any study procedures, the study protocol was approved by the Institutional Review Boards and before enrolment, all prospective patients or their legally authorized representatives received a full explanation of the study and provided written informed consent."
1,"We conducted a parallel-group, controlled trial in order to compare the effectiveness of domiciliary VR-based therapy versus domiciliary occupational therapy (OT) in inducing functional recovery and cortical reorganization in chronic stroke patients."
0,COREQ criteria for reporting qualitative interviews were used as a guideline for reporting this study [50].
8,"The sample size was based on the primary outcome,10 and accounting for possible dropouts the sample was 60 participants."
0,The likely magnitude and direction of the biases described in points 1 to 6 above was assessed and whether it was likely to impact on the findings.
8,This is a pilot study to evaluate the best (time-wise) intervention to add multi-professional education to KOA clinical treatment.
0,"Complications were assessed daily, including operational revision and intensive care transfers."
8,The authors aimed to have 30 patients in each group.
0,"Written consent was obtained where possible; for eligible women who could not read, consent was obtained orally and documented in writing by a witness."
3,"(1) Age ≥ 18 and <75 years old; (2) awareness of the cancer diagnosis; (3) starting first-line palliative chemotherapy; (4) Eastern Cooperative Oncology Group (ECOG-PS) ≤2; (5) life expectancy ≥6 to <24 months (according to the clinical oncologist’s opinion); (6) exhibiting one of the following metastatic or recurrent incurable cancers: breast cancer, platinum-resistant ovarian cancer, cervical cancer, endometrial cancer, neck and head cancer (after radiotherapy failure), castration-resistant prostate cancer, genitourinary cancer (bladder, kidney, testicular, penile), lung cancer, gastrointestinal cancer (colorectal, pancreas, liver, gastric, esophageal, gallbladder)."
0,"The n-back task has been used successfully in previous experiments to induce fatigue [27,31]."
3,"(1) Being under psychological treatment for any psychological disorder; (2) being under pharmacological treatment with antidepressants for depressive disorders and/or anxiety; (3) being under regular follow up at the PC unit; (4) the need for immediate consultation at the PC unit according to the attending physician’s opinion; (5) cognitive or attention deficits impairing subjects from responding to questionnaires or understanding the study (according to the researcher’s opinion); (6) a current of previous diagnosis of any of the following mental disorders: substance-related disorders; schizophrenia and other psychotic disorders, mood disorders (depressive disorders, bipolar disorders); anxiety disorders; dissociative disorders; personality disorders; and/or history of suicide attempt – to be detected by questioning subjects; no confirmatory instrument was applied; (7) cancer with single resected metastasis; (8) the presence of any comorbidity likely to hinder subjects from participating in the study according to the researcher’s opinion; and (9) unavailability (for any reason) to perform the required hospital visits."
0,Randomization was executed via stratification.
1,"This is a double blind placebo-controlled phase III multicenter study conducted at the University Hospitals Leuven, the University Hospitals of Antwerp, the Centre Hospitalier Universitaire de Liège in Belgium and at the Medical and Health Science Center at the University of Debrecen in Hungary."
0,Tumor response assessment using Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 [16] was conducted at screening and every 9 weeks thereafter.
14,Both patients and investigators are blinded to study medication and vitamin D levels.
0,"Total cholesterol (TCHOL), triglycerides (TGs) and high-density lipoprotein cholesterol (HDL-C) were measured enzymatically on an Olympus AU600 Clinical Chemistry analyser (Olympus Diagnostica, Hamburg, Germany)."
3,Diabetic patients with LVH will be identified for this study and all potential participants who meet the following criteria will be eligible for the trial: Inclusion criteria:Diagnosed with type 2 diabetes mellitus based on the current American Diabetes Association guidelines.Aged 18–80 yearsBody Mass Index ≥ 23 kg/m2 HbA1c 48-85 mmol/mol [last known result within in the previous 6 months]BP < 145/90 mmHg.
0,"Participants received information about STIs and HIV, and referrals for test results, counselling, and treatment when indicated."
3,"Participants were recruited from gastroenterology out‐patients departments at North Tyneside General Hospital, North Shields, UK and Wansbeck General Hospital, Ashington, UK between May 2010 and July 2011."
0,Throughout the intervention the person's main negative self-belief and a positive self-belief were measured to monitor progress.
3,"The exclusion criteria included being aged <16 or >85 years, being a prisoner at the time of endoscopy, being pregnant, or planning to become pregnant, diabetes mellitus, familial adenomatous polyposis syndrome, Lynch Syndrome, known colorectal tumor or prior colorectal cancer, prior colorectal resection, active colonic inflammation at endoscopy, iatrogenic perforation at endoscopy, incomplete left‐sided examination, colorectal carcinoma discovered at endoscopy, CRC on histology, chemotherapy in the last 6 months, administering non‐steroidal anti‐inflammatories, anti‐coagulants, or immunosuppressive medication."
0,"If only contralateral MEPs from each hemisphere are found, the child will be categorized as having a contralateral CST wiring pattern."
1,"ARTESp is a prospective, multicenter, single-arm, post-market clinical follow-up study to evaluate the safety and clinical outcome of MT with the pREset thrombectomy device in eligible patients."
0,Children who were aged ≥ four months and weighing ≥5 kg were randomized to receive either artemether-lumefantrine (AL) or dihydroartemisinin-piperaquine (DP) at the time they got their first episode of uncomplicated malaria.
1,The study was approved by the local ethics committees of all participating centers and registered at ClinicalTrials.gov (NCT02437409).
0,CT or MRI scans of the brain and/or spine were carried out when CNS metastases were clinically suspected only.statistics
1,"This was a prospective, open-label, single-arm, observational and multicentre study."
0,An adverse drug reaction was defined as a response to a drug which is noxious and unintended and which occurs at doses normally used in humans [9].
8,"Sample size was determined by considering an anticipated correlation of 0.4 between the mean PEST and SCORAD scores providing 80% power at a 5% significance level, applying Fisher’s z test for Pearson correlation."
0,"Consistent with standard economic theory [35], we assessed the cost-effectiveness of the P4P methods using incremental cost-effectiveness ratios (ICER)."
8,"Thus, 46 evaluable patients were required."
0,"Since these sugars are not significantly metabolized in the body after absorption from the intestine, excretion into the urine reflects intestinal permeability [48]."
6,"The endpoints for this investigation are as follows:Establishment of bicarbonate and acetate levels in the blood and dialysate before, during and after HD when using NaturaLyte® and GranuFlo® acid dialysate compositions.Investigation of the associations during and after HD in blood bicarbonate increases using NaturaLyte® and GranuFlo® acid dialysate compositions."
0,Data on the presence of a good quality embryo were collected by van Peperstraten et al32 from local IVF registries.
10,"ProACT randomizes at the patient level, with 1:1 study arm allocation using a computer generated, permuted block design, stratified by center, race, and age (Table 5)."
0,"Group 1 received 400 mg of moxifloxacin iv once daily and TZP placebo iv thrice daily, followed by 400 mg of oral moxifloxacin and oral AMC placebo twice daily."
12,We assure concealment via an automated centralized assignment system.
0,Parents of patients and partners are invited to return standardized questionnaires.
12,Only after enrollment does the system assign a study arm.
0,Potential participants will be screened for eligibility over three stages: 1) by a research assistant over the phone; 2) by a physiotherapist following clinical examination and; 3) following a pedometer trial.
1,This secondary analysis used the dataset from the original GOPCABE trial population and specifically assessed the influence of female sex on perioperative outcome and the impact on predictive accuracy of commonly calculated risk scores (logistic EuroSCORE and the KCH score).
0,Figure 1 is a CONSORT diagram showing the flow of participants through the study.
3,"Patients undergoing elective, routine anesthesia were asked to participate in this trial."
0,"The following inclusion criteria were applied: patients aged over 18 years, aided by a family member or paid caregiver for treatment application; risk of impaired skin integrity according to the Braden Scale ≤16, identified by a nurse, and nutritional status of ≤10 according to the Mini Nutritional Assessment (MNA)."
3,"Exclusion criteria were: age under 18 years, potential risk of regurgitation, pregnancy, ASA classification > III and patients with an anticipated difficult airway."
0,The arm with the highest value was used through the study for measuring BP.
1,"In this feasibility study, conducted April 1, 2014 to December 31, 2015 individuals with AHA Stage C/D and/or NYHA Class III/IV HF and their family caregivers received the ENABLE CHF-PC intervention and were followed for 24 weeks."
0,Investigators documented the presence or absence of urticaria or rash within 30 minutes after vaccination.
1,"The study protocol was approved by the institutional review boards of Dartmouth College (Lebanon, New Hampshire) and the University of Alabama at Birmingham (Birmingham, Alabama) and all participants provided written informed consent."
0,"Tables containing full summaries of all recorded values at the beginning of the study, for all 146 Gray Matters study participants, can be found in the study by Norton et al [22]."
14,Participants were not blinded to their group condition.
0,"The initial analysis of the relationship between plasma pazopanib concentrations and increased blood pressure was conducted with data from patients with advanced solid tumours enroled in a first-in-human Phase I study (Hurwitz et al, 2009)."
14,"However, the assessment at 3 months was done by health professionals blinded to participant condition allocation."
0,Safety was evaluated in all patients by recording adverse events during FMT and throughout long-term follow-up.
8,The trial was powered to detect a significant weight difference between the intervention and control group as published previously [6].
0,"[57]) delivered by a qualified asthma nurse (GH) and specific training in the use of the GOAL-elicitation tool and GOAL-setting process in the management of asthma delivered by the team of two nurse practitioners and a health psychology researcher (GH, AT and PA)..GOAL and action planning: In addition to a standard asthma review, patients received the GOAL intervention as part of the review consultation."
8,"Therefore, the analyses presented in this study should be considered exploratory."
0,"Blood was drawn during primary PCI, and blood glucose, HbA1c, insulin, creatinine, and cholesterol levels were assessed."
8,Sample size is calculated with 90% power to detect a difference in change of SBP of 3 mmHg between two groups at a two-sided significance level of 5%.
0,The population is multi-ethnic with Pashtoon being the dominant group.
8,"To satisfy these assumptions and allowing for a drop-out rate of 20%, a total of 238 patients (119 for each treatment arm) are required for the trial."
0,Subjects assigned to the control group were told to continue their daily life activities.
3,"Adult patients under MV for > 48 h, meeting readiness-to-wean criteria (see below) and exhibiting agitation, as defined by a RASS score ≥ 2 [8], at the time of sedation decrease or withdrawal were eligible and included in the absence of non-inclusion criteria."
0,All participants have signed a written informed consent.
3,"Non-inclusion criteria included pregnancy, contra-indication to loxapine (e.g., hypersensitivity or known history of epilepsy), on-going treatment with a dopamine agonist, limitation of life-sustaining therapy, planned extubation in the following 24 h, and contra-indication to enteral access through a nasogastric tube."
0,The symptomatic use of aluminum hydroxide was allowed until the beginning of treatment.
6,"The primary endpoint was the time between inclusion and successful extubation, as defined by the absence of re-intubation within 48 h after extubation."
0,"The presence of advanced symptomatic lung cancer was based on meeting all of the following criteria: The patient has been diagnosed with non-small cell carcinoma, stage II or higher, or small cell carcinoma, any stage; The patient has experienced a symptom that led them to seek contact with a physician since the time of the last study visit, or at the time of their next study visit the patient had developed a new symptom, or a change in a chronic symptom within the prior 6 weeks, that did not yet lead to a doctor’s visit; The symptom(s) are felt to be related to the diagnosis of lung cancer as adjudicated by an Outcomes Review Committee."
6,"Secondary outcomes were the rate of unplanned extubation, ventilator-free days during the first 14 days, evolution of physiological parameters (in the first 4 h after randomisation), rate of sedation resumption in the first 24 h (this outcome has not been pre-specified on ClinicalTrials.gov), rate of nosocomial pneumonia, rate of loxapine side effects, mortality at 14 days and 6 weeks, and factors associated with unsuccessful weaning."
0,"Nutrient intake analysis was automated for use in the Food4Me study, with the nutrient-related goals and feedback messages derived manually (using the priority system and decision trees) by Food4Me researchers using their own judgment to overrule the feedback system when appropriate."
6,"The primary outcome measure for each of the two diseases was the cumulative count of patients initiating TB and HIV treatment per 10,000 adults aged 12 years and above each month over the study period."
0,"After each blood draw, 2 mL of physiological salt solution (NaCl 0.9%) was injected into the canula to prevent it from clotting; before each blood draw an extra tube was drawn to remove the physiological salt solution."
6,Secondary outcome measures included TB and HIV testing rates.
0,"The protocol was reviewed and approved by the French Drug Agency (Agence Nationale de Sécurité du Médicament) and the local independent ethics committee (Comité de Protection des Personnes Ile-de-France II, Paris, France)."
3,"The French authorities have made available the instructions for analyzing I-Satis questionnaire [30], and according to these recommendations, the study was restricted to patients whose LOS included at least two consecutive nights."
0,"Transportation is an integrative melding of attention, imagery, and feelings, focused on story events [56–58] which influence the audience’s cognitive, affective, and potentially, health behaviors."
1,"Multicentre, pre- and post-intervention feasibility study with process evaluation."
0,"We also ask about marital status, employment and income."
3,"After signing of the informed consent, 140 adult patients between age 18–60 years, ASA physical status I and II and Mallampati class 1& 2, BMI < 35 kg/m2, undergoing elective surgical procedures (not exceeding two hours in duration) requiring ET intubation were included in the present study."
0,Racially concordant images were used to develop pamphlets to be displayed in clinic and used for recruitment.
3,"Patients undergoing day case, bariatric, cardiac, nasal, oral or head & neck surgeries, requiring placement of throat pack or nasogastric/ orogastric tube, patients assigned to rapid sequence induction, hoarseness, patients with anticipated difficult intubation, history of recent upper respiratory tract infection, history of difficult intubation and psychiatric disorders hindering proper evaluation, use of steroids (oral or inhalational) or non-steroidal anti-inflammatory drugs within one week of surgery or previous surgery within last two weeks were excluded."
0,Venous blood samples were collected for PD and PK analysis in K+ EDTA tubes and rapidly placed on ice until centrifuged at 4°C for 10 minutes.
1,BTOG2 was a three-arm randomised phase III clinical trial recruiting patients from 78 hospitals in the United Kingdom and Ireland.
0,"In mid-2007, MaiKhanda established 729 participatory women’s groups to mobilize communities around maternal and newborn health, using 81 volunteer facilitators, supported by nine staff, across the allocated clusters."
1,Ethics approval for the trial protocol (ultimately Version 4) was obtained from West Midlands Research Ethics Committee and local institutional review boards and ethical committees in accordance with national and international guidelines.
0,Blood pressures are the average of three readings using a Compact Dinamap (Johnson & Johnson).
3,"Eligible participants had a diagnosis of schizophrenia, as confirmed with the Structured Clinical Interview for DSM-IV-TR, and provided written informed consent."
0,"The 5 options were as follows: (1) I am not thinking about changing my diet; (2) I am thinking about changing my diet, but I am not sure; (3) I have decided to change my diet, and I am thinking about how to do this; (4) I am changing my diet, but I am having difficulties; and (5) I am changing my diet successfully."
3,Please refer to Supplementary Methods for inclusion and exclusion criteria and randomization procedures.
0,"Children of the pilot study and those from the RCT control group (n = 32) had to wait six months before entering the treatment, while children of the RCT intervention group (n = 34) and those enrolled after end of recruitment for the RCT were assigned to the next available training course."
1,This study was a secondary analysis of cross‐sectional and longitudinal data from a three‐armed randomized controlled trial of physical therapist–led exercise interventions (the Benefits of Effective Exercise for Knee Pain [BEEP] trial [ISRCTN: 93634563]) 18.
0,"For inclusion in the study, subjects had to be healthy, aged 18–45 years (actual median: 23, range: 20–41), have suitable veins for cannulation, a body mass index (BMI) between 19 and 30 kg/m2 (actual median: 23, range: 20–30) and weigh 50–100 kg (actual median: 76, range: 59–100)."
1,Full details of the BEEP trial are available elsewhere 18 and are summarized below.
0,"Plasma samples for drug level testing were drawn immediately pre-dose (Ctrough,ss) and at 1, 2, 3, 4, 5, 6, and 8 h post-dose, then once on the following day for a 24-h post-dose Ctrough,ss."
6,"Based on the CFIR and our research questions, we explored the following baseline variables as predictors of CRC screening among participants at follow-up."
0,Slit lamp assessment (biomicroscopy) and fluorescein and green lisamine stain were performed.
3,Patients with non-metastatic breast cancer and a Karnofsky Performance Score of at least 70 with a clinical tumour size of at least 3 cm and/or positive regional lymph nodes were eligible.
0,The lower limit of detection for HIV-1 RNA assays performed locally ranged from 20 to 400 copies/mL.
3,A total of 201 assessable patients were included from February 2006 through April 2009 from 21 hospitals in the Netherlands.
0,"For all panels, boxes represent mean +/- 1 standard error and whiskers represent 95% confidence interval."
1,"A randomized controlled study design was used, with a 1:1 allocation ratio of intervention to wait-listed control (8-week delay)."
0,"(f) Social functioning: the Global Assessment of Functioning scale (GAF, [72]) is a widely-used rating instrument which evaluates psychological, social and occupational functioning positioned on a hypothetical, 0 – 100 continuum of mental health - illness."
1,"The study was conducted at a single research site in Stanford, California."
0,"Women who have a positive pregnancy test will be excluded.AnthropometryBody weight: Subjects are weighed, without their shoes, on a calibrated scale after heavy objects (such as keys and coins) have been removed from their pockets."
3,Full details regarding the primary efficacy and safety outcomes of this study have been reported previously [1].
0,Information about the study was published on a public webpage.
3,"In summary, patients were ≥ 18 years old with moderately to severely active RA (≥6/68 tender and ≥ 6/66 swollen joints; high-sensitivity C-reactive protein ≥ 3.6 mg/L (upper limit of normal 3.0 mg/L); seropositive for rheumatoid factor or anti-citrullinated peptide antibodies) and naïve (or had no more than three prior doses of MTX) to DMARDs."
0,The force exerted by the ergometer motor exceeds the force of the participant creating eccentric or negative work of the knee and hip extensor muscles Participants were deemed eligible if: at least 65 years of age or older and had experienced at least one fall in the previous 12 months.
3,We included women enrolled in the MNH Registry before week 24 of pregnancy (Fig. 1) and excluded those enrolled in the ACT trial control clusters because there was no detection of HRPB in the control clusters.
0,"The patient is instructed to circle the number on the scale which represents their understanding, confidence, use or satisfaction of/with each topic [22,23]."
3,Additional exclusion criteria for this secondary data analysis included: i) miscarriage or medical termination of pregnancy; ii) no information about gestational age prior to delivery; and iii) missing birth weight.
0,"The HCCQ scale, the autonomous TSRQ scales and the PCDS had a skewed distribution for all items showing high ceiling effects (27–39% responded strongly agree)."
1,"This study is a multicenter, prospective, open-label observational cohort study in patients with histologically proven, noninvasive VPD."
0,"The trial ended in September 2008, with data collection continuing through October 2008."
1,"Patients will be treated with topical 5% imiquimod cream three times a week for 16 weeks, with follow-up of one year after the end of treatment."
0,"For study 2 participants were recruited during April–May 2014, and the study was executed during May–June 2014."
8,Sample size for the trial was based on the clinical effectiveness component17.
0,We have recruited all 26 CHCs and completed baseline assessment for Wave 1 in August 2014.
8,"A priori, based on a 10% annual consultation prevalence for clinical OA in those aged ≥4522, and a population base of 30,000 adults aged ≥45 years across the eight general practices, we estimated there would be 3000 patients consulting annually for clinical OA."
0,"The trial team comprised 15 newly employed community mobilizers from the study area, three community liaisons officers, and 38 educational assessors, all with at least secondary school level education."
8,"The study described herein will enroll 290 patients to accrue sufficient PFS and OS events to provide 80% power at two-sided α = 0.05 (74% at two-sided α = 0.025 for two-arm comparison) to detect a statistically significant difference between veliparib plus carboplatin/paclitaxel and placebo plus carboplatin/paclitaxel or between veliparib plus TMZ and placebo plus carboplatin/paclitaxel, assuming a true HR for PFS of 0.58 and 0.61 for OS (favoring the experimental treatment groups)."
0,Both groups trained by walking/jogging/running on an inclined treadmill 3/wk.
6,"Assessments (Table 2) will be conducted at baseline, 3, 6, and 12 months by research assistants blinded to group assignment."
0,Longer duration indicates higher cardiorespiratory fitness.
1,"This was an observational, cross-sectional prevalence study and it was approved by the ethics committee of the Charité-Universitätsmedizin Berlin (EA1/190/14)."
0,"Compared to usual PBMC processing, there was no difference in PBMC TFV-DP concentrations resulting from the tissue digestion cocktail, monoclonal antibody incubation, or running cells over the MACS column."
1,The study protocol was published previously.16
0,"Prevaccination sera were tested in 1∶16 dilution, to which 100 PFU of 17D-YF were added."
8,"We aimed to recruit 30 participants to allow for a sample size of 24 participants (12 per arm), with a 20% allowance for dropouts, which would allow 90% power (alpha=.05) to detect a difference of 14% in ICP (assuming a standard deviation of 10% for ICP)."
0,Participants signed a written informed consent at the time of their enrollment.
16,"The primary analysis of efficacy is based on the full analysis set, as defined by ICH guidance document E9: Statistical Principles for Clinical Trials."
0,A 7.5 MHz linear array transducer was placed perpendicular to the long axis of the thigh to obtain a frozen real-time cross-sectional image of the rectus femoris muscle.
16,This analysis adheres as closely as possible to the intention-to-treat ideal and is based on data from all randomized participants with participants analyzed in the treatment group to which they were randomized.
0,"Study logic model which laid out a theoretical framework for how SASA! would achieve its long term intended outcomes (Additional file 1) [33], and qualitative research on pathways of change conducted with SASA! community members [34]."
1,We plan to conduct a prospective observational cohort study.
0,"To evaluate the differences in quality of life of patients treated with focal vs extended ablation of PCa with IRE, measured by EPIC, VAS pain score and length of hospital stay."
4,The study is conducted in the critical care unit in a tertiary care centre in the United Kingdom.
0,"Thus, the 4F9 antibody was evaluated for specificity against ERCC1 by western blot, immunofluorescence, and IHC techniques in normal and XPF-ERCC1-deficient human fibroblasts as previously described (Niedernhofer et al, 2007; Bhagwat et al, 2009)."
8,A formal sample size calculation was not possible due to lack of data in the literature.
0,Any implant deviations from the planned position will be measured and categorized in 1 millimeters increments.
8,"Following discussion with experts in the field, a sample size of 12 participants with complete data for 48–72 h was considered to be adequate to gain better understanding of coagulation and fibrinolysis during citrate based CRRT and to inform the design of future studies."
0,"Recurrence probabilities additionally depend on strain and age [4, 10, 25]."
1,"This was a parallel-group, randomised clinical trial with two arms allocated in a 1:1 ratio."
0,The phase 3 MONET1 study initially enrolled patients with NSCLC of all histologies but was amended to enroll only patients with nonsquamous histology owing to unacceptable toxicity in patients with squamous histology who received motesanib [27].
1,"The primary aim was to assess the efficacy of individualised 4-week diets in participants with IBS: intervention—elimination diet consistent with leucocyte activation test results; versus comparison—elimination diet systematically inconsistent with test results, matched in rigour and complexity."
0,"The results of the recruitment, primary study outcome, additional secondary and exploratory outcomes, and compliance are described elsewhere (15)."
8,"Based on results from Kaptchuk and Lembo assessing responses to placebo interventions in IBS,19 an analytic sample of 46 participants was calculated with 80% power to detect a between-group difference of 1.1 points (SD=1.3) on the GIS (two-sided; α=0.05)."
0,"Responders, drop-outs, and unreachable women were compared at the bi-variate level with respect to socio-demographic characteristics, obstetrical history, lifestyle choices, psychosocial health, and life events."
8,"Accounting for up to 25% attrition, 29 participants per arm were recruited (total n=58)."
0,"It could, therefore, be any unfavourable and unintended sign (including an abnormal laboratory finding), symptom, disease or exacerbation of the pre-existing condition temporally associated with the use of the medication."
14,Neither participants nor researchers were blinded to allocation.
0,The 50% neutralisation titre of the serum was calculated according to the method of Reed and Muench [15].
14,An independent nurse evaluated the exit site wound status but assessment of outcomes was not blinded due to the different color of chlorhexidine from normal saline.
0,Individuals from six primary care trusts (PCTs) in Liverpool and Cambridge were approached with an invitation letter and a participation questionnaire.
4,"The following clinical/laboratory parameters and patient reported outcomes are collected as per routine care at baseline and at all follow-up visits, with suggested assessments every 6 months given that this is within acceptable practice patterns for patients with active PsA: morning (AM) stiffness, swollen joint count (SJC28), tender joint count (TJC28), patient’s global assessment (PtGA) and physician’s global assessment of disease activity (MDGA), Health Assessment Questionnaire (HAQ), patient’s assessment of pain, C reactive protein (CRP) and erythrocyte sedimentation rate (ESR)."
0,"Exclusion criteria comprised contra-indications for memantine and hypertension, severe cardiac insufficiency or diabetes (Type I and II), alcohol addiction and treatment with specific drugs (amantadine, ketamine, dextromethorphan, L-Dopa, dopaminergic, anticholinergic agonists, barbituric, neuroleptic, IMAO, antispastic agents, dantrolen or baclofen, phenytoin, cimetidine, ranitidine, procainamide, quinidine, quinine, nicotine, hydrochlorothiazide, warfarine)."
4,"A total of 43 study sites are planned across North America, Europe, and the Middle East."
0,"Risk factors included in the model were age, gender, TC, high-density lipoprotein cholesterol (HDL-C), SBP, DBP, diabetes (defined as treatment with insulin or oral hypoglycemic agents, or casual blood glucose > 150 mg/dL at 2 clinic visits or fasting glucose > 140 mg/dL), and cigarette smoking status."
4,"Patients may, after receiving the first two doses of study drug at the site and after completing training, self-administer lanadelumab off site."
0,"In melanoma patients, tumor tissue removed before the start of treatment will be analyzed for the presence of N-Ras mutations."
1,The open-label extension study will consist of patients who complete the double-blind study (rollover patients) and additional patients who are not part of the double-blind study (non-rollover patients).
0,Complete step data were available for 93.5% of 180 possible days on average.
1,"All patients will receive open-label lanadelumab every 2 weeks over a 364-day treatment period, followed by a 4-week safety follow-up before discharge from the study."
0,Peripheral leukocytes were used for the extraction of genomic DNA.
3,"Participants were aged 18–80 years and had sustained a recent MI according to the third universal definition of MI,11 with 12-hour plasma troponin I concentration ≥5000 ng/L."
0,"It was estimated that 10% of the population belonged to RFD group who would have 0.48 consultations per month [22,28,29]."
3,"Exclusion criteria were known critical stenosis (>95%) of left main stem, ongoing symptoms of angina, heart failure (Killip class ≥2), renal failure (estimated glomerular filtration rate <30 mL/min/1.73 m2) and contraindication to MRI or ferumoxytol infusion."
0,The final (7th) recording session was a control recording performed 48 hours after the 6th.
3,One hundred people who were within 4 months of an ischemic or haemorrhagic stroke (verified by Computerized Tomography or Magnetic Resonance Imaging) consented to participate in this RCT.
0,Women were blinded to a certain extent to the allocated intervention option because they were kept naïve of the exact content of both intervention options.
3,"Clinical depression was identified by the screening score of the Geriatric Depression Scale [12] and verified at entry to the trial by the Diagnostic Interview and Structured Hamilton, previously validated as consistent with criteria from the 4th Edition of the Diagnostic and Statistical Manual of Mental Disorders [10]."
0,"Mayo score, C-reactive protein (CRP) level, erythrocyte sedimentation rate (ESR), and Inflammatory Bowel Disease Questionnaire (IBDQ) criteria were recorded at enrollment and at weeks 4 and 12 post-treatment."
6,The primary outcome was the time to a 1‐mm ST segment depression on ETT.
0,"The model was adjusted for baseline weight, but no other adjustments were made given that no variables were found to differ in a statistically significant way between the categories."
6,"Secondary outcomes were time to chest pain onset, total exercise time, angina and GTN use frequency, modified Seattle Questionnaire, nitrate and nitrite plasma levels, angiogenic markers, and myocardial contractility assessment by peak systolic velocity measured by Doppler imaging (details described elsewhere).28"
0,Genes whose expression is significantly changed in response to lithium in responders but not non-responders will comprise a set of high-priority candidate genes for further study.
8,"In this non-inferiority trial, we assumed the following: 35% probability of having a relapse within 24 months of remission; relapse rate difference between-groups of 15% considered to be statistically significant using a two-tailed Fisher’s exact test; drop-out rate of up to 5%."
0,The purpose of this element of the study is to ensure that all women are provided with the knowledge to provide optimal nutrition to their infants during the period from birth to 6 months of age.
8,"Based on these assumptions, we estimated that 136 patients per group would achieve 80%-power with a level of statistical significance of 0.05."
0,The anaesthetist responsible for the patient was blinded to the ScvO2 in the control group and to the CVP in the ScvO2 group.
1,Prospective observational study carried out from December 2014 to December 2015.
0,Discrepancies were resolved unambiguously either by reaching consensus or by retyping.
3,Five-hundred practices from The Capital Region of Denmark were randomly invited to participate.
0,A-Part® Gel acts as a physical barrier for adhesiogenic tissue while the normal tissue repair takes place [26].
3,"Thirty-nine practices accepted to consecutively recruit patients with the following characteristics: i.) inclusion criteria: Adult patients (i.e. > 18 years of age) seeking care in general practice during office hours with dysuria and/or urinary frequency as the main reason for consultation, and in which GPs suspected a UTI; ii.) exclusion criteria: a) Currently taking antibiotics, b) Inability to provide a urine sample, c) Inability to sign an informed consent, d) Previous participation in this study."
0,"The Se, specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV) of the RDT were calculated comparing the results of the index test to the composite reference standard."
4,"The day of the index consultation, all patients provided 10 mL of urine, which was sent to Statens Serum Institut (SSI)."
0,The primary efficacy endpoint is the time to first occurrence of any FAP-related event in the patient as a whole (more than one site may be at risk).
4,The urine sample was preserved in boric acid and sent by certified post the same day of the consultation.
0,Half-life of Overexpressed AIP (WT and Variants) in HEK293 Cells Table 3.
6,The primary endpoint of the study was the area under the plasma concentration-time curve for ticagrelor during the first 6 h after administration of ticagrelor LD (AUC(0–6)).
0,"To assess motor hand functions and cognitive ability, the Jebsen Taylor Test (JTT) [9] and a comprehensive neuropsychological test battery were conducted, respectively."
6,"Secondary endpoints included AUC(0–6) for AR-C124910XX, AUC(0–12) for ticagrelor and AR-C124910XX, maximum concentration (Cmax) of ticagrelor and AR-C124910XX, time to maximum concentration (tmax) for ticagrelor and AR-C124910XX, platelet reactivity assessed by the vasodilator-stimulated phosphoprotein (VASP) assay and the Multiplate analyzer, percentage of patients with HPR after ticagrelor LD assessed with VASP and Multiplate, time to reach platelet reactivity below the cut-off value for HPR evaluated with VASP and Multiplate."
0,"Signal drift correction was performed with R (v.3.1.2; R Foundation for Statistical Computing, Vienna, Austria) via the QC-based robust locally estimated scatterplot smoothing signal correction method (30)."
8,"Since there was no reference study comparing the pharmacokinetics of ticagrelor in the acute phase of STEMI and NSTEMI, we decided to perform an internal pilot study."
0,The protocol for this trial and supporting CONSORT checklist are available as supporting information; see Checklist S1 and Protocol S1 Study design and patients
8,"Based on the results obtained from the analysis of the first 45 consecutively enrolled patients (15 with NSTEMI and 30 with STEMI), and assuming a two-sided alpha value of 0.05, we calculated, using the t-test for independent variables, that enrolment of at least 23 patients in each study arm would provide 95% power to demonstrate a significant difference in AUC(0–6) for ticagrelor between patients with different types of AMI as presented in the study protocol (S1 File) [15]."
0,"Food samples were prepared as consumed (raw or cooked), blended and freeze-dried (Edwards Modulyo EF4) to constant weight before composite samples were prepared for analysis of the target nutrients."
1,A multicentre observational study.
0,Fig 1 Patient disposition according to the STARD (Standard reporting in Diagnostic accuracy studies) flowchart.
6,"The primary outcomes of this study were to determine the serotype-specific serum IgG antibody geometric mean concentrations (GMC) pre- and 1month post-challenge with a 0.1mL dose of PPV23 at 3–5 years of age for serotypes contained in PCV7 (4, 6B, 9V, 14, 18C, 19F, 23F) and PPV23 serotypes 1, 2, 3, 5, 7F, 19A; and the proportion of children with serotype-specific serum IgG antibody levels ≥ 0.35 μg/ml and ≥ 1.0 μg/ml before and after a PPV23 low-dose challenge for the above serotypes."
0,Patients were compensated for daily completion of the DSCMR using the ePRO device.
8,The minimum target sample size (n = 120) for this pilot study was selected to provide adequate participant contact to assess the feasibility of the trial protocol and obtain reasonable estimates of effect sizes and variability.
0,The actual overall event rate observed during the conduct of the trial was found to be around 9%.
8,"The power of this RCT to detect between-group differences of at least 2 points on the RMDQ and 2.5 points on the pain NRS [48], based on 40 participants per group at a 0.05 level of significance and assuming a 15% drop-out rate at 12-weeks, exceeded 75%."
0,Table 1 Criteria for inclusion and exclusion of patients.
3,Patients (aged ≥18 years) with a documented diagnosis of nonspecific moderate-to-severe CLBP present for at least three months requiring continuous around-the-clock opioid analgesic treatment and an average daily NRS-Pain score for low back pain of ≥5 and ≤9 were included in the study.
0,"Because of the nature of the intervention, we calculated the estimated total costs and quality adjusted life years (QALYs) gained from the programme as a whole."
3,"Major exclusion criteria were history (within the past 2 years) of lumbosacral radiculopathy, spinal stenosis, documented drug or alcohol abuse, or a positive urine drug test for illicit substances or opioid medications not prescribed to the patient."
0,"Per time moment, measurements were performed in triplicate, and the largest diameters were used for calculations."
6,"The endpoints assessed were mean changes in the SF-36v2, EQ-5D-3L, and the WPAI:SHP from screening period to the end of titration period (open-label titration period), from randomization baseline to the end of study (double-blind treatment period), and from screening period to the end of double-blind treatment period (overall study period)."
0,"To assess adherence participants were asked to name their HIV medications, number of pills taken, dose (number of times per day), and whether they had missed any doses in the last 30 days [19], [20]."
1,"A prospective, controlled, intervention study."
0,"Secondary endpoints included duration of tumor response, CBR, progression-free survival (PFS), overall survival (OS), safety, pharmacokinetics (PK), and patient-reported outcomes (PROs)."
1,Evaluation of in-patient rehabilitation with follow-up at 1 month post-discharge.
0,"during all visits other than screening and post-study; at these visits, a single IOP measurement was obtained at any time of the day."
3,Pregnant women who underwent ECV for breech presentation were included.
0,"Table 2 Association of objectively measured sleep duration with insulin sensitivity and secondary measures of insulin secretion and glucose tolerance Second, since sleeping <6 h/day has been associated with increased risk of diabetes (2), study participants were classified according to their objectively measured sleep time at home as either short sleepers with average sleep time <6 h/day (n = 19) or reference sleepers with average sleep ≥6 h/day (n = 28)."
3,"Exclusion criteria were maternal age under 18 years, gestational age less than 34 weeks, a history of CS, no mastery of the Dutch language and contraindications for ECV."
0,"In addition, any changes indicative of myocardial ischemia were reported as adverse events."
6,"Behavioral assessments via CAPI were completed by participants at enrollment and follow-up visits every 4 months (4, 8, 12 and 16 month visits), with questions on overdose events, substance use, substance use treatment, dependence and HIV-related risk behaviors.[58–60] Reporting periods were 120 days at baseline and the time between consecutive study visits at follow-up visits."
0,"It was expected that through mere contact with the facilitators and other peers involved in the intervention, peer receivers would benefit from general social support and develop interpersonal skills."
6,"The primary outcome was number of overdose events, determined by self-report through a standard question structure that has proven reliable in multiple settings.[18, 24] After defining opioid overdose as minimal to no breathing or not being able to wake up without assistance, participants were asked how many overdoses they had experienced during the reporting period, then asked detailed questions regarding the most recent overdose events (see S1 File for study quetionnaire)."
0,Measurements were taken twice with a third taken if the first two measures differed by ≥ 10 mm/Hg.
6,"All measurements in both the exercise group and control group were performed at the following time points, i.e., before TKA operation (pre-operation), before exercise (pre-exercise), at 12 weeks after the beginning of the circuit training program (mid-exercise), and after completion of the circuit training (post-exercise)."
0,"To further examine the between-group differences in the BOLD responses during reappraisal, we ran between-group t-tests for early (first three time points, 0 to 4.5 s) and late (last two/three time points, 4.5 to 7.5 s or 4.5 to 9 s) BOLD responses for the contrast of Reappraise versus React."
16,We compared distributions of various characteristics at baseline for meaningful differences between arms.
0,The medication adherence goal remained unchanged from the baseline goal to continue taking doctor-prescribed medications.
16,"In exploratory analysis, baseline and 6-month proximal and cognitive outcomes were compared within each intervention group using a Wilcoxon signed ranks test; P values are reported only as a guide regarding which outcomes the intervention may possibly impact in the larger study."
0,"This study was approved by the Norwegian Regional Committee for Medical and Health Research Ethics (REC) South East (110-07038a 1.2007.67), and all patients signed an informed consent prior to inclusion."
8,"Previous work using a social norm intervention in a pretest–posttest observational design yielded small effect sizes with phi values of 0.1 (Burger & Shelton, 2011)."
0,"If the postoperative period was uneventful, the patients were informed and discharged at the day of PIPAC or the first postoperative day."
8,A power analysis was conducted (G-Power 3.1) revealing that at least 785 observations were required to detect a small effect (assuming an alpha of 0.05 and power of 80).
0,"Among the 798 patients in the intention-to-treat population [38], 226 patients were randomized at two ICUs that collected and stored research blood samples as part of the protocol after initiation of the present study (Rigshospitalet and Bispebjerg Hospital)."
3,"Inclusion criteria were women with signs of incomplete abortion, based on clinical assessments (ie, positive pregnancy test, bleeding, contractions and lower abdominal pain, open cervical os and partial expulsion) and physical examination (including vaginal examination), but without the use of ultrasound."
0,"Between February 2008 and March 2012, 47 patients were enrolled at five German institutions."
3,"Exclusion criteria were complete abortion (no bleeding or contractions), a uterine size estimated over 12 weeks of gestation, suspected ectopic pregnancy (severe abdominal pain), unstable haemodynamic status, signs of pelvic infection or sepsis, and known allergy to misoprostol."
0,slower-than-expected enrollment; 2).
3,Inclusion criteria aresigned informed consentpatients 18 years or olderpatients suffering from end stage-liver disease and/or malignant liver tumourslisted for OLTreceiving ECD allografts.
0,"Hence, QALYs combine both length of life and quality of life."
3,"Exclusion criteria arerecipients of split or living donor OLTprevious OLTcombined transplantations (liver-kidney, liver-lung, etc.)participation in other liver-related trialsthe subject received an investigational drug within 30 days prior to inclusionthe subject is unwilling or unable to follow the procedures outlined in the protocolthe subject is mentally or legally incapacitatedan inability to understand the procedures due to language barriersfamily members of the investigators or employees of the participating department."
0,"A history of allergy likely to be aggravated by any of the vaccine components, neurological disease/seizures, chronic illness or family history of immunodeficiency, or symptoms of acute illness at the time of enrolment were other reasons for exclusion."
1,"This was a multicentre, two-arm, parallel (1:1), double-blind, randomised controlled trial."
0,Typhi LPS specific IgA ELISPOT on day 7.
6,The primary outcomes were the feasibility of the mobile service.
0,Dog walking included three questions developed for this survey to identify the duration in hours and minutes of walking a dog on a typical day.
6,The secondary outcomes were changes from baseline in the anthropometry and fitness and the change in weekly time spent in moderate to vigorous physical activity.
0,"The model stems from social cognitive theory and assumes that an individual’s ability to manage life events is based on the interaction between behavioral, interpersonal, and external factors [28]."
6,"The primary outcome was the incidence of pesticide self-poisoning, whether fatal or non-fatal, in individuals aged 14 years or older, during a 3-year follow-up period starting from completion of container distribution to each band (follow-up was staggered across bands)."
0,The administrators and staff were also instructed to not consult the residents in the decision process.
6,"Secondary outcomes were the incidence of pesticide poisoning in children (aged <14 years), pesticide poisoning in general (deliberate and accidental, all ages), self-poisoning (all substances, fatal and non-fatal, age ≥14 years), non-fatal self-harm (all methods, age ≥14 years), fatal self-harm (all methods, age ≥14 years), non-fatal non-pesticide self-poisoning (age ≥14 years), and fatal non-pesticide self-poisoning (age ≥14 years)."
0,"In the second-phase, WIC providers joined with local initiatives to strengthen cross-sector collaboration."
3,"Potential participants were considered eligible if they were German-speaking, 18 years of age or older, and had either been diagnosed with colorectal cancer within the past 3 years before enrollment or—independent of time since diagnosis—had metastasized colorectal cancer and/or a relapse of the disease, and who consented to participate online on the study website."
0,"Comorbidities at the time of ICD implantation were systematically collected from review of medical records: cancer, chronic obstructive pulmonary disease, chronic renal failure, chronic liver disease, history of transient ischemic neurological attack, and others (including diabetes mellitus)."
3,Potential participants who indicated on the survey that the time since their diagnosis was more than 3 years and who indicated that they had no recurrence or metastases were excluded from the study.
0,"Each item is rated on a 1–5 scale, where scores of (1), (3), and (5) have specific anchors."
6,All questionnaires were given online.
0,"If only molars of one side were included, the other group in the selected combination would be discarded."
6,"Assessments were performed at discharge from the clinic (T0), at the end of the intervention of the IG (T1), 2 months later for follow-up assessment (T2; only IG), and at the end of the intervention of the WLCG (T3; only WLCG)."
0,"Fasting serum insulin (chemiluminescent immunoassay (Advia Centaur Immunoassay System, Siemens Medical Solution Diagnostics,Tarrytown, NY, USA), serum highly sensitive C-reactive protein (hs-CRP) nephelometry (Siemens, Eschborn, Germany), serum interleukin-1 receptor antagonist (IL-1Ra) (Quantikine Elisa Kits; R&D Systems Inc., Minneapolis, USA), serum high molecular weight adiponectin (HMW-adiponectin) (Quantikine ELISA for Human HMW Adiponectin/Acrp Immunoassay, R&D Systems Inc., Minneapolis, USA), plasma cortisol (LIAISON Cortisol, chemiluminescent immunoassay, Diasorin, Italy), and plasma dehydroepiandrosterone sulphate (DHEA) (LIAISON DHEA-S chemiluminescent immunoassay, Diasorin, Italy) were measured centrally at the University of Eastern Finland, Kuopio, Institute of Public Health and Clinical Nutrition."
3,We included all clients that had undergone a voluntary PrePex circumcision during the study period.
0,"In this study, more than half of the treated participants had recovered according to a structured interview, suggesting that a treatment effect size of 1.07 is clinically meaningful."
3,We excluded those (five) who had PrePex initially and followed up by a surgical circumcision as an intervention for an adverse event.
0,All participants read and signed the written consent document before the BL1 evaluation.
3,"Eligible patients were aged 18–80 years with untreated histologically confirmed CD20+ DLBCL, International Prognostic Index (IPI) 1–5 or IPI 0 with bulky disease (one lesion ≥7.5 cm), had at least one bidimensionally measurable lesion ≥1.5 cm at its largest dimension by computed tomography (CT), positron emission tomography-CT (PET-CT), or magnetic resonance imaging (MRI), had adequate hematologic function, and Eastern Cooperative Oncology Group (ECOG) performance status ≤2 (detailed inclusion/exclusion criteria are supplied in the Online Supplementary Appendix)."
0,We did routine laboratory safety investigations on days 28 and 49.
6,"Data collected in the self-administered survey included: age (years); education level (at least secondary or higher than secondary); sexual identity (homosexual or gay; bisexual; heterosexual; transgender; other); sexual role during anal intercourse with men (ie, activo, pasivo, moderno); transactional sex (ie, exchange of money/items of value for sex, ever, yes/no); sex and concomitant drug and alcohol use (past month, yes/no); cigarette use (ever, yes/no); age at first anal intercourse (years); oral sex (given) with a man (ever, yes/no); condom use during anal intercourse (last, yes/no); HPV knowledge (‘Have you ever heard of HPV or human papilloma virus prior to participating in this study?’, yes/no)."
0,Patient quality of life will be assessed using the FACT-B and EQ-5D instruments.
1,"We conducted a single arm, open-label study of regimen simplification to E/C/F/TDF plus darunavir 800 mg daily from stable therapy including two nucleoside/nucleotide reverse transcriptase inhibitors, a ritonavir-boosted protease inhibitor (atazanavir or darunavir), and raltegravir or dolutegravir."
0,Participation in decision making was measured by the Control Preferences Scale[21].
3,"Pregnant women were eligible for this trial if they were (1) able to speak or read English, (2) willing to be randomized to e-screening, and (3) willing to participate in a follow-up diagnostic interview within 1 week of recruitment."
0,Written feedback was provided on each assignment.
3,"Because the Web-based screening tool was intended to be completed unassisted, it was designed for use by women with varying levels of computer literacy."
0,"Systemic solicited symptoms were; fever (axillary temperature>37.5°C), feverishness, malaise, arthralgia, headache, myalgia and nausea or vomiting."
1,"We conducted a matched-pair, cluster-randomized controlled trial in government health facilities, which received either the BetterBirth program, a coaching-based implementation of the WHO Safe Childbirth Checklist (60 facilities; Figure 1) or the existing standard of care (60 facilities)."
0,"Concomitant treatment with aspirin at doses <160 mg and with selective cyclooxygenase-2 inhibitors was permitted, as was the use of elastic compression stockings; use of intermittent pneumatic compression devices was not permitted."
1,"We described the methodology of the BetterBirth Trial19, the BetterBirth Program/intervention20,21, and our Data Quality Assurance system22 elsewhere."
0,"All patients were treated for 3 months with insulin and metformin and then randomly assigned to treatment with either insulin plus metformin (INS group) or triple oral therapy (TOT group) with metformin, pioglitazone, and glyburide."
1,"The study was a prospective, randomized, double-blinded placebo-controlled trial to assess the impact of atorvastatin in septic shock patients."
0,"Another issue for consideration in complex interventions is the number and difficulty of performing behaviours required by those delivering and/or receiving the intervention, such as those involved in this intervention by the sibling-participants."
1,The trial was registered with the ClinicalTrials.gov with registration number NCT02681653.
0,"They then explore various factors that may influence the outcome measures, including personal experience with life-threatening illness, desired level of control in decision-making, and comfort with substitute decision-making."
6,The primary endpoint of this study was mortality at 28 days of study inclusion.
0,The conduct of each council session involved the following intentions and processes17: “The Circle.”
6,"Secondary outcomes included length of ICU stay, event-free (vasopressor-free, ventilation-free, and renal replacement-free) 28 days, effect on inflammatory biomarkers, lipid profile, and adverse effects of the trial drug."
0,"The described procedure demonstrated good reliability at 0.79 (95% confidence interval, 0.739–0.832) in patients with subacute or chronic LBP [18]."
1,This randomised controlled trial with blinding of patients and assessors was conducted in 17 general practices in the German speaking part of Switzerland.
0,How to establish an individual action plan toward a healthy diet and make it feasible; 6-8) Monitoring of the progress of women's action plans.
1,All women provided written informed consent.
0,"The dose of the study drug was titrated once every 4 weeks during the first 20 weeks and every 8 weeks during the subsequent follow‐up period (from a starting dose of 30 mg to a maximum dose of 180 mg daily), depending on blood levels of PTH and calcium."
4,"Using structured data collection forms on electronic tablets (CommCare, Dimagi, Cambridge, MA, USA), three trained assistants gathered demographic and clinical data and in-hospital outcome data through daily review of medical charts."
0,"In addition, women are not currently being supplied with the message that physical activity during pregnancy is safe [38] only half of obstetricians discuss physical activity with pregnant women and those who do are likely to advise not to start exercise [39]."
4,"Data were uploaded wirelessly to a remote, secure server and transferred into an interoperable electronic data platform approved by the Ministry of Health (DHIS2, Oslo, Norway)."
0,Primary and secondary efficacy analysis variables were measured in a laboratory classroom setting that was designed to model a typical school day plus after-school activity totaling 10 hours.
3,"This study included all the registered children with a diagnosis of unilateral/bilateral pediatric cataracts from the Childhood Cataract Program of the Chinese Ministry of Health (CCPMOH)24 who were treated between January 2011 and April 2014 at the Zhongshan Ophthalmic Center (ZOC),25 one of the largest eye hospitals in China."
0,"The study was approved by the ethical review board of the Nutritional Research Institute (Instituto de Investigación Nutricional, IIN), the cantonal ethical review board of Basel, Switzerland, Switzerland (Ethikkommission beider Basel, EKBB), the Cajamarca Regional Health Authority and the Peruvian National Institute of Health (Instituto Nacional de Salud, INS: 2-05-70-08-012)."
3,"Children with a history of premature birth or any previous surgeries, diagnosis of microphthalmia, micro-, or megalocornea, keratoconus, glaucoma, traumatic or complicated cataracts, vitreous or retinal diseases, lens dislocation or contraindications for pupil dilation, and sedation were excluded."
0,"All answers were recorded anonymously and individually, with no interaction between the participants."
4,"Hospitalized patients were consecutively recruited from a geriatric ward at Aalborg University Hospital, North Denmark Region, Denmark, between the 29th of February and the 14th of April 2016."
0,"To address these threats, we have limited eligibility criteria, paired the neighborhoods using important variables, and have sequentially enrolled eligible mothers to the target number per neighborhood."
1,"This was a descriptive, observational and cross-sectional study."
0,"The main components of the intervention were: development and implementation of an interdisciplinary care protocol (delivery system design), development and implementation of a structured education program for type 2 patients on diet or oral therapy (self-management support), establishment of a local steering group and the appointment of a program manager (organization of the healthcare delivery system), provider education (decision support) and regional audit (clinical information systems)."
1,"The detailed description of the procedures are provided in the study protocol, which was published previously [18]."
0,The aim of the study circle is to increase the knowledge and skills of staff in the area of health promotion in order to empower them to improve work routines and the social and physical environment of residents.
3,"The inclusion criteria were (1) resident of the respective nursing home, (2) aged ≥65 years, and (3) written informed consent given personally or by legal representative."
0,"Blood pressure was measured three times using a validated automated monitor (OMRON Healthcare Company, Kyoto, Japan) supplied to each site; at least one of the three systolic measurements had to be in the range 140–220 mm Hg before enrolment."
3,Residents at the end of life were not considered eligible.
0,Since three treatments or three pairs of treatments are under consideration for each of the above questions we have applied a Bonferroni correction for the best of three tests.
1,This was a secondary analysis of a parallel group RCT on the effect of 6-month long Schroth PSSE intervention added to standard of care compared to standard of care alone (observation or bracing) on the change in Cobb angle in patients with AIS.
0,"Patients who had other significant valvular heart disease (≥ moderate), contraindications to CMR or cardiomyopathies (acquired or inherited) were excluded."
8,"This RCT was powered to detect a 0.50 effect size when comparing the change in the primary outcome between two groups with 80% power using a two-tailed 0.05 hypothesis test, and considering a 0.6 correlation between repeated measures in two time points, 50 patients per group were needed."
0,The study used a “withdrawal to monotherapy” design.
8,"[28] However, the study ended after recruiting 50 participants when funding was received to continue the study as a multicenter RCT with slightly different participants’ criteria (Trial registration NCT01610908)."
0,The procedures are briefly described below with extensive detail in the Study Operations Manual (available at http://www.fnih.org/what-we-do/current-research-programs/biomarkers-consortium-beta-cell-project).
14,"Participants and site staff were unblinded as to participant treatment assignments among treatment groups T1, T2, T4, and T5, but blinded, except for site pharmacists, as to treatment assignment (active versus placebo) for treatment/placebo group T3/P3."
0,Recruitment will be conducted by a health professional with delegated authority.
14,"Study product assignments were accessible to study pharmacists, contract monitors, and SDMC staff, who are required to know this information in order to ensure proper trial conduct."
0,"The movement disorder neurologist, blinded to prior results, assessed tremor using UPDRS (items 20 and 21) during injection visits."
6,The primary endpoints of this study were rate of PVR ≤ 50 ml and proportion of patients in which the catheter was removed successfully on postoperative day 4.
0,The study was approved by our university hospital ethics committee and conducted according to the Helsinki Declaration.
3,The participating ICUs belong to the French Society of Critical Care (SRLF) or the French Society of Anesthesiology (SFAR).
0,"Depending on the centre, patients will be screened and asked for consent either during the outpatient screening or while hospitalized prior to surgery."
3,"The selection criteria were:Adult, medical, surgical or medical-surgical ICU patientsAgreement of the whole team to write in the diariesSupervision of the study by physicians or nursesAgreement with the randomized design in the ICUs which previously used diaries The participating ICUs are displayed in Additional file 2."
0,"Physical and emotional QoL domains were assessed using the Physical Component Summary (PCS) and the Mental Component Summary scores, respectively, where higher T-scores reflect better QoL."
1,"This is a prospectively registered, two-arm, open-label, randomized controlled trial."
0,"At the seventh and final study visit, 24 months from enrollment, participants will return their electronic medication monitors and take a 45-min survey."
3,The study will include patients aged over 18 years with a clinical or tomographic diagnosis of bronchiectasis who are in a stable clinical state (absence of changes in the symptoms of dyspnea and in the volume and color of sputum).
0,The quality of housing is poor and streets are not paved.
3,"The exclusion criteria are smoking, primary diagnosis of another lung disease (asthma, COPD, interstitial lung disease, or cystic fibrosis), severe cardiovascular disease, inability to perform the tests and the training protocol due to musculoskeletal limitations, and significant levels of desaturation (pulse oxygen saturation ≤80%) during baseline exercise testing will be excluded."
0,No information on premutation in parents is collected.
14,"Due to the nature of the interventions, it is not possible to blind patients and therapists, and due to lack of human resources, the outcomes of this trial will be collected by an unblinded outcome assessor."
0,"This study was designed as a 6-week randomized, double-blinded, placebo-controlled trial."
4,"This prospective, multicentre, open-label RCT will be conducted in four French university hospitals."
0,Bias was minimised by employing double-dummy blinding.
3,"We will include patients with the following conditions:Lung cancer (or high suspicion for malignant tumour) eligible for resection surgery (lobectomy or pneumonectomy with video-assisted thoracic surgery or open thoracotomy)COPD stages from 2 to 4 by the Gold classification (FEV1/FVC<70%, FEV1<80% of predicted value)Exertional dyspnoea stage mMRC (modified Medical Research Council) ≥1Receiving written information and giving signed consentAffiliated with the French social health insurance Non-inclusion criteria"
0,Note that one subject of an initial sample of 12 obese humans was not considered eligible for analysis because of technical failure during the methylation profiling procedure.
1,"This was a cluster-randomized, investigator-masked, controlled trial."
0,"For the secondary endpoints, truncation of observation time by the occurrence of the primary endpoint was potentially substantial and informative."
3,Eligible patients were aged 18 years or older and had been prescribed MAL DL-PDT as part of their routine medical care to treat mild to moderate AK on the face and/or scalp.
0,"On a 100-point scale, mean score changes of 5–10 points were interpreted as small, changes of 10–20 points were considered moderate and changes of >20 points were considered large clinical changes [19, 20]."
5,A single treatment of MAL DL-PDT was administered.
0,Two distinct customer segments or Facebook audiences were targeted in the second iteration of the social media campaign.
16,All collected variables were descriptively summarized without replacement of any missing values (observed data only).
0,"At the follow-up assessment, the 30s–CST and DEMMI were conducted with a ten-minute break between tests."
16,"The primary efficacy endpoint was evaluated in the intention‐to‐treat population; missing data were accounted for using a mixed effects model with a repeated measures approach,23, 24 using all available post‐baseline data within the analysis windows (weeks 8‐24)."
0,The fidelity index consists of 78 items assessing the presence or absence of certain activities within MISSION-Vet.
16,"Further details on the determination of sample size and statistical analysis of efficacy and safety endpoints are given in the Supporting Information, Text S3."
0,Comparisons within and between groups were done with Student’s paired and unpaired 2-tailed t-test for normally distributed data or as stated in the results section.
6,"Instruments in the study were validated in the local language and included the following: the International Prostate Symptom Score (IPSS) [25]; other ICS symptoms questions (related to splitting/spraying, hesitancy, terminal dribble, urgency); Overactive Bladder Symptom Score (OABSS) [26]; the 12-item short-form health survey for measuring health-related QoL (HRQoL-SF12v2; possible scores for mental health domain and physical health domain range from 0 to 100, with higher scores indicating better health) [27]; Work Limitations Questionnaire (WLQ) [28]; Hospital Anxiety and Depression Scale (HADS; total score for both anxiety and depression classified as normal, 0-7, borderline abnormal, 8-10, or abnormal, 11-21) [29]."
0,Enrollment proceeded in four steps.
6,"Presence of LUTS was based on ICS criteria (presence of voiding, storage or post-micturition symptom[s] with frequency ≥ 1 in 5 times), with the exception that nocturia was defined as ≥2 episodes per night (ICS definition for nocturia is ≥1 episode per night; the higher threshold was chosen to avoid over-estimation) [22]."
0,Results of the nucleic acid tests were used to determine HIV infection status regardless of serology.
16,"Data were analyzed using STATA® version 13 (STATA, College Station, Texas)."
0,We then applied the same process used for red.
16,"Our primary data analysis aimed at comparing the Aspergillus-specific IgG antibody levels at baseline compared with week 24, and relating them to baseline demographics and clinical parameters (Additional file 1) at a 95% confidence interval."
0,During the validation of the developed algorithm the anaesthesiologist had to judge tactile fading of the adductor pollicis before the acceleration transducer was applied to the distal phalanx of the thumb.
3,"This analysis is restricted to the three low HIV prevalence countries (The Dominican Republic, Georgia and India) and to women randomized in the COC group."
0,"Subtypes of RTA were determined as follows [3,9]: RTA type I (distal): hyperchloremic acidosis with a minimum urine pH ≥5.3 and low/normal plasma potassium (<5.5 mmol/L), based on reduced H+ secretion in the distal tubule."
3,We excluded women who had missing data for study variables.
0,"In the long-term phase of the model, for temporary and serious harmful event states, the QALYs (and costs) related to the event itself were calculated for the patient, using the utility value from the Sheffield Alcohol Policy Model and calculating a QALY for the time the patient was in that health state."
8,"As this was a Phase Ib trial, the sample size was shaped by the need to balance the number required for evaluation of safety and immunogenicity of an investigational vaccine with the risk of exposing a large group of study participants to an unlicensed vaccine."
0,A topic guide (463 words) was developed for the research nurse delivering the intervention.
8,"Thus, the sample size was not powered to detect differences between the study arms."
0,"In case of a diagnostic lymphadenectomy, a minimum number of ten lymph nodes had to be surgically removed."
5,Details about the study vaccines have been described elsewhere (8–10).
0,Glycogen was added (120 μg per ml of TriReagent) to the tendon samples to improve RNA precipitation.
5,"Briefly, ChAd63 ME-TRAP and MVA ME-TRAP were respectively manufactured by Clinical Biomanufacturing Facility, University of Oxford, UK, and Impfstoffwerke Dessau-Tornau, Germany, under Good Manufacturing Practice conditions."
0,The voluntary nature of their participation was explained and confidentiality was assured.
6,The primary endpoint was safety measured as (i) occurrence of solicited symptoms during a 3-day follow-up period after each immunization; (ii) occurrence of unsolicited symptoms during a 30-day follow-up after each vaccination; (iii) occurrence of abnormal laboratory results during study period; and (iv) occurrence of serious AEs throughout the study period.
0,"Following written informed consent from the subject or legal representative, patients with severe sepsis or septic shock [15] and AKI who fulfilled the protocol selection criteria (Table 1) were randomized in a double-blind, placebo-controlled design."
3,"Inclusion criteria according to the protocol are:Histologically confirmed cervical or endometrial cancerIndication for postoperative radiotherapyKarnofsky Index ≥70Age between 18 and 80 yearsWritten informed consent Exclusion criteria are the following:patients refusal or incapability of informed consentimplanted active medical devices lacking approval for ion beam radiationmetallic implants in the radiation field, e.g. hip prosthesesprior pelvic irradiationparticipation in another clinical trial which might influence the results of the APROVE trial Simultaneous chemotherapy is NOT an exclusion criterium."
0,Rule out the existence of treatment-related side effects.
3,"Inclusion criteria were: aged ≥16 years; stable symptoms of intermittent claudication for ≥3 months; resting ankle-brachial index ≤0.9 and/or imaging evidence of PAD; pain-free walking distance <250 m on 6-min walk test with ambulation limited primarily by calf claudication (assessed at screening visit), and; able to read and speak English and provide written informed consent."
0,"Overall, 794 park users agreed to participate (75.3% of those approached, excluding those who had already completed an interview)."
3,"We excluded people with: absolute contraindications to exercise testing (as defined by the American College of Sports Medicine [7]); critical limb ischemia; lower-limb amputation; co-morbidities that limit walking to a greater extent than intermittent claudication (e.g., severe knee osteoarthritis); ambulation limited by claudication in regions other than the calf; major ankle or foot pathology, and; current or previous (within 6 months) use of shoe inserts, knee or ankle braces or customised shoes prescribed by a health professional."
0,"A general template of the UHCE approach was developed by systematically reviewing the literature to identify evidence based interventions and validated assessment instruments for frailty, fall risk and polypharmacy (see www.uhce.eu)."
3,"Participants were eligible for trial enrollment if they (1) were 18 years or older; (2) reported the exchange of any vaginal, anal, or oral sex for money, goods, or other items of value; (3) said that they had never tested for HIV or self-reported negative HIV status without a recent HIV test (in the past 3 months); (4) had been working as FSWs in Kampala for at least 1 month prior to enrollment and planned on continuing to work as FSWs in Kampala for at least the next 4 months; and (5) had never used an oral HIV self-test."
0,Muscle tissue was obtained from the lateral vastus muscle 15 cm proximal to the knee joint line by the use of a Bergstrom biopsy needle.
3,"All eligible participants provided written informed consent; participants had to be of sound mind (i.e., not under the influence of drugs or alcohol) to be eligible for the informed consent process."
0,Repeat questionnaire packs were identical to the first pack other than slight changes to the wording of the letter that made it clear that this was a repeat mailing.
4,"The study was performed in the Neuroplasticity, Neurorehabilitation and Imaging (NEURI) Laboratory at Samsung Medical Center, Korea, and all subjects provided written informed consent before measurements."
0,A secondary sensitivity analysis will be performed to evaluate new-onset disability using a ≥4-point (8%) increase in the WHODAS score compared with the baseline (preoperative) score.
4,All procedures were approved by the ethics committee of the Samsung Medical Center Institutional Review Board.
0,"Three boxes of the same content labelled in consecutive order were assigned to each patient, one box for each 24-hour period up to 72 hours."
6,"All subjects were assessed for HbA1c at 2 weeks, and 3, 6, 9, and 12 months post-procedure and change from baseline in HbA1c was calculated."
0,"Each definition of HAIs was modified from the 2014 version of United States Center for Disease Control and Prevention’s National Healthcare Safety Network (CDC/NHSN) surveillance definitions of HAIs, considering locally available resources [12]."
6,"Other pre-specified outcome measurements included safety, change from baseline in glucose homeostasis (blood glucose area under curve (AUC) values at each visit were calculated using the linear trapezoidal rule based on the fasting value prior to the glucose tolerance test and the subsequent values collected at 30 min, and 1, 2, 3, 4, and 5 hours after the glucose tolerance test), whole-body insulin sensitivity (assessed from the OGTT data using the Matsuda Index15), β-cell function (assessed using the ratio of AUC C peptide/AUC glucose calculated from the OGTT data16), lipid levels, liver and renal function, and usage of anti-hyperglycemic, anti-hypertensive, and dyslipidemia medications."
0,Potential recruits taking cholesterol-lowering food products needed to stop these before the start of the study (wash-out period of 2 weeks).
16,"All analyses were performed using SAS, version 9.2 (SAS Institute Inc., Cary, NC)."
0,The revised curriculum was then implemented within the study sites selected for intervention activities.
16,"Within the intervention group only and for each post-baseline time point, Pearson correlation coefficients were computed for children’s mean changes (from baseline) in adiposity, weight, health behaviors, and self-efficacy, with their parents’ corresponding mean changes from baseline, to determine how strongly the dyads were correlated."
0,Respondents completed the second survey 15 to 36 days after the first survey.
14,"With our physical activity intervention, it will not be possible to blind the study participants themselves, the project physiotherapists, the project physicians and some of the assessors."
0,"When replying to the weekly questionnaires the participants reported day by day possible suffering from RTI or GTI symptoms during the previous 7 days, as well as, on a weekly basis, whether they had recognized exposure to other persons with RTI, GTI or both during the week."
14,"But wherever possible all other members of the project team will be blinded for group allocation of the participants, i.e. those who perform the DXA measurement, the physical performance test, the blood analysis, the quality check of the data in the database and the statistical analysis."
0,It was registered at ClinicalTrials.gov (NCT02306434) and approved by the Regional Ethical Review Board in Uppsala (No.
3,"Diagnosis of psychosis established by the clinicians using ICD10 criteria (including schizophrenia, schizoaffective disorder, or delusional disorder using ICD-10 research criteria).Individuals aged 18–65 years.Being a resident of Karachi.The participant could give informed consent (written)."
0,AL has been used as the first-line treatment for uncomplicated malaria since 2006.
6,Myocardial mass (MM) changes as determined by cardiac MRI from baseline to the end of the intervention after 22 weeks of exercise.
0,"For all randomized patients, treatment will continue for 24 months, or until the occurrence of an FAP-related event, as defined in Table 3."
6,Changes in end-diastolic volume (EDV) as determined by cardiac MRI from baseline to the end of the intervention after 22 weeks of exercise.
0,"After permeabilization, the cells were intracellularly stained with antibodies for IFN-©, TNFα, granzyme B and perforin."
4,The British Hypertension Society Research Network of academic investigators recruited participants from both primary and secondary care.
0,"All 3 studies were conducted in accordance with the principles of the Declaration of Helsinki and the International Conference on Harmonisation Guidelines for Good Clinical Practice, and all were approved by the appropriate institutional review board or independent ethics committee at each study site."
14,"Participants were informed they would be randomized to 1 of 2 doses of tai chi and, thus, were not blinded to their dose allocation."
0,Treatment outcomes were classified according to WHO guidelines for evaluation of the therapeutic efficacy of antimalarial drugs in the treatment of uncomplicated malaria [19].
14,"Study personnel, other than the research assistant responsible for participant randomization and monitoring of adverse events, were blinded."
0,"Women are sorted out from being invited to participate in the organised screening programme if they have had a recent opportunistic smear, as assessed by registry linkage with cytology registers."
3,"All patients aged ≥18 years who attended the participating practices during the study period were eligible for the trial, but those known by the GPs to suffer from severe psychiatric disorder, alcohol dependence, serious visual impairment or terminal illness were excluded, as were those judged to have inadequate command of the Italian language."
0,Data for the study are drawn from existing records that are routinely collected at the study sites as part of routine patient care.
1,"This was a single-centre retrospective study carried out at St Olavs Hospital, University Hospital in Trondheim, Norway, primary hospital for 300 000 inhabitants in the middle of Norway that treats approximately 400 hip fractures yearly."
0,The parameter of interest was the peak slow phase velocity (recorded in °/sec) of the caloric nystagmus response of the selected ear.
1,"In Norway, all hip fracture patients are treated in public hospitals."
0,Attitude scores were summed giving a possible range of scores from 7 to 35.
6,The main outcomes were change in AUDIT-C scores from baseline to 1- and 3 months post-intervention.
0,"COPDGene is an observational study of COPD conducted at 21 clinical centers in the U.S. (see Additional file 1: Supplementary Data and Methods) designed to discover epidemiologic and genetic risk factors for COPD [8, 14, 15]."
6,"Secondary outcomes were study recruitment and retention rates, intervention acceptability and feasibility, perception of group allocation among ED and research staff, and change in health and social services utilisation from 30 days prior to the adolescent’s ED visit (baseline) to 1- and 3 months post-intervention."
0,The primary prevention cohort had diabetes for 1–5 years (mean 2.6 years) and no retinopathy or microalbuminuria at baseline.
1,"This 52‐week, open‐label study was performed in 24 institutions in Japan."
0,"Patients’ feedback was then discussed during weekly or monthly meetings between the healthcare professionals and the technical team, so that appropriate changes to the digital health system were implemented and tested as soon as possible."
1,The participating institutions/investigators are listed in Appendix S1.
0,All data will be anonymised and coded so that data collection and statistical analysis will be blinded to treatment allocation.
14,AK was blind to group allocation when recruiting the patients.
0,The first participant was enrolled on 30 June 2017; enrollment is expected to be ongoing until July 2018; and planned data collection will continue until 2021.
14,No other blinding was implemented.
0,"Notably, HCC staging will be assessed in the explanted liver to determine the actual extent of tumor presence."
6,All outcome measures assessed in this study are presented in table 4.
0,Individual AEs were coded by MedDRA version 19.0 and classified according to System Organ Class and Preferred Term.
1,"We used a randomized, controlled design (see Fig. 1 of the protocol for this study [16])."
0,"If a mother weaned her child to an exclusively formula-fed diet, she was instructed to discontinue the supplements but to return for the final study visit regardless."
1,"The intervention group received the DE-REACH intervention and the control group received usual care, whereby services of usual care corresponded to the available care services determined by the actual version of the German Care Insurance Law (e.g. caregiver counseling, utilization of day care, low-threshold care services, short-term or prevention care)."
0,"Adult male Wistar rats (9 weeks old, 250-300 g, Harlan) were anesthetized with a mixture of Ketavet® (Ketamine, 66 mg/kg) and Domitor® (medetomidine hydrochloride, 0.090 mg/kg i.m.), intubated endotracheally and ventilated with a device (RUS-1301 Universeller Respirator, Föhr Medical Instruments GmbH, Germany)."
16,The method of Kaplan-Meier was used to estimate the distribution of survival.
0,The knowledge-related barriers were scored on a 2-point scale (yes/no).
16,"Statistical analyses were performed using SPSS version 16.0 (IBM, Armonk, NY)."
0,"Blood (target 7 mL) was collected and centrifuged, and serum was poured into 2 tubes, transported in nitrogen vapor, shipped on dry ice, and stored at −80°C until analysis at UW-Madison."
1,This is a study of the implementation of a healthcare intervention with a quasi-experimental design and mixed measurement methods that include both qualitative techniques and analysis and quantitative indicators.
0,"Servicios Hospitalarios S.L., Barcelona, Spain)."
1,"The design involves defining several geographic areas in which the INDI program will be implemented as well as other comparable areas which will serve as the control, where depression will be treated as usual."
0,Participants could also consent and receive the treatment on their initial visit if they were currently in pain due to menses.
3,"Mean age of the participants in each group was 57 (23–75) and 54 (19–74) years, respectively."
0,"It was approved by the Ethics Committees of the participating centres and the Central Committee on Research involving Human Subjects, and was conducted according to good clinical practice guidelines."
3,"There were no differences in sex, age, preoperative New York Heart Association (NYHA) functional class, and comorbidities (Table 1)."
0,"To assess the feasibility and effectiveness of our program in various subgroups, eligible patients were randomly selected across three stratification variables."
1,A quasi-experimental study was conducted to measure the total number of patients and the distribution of patients outside NPs’ scope of practice in out-of-hours primary care over the weekend (Saturday and Sunday) between 10:00 and 18:00 hours.
0,Each morning subjects were required to record the amount of sleep during the previous night in the sleep diaries.
1,"Two types of teams with NPs were compared with a team comprising only GPs, as follows:Team 1: care provided by a team of four GPs (care as usual);Team 2: care provided by a team of three GPs and one NP;Team 3: care provided by a team of two GPs and two NPs."
0,"During each visit, various aspects of the BD will be assessed: 1."
3,"Patients were eligible to participate in this study if they were aged ≥ 18 years, had been receiving lipid-lowering medication for ≥ 90 days with no dose change for ≥ 8 weeks, and had blood tests scheduled to measure levels of TC, LDL-C, HDL-C, glucose, creatinine, HbA1c, hemoglobin, and hematocrit at the screening visit (or if these tests were deemed necessary during the screening visit for reasons unrelated to the study)."
0,A urine sample for drug testing and a blood sample for serology testing were also collected.
3,"Individuals were excluded from participation if their cognitive status and/or home environment were judged by the investigator to have potentially compromised adherence to the treatment regimen during the past 8 weeks, if they had a low CV risk, or if they were participating in any other clinical trial."
0,"The antigen suspensions were manufactured to contain 15 μg/mL or 30 μg/mL haemagglutinin (HA) antigen; AS03-adjuvanted vaccine was prepared from the 15 μg/mL suspension (3.75 μg HA/0.25 mL+0.25 ml AS03: total vaccine dose=0.5 mL), while the non-adjuvanted formulation was prepared from the 30 μg/mL suspension (15 μg HA/0.5 mL)."
1,"This study was a clinic-randomized controlled trial using a 1 × 2 × 5 comparison: women × condition (experimental or control) × time (assessments given at baseline, 32 weeks pregnant, and 6 weeks, 6 months and 12 months postpartum)."
0,"Plasma samples from days 1 and 29 were analyzed by ELFA (Enzyme Linked Fluorescent Assay) on a VIDAS instrument for D-Dimer (bioMerieux Inc., Durham, NC), by a single-plex kit (Meso Scale Discovery, Gaithersburg, MD) for C-reactive protein (CRP) and by real time PCR for Cytomegalovirus (CMV) DNA quantification as described by Yun et al [33]."
1,"In addition to assessments, participants attended three group and one individual counselling intervention (or time-equivalent control) sessions prior to birth, and two individual counselling sessions postpartum [25]."
0,The programme was managed by the UK National Cancer Research Institute Radiotherapy Trials Quality Assurance Team.
6,"The primary outcome measure of this study was to assess change in treatment satisfaction of patients who utilized the system over a period of 6 months, using the DTSQ to determine baseline satisfaction (DTSQs), and change in treatment satisfaction (DTSQc).21"
0,"If the pre–percutaneous coronary intervention biomarker was greater than the upper reference limit (URL), both an increase by at least 50% over the previous value and documentation that the biomarker was decreasing prior to the suspected recurrent MI were required.1, 6"
6,Secondary measures included: change in diabetes-related distress as assessed by the DDS22; changes in glycemic control (HbA1c and mean BG); change in daily SMBG frequency; impact of structured diabetes data on healthcare professional's (HCP) ability to make informed decisions on diabetes management therapy changes; and number of unscheduled patient visits/consults.
0,"Patients could remain on combination treatment or selumetinib monotherapy after discontinuation of chemotherapy, providing they were continuing to derive clinical benefit, until disease progression or intolerable AEs occurred."
6,The main outcomes of the study were reoperation for small bowel obstruction and early severe postoperative complication [14].
0,They contacted participants by post within 10 days of the index call to give them the opportunity to opt out of follow up.
6,HRQoL was measured and analyzed as a post-hoc analysis.
0,"CMR was performed at baseline, 6, 12 and 18 months."
16,"Due to the small number of patients in this pilot study, statistical analysis was limited to descriptive statistics."
0,"The contents of the routine visits were not tailored to individual patient’s needs, nor were self management elements such as the use of a written exacerbation action plan included."
16,"For the purposes of this study, antibody responses that were increased 5-fold or greater in the post treatment serum sample compared to baseline were considered important."
0,"During surgery the internal fistula tract opening will be identified, followed by cleaning and debriding the fistula tract with hydrogen peroxide."
1,"This study was an evaluation of an RCT using a qualitative-driven, concurrent, embedded mixed-method approach in which data from questionnaires and telephone interviews were used [15, 16]."
0,"Sagittal T1-weighted three-dimensional (3D) magnetization prepared rapid gradient echo (MPRAGE) imaging data were acquired with the following parameters: echo time (TE) = 2.94 ms, repetition time (TR) = 1900 ms, fractional anisotrophy (FA) = 9°, bandwidth = 170 Hz/pixel, imaging matrix = 256 × 176 pixels, with a voxel size of 1 × 1 × 1 mm3 in the axial, coronal, and sagittal planes."
1,An embedded approach can be defined as one in which data collection and analysis are linked and may be used to examine subjects’ experiences of trial interventions [15].
0,"Thus, during the first 6 months, the intervention was designed such that a minimum of 80% of exercise sessions were conducted at home in an unsupervised setting."
4,"The study was conducted in the paediatric cardiac intensive care unit (PCICU) at Aga Khan University Hospital, Karachi, Pakistan."
0,The following formulae were used in calculating the cost and QALY impacts associated with provided CT scans to patients with adverse events who did not receive a CT scan.
3,The eligibility criteria for the DB period were previously reported.4
0,The reaction mixture was stirred for 2 h at 80°C.
3,Brief details are provided in the online supplementary materials.
0,Randomization will be stratified for gender and patients will be blinded for the assigned treatment during the first two years of follow-up.
1,"C-OPERA (NCT01451203) was a multicentre, DB, PBO-controlled, randomised, parallel-group study conducted in Japan and was previously described.4"
0,"Individuals were classed as having a salaried occupation if they received a monthly salary from a company and were not government employees, overseas workers or in the security forces, as these were separate categories in this data set."
1,Full details of the study design are provided in the online supplementary materials.
0,This included the length of in-patient visits to hospitals and the number of out-patient consultations and X-ray examinations.
3,"Women whose pregnancy exercise levels did not include self-reported participation in an exercise program (LTPA > 150 min/week), 18 years or older and living in the urban area of the city of Pelotas, Rio Grande do Sul State, Brazil were eligible for the trial."
0,Intervention schools received the Action 3:30 programme (see below) and control schools received £200 towards the school fund once all data had been collected.
3,"Exclusion criteria were self-reported hypertension, cardiovascular disease, or diabetes diagnosed before pregnancy, history of miscarriage or preterm birth, in vitro fertilization in the current pregnancy, twin pregnancy confirmed by ultrasound, persistent bleeding in the current pregnancy, body mass index (BMI) > 35 kg/m2, and heavy smoker (> 20 cigarettes a day)."
0,No assistance from NMES was provided during finger flexion to avoid the possible increase of finger spasticity after stimulation (30).
6,"Safety and reactogenicity of 10vPCV and 13vPCV in PNG infants;Serum PCV serotype-specific IgG and opsonizing antibody geometric mean titres (GMTs), and proportions of children with serum serotype-specific IgG antibody concentrations ≥0.35 μg/mL and opsonizing titres ≥8 for PCV serotypes at 4 and 9 months of age;Serum H. influenzae Protein D IgG GMTs at 4 and 9 months of age;Number of circulating memory B-cells specific for PCV serotypes and PCV carrier proteins (NTHi Protein D, Tetanus Toxoid and CRM197) and PCV serotype-specific IgG avidity maturation at 4 and 9 months of age;T-cell responses to PCV carrier proteins (NTHi Protein D, Tetanus Toxoid and CRM197) at 4 and 9 months of age;Nasopharyngeal carriage rates of S. pneumoniae (vaccine and non-vaccine serotypes) and serotypeable and non-serotypeable H. influenzae at 1, 4 and 9 months of age;Pneumococcal and H. influenzae nasopharyngeal density at 1, 4 and 9 months of age; andRates for hospitalization with ALRI or record of otitis media with perforation between 4 and 9 months of age."
0,The method in Chaloner [21] is used to detect outlying random effects.
6,"Serum PCV and PPV serotype-specific IgG and opsonizing antibody GMTs, and proportions of children with PCV and PPV serotype-specific IgG concentrations ≥0.35 μg/mL and opsonizing titres ≥8 at 10 and 23 months of age;Number of circulating memory B-cells and IgG avidity maturation for PCV and non-PCV serotypes included in PPV at 10, 23 and 24 months of age;Nasopharyngeal carriage rates and density of serotype-specific S. pneumoniae, and serotypeable and non-serotypeable H. influenzae at 10, 23 and 24 months of age; andRates for hospitalization with ALRI or record of otitis media with perforation between 10 and 24 months of age."
0,FFR was measured according to the prespecified protocol.
3,Enrolled patients were biologic-naïve and fulfilled the Classification Criteria for Psoriatic Arthritis21; had ≥3 of 68 tender joints and ≥3 of 66 swollen joints; had either ≥1 PsA-related hand or foot erosion on centrally read X-rays or C reactive protein >6 mg/L; and active or documented personal history of plaque psoriasis.
0,Basic characteristics of the cohort will be addressed using descriptive statistics (means and standard deviations for numeric variables and frequencies for categorical variables).
3,All patients provided written informed consent. The study was registered as SPIRIT-P1 on ClinicalTrials.gov (NCT01695239).
0,"A written informed consent was obtained for all adult patients, and from parents or guardians of minors."
8,"The power analyses were performed for the two subscales measures, physical and mental health components of SF-36 Quality of Life scale [19]."
0,"For example, first-line antibiotic choices for pneumonia were based on the Infectious Disease Society of America’s guideline [14] but tailored to local strep pneumonia resistance patterns."
8,"A sample size of 70 care coordinators each with an average of 4 patients (inflation factor 1.15 based on an assumed intraclass correlation of 0.05) and thus 280 patients, after allowing for 20% loss of care coordinator and an additional 30% loss of patients to follow up, was needed to detect a reduction of 5 points on both physical (d = 0.5) and mental health scale (d = 0.42) with at least 80% power using an alpha level of 0.05 and two-tailed assumptions."
0,Demographic data on all patients seen in the practices were obtained from the practices' EMR.
6,Primary outcomes of individual trials are summarised in Table 1.
0,Filter paper samples were taken for PCR analysis.
6,Individual trials have different primary outcomes but all trials collect a standard set of outcomes and apply the same definition for each outcome to ensure compatibility for future analysis.
0,Additional details have been previously published [16].
1,"This was a Phase 1, open-label, non-randomized, multicenter, multiple-dose study of tofacitinib (BID for 5 days) (A3921103; ClinicalTrials.gov: NCT01513902) in pediatric patients with JIA, conducted at nine Pediatric Rheumatology International Trials Organization and Pediatric Rheumatology Collaborative Study Group centers [18] in Germany, Poland, Slovakia, and the United States between March 2013 and December 2015."
0,Key secondary endpoints are summarized in Table2.
6,"Pre-defined, secondary endpoints of the PregnAnZI trial included the proportion of newborns with at least one episode of purulent conjunctivitis and ocular C. trachomatis infection within the first week of life, the first four weeks of life and during the eight weeks of the follow-up period [8]."
0,But the public health care facilities of both intervention and control areas received similar competency based trainings in stabilization and early referral of sick newborns for secondary care.
6,Purulent conjunctivitis caused by bacterial pathogens other than C. trachomatis was not a stated outcome of the trial and was investigated ad hoc.
0,The 4170 randomly assigned women were mailed an invitation letter revealing whether they had been assigned to the blind or the non-blind trial.
1,Cross-sectional study (PreCo survey) using an online survey.
0,"Blood sampling for PK analysis was performed for all patients in cycle 0 on day 1 at predose, 30 min after starting infusion, just after finishing infusion, 30 min, 1, 2, 4, 24, 72, 168, 336 h after infusion."
16,"Survival data were plotted using the Kaplan-Meier method, and were compared by the log-rank test as noted."
0,Participants visited the laboratory for two sessions.
16,"p values of < 0.05 were considered statistically significant in all analyses, which were done with Prism 5 statistical software (GraphPad Software)."
0,The number of included participants is not limited by physical capacity other than the number of coaches available.
3,Patients were included in the study if they had type 2 diabetes and were between 18 and 70 years of age.
0,Soft-tissue contour adjacent to the implant was assessed at implant insertion and 6-month and 1-year follow-ups using the Jemt papilla index (PI) [27].
3,"Individuals were excluded if they had any other form of diabetes, were treated with insulin or more than one oral anti-diabetic drug, were treated with any medication with loop diuretics, had an HbA1c level ≥ 10% (86 mmol/mol), had a fasting plasma glucose (FPG) level > 240 mg/dl, had BP ≥ 180/110 mmHg, had an eGFR < 60 ml/min/1.73 m2, or had a body mass index (BMI) > 40 kg/m2."
0,"Should, for any unforeseeable reason, the intervention or data collection place a burden on a given participant and should at the same time he or she be unwilling to terminate participation, the research worker and/or intervention worker are required to report this to the TSC who will then decide on whether or not the participant will have to be excluded."
9,The interim analysis for safety parameters will be done as soon as 20 patients have been treated and observed for at least 6 months.
0,Medical history and adverse events were coded using the Medical Dictionary for Regulatory Activities (version 17.0).
5,A detailed description of each intervention is provided in the published protocol.26
0,"The exclusion criteria comprised of the following: multicentric disease, extended intraductal component (EIC > 25%), Paget's disease, lobular adenocarcinoma, distant metastases."
5,A single experienced shoulder surgeon performed all arthroscopic evaluations and treatments.
0,The ISL is loaded into an 11-French delivery sheath and delivered into the left atrium.
8,The number of subjects needed for this study was calculated on the basis of a similar comparative PK trial [8] in which a single 180-μg dose was administered to 16 healthy volunteers.
0,"To assess potential correlation of peripheral immune signatures with occurrence of clinical and/or paraclinical disease activity, the study cohort was divided into three subgroups: “stable” (n = 6) “intermediate” (n = 5), and “exacerbated” (n = 4)."
8,"Assuming a difference of up to 30%, loss to follow-up of 10%, alpha error of 0.10 and power of 80%, and using the results obtained for CAVinf, which is a PK parameter calculated from the ratio of two underlying parameters (Cmax and AUC), we calculated that 29 to 32 subjects would have to be recruited."
0,"Participants randomised to Alternative Treatment initiated hydroxyurea at 20 mg/kg/day with escalation to maximum tolerated dose (MTD), defined as moderate marrow suppression of neutrophils and reticulocytes as previously described."
16,Survival rates were calculated using the Kaplan-Meier method in the statistical software R (version).
0,"Demographic data, including age, gender, and race, as well as comorbidities, severity of illness at the time of ICU admission, reason for MV initiation, physiological weaning predictors, and fluid balance (total inputs minus total outputs) 48 h before the SBT were recorded."
1,"This was a subject/investigator‐blind, parallel‐group, multiple‐ascending dose study."
0,"In India, male and female decision-makers were approached for participation when they accompanied women of reproductive age to the health centre."
1,"Healthy subjects were assigned into cohorts I through IV, with each cohort consisting of 13 patients randomized to receive LY3127760, celecoxib (400 mg), or placebo in a 9:2:2 ratio, for 28 days."
0,Meals and shakes were provided in cold packs for meals consumed offsite.
1,This was an open label prospective randomized controlled trial with a parallel study design and a 1:1 allocation ratio.
0,"Severe side effects as described by Awadzi [36] and as we had seen in Uganda [37], were not observed."
1,There were no changes to methods following trial commencement.
0,"Study personnel will collect data using standardized case report forms (paper copies will be retained and securely stored) and data transferred on a daily basis to an electronic database using a secure, internet-based portal."
3,"Preoperative exclusion criteria included the following: pacemaker implantation, atrial fibrillation, infective endocarditis, pericardial disease, infiltrative myocardial disease, ischemic heart disease, limited mitral annular motion,14 LVEF < 50% in preoperative transthoracic echocardiography (TTE) or contraindications to transesophageal echocardiography (TEE)."
0,All data was systematically documented using a standardized case report form (CRF).
1,"We designed a randomized, placebo-controlled, three-arm parallel-group, double-blind trial comparing the efficacy of Curamin with that of CuraMed and placebo (PL, negative control) (Fig. 1)."
0,"HbA1c was detected with a semi automated HPLC machine Primus Ultra 2 (Kordia, Leiden, The Netherlands)."
12,The Treatment Randomization Code was kept by the QP at the investigational product manufacturing site (at sponsor) until the study was finalized.
0,"The local school physiotherapist attends and contributes during the initial part (the introductory sessions, mapping and planning) and is responsible for the five monthly follow-up meetings after the first sessions."
1,"We performed a prospective, randomised, sham-controlled, blinded (physician, researcher) clinical trial."
0,"The RTW clinic is part of the Lovisenberg Community Mental Health Centre in Oslo, and employs clinical psychologists as therapists to treat patients referred by their general practitioners (GPs)."
4,The study took place between July 2011 and March 2016 in a regional cardiac centre.
0,The primary endpoint of this analysis was overall survival (OS).
4,Potentially eligible participants were identified by screening clinically-indicated referrals for invasive coronary angiography.
0,"Based on a randomized study, in the first postoperative dialysis bag, instilled directly after return from operation, cefuroxime (250 mg/L) is used as antibiotic prophylaxis.17"
16,"ECGs were analysed in the Glasgow ECG Core Laboratory by a blinded analyst (P.McC.) for PR duration, QRS duration, corrected QT interval (QTc, defined as the QT interval corrected for heart rate using Bazett's formula), presence of atrioventricular block and ST-segment deviation."
0,"Adipose tissue is not only a site of energy storage, but also an active endocrine organ secreting a number of hormones and cytokines that play critical roles in body energy homeostasis and metabolism [43]."
3,Healthy premenopausal women aged 18–40 years (inclusive) taking a combined OCP for ≥1 year prior to screening were eligible for enrollment.
0,The uveitis was not always granulomatous inside the the group of presumed ocular sarcoidosis.
3,Other inclusion and exclusion criteria are detailed in Appendix 1 in Supplementary Material.
0,One five-task session typically took approximately 15 minutes to complete.
1,"This early phase open pilot study had a pragmatic, multicentre, randomised parallel group design, comparing a 4-session social network intervention (B-SBNT) with an individually-based personal goal setting intervention of equivalent intensity (PGS), and with treatment as usual (TAU)."
0,"The Physical Health score is the sum of the subscale scores for Physical Function, Role Physical, Pain, and General Health Perceptions; and the Mental Health score is the sum of the subscale scores for Vitality, Social, Role Emotional, and General Mental Health."
1,"It targeted patients receiving OST for more than 12 months but still reporting opiate use in the preceding 28 days, and was conducted within three National Health Service (NHS) community drug treatment teams in two UK regions; the West Midlands (Solihull and Birmingham) and the East Midlands (Leicester)."
0,Primary endpoints were all-cause mortality (ACM) and cardiac mortality (CM).
1,"This national multiregistry matched cohort study uses prospectively collected electronic healthcare data from the Swedish National Patient Registry (NPR), the Swedish Cause of Death Registry (CDR) and the Swedish Prescribed Drugs Registry (PDR) between 2005 and 2014."
0,"Braintree, MA) or an equivalent generic polyethylene glycol and electrolyte solution."
1,This study protocol follows Strengthening the Reporting of Observational Studies in Epidemiology and REporting of studies Conducted using Observational Routinely collected health Data statements.14 15
0,"Twelve children (11 boys and 1 girl, mean age 6.2 ± 4.0 years, range 3–16 years) were assigned to separately receive hyperbaric therapy at approximately 1.3 atm and 24% oxygen in a monoplace hyperbaric chamber."
6,The primary endpoint of the present post hoc analysis was the change in TSS reported at each designated time point during the dosing periods in the study groups receiving loratadine or placebo.
0,Written informed consent was obtained from the parents or guardian of each participating infant.
6,"Secondary endpoints included the change in TOSS reported at each time point, and the percentage of participants who reported a symptom score of 0 or 1 (none or mild respectively) for all individual symptoms comprising the TSS or TOSS at each time point during the dosing periods."
0,"We also conducted an interview at 30 days, at 1 year, and at 2 years."
6,"ECHO study outcomes include: Primary study endpoint: HIV infection as measured by documented HIV seroconversion (defined by the study HIV algorithm) occurring post-enrolment (see Supplementary materials, Appendix 7); Secondary endpoints: Pregnancy, method-related serious adverse events, method related adverse events resulting in method discontinuation, and method discontinuation; Tertiary endpoints: include a) HIV infection by age (<25 years versus ≥25 years) and b) by HSV-2 status; and c) HIV plasma viral load and CD4 count."
0,The cardiovascular risk factors were also assessed: Hypertension was defined as either blood pressure readings of above 140/90 mm Hg on three occasions; Diabetes Mellitus: By case history or two prandial glycaemia readings > 126 mg/dl; -Smoking: n° packets/year.
1,"The ECHO Trial is a multi-centre, open-label, randomised clinical trial designed to compare the benefits and risks, including HIV acquisition, between women randomized to one of three commonly used, effective contraceptive methods."
0,Informed consent was obtained for all participants prior to the start of study-related activities.
4,"The study includes women from settings with high HIV incidence and high use of hormonal contraception (particularly DMPA IM) in four countries (South Africa, Kenya, Zambia and Swaziland) across eastern and southern Africa."
0,Potentially eligible patients were given information about the study and asked for their written agreement to participate.
3,Adults who were enrolled in this study had active RA with moderate disease activity (DAS28 > 3.2 and ≤5.1) at screening and baseline and had received stable methotrexate doses.
0,HDL cholesterol was quantified according to the modified heparin-manganese precipitation procedure of Warnick and Albers (15).
3,Randomized patients who received double-blind treatment had completed the first 36 study weeks and achieved sustained LDA.
0,A balloon that is appropriately sized to approximate the reference vessel diameter (RVD) of SB is advanced into the SB.
1,"This was a parallel, individual participant 1:1 randomized, superiority, multicenter, double-blind placebo controlled trial."
0,A similar multivariable regression approach was used to explore the effect of various parameters on serum copeptin (separately for children with FS and those with fever without seizures).
2,"The timing of primary outcome ascertainment, the analysis plan for the primary outcome, the secondary outcomes, and the sample size justification were apparently changed after the study was completed although it is unclear if changes to the analysis plan were made prior to initiating analysis."
0,The effect of the intervention on cholesterol and triglyceride concentrations was examined in the full sample in Malawi and in the subsample in Ghana.
2,These changes are discussed in detail below and some are listed in Table A and Table B in S1 File.
0,They were consecutively recruited in a tobacco smoking cessation program in two academic centres in France (Montpellier and Clermont-Ferrand university hospitals).
9,No interim analyses or stopping rules were described.
0,A full covariate model was constructed and backward elimination was performed to identify a parsimonious covariate model [20].
14,The trial was described as “double-blind” and this presumably means that patient and clinicians were blinded to group assignment.
0,"AS in bicarbonate (Guilin pharma) was given to all study participants intravenously at a dose of 2.4 mg/kg bodyweight at 0 hours, and after 12 hours."
15,"According to the clinical study report, “the placebo tablets were of identical in size, shape, taste, and color” as the doxylamine-pyridoxine tablets and only the lot number differed."
0,"Nucleic acid extraction was done by Nuclisens EasyMag (bioMérieux, Marcy-l’Étoile, France) and DNA/RNA was stored at − 70 °C."
6,We present the secondary outcome analyses from the clinical study report.
0,"These reference populations included HapMap reference panels (YRI, ASW, HCB, JPT and MXC populations), and indigenous populations from the Americas (Nahua, Quechua, Aymara, Zapoteca, Tepehuano, and Maya) (16)."
6,"According to the clinical study report, only available data were used for some secondary outcomes but for the following secondary outcomes missing data were imputed using the “period mean”: time loss from household tasks, time loss from employment, number of visits and number of phone calls to health care providers."
0,"A flick test is positive if in their response to being asked ""What do you actually do with your hand(s) when your symptoms are at their worst?"" a patients gestures by flicking the wrist(s) [66-74]."
3,"A convenience sample of families was recruited through advertisements at local community centers (e.g., Early Years Centres, Boys and Girls Clubs, Public Libraries) from May to July 2015."
0,The threshold for transfusion of packed erythrocytes was hematocrit <20% during CPB or <25% after CPB.
3,"Children were eligible to participate if they were between the ages of 3 years, 0 months, to 4 years, 11 months at baseline, and must not have been diagnosed with any developmental delay or health condition that would prohibit safe participation in the program."
0,Each participant was given a stamped vaccination card to fill out the date and provide the signature of their physician following each completed hepatitis B vaccination.
8,Calculation of sample size for this study has been previously detailed [10].
0,"An end-diastolic, four-chamber view of the left ventricle at end-expiration provided the reference image on which a series of contiguous short axis slices was positioned to cover the entire left ventricle."
3,Participants will comprise men and women aged 18 years and over with diagnosis of ZIKV infection.
0,Each pre-filled applicator contained a dose of approximately 4 mL of TFV gel or the HEC placebo.
3,They will include symptomatic cases diagnosed at the study collaborating clinics (index cases) and their asymptomatic or symptomatic household/sexual contacts.
0,"Over the course of the 12 workshops, a variety of topics are explored."
3,Inclusion criteria were age 7 to 12 years and BMI ≥85th United States CDC BMI percentile [22] for age and sex.
0,"Normotensive, normoalbuminuric participants with T1D were recruited."
3,"Exclusion criteria included chronic illness (e.g., diabetes), impairments that would affect ability or safety to follow the study protocols, treatment with medications known to affect body weight, and enrollment in another weight management program within 2 years."
0,"Provider-level variables will include provider recruitment to participate, fidelity to TF-CBT procedures, use of the resources within the e-workbook, and adherence to the session audiotaping protocol."
3,"The inclusion criteria were as follows: chronic HF diagnosed according to the European Society of Cardiology (ESC) guidelines24 ≤12 weeks before enrollment; moderate to severe left ventricular systolic dysfunction (LVEF ≤45% by an imaging method such as echocardiography, radionuclide angiography, left ventriculography, or cardiac magnetic resonance imaging) documented <12 weeks before enrollment; NYHA class III or IV at the time of inclusion, or NYHA class II with ≥1 hospitalization for HF in the past 12 months; patient able to fully understand study information and give written informed consent."
0,Another possibility is to consider median as a measure of location and inter-quartile range as a measure of variance.
3,"Patients were excluded if they had any of the following: current use of positive airway pressure therapy; life expectancy <1 year for diseases unrelated to chronic HF‐REF; cardiac surgery, percutaneous coronary intervention, myocardial infarction, or unstable angina within 6 months before randomization; cardiac resynchronization therapy implantation scheduled or performed within 6 months before randomization; transient ischemic attack or stroke within 3 months before enrollment; primary hemodynamically significant uncorrected valvular heart disease (obstructive or regurgitant) or any valvular disease expected to require surgery; acute myocarditis/pericarditis within 6 months before enrollment."
0,All 67 articles were read to search for information related to the safety assessment.
6,"The primary outcome was excess mortality at 6 months, 1 year, and 5 years following hospitalization with AMI."
0,Patient’s clinical featuresare recorded by participants on web-based CRF (case report forms).
14,"The study will be blind for the trial participants, investigators of the project and data managers, but will not be blind to the physicians."
0,"The unsupervised aerobic training programme included aerobic training four times per week, with 50 minutes of exercise each time."
1,"GARFIELD-AF is an ongoing, prospective, non-interventional, international registry of adults (≥18 years) diagnosed with AF."
0,"The study was performed in accordance with the Declaration of Helsinki, and all study procedures were approved by the Brigham and Women’s Hospital Institutional Review Board."
1,Patients were recruited into five independent cohorts; the first cohort also included a validation cohort of retrospective patients.
0,The PPS is defined as the group of patients in the FAS who also completed treatment without serious breach (such as contraband drug use) and good drug compliance.
1,"We conducted a prospective, unblinded, parallel group, block randomized phase II pilot trial in six ICUs in Australia and New Zealand."
0,Capsule counts were also undertaken at all visits to monitor treatment compliance.
6,The primary outcome was mean energy delivered from both EN and/or PN therapy through the first 7 days of the study (the intervention period).
0,"An expert panel, consisting of two cardiologists and one GP with special expertise in heart failure, determined presence or absence of heart failure based on all available diagnostic test results, including echocardiography."
6,"Secondary outcomes included: (1) total protein delivered in the first 7 days of the study period; (2) total energy and protein delivered in the ICU stay (up to 28 days); (3) number of new antibiotics commenced while in ICU to day 28; (4) SOFA scores; (5) duration of MV to day 28; (6) duration of ICU and hospital stay; (7) mortality to 180 days post randomization; (8) assessment of physical function using the ICU mobility scale (or 6-minute walk test where possible) at hospital discharge (D/C), hand grip strength (HGS) at ICU and hospital D/C and (9) quality of life with the EuroQuol-5 Dimension 3 Level (EQ-5D-3L) at hospital D/C, 90 and 180 days post randomization [23, 24]."
0,"Inclusion occurred between March and June, 2010."
16,"Frequencies were used to calculate the percent of sessions in each broad intensiveness category (i.e., low, medium, high)."
0,"Assay systems and LLOQ were as follows: rHuIL-12 - Quantikine® HS Human IL-12 High Sensitivity ELISA Kit, (R&D Systems; Minneapolis, MN; Cat."
16,"To examine the variance in content and technique intensity attributable to clinician and supervisor levels, ICCs were calculated using unconditional three-level random effects mixed models (session nested within clinician nested within supervisor, with random intercepts for clinician and supervisor)."
0,The secondary outcome was the changed DBP.
6,"The pooled analysis of the effect of DPPIVi use was carried out for the following endpoints: change from baseline to month 6 in mean HbA1c (% [NGSP units]), percentage of participants achieving HbA1c <7.0%; daily basal insulin dose (U/kg) and body weight (kg); percentage of participants with ≥1 hypoglycaemic event, hypoglycaemic event rates per participant-year and cumulative mean number of hypoglycaemic events per participant (during the night [00:00–05:59 h] or at any time of day [24 h]); and adverse events during the 6-month study period."
0,"Based on Nepal hospital data (Hodgins et al [26]) the sample size was estimated to be 80 in each intervention group for the hospital setting, with an alpha of 0.05 and power of 80 %, to detect a reduction in bacterial colonization from 29 to 11 % in the chlorhexidine group."
6,"Confirmed or severe hypoglycaemia combined three American Diabetes Association definitions of hypoglycaemia [14]: documented symptomatic hypoglycaemia (typical symptoms of hypoglycaemia accompanied by a measured plasma glucose concentration of ≤3.9 mmol/L [≤70 mg/dL] or <3.0 mmol/L [<54 mg/dL]), asymptomatic hypoglycaemia (no symptoms of hypoglycaemia, but confirmed by a measured plasma glucose concentration of ≤3.9 mmol/L [≤70 mg/dL] or <3.0 mmol/L [<54 mg/dL]), and severe hypoglycaemia (an event requiring the assistance of another person to actively administer carbohydrate, glucagon or other resuscitative actions)."
0,"Limit of detection levels for the cytokine and chemokine markers were IFN‐α=0.8, IFN‐β=2.3, IL‐1β=0.4, IL‐6=0.4, IL‐13=0.4, MCP‐1=19.5, and MIP‐1α=6.2 pg/mL."
4,"The data were collected from the pilot study’s clinical database,22 examination of patient clinical records and IUCPQ-UL financial databases, as well as discussions with healthcare staff to provide us with information about some resources used to deliver various clinical activities to hospitalised patients with COPD (see the details in online supplementary appendix 1)."
0,"The exclusion criteria included severe malaria, as defined by the World Health Organization (WHO) (42), or significant other illnesses (such as HIV and tuberculosis [TB]), hemoglobin (Hb) level of <7.0 g/dl, concurrent use of medications with potential interactions with the study drugs, and antimalarial drug treatment within 2 weeks prior to study enrollment."
3,"Patients must:have an upper GI metastatic cancer, including pancreatic cancer, biliary tract cancer or gastric cancer (including junctional Siewert 2 and 3 cancers) (an amendment is being submitted to our ethic committee in order to include other oesophageal cancers, too),be 18 years of age or older,have an ECOG performance status ≤2,be planned for treatment with first-line Ct,have a life expectancy of more than 4 weeks,have a good understanding of the French language,have health insurance coverage,sign and date a written informed consent form."
0,"For example, one catchment area was identified to be across a river bank that necessitated crossing by means of a ferry."
3,"Patients with any of the following conditions or characteristics are excluded from the study:locally advanced cancer,junctional Siewert one oesophago-gastric cancer (An amendment is being submitted to our ethic committee in order to include these cancers together with other oesophageal cancers),gastric or junctional oesophago-gastric cancer with dysphagia,gastric or junctional oesophago-gastric cancer with unknown or positive HER2 status,compression of the biliary tract without any bypass procedure."
0,"Following centrifugation, pellets were gently rinsed with 1 ml of the extraction buffer and centrifuged at 100,000 g for 20 minutes at RT."
12,"Adequate concealment of allocation sequence will be assured because the online system, independently, will safeguard the generation of sequence to randomisation."
0,A contrast-enhanced CT or MRI of the head and neck is also obtained at each follow up.
12,"Therefore, people who are in charge of the enrolment and assignment of participants will not have influence on the generation of the sequence."
0,"The research associate will also keep a copy for the trial file, and then send the original to the patient's GP practice for inclusion with the patient's medical notes."
3,"Eligible patients were women with previously untreated, clinical stage IIB/III breast cancer that was negative for estrogen and progesterone receptors by immunohistochemistry (IHC; <10% staining) and with no HER2 overexpression/amplification by IHC (from 0 to 2+) or in situ hybridization (in cases IHC-defined as 2+)."
0,"Luminal coronary artery disease (CAD) stenosis was estimated qualitatively on an ordinal scale (No stenosis, 1–30%, 31–50%, 51–70%, 71–99%, 100%) and validated by quantitative coronary angiography analysis in vessels greater than 1 mm."
3,"Moreover, only patients with an Eastern Cooperative Oncology Group Performance Status ≤2, measurable disease, appropriate hematologic, liver, renal, cardiac functions, and able to follow the protocol were considered as eligible."
0,Fasting blood samples from participants were obtained at the end of 2 weeks in each study for the isolation of peripheral leukocyte DNA.
1,"This was a non-randomized, single group, prospective interventional study with no comparison group."
0,"The dose of fulvestrant was derived from studies in breast cancer patients, and was initiated at 2 mg/kg via monthly intramuscular injections in the first 10 patients [10]."
3,Patients aged > 18 years treated with meropenem and receiving SLED during daytime were eligible for study inclusion.
0,Eleven medical centers (of 47 in KPNC) were chosen to represent both urban and suburban locations and various clinic sizes.
4,"The following parameters were collected: age, sex, severity assessed according to the Simplified Acute Physiologic Score II and the Sequential Organ Failure Assessment score during the 24 h following intubation, reasons for ICU hospitalization, and intubation."
0,The placebo consisted of 0.9% sodium chloride solution for intravenous injection.
4,"Moreover, the number of intubations before randomization during the current hospitalization and the duration of intubation between T0 and T1 were recorded."
0,Ibrutinib-resistant TMD8 cells were generated by continuous passaging in the presence of ibrutinib for 12 weeks then dose-escalating to 10 or 20 nM until stable resistance to ibrutinib was established (TMD8BTKi-R).
1,A secondary analysis of interview data collected with individuals who had been newly diagnosed with T2DM and were participants in the Early ACTID (Early ACTivity In Diabetes) trial.
0,", with a maximum of 2 sentences."
6,"The primary objectives of this study were to assess the pharmacokinetics of a single oral dose of [14C]-volixibat and to determine the resulting total radioactivity in whole blood, plasma, urine, and feces."
0,The data were then transferred to a SPSS file.
6,"The secondary objectives were to characterize and identify, if present, the metabolites of [14C]-volixibat in plasma, urine, and feces, and assess the safety and tolerability of [14C]-volixibat."
0,"The quantity of infused contrast agent was determined by the radiologists depending on the type of CT imaging, and patients related characteristics and was recorded in a dedicated chart."
16,"Observations by the implementation team and proceedings of meetings with the village health teams, clinicians and community leaders were summarized as statements."
0,"After a minimum 8 h of fasting overnight, all participants without known diabetes underwent a standard oral glucose tolerance test (OGTT) (75 g anhydrous glucose in 250 ml water) at each examination."
16,The frequency and mean duration (in months) from submission to receipt of protocol-related items were calculated using MS Excel 2013.
0,"The Harvey-Bradshaw Index (HBI) was assessed in patients with CD and consisted of the following clinical variables; wellbeing, abdominal pain, number of loose stools, abdominal mass, and complications.27"
1,This was a quasi-experimental study which adopted a multisite nonequivalent control group pre- and post-test design (Clinical trial registry: CREC Ref.
0,Urine was collected in standing or sitting position.
17,"Subgroup analysis was undertaken based on race (Caucasian vs non-Caucasian), comorbid anxiety (none vs mild or moderate defined by Generalized Anxiety Disorder-7 score), comorbid depression (none vs mild or moderate defined by Patient Health Questionnaire-9 total score), body mass index (< 18.5 kg/m2 vs 18.5 to < 25 kg/m2 vs 25 to < 30 kg/m2 vs ≥ 30 kg/m2), history of acute headache medication overuse (yes vs no), age (18 to < 25 years vs 25 to ≤65 years vs > 65 years), use of oral preventive treatment for headache at baseline (yes vs no), previous use of preventive treatment for headache (yes vs no), and country (United States, Australia, and South Korea)."
0,"While participants were supine, a 20-gauge Teflon catheter (Arrow Inc., Limerick, PA) was inserted into the brachial artery of the nondominant arm (left in most cases) for drug infusion."
8,"In a previously published trial with two NSAIDs and paracetamol, adverse drug effects were seen in 1.4% in the least affected group and 4.4% in the worst affected group [26]."
0,"The second factor (healthy food intake score) consisted of servings of milk, yogurt, and fruits and vegetables.(34, 35) A higher score indicates more consumption of these healthy foods."
8,"Using a two sided alpha of 0.05 and a beta of 0.2, the minimum numbers in each group to detect a difference in adverse events of that magnitude was 261 patients, which means 783 patients were required overall for the three groups."
0,"Lastly, the percentage of problematic SxQOL issues for which clinicians verbalized a treatment or referral was calculated for each patient and compared between two study group with the Wilcoxon rank test."
3,"Subjects over the age of 40 years with a multi-disciplinary diagnosis of IPF as defined by current international guidelines [16] and confirmed on high resolution computed tomography (HRCT) within 60 days of study entry, were eligible for participation."
0,"After referencing and matching of the operative situation to the preoperative plan by means of 2 fluoroscopy images, the SpineAssist workstation will direct the miniature robotic device to the correct position."
3,Exclusion criteria included: co-existing respiratory disease; adverse reaction to ß2-adrenergic receptor agonists; acute respiratory exacerbation within four weeks of study enrolment.
0,Plasma and platelets were stored at -80°C until analysis.
16,"Data analyses were performed using JMP (SAS Institute, Cary, NC), and graphs were plotted using GraphPad Prism (GraphPad Software, La Jolla, CA)."
0,"enteral feeding is reduced/withheld in case of gastric residuals (> total volume of past 2 feedings), bilious residuals, emesis, ileus or necrotising enterocolitis Bell's stage ≥ II [25]; 2."
16,Statistical comparisons for the functional studies were made using Student’s t-test or one-way ANOVA.
0,"If they failed to return the primary outcome measure, the BDI-II, they were telephoned by the practice research nurse to prompt them to return the questionnaire."
4,Recruitment referred to those who consented to participate out of those eligible.
0,The determination of sample size is based upon a comparison for the primary outcome (revision surgery) of the sliding hip screw versus multiple cancellous screw groups.
4,"A recruitment rate of between 25 and 40% would be considered reasonable based on similar research in this population [20, 21]."
0,"DF, L-MY, and LC had full access to all the data in the study and had final responsibility for the decision to submit for publication."
1,"We conducted a prospective, randomized single-centre study in the simulation centre of KK Women’s and Children’s Hospital, a tertiary paediatric hospital in the Republic of Singapore."
0,All patients provided written informed consent.
1,(ClinicalTrials.gov Identifier NCT02211378).
0,"Typical field of view was 350×262 mm2, matrix 256×192, slice thickness 7 mm, slice gap 2.8 mm, and bandwidth 465 Hz/pixel."
8,An a priori power calculation based on a two-sample t test and using pilot data from 19 subjects indicated that a sample size of n = 18 per group would provide 80% power at α = 0.05 to detect a clinically meaningful 6-point difference in mean ANTS scores between the ‘hot-seat’ and ‘observer’ groups.
0,"The eight-item scale has high internal reliability and sound test--retest reliability, correlates strongly with a wide range of theoretically related constructs, and is responsive to weight loss intervention [32]."
6,The primary objective was to compare the interval between leaving the PACU and receiving the first PCIA bolus injection on the first postoperative night between patients who received preoperative RSB and those who received postoperative RSB.
0,For comparison of drop-outs between the treatment stains a Cox proportional-hazard-ratio model will be applied.
6,"The secondary objectives were to compare the following: (1) cumulative oxycodone consumption at 48 h after surgery between patients who received preoperative versus postoperative RSB; (2) postoperative sleep status, which was measured using a BIS-Vista monitor during the first night after surgery; and (3) cytokine levels (IFN-γ, IL-1β, IL-6, and TNF-α), which were compared during the operation and at 24 and 48 h postoperatively."
0,"Advertisements were placed in newspapers and magazines, on the radio, and on television, and a website was created to promote the service."
6,"Disease assessments with computed tomography (CT), magnetic resonance imaging or PET/CT (for those evaluated by PRC) were performed at baseline and then every 8 weeks until disease progression, death or withdrawal."
0,"In addition to these measures of self-reported health status, morbidity and function, we will also consider the impact of the interventions on reducing mortality."
6,Adverse events were graded by the investigator according to the Common Terminology Criteria for Adverse Events (version 4.0) until day 28 after discontinuation of study treatment.
0,"In contrast to the lateral orientation of the patellar groove in the PFC prosthesis, the trochlea of the CKS prosthesis is deeper and has a neutral direction."
3,"The study was conducted in male or female T1DM or T2DM patients treated with insulin for more than 12 months and who were 18 years or older, ambulatory, literate, and had given informed consent to participate in the study."
0,"This study was conducted at the Hospital Universitari de Bellvitge, a 900-bed hospital in Barcelona, Spain, which serves a population of about 1,100,000 people."
3,"To minimize selection bias, eligible patients were enrolled consecutively during routine clinic visits."
0,"The different levels used for ratings were: 1 = very alert, 3 = alert, 5 = neither alert nor sleepy, 7 = sleepy (but not fighting sleep), 9 = very sleepy (fighting sleep)."
8,"Sample size of the total cohort across 9 countries of the IO HAT study was determined to be 6000 patients assuming a worst case scenario proportion of patients (50%) reporting at least 1 hypoglycemic episode during the 4-week prospective observation period, and that the range of the 95% confidence interval was < 3 percentage point for the total cohort."
0,"If a patient screening positive for TB was unable to spontaneously produce sputa, MOH-recommended sputum-induction procedures were encouraged if there were no contra-indications [23]."
8,"Of these, 2000 patients were planned to be recruited from Turkey."
0,"Every session had three phases: warm up, main phase, and cool down (10, 20, and 10 min, respectively)."
8,"This study was purely exploratory, thus no prospective sample size calculation had been done."
0,"All patients met the following entry criteria: histopathologic diagnosis of metastatic (stage IV) melanoma expressing antigens Mart-1, gp100, or tyrosinase by immunohistochemistry, HLA-A0201+, age<75, well-controlled CNS disease or absence of CNS disease, and no clinically significant cardiac, hepatic, renal, or pulmonary dysfunction."
3,"Patients diagnosed with adenocarcinoma of the colon and rectum above the peritoneal reflection with cT4 N0–2 M0 stage based on preoperative imaging, are eligible for the study when they meet the following inclusion criteria:Male and female patients between the ages of 18 and 75 years;Adenocarcinoma of the colon, sigma and colon-rectal joint which represent cT4a/b in line with The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual;Lymph node involvement: N0, the presence of N1/2 according to the 7th edition of the AJCC is allowed, provided they can be resectable;Metastatic extent: M0.Karnofsky index > 70 or Performance status ≤2.Informed consent properly completed."
0,"AL (Coartem™, Novartis, Switzerland) was administered twice a day (at enrolment and at 8, 24, 36, 48 and 60 h) according to the following dosage: weight 5-14 kg: one tablet per dose; weight 15-24 kg: two tablets per dose; weight 25-34 kg: three tablets per dose."
3,"Presence of metastasis (M1);Presence of unresectability criteria;Urgent intervention for obstruction or perforation removing the tumor;Extraperitoneal rectal cancer (avoiding alterations for neoadyuvance);Coexistence with another malignant neoplastic disease;Severely altered liver, kidney and cardiovascular function;Intolerance to treatment;Administration of chemotherapy before the trial (use of neoadyuvant is discarded);Pregnant or breastfeeding women."
0,"Estimates of portion sizes were also recorded as large, medium or small based on photo graphs of example foods."
1,"This was an assessor-blind, 2-group, cluster randomized (1:1 ratio) clinical trial, carried out in the Araucanía Region, Chile."
0,Correct placement was assessed by aspiration of gastric content or detection of injected air by epigastric auscultation [9].The time taken for correct placement was recorded (picking up the gastric tube until confirmation of placement).
1,Randomization was conducted using computer-generated random numbers.
0,"We assessed changes from baseline to each evaluation time point in VAS scores, SF36 scores, CRP level and ESR."
8,"On the basis of previous studies [35,38], a sample size of 237 depressed adolescents was needed to detect a difference between groups in terms of an expected reduction in mean Beck scores of 3.2 points across arms at 12 weeks, representing approximately one-third of SD difference."
0,OTSA-101-DTPA was radiolabeled with Indium 111 (111In-OTSA-101- Step 1 Imaging part) or Yttrium 90 (90Y-OTSA-101- Step 2 Therapeutic Part).
8,"This sample size has a power of 82%, with a one-sided alpha of .05."
0,The nine health post areas in Zone 6 remained untreated.
3,"The specific inclusion criteria were as follows: (1) age between 18 and 85 years, (2) pleural effusion occupying at least one third of the ipsilateral hemithorax in posteroanterior chest radiograph (CXR), (3) no contraindications for therapeutic thoracentesis, (4) general health condition allowing prolonged procedure of therapeutic thoracentesis."
0,"On this occasion, they have their eligibility criteria verified."
4,"Participants were recruited from community stroke services by National Institute for Health North East Stroke Local Research Network clinical trial officers, stroke health professionals, or advert."
0,"The OPTN queries centers for information on acute rejection according to periods covered by specific reporting forms (0 to 6 months, 7 to 12 months, then annual periods), but dates of acute rejection within reporting periods are not collected."
3,"Between September 2013 and December 2015, 49 men with a prostate-specific antigen ≥15, a multi-parametric MRI detectable lesion in the prostate and no prior prostate-directed biopsies or treatments were enrolled into the PROGENY study, with local ethics committee approval."
0,External laryngeal manipulation using bimanual laryngoscopy7 was performed to improve the glottic view or adjust the position of the ETT tip relative to the vocal cords.
3,"Of these, 23 patients and a further 2 contemporaneous patients from the institutional biobank met the criteria for the planned genetic and T-cell analysis (supplementary Table S1 and Figure S1, available at Annals of Oncology online)."
0,Subjects will be requested to complete this exercise 4 times daily for 10 repetitions each session.
1,"A prospective, open-label, single-arm clinical trial."
0,The cell product (5 × 107 cells/1.25 ml of normal saline/vial) and HA derivative (Tissuefill®) were delivered to the operating room from the GMP facility.
4,"Recruitment will be from locality-based, secondary-care memory clinics, and therapy delivered in the participant’s home."
0,The research assistant determined the total volume administered on completion of the intervention.
8,"Our pilot RCT sample size (n = 115) was calculated such that we would be able to estimate our protocol adherence rate within a margin of error of ± 5%, with 95% confidence, with an adherence rate of 90%; or ± 7%, with 95% confidence, with an anticipated adherence rate of 80%."
0,"Specificity, negative, and positive predictive values will be calculated according to the standard definitions."
4,Sixty-five German ICUs participated in this registry.
0,"To capture the participants’ perspective, we valued their time spent in counseling, travel time and costs, and the cost of pharmacotherapy, if applicable."
6,"The primary outcome was all-cause post-neonatal under-5 child mortality, the secondary outcome was all-cause under-5 child mortality, and intermediate outcomes included the coverage of the campaign (as measured by the proportion of mothers who reported listening to the campaign) and family behaviours targeted by the campaign as listed in table 1 (as measured by the proportion of mothers who reported a given behaviour during interviews and the number of attendances at primary health facilities)."
0,All aspects of the PANIC study were approved by the Research Ethics Committee of the Hospital District of Northern Savo.
14,In a study of this type it is impossible to mask the intervention.
0,"Fortnightly study team conference calls will be used to ensure that all queries are promptly resolved, attended by all members."
14,The analysis data will be performed by independent professionals blinded to the allocation group.
0,Data were collected using a BD Fortessa instrument running FACS DIVA software.
6,"The principal objective of the study was to assess feasibility and impact of implementing the PROBE questionnaire by the participating NGO, measured by staff and volunteer time required, cost incurred and barriers encountered."
0,We used the permuted block randomization stratified by the acupuncture-treated knee.
6,Free text comments and questions on the questionnaire were invited from participating NGOs via a separate questionnaire (Additional file 1).
0,All patients received home-based CAPD treatment after training was completed.
3,Patients undergoing either elective or emergency surgery can be screened for eligibility.
0,"During the follow-up period, clinical malaria cases were tracked and parasite densities and immunogenicity measured."
3,Participants fulfilling the following inclusion criteria are eligible for the study:Adult patients age 65 years or olderScheduled for surgery within the following fields:○ Visceral○ Orthopaedic○ Vascular○ Gynaecological○ Cardiac○ ThoracicReceive general or combined anaesthesia for their surgerySigned informed consent agreement Exclusion criteria
0,"At enrollment, a nurse conducted a clinical examination and collected data using structured questionnaires for sociodemographic variables (number of people in the household, house ownership, fuel used in cooking, type of employment, child birth day) and breastfeeding status (breastfed or not on the day of enrollment)."
6,"Superiority of one of the active comparator treatment arms in patients after surgery for prevention of hypoactive, hyperactive or mixed delirium, which is assessed by 2-point drop in MMSE score when assessed during one of the 3 postoperative days."
0,Drains were not used.
10,The allocation sequence follows computer-generated random numbers provided by the Clinical Trials Center (CTC) Zurich.
0,"If a variant was called in only one sample, flanking region assessment equals “true” was converted into a flanking region feature equals “1” and “false” to “0”."
10,"To reduce predictability of the random sequence, the lists are stored in the office of the head nurse with no access permitted by any member of the study team."
0,"We have not found a published validation study about the Fitbit Tracker (Fitbit, Inc., San Francisco, CA) so far but our research group will conduct a validation study before the data analysis of this study to fulfill this limitation."
14,Trial participants and care providers including the anaesthesiologist administering the study drug are blinded.
0,"A cholesterol oxidase assay was used to assess total cholesterol, a cholesterol esterase assay was used to assess HDL cholesterol, and a glycerol kinase assay was used to assess triglycerides."
14,The study drugs are prepared as follows to avoid assumption by any colour difference from the placebo (see Table 2 for weight dependent dosing).
0,The primary outcome is systolic blood pressure assessed using American Heart Association (AHA) guidelines [30].
9,No interim analyses are planned for this study.
0,"Forty-eight subjects were randomly allocated to receive treatment (a-tDCS/saline, s-tDCS/saline, a-tDCS/remifentanil, and s-tDCS/remifentanil)."
8,The sample size calculation determined that 14 subjects per treatment arm would provide 90% power to detect a minimum difference of 1% (SD 0.8) change in HbA1c level between the treatment and the control group.
0,"Immediately after informed consent was obtained, venous blood was obtained in EDTA plastic tubes, centrifuged, and stored at −80°C."
8,"To compensate for possible drop out during the study period, a sample of 17 subjects per arm (34 in total) was recruited."
0,"The primary endpoint of the phase IIa study was to establish the accuracy of HIFU in relation to a metallic O-twist-marker (BIP GmbH, Türkenfeld, Germany) with a diameter of 5 mm implanted in the liver parenchyma to mimic a major anatomical structure."
6,"The primary outcome measure was the percentage change in MCQ score (ie, “knowledge gain”) after the M-TEL."
0,"Patients were randomly assigned in a 1:1 ratio by a centralised randomization service (Heartlands Hospital Pharmacy, England, UK)."
6,"Other outcomes were the percentage changes in MST (ie, “competence gain”) and GSS."
0,We had previously done structured interviews to identify areas of the standard information booklet susceptible to being misunderstood and used this information to design the gist leaflet.
1,"ReTrain was a two-group, assessor-blinded, randomised controlled external pilot trial with parallel mixed methods process and economic evaluations."
0,"Information regarding age, sex, education level, body mass index (BMI), and waist-hip ratio (WHR) was collected at study entry."
1,Eligible participants were individually randomised 1:1 to intervention (ReTrain) or control (exercise advice booklet23).
0,Total body mass-corrected SUVs were calculated for each ROI by normalizing for injected activity and body weight as follows: SUV = tissue concentration (Bq/ml) X weight (g) / Dose (Bq).
8,"We required 48 participants (24 per group) as (1) 30 complete data sets are recommended for pilot studies to estimate outcome variance39 and (2) we wanted to investigate variations in context by running the intervention three times (ie, 3×8 patients)."
0,A repeated-measures ANOVA was applied to identify main effects of protein quantity and protein distribution for all outcomes.
8,This number also allowed estimation of a predicted attrition rate of 20% with a precision of ±5% with 95% certainty.
0,The BCS was calculated using the first 9 of the 10 items in our analyses with the last item assessing pain excluded as recommended by the scoring guidelines for FACT-B v4.0.
5,We employed college graduates with mental health research experience as care managers and assigned each exclusively to one intervention arm.
0,"Research assessors judged whether participants met the London criteria for ME at 52 weeks (Tyrrell, 1994)."
5,"We first prepared them in a basic understanding of mood and anxiety disorders, our pharmacotherapy algorithm,23 CCBT program, and tracking registry and later reinforced this training in our weekly case review sessions."
0,"Briefly, healthy subjects between 18 and 35 years old, weighing between 50 and 85 kg and without a family history of cardiovascular disease or unexplained sudden cardiac death were eligible for participation in the study."
6,Discrepancies between original and central pathology review were assessed as discrepancies with and without change of eligibility for the PORTEC-3 trial.
0,Pre- and post-bronchodilator spirometry was performed according to American Thoracic Society guidelines [30] and normal values were obtained from Hankinson et al. [31].
6,Reasons for non-eligibility were checked by two expert gynaeco-pathologists (TB and NS).
0,Grant funding was used to reimburse the wholesalers.
3,Patients were randomly assigned (1 : 1) by telephone to the Warwick Clinical Trials Unit.
0,"The third survey was an exit survey administered at the end of the study, 2 weeks after the last biweekly survey."
3,"Using a central computerized minimization procedure, stratification was by age (≤50 : >50), ER status [strongly positive (Allred score 6–8): weakly positive (Allred score 3–5): negative (Allred score ≤2)], total tumor size (≤5 cm : >5 cm), clinical involvement of axillary lymph nodes (yes : no) and disease type (inflammatory and/or locally advanced: neither)."
0,The patients were randomly allocated to two groups - Group G where G-LMA was used and Group P where P-LMA was used; each group had 40 patients.
1,Integrated allelic influences of the position and type of PKD1 mutations on renal survival were examined in 410 patients with documented PKD1 or PKD2 mutations.
0,The flexor torque reaches its peak around initial swing.
16,Rilpivirine pharmacokinetic parameters (total and unbound) were summarized per exposure period [second and third trimesters (tests) and postpartum (reference)] and compared between pregnancy and postpartum using linear mixed effects modeling.
0,"They will be given written and verbal information on principles of aerobic conditioning such as pacing, gradually progressing intensity and time of exercise, doing 'little and often' and incorporating exercise into daily life."
16,Efficacy and safety data were summarized using descriptive statistics; no comparisons across exposure periods were performed.
0,"Briefly, plasma lipids were extracted according to a modified Folch method [45]."
3,"The patients included in this trial were ≥18 years of age and had indications for CRT-D implantation according to the 2008 European Society of Cardiology (ESC) guidelines,24 i.e. patients with a documented LVEF (assessed by the implanting centre) ≤35% in the last 3 months, a New York Heart Association (NYHA) class III or ambulatory class IV stable for the last month prior enrolment receiving optimal medical therapy for at least 1 month, a QRS ≥120 ms with a stable sinus rhythm."
0,Only patients with at least three chronic conditions out of a list of 42 diagnosis groups28 were included in the study.
3,The inclusion criteria were modified after the release of the ESC updated Guidelines 201025 with extension of the inclusion to NYHA class II patients with a QRS ≥150 ms.
0,"It’s good that she’s in good hands here for two days; she can play and romp as she wants and is also dog-tired, evenings just has a sandwich and quickly goes to bed."
6,"The primary endpoints of this study included DGF in 1 week post transplantation, biopsy proven acute rejection (BPAR) in 1 year."
0,"Ltd., France) were adopted for culture."
6,"The secondary endpoints were severe opportunistic infections related with opportunistic infection as well as pulmonary and urinary tract infection, and other donor specific immune response in 1 year postoperatively."
0,"Rotateq is a trademark of Merck and Co., Inc."
17,"In order to estimate cost-efficacy of ECLS based on indication patients will be categorized into six different subgroups: respiratory – bridge to recovery, respiratory – bridge to transplant, cardiac – bridge to recovery, cardiac – bridge to transplant, cardiac – post-cardiotomy, and extracorporeal cardiopulmonary resuscitation."
0,We have no information about the reasons for those schools that were lost to follow-up.
6,Changes in total body fat mass (TBF) from baseline to 16 week follow-up Secondary study outcome
0,Randomization was conducted by a member of a clinical trials unit with no other involvement in the study.
6,Changes in trunk fat mass (TF) from baseline to 16 week follow-upChanges in waist circumference from baseline to 16 week follow-upChanges in total cholesterol/HDL-Cholesterol ratio from baseline to 16 week follow-upChanges in triglycerides (TAG) from baseline to 16 week follow-up Experimental study outcome
0,"Then, after a washout period of 10 days, clarithromycin (Klaricid Film Coated Tab., Abbott Korea) 500 mg and amoxicillin (Amoxicillin Cap."
7,No changes in trial outcomes were made after trial commencement.
0,Each study consisted of a tracer equilibration period (0–120 min) and a 90-min experimental period (120–210 min).
14,The blinding strategy refer to the assessments of the study outcomes.
0,Two patients had been withdrawn after four weeks.
14,"Research assistants/outcome assessors did not know the group allocation of the participants (WB-EMS&P, WPS or CG) and were requested not to ask either."
0,The STEP-UP trial inclusion and exclusion criteria are outlined in Tables 2 and 3.
5,Men completed all measures at their initial visit prior to randomization to the weight loss arm or a wait-listed control arm.
0,Additional fleeces could be put on the site at any time during the measurement phase if blood seeped through the fleece.
5,The weight loss arm received guidance from a registered dietitian on a nutritionally adequate energy-restricted diet and daily aerobic exercise was prescribed and supervised by an exercise physiologist with the goal promoting 0.91 kg per week over the duration of the study [20].
0,"To avoid measurement bias related to well positions, sample positions were randomized for each biomarker assay."
16,Please see Supplementary Methods.
0,"The diagnosis of APA was established in hypertensive patients with elevated ARR, TAIPAI score more than 60% and evidence for lateralized disease by adrenal CT (n = 41), NP59 scintigraphy (n = 13) or AVS (n = 22) (Text S1 and Figure S1)."
6,"The primary outcome measure for the study was the physicians’ selection of imaging tests after receiving CCHR information, malpractice case review information, and patient out-of-pocket expense information."
0,"Participants self-reported comorbidities including heart disease, hypertension, diabetes, osteoarthritis, and others."
6,We also measure the physicians’ selection of imaging tests immediately following clinical vignette #1 and after presentation of clinical vignette #2.
0,"Since all injections were administered in our hospital by one of the researchers, patients were frequently seen during treatment."
4,Emergency department and trauma center in an urban 689-bed university hospital.
0,"The CDT and FAB-D [34, 35] were used to assess executive function."
3,Adult patients requiring phlebotomy for blood culture due to clinical suspicion of serious infection.
0,Time costs were calculated by combining the reported duration of an event with the prevailing average wage.18
3,Healthy men and nonpregnant women (aged 18–45 years) with a body mass index of 18 to 32 kg·m−2 were enrolled.
0,The study drug was handed out along with instructions regarding the blood samples after informed consent was obtained.
6,The primary outcome was the proportion of patients achieving an oocyte yield (percentage of mature oocytes collected from the number of follicles ≥14 mm in diameter on ultrasound scan performed on the morning of first kisspeptin-54 trigger administration) of at least 60%.
0,They were presented with a word and asked to identify the closest synonym from six given alternatives.
6,"Secondary outcomes were reproductive hormone levels, implantation rate (proportion of embryos transferred that implant at 6 weeks gestation) and occurrence of OHSS."
0,"Irradiation took place three or four times a week (every other day), sometimes starting with daily irradiations."
3,Patient eligibility criteria have been described in detail previously [6].
0,Participants with SAEs were followed-up until events resolved.
3,"Briefly, patients diagnosed with RA for ⩾6 months and ⩽15 years prior to screening, with a swollen joint count (SJC) ⩾6 and a tender joint count (TJC) ⩾6 and either ESR ⩾28 mm/h or serum CRP ⩾1.0 mg/dl and patients who took MTX for ⩾6 months (stable dose of 10–25 mg/week for ⩾4 weeks prior to screening) were eligible for the study."
0,"If symptoms were zero or 1 point per day or did not last for 5 days or more, no RTI episode was recorded."
8,"Based on data from a previous study of patients with low back pain or osteoarthritis pain,22) the sample size needed to achieve a significance level of 0.05 for the primary end-point was 189 patients."
0,"Patients with long-term use of sedative, anti-spasmodic, prokinetic, laxative or anti-diarrheal medications were also excluded."
8,"Assuming a 20% dropout rate, the aim was to enroll 237 patients into the study."
0,Samples were assayed in duplicate.
3,Adults aged ≥50 years were eligible to participate in the study.
0,"Eligible patients were randomly assigned in a 1:1 ratio to receive either vorapaxar sulfate 2.5 mg (vorapaxar 2.08 mg) daily or placebo, stratified according to the qualifying atherosclerosis (previous MI or PAD), and the responsible physician's intent to administer a thienopyridine."
3,"They were excluded if they had taken (or planned to take) any investigational or nonregistered drug or vaccine, or any nonstudy vaccine, from 30 days before study inclusion through 30 days after the second dose of HZ/su, had received influenza vaccine or had received long-term treatment with immunosuppressant drugs or immune-modifying drugs within 6 months before study inclusion, had received a previous VZV or HZ vaccination, or had a history of HZ."
0,"The alternatives to continuous infusion of midazolam or propofol in the intervention group were other benzodiazepines, antipsychotic agents, zolpidem, and hydroxyzine."
1,"The study is a phase II single center, one-arm open-label clinical trial for patients with metastatic CRC."
0,"Further test personnel were a physiotherapist and qualified master students, whom all had gone through thorough instructions prior to testing in addition to on-set follow-up during testing."
8,"The study sample was all home care clients, meeting inclusion criteria and giving voluntary informed consent, in the Lohja Home Care Unit due to the practical, administrative and financial issues."
0,"The rapid blood glucose was measured at 3:00, 6:00, 9:30, 11:00, 14:00, 16:30, 19:00 and 21:00."
8,Sample size calculations were not performed.
0,"Safety was assessed through the incidence, occurrence and severity of adverse events (AEs) during treatment, at follow-up 4 weeks after the last administration of pegfilgrastim (PROTECT-2 study) and at 6 months (PROTECT-1 study)."
2,Important protocol amendment would require new ethical approval.
0,"Euclidean distance was calculated between samples, and the complete method was used for hierarchical clustering via R software, version 2.15.1 (36)."
2,Any important amendments have not been made during the study.
0,"Data reported here were collected during the baseline visit for HCSF2, prior to starting the 2-year intervention."
3,"Key inclusion criteria were refractory solid tumors (in dose escalation phase) and RR-SCLC (in dose expansion phase), not more than three prior lines of cytotoxic therapies, age ≥18 years, ECOG performance status 0–1, adequate organ/marrow function, and life expectancy >3 months; key exclusion criteria included LVEF <50%, lifetime cumulative doxorubicin dose >150 mg/m2, untreated, symptomatic brain metastases, known serious cardiac illness including, but not limited to clinically significant atrial and ventricular arrhythmias and heart block, QTc >470 ms, strong inhibitors, or inducers of CYP 3A4 or 2C19 and known allergic or hypersensitivty reactions to taxanes."
0,"The anesthesiologists were responsible for several simultaneously ongoing surgical procedures, and were seldom present in the operating room for the review of the WHO checklist."
3,We enrolled pregnant women in their first or second trimester of pregnancy who intended to stay in their villages for 24 months post enrolment; their in utero children were considered to be the index children.
0,"Finally, Sessions 11 and 12 explored images of what future life might be like if participants were to consistently follow healthy eating and active living practices, and what specific next steps they could take to move toward that outcome."
3,"After obtaining verbal and written informed consent, trained research assistants enrolled pregnant women in the study."
0,"The oscillatory components were classified as follows: very-low frequency (VLF: 0.001 to 0.04 Hz), low frequency (LF: 0.04 to 0.15"
8,The literature suggests that a sample size of 20 is sufficient for detecting usability issues as measured with the SUS [40].
0,Unacceptable toxicity is defined as unpredictable or irreversible grade 4 toxicity.
8,"To determine usability of the adapted Wii Fit Balance Board, we asked a random subset of participants (n=25) from our larger study [41] to complete the SUS."
0,"With the first mailing, physicians in the intervention group receive (1) an accompanying letter from the investigators providing basic information on the study and explaining the rationale of the intervention, which is described as quality improvement program, but no details about the conduct and design of the trial are provided; (2) a letter from SASIS AG (the organization providing the routinely collected data, see below) that clarifies privacy and data protection issues and justifies the rationale for the use the anonymized administrative data for scientific purposes; (3) evidence-based guidelines for optimized antibiotic use in primary care; (4) a response postcard allowing the physicians to opt-out from the intervention; (5) an individual access code to a dedicated study website with detailed prescription feedback and explanation of frequently asked questions on antibiotic use."
6,"The primary outcome was all-cause in-hospital mortality, defined as mortality at hospital discharge, or at 90 days after start of invasive mechanical ventilatory support while still in hospital, whichever occurred first."
0,"Amplification comprised of 15 min at 95°C, followed by 50 cycles of 15 sec at 95°C, 30 sec at 60°C and 30 sec at 72°C."
6,"The secondary outcome was ICU mortality, defined as mortality at ICU discharge or at 90 days after start of mechanical ventilatory support while still in ICU, whichever occurred first."
0,Electrical stimulation that was above the motor threshold induced muscle twitching; this uncontrolled muscle twitching would produce conflicting afferent inputs during the performance of TOT.
3,"The study inclusion criteria were as follows: child less than 2 weeks of age, parent or guardian or at least one person in the household has a valid mobile phone connection, ability to use and read SMS text messages, and parent or guardian providing consent."
0,"The goal of the exercise intervention was 30 minutes of daily physical activity, if the woman previously exercised < 2.5 hours per week, and 45 minutes activity [22], if the woman already engaged in 2.5 hours or more per week of physical activity."
3,Study exclusion criteria were a child from outside HDSS area or family plans to stay in the catchment area for less than 6 months.
0,We did the ex-vivo interferon-γ ELISpot assay on fresh peripheral blood mononuclear cells separated from whole blood as previously described.11
8,"Target enrollment was 300 infants per site, 150 in each arm [21]."
0,"After screening into the study, agreeing to the online informed consent, and submitting the baseline assessment, participants were blocked on race/ethnicity and randomized within block into either (1) treatment intervention group (n=150), which used the MoodHacker intervention for 6 weeks, or (2) alternative care group (n=150), which received links to six websites with information about depression."
8,"Assumptions used for calculating sample size increased in coverage rate from 60% to 80%power at 0.8, an alpha error at .05, and allowing for 10% dropout."
0,"All procedures were carried out using a minimally invasive technique for the Oxford III UKA (Biomet China, Bridgend, United Kingdom) [25]."
3,"Major eligibility criteria were age ≥18 years, T1D for ≥1 year being treated with an insulin pump for at least 3 months (and not currently using a low-glucose-suspend function), and point of care HbA1c ≤9.0% (≤75 mmol/mol)."
0,"Providers were informed of patient participation, and their consent was obtained."
3,"Exclusion criteria included the occurrence of a severe hypoglycemic event resulting in seizure or loss of consciousness in the past 3 years or an event without seizure or loss of consciousness requiring the assistance of another individual in the past 12 months, significant hypoglycemia unawareness based on the Clarke Hypoglycemia Unawareness Survey (19), >10.0% of baseline CGM glucose concentrations <60 mg/dL, more than one episode of diabetic ketoacidosis (DKA) in the past year, history of seizures other than those due to hypoglycemia, current use of a threshold-suspend pump feature, myocardial infarction or stroke in the past 6 months, estimated glomerular filtration rate <30 mL/min/1.73 m2, abnormal thyroid function, use of a systemic β-blocker, regular use of oral corticosteroids, initiation of a noninsulin drug for glucose control during the past 3 months, pregnancy, inpatient psychiatric treatment in the past 6 months, and presence of a contraindicated medical condition or medication, including ongoing use of acetaminophen."
0,A p < 0.05 indicates significance.
3,The present trial included healthy children and young adults aged ≥ 6 months to < 19 years.
0,"Based on the power calculations we need to include 300 - 380 women with full retention, to be able to answer the main study question and the sub-analyses with sufficient power (at least 70 %) to show statistically significant (5 %) associations of a relevant size."
3,"Exclusion criteria included a history of hypersensitivity to any component of the vaccines, including eggs and chicken meat; receipt of an influenza vaccine during the previous 6 months; immunosuppressive disorder including immune deficiency; history of Guillain-Barré syndrome; Down syndrome or cytogenetic disorder; moderate to severe chronic illness potentially interfering with full participation in the trial as determined by the researcher; any coagulation disorder contraindicating intramuscular injection or receipt of coagulating agent; acute febrile illness (temperature ≥ 38.0°C) within 72 hours prior to scheduled receipt of vaccine in the trial; receipt of vaccine (of any kind) within 28 days prior to screening; receipt of immunosuppressive or immunomodulating agents within 3 months prior to screening; receipt of immunoglobulin or blood derived products within 3 months prior to screening; anticipated receipt of immunoglobulin or blood derived products during the trial period; fever/pain reliever (analgesic) or non-steroidal anti-inflammatory drug within 4 hours prior to scheduled receipt of vaccine in the trial; participation in a clinical trial within 28 days prior to screening; and other significant medical or psychiatric conditions deemed inappropriate for trial entry by the researcher."
0,Table 2 Description of the treatment steps and number of patients reaching each step Three clinical psychologists managed the online therapeutic contact in this study.
3,"We included patients 18 to 65 years of age with hypertension,13 with a body mass index (BMI) ranging from 30.0 to 39.9 kg/m2, and treated with ≥2antihypertensive drugs at maximum doses or >2 drugs at moderate doses (Table I in the online-only Data Supplement).14"
0,"After confirmation of eligibility, infants were randomized in a 3:1 ratio to receive 2.5 × 105 (range, 1 × 105 to 4 × 105 CFU) of either VPM1002 (ΔureC hly+ Hyg+ strain [manufactured at Vibalogics GmbH, Germany, according to EU-GMP and WHO TRS 979, Annex 3 {64}]) (n = 36) or BCG (Danish strain BCG [Statens Serum Institut, Denmark], batch 110049A) (n = 12)."
3,"Exclusion criteria were systolic blood pressure ≥180 mm Hg or diastolic blood pressure ≥120 mm Hg; cardiovascular disease (myocardial infarction or stroke within 6 months, angina, coronary revascularization, heart failure); severe psychiatric disorders because of increased risk of low compliance with the study procedures; chronic kidney disease (diabetic nephropathy or glomerular filtration rate <30 mL/min); secondary hypertension, except because of sleep apnea; peripheral arterial disease; atrophic gastritis; type 1diabetes mellitus, latent autoimmune diabetes of adults, or type 2 diabetes mellitus with glycohemoglobin >7.0%; alcoholism or use of illicit drugs; current smoking; previous abdominal surgery; severe hepatic diseases; pregnancy or women of childbearing age not using effective contraceptive methods; cancer in the past 5 years; use of immunosuppressive drugs, chemotherapy, or radiotherapy; or inability to understand or adhere to study procedures (detailed criteria for eligibility are provided in Box I in the online-only Data Supplement)."
0,"Then, a primed (4 mU · kg−1 · min−1 for 8 min), continuous (2.4 mU · kg−1 · min−1) insulin infusion was maintained for 2 h."
3,"Those who completed the week 54 visit of the randomised, double-blind period and were willing to participate were eligible for the transition period."
0,Each participant gave informed consent to the study and was individually informed by a researcher.
3,"Patients who experienced any significant medical condition(s) during the randomised, double-blind period, such as the occurrence of a serious AE (SAE) or intolerance of SB2 or INF, and who were determined to be unfit for further treatment were excluded."
0,Our intervention will focus on the pharmacologic contribution of those neurotransmitter systems through a combination of human and electronic activity.
2,"The trial protocol was amended with respect to the eligibility criteria (the maximum time between delivery and randomization was increased from 7 months to 9 months), the vildagliptin dose regimen (from 100 mg once daily to 50 mg twice daily), a change to diagnostic criteria (use of the ADA 2012 criteria [21] as an alternative primary efficacy outcome), the inclusion of IGT and/or IFG as additional efficacy outcomes, and the decision to perform an interim (futility) analysis in November 2015."
0,"CHLs receive a modest allowance (TZS 5,000, equivalent to USD 2.44) for the training days to cover costs associated with transportation to get to and from the training venue."
1,"We used a pretest-posttest design to examine the effect of the IST program on self-efficacy and burden, which were measured on three occasions: at T0 (baseline), T1 (after the training) and T2 (three months after termination of the training)."
0,"Each participant was fitted with an Applied Science Laboratories’ Mobile Eye XG gaze registration system (ASL, Bedford, MA), measuring point of gaze at 30 Hz."
1,The third measurement also included a brief evaluation of the caregivers’ perspective on the training.
0,"Participants underwent a standard 75 g oral glucose tolerance test (OGTT) with blood samples drawn at 0, 30 and 120 min."
8,"Sample size analysis indicated that we needed a total of 720 participants, eligible for randomization into one of the two study groups to have 80% power for detecting an effect size as small as 0.2 standard deviations (SD) in outcomes."
0,Army were considered for participation.
8,"All participants were followed-up for 2 years and outcomes were assessed at baseline, at and 3-, 6-, 12-, and 24-month follow-up."
0,"In addition, an unstructured interview was conducted with the kindergarten teachers."
16,We summarized the patient-centered recruitment and retention strategies in the context of the four concepts.
0,"All scores were entered into the WIAT-III computerized scoring assistant, which automatically disallows out-of-range values and computes subtest and composite scores."
16,We also compared the baseline demographic and clinical characteristics of the intervention group and usual care groups.
0,"Other exclusion criteria were co-infection with hepatitis B, immunodeficiency virus, decompensated liver disease of any cause, coronary heart disease, diabetes mellitus requiring insulin therapy, autoimmune disorders, active alcohol or drug addiction and/or any other unstable chronic medical condition."
8,"The study aims to enroll 56 patients, 28 in each group."
0,"Women allocated to the SP group received standard IPTp (three tablets of the fixed combination therapy containing 500 mg of sulfadoxine and 25 mg of pyrimethamine), whereas participants allocated to the MQ groups received 15 mg/kg of the drug."
8,"This is based on: (1) unpublished, preliminary data from the quality improvement project showing a MAC or death rate of 55% in patients undergoing DCL who may have safely undergone definitive laparotomy and 18% in patients undergoing definitive laparotomy; (2) an α of 0.05, (3) 80% power; and (4) a 10% drop out rate."
0,The patients were given a specific drink to their group on the evening prior to surgery and three hours before the operation.
6,"The main study outcomes are: (1) the proportions of CC and trial participants by age group, gender, ethnicity, educational level, type of trauma and matching postal codes; and (2) the acceptability and beliefs of CC participants toward the proposed EFIC research protocol."
0,"To assess the relationship between the exposure to AGTO (i.e., TA hours, by performance domain) and change in program performance, we aggregated across all AGTO programs and treated each AGTO domain as a case (i.e., n = 7), and calculated the relationship of TA hours spent on each domain with the amount of change exhibited in that domain’s Performance rating."
1,"We conducted a three-parallel arm, single-centre feasibility RCT of the SupportBack internet intervention for LBP in primary care."
0,The patient manual for the HHC program is provided in supplementary data.
1,The full details of the method and interventions can be found in the published trial protocol.17
0,"Serial spirometry tests were performed at day 1, as well as at weeks 1, 13, and 26, which included measuring the pre-dose FEV1 30 minutes and immediately prior to the AM dose, and then at 5, 15, 30 minutes, and 1, 2, 3, 4, 6, 8, 10, 11, and 12 hours post-dose."
1,This was a cluster randomised controlled trial (cRCT) of school children in Northern Ireland (NI) and Glasgow/Inverclyde Education Authority (Scotland) areas in the UK with schools as the unit of randomisation.
0,The probability of seeking additional care within a one-week period was obtained from the household cost interviews.
1,The trial protocol is available from http://www.nets.nihr.ac.uk/projects/phr/10300209.
0,All slides were double-checked by a second laboratory technician and only considered negative if no Plasmodium were detected in 100 x oil immersion field by the two independent microscopists.
3,The target enrollment was 173 patients who met the inclusion and exclusion criteria listed in Table 1.
0,"If the MAP was ≥ 70 mmHg, the norepinephrine dose was decreased."
3,Patients were enrolled at 14 academic medical centers.
0,"Attention-to-task will be assessed by trained research staff on the same random schedule for recording classroom physical activity, described in the process evaluation section below, using a modification of the procedures from Mahar et al [33]."
8,We aimed to recruit 120 (60 intervention and 60 control) participants in order to be able to assess feasibility objectives allowing for a loss to follow-up of 10% with precision of ±1% at 95% CI.22
0,"Hence, all investigators, care providers and participants were blinded of the study drug."
16,Continuous variables are presented as the mean ± SD and were analyzed using paired t-tests.
0,Ceftriaxone concentrations were determined in chyme supernatant and plasma samples of both studies using a fully validated (plasma) or qualified (chyme) liquid chromatography turbo ion spray-tandem mass spectrometry method (LC-MS/MS).
16,"Statistical analyses were performed using SPSS 13.0 (SPSS Inc., Chicago, IL, USA)."
0,A key inclusion criterion was an average of more than 7 to 8 moderate to severe hot flashes/day or 50 to 60 moderate to severe hot flashes/week reported for 30 days or more before screening.
1,"The study includes a three-arm, parallel, and randomized clinical trial examining the effectiveness and feasibility of digital gaming for improving cognitive functioning and general well-being in people with TBI."
0,"Mean treatment session duration was 30 minutes, mean total of treatment sessions Outcome assessment"
1,The full study design and detailed description of the study methods can be found elsewhere [48].
0,"Anthropometric measurements are body weight, height, thickness of biceps, triceps, sub scapula and supra-iliac skin fold, and circumference of mid-arm, waist and hip."
8,"To identify a clinically relevant between-group change of 0.3 logits on the ADL motor ability, we needed to recruit 272 participants with an expected attrition of 32% (N = 184 would provide 80% power)."
0,Emergency envelopes were stored in the Schering Institute for Clinical Pharmacology and were also available for the investigator.
8,Alpha was 5% and the standard deviation (SD) 0.727.12
0,"Second, we sought feedback on whether patients find it an acceptable aid."
1,"Our protocol followed the guideline of the Cochrane Handbook for Systematic Reviews of Interventions,19 and findings are reported according to the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses20 (online supplementary table S1)."
0,"Analyses of the Psoriasis Symptom Inventory included mean total and item scores over time, mean improvement in Psoriasis Symptom Inventory total score over time, and proportion of subjects with individual item scores (0–4) for each symptom."
1,"The protocol is registered at ClinicalTrials.gov (identifier, NCT02961088; Results)."
0,"The inclusion criteria were pain on one of two isometric tests (abduction or external rotation), positive Hawkins-Kennedy impingement sign [15] and normal passive glenohumeral range of motion."
6,The primary outcome for this study was the effect of NT on HbA1c after 16 weeks of intervention.
0,Metabolites measured with more than 20% missing data were dropped from subsequent statistical analysis.
6,"Secondary outcomes include the change in body weight, body composition, visceral fat, waist and hip circumference, blood pressure, lipid profile, fasting glucose, insulin, c-peptide, insulin sensitivity (HOMA-IR), urinary microalbumin/creatinine ratio, high-sensitivity C-reactive protein (hs-CRP) and dietary macronutrients values."
0,"Normalised LF and HF components of R–R variability were considered, respectively, as markers of cardiac sympathetic and parasympathetic modulation, and the ratio between them (LF/HF) was considered as an index of the autonomic modulation of the heart.20"
3,"Key inclusion criteria: male or female, ≥18 years at screening; diagnosis of adult-onset PsA ≥6 months prior to screening, classified according to the Classification Criteria for PsA (CASPAR); active psoriatic lesions or history of skin PSO; active arthritis as defined by ≥3 tender joints and ≥3 swollen joints at screening and baseline, and either erythrocyte sedimentation rate of ≥28 mm/hour or high sensitivity C reactive protein >3 mg/L; inadequate response to ≥1 non-biological disease-modifying anti-rheumatic drug (DMARD, including methotrexate) and/or one approved biological DMARD; and receiving concurrent methotrexate for ≥3 months at the time of screening."
0,"Prespecified ordered secondary end points (all at week 24) were 1) change from baseline in FSG, 2) proportion of subjects with HbA1c <7.0% (53 mmol/mol), and 3) change from baseline in 2-h postprandial glucose (PPG)."
3,Key exclusion criteria: inadequate response to >1 approved biological DMARD (no specific medication detailed); absolute neutrophil count <1.50×109/L and/or lymphocyte count <1.00×109/L.
0,"Questions were addressed to the patient initially, wherever appropriate, based on age and responsiveness, followed by the parent for an additional perspective or confirmation."
8,A total of n = 50 subjects (25 patients per treatment arm) will be included in the analyses.
0,Hospitals report mandatorily to the registries and the reported data on diagnoses and procedures translates directly to the funding of the hospitals.
6,The primary outcome measure is the change in neuropsychological performance based on the above described neuropsychological test battery after ten weeks of hormonal substitution with an estrogen-progestin-combination.
0,These last settings were maintained unmodified throughout the study.
6,"The secondary outcome measures following the 10-week intervention are: a) incidence of treatment-emergent adverse events (AEs) (safety/tolerability) mirrored by the number of AEs (including AEs, adverse reactions [ARs], serious AEs, serious ARs and suspected unexpected serious ARs [SUSARs]), b) changes in psychopathology (EDE-Q, EDI-2, STAI, PHQ-9, EDQOL) mirrored by changes in sum scores, c) changes in cortisol mirrored by changes in plasma cortisol levels during a dexamethasone suppression test as well as changes in plasma concentrations of the appetite-regulating peptides ghrelin, leptin, insulin and glucose during an OGTT and d) changes in antidepressant medication mirrored by changes in their use."
0,The laboratory then notified the RCB of the participant’s APOE status and cholesterol level via the portal.
1,"The current study is an analysis of the baseline characteristics of participants enrolled in “Exercise and Activity Guidance in Older Adults with Diabetes”, a randomized controlled trial to improve PA in sedentary older adults with type 2 diabetes."
0,Two patients used crutches with anatomic grips.
3,People with a clinician-assigned diagnosis of T1D aged ≥5 years were recruited within 6 months of diagnosis.
0,Trial participants who required the spectacles to be remade as they could not wear them were allocated their presenting uncorrected acuity.
3,Written informed consent was obtained for all participants.
0,Detailed patient-level data obtained through the cardiogenic shock database can facilitate hypothesis-driven clinical studies.
3,"Between June 2015 and May 2016, ten people with PD (mean age: 64.2 ± 6.1 years, 5F/5M) were recruited at the Pitié-Salpêtrière Hospital and included according to the following criteria: 1) diagnosis of PD, 2) age below 71 years, 3) disabling FOG and/or falls despite optimal drug treatment and subthalamic deep-brain stimulation (items 13-falls and/or item 14-FOG of the UPDRS part II ≥ 2 ON treatment) [27] (Table 1)."
0,"The intervention and control dialysates, CD and AD, are packaged identically by the manufacturer (Chief Medical Supplies, Ltd., Calgary, Alberta, Canada) for blinding of investigators, patients, and health care staff."
3,"Exclusion criteria included dementia (Mini Mental State Examination Score < 24), inability to maintain upright posture or walk independently, patients suffering from other pathologies affecting gait and balance, or severe medical conditions that prevented assessment."
0,"The score ranged between 2.5 and 67.5 with higher values corresponding to a healthier diet – a healthy diet consisting of one that is high in fruit, vegetables, white meat and fish, PUFA, fibre and nuts and seeds and low in SFA and red meat)."
3,"Inclusion criteria were a CTS-6 score of ≥12 points, female gender, aged 40–80 years, unilateral or bilateral involvement (only a more symptomatic hand was considered for inclusion), previous conservative treatment for CTS without clinical improvement."
0,"For 127I-CLR1404 mass measurements, blood was drawn pre-treatment and at 5, 15, 30, 60 minutes, 4–6, 18–24, 48, and 72 hours, 6, 14, 30 and 42 days post-infusion."
3,"Exclusion criteria were the presence of cervical radiculopathy, thoracic outlet syndrome, pronator syndrome; a history of previous surgical release of the carpal tunnel, with sequelae of fracture of the wrist; a CTS-6 score of ≤12 points; lack of compliance at any stage of the study."
0,"Safety was assessed in accordance with local regulations, and registered with the drug manufacturer’s global pharmacovigilance department."
1,"RESPITE was a 24-week, prospective, exploratory, open-label, multicentre, uncontrolled, single-arm study including patients from nine countries in Europe and North America (ClinicalTrials.gov Identifier NCT02007629) [30]."
0,Tablets were taken with 50 ml of water.
3,Adult BD patients will be eligible after stabilization of an acute mood episode for at least 4 weeks.
0,Interventionists review daily routines and help participants select a goal and specific activity to add pleasure and personal satisfaction.
3,Eligible patients will be identified in advance during their hospitalisation or from the appointment schedules of participating practitioners.
0,This was done in the same concealed manner.
3,"All children admitted in the paediatric wards of the four hospitals during the study period were screened for SAM, and those eligible and consented were enrolled after completing the stabilization phase of complicated SAM inpatient treatment (WHO, 2013)."
0,This study was approved by the Committee on Human Research of Johns Hopkins Bloomberg School of Public Health in March 2013.
3,"Children were eligible for the trial if they had a negative HIV rapid‐antibody test, were aged 2 to 59 months, and were hospitalized with complicated SAM defined as mid‐upper arm circumference (MUAC) < 11.5 cm for children 6 to 59 months old or MUAC < 11.0 cm for children 2 to 6 months or oedema at any age (Berkley et al., 2016)."
0,All patients fulfilled the ASAS imaging (sacroiliitis on imaging and ≥1 SpA feature) or clinical criteria (human leucocyte antigen-B27 positive and ≥2 other SpA features).
4,The empirical data consisted of 4 h of video (n = 10) and 4 h of audio recordings (n = 10) from 20 patients’ follow-up consultations with their nurse or GP after using the self-report system.
0,Smoking data were collected as current/previous/never.
4,"The analyses demonstrated saturation of data as no new information related to the research questions emerged from the last recording analyzed, and further coding was not feasible."
0,"The unit costs were obtained from the national working paper of the Finnish Ministry of Social Affairs and Health [25], expressed in euros, and converted to the 2004 level (the final follow-up visit was in 2004)."
6,The content of the questionnaires was almost entirely based on surveys previously used and validated for use in South Africa.
0,The arm with the sampling catheter was maintained in a heating blanket to ensure arterialization of the venous sample.
6,Our two key outcomes for this analysis were past week depressive symptomology and past month suicidal ideation.
0,A total of 52 plasma samples and six urine samples were re-analyzed to assess incurred sample reproducibility.
4,"Interventions will be done across five sites: London (lead and sponsor site), Waterloo-University of Waterloo, Waterloo-Wilfrid Laurier University, Montreal, and Vancouver."
0,"On the day before surgery or on the morning of surgery, the surgeon called the hospital pharmacy to receive the group randomization."
4,Participants will be recruited primarily from the community and from clinics serving MCI populations.
0,The starting dose of ESA was based on patient’s cumulated dose in the month before randomization according to approved labeling [10].
3,"Children aged 2–59 months who presented to the HEWs in the study area with fever (≥37.5°C) or a history of fever, a negative mRDT, no pneumonia or diarrhoea according to iCCM criteria, and no danger signs were eligible to participate in the study."
0,The population PK model EBR was developed based on pooled PK data from patients in phase 1 to phase 3 studies.
3,Written informed consent was obtained from each caregiver before enrolment in the study.
0,"Weight was assessed daily, whereas the length and head circumference were assessed weekly."
6,Primary outcome will be all-cause mortality at 28-day.
0,"To achieve the second objective the sensitivity, specificity and positive and negative predictive values of peak flow compared to spirometry will be determined."
6,"Secondary outcomes:Free days of MV, RRT and vasopressor support during the first 28 days after randomization;Multiple organ dysfunction during the first 72 h after randomization [26];Intensive care unit (ICU) and hospital lengths of stay;All-cause mortality at 90-day."
0,We treated all data as protected health information and stored it securely in an encrypted and password-protected database at the coordinating centre.
1,"ANDROMEDA-SHOCK is a prospective, multicenter, parallel-group, randomized trial aimed to compare an 8-h protocol of PPTR vs."
0,The primary hypotheses were that etoricoxib 90 mg once daily is not inferior to naproxen 1000 mg according to the primary endpoint and that etoricoxib 60 mg once daily is not inferior to naproxen 1000 mg according to the primary endpoint.
1,LTR in patients with septic shock [27].
0,Figure 1 Architecture of the MTH system evaluated.
5,Palbociclib or placebo was administered orally 125 mg daily for 21 days of every 28-day cycle followed by 7 days off.
0,"Four coders, who independently reviewed the interview transcripts, assessed evidence of each code or theme."
5,Letrozole was administered orally 2.5 mg on a continuous daily dosing schedule.
0,By looking at 'hope' and 'wellbeing' in a way linked to 'capacity' we connect it to aspects of the environment in which the individual operates and thus make this measure responsive to changes likely to be brought about by the Well London interventions.
4,"Participants were recruited from an American Diabetes Association certified diabetes education program located in a community health center primarily serving uninsured or underinsured individuals living in Harris County, Texas."
0,"All other referral services were costed at Chawama Clinic, a representative public health facility."
4,Flyers were distributed to the patients attending diabetes self-management education classes by their diabetes educators.
0,"Exclusion criteria included type 2 diabetes (fasting blood glucose ≥ 7 mmol/l), manifest cardiovascular disease, use of statins, steroids or non-steroidal anti-inflammatory drugs at baseline, heart failure (New York Heart Association class I or higher), QTc time interval of 450 ms or longer on baseline electrocardiogram (ECG), primary dyslipidemias, presence of potential hepatic disease (i.e. subjects with alanine aminotransferase, total bilirubin, or alkaline phosphatase levels exceeding 2.5 times the upper limit of the normal laboratory values), alcohol abuse (> 30 units/week) and CMR contraindications."
1,"At the end of 2011, the ERTTAC published for the TraumaNetwork DGU® were introduced for emergency room trauma team activation (ERTTA) at our hospital as part of a quality assurance programme [7]. The ERTTAC list (Table 1) was used in a standardized manner for all emergency trauma cases, i.e. if at least one of these criteria was fulfilled the dedicated interdisciplinary trauma team on call was activated by an appel circulaire to await the patient’s arrival in the emergency room."
0,"Very degenerated worms, still APR-positive, were classified as moribund and grouped in the category “dead”."
1,"In contrast, trauma patients which did not meet the ERTAAC were primarily treated by single emergency nurses and specialists in the emergency department."
0,"Second, we conducted a more global assessment of bias through the use of propensity score distributions to demonstrate the extent of differences between the populations exposed to these two drugs in terms of their propensity to be prescribed paracetamol versus ibuprofen."
6,"The primary goal was to obtain an improvement in lower limb gait and balance at the end of the training getting the MCID for the 10MWT, RMI, and TUG scales (composite primary outcome)."
0,Informed written consent was obtained from all practices: each general practice filled out an online registration form in which they agreed with the design of the study and the use of NHGDoc server data as described on the website (www.nhgdoc-evaluatie.nl) and gave consent on behalf of all practice staff (GPs and PNs).
6,"Secondary outcomes consisted of the modifications of FPEC, CSE, and SMI magnitude, overall gait quality, and hip and knee muscle activation."
0,The study was performed in accordance with the Good Clinical Practice and current International Conference on Harmonization Guidelines.
3,Patients with cirrhosis and HE will be enrolled into PROSPER.
0,Only exclusion criterion was patient inability or unwillingness to provide informed consent to participate.
3,The study will employ a limited number of inclusion and exclusion criteria in order to reflect the diversity of patients encountered in clinical practice (Table 1).
0,"Low salt diet was defined as sodium intake below 3 gr/day, moderate salt intake as sodium intake of 3–7 gr/day, and high salt diet as more than 7 gr/day of sodium intake [10]."
8,"This study was designed to provide adequate power to detect a meaningful group difference [16] in MVPA of 10 mins/day assuming a standard deviation of 18 mins/day in MVPA [17], a power of 90%, a significance of 0.05, a cluster size of 56 girls and an intra-class correlation of 0.1."
0,The normal value reported by the manufacturer of the assay is 1135 ng/mL with a range of 103–3308 ng/mL (R&D Systems).
8,Twenty schools and ≥ 80 girls/cluster allowed for cluster attrition and 30% loss to follow-up and non-compliance with accelerometer wear.
0,The bilateral DBS electrode implantation was performed under local anesthesia with the patient in a semi-sitting position.
6,AIDU are measured during baseline and at 5-monthly follow ups starting 1 month after the first Community Wise session is initiated.
0,"Then a small amount of topic anaesthetic (Xylocain 2%; Astra Zeneca, Södertälje, Sweden) was placed in the nostril."
6,We use the Timeline Follow Back [77] and a urine toxicology screen (dichotomous) collected by a trained research assistant.
0,"The product acceptability questionnaires included questions on gel’s characteristics, application process and applicator preferences, product use, product liking and likelihood to use if proven effective against HIV."
5,All patients received standard oncological care as determined by their individual requirements.
0,"In addition, a start-up meeting in which all investigators from a single facility participated was held at each facility."
5,Patients in both groups were advised to maintain their regular physical activity and to abstain from other new integrative or supportive treatments during the study period.
0,"Tobacco-related measures include assessments of dependence, and psychosocial measures include the Kessler 6 [46], Perceived Stress Scale [47], and Center for Epidemiologic Studies-Depression scale [48]."
1,"A nonrandomized, quasi-experimental, parallel study was conducted."
0,"Data to assess the likelihood of potential subsequent adoption of the weight loss intervention by the health care system, such as the representativeness of physician approval of their patients' participation, patient willingness to enroll in the study, and reasons for declining to participate will be documented."
1,Follow-up was performed at 30 days and at 26 weeks after discharge from the short-stay unit at the ED.
0,"Following the educational intervention, all subjects were asked to give written feedback, by means of a standard form, on the content and delivery of the session."
16,Statistical tests are indicated in the Figure legends.
0,"NimbleGen arrays were positionally annotated based on hg19 genomic coordinates, and log ratio data were preprocessed in R, as previously described [17]."
16,The threshold for statistical significance was set at P<0.05.
0,"To ensure methodological rigour and trustworthiness of the analysis, we used the following strategies: multiple authors participated in data analysis; a dependability audit [48] was kept which included audio recordings, transcripts, interview guides, and data analysis processes and products (e.g. coding scheme and supporting quotes from the interview transcripts, minutes from analysis meetings, NVivo node reports); frequent reviews were made of the audit by the research team; and sufficient detail was provided in the audit to allow outsider assessment of theoretical generalizability (i.e. ‘fittingness’ of the findings with other contexts) [48]."
8,"Assuming a standard deviation in chrome-EDTA clearance of 10 mL/min, a sample size of 126 patients (63 in each group) will be able to detect a difference in chrome-EDTA clearance of 5 mL/min between the groups with 80% power and a significance level of 0.05."
0,"A PPK model was developed using nonparametric estimation in Pmetrics software (v1.3.2; University of Southern California, Los Angeles, CA) (17)."
8,"With an expected dropout rate of 15%, the planned total was set to 170 patients."
0,Individual subjects were assigned to positive and negative gene signature groups using RNA expression data.
6,"Change in Walking Impairment Questionnaire (WIQ, rating 0–100 from worst to best) [17], ABI, and absolute walking distance was measured by a standardized treadmill test (speed 3 km/h, without incline, maximum duration 20 min or 1000 m) between baseline and 24 months."
0,The patient had their medication dispensed at the hospital pharmacy free of charge (if they have a social health insurance) or at any private pharmacy with payment.
5,Patients randomized to the treatment arm received selective intestinal decolonization with colistin in a dose of 2 mln I.U. 4 times per day PO for 14 days.
0,One member of the investigatory team (AZ) will perform all measures in the trial.
5,Patients in the control group were observed during the study period without any interventions while they received their standard treatment for hematological malignancies (“watch and wait” strategy).
0,"Tumors had to be strongly HER2+ invasive breast cancer defined as immunohistochemistry (IHC) score of 3+ or gene amplified by fluorescence in situ hybridization by reference laboratory testing, confirmed at the study central laboratory using the manufacturer’s definition."
14,"Due to the decision of IRB and Ethical Committee, blinding in the planned study was not considered appropriate from the ethical positions, so the study protocol did not include it."
0,"We dichotomized maternal characteristics at enrollment: parity (0 and ≥1), education (≤6 and >6 years), age (≤ 20 and >20 years), and body mass index (BMI; <18.5 and ≥18.5 kg/m2)."
3,"Eligible participants had to have given birth in the last 12 months, be aged over 18 years, be living in England, be able to read and write English, have internet access, and have scored ≥5 on the Generalized Anxiety Disorder Scale (GAD-7) [35]."
0,Eight weeks after randomization participants attended the clinical research facility for a venous blood test for HbA1c.
3,"Women were excluded if they were receiving formal psychological treatment at the start of the study, reported self-harm or suicidal ideation, or had a stillbirth or the baby was seriously ill."
0,"Height, weight, BMI and waist circumference were measured according to the World Health Organization recommendations."
3,"Patients age 18 and older who presented to the office with sinus symptoms were eligible for inclusion if not previously enrolled and if, in the judgment of the treating clinician, they fit into one of the three diagnostic categories for acute bacterial sinusitis, as defined by the 2012 IDSA clinical guidelines [2]: 1) persistent symptoms and not improving (lasting for ≥ 10 days); 2) severe symptoms or signs of fever ≥ 102 degrees F and nasal discharge or facial pain (lasting for ≥ 3–4 days); or 3) worsening symptoms or signs characterized by new onset of fever, headache, or increase in nasal discharge following a typical viral URI that lasted 5–6 days and was initially improving (double sickening)."
0,"To control family-wise type I error rate, a 2-step Hochberg method (e-Methods) was applied to demonstrate superiority of either abobotulinumtoxinA dose to placebo."
3,"Patients were excluded if they were allergic or intolerant to amoxicillin or amoxicillin/clavulanate; were breastfeeding; were cognitively unable to give informed consent and/or to assess their symptoms; were taking allopurinol; had chronic or recurrent “sinus” problems, defined as persistent “sinus” congestion, not attributed to nasal allergies, for 8 weeks or more [30] or 2 or more episodes of antibiotic-treated “sinusitis” in the past 3 months; were judged by clinicians to need HD amoxicillin/clavulanate, doxycycline, or levofloxacin because of severe infection, treatment with amoxicillin or penicillin within the past month, or immune compromise; needed hospitalization; were suspected to harbor methicillin-resistant Staphylococcus aureus; or had a contraindication to amoxicillin/clavulanate because of chronic kidney disease stage 4, hepatic impairment, current mononucleosis, or a history of antibiotic-associated colitis."
0,The reactions were stopped with 1 N sulphuric acid.
3,"Sixty preterm infants born at our hospital within the above time frame, and with gestational age < 32 weeks at birth and weight < 1500 g were included."
0,The study protocol was also approved by the Associate Director for Science at the US Centers for Disease Control and Prevention.
3,Main exclusion criteria were major congenital or chromosomal abnormalities.
0,Six final semester-M.Sc.
3,Children aged 1 to 5 years enrolled at the CREN in the city of Maceió whose parent/guardians signed as statement of informed consent agreeing to the participation of the children.
0,"pemetrexed 500 mg/m2, administered over 10 minutes, on Day 1 of a 21-day cycle until progressive disease (PD) or unacceptable toxicity, or until the patient discontinues from the study for any other reason."
3,"Children aged 1 to 5 years not enrolled at the CREN in the city of Maceió and children whose parents/guardians did not sign a statement of informed consent, teachers, caregivers, health professionals, and voluntary interns."
0,"The spots were enumerated with an AID Elispot reader, and each spot was interpreted as a print of one ASC."
8,Next GeneSiS is performed in terms of an exploratory pilot study and is therefore not statistically powered.
0,"Samples from subjects with confirmed virologic failure or cVF (defined as failure to suppress HIV-1 RNA to <400copies/mL by Week 36 or confirmed virologic rebound to >400copies/mL after suppression to <400copies/mL at any time) during ARIES were analyzed by Phenosense GT at baseline and time of cVF (Monogram Biosciences South San Francisco, California, USA)."
8,We estimate that approximately 500 patients need to be enrolled to enable a reasonable assessment of the performance of the NGS-based approach when compared with standard-of-care microbiology.
0,"Employees felt that they generally followed healthier diets during summer, when their intake of salads was higher, and there was a greater variety of fruit and vegetables."
2,Changes to the protocol are made in writing and require the approval of all signatories of the protocol.
0,"This shows the intervention, intervention process, immediate effects, effect on care provided to patients, expected output and expected outcome."
2,Subsequent amendments also require a positive assessment from the competent ethics committee.
0,"Long-lasting, insecticide-treated mosquito nets is the major vector control method [10]."
16,"T tests were applied to compare the baseline scores for PDSS, QOLS, and MOSES to those for the same at the completion of the study for 18 patients (12 females and six males)."
0,In the Netherlands studies involving human subjects need to undergo a medical ethics review if they are subject to the Medical Research Involving Human Subjects Act (WMO).
16,"Analyses and descriptive statistics were obtained using the R 3.1.1 statistical software (R foundation for Statistical Computing, Vienna, Austria)."
0,The research study was approved by the IRBs of all participating sites and informed parental consent was obtained for all enrolled infants once eligibility was confirmed and before institution of study intervention.
1,"This is a secondary analysis of the prospectively collected patient-level dataset from the MEDUSA study, a cluster randomized quality improvement trial aiming to improve early sepsis diagnosis and treatment in the participating hospitals by a multifaceted educational program [11]."
0,The IL-15 gene is under the control of the hCMV promoter and the BGH polyadenylation signal.
1,The original trial was registered at ClinicalTrials.gov (NCT01187134) and was approved by the local ethics committees at each participating institution (see Additional file 1 for a complete list) and by the responsible state data protection boards.
0,Net OAT-mediated uptake was determined from total uptake in OAT-expressing cells minus uptake in vector-treated control cells.
3,"Patients treated between July 1, 2011 and May 31, 2015 on the participating intensive care units (ICUs) with proven or suspected infection and at least one new infection-related organ dysfunction were eligible for inclusion."
0,"Thereafter, isometric exercise was started and maintained for 6 minutes."
3,"Patients were excluded if they had relevant limitations of therapy, were not treated on a participating ICU or had infection control measures started at another hospital before transfer."
0,"Adverse events such as severe self-harm, suicide attempt, hospitalization and death during the trial were collected."
1,"Five matched retrospective case–control analyses were performed, nested within the Hopkins Lupus Cohort."
0,"Sorted specimens were used fresh for IUI or IVF/ICSI at GIVF or HRC or were cryopreserved and stored at the laboratory for future IVF/ICSI use at GIVF, HRC, or for shipment to a collaborating physician’s facility."
1,"This was a nonrandomized, open-label, two-arm clinical trial with a blinded outcome assessor."
0,These data were not used to alter insulin infusion rates during the visits for closed loop delivery or control.
1,"Patients in the usual care group were recruited first; 3 months later, patients were enrolled for the intervention."
0,"Daily taking adherence will be determined for each participant for each day of follow-up [45]; the median daily taking adherence will be determined for participants in each of the intervention and control groups, and plotted against time."
3,"Children were eligible to participate if they were 6 months to 12 years of age, weighed at least 5 kg, lived within 10 km from the study clinic and had microscopically confirmed P. falciparum mono-infection with 1000–200,000 asexual parasites/µL."
0,"An enrichment analysis was performed, which evaluated the overlap between the differentially-expressed genes and gene groupings from canonical pathway maps (biological mechanism), process networks (metabolic and signaling processes), toxic pathologies, and disease biomarkers."
3,"Exclusion criteria were complicated or severe malaria, non-P. falciparum or mixed Plasmodium infection, a history of hepatic and/or renal impairment, any clinically significant illness other than malaria, anaemia with a haemoglobin (Hb) concentration < 6 g/dL, severe malnutrition, treatment with anti-malarial therapy in the previous 2 weeks, known hypersensitivity to artemisinins, previous participation in this study, current participation in other anti-malarial drug intervention studies or not being available for follow-up."
0,The focus groups and individual interviews with patients explored factors that prompt individuals to seek and continue or discontinue A/C care as well as reasons for seeking care.
1,This is a randomized controlled trial with a follow-up.
0,Participants were recruited online through a master’s student’s social network on Facebook.
8,"The sample size was calculated according to a confidence interval of 0.95, a sampling error of 0.05, and a power effect of 0.8."
0,How short of breath were you when You put on long pants or stockings?You put on your shoes (sandals)?You washed yourself?You reached above your head to put things away?You cleaned or fixed something at floor level?You put things away in the cupboard or shelf at chest level?You put things away in the cupboard or shelf at knee level?You prepared food or a meal?You picked up light objects off the floor?You carried objects at your side like bags or baskets?You walked at a slow pace?You walked up 3 stairs?You walked up 8 stairs?Response options included I did not do the activity todayNot at allSlightlyModeratelySeverelySo severely that I did not do the activity today Analyses were conducted aggregating daily data over weekly time periods to account for day-to-day variability and the fact that not all the activities were performed every day.
8,"From this data, a sample size calculation was conducted and a minimum of 15 participants in each group was determined."
0,"We chose this area because of its well-separated and accessible communities and because, to our knowledge, no major health promotion programmes were currently implemented."
1,This economic evaluation from a healthcare perspective was performed alongside a cluster controlled effectiveness study with a follow-up of 12 months.
0,Radiation was administered to the primary tumor or a pulmonary metastasis.
1,"Design, methods and outcomes of the effectiveness study have been reported elsewhere [18]."
0,"Separately, a USI examination was performed which included assessment of the lateral abdominal muscles (transverse abdominus, internal and external oblique muscles) during an active straight leg raise and symmetry of the multifidi muscles [8]."
3,"The inclusion criteria were: 1) multiple Miller Class I gingival recession defects on the lower and/or upper incisors, canines, or premolars; 2) similar tooth numbering of teeth with multiple GR defects, ranging from two to three defects, 3) presence of ≥1 mm keratinized tissue apical to the recession; 4) presence of an identifiable cementoenamel junction (CEJ); 5) ≤2 mm probing depth (PD); and 6) no previous periodontal surgical procedures in the recession area."
0,"During the study period, research assistants reviewed the electronic medical records to identify study participants who had linked to care at their diagnosing facility."
3,"Exclusion criteria were: 1) smoking; 2) pregnancy; 3) caries, deep abrasion, restoration or pulpal pathology on the teeth involved; and 4) use of steroid, bisphosphonates, or irradiation therapy."
0,The event did not necessarily have a causal relationship with this treatment.
1,"This study was a randomized, controlled clinical trial that compared different amounts of PRF membrane layers and CTG for the treatment of Miller Class I gingival recessions."
0,"After the first menstruation, EcoVag® capsules were given again for 10 days along with a weekly course of 200 mg fluconazole for two months."
1,"In the 2PRF+CAF, 21 teeth with GR defects were treated with two layers of PRF membranes+CAF and the group was defined as 2PRF+CAF; in the 4PRF+CAF, 21 teeth with GR defects were treated with four layers of PRF membranes+CAF and the group was defined as 4PRF+CAF; and in the control group, 21 teeth with GR defects were treated with CTG+CAF."
0,Rescue medication was allowed in the form of an acetaminophen extended-release (ER) 650 mg tablet.
3,"Individuals who meet all the following criteria will be included as appropriate participants in the clinical trial:(1)Those aged from 19 to 78 years;(2)Those with a diagnosis of degenerative lumbar spinal spondylolisthesis or who have low back pain, lower limb radiating pain, or leg discomfort when standing or walking with a severity of at least 5 on a visual analogue scale (VAS) of 0 to 100 for each symptom;(3)Those suffering from neurologic claudication or radicular pain for at least 1 year;(4)Those with neurogenic claudication within 5 minutes of walking on a treadmill at a speed of 1.5 miles per hour;(5)Those who have not received an epidural injection within the past month;(6)Those who have not undergone lumbar surgery;(7)Those who have confirmed spondylolisthesis on lumbar spine AP, lateral, nd both oblique views;(8)Those who weigh 250 lbs (113.398 kg) or less;(9)Those whose height is 2.1 m (6.890 ft) or shorter; and(10)Those who agreeing to participate in this clinical trial after receiving a thorough explanation of the purposes and characteristics of the trial and who are willing to sign the written informed consent form."
0,The Wilcoxon rank sum test was used to compare the change in physical activity between randomization groups.
3,"Participants who have any of following conditions will be excluded:(1)Those with a past or current history of diseases that cause ambulatory functional disability;(2)Those with knee joint and hip joint disorders that severely limit walking (i.e., moderate or severe osteoarthritis of the knee or hip joints);(3)Those who have been previously diagnosed with peripheral blood vessel diseases or vascular diseases, those who show an ankle-brachial index below 0.9 or those who have been diagnosed with peripheral arterial disease by Doppler ultrasonography of lower limbs, if necessary;(4)Those with severe diseases (cardiac disorders or renal insufficiency) to such a degree that an ambulatory evaluation cannot be performed;(5)Those with other specific spinal diseases (ankylosing spondylitis, spinal osteomyelitis, metabolic diseases, severe osteoporosis, etc.);(6)Those with severe neurological defects including foot drop or cauda equina syndrome;(7)Those with spinal instability confirmed by lumbar spine X-ray flexion and extension views, where spinal instability will be defined as observing one or more of the following: 4.5 mm sagittal plane translation, 20 degrees of sagittal plane rotation at L4-5, or 25 degrees of sagittal plane rotation at L5-S1;(8)Those with malignancies;(9)Those with past or current psychiatric conditions, such as major depressive disorder, anxiety disorders, panic disorders, or episodes of mania, delusion, and schizophrenia;(10)Those using narcotic analgesics including external dosage forms or patches;(11)Those women who are pregnant, lactating, or planning to become pregnant;(12)those who appear to be likely to encounter difficulties in adhering to this protocol; and(13)Those subjects whom the clinical investigators judge to be inappropriate."
0,"Participant’s quality of life was measured on four domains (physical health, psychological, social relationship, and environment) in the WHO Quality of Life-BREF (WHOQOL-BREF).46"
16,"The measured signed translations in the phantom study followed a Gaussian distribution, and therefore statistical comparisons of the means was done with Students paired ttest, and comparison of variations were performed with an f-test."
0,The phytosterol dose was chosen on the basis of the minimal efficacious dose identified by the meta-analysis of randomized clinical trial performed by Demonty et al. [18].
16,The primary endpoint of the phantom and clinical study was precision of measured migration along the X-axis (frontal plane motion of the sternal halves).
0,"They counted the remaining capsules and estimated by eye the amount of fish/meat eaten using a scale from zero to four: ‘0 = nothing eaten’, ‘1 = 1/4 eaten’, ‘2 = 2/4 eaten’, ‘3 = 3/4 eaten’ and ‘4 = all eaten’."
6,"The outcome measures were in-hospital death, limb amputations and resource consumption (number of surgeries, length of hospitalization)."
0,Participants will be asked to complete all study measures before randomization.
4,We will collect worksheets and clinical note templates (which contain adherence checklists) from clinicians who have varying degrees of CBT expertise in a variety of settings The data sets will include variability in population characteristics and clinician training/education level.
0,"Blood samples for assessment of serological humoral responses (measured by ELISA24,25 and PBNA25) were collected at yearly visits during follow-up."
5,"The TTM intervention, which involves five sessions, and the regular occupational therapy aimed to increase the ability to cope with everyday life and to enhance satisfaction with everyday life."
0,It was chosen because the depression instrument had 20 questions.
5,"In order to compare the TTM intervention with regular occupational therapy, i.e. best practice, both interventions involved five sessions, even though regular occupational therapy is normally not structured within specific time limits."
0,Participants were recruited from the outpatient cardiology clinic and inpatient ward Mulago Hospital Complex with the assistance of two research assistants and a screening questionnaire.
6,"The primary outcome measures were fasting serum LDL-C and TG concentrations, secondary outcomes included fasting TC, HDL-C, lipoprotein (a) (Lp(a)) and safety and tolerance of the study products and tertiary (exploratory) outcomes were fasting non-HDL-C, remnant cholesterol (remnant C), glucose and insulin, and postprandial TG, TC, LDL-C, HDL-C, glucose and insulin response after a mixed meal challenge."
0,"Severity of depressive symptoms was rated at each visit using a 24-item SIGH-SAD, a scripted version of the Hamilton Depression Rating Scale [15] modified to reflect better the atypical symptomatology of SAD [16]."
16,"To compare metabolic test results of AN-C and HC, the Saphiro-Wilk test was used to test for normal distribution."
0,Figure 8 Results of exit survey completed by parents/caregivers of ASD children.
16,"If data were distributed normally, an independent samples t-test was applied, and for non-normally distribute data, the Wilcoxon test."
0,"To prevent coronary microembolization, a distal balloon occlusion/aspiration device (GuardWire Temporary Occlusion & Aspiration System; Medtronic Inc., Minneapolis, MN USA) [33] was used."
16,The primary efficacy endpoint was analysed using a mixed‐effect model with a repeated measures approach to account for missing data.
0,"Absolute total plaque volume was measured in each plaque, as well as the volume and percent of each of the four plaque components."
16,Further information on analysis methods is presented in Appendix S1.
0,"Therefore, the final main study sample included 300 Miami and 315 LA participants who were randomized in a ratio of 3 intervention: 2 comparison, resulting in 180 intervention and 120 comparison participants in Miami, and 190 intervention and 125 comparison participants in LA."
3,"Patients were enrolled if they met the following criteria: male or female outpatients ≥20 years of age, endoscopically confirmed history of peptic ulcer before study start and required long-term LDA therapy during the treatment period to prevent the formation of thrombi related to chronic disease (eg, ischaemic heart or cerebrovascular disease)."
0,The immediate consequence of ΔS and ΔT being non-identifiable is that estimation of the ICA results in a density rather than a fixed value.
3,"Patients were excluded if they had: active peptic ulcer or bleeding endoscopically confirmed at the screening visit, current or past history of aspirin-induced asthma, history of surgery or a planned operation affecting gastric acid secretion (eg, upper GI tract resection, vagotomy), current or past history of Zollinger-Ellison syndrome or other gastric acid hypersecretion disorders, clinically significant liver or kidney disorder, including liver tests demonstrating aspartate aminotransferase/alanine aminotransferase values >2.5 times the upper limit of normal (ULN), total bilirubin >2.0 times the ULN or creatinine levels >2.0 mg/dL or history of malignancy within 5 years before screening."
0,All patients were clinically managed at the local participating institutions.
6,The primary safety outcome was the largest within-person percentage decrease in Hb concentration between baseline levels (day 0) and day 10 following PQ administration.
0,"Transport teams provided written information about the study for the parents of infants from referring hospitals, and study personnel assessed the infants on admission to the participating centre."
6,"Prespecified secondary outcomes consisted of the incidence of AEs, graded by severity and relation to the study drug; the occurrence of acute hemolytic anemia at each PQ dose, including absolute and fractional changes in Hb concentration on day 7 and day 28 as compared to baseline; urine color assessment; reticulocyte count; total and direct bilirubin levels if a within-person Hb concentration drop of ≥30% from baseline levels was seen in an individual between day 0 and 7 (inclusive); methemoglobin concentration and development of physical signs or symptoms of hemolytic anemia; comparison of the change in the Hb concentration, the frequency and severity of AEs, and the occurrence of markers of acute hemolytic anemia between G6PD-d and G6PD-n participants; and exploratory studies among adults on whether cytochrome P450 2D6 (CYP2D6) SNPs are associated with hemolysis in G6PD-d individuals (Supplementary Materials)."
0,Routine HIV counselling and testing were carried out according to the Uganda Ministry of Health guidelines (2006) [27].
16,"Because of the small number of participants, absence of sham surgery control, and the fact that it was an open-labeled study design, we did not perform statistical analysis to compare the outcome measures of the low- and high-dose hUCB-MSC recipients."
0,"Based on the WHO depression questionnaire MDI, it was established whether or not the participant had a depression."
3,The eligibility criteria included treatment naïve metastatic PCA; age > 18 years; Eastern Cooperative Oncology Group (ECOG) ≤ 1; adequate organ function; had measurable disease as defined by the Response Evaluation Criteria in Solid Tumor (RECIST) version 1.1; ≥ 6 months elapsed since completion of previous therapy; and patients who enrolled in phase II cohorts were required to had biopsies for correlative studies.
0,"At the beginning of the study, 22 subjects were recruited, but 6 of them left the football team during the experimental time and joined the first and professional team and one broke the anterior cruciate ligament of the knee."
3,"We excluded patients who had prior systemic therapy, had brain metastases, were pregnant or nursing, had uncontrolled illness that would limit study compliance, and had another cancer, except treated basal or squamous cell skin carcinoma or cervical carcinoma in situ, or if patient had been disease-free for > 2 years."
0,Patients were reminded by text messages and telephone calls to return the diary and bring the control urine sample.
6,"The primary outcome of the study was to assess the accessibility and availability of individual POC diagnostics in rural PHC clinics in KZN, South Africa."
0,Peers were provided regular supervision to identify and address any work related issues.
6,"The secondary outcome of this study was to determine the current need for POC diagnostics in rural PHC clinics in KZN, South Africa."
0,"PEAR whites and PEAR-2 white and black participants were selected for gene expression profiling with RNA-Seq based on the differences in their BP response to HCTZ and chlorthalidone treatment, respectively."
1,"This study is an investigator-initiated, randomised, biopsy-controlled, crossover, multicentre study."
0,Randomisation will be performed by a non-blinded cardiac research nurse using a freeware computer programme (MinimPy 0.3).
1,Each patient served as its own control for pathology outcome and for blinded versus unblinded interobserver agreement analysis.
0,"Based on the superiority design, one-sided proportion test and log-rank test with α-error of 0.025 and a power of 90% was conducted for both primary endpoints: pCR and 3-year DFS."
3,Eligible patients included men and women (aged ≥ 18 years) who: provided informed consent; had a history or presence of gout based on criteria defined by the American Rheumatism Association [18]; had an sUA level ≥ 8.0 mg/dl at the day −4 screening visit or at the retest visit; had moderate renal impairment as defined by an eGFR (Modification of Diet in Renal Disease) ≥ 30 and < 60 ml/min at screening visit on day −21 for patients on ULT and on day −4 for patients not on ULT or at the retest visit; and had a self-reported history of ≥ 1 gout flare within the 12 months prior to the screening visit.
0,All BASDAI questions use a 10-point NRS.
3,"Patients were excluded from the study if they met any of the following criteria: received an investigational compound within 30 days prior to screening, secondary hyperuricemia; history of xanthuria, known hypersensitivity to febuxostat or any components in its formulations, known hypersensitivity to naproxen, any other nonsteroidal anti-inflammatory drug (NSAID), aspirin, lansoprazole, colchicine, or any components in their formulation; had experienced either a myocardial infarction, stroke, hospitalized unstable angina, cardiac or cerebrovascular revascularization procedure, or hospitalized transient ischemic attack; or had a history of cancer (other than basal cell carcinoma of the skin) within 5 years prior to the screening visit, history of drug or alcohol abuse, presence of rheumatoid arthritis, active peptic ulcer disease, or any significant medical condition that would interfere with the treatment, safety, or compliance with the protocol."
0,"Postocclusive reactive hyperemia was assessed during the examination by a 5-min occlusion of the upper limb, which was performed using a cuff placed on the upper arm."
6,"To assess the prevalence of anemia, the primary outcome measures is hemoglobin concentration < 12 g/dL."
0,"School characteristics are shown in table 1: two were all-boys schools, two all-girls schools and one was a co-educational school."
6,"There are many additional secondary outcomes within the trial related to health, nutrition, and empowerment that will be also assessed (see Additional file 1)."
0,This is for a preliminary report with another 8 days for completion of the report.
8,"Based on results from a previous intra-individual trial designed as a right–left comparison of A0.1/BPO2.5 gel versus vehicle, a sample size of 50 evaluable subjects was necessary to ensure 80% power to detect superiority of A0.3/BPO2.5 over vehicle."
0,"For flow cytometry, cells were stained for surface markers CD3 (UCHT1), CD45 (HI30), CD4 (RPA-T4), CD8α (RPA-T8), CD8β (SIDI8BEE), CD44 (IM7), CD103 (B-Ly7), TCRβ (WT31), TCRγδ (B1.1), and a viability dye (Ghost Dye™ Violet 510, Tonbo Biosciences, San Diego, CA, USA) and then fixed in 4% paraformaldehyde in PBS."
8,"Assuming 20% of subjects would be excluded from the analysis at week 24, a total of 60 enrolled subjects were required."
0,"These included estimated intensity of pain or discomfort according to VAS as perceived and assessed by the patients on admission to hospital, as well as any further requirements for pain treatment."
1,"The Moms Online Video Exercise (MOVE) Study was an 8-week, 2-armed, parallel, Web-based randomized trial comparing the effectiveness of an intervention arm consisting of exercise groups that used videoconferencing and mobile apps with a waitlist control arm."
0,"Nutrient composition per 100 ml of the yogurt drink: Energy 54 kcalFat 1.5 gProtein 2.8 gCarbohydrates 7.3 gPlant stanols 2.0 g Supply of yogurt drinks was conducted between July to September 2012, subjects were given detailed instructions on how to use the test products."
1,We detailed our methods below and in an eHealth checklist (Multimedia Appendix 1).
0,The IMR Fidelity Scale consists of 13 items that are rated on a 5 point scale [22].
3,"Eligible participants were children younger than 5 years with acute gastroenteritis, defined as a change in stool consistency to a loose or liquid form (according to the Bristol Stool Form (BSF) Scale, or, in the case of infants, the Amsterdam Stool Form (ASF) Scale) and/or an increase in the frequency of evacuations (typically ≥3 in 24 hours), lasting for no longer that 5 days."
0,"Each exercise session lasted about 60 min and comprised the following steps: 1) Warm-up (10 min): stretching and low-intensity exercises (walking); 2) Exercise protocol (30–40 min): patients performed exercise training on a stationary cycle ergometer, and this period was divided into 6 steps."
3,"Exclusion criteria included the use of antibiotics, gelatine tannate, diosmectite, probiotics, racecadotril or zinc (including zinc-containing oral rehydration solution (ORS)) within a week prior to enrolment; exclusive breast feeding; chronic diarrhoeal gastrointestinal disease (eg, inflammatory bowel diseases, cystic fibrosis, coeliac disease, food allergy); immunodeficiencies and malnutrition (weight/height/length under third percentile, WHO Child Growth Standards were used).10"
0,Our research technicians performed all measurements and daily calibrated the DXA apparatus with a phantom.
6,"The primary outcome measure was the duration of diarrhoea, defined as the time until the normalisation of stool consistency according to the BSF or ASF Scale (on BSF Scale, numbers 2, 3, 4 and 5; on ASF scale, letters B or C) or the time until the normalisation of the number of stools (compared with the period before the onset of diarrhoea) as well as the presence of normal stools for 48 hours."
0,"Age-, gender-, and disease-matched control groups for the walk and sweep tests were selected from subjects with a pacing percentage of ≤20% in CLS and XL."
6,"The secondary outcome measures included the need for intravenous rehydration, need for hospitalisation of outpatients, number of watery stools per day, vomiting, weight gain, adverse events, recurrence of diarrhoea (48 hours after the intervention), severity of diarrhoea according to the Vesikari Scale11 and use of concomitant medications."
0,"A small percentage of individuals received VIS410 prophylaxis (between 0% and 6%) in the early stages of the epidemic, and two modes of distribution were included: randomly to all individuals or randomly to only elderly individuals (> 65 years old)."
1,"We performed a randomised, controlled, double-blind, pilot study between July 2012 and June 2016 that was approved by the Medical Research Ethics Committee (MREC) of the University Medical Centre of Utrecht and registered at ClinicalTrials.gov, number NCT01362959."
0,"When no standardized unit cost prices were available, costs were derived from the Dutch Healthcare Authority."
1,"The feasibility study was a prospective, single-arm design."
0,Each item is scored on a 3-point ordinal scale.
1,Interested participants completed a baseline questionnaire and were immediately provided with access to the RiseTx web-based intervention.
0,"FIRE AND ICE (ClinicalTrials.gov Identifier: NCT01490814) was a controlled, prospective, randomized, noninferiority, blinded‐outcomes, parallel‐group trial designed to evaluate PVI using cryoballoon or RFC catheter ablation for the treatment of symptomatic, drug‐refractory, paroxysmal AF."
1,"This is a single-centre, parallel group double blind-RCT."
0,These criteria have been used by the UN to define slums(
1,"We conducted a cluster randomized controlled trial (RCT), in which physicians (the clusters) were randomized to either the DD-DT intervention or a control group."
0,"At that point, a ranking/selection comparison [19, 20] would have been done between the treatment groups and a minimum rate of success criterion would have been applied to each treatment group."
1,"The trial ran from September 9, 2014 to January 29, 2016."
0,Patients are allocated to the control or intervention group according of the study group of their PCP (Figure 1).
3,"Patients were required to have metastatic, histologically confirmed, synovial sarcoma, resistant to standard treatment, not amenable to therapy with curative intent (surgery or radiotherapy) and previously treated with doxorubicin and ifosfamide."
0,"ACT can be performed on a portable instrument; thus, it was used during the first 12 h in both groups to uniform the heparin-guided management in case of transport/centralization of a patient."
3,"Other key inclusion criteria were: measurable disease as per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1); Eastern Cooperative Oncology Group Performance Status (ECOG PS) ≤ 2, life expectancy ≥3 months, adequate organ function, left ventricular ejection fraction > 50%; normal pulmonary function with Force Vital Capacity (FVC) at least 60% and diffusing capacity or transfer factor of the lung for carbon monoxide (DLCO) of at least 50%, no positive human anti-mouse antibody (HAMA) or human anti-chimeric antibody (HACA) response."
0,LV ejection fraction was estimated using the Simpson biplane method.
3,"Women aged 18–45 years were eligible to participate in the study if they had endometriosis confirmed by laparoscopy or laparotomy during the 5 years before the baseline visit and endometriosis symptoms (i.e. pain) during the 4 weeks before the baseline visit, as assessed by the participant using a 0–10 numeric rating scale (NRS), and had otherwise good general health, as evidenced by medical history [16]."
0,"The study was approved by the Regional Ethical Review Board, Gothenburg, 15 May 2008, Dnr: 136–08."
3,"Women were excluded from the study for any of the following reasons: presence of diseases or conditions that might have interfered with the conduct of the study or the interpretation of the results; undiagnosed abnormal genital bleeding; abuse of alcohol, drugs or medicine; simultaneous participation in another clinical trial or participation in another clinical trial before study entry that might have had an impact on the study objectives (at the discretion of the investigator); major surgery scheduled for the study period (except therapeutic surgical procedures for endometriosis); close affiliation with the study site; inability to cooperate with the study procedures for any reason; regular use of pain medication owing to other underlying diseases; or known pregnancy [16]."
0,Table 3 Variables and measures Participant characteristics
8,Version 3.1 G Power was used to estimate sample size.
0,A quantification code of 1–3 was considered low density while 4–6 was considered high density.
8,"A minimum of 78 subjects per group will be needed “a priori” to have sufficient statistical power (80%), alpha error (0.05) and size 0.4 effect on the visual analog pain scale [49]."
0,A 3-in.-wide measuring strip is placed directly underneath their knees on the mat.
3,"There were 10 participants with a mean ± SEM age of 31 ± 3 y (6 men and 4 women), all of whom were judged to be in good health after a review of their medical histories and screening of blood samples obtained after a 12-h overnight fast (Table 1)."
0,Samples with values greater than the last dilution were diluted further and retested.
3,"All of the participants were nonsmokers, nondiabetic (fasting glucose <6.1 mM and glycated hemoglobin <6.0%), and had normal renal function, serum electrolytes, liver function (normal aspartate aminotransferase and alanine aminotransferase), thyroid-stimulating hormone, HDL and LDL cholesterol, TGs, and albumin and no overt nutritional problems."
0,The practicalities of recording and storing research data in the practices were addressed by providing a data collection form one page in length and a laminated colour coded reference list of CHD medications to aid practitioners' recording of patient's drugs within specified categories.
6,"Data was collected at baseline (anthropometry, activity measures and questionnaire data), after 1 month (activity measures) and after 3 months (anthropometry and activity measures)."
0,"For those with stage II CC, the decision of adjuvant chemotherapy in this Arm will be will be done according to the investigator discretion."
6,"Questionnaire data was web-based and included information on work environment, socio-demographic factors, health status, and health behaviour."
1,"This was a 13-week, multicentre, parallel-group, double-blind, randomised placebo-controlled trial conducted in long-term and dementia wards in 47 nursing homes from 12 municipalities in Norway (Bergen, Baerum, Fjell, Kvam, Meland, Os, Oslo, Sandnes, Stavanger, Sula, Sund and Aalesund)."
0,The impact evaluation includes a sub-study focussing on nutrition in school feeding with and without micronutrient fortification.
1,"Depending on ongoing medical treatment and clinical investigation, participants were prescribed either paracetamol tablets (maximum 3 g/day) or buprenorphine TDS (maximum 10 µg/hour), and were randomised to receive either active treatment or placebo."
0,"If participants are withdrawn from the study for any of the reasons noted above prior to randomization, they will be replaced until a total of 260 participants have been randomized to the study at each study site (VCU and PSU)."
8,A six-sequence Williams design was used to calculate the sample size.
0,"Each subject underwent 2 PET scans (PET1 and PET2), which were performed at the Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Austria, using a GE Advance PET scanner (General Electric Medical Systems, Milwaukee, Wisconsin) at the end of the respective treatment period, as previously described (Lanzenberger et al., 2007)."
8,"This design and an assumed standard deviation (SD) of 17.7 L/min (calculated according to previous findings) and a sample size of 96 patients (16 in each of the six possible sequences, i.e. 16 × 6 = 96) had > 90% power to detect a difference in PIF values between a pair of inhalers of 10 L/min (2-sided alpha 0.05)."
0,The trial is ongoing and in the recruiting phase at the time of manuscript.
4,"Demographic characteristics, co-morbidities, symptoms and signs were collected at inclusion."
0,"As noted earlier, general clinical characteristics of these subjects were previously reported in Baum et al 12 and a summary also can be found in supplemental Table 1."
4,Blood pressure was measured with an automated device (Omron® M6).
0,The prior period was used to assess the baseline consumption of health care resources.
16,The data were captured on Excel spreadsheets in the participating centers and were merged with data exported from COMPERA.
0,Follow-up MRIs were maintained on the same scanner as the first MRI.
16,All descriptive analyses were done with SPSS v25 and no formal statistical analyses were performed.
0,"The gastric mucosa healing rate of DA-5204 was considered non-inferior to that of DA-9601 (control group) if the one-sided 97.5% (equivalent to two-sided 95%) lower limit was greater than −14, which was the pre-specified non-inferiority margin (1)."
3,"Generally healthy women between 17 and 24 weeks of gestation were enrolled after providing written informed consent between March 2014 and September 2015 at the Maternal and Child Health Training Institute (MCHTI), a public hospital in Dhaka, Bangladesh."
0,The case sheet was designed for use with women in labour from arrival to discharge.
3,Inclusion and exclusion criteria are shown in Table S1 in the Supplementary Appendix.
0,"To perform the test, the subject runs a 20-meter course back and forth."
8,"The sample size calculation was based on an estimated intra-class correlation coefficient (ICC) of 0.75, ratings of two independent raters (registered nurses and nursing assistants) and a width of 0.20 for the 95% Confidence Interval (CI)."
0,A backward design allowed us to create an educational content that allowed us to achieve our goals and promote the achievement of goals by our learners.
8,This resulted in a calculated sample of 75 residents with dementia [25].
0,Circumferential lesions around the veins will be considered complete when the procedural end point has been reached (see Procedural Endpoint section below).
8,"As for a rule of thumb of simulation study, at least 10–20 of interested events (i.e., SSI) were required per one predictor in the final model to prevent model optimism [14]."
0,If necessary a Stamm gastrostomy was performed.
8,"Our data contained 48 SSIs [12]; thus, the final model should include not more than five predictors."
0,Evaluator of IOP was also masked to treatment assignment.
6,The primary outcome was safety; efficacy was a secondary outcome measure.
0,"Enrolled subjects were allocated consecutively numbered sealed envelopes containing one of four vaccine regimens: homologous prime boost regimen 1 (Group 1): LAIV two doses separated by 8 weeks (±7 days), n = 5; homologous prime boost regimen 2 (Group 2): IIV two doses separated by 8 weeks (±7 days), n = 5; heterologous prime boost regimen 1 (Group 3), LAIV single dose, followed by IIV single dose 8 weeks (±7 days) later, n = 8; heterologous prime boost regimen 2 (Group 4): IIV single dose followed by LAIV single dose 8 weeks (±7 days) later, n = 8."
6,"The incidence of treatment-emergent AEs was monitored, recorded, and graded for severity and assigned attribution."
0,"As a general rule changes in PS were carried out by steps of 2 cmH2O, and changes in inspiratory and expiratory triggers by steps of 5 to 10%."
3,"Eligible patients were age ≥ 18 years with histologically confirmed solid tumors that were refractory to standard therapies or for which no approved or curative therapy was available, had Eastern Cooperative Oncology group (ECOG) performance status of 0-1, adequate hematologic and end organ function, and evaluable or measurable disease per RECIST v1.1."
0,The package contains general study information and consent forms.
3,"Patients were excluded if there was a history of autoimmune disease, prior treatment with any anti-cancer therapy, cytokines or toll-like receptors within 5 drug half-lives, antibodies directed at PD-1, PD-L1 or CTLA4, or other IDO inhibitors, prior malignancy other than non-melanoma skin cancer or carcinoma in situ of the cervix, infection with HIV, Hepatitis B or C, concomitant immunotherapy, untreated brain metastases, or current treatment with drugs associated with Torsades de Pointes, which could not be safely discontinued."
0,Cp of warfarin enantiomers was measured as reported previously.
3,"Patients aged ≥40 years with a post-bronchodilator forced expiratory volume in 1 s (FEV1) ≥25 and < 60% predicted, a documented history of ≥1 COPD exacerbation (for which they received treatment with systemic corticosteroids and/or antibiotics) in the previous 12 months, and modified Medical Research Council (mMRC) dyspnea scale grade ≥ 2 were included in the FLAME study."
0,"To determine the concentration of the various cytokines and adhesion molecules, plasma was processed immediately by centrifugation at 2,000 g at 4°C for 15 minutes and stored at -80°C until analyses."
3,Full inclusion and exclusion criteria have been described previously [10].
0,At least 200 tumor cells were scored per 40× field.
3,"Patients who were scheduled for an elective RALP using the da Vinci™ robot system (Intuitive Surgical, Inc., Sunnyvale, CA, USA) were enrolled in this study."
0,Attitude was measured using a 5-item questionnaire on health consciousness attitude and a 6-item questionnaire on health-oriented beliefs; all questions used a 5-point Likert-scale ranging from 1 (very unfavorable) to 5 (very favorable).
3,"Patients with a history of cerebrovascular disease, those who refused to participate, and those younger than 20 or older than 79 were excluded."
0,This was followed by a 2-month period of monitoring and observation.
3,Histologically confirmed EAC or ESCC.Stage appropriate for treatment by both nCRT and surgery.Disease deemed resectable by surgeon assessment and imaging.
0,"To this end, MI skills such as “Ask-Tell-Ask” might be deployed (e.g., Ask patient what he/she already knows about the effects of crack smoking on the lungs."
3,Patients for whom nCRT followed by surgery is not the appropriate management:Early stage disease requiring local therapy without nCRT.Metastatic disease.Performance status that precludes nCRT and/or surgery.Biopsy prior to starting nCRT not obtainable.
6,"The assessments were conducted at pretreatment, and at 8, 16, and 32 weeks since the trial initiation (i.e. at post-treatment, 8 weeks post-treatment and 24 weeks post-treatment)."
0,All participants are requested to complete physical activity monitoring for 7 days at the 12-week time point following the same procedure as at baseline.
4,Basic characteristics including sex and age were collected prospectively.
0,"For the analysis of the primary endpoint, MBEs, and the number and percentage of patients with MBEs were presented including 2-sided 95 % CI (exact interval by Pearson and Clopper)."
4,"Data on the capsule as excretion of the capsule, capsules retained before the cecum, total transit time, colon transit times and bowel cleansing quality were collected prospectively from the CCE evaluation reports."
0,"The PLA reactions were performed using Duolink® In Situ reagents, from Olink® Bioscience, according to manufacturer's instructions."
1,"The current study is a pre-electroconvulsive treatment, exploratory study comparing old psychiatric inpatients diagnosed with unipolar MD to a non-depressed control group of old persons."
0,g) Develop a risk model for patients with HF using key baseline characteristics to allow clinicians to accurately assess prognosis in individual patients.
1,"The study includes a subgroup of the patients from a larger randomized controlled trial [21], registered with the identifier: NCT01559324 at the online clinical database ClinicalTrials.gov."
0,Analysis of reliability of echocardiographic LV mass yielded an intraclass coefficient of 0.93 in this laboratory (p < 0.001) [21].
3,"Patients aged 18–75 years with a diagnosis of asthma in accordance with the GINA guidelines [1], as evidenced by the presence of an Asthma READ Code (UK diagnostic coding system), were eligible to participate in the study provided they were receiving step 3 or 4 therapy for asthma as defined by the British Thoracic Society (BTS) guidelines for persistent asthma [35]."
0,IOP was measured after other ophthalmic examinations but prior to pupil dilation.
3,"Exclusion criteria included any previous use of BF Spiromax, use of the BF Turbuhaler device in the preceding 6 months, the presence of a significant chronic lower respiratory tract disease other than asthma, a significant asthma exacerbation, a prescription of oral corticosteroids or antibiotic treatment within the preceding 2 weeks."
0,An outline of each of the two examination days is given in Additional file 1: Table S1.
8,"For the assessment of device mastery, a sample size of 477 patients was needed to achieve 90% power to detect a difference in proportions of 0.08 when the proportion of discordant pairs is expected to be 0.282 and the method of analysis is a McNemar’s test of equality of paired proportions with a 0.05 two-sided significance level [37, 38]."
0,"They also rated the overall level of shoe comfort using an 11-point (0–10) numeric rating scale (with terminal descriptors of ‘extremely uncomfortable’ and ‘extremely comfortable’), and perceived changes in walking ability and physical activity using 5-point (1–5) scales (with terminal descriptors of ‘much worse’ to ‘much better’ and ‘much less physically active’ to ‘much more physically active’, respectively)."
8,"For the longitudinal phase, a two-group Chi-squared test would have 90% power to detect the difference between maintenance of device mastery of 61.2% for BF Turbuhaler [39] and maintenance of device mastery of 78.9% for BF Spiromax (OR 0.422) when the sample size in each group is 139."
0,"It provides with clinically important patient relevant symptoms in the areas of pain, stiffness and physical function in patients with hip and/or knee OA."
3,"Male or female patients to be enrolled in the study should meet the following inclusion criteria: age ≥ 18 years, to be hospitalized in participating hospitals, rAAA confirmed and operated."
0,Participants were also asked how frequently they ate food prepared away from home to assess whether the salt consumed in the household represented the bulk of their salt consumption.
3,"Exclusion criteria are pregnancy, patients with bladder tumor or bladder surgery or trauma bladder can distort bladder pressure measurement, cystectomy, patients died before arrival in the operating room, patients died during surgery or within one hour of the initial surgical procedure, and patients whose abdominal closure at the end of the procedure is not possible."
0,"Patients were asked, always by the same researcher (L.G.A.), to cough as forcefully as possible [5] from total lung capacity (TLC)."
8,"For a sensitivity of 0.75, a precision of 0.15 and an alpha risk of 5%, the number of subjects required is 33 patients with ACS."
0,The contents of the envelopes were not known to the investigators.
3,"Patients with genetically confirmed CANDLE or SAVI or a suspected undifferentiated interferonopathy, who were referred to our center for evaluation and treatment recommendations and who were 17.5 months of age or older, weighed 8.5 kg or more, and had active clinical disease (CANDLE diary score ≥0.5 or a SAVI diary score ≥1.0) were eligible to participate in this study."
0,Urine was collected from 7:30-9:30 to measure the effect variables after a period of 24 hours of fasting.
3,Patients had to receive or to have previously failed treatment with oral corticosteroids (≥0.15 mg/kg/day prednisone or its equivalent).
0,"Our research partners in VA Central Office are interested in adopting the CALM tool for use in the VA, especially in CBOCs."
1,"REGATTA is a double-blind, randomized, controlled comparative effectiveness trial with active control and parallel groups comparing initial herbal treatment of uncomplicated UTI with immediate antibiotic therapy."
0,"The volunteers enrolled were fifty age- and gender-matched healthy Finnish-born volunteers (both groups comprised 17 females, 8 males, all aged 22–62, mean 32 years) (Table 1) with no history of enteric fever or typhoid vaccination, the numbers of volunteers were evaluated in pre-study power calculations based on responses in pilot experiments."
3,"Women between 18 and 75 years with suspected UTI presenting at general practice with at least two of the following symptoms: dysuria, urgency, frequency and lower abdominal pain will be asked for participation, assessed for eligibility and included after written informed consent."
0,"For moderation analyses, we will use random-effects multiple regression modeling the change in cotinine levels and parent quit status, using confounding variables as necessary."
3,"Key exclusion criteria comprise any signs of complicated UTI (i.e. temperature > 38 °C, loin tenderness), any conditions that may lead to complicated infections (i.e. renal diseases, patients with urinary catheter), pregnancy or breastfeeding, current self-medication with UU preparations, antibiotic use in the last 7 days, previous UTI in the past 2 weeks, history of pyelonephritis, contraindications for trial drugs, severe diseases (i.e. serious infection, multiple sclerosis), inability to understand trial information, and current participation in another clinical trial."
0,Urinary albumin will be measured using a nephelometric immunoassay.
3,"The inclusion criteria were age from 16 to 45 years, a medical diagnosis of moderate to severe SAR lasting for at least 2 years, and no contraindications to cetirizine."
0,All participants underwent exercise ECG before study participation.
3,"The exclusion criteria were perennial AR, allergic asthma, moderate to severe atopic dermatitis, autoimmune disorders, severe chronic inflammatory diseases, a history of anaphylactic reactions, hypersensitivity to cetirizine or related drugs, specific immunotherapy during the last 3 years or planned in the next 2 years, pregnancy or breastfeeding, previous acupuncture treatment for SAR, and any further use of CAM."
0,The scale is scored from 0 to 100 with a lower score being more favorable.
1,"SISTERS was a randomised, controlled, open-label, two-arm, parallel-group, phase IV study conducted in rehabilitation hospitals at 11 European centres (Austria, Belgium, Germany, Italy, the Netherlands, Spain, UK, Slovenia) and 7 US centres."
0,"For each test, the child’s parent records the observation as it appears on the meter and these observations are later checked for accuracy against the digital log of the instrument."
1,The study is registered at ClinicalTrials.gov (number NCT01032239).
0,Five college-educated social or health service professionals were chosen by the county health departments to be trained and deliver both interventions.
6,"The primary outcome was the change in spastic hypertonia and muscle tone in the affected lower limb, as measured by the change in average AS score in the LE of the affected body side from baseline to month 6."
0,"ArcGIS 9.3, a geographic information system, was used.23"
6,"Key secondary outcomes (see the online supplementary appendix table S1 for full list) included assessment of safety (primarily AEs), muscle tone in the UE of the affected side and function assessed by the FIM (total score, motor and cognition sub scores and individual FIM dimensions)."
0,"At each visit, electronic diary-card data were collected, a clinical assessment of CD and a physical examination were carried out, disease activity measured by CDAI, adverse events (AEs) and concomitant medications reported and samples taken for laboratory analysis."
3,"Participants were required to be age 18 years or older, have a BMI between 30 and 45 kg/m2, currently use an Android smartphone daily, have a Gmail account or be willing to open one (the app was located on Google Play), have connectivity to the internet at home and work, and have written physician clearance."
0,"The WLM is a four-center, randomized clinical trial testing the long-term efficacy of different strategies for maintaining weight loss."
3,"Participants were excluded if they were not regular users of Facebook, were not comfortable using a weight loss app, had severe mental illness or substance abuse, were pregnant or lactating, had bariatric surgery, were taking medication that affects weight, had type 1 or 2 diabetes, or had a medical condition that precludes lifestyle changes."
0,Participants were then presented with a 20 min educational slideshow on the function of the p16 gene and the role of methylation of p16 in the development of lung cancer (educational materials are available on request).
3,"From January 2009 to January 2016, PE was performed on 40 patients, 38 of whom were patients with recurrent or persistent cervical cancer."
0,The authors concluded that an intact articular surface may provide a partial barrier to cytoxicity due to bupivacaine.
3,"Before surgeries, all patients accepted detailed counseling about plans, complications, and prognosis of PE, and all gave consent."
0,Randomisation was carried out using block randomisation with a block size of 10 stratified per centre and an online randomisation procedure with a printed confirmation.
16,"Statistical differences in liver and spleen volumes, as a percent of body weight (BW), at 52 weeks, relative to baseline, and differences in shoulder extension and flexion at 26 weeks, relative to baseline, were evaluated with the Paired T-Test and a two-tailed P value (GraphPad, La Jolla, CA)."
0,I) The physical coordination training is divided into 2 phases.
2,"No major change was made since the original protocol and statistical analysis plan [32, 33]."
0,"Groeneveld et al. found that employees participating in a worksite-based motivational interviewing intervention reduced their body weight by an average of 0.9 kg after one year, compared to an increase in weight in the control group [19]."
2,Our published protocol [32] lists the several minor changes in the details since the original protocol.
0,"For the first month calls were weekly, the next month calls were bi-weekly, then for the remainder of the intervention calls were monthly."
1,"A prospective, single-centre, observer and patient blinded (double blinded), fixed design randomised trial."
0,"If a patient is not improving and a collection is deemed inadequately drained on repeat CECT after 72 hours, additional drainage is performed."
3,"All adults undergoing elective incisional hernia repair for midline abdominal incisional hernia, with a defect of 3-10 cm in diameter."
0,At that time all participants are informed that they can cancel participation without disclosing any reason at any time during the study.
3,Midline abdominal incisional hernia defined as any hernia that arises from a previous surgical incision in the anterior abdominal wall musculature providing that there is a minimum distance of 3 cm from the border of the defect to the costal margin or pelvis.
0,"The training team provided one-on-one training on how to use the out-of-pocket training module in the clinic, monitored its use, and periodically visited each practice to provide proactive support."
6,Primary outcome measures included change in retinal sensitivity at week 12 compared to baseline.
0,"These data are part of the STRRIDE project described in detail previously (11,12)."
6,"Secondary outcome measures included change in CMT, BCVA, retinal volume on SD-OCT macular thickness map."
0,"Two patients had stable hypothyroidism treated with thyroxin, and one had stable ulcerative colitis treated with mesalazin."
1,"This is to be a multicentre randomised type II hybrid implementation trial of feasibility and potential effectiveness in nine primary care centres that will be randomly allocated to one of the two strategies for engaging healthcare professionals in the development and execution of a process for adopting the recommended clinical practice for T2D prevention: a global strategy, seeking cooperation between professionals at all levels from the outset; or a sequential strategy, first led by nurses, and then seeking the pragmatic cooperation of the rest of the professionals in the centres."
0,"For data entry, we used secure, web-based, electronic case report forms developed by the central coordinating office."
1,The research protocol has been approved by the Basque Country Clinical Research Ethics Committee (Ref.
0,Malaria transmission around Chittagong is seasonal and of low intensity.
3,"Nine PHC centres of Osakidetza will be included in the study based on their organisational willingness to optimise the primary prevention of T2D, assessed through the obtaining of written commitment and consent to collaborate from a majority (> 51%) of the centre’s nurses and a substantial proportion of the doctors whose patients’ lists are involved through the nursing staff, after a session presenting the project."
0,Participants returned for follow-up at 6 weeks and 6 months.
3,"All the patients aged between 45 and 70 years old who seek medical attention in the participating centres at least once with a high risk of developing T2D and/or with moderate hyperglycaemia (high baseline glucose levels or glucose intolerance), but no diagnosis of T2D documented the medical record, will be candidates to participate in the T2D prevention programme."
0,This pilot study was performed in line with the 2004 Declaration of Helsinki.
1,"The NeuroVISION Study is a multicentre, prospective cohort study being conducted in 12 tertiary hospitals from 10 countries on 5 continents."
0,"The EOTV interviews focused on patients’ experiences during the clinical trial, particularly any symptoms that had changed (regardless of treatment assignment); participants were also asked about the timing and importance of any changes they experienced."
4,"Preliminary chart review in EPIC will be performed on all patients in our practice and those who have a previously undergone Cardiogenic Shock team intervention for acute decompensated heart failure cardiogenic shock, or acute myocardial infarction cardiogenic shock."
0,Prices are presented in 2012 terms (the year the trial concluded).
4,No recruitment process will be necessary to obtain information.
0,"The study coordinator, who was not involved in delivery of interventions or outcome assessments, communicated the allocation to each participant."
6,"The primary outcomes of this study are to create an archive of retrospective clinical outcomes (acute decompensated heart failure cardiogenic shock, or acute myocardial infarction cardiogenic shock) and compare current versus historical survival rates and to evaluate all-cause mortality at hospital discharge."
0,The assays were performed on Luminex® 200™ instrument.
6,"Analysis of mortality by subgroup (age, sex, initial etiology, time to presentation, time to treatment, use of mechanical circulatory support, Incidence of major adverse cardiac and cerebrovascular events, and preservation of left ventricular function."
0,We define a “Non-BCC neighbor” household as a household that is: (a) a neighbor of a TMRI household that had received a cash or food payment but no BCC; and (b) had a child aged 0-24m at the time of the survey.
8,We are estimating 300-400 patients will be included in this analysis.
0,"Patients with symptomatic brain metastases, autoimmune disease, peripheral neuropathy ≥ Grade 2, prior treatment with a CD137 agonist or a CTLA-4 agonist/inhibitor, chronic use of immunosuppressive drugs or of systemic corticosteroids were excluded."
8,This size is based on prior smaller studies.
0,"A pellet pestle (Sigma-Aldrich Sweden AB, Sweden) was used to homogenise the biopsies, with 50 μl of lysis buffer used to rinse the pestle."
6,The primary end point was change from baseline FeNO over time following the cessation of repeat dose treatment with FF/VI.
0,"The adaptive components include intrinsic and extrinsic changes, like supporting them to prioritise time and to divide activities into smaller parts, teaching them strategies to use their body in a more efficient and safe manner, and providing assistive technology and home modifications."
6,"Pre-specified secondary end points were change from baseline FeNO over the FF/VI treatment period, measurement of PEF during treatment and following cessation of repeat dose treatment with FF/VI, and measurement of FEV1 pre-treatment and twice daily for five days after cessation of repeat dose treatment with FF/VI, with a final FEV1 reading on day seven."
0,Four patients in whom temporal artery biopsies were obtained at the time of diagnosis before starting glucocorticosteroid treatment agreed to have second biopsies performed on the contra-lateral side after 46–52 weeks of treatment.
8,It was assumed that approximately 40–55% of men (≥18 years) who come to the facility for MMC would be within the target age range of 25–49 years with a variance of 2.5%.
0,The clinical investigation was registered at ClinicalTrials.gov with the identification number NCT01089231.
8,The minimum number of men to be recruited was 1537 for a minimum power of 80% at 5% significance level.
0,Sick children were referred to the research clinic.
1,"This study was an open, nonblinded explorative study."
0,"This general objective can be broken down into several specific objectives: i) to evaluate the results of the intervention programme in terms of reduction in the incidence of DM2, change in dietary habits, and increase in physical activity, among high-risk individuals attending OSAKIDETZA primary care centres in which the programme has been implemented."
3,Adult patients with type 1 or type 2 diabetes mellitus who presented with central-involved DME (defined as retinal thickening involving the 1 mm central subfield thickness) were included if best-corrected visual acuity (BCVA) was between 73 and 24 letters (20/40–20/320 Snellen equivalent) in the study eye.
0,Enzastaurin monohydrochloride was supplied by Eli Lilly and Company for oral consumption as 125 mg tablets in bottles.
3,Only one eye per patient was included.
0,Subjects were men and premenopausal women aged 18 to 50 years of age with a body mass index (BMI) between 30 and 55 kg/m2 who reported sleeping less than 6.5 h per night.
3,"For facility observations, all consecutive deliveries will be observed."
0,This will ensure that consent is being obtained and the inclusion and exclusion criteria are adhered to.
3,"If a pregnant woman or health worker declines to participate in the consent process, no observations will be recorded."
0,"Blood glucose and serum lipid levels were also measured in the hospital routine analytical laboratory using a Random Access Analyzer and Beckman reagents (SYNCHRON LX Systems; Beckman Coulter), with a coefficient of variation of 1.6–2.3% for blood glucose level and 1.3–3.0% for total cholesterol (total-C), triglycerides, and high-density lipoprotein cholesterol (HDL-C) levels."
1,"BeHealthyR is a three-arm RCT with three points in time: baseline (T0), four weeks post-baseline (T1) and twelve weeks post-baseline (T2)."
0,"Employees with low or moderate PA levels (0 to 3000 MET·min·wk.−1) [28] were invited to participate in the intervention by email or phone calls (n = 345, 62%)."
1,"Between February 2018 and July 2019, a total of 300 participants will be recruited and randomized either to a stress management program (SM), stress management with a buddy program (SM-B) or a control condition (CC)."
0,The protocol was approved by an independent ethics committee/institutional review board and regulatory agency in each centre (as appropriate).
1,"Between November, 2012 and July, 2014, we conducted a four-arm, factorial RCT (NCT01720641) to assess the effect of new PN tools on notification outcomes among MSM in Lima, Peru, with untreated syphilis infection."
0,Blood was drawn by venepuncture through a 21-gauge needle into evacuated tubes containing 3.8% sodium citrate.
1,The 4 arms included were (1) printed referral cards; (2) Web-based PN; (3) both printed referral cards and Web-based notification; and (4) control (standard of care) counseling procedures.
0,"The primary outcome, and treatment time intervals, will be analyzed with one-way ANOVA and subsequent pair-wise multiple comparison procedures across the four treatment strategies."
3,The study population comprised male and female adult patients (20–60 years of age) presenting with any type of superficial hematoma.
0,"The form of vitamin B6 used was pyridoxine, because that form can enter the cell and be converted into the active form, pyridoxal-5-phosphate (P5P); in contrast, P5P cannot enter cells [22]."
3,"Patients were excluded if they presented with an infection or wound requiring hospitalization or a surgical procedure, had a history of allergy towards r‐hirudin or any component of the r‐hirudin gel, had coagulation disorders (e.g, hemophilia), or were receiving additional anticoagulants (warfarin and/or acetylsalicylic acid) or digestive enzymes such as α chemotrypsin, during the study period."
0,"The study had an “all comers” design (i.e., all patients presenting for CABG surgery at age >74 were considered candidates for the trial) and randomized patients who were scheduled for isolated, first-time CABG at age ≥75, were either randomized to on- and off-pump CABG."
3,"Inclusion criteria For inclusion in the study, all of the following inclusion criteria must be fulfilled:○ Signed and dated informed consent○ Patients willing and able to comply with protocol requirements.○ Histology-proven, adenocarcinoma of the pancreas.○ Resectable adenocarcinoma (according to NCCN classification 2017) [9]: the absence of distant organ or distal lymph node metastases, the absence of evidence of SMV and PV distortion, tumour thrombus, or venous encasement, the existence of clear fat planes around the celiac axis, hepatic artery and superior mesenteric artery (SMA)."
0,"Both tests have shown to be very accurate with an intratest coefficient of variation of 1.93% and 5.59%, respectively."
3,"Resecability is evaluated on arterial-phase and portal-phase IV contrast-enhanced multislice CT-scan of the pancreas (slice thickness: 2.5 mm) and Diffusion Weighted MRI of liver, as evaluated in a multidisciplinary staff meeting including at least one radiologist and one expert surgeon.○ No prior chemotherapy.○ Age ≥ 18 or < 85 years○ ECOG performance status 0–1.○ Adequate hematologic function: neutrophils > 1.5 × 109/L; platelets > 100 × 109/L; hemoglobin ≥10 g/dL (transfusions are authorized).○ Adequate renal function: creatinine clearance (according to Cockroft and Gault’s equation) > 60 ml/min○ Adequate liver function: AST (SGOT) and ALT (SGPT) ≤ 2.5 x ULN (≤5 x ULN in case of liver metastases), total bilirubin ≤1.5 x ULN.○ Baseline evaluations performed before randomization: clinical and blood evaluations no more than 14 days prior to randomization, tumor assessment (thorax-abdominal-pelvis CT-scan and liver MRI) no more than 21 days prior to randomization.○ Women of child-bearing age not having undergone a hysterectomy or tubal ligation must undergo a negative pregnancy test (i.e. normal serum or urine beta-HCG level) before inclusion, and should use effective contraception throughout the study and for the following 6 months.Exclusion criteria Patients are not eligible for this study if any of the following criteria apply:○ PDAC defined as “borderline”, locally advanced non-resectable or metastatic.○ Prior cancer therapy for PDAC○ Surgical or anaesthesiological contra-indications:○ non-controlled congestive heart failure - non-treated angina – recent myocardial infarction (in the previous year) – non-controlled arterial hypertension (SBP > 160 mm or DBP > 100 mm, despite optimal drug treatment), long QT.○ major non-controlled infection.○ Any medical, psychological or social situation that (in the investigator’s opinion) could limit (i) the patient’s compliance with the protocol or (ii) the ability to obtain or interpret data.○ History or current evidence on physical examination of central nervous system disease or peripheral neuropathy ≥ grade 1, according to according to Common Terminology Criteria for Adverse Events (CTCAE) v.4.0.○ Known hypersensitivity reaction to any of the components of study treatments.○ Pregnancy (the absence of which must be confirmed in a ß-hCG test) or breast-feeding.○ Any significant disease which, in the investigator’s opinion, would exclude the patient from the study.○ Patients having been included in a clinical trial within the previous 4 weeks or participating in another trial."
0,The area under the curve (AUC) was used to identify the final model and the model was tested with Hosmer–Lemeshow and for internal validity by bootstrapping [45].
4,The study setting for this community RCT includes 22 villages in the Agincourt Health and socio‐Demographic Surveillance System (Agincourt HDSS) site in the rural Bushbuckridge sub‐District in Mpumalanga province of South Africa 35.
0,Isoniazid preventive therapy (IPT) was being introduced but not routinely conducted at any of the CLADE sites during the study.
4,HIV prevalence in Mpumalanga is estimated to be 21.8% among adults ages 15 to 49 36 and prevalence in the study area was over 45% among 35 to 39 year olds in 2010 to 2011 37.
0,The reliability of measurements within and between observers and equipment has been tested and reported previously.[17] Statistics
8,"Power and sample size were calculated to detect changes in the primary endpoint of interest, the GEMS score, in men and women separately."
0,"The Ethics Committee of Fuwai Hospital approved the research protocol (Ethics application number: IRB2012-BG-006 and approval number: 2013-449), and all patients signed informed consent."
8,"A total sample size of 1200 (600 participants per arm) would result in 91% power in men and 80% power in women to detect a four‐point increase (men) and three‐point increase (women) in GEMS between arms, assuming an intra‐cluster correlation of 0.05 and an average cluster size of 55 resulted in an estimated design effect of 3.7."
0,Percentage cell viability was calculated by dividing the absorbance values of drug treated wells by those of control wells and multiplying by 100.
5,"All children were treated with our school-based CBT (the treatment is described in the introduction) by local clinically experienced therapists who had no (n = 4), some (n = 11), or extensive (n = 6) previous work with selectively mute children."
0,Most employees identified healthy nutrition and regular physical activity as the main components of a healthy lifestyle.
5,"None had specific CBT training, but used our detailed manual describing defocused communication and weekly behavioral school-based interventions for a maximum of 6 months (mean 21 weeks, sd 5, range 8–24) under supervision from the first or last author, with no further treatment adherence measures."
0,"This analysis will enable any variations in resource use between the two treatment groups to be identified, measured and valued and facilitate the linking of patterns/costs of resource use to maternal and child health outcomes and other agreed measures of ‘effectiveness’ and ‘success’."
1,"MS-ON was a 6-month double-blind, multi-center, randomized, placebo-controlled study followed by a 6-month extension phase during which all patients received MD1003 [Online Resources 1, see electronic supplementary material (ESM)]."
0,"For all participants in studies 1 and 2, MPRAGE type T1-anatomical brain images were acquired as described before [15]."
1,The study was conducted between October 2013 and September 2015 at 19 sites in France and one site in the United Kingdom.
0,"All patients provided written informed consent before study-related procedures were conducted, and the study was performed in accordance with the principles of good clinical practice and the Declaration of Helsinki (1964 and subsequent revisions)."
1,"FAVOR II E‐J was a prospective, blinded, observational study with paired assessment of QFR, 2D‐QCA, and FFR performed at 11 international sites: Italy (4), The Netherlands (1), Germany (2), Poland (1), Spain (1), Japan (1), and Denmark (1)."
0,Figure 1 Study flow.
1,Clinicaltrials.gov identifier: NCT02959814.
0,CMV-pp65 peptide pool was used as quality control.
1,"The eMotion trial was a 2-arm, individually randomized, parallel-group pilot RCT with a nested process evaluation (ClinicalTrials.gov Identifier: NCT03084055)."
0,The pace was indicated by successive audible beeps.
1,The study was reported in accordance with Consolidated Standards of Reporting Trials (CONSORT-EHEALTH) recommendations for reporting of RCTs of eHealth interventions [32] and the Template for Intervention Description and Replication (TIDieR) recommendations on reporting of behavior change interventions [33].
0,"Patients who had a primary diagnosis of COPD as documented in medical and/or pulmonary rehabilitation notes, who had a good understanding of written English (as reported by the individual patient) and who were eligible for pulmonary rehabilitation based on a medical and clinical assessment were eligible to participate."
6,The primary outcome will be the TSPO density assessed by the volume of cerebral distribution of the tracer [18F]DPA-714 in the currently depressed group vs. the control group.
0,Figure 1 illustrates the study protocol.
6,"The secondary outcomes will be: (1) the TSPO density evaluated by the brain distribution volume of the [18F]DPA-714 tracer in the currently depressed vs. remitted depressed groups, (2) the clinical severity assessed by the Montgomery and Asberg Depression Scale—MADRS), BAS (Brief Scale for Anxiety), and the Columbia-Suicide severity rating scale—CSSRS), (3) MRI imaging: (i) structural (i.e., cortical thickness to quantify cortical atrophy); (ii) diffusion (i.e., the mean diffusivity for measuring microstructural integrity); (iii) T2* relaxometry (i.e., the R2* for measuring intracerebral iron content), and (iv) resting-state functional MRI (i.e., default mode network connectivity strength), (4) the concentrations of biological markers of peripheral inflammation (i.e., hs-CRP, IL-6, TNF alpha)."
0,"Telephone counseling was designed to provide regular, credible, individualized counseling that incorporated theoretically derived constructs, using culturally sensitive techniques (Resnicow et al., 1999)."
1,"This was a 24-week multicentre, open-label extension phase of the BLISS-SC study (GSK study BEL112341; NCT01484496), conducted between November 2011 and October 2015 at 177 sites in 30 countries across North America, Central America, South America, Western Europe, Eastern Europe and Asia.7"
0,We collected individual-level study outcomes based on a population-based survey sampling strategy in order to assess the community-level impact of the testing and voucher program.
1,Details of the BLISS-SC study design have been reported previously.7
0,"To relax the neck and upper back in preparation for spinal manipulation [21], the chiropractor administered a moist heat pack for five minutes and conducted a light massage for two minutes (described next)."
3,We included male and female adult (18 years and older) migrant workers who were directly involved in agricultural work at farm sites.
0,This clinical trial involves 19 hospitals/institutions in China.
3,"We excluded workers who were not directly involved in agricultural work (eg, accountants, administrative, etc)."
0,We defined HFOV-associated hemodynamic failure as major hemodynamic instability linked to HFOV: significant arterial hypotension (systolic arterial pressure under 90 mmHg or a decrease >30 % of initial systolic pressure) and/or CI decrease >30 %.
8,It has been recommended that an external pilot study should have at least 70 measured participants (35 per group) when estimating the SD for a continuous outcome.29
0,Rest breaks were interspersed as indicated.
8,"A sample size of 80 patients, with approximately 10% allowance for loss to follow-up allows the SD of an outcome to be estimated to within a precision of approximately ±16% of its true underlying value with 95% CI."
0,"Self-monitoring has been identified as one of the most important behaviour change techniques to increase health behaviours [26], including reducing sitting time [27]."
1,This was a 3 + 3 dose-escalation single-center study.
0,"Data on demographics, previous medical history, clinical symptoms, and functional status were collected."
1,The primary objective was to determine the recommended phase II dose of weekly paclitaxel administered in combination with a fixed dose of OMC.
0,"For participants scoring above a brief screen (AUDIT-C) cut-off (female >2 points; male >3 points), the online portal will launch a mandatory, full AUDIT (AUDIT-10) screen for alcohol dependence risk [38]."
3,"Patients aged ≥18 years with histologically proven, MAGE-A3-positive (MAGE-A3 expression in at least one of the two baseline tumour biopsies), metastatic, Stage III (in transit or unresectable) or IV M1a cutaneous melanoma, with documented PD within the 12 weeks preceding the first study treatment administration and with at least three tumour lesions of ≥5 mm diameter who signed the informed consent form were eligible for the study."
0,"For histology, hematoxylin/eosin staining was performed according to standard methods."
3,Detailed exclusion criteria can be found in the online supplementary materials.
0,"Confirmatory factor analysis demonstrated a good fit to the single factor questionnaire in patients with RA (Satorra-Bentler chi-square = 29.56 (5), CFI = .98, SRMR = .03 and RMSEA = .13"
8,"In the cluster -randomised trial, power calculations were performed,15 and sample size was decided based on the primary outcome, the Stroke Impact Scale22 domain participation."
0,In either case they were asked to complete a 7-day antibiotic course.
8,No power calculation was performed for the outcome use of health services.
0,"In addition, serum total cholesterol was measured using standard methods and creatinine measured colorimetrically using the alkaline picrate method (18)."
14,The data collectors were blinded to which type of interventions that was delivered by which site.
0,"Therefore, the plan was to collect information on attendance at therapy sessions and completion of treatment."
14,"Further, during the data analysis of the present study, the first and the last authors and the statistician were blinded to the participants’ group belonging."
0,"The study sites were provided with randomly numbered packages of study medications (according to the randomization sequence generated at the production site), which were randomly assigned to patients."
1,"This is an open-label, randomized, non-comparative, two armed exploratory study to evaluate the safety, and efficacy of two regimens of Anfoleish."
0,"To ensure optimal performance and to confirm specificity, antibodies against phosphorylated AMPK (p-AMPK) T172, phosphorylated acetyl coenzyme A carboxylase (p-ACC) S79, phosphorylated protein kinase B (p-PKB)/Akt S473 and phosphorylated extracellular signal-regulated kinase (p-ERK) T202/Y204 were optimized for immunohistochemistry (IHC) using FFPE MCF-7 breast cancer cells (American Type Culture Collection, Manassas, VA, USA)."
8,"It was calculated that a sample size of 36 subjects per treatment arm (36 TID and 36 BID) would provide a precision estimate of 15% with 95% CI, based on an anticipated cure rate at Day 90 of 70%."
0,Scores were converted to a five-point scale and reported as averages.
8,"Accounting for 10% subjects lost during follow up, four more subjects were added resulting in sample size of 40 subjects per regimen, or 80 subjects in total."
0,"Eligibility criteria included age 50–75 years, BMI 23–34.9 kg/m2, glomerular filtration rate (GFR) > 60mL/min, and Blessed mental score [31] equal to or less than 3."
6,"Sensitivity and specificity for a multi-parametric diagnostic model, incorporating different pathogen- and host-related factors, in differentiating between bacterial and viral aetiology in patients with LRTI and/or sepsis."
0,"In both groups, sticky tubes were used to conceal the type of needle used."
6,"Sensitivity and specificity for host-related individual blood biomarkers, in differentiating between bacterial and viral aetiology from other aetiologist in patients with LRTI and/or sepsis;Sensitivity and specificity for host-related sets of blood biomarkers, in differentiating Gram positive or Gram negative or atypical aetiology from other disease aetiologist in patients with LRTI and/or sepsis;Monitoring the temporal dynamics of host-related blood biomarkers levels during the course of disease in patients with LRTI and/or sepsis;A list of significant bacterial microbiome components that are associated with poor or favourable clinical outcome in patients with LRTI and/or sepsis;Sensitivity and specificity for liquid chromatography-mass spectrometry (LC-MS/MS) and lipid-based Protein Immobilization (LPI) proteomics-based rapid detection technique in identifying pathogens in clinical samples of patients with LRTI and/or sepsis;A web-based application that recommends physicians with a preferred antimicrobial treatment based on patients clinical, molecular and biochemical data;To define genetic mechanisms underlying the different host response between patients with viral versus bacterial infection."
0,Daytime is defined as the fixed period between 7 a.m.
1,"INCB 18424-261 (NCT01445769) was an open-label, multicenter, single-arm, phase 2 study evaluating an alternative dose regimen of ruxolitinib in adults with PMF, PET-MF, or PPV-MF."
0,"During weeks 1–6, subjects were instructed to use one to two sprays when they normally would have smoked a cigarette or when they experienced an urge to smoke; the second spray could be used if cravings were not reduced within a few minutes of the first spray."
1,"The study consisted of four phases: screening (up to 21 days), baseline (7 days), treatment (24 weeks), and follow-up (30–37 days after the last on-study ruxolitinib dose)."
0,All but one of the opinion leaders in the academic detailing arm agreed to meet personally with the expert OL for CRC (96%) on an individual basis.
3,"Clinical stage T3–4 N + M0 gastric cancer or Siewert II/III esophagogastric junction carcinoma; pathologically confirmed adenocarcinoma; 18–75 years old, male or female; Karnofsky score ≥ 70; white blood cell count ≥4 × 109/L; platelet count ≥100 × 109/L; serum creatinine ≤1× upper limit of normal, total bilirubin ≤1× upper limit of normal, alanine aminotransferase and aspartate aminotransferase ≤2.5× upper limit of normal, and alkaline phosphatase ≤5× upper limit of normal."
0,The primary outcome measure is the safety and tolerability of Sorafenib maintenance for a scheduled period of twelve months.
3,Participants of the present study were those randomized to one of the intervention study arms as part of the parent trial and completed the ‘end of treatment experience questionnaires.’
0,Grade refers to the severity of the Adverse Event (AE).
3,"Participants assigned to the UC condition are not reported on in this study, as they were not exposed to the CCBT program."
0,"Anesthesia was induced by propofol and fentanyl or remifentanil, and maintained with sevoflurane and either of the opiates used for induction."
3,"Patients presenting with a subjective indication for a fixed implant-retained prosthesis in the mandibular posterior region (i.e., distal to the canine).Extensive lateral bone loss of the edentulous alveolar ridge.Edentulous alveolar ridge width less than 4.5 mm.Edentulous for more than 6 months in the region requiring reconstruction.At least one missing tooth to be replaced in the edentulous area.Absence of clinical signs of infection in the region requiring reconstruction.Absence of any major oral pathology.Age 18 years and older.In good health."
0,"Postoperatively, patients were monitored for the occurrence of POD using the flowsheet version of the Confusion Assessment Method for Intensive Care Units (CAM-ICU-Flowsheet), which is explained in more detail elsewhere [20,21]."
3,"Evidence of infection with HIV, or hepatitis B or C, or any contagious disease (specifically, serologically negative for anti-HIV 1–2 Ab, anti-HCV Ab, HBs Ag, anti-HBc syphilis, and negative (not detected by PCR) in HIV NAT, HCV NAT, or HBV NAT).Smoker.Pregnant or breastfeeding.Untreated infections.History of malignancy.History of or scheduled cervico-facial radiation therapy.Chronic treatment with steroids, immunomodulatory drugs, or bisphosphonates."
0,"Research assessors (RL for most of the trial, with the last follow-up assessments completed by a replacement graduate psychologist [JM]) were masked to group allocation; the trial therapists informed patients of the randomisation outcome to maintain allocation concealment."
8,Sample size and power calculations are based on an estimated incidence of corneal ulceration of 100 per 100 000 person-years.
0,"For example, if a colposcopy, and cervical biopsy and/or ECC were both performed, the patient was counted into the cervical biopsy/ECC group."
8,"We estimate that 12 VDCs per arm will provide >80% power to detect a 30% reduction in incidence of corneal ulceration, assuming 9000 people per VDC, an intraclass correlation coefficient of 0.00015 and a two-tailed alpha of 0.05."
0,A coordination committee with access to all the information it needs will undertake preliminary analyses of the data to monitor the safety of the programme.
6,Clinical competency level in BEmONC skills of service providers at 3 months post-training.
0,Neither surgical team nor patient knew the next treatment allocation.
6,Retention in clinical competency level in BEmONC skills as assessed through OSCEs and MCQ scores at 12 months post-training.Service provider satisfaction with a simulation-based LDHF/m-Mentoring and group-based training approaches.Direct cost and cost-effectiveness of LDHF/m-Mentoring and group-based training approaches.
0,"Patients were seen at 2, 7, 11, and 24 weeks after starting on RCI."
6,Oxygenation by the end study drug infusion (assessed by P/F ratio: PaO2/Fraction of inspired oxygen).
0,All research activities were conducted at the Group Health Research Institute and approved by the Group Health Institutional Review Board.
6,"Intraoperative oxygenation, lung compliance (static and dynamic), dead space (Vd/VT), and PaCO2 (5 minutes after endotracheal intubation and positioning, at 45 min, and at 90 min after starting drug infusion).Heart rate, Systolic blood pressure (SBP), diastolic blood pressure (DBP), and plateau airway pressure (At the baseline, then every 15 min for 2 h).Demographic data (age – gender - BMI – smoking – comorbidities), operative data (surgical time – intraoperative fluids – blood loss), the need for postoperative ICU, the need for postoperative mechanical ventilation, postoperative complications, and Pasero opioid-induced sedation scale [9].The change in each of P/F ratio and dynamic lung compliance (Δ P/F ratio: P/F ratio by the end of the study drug infusion – P/F ratio at the baseline, Δ compliance: dynamic lung compliance by the end of the study drug infusion – dynamic lung compliance at the baseline)Δ dead space (%): dead space by the end of the study drug infusion – dead space at the baseline/dead space by the end of the study drug infusion %)."
0,"In addition, the patients will be asked to record their symptoms according to a VAS each morning and evening during the duration of the trial."
1,"This was a multicentre, qualitative study which was embedded within a trial."
0,"Control smokers had normal spirometry, defined as FEV1/FVC ≥ 0.7 and FEV1 ≥ 80 %."
3,"Eligible neonates were babies born at 34 weeks gestational age or more, presenting: 1) early neurological distress with clinical signs of moderate to severe HIE on standardized neurological examination performed by a senior investigator, 2) biological criteria of asphyxia during the first hour of life, including 2a) severe biological signs of asphyxia or 2b) moderate or no biological signs of asphyxia with perinatal adverse events (Table 1)."
0,Their role was to encourage other participating employees in the organisation to increase walking during their journey to and from work.
3,"Neonates with congenital malformations, chromosomal disorders and congenital neuromuscular disorders were not-included or subsequently excluded, as the pathogenesis of HIE requires several days to be confirmed."
0,"A single expert radiologist, blinded to both treatment assignment and time order, scored all images for synovitis, osteitis and bone erosion according to the OMERACT rheumatoid arthritis MRI score (RAMRIS) method.18"
1,This is a three-arm parallel randomized controlled trial which recruited adults (18–60 years) participants classified as overweight or obese (body mass index – BMI > =25 kg/m2) and who had the intention to lose weight.
0,A research assistant contacted women carrying out home-assessment over phone or at home.
8,"Based on a 90% power to detect a significant difference of 4 kg weight loss between groups, assuming the SD of weight is 6.0 and using a two-sided significance level of 0.05, and a 40% attrition rate, a sample size of 90 participants was calculated for each group [7]."
0,Enrolled practices were assigned at random to one of three forms of CME described below.
14,"In order to ensure study blinding, only the pharmacist of each centre will know the nature of the box (BTX-A or placebo)."
0,BMI was then calculated.
14,"Moreover, an independent nurse will prepare the syringe in a separate room."
0,"Baseline, 12-week and 24-week blood samples were drawn in the morning, after a 12-hour fast, for glucose, lipid profile, including apolipoprotein A-I and B, leukocyte count and inflammatory markers were made."
14,"Using an electronic platform for data collection, study group allocation, and intervention viewing will allow participants to access the interventions and provide data independent of the research team."
0,Consensus codes were integrated to develop a thematic framework that encapsulated the data [9].
14,Participants and study staff will be blind to how the content on the iPads differs between groups during data collection.
0,"Further serum samples were obtained immediately following surgery, at the end of the intervention period and 24 hours after the end of surgery."
16,This was a proof-of-concept study to demonstrate feasibility and generate data to help design and power a subsequent clinical trial.
0,"Three visits were planned, consisting of baseline examination (visit 1), a control visit after 4 weeks (visit 2), and the final examination after 4 months (visit 3)."
16,"Therefore, a convenience sample of 7 subjects was enrolled, and statistics were not applied to the data because of the small sample size."
0,Patients allocated to face-to-face BI were invited to check a box online which automatically generated an email to their GP requesting an appointment within the next 7–10 days.
4,"This was an external pilot study [14,15] conducted to inform the design and implementation of a separate full-scale trial."
0,"Treatment sessions will be delivered at the cancer clinic, at home, in the hospice."
4,The study design was a randomized encouragement trial.
0,"The condition number should ideally be ≤1,000, as a condition number exceeding 1,000 is indicative of ill conditioning of the model."
6,"Symptoms of anxiety and depression were measured by The Hospital Anxiety and Depression Scale (HADS) (Zigmond and Snaith, 1983), and the Chalder Fatigue Scale (Chalder et al., 1993) was used to measure physical and mental symptoms of fatigue at baseline, post treatment and the 6-month non-randomized follow-up."
0,"The BP was measured at randomization (baseline), at monthly intervals to achieve the target BP after randomization (drug titration phase) and every 6 months thereafter."
6,"Only the total HADS score was used, as research indicate that the HADS subscales' ability to differentiate between depression and anxiety is suboptimal (Cosco et al., 2012)."
0,A thorough process of obtaining informed consent and satisfying eligibility criteria was a prerequisite for enrolment in the trial.
3,Sixteen healthy subjects with no known motor or cognitive deficit were to be recruited among the population of Zurich.
0,All cost-effectiveness analyses require a ‘no active intervention’ or ‘standard care’ control.
3,Most of them were employees and students of ETH Zurich.
0,"This refers to injury severity, location, type and diagnosis as well as definitions for training and match exposure."
3,"We will include community-dwelling men and women who (1) are aged between 65 and 85 years and are living in their own home; (2) have preserved general cognition as indicated by a Mini-Mental State Examination (MMSE [45]) score ≥ 24/30; (3) have a baseline Montreal Cognitive Assessment (MoCA [46]) score < 26/30; (4) do not have dementia of any type; (5) do not have any significant impairment in daily function; (6) are currently experiencing poor sleep quality as indicated by a Pittsburgh Sleep Quality Index (PSQI [47]) score > 5; (7) scored < 5/15 on the 15-item Geriatric Depression Scale [48, 49]; (8) are able to walk independently and are in sufficient health to participate in regular PA as indicated by the PAR-Q [44]; and (9) understand, speak, and read English with acceptable visual and auditory acuity."
0,Fig. 4 Diagram of weekly repayment plans Peer Health Leader component
3,We will exclude individuals who are (1) diagnosed with obstructive sleep apnea; (2) receiving continuous positive air pressure (CPAP) treatment; (3) at high risk for cardiac complications during PA or unable to self-regulate activity or to understand recommended PA level; and (4) have clinically important peripheral neuropathy or severe musculoskeletal or joint disease that impairs mobility.
0,A multivariable analysis was also undertaken using multinomial logistic regression to investigate for any evidence of a change in epidemiological trend for hospital admissions for RVGE following the switch from lyophilized to liquid formulation of Rotarix in August 2011.
3,"Eligible participants included male and female adults (≥20 to ≤65 years), with T1DM who were treated for ≥12 months with multiple daily injections of insulin prior to study initiation (≥1 basal and ≥3 bolus injections, with total daily insulin dose needs of ≥0.3 to ≤1.5 U/kg), and with HbA1c of ≥7.5% to ≤10.0% (National Glycohaemoglobin Standardization Programme % units; mmol/mol = [10.93 × %] – 23.5), with a fasting C‐peptide value of <0.6 ng/mL, with BMI of ≥18.5 to ≤35.0 kg/m2, and with an estimated glomerular filtration rate (eGFR) of ≥60 to ≤150 mL/min/1.73 m2, who could manage blood glucose monitoring, carbohydrate counting and insulin dose adjustment."
0,"Thereafter, 3 and 3.5 ml of blood samples were taken at 15, 30, 45, 60, 90 and 120 min to analyze postprandial glucose and insulin responses, respectively."
3,"Participants were excluded if they had a history of T2DM, maturity onset diabetes of the young, pancreatic surgery or chronic pancreatitis; acute coronary syndrome, stroke, transient ischemic attack or indication of liver disease; severe hypoglycaemia, treatment with any antihyperglycaemic drug except insulin, anti‐obesity drugs or other treatment leading to unstable body weight within 3 months before screening; DKA within 3 months prior to screening or occurring between screening and randomization."
0,They also understand that their consent to the study will not directly benefit them.
1,Multicenter descriptive and analytic cross sectional survey of acutely admitted patients for risk factors and carriage of MRB.
0,"Harvesting was performed with a 10 mL syringe in a closed circuit using a 3 mm Coleman cannula with 2 terminal 4 mm×2 mm openings with a two-way non-return AT valve, sterile tubing and a 250 mL collection bag."
3,Patients aged 18 years or above.Patients present in one of the participating emergency departments at least 4 h.Patients must be mentally competent and able to consent to participate.
0,DAVID's functional annotation tool identifies clusters of genes from annotation categories that are differentially expressed between the groups.
3,"Patients who have been admitted for more than 16 h before enrollment.Patients where swabbing in the rectum, nose or throat is not possible due to anatomic or surgical reasons."
0,Detail on each of these measures follows: Fig. 2 Logic model Anthropometric measures
5,There are no interventions in this study.
0,A composite appetite score (CAS) was calculated as: CAS = (desire to eat + hunger + Prospective Consumption + (100 – Fullness)) / 4 (16).
6,"The primary outcome is the presence of MRB (MRSA, ESBL, VRE, CPE) and CD in patients in the ED, expressed as prevalence (proportion) in percentage on admission among the included patients."
0,"Thanks to the two locations, the investigators who conducted the assessments in one nursing home supervised patients from the other nursing home so that they would not know to which group the patient, they were assessing, belonged."
6,"The secondary outcomes are the information on admission concerning risk factors for carriage of antibiotic resistant bacteria, expressed as the proportion and odds ratios between patients with and without MRB (Table 1)."
0,"Plasma samples were drawn using commercially available pre-heparinized syringes (safe PICO Aspirator, Radiometer, Copenhagen, Radiometer Medical ApS, Åkadevej 21, DK- 2700 Brønshøj, Denmark)."
2,"Important protocol modifications like changes in eligibility criteria or outcome will be communicated to the relevant parties, i.e. sponsor, trial registry and scientific ethical committee."
0,Cost analysis will also use standard Centers for Medicare and Medicaid Services (CMS) costing information and reimbursement information.
8,"For each dose level, a minimum of 30 patients will be included."
0,"At community awareness meetings, the health messages included information on the signs and symptoms of TB, HIV and AIDS and emphasized that treatment is provided free in local primary care facilities."
8,The maximal tolerated dose will be defined as the dose level below which at least 10 patients present with a DLT at 6 months after SABR.
0,"The target 100%T>MIC (i.e., meropenem serum concentrations exceeding one times the MIC for the entire dosing interval) was selected because it has previously been shown to improve clinical cure and bacteriological eradication in patients with serious bacterial infections treated with β-lactam antibiotics [20, 37]."
1,"We conducted a multicenter, randomized controlled trial, which enrolled mechanically ventilated patients with COPD in southern Brazil."
0,Community-based participatory research (CBPR) is a collaborative research approach that is designed to ensure and establish structures for participation by all stakeholders in different aspects of the research process [13].
16,"GraphPad Prism 6 was used to compare group means by student’s T test and analysis of variance and group proportions by Fisher’s exact test, and to determine Spearman’s correlation coefficients to evaluate RLU and CFU correlations."
0,"Due to time constraints, the educators were not able to engage with the vodcasts in the study groups, and the themes were instead incorporated into workshop sessions and other materials."
1,"This study is designed as a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial."
0,The list of autoimmune diseases and other immune-mediated inflammatory disorders is included in online supplementary materials.
1,Patients will be recruited in 21 centers in Germany.
0,"Embassy in Mozambique (coordinator of President's Emergency Plan for AIDS Relief [PEPFAR] activities), and the Millennium Challenge Corporation [32]."
3,Key eligibility criteria are summarised in table 1.
0,The researcher arranged a first nurse appointment for participants (either as an individual or as a couple).
3,"Briefly, patients aged ≥40 years, with a diagnosis of IPF according to ATS/ERS/JRS/ALAT guidelines1 within 3 years, chest HRCT and surgical lung biopsy pattern (if available) consistent with a diagnosis of IPF and FVC ≥80% predicted were eligible to participate."
0,The inversion stress test is intended to elicit symptoms or excessive mobility due to calcaneofibular ligament rupture [38].
3,Inclusion and exclusion criteria for the PATH-2 trial are presented in Table 2.
0,Bioassays were carried out at 25 ± 2°C and 65 ± 10% relative humidity.
5,"Patients received oral alpelisib QD in 28-day cycles (300, 250, or 150 mg) and paclitaxel 80 mg/m2 QW as a 1-hour (±15 minutes) IV infusion after standard premedication (per local standard practice)."
0,Per patient costs of patient-specific training were based on planned time and valued based on a mean hourly wage for a community district nurse.
5,"Patients received treatment until disease progression, unacceptable toxicity, patient decision, death, or discontinuation for any other reason."
0,"In case of agreement, an average SYNTAX score was calculated."
6,The primary outcome measures of the study were:The amount of intra-operative blood loss.The change in pre and post-partum hemoglobin.
0,Patients meeting inclusion criteria as per WHO protocol of 2009 [31] with minor modifications (to assess cardiotoxicity effects associated with DP [32]) were recruited and randomized to receive therapeutic doses of either AL or DP.
6,The secondary outcome measures were:The need for blood transfusion.The need for further surgical intervention to control intraoperative bleeding.The operative time.
0,"Instead, several actors negotiate decision-making, and power is rarely symmetrically distributed within the household [60, 61]."
1,We have complied with the World Medical Association Declaration of Helsinki regarding ethical conduct of research involving human subjects and/or animals.
0,"This retrospective observational monocentric study included all adult patients with ulcer pressure-related sacral or ischial chronic osteomyelitis managed by a two-stage surgical strategy (i.e, debridement followed by NPT before myo- or fascio-cutaneous flap reconstruction) associated with prolonged antimicrobial therapy from January 1st 2012 to April 30th 2016."
1,All patients provided written informed consent to be involved in the study.
0,The average values from years 1–3 were used to measure dietary intakes during follow-up (11).
6,"The primary outcome of the COSIMO study is treatment satisfaction, assessed as change in the Anti-Clot Treatment Scale (ACTS) Burdens score [26] from enrolment to week 4."
0,"RA disease assessments were completed during a screening visit and on day −1, 15, 29, 57 and 85 post–brodalumab administration."
6,"Secondary outcomes include patient preferences with regard to convenience attributes; the change in ACTS Burdens score at month 3 and month 6; change in health-related QoL (HRQoL); patterns of anticoagulant use and incidence of bleeding, thromboembolic events and other AEs and serious AEs."
0,"Data on family social class, collected and coded from the pupil’s survey [27], is compared to data from the Danish contribution to the international study on family social class, Health Behaviour in School-aged Children [32, 33]."
6,The primary outcome was the change in the 24-hour ABPM mean value from baseline to week 12.
0,"Table 1 Cost of food supplementation for pregnant women in Bangladesh by implementation strategy, NGO run community nutrition centres (CNSs), government (Govt.) run CNCs, and by a hypothetical highest cost scenarioa Analyses"
6,Secondary outcomes were a target SBP of 140 mmHg or less and/or a target DBP of 90 mmHg or less in office BP measurements 12 weeks after the start of medication administration.
0,Potohar is one of the seven sub-districts of Rawalpindi and is located 65 km southeast of Rawalpindi city.
1,A single blind randomized study was conducted with two treatment groups and one control group.
0,The specific IgG or IgA was recognized by goat anti-human IgG or IgA conjugated with peroxidase.
1,"Patients included in the experimental groups received physical therapy treatment, namely manual therapy (MT group) and educational therapy (EG group)."
0,"Therefore, any aspects of culture or language status that may have affected the test results would have a similar effect on the patient's performance at all three time points and therefore cancel out in the analyses."
3,"Hospitalized adult patients > 18 years of age with CF were included in the study if they had a clinical indication for NIV at the time of admission based on at least one of the following criteria [4, 21] and had been stabilized with NIV as set by respiratory therapists, medically optimized with antibiotics and bronchodilators as necessary according to their treating physician before entering the study (in order to minimize the risk of abrupt decompensation):Signs of clinical respiratory distress: respiratory rate > 24/min or accessory muscle usePartial pressure of arterial carbon dioxide (PaCO2) level > 45 mmHg from the time of hospital admissionNocturnal hypoventilation treated by NIV but requiring daytime NIV because of clinical worsening defined as either of the two conditions aboveDiurnal hypercapnia (PaCO2 > 45 mmHg) or PtcCO2 > 40 mmHg in patients who have persistent elevation of serum bicarbonate level (HCO3− ≥ 32 mmol/L)."
0,"The CAQ consists of 3 subscales: fear, avoidance, and heart-focused attention."
4,"Anthropometric data were obtained from the patient’s medical chart including age, gender, height and weight, and the most recent pulmonary function testing and arterial blood gasses."
0,Reactogenicity and safety were also evaluated.
4,"In addition, patient baseline characteristics including significant comorbidities, admission diagnosis and severity of illness (APACHE II) scores were collected."
0,Each participant’s day 21 and day 63 samples were analyzed on the same day for consistency.
4,"The study will take place in high schools across Michigan’s 83 counties, with CBT delivered by existing SPs for students with depression and anxiety."
0,Up to five biopsy cores were obtained using 18-22G biopsy needles and embedded in optimal cutting temperature (OCT) compound.
4,"The REP (which includes CBT manual package, training, and technical support for SPs), coaching, and facilitation implementation strategies will be provided through the TRAILS program [31]."
0,Figure 1 Trial flow diagram.
3,"Individuals were considered eligible for this study if they (1) were aged 18-75 years, (2) self-identified as African American, (3) were a member of a participating church, (4) had a body mass index (BMI) of >30 kg/m2, (5) owned a mobile phone with SMS text messaging capabilities, (6) were at risk for diabetes (ie, had a history of gestational diabetes or at least one diagnosed nuclear family member) or had been diagnosed with type 2 diabetes, (7) were willing to change their diet and physical activity to promote weight loss, (8) were able to participate in face-to-face counseling sessions as scheduled, and (9) had low to moderate cardiovascular disease risk."
0,"(ii) Impact of alcohol consumption: Based on reported quantity and frequency of drinking, estimated financial costs of this consumption and caloric intake were calculated."
3,Participants were paid up to US $60 for completing the study.
0,Asexual parasites were counted on thick blood films against 200 white blood cells (WBCs) and parasite density was calculated assuming an average WBC count of 10.000/μL.
2,Future protocol modifications will be submitted as amendment at the central medical ethics committee.
0,"This randomized, prospective study was conducted from 2009-2013 at the University Medical Centre Ljubljana, Department of Anesthesiology and Surgical Intensive Care and at the Department of Thoracic Surgery, in close cooperation with the Department of Clinical Chemistry and Biochemistry."
2,"After obtaining approval, this will be communicated to the participating sites by the study coordinator or project manager."
0,"We included the following constructs: knowledge (assessed by asking 7 questions on tick ecology, basic prevention, and tick bites); perceived susceptibility (asking the respondents whether they think they could personally become ill after a tick bite); an additional proxy for perceived susceptibility (asking whether the respondent personally knows someone who became ill after a tick bite); perceived importance of preventive behavior as a proxy for response efficacy (asking whether the respondent thinks tick-checks are important), and actual preventive behavior (asking for the frequency of tick checks performed by the respondent’s parent(s))."
3,"In both studies, healthy male subjects aged 18–55 years with a body mass index (BMI) of 18.5–29.9 kg/m2 were eligible to participate."
0,"Quantification of anti-HBs titers were performed on collected sera at the Research Institute for Health Sciences laboratory, Chiang Mai University, using a standardized assay (Microparticle enzyme immunoassay; AXSYM, Abbott, USA; sensitivity 100%; specificity 100%)."
3,"Exclusion criteria included any clinically relevant laboratory values or findings on medical examination; cardiovascular, hepatic, hormonal, immunologic, renal, respiratory, metabolic, and gastrointestinal disorders; diseases of the central nervous system; psychiatric disorders; neurologic disorders; chronic or relevant acute infections; any other clinically relevant disease; history of orthostatic hypotension, fainting spells, blackouts; allergy/hypersensitivity; and alcohol or drug abuse."
0,Lipid bioaccessibility was estimated by calculating the difference between the total lipid content of the original almond samples and the lipid content of the almonds after mastication but appropriately adjusted to account for the loss of almonds in the mouth.
3,"Adult patients with ≥1-year history of active moderate-to-severe RA disease activity (DAS28-ESR ≥3.2; ≥6 tender joint count [TJC], and ≥6 swollen joint count [SJC] or ESR ≥28 mm/h; and C-reactive protein [CRP] ≥3.5 mg/L), nonresponsive to prior MTX (≥10 mg/wk for ≥12 wks) were included in the study."
0,"Our efficacy analysis by age group based on the trial data showed that the effect of the intervention in SBP differed by younger (<60 years old) and elder adults (> = 60 years old), a reduction of 0.7 mmHg (95%CI: -1.6 to 2.9) and 9.5 mmHg (95%CI: 2.2 to 16.7) separately."
6,The primary endpoint was the proportion of patients maintaining LDA without flare at week 52.
0,All costs are expressed in 2015 Canadian dollars ($C).
6,"Secondary endpoints included the overall proportion of patients maintaining LDA by DAS28-ESR and DAS28-CRP criteria, maintaining remission (DAS28-ESR <2.6), achieving 20% (ACR20), 50% (ACR50), 70% (ACR70), and 90% (ACR90) improvement from baseline based on American College of Rheumatology (ACR) criteria, the proportion of patients achieving normal scores on the Health Activity Questionnaire-Disability Index (HAQ-DI) at week 52, and change from baseline for other patient-reported outcome assessments."
0,"Individual CrCls were estimated by the Cockcroft–Gault formula using serum creatinine data from screening (day −21 to day −1), or from baseline visits if the screening value was missing."
4,"Children were recruited in the pediatric wards of 3 secondary hospitals—Kilifi County Hospital (rural), Malindi subcounty hospital (rural), and the Mbagathi subcounty hospital in Nairobi (urban)—and 1 tertiary-level hospital, Coast General Hospital in Mombasa (urban)."
0,The information was obtained from Statistics Denmark and by use of a Geographic Information System (GIS).
4,Inpatient care for SAM and other conditions and subsequent outpatient care was provided according to WHO and Kenyan national guidelines (5).
0,"Patients evaluable for immune response were those eligible patients who had received at least two doses of IDD-3 vaccines, had a valid baseline immune response assessment and provided at least one post-vaccination blood sample."
3,"Participants were healthy, non-athlete individuals aged 18–40 years, approached through flyers and announcements on official web pages."
0,Fever = Patient has a fever.
3,"Exclusion criteria were cardiac abnormalities, pulmonary disease, syndromes (eg, Down’s), pregnancy or current breast feeding, and metabolic disorders (eg, hyperthyroidism)."
0,Participants are free to withdraw from the trial at any stage.
6,The primary outcome was the effect of salbutamol on peak oxygen uptake.
0,"As a separate analysis, we assessed the time to occurrence of treatment failure in both groups."
6,"Secondary outcomes were the effects from salbutamol on workload, heart rate, breath rate, minute ventilation, breathing reserve and ventilation efficiency, defined as VE/VCO2."
0,The expected adverse effects were minor gastrointestinal disturbances.
6,"We assessed the time from randomisation until the first occurrence of one of the following events: acute myocardial infarction, unstable angina pectoris, cerebrovascular disease and all-cause death (the composite outcome) and the time from randomisation to all-cause death."
0,"BP was assessed using a semi-automatic device (Digital blood pressure monitor OMROM UA-787; OMRON Corporation, Kyoto, Japan)."
6,The algorithm used to get from the International Statistical Classification of Diseases used in the national registries12 13 to the events of the composite outcome is described in refs 4 5.
0,"Although we have previously shown that EpCAM is not expressed on the surface of hematopoietic cells [16], this does not preclude that normal epithelial cells which have been disseminated into blood are detected by this approach."
1,"The study was a multicenter, randomized, open-label, controlled clinical trial among patients admitted at 2 hospitals in southeastern Bangladesh, Thailand: Ramu Upazilla Health Complex (primary subdistrict hospital) and Chittagong Medical College Hospital (CMCH; tertiary referral hospital)."
0,"An online support centre is available to participants for queries over their usernames, passwords and/or any problems with access."
1,"A RCT, with a PA intervention programme of 9 months duration, comprising a walking group of 120 min/week, supervised, and with socio-cultural activities."
0,Patients were randomized by country and stratified within country based on SFU and thiazolidinedione (TZD) use.
1,"The EXIT-trial is a phase II, single arm study."
0,"You have experienced repeated severe episodes of it, ever since the teen years."
1,"The study was initiated by the Department of Radiation Oncology in collaboration with the Departments of Radiology, Pathology, Medical Oncology and Gynaecologic Oncology (Ghent University Hospital, Ghent Belgium)."
0,"Throughout the study, subjects maintained their usual training routine and diet."
16,"We measured feasibility via the ease of recruitment based on the ratio of enrolled women to the number of women approached about the study, and via maintenance of contact with a health coach based on the study participant attrition and follow-up survey completion rates (retention)."
0,All of the patients were ventilated with a tidal volume of 8 ml/kg.
16,We measured acceptability via survey items about components of the intervention and through qualitative comments from a semi-structured interview.
0,The mRNA expression levels were investigated in 379 CRC tissues and 32 PN tissues in TCGA datasets by Illumina HiSeq 2000 RNA Sequencing Version 2 analysis and normalized by the RSEM algorithm.
1,A pragmatic parallel observer-blinded RCT nested in a school-based open cohort.
0,The study complied with the Declaration of Helsinki.
14,"Due to the nature of the intervention, blinding of the treating chiropractors was not possible, however, neither parents nor children were informed about group allocation and parents did not attend treatment sessions and answered the SMS without contact with clinicians or researchers."
0,For each activity type a total was computed for individual participants by summing the number reported each day.
14,The coding of the intervention group was not revealed to the primary investigator or the statisticians until after the analyses had been completed.
0,"The assessment includes an interview with an informant or care-giver of the patient, which covers six cognitive and functional domains: memory, orientation, judgment and problem solving, community affairs, home and hobbies and personal care."
6,The primary outcome was the number of recurrences as measured via the weekly SMS messages.
0,"Independent ethics committee and hospital-based institutional review board approvals were obtained, as necessary, for the registry protocol."
6,"A recurrence was defined as a new episode of spinal pain (ie, back and/or neck pain) occurring after at least 1 week without spinal pain following the end of the previous episode (see secondary outcomes, table 3)."
0,Participant recruitment is performed from a randomized list of overweight or obese patients who had a BMI measure recorded at least 9 months prior to study initiation (Fig. 1).
8,"As the study had continuous inclusion, we continued to recruit participants until 3 months prior to the end of data collection in summer 2014, to include as many participants as possible with varying follow-up times."
0,Camera exposure was between 5 and 250 ms as indicated.
8,"Based on preliminary analyses, this resulted in a power of 76% for the number of recurrences, 20% for episode length and 87% for overall complaint time.22"
0,The titers were expressed as the reciprocal of the highest dilution that showed complete inhibition of hemagglutination.
6,The primary outcome was the number of patients recruited into the ECLS trial.
0,"After verification of inclusion and exclusion criteria, at 8:30 a.m."
6,The secondary outcome was the proportion of patients expressing an interest in participating in ECLS.
0,The patients were asked to place an “X” at the number that represented their pain.
6,The primary feasibility assessment outcome was knowledge acquisition and retention as defined by changes in MCQ scores (post-training score to pre-training score) and post-training clinical test scores for both the intervention and control groups.
0,Subjects were nested within schools.
6,The secondary outcome measures assessed the experiences of CHWs using the tablet-based form of training.
0,at the splenic hilum.
8,"In a preliminary study 10 healthy volunteers rated 13% lower AH on VAS with inhaled furosemide relative to inhaled saline [21], with a standard deviation of 16% resulting in an effect size of 0.81."
0,The detailed protocol is available on the University of Maryland website (http://www.medschool.umaryland.edu/malaria/Protocols/).
8,"Based on this observation, it was determined that 16 participants were required to detect an effect size of 0.81 using matched pairs t-test at 5% significance level and 86% power."
0,Horseradish peroxidase-labeled rabbit polyclonal anti-panitumumab antibody (Amgen Inc.) was added to the wells and allowed to react with the captured panitumumab.
8,We assumed a mortality rate of 22% in the control group at day 90.
0,"As the European Society of Cardiology9, 10 considers the pretest probability >15% as a fundamental component to select the most appropriate diagnostic test in patients with stable angina, all such patients were considered for further non‐invasive cardiac investigations, eg, stress echocardiography, exercise stress testing, myocardial perfusion scintigraphy, and multi‐slice computed tomography coronary angiography (MSCTA)."
8,"To show a 5% absolute reduction in 90-day mortality in the OSP group, with a two-sided type I error of 5% and a power of 90%, the planned enrolment was 2720 patients."
0,The follow-up visits consisted of physical examination and medical history and had a scheduled duration of approximately 10 minutes.
1,"This phase Ib, open-label, dose-escalating study (ClinicalTrials.gov Identifier: NCT01918254) investigated the safety, pharmacokinetics (PK), pharmacodynamics (PD) and clinical activity of lumretuzumab in combination with pertuzumab and paclitaxel."
0,See Table 2 for examples.
1,The study was conducted in two phases: a dose escalation phase and an extension phase.
0,Serum TSH concentrations were considered within the normal range or above the normal range based on age specific references ranges31.
3,Patient eligibility criteria for the randomized controlled PRIME study have been previously described (Douillard et al. 2010).
0,Participants randomized to the SmokefreeMOM + Quitline group received the same intervention as the SmokefreeMOM group with the addition of the opportunity to be enrolled in state quitline services at the time of enrollment.
1,We conducted an interventional study in which we invited all parents living with HIV/AIDS receiving HIV care in three hospitals in Cameroon to have their children of unknown HIV status aged 6 weeks to 19 years to be tested for HIV (tPITC group).
0,This study involved a subset of patients (40) who took part in a larger randomized controlled trial (n = 70).
1,"In the same hospitals, all parents/guardians who accompanied their sick children of the same age group for consultation at the outpatient departments were also counseled, and these children were invited to test for HIV irrespective of the presenting complaint (bPITC group)."
0,The information will be sent to the research coordinator.
3,"The target population was underserved minority children entering kindergarten through fifth grade and their adult caregiver from underserved neighborhoods in Columbus, Ohio [13]."
0,"The last minute of each trial was manually analysed off-line using customized software based on Microsoft Excel, as previously described [9]."
3,"Patients at least 18 years of age with chronic kidney disease, who were either receiving maintenance hemodialysis or were expected to commence maintenance hemodialysis within six months and required the creation of an AVF, were enrolled."
0,"If visible contraction of the innervated muscle was elicited, the needle was withdrawn slowly until the corresponding muscle contraction disappeared to avoid intrafascicular puncture [10]."
3,"Exclusion criteria were alpha 1-antitrypsin deficiency, cephalic vein lumen diameter by ultrasound < 2.0 mm with a tourniquet, lack of continuity of the cephalic vein with the subclavian vein, central venous stenosis or occlusion, and treatment with any investigational agent within 30 days or investigational antibody therapy within 90 days of signing the informed consent document."
0,The analysis of key outcomes was repeated on an as-treated basis as validation and for sensitivity testing.
3,Patients were at least 18 years of age with chronic kidney disease and were either receiving maintenance hemodialysis or were expected to initiate maintenance hemodialysis within 3 months.
0,Moderate to high test-retest reliability was found respectively for the Physical Activity subscale (ICC = 0.72 to 0.90) and the Work subscale (ICC = 0.8 to 0.91) [31].
3,Exclusion criteria were alpha 1-antitrypsin deficiency and suspected ipsilateral outflow vein or central vein lumen stenosis or occlusion.
0,"A sample of another 55 patients from the Brownstone outpatient clinic in Hartford Hospital (Hartford, CT, USA) constituted the external ‘validation cohort’, which was used for testing validity of the developed pharmacogenetic model."
5,"Immediately after creation of the AVG, 2.5 mL of PRT-201 or placebo solution was delivered by the surgeon as a series of drops over 10 minutes to the exposed graft-vein anastomosis and the adjacent outflow vein."
0,"The study was conducted in accordance with the Declaration of Helsinki, and approval by the ethics committee of the Ärztekammer Nordrhein was obtained."
5,Drug application was followed by lavage of the surgical site with saline for 1 minute.
0,For a more detailed description see the study protocol paper [16].
4,All data will be retrieved from the electronic medical database and collected on Clinical Research File sheets.
0,The study was not registered because patient enrollment preceded development of major public trial registries.
4,Three-minute long video files of the ICGA will be stored on a computer and analyzed with AMIDE ROI software (http://amide.sourceforge.net).
0,"To increase response rates, a £20 incentive was offered to each participant who returned the first questionnaire [25,26]."
1,"To compare the efficacy of bLf treatment vs. the Italian ferrous sulfate one, usually applied worldwide as standard treatment, in the management of anemia and AI in pregnant and non-pregnant women affected by minor β-thalassemia and HT, respectively, a monocentric interventional clinical study has been conducted."
0,It was designed to assess the effect of vildagliptin (100 mg/day b.i.d.) on endothelial function in patients with T2DM and hypertension compared to glibenclamide (5–20 mg/day depending on glycemic control).
1,"In addition, the efficacy of bLf oral administration was also carried out on anemic pregnant women suffering from different pathologies as epilepsy, insulin resistance diabetes type 2, Crohn's disease, hypertension and HT (twin pregnancies)."
0,All patients with non-valvular AF aged >18 years and with a follow-up of at least 1 year were included in this prospective study.
16,Statistical analysis was carried out using the ANOVA test.
0,This is standard procedure in smoking cessation studies.
16,"P-values has been obtained comparing before and after 30 days of each treatment the number of RBCs, the concentration of Hb, TSI, sFtn, IL-6 and hepcidin."
0,"The study was initiated by the investigators and conducted according to the ethical guidelines of the 1964 Declaration of Helsinki, as revised in 2002."
1,The study has a cross-sectional design.
0,Outcome and medical data continued to be collected and assessed for intervention arm participants despite an inability to remain on ß-blocker therapy for the study duration.
4,Psychiatric health care services in Norway are publicly funded and the hospitals have catchment area responsibilities.
0,"After providing informed consent, patients were assessed at home and their eligibility determined by a research assistant."
4,From 2003 to 2012 data were collected from 17 psychiatric hospitals and outpatient clinics collaborating in the Bipolar Research And Innovation Network Norway (BRAIN) study (Morken et al. 2009).
0,"Patients were allowed to continue on the same or a lower dose of NSAIDs during the study, as compared to their treatment before inclusion in the study."
16,Due to the non-normal distribution of the data we report data as median and interquartile range (IQR) and depict data as box plots.
0,"During monthly calls, RCs solicited information from sites on changes in staffing, data collection, and client services (including funding, referrals, budget, and case management)."
16,"We compared groups using the Mann-Whitney U test, considering a p value < 0.05 significant."
0,The review also highlighted areas for further work.
5,All patients accrued will be treated with ablative techniques (e.g.
0,"Brachial artery diameters were analyzed by commercially available software (Brachial Analyzer, Medical Imaging Application, Iowa City, IA)."
5,SABR or surgery) to all sites of active metastatic disease.
0,"Mouse tissue slides underwent histological analysis with elastic Van Gieson staining and immunohistochemistry for α‐smooth muscle actin (α‐SMA), TGF‐β1, TGF‐β2, Mac‐2, Mac‐3, leptin, and Ki‐67."
3,"The sample included community advisory board members (CAB); healthcare providers (henceforth “providers”); and patients registered with an urban primary HIV clinic in Kampala, Uganda, an area that is largely representative of other areas in the capital and includes lower-income market areas as well as upscale shopping areas."
0,The study background and methods have been published [16].
16,"Using Dixon and Massey’s methodology and equation, the ED50 was calculated using the series of up and down sequentially allocated doses."
0,The patients aged less than 85 years and diagnosed primary osteoarthritic knees were included.
16,"Amongst patient for whom the drug was effective, the median time to effectiveness was calculated."
0,"Even today, DDDR pacemakers without ventricular pacing minimization algorithms are still used in sinus node disease, and some reduction of RV pacing—even if less pronounced than that achievable with MVP—is obtained by programming a long AV delay or with other algorithms based on extension of the AV interval.The occurrence of each endpoint was reported by study investigators according to pre-defined conditions and was then adjudicated by an independent Event Adjudication Committee according to the guidelines.15"
6,The primary endpoint was to evaluate late (cutaneous and subcutaneous) toxicity.
0,"The suspension was prepared by manually pushing through a 22 gauge syringe coupling piece (3038068 Omnilabo International, Breda, The Netherlands) at +20C° for twenty up and down strokes."
6,"Secondary endpoints were acute toxicity, LC, and survival."
0,All participants in the NMES-robot group could grasp the sponge and conduct the horizontal arm transportation with the affected limb in the evaluation from the first session.
3,"The subjects who were included in the trial at the Pediatric Intensive Care Unit (PICU) had to be undergoing cardiac surgery at the IC/FUC of Rio Grande do Sul, were considered infants with an age of 0 (minimum age) to 4 years (maximum age), and had a chest X-ray exam requested by doctors."
0,"Breakpoint Tables for Interpretation of MICs and Zone Diameters, Version 1.3, 2011."
3,"The individuals not admitted for the trial were pediatric patients with scans that failed to comply with the technical quality criteria for diagnostic radiographic images proposed by the CEC, as evaluated by the radiologist responsible for that exam report [8]."
0,The two conditions will also be compared on body weight and secondary outcomes at the 2-year follow-up relative to baseline to examine long-term maintenance.
